AAOS Final Program 2014
AAOS Final Program 2014
AAOS 2014
STABILITY IN MOTION. When it comes to knee replacement, were with you every step of the way.
AAOS Annual Meeting Booth 4049 March 1214, 2014
Annual Meeting
Introducing
Rotating
Platform
*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc. DePuy Synthes Joint Reconstruction, a division of DOI 2014
2014FinalProgram-8.5x10.875.indd 1
1/31/14 1:44 PM
FINAL PROGRAM
UN I T E
PLATFORM SHOULDER SYSTEM
Every shoulder procedure provides unique challenges to the surgeon. That is why DePuy Synthes
At DePuy Synthes Companies, our solutions are defined by the people who inspire
Joint Reconstruction* created the GLOBAL UNITE Platform Shoulder Arthroplasty System,
a next generation platform system to provide the surgeon Principled Adaptability within the
providing the procedural support and services to help deliver more efficient outcomes.
Operating Room. When it comes to shoulder arthroplasty, were with you every step of the way.
When it comes to orthopaedic solutions, were with you every step of the way.
*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc. DePuy Synthes Joint Reconstruction, a division of DOI 2014
2014FinalProgram-8.5x10.875.indd 4
1/31/14 1:44 PM
2014FinalProgram-8.5x10.875.indd 2
1/31/14 2:47 PM
Orlando, FL
Henderson, NV
Henderson, NV
Long Beach, CA
Chicago, IL
Chicago, IL
Atlanta, GA
Denver, CO
Atlanta, GA
Henderson, NV
Annecy, France
Annecy, France
Annecy, France
Annecy, France
Chicago, IL
To register for a course contact your Joint Reconstruction Sales Consultant or send an
email to the Professional Education Team at [email protected]
*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc. DePuy Synthes Joint Reconstruction, a division of DOI 2014
2014FinalProgram-8.5x10.875.indd 3
1/31/14 1:44 PM
Table of Contents
General
4
4
4
5
6
8
9
10
14
17
18
22
31
34
Opening Ceremony
Ceremonial Meeting
Guest Speakers
Welcome
Board of Directors
Business Meetings
AAOS Award Presentations
Daily Schedule
Important Information
CME Credit
Disclaimer
FDA Statement
Meeting Objectives
Hotel Map
Hotel Shuttle Bus Routes
General Meeting Information
Advocacy Booth
Allied Organization Displays
Housing
Job Placement Center
Offices
Planning Committees
Registration
Resource Center
Safety
Social Program
Specialty Day
Educational Programs
46 Orthopaedic Review Course
47 Faculty Development Sessions
48 Tuesday Highlights
50 Poster Tours
51 Symposia Webcast
Instructional Courses, Symposia &
Paper Presentation
52 Tuesday, March 11
82 Wednesday, March 12
126 Thursday, March 13
171 Friday, March 14
217 Orthopaedic Video Theater
230 Scientific Exhibits
241 Posters
306 Nursing and Allied Health Program
Disclosures
311 Disclosures
Technical Exhibits
360
362
363
385
Participant Index
445 Index
General
Special Events
Special Events
Special Events
Opening Ceremony
Business Meetings
Wednesday, March 12
4:00 5:30 PM
Ceremonial Meeting
Thursday, March 13, 10:00 AM
Joshua J. Jacobs, MD
Presidential Remarks
The Three Curses
Redux
Welcome to France as the Guest Nation
Recognition of Industry Donors
Chief Executive Officer Report
Kappa Delta & OREF Awards
Frederick M. Azar, MD
Incoming Presidential
Address
Building A Bigger Box
David D. Teuscher, MD
Incoming First Vice
Presidential Remarks
Relationships that
Matter Most
Humanitarian Award
Diversity Award
William W. Tipton, Jr, MD, Leadership Award
Welcome
Welcome
Welcome to New Orleans for the American Academy of Orthopaedic Surgeons 2014 Annual Meeting!
We are glad youre here to experience the new ideas and discoveries the very best in orthopaedic
education, research and technology. Your participation and support is essential to the Academys success.
Board of Directors
Board of Directors
Joshua J. Jacobs, MD
President
Frederick M. Azar, MD
First Vice-President
Chicago, Illinois
Memphis, Tennessee
David D. Teuscher, MD
Second Vice-President
Andrew N. Pollak, MD
Treasurer
Beaumont, Texas
Baltimore, Maryland
John R. Tongue, MD
Past-President
Wilford K. Gibson, MD
Chair
Board of Councilors
Tualatin, Oregon
John J. McGraw, MD
Chair-Elect
Board of Councilors
David J. Mansfield, MD
Secretary
Board of Councilors
El Paso, Texas
David C. Templeman, MD
Chair-Elect
Board of Specialty
Societies
Orange, California
Minneapolis, Minnesota
Board of Directors
William J. Best
Lay Member
Jackson, Wyoming
Annunziato Amendola, MD
Member-at-Large
Matthew B. Dobbs, MD
Member-at-Large
Todd A. Milbrandt, MD
Member-at-Large
Lexington, Kentucky
Karen L. Hackett,
FACHE, CAE
Chief Executive Officer
(Ex-Officio)
Rosemont, Illinois
Board of Directors
David A. Halsey, MD
Secretary
Board of Specialty
Societies
Business Meetings
Business Meetings
Business Meetings
Business Meetings
Paul Levin, MD
Edward A. Toriello, MD
10 Daily Schedule
Daily Schedule
Tuesday, March 11
Education
Time
Instructional Courses
8:00 10:00 AM
8:00 11:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
8:00 10:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
Posters
Academy Hall BC
8:00 AM 6:00 PM
Scientific Exhibits
Academy Hall D
8:00 AM 6:00 PM
Academy Hall E
8:00 AM 6:00 PM
Great Hall B
8:00 11:00 AM
Rivergate Room
8:00 AM 5:00 PM
Room R06
8:15 AM 5:45 PM
Great Hall B
12:00 5:30 PM
Room 345
1:30 4:30 PM
Room 353
1:30 5:30 PM
General
Time
Ready Rooms
6:30 AM 6:00 PM
Registration Physician
Lobby B, E, & H
7:00 AM 6:00 PM
Lobby A
7:00 AM 6:00 PM
Playground Build
7:00 AM 2:30 PM
Academy Hall B
8:00 AM 6:00 PM
Resource Center
Academy Hall E
8:00 AM 6:00 PM
Lobby G
8:00 AM 6:00 PM
Lobby G
8:00 AM 6:00 PM
Lobby G
8:00 AM 6:00 PM
Lobby G
8:00 AM 6:00 PM
Lobby G
8:00 AM 6:00 PM
Education
Time
Posters
Academy Hall BC
7:00 AM 6:00 PM
Scientific Exhibits
Academy Hall D
7:00 AM 6:00 PM
Academy Hall E
7:00 AM 6:00 PM
Instructional Courses
8:00 10:00 AM
8:00 11:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
8:00 10:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
Room R06
8:15 AM 5:45 PM
Exhibit Hall
Time
Technical Exhibits
Halls B-I
9:00 AM 5:00 PM
9:00 AM 5:00 PM
WEDNESDAY, MARCH 12
Daily Schedule
11
9:00 AM 5:00 PM
9:30 AM 4:15 PM
10:30 AM 4:15 PM
3:30 4:00 PM
General
Time
Ready Rooms
6:30 AM 6:00 PM
Registration Physician
Lobby B, E, & H
7:00 AM 6:00 PM
Lobby A
7:00 AM 6:00 PM
Academy Hall B
7:00 AM 6:00 PM
Resource Center
Academy Hall E
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Room 260
9:00 11:00 AM
Room 349
1:00 PM
Room 349
1:30 PM (estimated)
La Nouvelle Ballroom
4:00 5:30 PM
Time
Opening Ceremony
*No educational activities are scheduled.
THURSDAY, MARCH 13
Education
Posters
Academy Hall BC
7:00 AM 6:00 PM
Scientific Exhibits
Academy Hall D
7:00 AM 6:00 PM
Academy Hall E
7:00 AM 6:00 PM
Room R03
7:30 AM 12:00 PM
1:30 PM 6:00 PM
Instructional Courses
8:00 10:00 AM
8:00 11:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
8:00 10:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
Exhibit Hall
Time
Technical Exhibits
Halls B-I
9:00 AM 5:00 PM
9:00 AM 5:00 PM
9:00 AM 5:00 PM
9:30 AM 4:15 PM
9:30 AM 4:15 PM
Halls B-I
12:30 1:30 PM
3:30 4:00 PM
General
Time
Ready Rooms
6:30 AM 6:00 PM
Registration Physician
Lobby B, E, & H
7:00 AM 6:00 PM
Daily Schedule
12 Daily Schedule
Daily Schedule
Lobby A
7:00 AM 6:00 PM
Academy Hall B
7:00 AM 6:00 PM
Resource Center
Academy Hall E
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Business Meetings
La Nouvelle Ballroom
9:00 AM
Ceremonial Meeting
La Nouvelle Ballroom
10:00 AM
Room 349
10:30 AM 12:30 PM
La Nouvelle Ballroom
11:00 AM
Education
Time
Academy Hall BC
7:00 AM
Posters
Academy Hall BC
7:00 AM 6:00 PM
Scientific Exhibits
Academy Hall D
7:00 AM 6:00 PM
Academy Hall E
7:00 AM 6:00 PM
Room R03
7:30 AM 12:00 PM
1:30 PM 6:00 PM
Instructional Courses
8:00 10:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
8:00 10:00 AM
10:30 AM 12:30 PM
1:30 3:30 PM
4:00 6:00 PM
Great Hall A
8:00 AM 5:35 PM
Exhibit Hall
Time
Technical Exhibits
Halls B-I
9:00 AM 4:00 PM
9:00 AM 4:00 PM
9:00 AM 4:00 PM
9:30 AM 3:15 PM
9:30 AM 3:15 PM
10:00 10:30 AM
Halls B-I
12:30 1:30 PM
FRIDAY, MARCH 14
Beignet Social
2:00 3:30 PM
General
Time
Ready Rooms
6:30 AM 6:00 PM
Registration Physician
Lobby B, E, & H
7:00 AM 6:00 PM
Lobby A
7:00 AM 6:00 PM
Academy Hall B
7:00 AM 6:00 PM
Resource Center
Academy Hall E
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Daily Schedule
13
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Lobby G
7:00 AM 6:00 PM
Education
Time
Specialty Day
See page 34
Times vary
Posters
Academy Hall BC
7:00 AM 3:00 PM
Scientific Exhibits
Academy Hall D
7:00 AM 3:00 PM
Academy Hall E
7:00 AM 3:00 PM
General
Time
Ready Rooms
6:00 AM 5:30 PM
Registration Physician
Lobby B, E, & H
6:30 AM 5:30 PM
Lobby A
7:00 AM 12:00 PM
Academy Hall B
7:00 AM 3:00 PM
Resource Center
Academy Hall E
7:00 AM 3:00 PM
SATURDAY, MARCH 15
Ad-FinalProgram2014.indd 1
11/18/2013 11:14:18 AM
Daily Schedule
General
CME Credit
Checked In OR
Register at the
Meeting on:
Maximum
Daily Credit
Maximum
Meeting Credits
Tuesday, March 11
Up to 10 Credits
35 Credits
Wednesday, March 12
Up to 8.5 Credits
25 Credits
Thursday, March 13
Up to 8.5 Credits
16.5 Credits
Friday, March 14
Up to 8 Credits
8 Credits
CME Certificates
The AAOS transcript system will not allow you to claim
available CME credit before you officially check in to the
meeting. Therefore it is important to check in as soon as you
arrive. Physicians should claim only the number of credits for the
learning activities at the Annual Meeting in which they actively
participated.
The grid below outlines the types of activities that are available
at the Annual Meeting and notes which qualify for AMA PRA
Category 1 Credit:
Activity
Yes
Yes
Yes
Instructional Courses
Yes
Yes
Yes
Papers
Yes
Yes
Yes
Yes
Specialty Day
Yes
Symposia
Yes
Yes
Yes
Ask an Expert
No
No
Technical Exhibits
No
2014 American Academy of Orthopaedic Surgeons
Disclaimer
The material presented at the Annual Meeting has been made
available by the American Academy of Orthopaedic Surgeons
for educational purposes only. This material is not intended to
represent the only, nor necessarily best, method or procedure
appropriate for the medical situations discussed, but rather is
intended to present an approach, view, statement or opinion
of the faculty which may be helpful to others who face similar
situations. The AAOS disclaims any and all liability for injury or
other damages resulting to any individual attending a session and
for all claims which may arise out of the use of the techniques
demonstrated therein by such individuals, whether these claims
shall be asserted by a physician or any other person.
Reproduction Policy
The Academy reserves any and all of its rights to
materials presented at the Annual Meeting, including
Posters and Scientific Exhibits. Reproductions of any
kind, by any person or entity, without prior written
permission from the Academy, are strictly prohibited.
Prohibited reproductions include, but are not limited to,
audiotapes, videotape, and/or still photography. Persons violating
this policy may have their badge confiscated and be escorted from
the meeting.
No unapproved surveys, handouts or literature may be distributed
at the meeting.
FDA Statement
Some drugs or medical devices demonstrated at the Annual
Meeting have been cleared by the FDA for specific purposes only
or have not been cleared by the FDA. The FDA has stated that it is
the responsibility of the physician to determine the FDA clearance
status of each drug or medical devices he or she wishes to use in
clinical practice. Academy policy provides that off label uses
of a drug or medical device may be described in the Academys
CME activities so long as the off label use of the drug or medical
2014 American Academy of Orthopaedic Surgeons
Global Objectives
Develop and refine a perspective on the broad range of
orthopaedic knowledge, care and surgical practice.
Expand and integrate an understanding of the scientific and
clinical tenets of orthopaedic surgery to better prevent and treat
musculoskeletal disease.
Develop an understanding of economic and practice
management challenges that can lead to strategies that protect
continued access to care for patients and viability of the
profession.
Provide a forum to strengthen professional relationships and
develop networks that lead to better patient care, individual
surgeon career satisfaction, and a more robust profession as a
whole.
Instructional Objectives
To facilitate a personalized educational experience through a
comprehensive offering of instructional courses, symposia, and
scientific presentations.
Support a forum for discussion of current issues in orthopaedics
including patient safety, advocacy, practice management,
technology, and culturally competent care.
Offer complementing formats to facilitate career-long education
that meets the expectations of patients, colleagues and
Maintenance of Certification.
To provide a forum for the presentation of basic and clinical
research with current as well as future potential applications
in the management of patients with musculoskeletal disease or
injury.
Learner Objectives
Synthesize a basis for the practice of delivering evidence-based,
cost effective orthopaedic care.
Integrate current basic science, translational research, and stateof-the art procedures and technology into clinical practice.
Become more informed and involved in advocacy issues related
to orthopaedics.
To provide a forum for resident education on current clinical
practice, relevant basic science, practice management, and
advocacy issues in preparation for careers as competent and
ethical orthopaedic surgeons.
Private Meeting
The AAOS 2014 Annual Meeting is a private meeting. The AAOS
reserves the right to control space and ask people to leave the
meeting who are not qualified to attend or who cause disruptions,
at AAOS sole discretion.
General
15
Technology
16 Technology
Electronic Handouts
Handouts for all Instructional Courses were
available electronically two weeks prior to the
meeting if you have purchased a ticket for a course.
Beginning with the 2015 Annual Meeting handouts
will only be available electronically.
and submit your evaluation form for the sessions you attended.
Also, Poster Tour evaluations can be completed at the ePoster and
eScientific Exhibits Kiosks or by QR code.
New
Internet Connections stations are located throughout
the Morial Convention Center and offer internet links
to the most used Email websites, 2015 Annual Meeting Member
Housing, the Exhibitor Directory, and Flight Check-in. These new
all-in-one stations allow you to utilize key connections not just
Emails.
Proceedings
Be sure to visit our website to view the 2014 Annual Meeting
Proceedings. A website will be available to view the Proceedings
on a PC, tablet, or mobile device at www.aaos.org/proceedings.
Webcasting
View 13 symposia webcasts as they are simulcast live from the
Annual Meeting. Choose from a variety of topics addressing joint
replacement procedures including shoulder, hip, and sports. Did
you miss the live simulcasts? View the webcasts anytime 24 hours
after the start of the symposium through Sunday, March 23. Both
the AAOS.org/annual website and the AAOS Mobile Meeting
Guide app provide access to the webcasts.
AAOS Members and AAOS Residents: Free
Non-Members: $199 unlimited viewing through March 23
Evaluations
Instructional Courses and Symposia evaluations can be accessed
through the AAOS Mobile Meeting Guide App available for your
Smartphone or internet connected device. You can easily complete
2014 American Academy of Orthopaedic Surgeons
Hotel Map
DOWNTOWN NEW ORLEANS ACCOMMODATIONS LOCATOR
17
AAOS 2
Hotel Legend
24
37
47
50 9
46
61
21
44
16
11
29
15
35
26
49
48
13
62
10
23
28
32
34
55
51
40
38
41
33
31
59
25
57
42
54
27
60
12
58
56
53
36
19
43
14
45
22
63
52
20
39
30
17
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Ambassador Hotel
Astor Crowne Plaza
Best Western Plus St. Christopher
Bienville House Hotel
Bourbon Orleans
Cotton Exchange
Country Inn & Suites
Courtyard by Marriott
Convention Center
Courtyard Iberville
Courtyard French Quarter
Dauphine Orleans
Doubletree New Orleans
Drury Inn & Suites
Embassy Suites
Four Points by Sheraton
French Quarter Chateau
LeMoyne-A Holiday Inn Hotel
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
La Quinta Inn
Le Pavillon Hotel
Loews New Orleans
Maison Dupuy Hotel
New Orleans Marriott
New Orleans Marriott
Convention Center
Omni Royal Crescent
Omni Royal Orleans
Queen & Crescent Hotel
Renaissance Arts
Renaissance Pere Marquette
Residence Inn
The Ritz-Carlton
Roosevelt New Orleans
Royal St. Charles
Royal Sonesta
The Saint Hotel
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
Ambassador Hotel
Astor Crowne Plaz
Best Western Plus
Bienville House Ho
Bourbon Orleans
Cotton Exchange
Country Inn & Suit
Courtyard by Marri
Center
9. Courtyard Iberville
10. Courtyard French
11. Dauphine Orleans
12. Doubletree New O
13. Drury Inn & Suites
14. Embassy Suites
15. Four Points by Sh
16. French Quarter Ch
A Holiday Inn Hote
17. Hampton Inn & Su
18. Hampton Inn & Su
French Quarter Ar
19. Harrahs New Orle
20. Hilton Garden Inn
21. Hilton Garden Inn
22. Hilton New Orlean
23. Hilton New Orlean
24. Holiday Inn Super
25. Hotel Le Marais
26. Hotel Mazarin
27. Hotel Modern
28. Hotel Monteleone
29. Hyatt French Qua
30. Hyatt Place
31. Intercontinental N
32. International Hous
33. JW Marriott
34. La Quinta Inn
35. Le Pavillon Hotel
36. Loews New Orlea
37. Maison Dupuy Ho
38. New Orleans Marr
39. New Orleans Marr
Center
40. Omni Royal Cresc
41. Omni Royal Orlea
42. Queen & Crescen
43. Renaissance Arts
44. Renaissance Pere
45. Residence Inn
46. The Ritz-Carlton
47. Roosevelt New Or
48. Royal St. Charles
49. Royal Sonesta
50. The Saint Hotel
51. Sheraton New Orl
52. SpringHill Suites
53. Staybridge Suites
54. St. James Hotel
55. The Blake Hotel
56. W New Orleans
57. W New Orleans F
58. Westin Canal Plac
59. Whitney Wyndham
60. Windsor Court
61. Wyndham Baronn
62. Wyndham French
63. Wyndham Riverfro
Hotel Map
1.
2.
3.
4.
5.
6.
7.
8.
Shuttle Routes
Hotel Shuttle
Airport Shuttle
No Service
8:00 AM 6:30 PM
Saturday
March 15
6:30 AM 6:30 PM
8:00 AM 6:30 PM
Route #
Hotel
Boarding Location
at Convention
Center
Route 8
Ambassador Hotel
Lobby I
Route 5
Lobby I
Route 4
Lobby D
Route 3
Bienville House
Lobby D
Route 2
Bourbon Orleans
Lobby D
Route 2
Chateau LeMoyne
Lobby D
Route 6
Cotton Exchange
Lobby I
Lobby D
Courtyard Iberville
Lobby I
Walk
Route 4
Lobby D
Route 2
Dauphine Orleans
Lobby D
Route 4
Lobby D
Route 6
Lobby I
Embassy Suites
Walk
Four Points
Lobby D
Walk
Route 4
Route 5
Route 1
Route 5
Lobby I
Route 8
Lobby I
Route 6
Lobby I
Walk
Route 7
Lobby I
Route 6
Lobby I
Route 7
Hotel InterContinental
Lobby I
Route 8
Hotel Modern
Lobby I
Route 3
Hotel Monteleone
Lobby D
Route 5
Lobby I
Walk
Route 4
International House
Lobby D
Route 4
JW Marriott
Lobby D
Route 7
La Quinta
Lobby I
Route 1
Le Marais
Lobby D
Route 6
Le Pavillon
Lobby I
Route 8
Lobby D
Walk
19
Boarding Location
at Convention
Center
Route 2
Masion Dupuy
Lobby D
Route 1
Mazarin
Lobby D
Route 8
Lobby I
Breezeway Entrance
Route 3
Lobby D
Route 4
Lobby D
Route 2
Lobby D
Route 7
Lobby I
Renaissance Arts
Walk
Lobby I
Residence Inn
Walk
Route 5
Lobby I
Route 6
Roosevelt
Lobby I
Route 1
Royal Sonesta
Lobby D
Route 4
Lobby D
Route 4
Lobby D
Walk
Lobby D
Route 6
Route 4
St. James
Route 8
Staybridge Suites
Lobby I
Route 7
The Blake
Lobby I
Route 5
The Saint
Lobby I
Route 1
W French Quarter
Lobby D
Route 7
W New Orleans
Lobby I
Route 3
Lobby D
Route 7
Whitney Wyndham
Lobby I
Route 7
Windsor Court
Lobby I
Route 6
Lobby I
Route 5
Lobby D
Wyndham Riverfront
Walk
= Passenger Pickup
=Walk to Hotel
= Wheel Chair Accessible Vehicles: Call (504)428-2237 and allow (1) Hour for service.
EXPERIENCE
The very best in orthopaedic education, research, and technology
2015 Annual Meeting
March 24 28
Las Vegas, Nevada
Shuttle Routes
Hotel
General Information
Mathias P. G. Bostrom, MD
New York, NY
ORS Representative
Joseph T. Moskal, MD
Roanoke, VA
Exhibits Chair
Jason J. Scalise, MD
Phoenix, AZ
Member-At-Large
Nathan W. Skelley, MD
St. Louis, MO
Resident Member
Francois D. Lalonde, MD
Orange, CA
Leadership Fellowship
Program Member
Ruth L. Thomas, MD
Little Rock, AR
BOS Representative
Guido Marra, MD
Chicago, IL
International Committee
Representative
IMPROVING LIVES
by supporting excellence in
orthopaedic research
Am I going to be
able to walk again
without help?
Amanda Marshall, MD
hears this question nearly
every day in her office.
Amanda Marshall, MD
www.oref.org/donate14
Orthopaedic Research and Education Foundation
6300 North River Road, Suite 700 | Rosemont, Illinois 60018-4261
(847) 698-9980 | www.oref.org
2014 Orthopaedic Research and Education Foundation. All Rights Reserved.
1090-006
General
2013-14
Annual Meeting
Committee
21
22 General Information
Safety
General
Emergency Numbers
Fire/Police Emergency: In case of an Emergency please use
any house phone located throughout the Morial Convention
Center and dial extension 3040.
Morial Convention Center Security Dispatch (24 hours):
(504)582-3040
City Police Emergency: 911
City Police Non-Emergency: (504)821-2222
Poison Control: (800)222-1222 (Nationwide)
Nearest Hospitals
New Orleans Urgent Care
900 Magazine Street, (504)552-2433
0.3 miles
1.2 miles
Drug Stores
Pharmacy Hours:
Monday Friday.............................8:00 AM 8:00 PM
Saturday..........................................9:00 AM 6:00 PM
Sunday...........................................10:00 AM 6:00 PM
AAOS Now
The Daily Edition of AAOS Now, the
official newspaper of the AAOS Annual
Meeting, is published Tuesday through
Friday. Pick up a copy from the newspaper
racks located throughout the convention
center and on the shuttle buses. Each issue
contains coverage of events and scientific
presentations, news items, and reports on
guest speakers and award winners, along
with late-breaking news. Its your source
for news during the Annual Meeting!
Academy Lounges
ADA Needs
The Morial Convention Center is ADA compliant. In
accordance with the ADA, they are responsible for
permanent premises access accommodations, such
as, but not limited to, elevator standards, door width
standards, and restroom accessibility. It is the groups
responsibility to provide non-permanent accessibility
requirements, such as, but not limited to, hearing-assisted or
visually-assisted devices, and temporary seating accessibility and/
or interpreters. Wheelchairs are available through the following
company:
The UPS Store Mobility Scooter Rental
(504)670-8941 or www.theupsstorelocal.com/6216
Advocacy Booth
General Information
Airline Information
American Airlines...................................................(800)433-7300
Delta.......................................................................(800)221-1212
United Airlines........................................................(800)864-8331
CorpTrav................................................................(800)211-8016
Audio Sales
Badge Information
Everyone who attends the AAOS Annual Meeting must register.
Badges are required for entrance to the Exhibit Halls and to
attend all other official AAOS sessions. The following badge
holder and badge stock colors have been issued:
Badge Holders
Yellow....... AAOS Fellow
Tan............ AAOS Members, Resident/Candidate Member,
International Members
Blue........... Non-Member Physician, International Attendee, and
U.S. Residency, U.S. Fellowship
Gray.......... U.S. Allied Health
Clear......... Social Program
Black......... AAOS Staff
Pink.......... Press
Badge Stock Colors
Lavender... Social Program
Orange...... Commercial Representative
Green........ Technical Exhibitor
Cash Station/ATM
General
23
24 General Information
General
Whitney Bank
610 Poydras St, (504)586-7380
Branch Hours of Operation:
Monday - Friday.............................................9:00 AM 5:30 PM
ATM Hours of Operation:
Monday - Sunday................................................... Open 24 Hours
Charging Stations
Stop by the electrical plug-in stations to recharge your cell phones,
laptops, and tablets.
Morial Convention Center, Lobby B and G
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 5:30 PM
Morial Convention Center, Academy Hall B and Academy Hall E
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 3:00 PM
Morial Convention Center, Hall G and Hall I
Hours of Operation:
Wednesday Thursday................................9:00 AM 5:00 PM
Friday...........................................................9:00 AM 4:00 PM
Children
The following guidelines have been approved for the Annual
Meeting. Only children 16 or over will be admitted to the
educational programs, including the exhibit hall.
Opening Ceremony
Posters
Scientific Exhibits
Focus Groups
CME Kiosks
Print your CME certificate for the Annual Meeting and
participating Specialty Societies.
Morial Convention Center, Academy Hall E
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 3:00 PM
Focus Group discussions are being held in rooms 211 and 213
on Wednesday and Thursday. Those who have been invited to
observe the discussion groups, please meet inroom 212. For
additional details please reference the AAOS Annual Meeting
Mobile Meeting Guide App. Please note that these are invite-only
events.
Hours of Operation:
Wednesday........................................................ 12:00 1:30 PM
Thursday.......................... 6:00 7:30 AM and 12:00 1:30 PM
Food Service
The Morial Convention Center has ample food and beverage
concession areas to satisfy any appetite. Food and beverage
schedule is subject to change. Detailed menu and location
information is available at the Welcome & Information Booths
located throughout the Morial Convention Center.
AAOS Bistro located in Hall E-F with an all-inclusive buffet lunch
and available table reservations, Wednesday Friday, from 11:00
AM 2:30 PM. Tickets can be purchased in Lobby G and the
back of Hall F.
General Information
Handout Sales
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 5:30 PM
Morial Convention Center, Academy Hall C and E
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 3:00 PM
Morial Convention Center, Hall E, Near Booth 4563
Hours of Operation:
Wednesday Thursday................................9:00 AM 5:00 PM
Friday...........................................................9:00 AM 4:00 PM
Image Capture
The Academy is videotaping certain portions of the Annual
Meeting. The tapes will be used for educational purposes and/or
may be sold alone or in connection with other AAOS products.
Please note that by attending the Annual Meeting, your image
and/or voice may be captured and included as part of this event.
General
25
26 General Information
General
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 5:30 PM
Internet Connections
These new all-in-one stations allow you to utilize the following
key connections:
2014 Exhibitor Directory
2015 Member Housing
Email sites
Flight Check-in
Morial Convention Center, Lobby A, B, D, G, and H
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 5:30 PM
Morial Convention Center, Academy Hall C and E
Hours of Operation:
Tuesday........................................................8:00 AM 6:00 PM
Wednesday Friday.....................................7:00 AM 6:00 PM
Saturday.......................................................7:00 AM 3:00 PM
Morial Convention Center, Hall E, Near Booth 4563
Hours of Operation:
Wednesday Thursday................................9:00 AM 5:00 PM
Friday...........................................................9:00 AM 4:00 PM
Non-Smoking Policy
The AAOS Annual Meeting is a non-smoking meeting. Smoking
is not permitted in public areas such as restaurants, hotel lobbies,
the Morial Convention Center, or Louis Armstrong International
Airport (MSY).
General Information
To attend any of the Nursing and Allied Health courses, you need
to register for the AAOS Annual Meeting and purchase a ticket
for each course. The Annual Meeting on-site registration fee is
$250.
Tickets for NUR courses are $140 per course. Tickets for the
CAST1 and CAST2 courses are $220. A complete listing of the
courses can be found on pages 306-309.
Offices
Room 238
Room 235
Room 341
Room 337
Room 336
Room 338
Room 228
Room 252
(504)670-6025
(504)670-6018
(504)670-6037
(504)670-6044
(504)670-6047
(504)670-6011
(504)670-6013
Parking
The Morial Convention Center is located at 900 Convention
Center Blvd., New Orleans, LA, 70130. Parking is available at
the center for a daily fee. Many parking lots have reduced rates
(Early Bird Specials) if you arrive before 9:00 AM. Downtown
businesses and department stores offer free or discounted parking
with minimum purchases. Metered Parking is also available from
8:00 AM to 6:00 PM. You cannot park at bagged meters. Call
Parking Enforcement at (504)826-1880 if you have a question
about parking in New Orleans. DONT GET TOWED - ALWAYS
READ THE SIGNS BEFORE YOU PARK!
Planning Committees
Playground Shuttle
Private Meeting
The AAOS 2014 Annual Meeting is a private meeting. The AAOS
reserves the right to control space and ask people to leave the
meeting who are not qualified to attend or who cause disruptions,
at AAOS sole discretion.
Proceedings
Be sure to visit our website to view the Proceedings on a PC,
tablet, or mobile device at www.aaos.org/proceedings.
Public Transportation
New Orleans is a city remarkably compact and easy to navigate.
Many of the citys attractions, accommodations, and event venues
are within walking distance of each other. It only costs $1.25 to
take an RTA bus or one of the citys famed streetcars, which travel
the Riverfront and Canal Street. The RTA Customer Care Rideline,
(504)248-3900, is available weekdays 8:00 AM to 4:00 PM for live
assistance with routes and schedules. To access fare information,
detailed maps, and schedules online, go to www.norta.com.
General
27
28 General Information
General
Ready Rooms
Redemption Centers
Refund Policy
The Academy will not issue refunds on-site during the meeting.
All requests for refunds (registration and/or instructional courses)
must have been received in the Academy office on or before
January 31, 2014.
Registration On-Site
Rental Cars
AAOS has negotiated special rates for rental cars during the
meeting. Car reservations can be made via the AAOS website or
directly with the rental car companies. Call the number below and
mention the discount code listed.
Car Company Meeting Code Phone
Internet
Hertz
CV# 02KS0019 (800)654-2240 www.hertz.com
Avis
J095822
(800)331-1600 www.avis.com
Reproduction Policy
The Academy reserves any and all of its rights to
materials presented at the Annual Meeting, including
Posters and Scientific Exhibits. Reproductions of any
kind, by any person or entity, without prior written
permission from the Academy, are strictly prohibited.
Prohibited reproductions include, but are not limited to,
audiotapes, videotape, and/or still photography. Persons violating
this policy may have their badge confiscated and be escorted from
the meeting.
No unapproved surveys, handouts or literature may be distributed
at the meeting.
Resource Center
Resource Center
8:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 3:00 PM
Restaurant Concierge
Ribbons
If you did not receive your participant/volunteer ribbon(s) in
advance, please stop by the Ribbon Counter located in the Morial
Convention Center, Lobby E. Committee members and Board of
Councilors will receive their ribbons from their liaisons.
Social Media
Follow the AAOS Annual Meeting:
www.facebook.com/AAOSannual
www.twitter.com/AAOSannual
2014 American Academy of Orthopaedic Surgeons
General Information
Social Program
Taxi Service
Many taxis are privately owned, so one will look different from
the other - even those within the same company. Rates from the
airport are $33.00 for 1 or 2 passengers and $14.00 per passenger
for 3 people and up. A taxi ride within the city will cost you $3.50
plus $2.00 per mile and $.25 cents per 40 seconds of waiting
time (stuck in traffic, etc). Theres a $1.00 charge per additional
passenger. Call the Taxi Bureau at (504)565-6272 if you have
questions regarding rates or meter charges.
Technical Exhibits
Webcasting
View 13 symposia webcasts as they are simulcast live from the
Annual Meeting. Choose from a variety of topics addressing
joint replacement procedures including shoulder, hip, and sports.
Did you miss the live simulcasts? View the webcasts anytime 24
hours after the start of the symposium during the Annual Meeting
through Sunday, March 23. Both the AAOS.org/annual website
and the AAOS Mobile Meeting Guide app provide access to the
webcasts for both meeting attendees and virtual participants.
AAOS Members and AAOS Residents: Free
Non-Members: $199 unlimited viewing through March 23
Wi-Fi
General
Specialty Day
29
30 General Information
General
Social Program
Registration
Registration Hours:
Monday..................................2:00 PM 6:00 PM
Tuesday-Friday...................... 7:00 AM 6:00 PM
Saturday............................... 7:00 AM 12:00 PM
Tuesday, March 11
12:30 PM - 3:30 PM
$70
1:00 PM - 4:00 PM
$50
1:30 PM - 4:30 PM
$45
Wednesday, March 12
8:00 AM - 10:00 AM
8:00 AM - 10:00 AM
Complimentary
$70
9:00 AM - 1:00 PM
$75
9:00 AM - 2:30 PM
$95
9:30 AM - 12:30 PM
10:00 AM - 2:30 PM
10:30 AM - 12:30 PM
$70
12:30 PM - 5:30 PM
$85
1:00 PM - 5:00 PM
1:00 PM - 4:30 PM
$130
1:30 PM - 4:30 PM
$125
2:00 PM - 5:00 PM
$55
$135
$65
$60
Thursday, March 13
9:00 AM - 12:00 PM
$70
9:30 AM - 12:30 PM
$45
10:00 AM - 2:30 PM
10:00 AM - 2:00 PM
$90
12:30 PM - 5:30 PM
$85
1:00 PM - 5:00 PM
$65
Attire
$145
1:00 PM - 5:00 PM
1:30 PM - 4:30 PM
$100
1:30 PM - 5:00 PM
$130
$150
$65
Friday, March 14
9:00 AM - 4:00 PM
9:00 AM - 2:30 PM
9:30 AM - 1:00 PM
Tours
10:00 AM - 2:00 PM
$90
12:30 PM - 3:30 PM
$70
1:00 PM - 5:00 PM
$75
1:30 PM - 4:30 PM
$125
2:00 PM - 5:00 PM
$70
9:00 AM - 12:00 PM
$50
9:00 AM - 12:00 PM
$55
$95
$130
Saturday, March 15
Social Program
31
FIND IT at the
AAOS Resource Center
Your Source for Lifelong Orthopaedic Learning
Academy Programs
SAVE
10%
ON ORDERS
OF $300
OR MORE
Publications
Surgical Video
Member Benefits
Web Resources
Practice Management
International Membership
CME
MOC
Examinations
Expert Presentations
OKU
OrthoPortal
eBooks
Coding
ICL Handouts
Patient Education
Tuesday
Wednesday Friday
Saturday
8:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 3:00 PM
www.aaos.org/store
General Information
33
Look for special activities that focus on issues facing our colleagues in France, including
10 special educational posters, remarks and video by the President of the French
Orthopaedic Society (SOFCOT) during the Opening Ceremony, and the following ICLs
with special guest lecturers from France:
I CL 122 - International Perspective on Improving the 10-year Outcome of Total Knee
Arthroplasty: Get It Right the First Time. 11 March 2014, 10:30 AM - 12:30 PM
I CL 147 - International Perspective on Preventing and Dealing with Complications in
Reverse Shoulder Arthroplasty. 11 March 2014, 1:30 PM - 3:30 PM
I CL 151 - International Perspectives on the Masquelet Technique for the Treatment of
Segmental Defects in Bone. 11 March 2014, 1:30 PM - 3:30 PM
Inaugurated in 2005, the AAOS Guest Nation program was established to foster greater
recognition and awareness of the contributions made to the practice of Orthopaedics from
the many nations of the world, and to further enhance the robust international flavor and
excitement of the AAOS Annual Meeting. AAOS is honored to welcome France as the
2014 Guest Nation.
If you are a doctor looking for a new practice opportunity or if you are expanding your orthopaedic staff,
the Placement Service is designed to help you in your search.
Morial Convention Center, Academy Hall B
Convenient Hours:
Tuesday..............................................8:00 AM 6:00 PM
Wednesday - Friday............................7:00 AM 6:00 PM
Saturday.............................................7:00 AM 3:00 PM
General
Help us welcome France as the Guest Nation for the New Orleans meeting. Please stop by
the Guest Nation exhibit located in the Morial Convention Center, Lobby G to learn about
the accomplishments of the French orthopaedic community.
34
Specialty Day
Specialty Day
SATURDAY, MARCH 15
Specialty Day is a day set aside for scientific programs presented by organizations that are members of the Board of Specialty Societies
(BOS). Each society has its own educational program within the Specialty Day Program. The final programs for each society are available
at the individual meeting rooms on Specialty Day.
collaboration on issues
resolution through communications
unity among leaders
Collaborating in the
Science of Patient Care
Sunday, March 16, 2014
ORS 2014 Annual Meeting
Hyatt Regency New Orleans
Make plans to attend the ORS 60th Annual Meeting on Sunday, March 16, when we invite all AAOS
Annual Meeting registrants to take advantage of the opportunity for scientists and orthopaedic surgeons
to collaborate in the science of patient care.
Complimentary Programs:
HOW TO REGISTER:
36
Sponsors
Sponsors
The American Academy of Orthopaedic Surgeons gratefully acknowledges the following companies,
organizations and individuals for their financial support of AAOS programs and projects throughout 2013.
(as of 2/1/14)
Medtronic
MicroPort Scientific Group
National Institute of Arthritis and Musculoskeletal
and Skin Diseases
NYU HJD
Orthopaedic Trauma Association
Otto Bock Healthcare
Pediatric Orthopaedic Society of North America
Pega Medical, Inc.
Scoliosis Research Society
Shriners Hospitals for Children
Sociedad Espaola de Ciruga Ortopdica y
Traumatologa (SECOT)
Stryker Spine
Stryker Trauma
Synthes USA
Wright Medical
2014 American Academy of Orthopaedic Surgeons
Sponsors
37
The Academy would also like to thank the following companies for their support for its 2013 Skills Courses and
international activities by providing essential equipment and supplies:
Accu-Line Products
Acumed
Arthrex, Inc.
ArthroCare
Arthrosurface
Biomet
Biomet Spine
Biomet Sports Medicine
Buxton Biomedical
ConMed Linvatec
DePuy Synthes Joint
Reconstruction
Exactech
FluoroScan Imaging Systems
OrthoPediatrics
Orthosonics
Sloan Medical
Small Bone Innovations, Inc.
Smith & Nephew, Inc.
Stryker Endoscopy
Stryker Instruments
Stryker Joint Preservation
Stryker Spine
Tornier
TriMed, Inc.
Wright Medical Technology
Zimmer
Sponsors
Acumed
Advanced Biologics
Aesculap Implant Systems
Alexandras Playground
American Association of Orthopaedic Executives
American Orthopaedic Foot & Ankle Society
American Shoulder and Elbow Surgeons
American Society for Surgery of the Hand
American Society of Orthopaedic Assistants
American Spinal Injury Association
Association of Residency Coordinators in
Orthopaedic Surgery
Baxano Surgical
Bonutti Technologies
Endo Pharmaceuticals
Richard E. Gayle, MD
Geneva Foundation
Dr. Stuart and Lisa Hirsch
Hospital for Special Surgery
Dr. Stephen and Sonny Hurst
Indonesian Orthopaedic Association
Integra Foundation
J. Robert Gladden Orthopaedic Society
TM
of AAOS 2014
TM
2014
What is Best of AAOS?
The most highly-rated instructional courses, symposia, and
most popular poster tours of the AAOS 2014 Annual Meeting...
Presented in streaming online video for review
and study at your convenience
Customizable from every subspecialty to your
specific interests
These are the most important breakthroughs and new ideas
in orthopaedicsexactly what you need to tap into the latest
thinking and sharpen your practice. See and hear the top
takeaways, lively discussion, and surprising debates, all at
your convenience.
The AAOS Academy Meeting offers so many great
programshow could you see it all? So order Best of
AAOS to go and extend your educational experience.
Select from more than 30 top-rated sessions across all
specialty areas!
Best of AAOS brings you more than 65 hours of the most highly-rated Annual Meeting
programming, ready for streaming online review and study in mid-April and viewable
through April 2016.
bestof.aaos.org
Educational
Programs
40
Educational Programs
Educational Programs
Educational Programs
Orthopaedic Video Theater presents peer reviewed videos and
media programs developed and produced by your colleagues.
Here you are able to observe and study the very latest in
orthopaedic surgical technique. Discover leading edge devices
as well as new techniques and technologies in a wide range of
orthopaedic specialties. Strengthen your knowledge of surgical
anatomy, exposures, treatments, and more.
Also, make plans to attend the Orthopaedic Video Theater, an
intimate setting where you can meet video authors, view programs
as part of the live audience, and participate in question and
answer sessions.
A complete listing of the Orthopaedic Video Theater programs is
listed beginning on page 217.
Proceedings
Access the Proceedings on-line, now you can view the symposia
handouts and abstracts from the Papers, Posters, Scientific
Exhibits and Orthopaedic Video Theater all on-line at
(www.aaos.org/proceedings).
will focus on cutting edge research that could change the way you
might practice in the next 2-3 years. It represents research that
could change the way you think or address a difficult problem
that impacts current practice. Game Changers will be a session
that includes the most influential and cutting edge research likely
to shape the way we practice in the near term.
Educational Programs
41
42
Educational Programs
Educational Programs
182
Sports Medicine Review Course
Moderator: Asheesh Bedi, MD
Comprehensive and updated summary of the most
pertinent and frequently tested concepts in sports
medicine surgery, with specific consideration of athletic
injuries to the shoulder, knee, hip, and elbow as well the
diagnosis and management of commonly encountered
medical problems in athletes.
Spine Review Course
183
Moderator: Thomas J. Errico, MD
Updates on cervical degenerative spine surgery; thoracic
and lumbar degenerative spine surgery; spinal trauma
surgery and adult spinal deformity surgery.
Trauma Review Course
184
Moderator: Paul Tornetta III, MD
Review recent state of the art management of common
fractures as well as future directions and evolving
treatments.
MOC
TeamSTEPPS
Educational Programs
Instructional Course Ticket Fees
TICKET
For those who have not registered and purchased their tickets in
advance, available tickets may be purchased when registering onsite.
The following fee is applied:
Instructional Course Lecture (2 hours)..............................$70.00
Instructional Course Lecture (3 hours)..............................$80.00
U.S. Orthopaedic Resident (2 or 3 hours).........................$25.00
Top 10 Coding Errors Made by the Practicing
Orthopaedic Surgeon........................................................$80.00
Orthopaedic Review Course.......................................... $400.00
Orthopaedic Review Course
(U.S. Orthopaedic Residents)......................................... $160.00
AAOS Videotaping
The Academy is videotaping certain portions of the Annual
Meeting. The tapes will be used for educational purposes and/or
may be sold alone or in connection with AAOS products. Please
note that by attending the Annual Meeting, your image and/or
voice may be captured and included as part of this event.
Reproduction Policy
The Academy reserves any and all of its rights to
materials presented at the Annual Meeting, including
Posters and Scientific Exhibits. Reproductions of any
kind, by any person or entity, without prior written
permission from the Academy, are strictly prohibited.
Prohibited reproductions include, but are not limited to, audiotapes,
videotape, and/or still photography. Persons violating this policy may
have their badge confiscated and be escorted from the meeting.
No unapproved surveys, handouts or literature may be distributed
at the meeting.
2014 American Academy of Orthopaedic Surgeons
Private Meeting
The AAOS 2014 Annual Meeting is a private meeting. The AAOS
reserves the right to control space and ask people to leave the
meeting who are not qualified to attend or who cause disruptions,
at the AAOS sole discretion.
Cell phones and beepers are a necessity to a doctor but a ringing
phone or beeper during an educational session is distracting to the
audience and speakers. Please place your cell phone on vibrate as
a courtesy to others. When taking or making a call, please step
outside the meeting room.
Education Committees
The Central Program Committee, Central Instructional Course
and Exhibits Committee gratefully acknowledge the efforts of
all of the committee members who work so hard to put on an
excellent educational experience for all attending.
Educational Programs
43
44
Educational Programs
Educational Programs
Educational Programs
David R. Diduch, MD, Charlottesville, VA
Christopher T. Donaldson, MD, Johnstown, PA
Greg J. Folsom, MD, Lenexa, KS
Peter G. Gerbino II, MD, Monterey, CA
Thomas J. Gill, MD, Boston, MA
John R.T. Green III, MD, Seattle, WA
Christopher C. Kaeding, MD, Columbus, OH
Michael A. Kuhn, MD, Cape Carteret, NC
Christian Lattermann, MD, Lexington, KY
Eric B. Pifel, MD, Pewaukee, WI
Scott E. Powell, MD, Burbank, CA
Anil S. Ranawat, MD, New York, NY
Stephen R. Soffer, MD, Wyomissing, PA
Armando F. Vidal, MD, Denver, CO
Rick W. Wright, MD, Saint Louis, MO
Educational Programs
Trauma
Ivan S. Tarkin, MD, Pittsburgh, PA, Chair
Jason M. Evans, MD, Franklin, TN
Steven P. Haman, MD, Lima, OH
Eric M. Hammerberg, MD, Boulder, CO
James C. Krieg, MD, Philadelphia, PA
Amer J. Mirza, MD, Portland, OR
Yvonne M. Murtha, MD, Wichita, KS
Gilbert R. Ortega, MD, Scottsdale, AZ
Edward Perez, MD, Memphis, TN
Bogadi R. Prashanth, MD, Mysore Karnataka, India
Frederic B. Wilson, MD, Phoenix, AZ
45
46
Review of current knowledge on diagnosis and management of clinical problems from a nationally accepted orthopaedic practice
perspective
Major sections of the course are pediatrics, upper and lower extremities, tumors and metabolic bone disease, and spine
Each section includes discussion of fractures, complications, infections and trauma
Educational Programs
Please note: the Orthopaedic Review Course is not intended as a review for the Board Examination, it is a review of orthopaedic basics.
8:00 - 10:00 AM
Lower Extremity
Moderator: Thomas S. Thornhill, MD
8:00 AM
8:30 AM Trauma
Donald A. Wiss, MD
Lower Extremity
Lori A. Karol, MD
9:00 AM
9:30 AM
Sports Knee
Mark D. Miller, MD
2:45 PM Trauma
Jens R. Chapman, MD
3:15 PM Degenerative
Todd J. Albert, MD
10:15 - 11:50 AM
Upper Extremity
Moderator: Leesa M. Galatz, MD
10:15 AM
10:50 AM
4:30 - 5:35 PM
11:20 AM
4:30 PM Tumors
Albert J. Aboulafia, MD
3:45 PM Pediatric
David L. Skaggs, MD
4:15 - 4:30 PM BREAK
5:00 PM
5:35 PM Adjourn
12:30 PM Hip
William C. Warner, Jr, MD
1:00 PM Infection, Congenital, Developmental
Problems/Miscellaneous
Jeffrey R. Sawyer, MD
Continental breakfast and a box lunch are included in the fee, which is $400 on-site.
Attention U.S. Orthopaedic Residents! Discounted tickets are available for the Orthopaedic Review Course and can be purchased on-site
for $160.
2014 American Academy of Orthopaedic Surgeons
Educational Programs
47
48
Educational Programs
Tuesday Highlights
FREE
FREE
Tuesday Highlights
Practice Management Symposium for
Orthopaedic Residents #191
FREE
Educational Programs
New Topics and New Faculty this year! This fast-paced session
uses didactic lectures and panel discussions to provide the
foundation for an effective transition from resident to practicing
physician. Course Directors, Gail Chorney, MD, Charles
Goldfarb, MD, and Fred Meyer, MD, re-designed this course to
cover the most pertinent issues for this daunting transition. This
day track covers essential elements of practice management
not covered in most residency programs and while especially
beneficial for fourth-year and fifth-year residents, all residents
are welcome. Topics include: how to evaluate employment
opportunities, negotiating physician employment agreements, how
reimbursement works, RVUs, how to read a financial statement,
dictating and documenting for ICD-10, and how to build and run
a successful practice. Best of all, this Symposium is complimentary
to all U.S. residents!
49
50
Poster tours
Educational Programs
Date
Classification
Expert
10:00 AM 11:00 AM
William J. Maloney, MD
11:30 AM 12:30 PM
Trauma
3:00 PM 4:00 PM
Sports Medicine/Arthroscopy
Brian J. Cole, MD
4:30 PM 5:30 PM
John J. Callaghan, MD
8:30 AM 9:30 AM
Pediatrics
Steven L. Frick, MD
10:00 AM 11:00 AM
Joseph D. Zuckerman, MD
11:30 AM 12:30 PM
Daniel J. Berry, MD
3:00 PM 4:00 PM
Annunziato Amendola, MD
4:30 PM 5:30 PM
Spine
Robert A. Hart, MD
8:30 AM 9:30 AM
Tumor\/Metabolic Disease
Franklin Sim, MD
10:00 AM 11:00 AM
Sports Medicine/Arthroscopy
Michael J. Stuart, MD
11:30 AM 12:30 PM
Pediatrics
Martin J. Herman, MD
3:00 PM 4:00 PM
Terry R. Light, MD
4:30 PM 5:30 PM
Spine
Todd J. Albert, MD
8:30 AM 9:30 AM
10:00 AM 11:00 AM
Practice Management
Thomas A. Malvitz, MD
11:30 AM 12:30 PM
Trauma
Richard F. Kyle, MD
3:00 PM 4:00 PM
Anthony A. Romeo, MD
Tuesday, March 11
Wednesday, March 12
Thursday, March 13
Friday, March 14
Time
Language
Classification
Tour Expert
Tuesday, March 11
1:30-2:30 PM
Spanish
Hip/Knee
Wednesday, March 12
1:30-2:30 PM
French
Shoulder
Thursday, March 13
1:30-2:30 PM
Spanish
Trauma
Friday, March 14
1:30-2:30 PM
French
Sports Medicine
52
Educational Programs
Tuesday, March 11
Special Sessions Practice Management Focus
190
TICKET
Great
Hall B
FREE
Tuesday
8:00 AM 5:00 PM
Rivergate Room
SYMPOSIUM
12:00 PM 5:00 PM
Great Hall B
FREE
SYMPOSIUM
V.
VI.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
53
Tuesday, March 11
SYMPOSIUM
8:00 AM 10:00 AM
Theater B
8:00 AM 10:00 AM
101
TICKET
IV.
Room
208
V.
VI.
VII.
IX.
The following symbols appear next to educational sessions and indicate one
or more of the following:
U.S. Food and Drug Administration has not cleared the drug and/
or medical device for the use described in this presentation (i.e., the
drug or medical device is being discussed for an off label use). For full
information, refer to page 15.
TICKET
TICKET
IEF
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
54
Educational Programs
Tuesday, March 11
104 Pediatric Sports Medicine Operative Challenges and
Solutions: A Case Based Approach
Moderator: Mininder S. Kocher, MD, MPH, Boston, MA
Michael T. Busch, MD, Atlanta, GA
Eric J. Wall, MD, Cincinnati, OH
Room
350
Peter M. Waters, MD, Boston, MA
182
TICKET
Room
218
Room
353
183
TICKET
Room
106
TICKET
Room
260
Tuesday
TICKET
Rotator Cuff
Moderator: Peter D. McCann, MD, New York, NY
Sumant G. Krishnan, MD, Dallas, TX
Stephen S. Burkhart, MD, San Antonio, TX
E L. Cain Jr, MD, Birmingham, AL
Mark D. Lazarus, MD, Philadelphia, PA
Room
221
Topics
271
184
TICKET
Room
207
Special
Session
11:15 AM 12:30 PM
Room
356
MOC
Room
271
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
55
Tuesday, March 11
PAPER PRESENTATION
8:00 AM 10:00 AM
Theater A
Adult Reconstruction Hip I: Primary THR I
Moderator(s):Peter F. Sharkey, MD, Media, PA
Kipling P. Sharpe, MD, Mesa, AZ
8:00 AM
PAPER: 001
Effect of Tranexamic Acid on Blood Utilization and
Thromboembolic Events after Hip and Knee Surgery
Scott A. Wingerter, MD, PhD, Leawood, KS
Ryan Nunley, MD, Saint Louis, MO
Ronald Jackups Jr, MD, PhD, Saint Louis, MO
Staci Johnson, M.Ed, Saint Louis, MO
Robert L. Barrack, MD, Saint Louis, MO
TXA aids in decreased transfusion rate following primary
and revision hip and knee arthroplasty and, for the first time,
prospective data on VTE shows no increase in events with the
addition of TXA.
8:48 AM
PAPER: 007
Total Hip Arthroplasty Outcomes in Psoriatic Arthritis,
Osteoarthritis with Psoriasis and Osteoarthritis Alone
Lisa A. Mandl, MD, MPH, New York, NY
Susan Goodman, MD, New York, NY
Rebecca Zhu, New York, NY
Wei-Ti Huang, MS, New York, NY
Michael M. Alexiades, MD, Manhattan, NY
Mark P. Figgie, MD, New York, NY
Despite increased risk factors, patients with psoriatic arthritis and
patients with cutaneous psoriasis and osteoarthritis have equally
good outcomes compared to patients with osteoarthritis.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
8:06 AM
PAPER: 002
Allogenic Blood Transfusion in Total Hip Arthroplasty:
Results from the Nationwide Inpatient Sample, 2000-2009
Anas Saleh, MD, Beachwood, OH
Travis Small, DO, Meadville, PA
Aiswarya Lekshmi Pillai Chandran Pillai, MD, MS, Cleveland, OH
Nicholas K. Schiltz, BS, Cleveland, OH
Alison K. Klika, MS, Cleveland, OH
Wael K. Barsoum, MD, Cleveland, OH
8:24 AM
PAPER: 004
Direct Anterior vs. Mini-Posterior Hip Arthroplasty with
Advanced Pain & Rehabilitation Protocols: Some Surprises
Kirsten L. Poehling-Monaghan, MD, Rochester, MN
Atul F. Kamath, MD, Massapequa, NY
Michael J. Taunton, MD, Rochester, MN
Mark W. Pagnano, MD, Rochester, MN
56
Educational Programs
Tuesday, March 11
8:54 AM
PAPER: 008
Total Joint Arthroplasty in Patients with Inflammatory Bowel
Disease: Disease Modifying Drugs Should be Halted
Jeffrey Oliver, BS, Philadelphia, PA
Camilo Restrepo, MD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
Patients with BIC may exhibit higher incidence of reoperation,
cardiopulmonary complications and possible need for subsequent
revision arthroplasty.
9:00 AM
PAPER: 009
Perioperative Outcomes of Solid Organ Transplant Patients
Following Total Hip Arthroplasty in the United States
Caleb Szubski, BA, Cleveland, OH
Alison K. Klika, MS, Cleveland, OH
Aiswarya Lekshmi Pillai Chandran Pillai, MD, MS, Cleveland, OH
Nicholas K. Schiltz, BS, Cleveland, OH
Siran M. Koroukian, PhD, Cleveland, OH
Wael K. Barsoum, MD, Cleveland, OH
Transplant patients have significantly greater morbidity, length of
stay, admission costs, and acute complication risk after total hip
arthroplasty compared with non-transplant patients.
Tuesday
Discussion 6 Minutes
9:12 AM
PAPER: 010
Differences in Patient Characteristics prior to Total Hip
Arthroplasty between Switzerland and the U.S.
Anne Lubbeke-Wolff, MD, DSc, Geneva, Switzerland
Laurent-Panayiotis Christofilopoulos, Geneve, Switzerland
Pierre J. Hoffmeyer, MD, Geneve, Switzerland
Patricia Franklin, MD, MBA, MPH, Worcester, MA
We found substantial differences in baseline characteristics,
especially in age, obesity and diabetes prevalence, and
preoperative hip pain levels between a U.S. and a Swiss cohort of
THA patients.
9:18 AM
PAPER: 011
TJA Appears Cardioprotective in Patients with Moderate-severe
OA: A Propensity-score Matched Landmark Analysis
Bheeshma Ravi, MD, Toronto, ON, Canada
Ruth Croxford, MSc, Toronto, ON, Canada
Peter Austin, Toronto, ON, Canada
Lorraine Lipscombe, Toronto, ON, Canada
Arlene Bierman, MD, MS, Toronto, ON, Canada
Paula Harvey, MBBS, PhD, Toronto, ON, Canada
Gillian Hawker, MD, Toronto, ON, Canada
9:24 AM
PAPER: 012
Non-Steroidal Anti-Inflammatory Drug Use in the First Year
Following Total Hip Arthroplasty and Implant Survival
Tamer T. Malak, MB, Oxford, United Kingdom
Muhammad Javaid, Oxford, UK, United Kingdom
Mireia Espallargues-Carreras, MPH, MD, Barcelona, Spain
Nigel Arden, MD, Oxford, United Kingdom
Andrew J. Carr, FRCS, Headington Oxford, United Kingdom
Andrew Judge, PhD, Oxford, United Kingdom
Daniel Prieto-Alhambra, MD
Sion Glyn-Jones, MA, MBBS, Oxford, United Kingdom
Significant association between Non-Steroidal Anti-Inflammatory
Drug use in the first year following Total Hip Arthroplasty and
revision rate highlights its potential as a surrogate measure of
outcome.
Discussion 6 Minutes
9:36 AM
PAPER: 013
Radiostereometric Analysis of Cementless Femoral Stem
Stability in Young Total Hip Replacement Patients at 5 years
David C. Ayers, MD, Worcester, MA
Anthony Porter JR, MD, Worcester, MA
Benjamin M. Snyder, MD, Worcester, MA
Marie E. Walcott, MD, Worcester, MA
Michelle Aubin, MD, Worcester, MA
Jacob M. Drew, MD, Charlotte, NC
Audrey Nebergall, Boston, MA
Henrik Malchau, MD, Boston, MA
Charles R. Bragdon, PhD, Boston, MA
In young, active patients cementless THR demonstrates excellent
prosthetic stability by RSA and outstanding clinical outcomes at 5
years using a tapered titanium femoral stem.
9:42 AM
PAPER: 014
Min. 20-Year Followup Straight-Stemmed Plasma-Sprayed
Titanium-Alloy Uncemented Femoral Component Primary THA
John B. Meding, MD, Mooresville, IN
E. Michael Keating, MD, Mooresville, IN
Philip M. Faris, MD, Mooresville, IN
Michael E. Berend, MD, Mooresville, IN
Kenneth Davis, MS, Mooresville, IN
The present study evaluates the minimum twenty-year results of
primary THA performed with the use of a proximally porouscoated, plasma-sprayed, straight-stemmed, titanium-alloy femoral
component.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
57
Tuesday, March 11
9:48 AM
PAPER: 015
A Decade of Experience with Highly Cross Linked Polyethylene
in Total Hip Replacements: A Review of 1,484 Cases
John Mutu-Grigg, MD, London, ON, Canada
Richard W. McCalden, MD, London, ON, Canada
Douglas Naudie, MD, FRCSC, London, ON, Canada
James P. McAuley, MD, London, ON, Canada
Steven J. MacDonald, MD, London, ON, Canada
Similar to other published literature, our data suggests the use
of HXLPE is both safe, effective and arguably the gold standard
bearing surface in modern total joint replacement.
Discussion 6 Minutes
8:12 AM
Lateral Ulna Collateral Ligament Reconstruction:
An Analysis of Ulna Tunnel Locations
Oke A. Anakwenze, MD, Philadelphia, PA
Krishn Khanna, BS, New York, NY
William N. Levine, MD, New York, NY
Christopher S. Ahmad, MD, New York, NY
PAPER: 018
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 245
Sports Medicine/Arthroscopy I: Elbow, Hand, Cartilage
Moderator(s):Champ Baker III, MD, Columbus, GA
Armando F. Vidal, MD, Denver, CO
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
8:00 AM
PAPER: 016
Incidence of Avulsion Fracture of the Medial Epicondyle After
Ulnar Collateral Ligament Reconstruction
Ryan W. Hess, MD, Columbia, SC
Aaron K. Mates, MD, Mobile, AL
Jeremy Bruce, MD, Chattanooga, TN
Patrick W. Joyner, MD, Chesapeake, VA
James R. Andrews, MD, Gulf Breeze, FL
8:24 AM
PAPER: 019
Performance Metrics Before and After Tommy John Surgery in
160 Professional Pitchers
Eric C. Makhni, MD, NY City, NY
Randall Lee, Hoboken, NJ
Zachary Morrow, BS, New York, NY
Anthony Gualtieri, BA, NY City, NY
Christopher S. Ahmad, MD, New York, NY
58
Educational Programs
Tuesday, March 11
8:48 AM
PAPER: 022
The Utility of MRI in the Evaluation and Treatment of
Distal Biceps Brachii Ruptures
Nimrod Snir, MD, New York, NY
Mathew Hamula, BA, BS, New York, NY
Theodore S. Wolfson, BS, New York, NY
Soterios Gyftopoulos, MD, Long Island City, NY
Robert J. Meislin, MD, New York, NY
Eric J. Strauss, MD, New York, NY
Laith M. Jazrawi, MD, New York, NY
In our series, the combination of retraction greater than 80 mm,
lacertus fibrosis disruption, and absence of extra-articular edema
correlated highly with need for reconstruction.
8:54 AM
PAPER: 023
Initiation of Tennis Elbow; Anatomic Findings of Origin of
Extensor Carpi Radialis Brevis and Joint Capsule
Akimoto Nimura, MD, Tokyo, Japan
Tomoyuki Mochizuki, MD, Tokyo, Japan
Hitomi Fujishiro, Bunkyo-Ku, Japan
Junya Imatani, MD, PhD, Okayama, Japan
Hiroyuki Sugaya, MD, Chiba, Japan
Takeshi Muneta, MD, Tokyo, Japan
Keiichi Akita, MD, Tokyo, Japan
Tuesday
9:12 AM
PAPER: 025
A Systematic Review of Repair Techniques for Acute Distal
Biceps Tendon Ruptures
Jonathan Watson, MD, Chicago, IL
Vincent M. Moretti, MD, Berwyn, IL
Leslie E. Schwindel, MD, Chicago, IL
Mark R. Hutchinson, MD, Elmhurst, IL
We conducted a systematic review of repair techniques for
acute distal biceps tendon ruptures, and found no difference
between incision number, but bone tunnel fixation had the fewest
complications.
9:18 AM
PAPER: 026
Delayed Onset Ulnar Neuritis After Release of Elbow
Contracture: Prevention Strategies
Davide Blonna, MD, Torino, Italy
Shawn W. ODriscoll, MD, Rochester, MN
Open ulnar nerve decompression or transposition can reduce
the incidence and severity of DOUN. Decompression is as
effective as transposition but associated with significantly fewer
complications.
PAPER: 027
9:24 AM
Chondrogenesis Using Adipose-Derived Stem Cells and FDAApproved Biomatrices
Jason L. Dragoo, MD, Redwood City, CA
Hillary Braun, BA, Redwood City, CA
Hyeon Joo Kim, PhD
Translation of articular cartilage tissue engineering remains
hindered by the use of non-FDA approved scaffold materials.
This investigation evaluates FDA approved scaffolds for
chondrogenic potential.
Discussion 6 Minutes
9:36 AM
PAPER: 028
Matrix
Assisted
Autologous
Chondrocyte
Transplantation:
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
59
Tuesday, March 11
9:42 AM
PAPER: 029
Characterization of a Novel Viable Cartilage Mesh for
Microfracture Augmentation for Focal Chondral Defects
C. Thomas Vangsness Jr, MD, Los Angeles, CA
Sandy Deitch, Phd, Columbia, MD
Jin-Qiang Kuang, MD, Columbia, MD
Dana Yoo, PhD, Columbia, MD
Michelle Leroux-Williams, PhD, Columbia, MD
Description of a novel cartilage mesh derived from human
articular cartilage that contains chondrogenic growth factors and
viable chondrocytes within an intact extracellular matrix.
9:48 AM
PAPER: 030
Magnesium Sulfate - A Chondroprotective Alternative to
Intraarticular Local Anesthetic?
Joseph Baker, MD, Dublin, Ireland
Daniel Byrne, PhD, Santry Demsne, Ireland
Pauline Walsh, BSc, PhD, Dublin, Ireland
Kevin J. Mulhall, MD, Dublin, Ireland
In this in vitro study cell viability was better preserved when
chondrocytes were treated with magnesium sulfate either alone or
in combination with local anaesthetic.
Discussion 6 Minutes
SYMPOSIUM
10:30 AM 12:30 PM
Theater C
Moderator: David L. Nelson, MD, Greenbrae, CA
V.
VI.
10:30 AM 12:30 PM
121
TICKET
Room
260
Room
226
Room
347
TICKET
Room
270
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
60
Educational Programs
Tuesday, March 11
125
TICKET
IEF
Room
350
126
TICKET
Room
276
Room
208
Tuesday
TICKET
128
Room
221
127
TICKET
129
TICKET
Room
215
Room
218
Room
210
Educational Programs
61
Tuesday, March 11
PAPER PRESENTATION
10:30 AM 12:30 PM
Theater A
Shoulder and Elbow I: Elbow Conditions
Moderator(s):Russell Huffman, MD, Philadelphia, PA,
Robert Z. Tashjian, MD, Salt Lake City, UT,
Mark Wright, MD, Auckland, New Zealand
10:30 AM
PAPER: 031
Outcome of Total Elbow Replacement:
A Four-Year Mean Follow Up
Omid Alizadehkhaiyat, MD, Liverpool, United Kingdom
Ahmed Al Mandhari, MD, Liverpool, United Kingdom
Alexandros Kyriakos, MD, Liverpool, United Kingdom
Simon Frostick, MD, Liverpool, United Kingdom
Total elbow replacement (TER) using a linked system produced
effective functional improvement in both primary and revision
total elbow replacement. The incidence of major complications
was in an acceptable range.
10:36 AM
PAPER: 032
Total Elbow Arthroplasty: A National Analysis of Factors
Effecting Length of Stay
Evan ODonnell, BA, New York, NY
Oke A. Anakwenze, MD, Philadelphia, PA
William N. Levine, MD, New York, NY
Christopher S. Ahmad, MD, New York, NY
Charles M. Jobin, MD, New York, NY
PAPER: 033
10:42 AM
Osteosynthesis or Arthroplasty for the Treatment of Geriatric
Distal Humerus Fractures: A Meta-analysis
Michael Githens, MD, Redwood City, CA
Julius A. Bishop, MD, Palo Alto, CA
A meta-analysis revealed that after treatment of geriatric distal
humerus fractures with either TEA or ORIF there is no difference
in functional outcomes, yet an increased reoperation rate after
ORIF.
Discussion 6 Minutes
10:54 AM
PAPER: 034
The Bicipital Aponeurosis Flex Test and its Role in the
Diagnosis and Treatment of Distal Biceps Tendon Ruptures
Amr Elmaraghy, MD, Toronto, ON, Canada
Moira Devereaux, MSc, Mahone Bay, NS, Canada
11:18 AM
PAPER: 037
Allograft Ligament Reconstruction for Post-Traumatic Elbow
Posterolateral Rotatory Instability
Yaser M. Baghdadi, MD, Rochester, MN
Bernard F. Morrey, MD, Fayetteville, TX
Shawn W. ODriscoll, MD, Rochester, MN
Scott P. Steinmann, MD, Rochester, MN
Joaquin Sanchez-Sotelo, MD, Rochester, MN
Allograft reconstruction of the lateral collateral ligament complex
restores elbow stability in approximately 85% of the elbows with
post traumatic posterolateral rotatory instability.
11:24 AM
PAPER: 038
Acute Arthroscopic Repair of the Radial Ulnohumeral Ligament
Following Elbow Dislocation in High-Demand Patients
Michael J. OBrien, MD, New Orleans, LA
Randall L. Murphy Jr, MD, Jackson, MS
Felix H. Savoie III, MD, New Orleans, LA
Arthroscopic repair of the RUHL is a safe, effective procedure
that restores stability to the elbow and allows a select group of
high-demand patients to quickly return to work and play.
Tuesday
11:00 AM
PAPER: 035
Proximal Radioulnar Impingement: The Association of Radial
Tuberosity Size with Distal Biceps Rupture
Nicholas R. Slenker, MD, Los Angeles, CA
Neal S. ElAttrache, MD, Los Angeles, CA
Aram Salem, MD, Santa Monica, CA
John Crues, MD, Los Angeles, CA
Orr Limpisvasti, MD, Los Angeles, CA
62
Educational Programs
Tuesday, March 11
11:30 AM
PAPER: 039
The Differential Expression Patterns of Minor Collagens in Post
Traumatic Anterior Elbow Contracture Capsules
Srinath Kamineni, MD, Lexington, KY
Minor collagens have a specific sequence of expression during the
formation of an post-traumatic elbow contracture.
Discussion 6 Minutes
11:42 AM
PAPER: 040
The Long-term Outcomes after Closed Reduction of
Simple Elbow Dislocations
Chetan S. Modi, MBChB, MSc, Birmingham, United Kingdom
David Wasserstein, MD, MSc, North York, ON, Canada
Ian Mayne, MD, Toronto, ON, Canada
Patrick Henry, MD, Portland, ME
Nizar Mahomed, MD, Toronto, ON, Canada
Christian Veillette, MD, Toronto, ON, Canada
Tuesday
12:06 PM
PAPER: 043
The Role of Elbow Rotation in the Management of Radial Head
Fractures. A Prospective Randomized Controlled Study.
Nikolaos K. Paschos, MD, Davis, CA
Khaled Abuhemoud, MD, PhD, Ioannina, Greece
Dimitrios Gartzonikas, MD, Ioannina, Greece
Anastasos Georgoulis, Ioannina, Greece
Introducing active elbow rotation in the early management of
radial head fractures is associated with worse outcome and poor
fracture healing.
PAPER: 044
12:12 PM
Strength of Coronoid Fracture Fixation: A Biomechanical Study
Bashar Alolabi, MD, Toronto, ON, Canada
Simon R. Deluce, London, ON, Canada
Alia Gray, MSc, Belleville, ON, Canada
Louis Ferreira, MSc, London, ON, Canada
James A. Johnson, PhD, London, ON, Canada
George S. Athwal, MD, London, ON, Canada
Graham J. King, MD, London, ON, Canada
In assessing fixation methods in 40% coronoid fractures, plate
fixation was most secure followed by 2 screws, regardless of
orientation, followed by 1 screw. Suture fixation failed at very
low loads.
12:18 PM
PAPER: 045
Prediction of Olecranon ORIF Complications with Radiographic
Parameters
Anshuman Singh, MD, San Diego, CA
Diego A. Figueira, MD, San Diego, CA
Jun Wu, MD, MS, Pasadena, CA
Ronald A. Navarro, MD, Rolling Hills, CA
We have defined simple radiographic parameters which can help
to predict complications after olecranon ORIF.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
63
Tuesday, March 11
10:30 AM 12:30 PM
Room 245
11:00 AM
PAPER: 050
Killing
Staphylococcus
epidermidis
on
Prosthetic
Joint
PAPER PRESENTATION
10:30 AM
PAPER: 046
The Host Response: Toll Like Receptor Expression in
Periprosthetic Tissues as a Biomarker for Deep Joint Infection
Cara A. Cipriano, MD, Palo Alto, CA
Aparna Maiti, PhD, Richmond, VA
Gregory Hale, MD, Richmond, VA
William A. Jiranek, MD, Richmond, VA
In our pilot study, Toll Like Receptor 1 expression in
periprosthetic tissues accurately predicted infection (AUC 0.995,
94.4% sensitivity, 95.5% specificity).
10:36 AM
PAPER: 047
Serum Interleukin 6 Improves Screening for Infected Total Knee
Arthroplasty
Vivek S. Jagadale, MD, MS, Mayfield, KY
Edward Y. Cheng, MD, Minneapolis, MN
Serum IL-6 in combination with synovial WBC has highest
sensitivity, specificity and NPV, making it a useful screening test
in infected total knee arthroplasty.
10:54 AM
PAPER: 049
Prospective, Randomized, Blinded Study to Evaluate Two
Surgical Skin Preparations in Reducing SSI after TJA
Tiffany N. Morrison, Philadelphia, PA
Mayank Taneja, Columbus, OH
James J. Purtill, MD, Philadelphia, PA
Matthew Austin, MD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
11:18 AM
PAPER: 052
Serum Inflammatory Markers for Periprosthetic Knee Infection
in Obese versus Non-Obese Patients
Jane Liu, Cleveland, OH
Anas Saleh, MD, Beachwood, OH
Alison K. Klika, MS, Cleveland, OH
Wael K. Barsoum, MD, Cleveland, OH
Carlos A. Higuera, MD, Lakewood, OH
There is a difference of CRP cut-off value on obese patients when
compared to non-obese patients to diagnose knee PJI.
11:24 AM
PAPER: 053
Diagnostic Threshold for Synovial Fluid Analysis in Late
Periprosthetic Infection Depends on Duration of Symptoms
Kshitijkumar Agrawal, Arlington, MA
Horim Choi, MD, Boston, MA
Viktor Hansen, MD, Boston, MA
Hany S. Bedair, MD, Boston, MA
Symptom Duration is important in synovial fluid analysis for late
periprosthetic infection. The cutoff for 5800 cell/uL in patients
with acute symptoms is 3 times higher than in more chronic
symptoms.
Tuesday
PAPER: 048
10:42 AM
Diagnosing Periprosthetic Joint Infection: The Era of the
Biomarker has Arrived
Carl A. Deirmengian, MD, Wynnewood, PA
Keith Kardos, PhD, Wynnewood, PA
Patrick Kilmartin, BS, MS, Wynnewood, PA
Alexander Cameron, Wynnewood, PA
Kevin Schiller, BS, Wynnewood, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
11:06 AM
PAPER: 051
Aseptic Protocol Decreases Surgical Site Infections After Knee
Arthroplasty
Joseph Lamplot, BS, Chicago, IL
Gaurav A. Luther, MD, Boston, MA
Tyler R. Krummenacher, MD, Chicago, IL
Mohammed Hussain, BS, Chicago, IL
Hue H. Luu, MD, Chicago, IL
David W. Manning, MD, Chicago, IL
64
Educational Programs
Tuesday, March 11
11:30 AM
PAPER: 054
Sonication Adds Value in Predicting Failure During Two-stage
Reimplantation for Prosthetic Knee and Hip Infections
Robert Jones, MD, Danville, PA
Kaan Irgit, MD, Ankara, Turkey
Nathaniel C. Wingert, MD, Danville, PA
Michael Foltzer, MD, Danville, PA
Thomas R. Bowen, MD, Danville, PA
Charles L. Nelson, MD, Philadelphia, PA
Sonication of antibiotic spacers after two-stage reimplantation
increases the sensitivity of intra-operative cultures.
Discussion 6 Minutes
11:42 AM
PAPER: 055
Incubation of Sonicate Fluid in Blood Culture Bottles Leads to an
Improved and Quicker Rate of Bacterial Isolation
Viktor Janz, MD, Berlin, Germany
Georgi Wassilew, MD, Berlin, Germany
Carsten Perka, MD, Berlin, Germany
Viktor Janz, MD, Berlin, Germany
Tuesday
12:06 PM
PAPER: 058
Diabetes Mellitus, Hyperglycemia, Hemoglobin A1c and the Risk
of Prosthetic Joint Infections
Hilal Maradit-Kremers, MD, MSc, Rochester, MN
Laura Lewallen, MD, Rochester, MN
Brian D. Lahr, MSc, Rochester, MN
Tad M. Mabry, MD, Rochester, MN
James Steckelberg, MD, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
Arlen D. Hanssen, MD, Rochester, MN
Elie Berbari, MD, Rochester, MN
Douglas R. Osmon, MD, Rochester, MN
PAPER: 056
PAPER: 059
12:12 PM
Prosthetic Joint Infection Risk Stratification in Total Hip (THA)
and Total Knee (TKA) Arthroplasty
Hilal Maradit-Kremers, MD, MSc, Rochester, MN
Laura Lewallen, MD, Rochester, MN
Brian D. Lahr, MSc, Rochester, MN
Tad M. Mabry, MD, Rochester, MN
James Steckelberg, MD, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
Arlen D. Hanssen, MD, Rochester, MN
Elie Berbari, MD, Rochester, MN
Douglas R. Osmon, MD, Rochester, MN
Prosthetic Joint Infection Risk Stratification.
PAPER: 060
12:18 PM
Comparison of a Clinically Derived Prosthetic Joint Infection
(PJI) Risk Model and the NHSN Risk Model
Laura Lewallen, MD, Rochester, MN
Hilal Maradit-Kremers, MD, MSc, Rochester, MN
Brian D. Lahr, MSc, Rochester, MN
Tad M. Mabry, MD, Rochester, MN
James Steckelberg, MD, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
Arlen D. Hanssen, MD, Rochester, MN
Elie Berbari, MD, Rochester, MN
Douglas R. Osmon, MD, Rochester, MN
compare the prediction of PJI with the THA and TKA specific
NHSN risk scores and a clinically-derived risk score that includes
patient- and surgery-specific risk factors.
Discussion 6 Minutes
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
65
Tuesday, March 11
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 265
Trauma I: Ankle/Pilon
Moderator(s):Eric M. Hammerberg, MD, Boulder, CO
J. Lawrence Marsh, MD, Iowa City, IA
10:30 AM
PAPER: 061
The Impact of Popliteal Block on Post-operative Medication
Administration and Time to Discharge from PACU
Rachel Y. Goldstein, MD, Boston, MA
Ji Hae Park, BS, New York, NY
Sudheer Jain, New York, NY
Nirmal C. Tejwani, MD, New York, NY
Patients who received popliteal blocks did not require any
less medication in the PACU and were no less likely to require
overnight hospitalization than those who received general
anesthesia.
10:36 AM
PAPER: 062
Normal Distal Tibiofibular Syndesmosis Measurements in 91
Ankles by Computed Tomography
Samuel Rosenbaum, MD, Ann Arbor, MI
John Lee, MD, MS, Ann Arbor, MI
Mark Hake, MD, Ann Arbor, MI
Sven Holcombe, BS, Ann Arbor, MI
Stewart C. Wang, Ann Arbor, MI
James A. Goulet, MD, Ann Arbor, MI
PAPER: 063
10:42 AM
A Randomized Controlled Trial of Early vs Delayed
Weightbearing After Surgical Fixation of Unstable Ankle
Fractures
Niloofar Dehghan, MD, Toronto, ON, Canada
Richard Jenkinson, MD, Toronto, ON, Canada
Michael D. McKee, MD, Toronto, ON, Canada
Aaron Nauth, MD, Toronto, ON, Canada
Emil H. Schemitsch, MD, Toronto, ON, Canada
Jeremy Hall, MD, FRCS, Toronto, ON, Canada
David J. Stephen, MD, Toronto, ON, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
There is no difference with regards to time to return to work,
however the early group has improved ankle function and health
outcome scores early on, with no increase in rate of complication/
failure.
Discussion 6 Minutes
11:18 AM
PAPER: 067
Corrective Effect of Suture-Button Fixation on Iatrogenic
Syndesmotic Malreduction: A Cadaveric Study
Robert W. Westermann, MD, Iowa City, IA
Chamnanni Rungprai, MD, Iowa City, IA
Jessica Goetz, PhD, Iowa City, IA
John E. Femino, MD, Iowa City, IA
Annunziato Amendola, MD, Iowa City, IA
Phinit Phisitkul, MD, Iowa City, IA
Malreduction is a common with syndesmosis screw treatment;
our study suggests suture-button syndesmotic fixation is able
to correct for 57-88% of screw-produced malreduction in a
cadaveric model.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
10:54 AM
PAPER: 064
Trimalleolar Ankle Fractures; A Comparison of Surgical
Techniques for Posterior Malleolus Fixation
Benjamin Mueller, MD, PhD, Saint Paul, MN
Aaron Jacobson, DC, Saint Paul, MN
Eric R. Nelson, MD, De Pere, WI
Peter A. Cole, MD, Saint Paul, MN
66
Educational Programs
Tuesday, March 11
11:24 AM
PAPER: 068
Male Sex and Syndesmotic Screw Fixation are Risk Factors for
Post-Traumatic Synostosis in Operative Ankle Fractures
Richard M. Hinds, MD, New York, NY
Lionel E. Lazaro, MD, New York, NY
David L. Helfet, MD, New York, NY
Dean G. Lorich, MD, New York, NY
Syndesmotic screw fixation and male sex positively correlate with
post-traumatic synostosis in operative ankle fractures.
11:30 AM
PAPER: 069
Does Ankle Syndesmosis Screw Removal Affect Patient
Outcomes? A Prospective, Randomized, Controlled Trial
Matthew J. Boyle, MD, Durham, NC
Ryan Gao, Auckland, New Zealand
Brendan Coleman, MD, Wellington, New Zealand
In this prospective, randomized, controlled trial we have
identified no significant benefit associated with syndesmosis screw
removal in adult ankle fracture patients.
Tuesday
Discussion 6 Minutes
11:42 AM
PAPER: 070
Comparison of Modern Locked Plating and Antiglide Plating for
Fixation of Osteoporotic Distal Fibular Fractures
Robert J. Wetzel, MD, Chicago, IL
Neel Jain, MD, La Porte, IN
Paul Switaj, MD, Chicago, IL
Brian M. Weatherford, MD, Columbia, MD
Li-Qun Zhang, PhD, Chicago, IL
Bradley R. Merk, MD, Chicago, IL
Mahesh Polavarapu, Philadelphia, PA
Yupeng Ren, Chicago, IL
The use of modern lateral locked plating with additional distal
fixation is a biomechanically stronger construct than antiglide
plating for an osteoporotic, unstable distal fibula fracture.
11:48 AM
PAPER: 071
Fragility Fractures of the Ankle in the Frail Elderly: Treatment
of 48 Cases with a Long Calcaneotalotibial Nail
Shafic S. Al-Nammari, MRCS, London, United Kingdom
Sebastian Dawson-Bowling, MD, East Sussex, United Kingdom
Syed Nawaz, MRCS, Surrey, United Kingdom
Jeya Palan, MD, Market Harborough, United Kingdom
Howard Cottam, MD, London, United Kingdom
Amit Amin, FRCS, Harrow, UK, United Kingdom
Dominic Nielsen, Surrey, United Kingdom
48 fragility fractures of the ankle were treated with a long
intramedullary nail across the os calcis, talus into the tibia.
One required removal for infection but the remainder united
satisfactorily.
11:54 AM
PAPER: 072
Ankle Fragility Fractures Treated with Primary Retrograde
Tibiotalocalcaneal Nail
Dane C. Hansen, DO, Columbus, OH
Benjamin Taylor, MD, New Albany, OH
Our study shows that retrograde TTC nail is an acceptable
treatment in ankle fragility fractures, especially in the setting
of comorbidities, leading to early activity and minimal
complications.
Discussion 6 Minutes
12:06 PM
PAPER: 073
Combined Approaches Increases Nonunion in Tibial Pilon
Fractures
Paul M. Balthrop, MD, Savannah, GA
Daniel S. Chan, MD, Tampa, FL
Roy W. Sanders, MD, Tampa, FL
Brian D. White, MD, Tampa, FL
David Glassman, Portsmouth, VA
Combined approaches facilitate anatomic reduction but may
increase nonunion risk.
12:12 PM
PAPER: 074
Tibial Pilon Fractures Associated with Acute Compartment
Syndrome: A Case-Control Study
Todd S. Yecies, BS, Pittsburgh, PA
Ivan S. Tarkin, MD, Pittsburgh, PA
Peter Siska, MD, Pittsburgh, PA
Gary S. Gruen, MD, Pittsburgh, PA
Andrew R. Evans, MD, Pittsburgh, PA
The objective of this study is to determine the effects of comorbid ACS on the outcomes of tibial pilon fractures.
12:18 PM
PAPER: 075
Complications of Surgical Management of Grade IIIB and IIIC
Open Pilon Fractures in an Urban Level 1 Trauma Center
Joshua L. Gary, MD, Houston, TX
Jose A. Romero, MD, Dallas, TX
Evan G. Meeks, MD, Houston, TX
Catherine G. Ambrose, PhD, Houston, TX
John W. Munz, MD, Houston, TX
Timothy S. Achor, MD, Bellaire, TX
Major complication rate after ORIF of grade IIIB and IIIC open
pilon fractures is greater than 50% in our urban level-1 trauma
center with a 38% infection rate and 30% nonunion rate.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
67
Tuesday, March 11
I. The Development of Normal Upright Balance in Children:
The Global Relationship of the Pelvis to the Spine
Hubert H. Labelle, MD, Montreal, QC, Canada
SYMPOSIUM
1:30 PM 3:30 PM
La Nouvelle Ballroom
New Paradigms and State of the Art Treatment of
Osteonecrosis of the Femoral Head (C)
Moderator: Rafael J. Sierra, MD, Rochester, MN
This symposium will discuss the new insights into the etiologic
factors (epigenetics, gene abnormalities, thrombotic conditions)
associated with osteonecrosis of the femoral head and
multifocal osteonecrosis. The world- class expert faculty will
review their years of experience in nonoperative and surgical
management of patients with osteonecrosis.
I.
II.
III.
Epigenetics of ON
Javad Parvizi, MD, FRCS, Philadelphia, PA
IV.
V.
VII. THA
Carlos J. Lavernia, MD, Coral Gables, FL
SYMPOSIUM
1:30 PM 3:30 PM
Theater C
Loss of Standing Balance: The Lifelong (Cradle to Grave)
Management of Sagittal Imbalance of the Spine (D)
Moderator: John R. Dimar II, MD, Louisville, KY
The loss of sagittal balance of the spine during aging is the result
of progressive changes in alignment of the thoracic & lumbar
spine along with the pelvis. These changes may ultimately result
in significant positive sagittal imbalance & degradation of the
patients quality of life by limiting activities of daily living. When
severe sagittal decompensation develops, it may require surgical
realignment via a wide array of surgical procedures. Since there
has been extensive research into establishing normal pelvic &
spinal alignment parameters, careful adherence to these concepts
during surgical correction will avoid needless exacerbation of the
patients sagittal imbalance.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
68
Educational Programs
Tuesday, March 11
INSTRUCTIONAL COURSE Lecture
145
TICKET
1:30 PM 3:30 PM
141
Advances in Acetabular Reconstruction in Revision
Total Hip Arthroplasty: Maximizing Function and
Outcomes
Room
Moderator: Khaled J. Saleh, MD, MSc, Springfield, IL
260
Wayne G. Paprosky, MD, Winfield, IL
Michael D. Ries, MD, San Francisco, CA
William J. Maloney, MD, Redwood City, CA
TICKET
IEF
Room
356
Room
352
TICKET
Room
276
Room
221
TICKET
Room
350
144
Room
Room
215
TICKET
143
147
146
TICKET
Tuesday
TICKET
218
Room
208
Educational Programs
69
Tuesday, March 11
152
TICKET
1:30 PM 3:30 PM
150
Hip Arthroscopy: Tales from the Crypt
Moderator: Dean K. Matsuda, MD, Los Angeles, CA
Marc J. Philippon, MD, Vail, CO
Marc Safran, MD, Redwood City, CA
Room
Thomas G. Sampson, MD, San Francisco, CA
TICKET
226
151
TICKET
Room
347
207
TICKET
Room
210
FD1
Room
217
Perspectives on Mentorship
Moderator: Robert A. Hart, MD, Portland, OR
Vernon T. Tolo, MD, Los Angeles, CA
James H. Beaty, MD, Memphis, TN
Edward N. Hanley Jr, MD, Charlotte, NC
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
Room
70
Educational Programs
Tuesday, March 11
INSTRUCTIONAL COURSE Lecture
1:30 PM 4:30 PM
192
TICKET
Tuesday
193
TICKET
Room
353
PAPER PRESENTATION
1:30 PM 3:30 PM
Theater A
International Paper Session
Moderator(s):Robert P. Dunbar, MD, Seattle, WA
Xavier A. Duralde, MD, Atlanta, GA
1:30 PM
Welcome Overview of Session
1:36 PM
PAPER: 272
The Implications of Clopidogrel on the Management of Hip
Fractures: An Institutional Review
Stephen Preston, MD, London, ON, Canada
Sagar Desai, MD, London, ON, Canada
Lyndsay Somerville, PhD, London, ON, Canada
Dennis Angevine, London, ON, Canada
David Sanders, MD, London, ON, Canada
James Howard, MD, London, ON, Canada
We reviewed our institutions management of hip fractures in
those taking Clopidogrel (delay to surgery) and determined its
effects on bleeding risk, length of hospital stay, morbidity and
mortality.
PAPER: 279
1:42 PM
The Effects of Diabetes Medications on Post-operative Long
Bone Fracture Healing
Christopher M. Simpson, MBChB, Leeds, United Kingdom
Suribabu Gudipati, MBBS, MRCS, Carmarthen, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
Diabetic medications have a significant impact on the fracture
healing process including the timescale and the eventual outcome
of union vs. non-union.
Discussion 6 minutes
1:54 PM
PAPER: 555
Distributed Analysis of Hip Implants Using Five International
Registries: Pioneering Study of Bearing Surfaces
Ove N. Furnes, MD, Bergen, Norway
Guy Cafri, PhD, La Jolla, CA
Liz Paxton, MA, San Diego, CA
Stephen Graves, MD, Adelaide, Australia
Barbara Bordini, MD, Bologna, Italy
Thomas K. Comfort, MD, Stillwater, MN
Samprit Banerjee, PhD, New York, NY
Danica Marinac-Dabic, MD, PhD, Rockville, MD
Art Sedrakyan, PhD, MD, New York, NY
Younger patients with large size but not small size metal on
metal implants are at higher risk of revision compared to crosslink polyethylene bearing in worldwide distributed study of five
registries.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
71
Tuesday, March 11
2:00 PM
PAPER: 604
Influence of Physical Activity on Metal Concentrations and
Pseudotumor Formation in Patients with MoM Arthroplasty
Jetse Jelsma, MSc, Maastricht, Netherlands
Rachel Senden, PhD, Heerlen, Netherlands
Ide Heyligers, Heerlen, Netherlands
Bernd P. Grimm, PhD, Aachen, Germany
This first study to measure patient physical activity and correlate
it with blood ion levels suggests that metal-on-metal wear may be
more influenced by the intensity than the quantity of activity.
APER: 243
2:06 PM P
Ceramic-on-Ceramic and Ceramic-on-Highly-X-Linked PE in
Same Pts. with Primary Cementless THA
Young-Hoo Kim, MD, Seoul, Republic of Korea
Jangwon Park, MD, Seoul, Republic of Korea
Jun S. Kim, MD, Seoul, Republic of Korea
Jeong-Hwan Oh, Seoul, Republic of Korea
Cementless THA with Al-on-Al ceramic or Al-on- highly-Xlinked PE bearings in 100 pts. (200 hips) younger than 50 years
provided high rate of survivorship without osteolysis.
Discussion 6 minutes
2:42 PM
PAPER: 750
Assessing Knowledge Translation in Orthopaedic Surgery Using
Time-series Analysis of Clavicle Fracture Treatment
David Wasserstein, MD, MSc, North York, ON, Canada
Timothy S. Leroux, MD, Toronto, ON, Canada
Patrick Henry, MD, Portland, ME
Michael Paterson, Toronto, ON, Canada
Michael D. McKee, MD, Toronto, ON, Canada
Bheeshma Ravi, MD, Toronto, ON, Canada
Darrell J. Ogilvie-Harris, MD, Toronto, ON, Canada
Nizar Mahomed, MD, Toronto, ON, Canada
Christian Veillette, MD, Toronto, ON, Canada
Using time-series analysis we demonstrated a statistical
association between an increase in clavicle fracture surgery that
corresponded with published high level evidence supporting that
change.
2:24 PM
PAPER: 187
Meniscal Allograft with or without Osteotomy - A 15-Year
Follow-Up Study
Hussain Kazi, MB, ChB, , Toronto, ON, Canada
Wael Abdelrahman, MD, Toronto, ON, Canada
Philip Brady, MD, Toronto, ON, Canada
John C. Cameron, MD, Toronto, ON, Canada
2:48 PM
PAPER: 127
Return to Sport after Recurrent Shoulder Instability: Open
Latarjet vs. Arthroscopic Bankart Repair
Davide Blonna, MD, Torino, Italy
Francesco Pasquero, Chieri, Italy
Francesco Caranzano, MD, Turin, Italy
Umberto Mariotti, Milan, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Umberto Cottino, Pecetto Torinese, Italy
Davide E. Bonasia, MD, Torino, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Filippo Castoldi, MD, Torino, Italy
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
2:18 PM
PAPER: 194
A Randomized Clinical Trial Comparing Hyaluronic Acid for Knee
Osteoarthritis Treatment to Placebo
Walter A. van der Weegen, MD, Geldrop, Netherlands
Hub Noten, PhD, Helmond, Netherlands
Jorgen Wullems, MSc, Geldrop, Netherlands
Ellis Bos, AB Geldrop, Netherlands
Rogier Van Drumpt, Geldrop, Netherlands
2:30 PM
PAPER: 485
Joint Aspiration during Two Stage Septic Knee Revision Surgery
is Inadequate for Detection of Infection Persistence
Bernd Preininger, MD, Berlin, Germany
Viktor Janz, MD, Berlin, Germany
Philipp Von Roth, MD, Berlin, Germany
Tobias Winkler, MD, Berlin, Germany
Tilman Pfitzner, MD, Berlin, Germany
Andrej Trampuz, MD, Berlin, Germany
Carsten Perka, MD, Berlin, Germany
72
Educational Programs
Tuesday, March 11
2:54 PM
PAPER: 449
Revision Rate and Reasons for Revision Following Resurfacing
Shoulder Replacement in Patients with Osteoarthritis
Jeppe Rasmussen, MD, Brondby, Denmark
Stig Brorson, PhD, Copenhagen, Denmark
Patient reported outcome, revision rate and reason for revision
following resurfacing arthroplasty in patients with osteoarthritis:
837 operations reported to the Danish Shoulder Arthroplasty
Registry.
Discussion 6 minutes
3:06 PM
PAPER: 755
Anterior Cruciate Ligament Reconstruction with Autologous
Ruptured Tissue
Tomoyuki Matsumoto, MD, PhD, Kobe, Japan
Ryosuke Kuroda, MD, Kobe, Japan
Takehiko Matsushita, MD, Kobe, Japan
Daisuke Araki, MD, PhD, Pittsburgh, PA
Yohei Kawakami, MD, Hyogo, Japan
Koji Takayama, MD, PhD, Kobe, Japan
Yuichi Hoshino, MD, Kobe, Japan
Kouki Nagamune, PhD, Fukui, Japan
Masahiro Kurosaka, MD, Kobe, Japan
Tuesday
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 245
Trauma II: Knee/Tibia
Moderator(s): Paul J. Duwelius, MD, Portland, OR
Jason M. Evans, MD, Franklin, TN
1:30 PM
PAPER: 076
Intramedullary Nail and Plate Combinations for Complex Tibial
Fractures: Use Beyond the Proximal Tibia
Richard S. Yoon, MD, New York, NY
Jesse E. Bible, MD, MHS, Nashville, TN
Matthew S. Marcus, MD, Chicago, IL
Justin C. Siebler, MD, Omaha, NE
Derek J. Donegan, MD, Philadelphia, PA
Karl Bergmann, MD, Omaha, NE
Hassan R. Mir, MD, Nashville, TN
Frank A. Liporace, MD, Englewd Clfs, NJ
Combined IMN and plate fixation offers reliable outcomes in
complex tibial fractures distal to the proximal third.
1:36 PM
PAPER: 077
Infection Rates After Intramedullary Nailing of Open Tibial Shaft
Fractures in Low- and Middle-Income Countries
Paul S. Whiting, MD, Boston, MA
Daniel D. Galat, MD, Bomet, Kenya
Lewis G. Zirkle Jr, MD, Richland, WA
An international database analysis of over 6,000 open tibial shaft
fractures treated in low- and middle-income countries with the
SIGN nail revealed an overall infection rate between 3.4% and
12.5%.
PAPER: 078
1:42 PM
Dynamizations and Exchange Nailing: Success Rates and
Indications
Jody Litrenta, MD, Boston, MA
Paul Tornetta III, MD, Boston, MA
Cory A. Collinge, MD, Fort Worth, TX
Heather A. Vallier, MD, Cleveland, OH
Clifford B. Jones, MD, FACS, Grand Rapids, MI
Christiane G. Kruppa, Bochum, Germany
Reza Firoozabadi, MD, Seattle, WA
Kenneth A. Egol, MD, New York, NY
Ross K. Leighton, MD, Halifax, NS, Canada
The purpose of this study is to report on the timing, indications,
and success rates of dynamization and exchange nailing in a
multicenter study and to compare these two techniques where
appropriate.
Discussion 6 Minutes
The first long term results after MACT of the knee demonstrate
that is an effective surgical therapy for full-thickness cartilage
defects with good long term results, in particular for simple defects.
Discussion 6 minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
73
Tuesday, March 11
1:54 PM
PAPER: 079
Are Locked Plates Needed for Split Depression Tibial Plateau
Fractures (OTA type 41B)?
Michelle Abghari, BS, Detroit, MI
Alejandro Marcano, MD, New York, NY
Roy Davidovitch, MD, New York, NY
Sanjit R. Konda, MD, Charlotte, NC
Kenneth A. Egol, MD, New York, NY
Locked and non-locked plating are commonly used implants in
the treatment of Schatzker Type-II, OTA type 41-B tibial plateau
fractures. The effectiveness of these implants is compared in this
study.
PAPER: 080
2:00 PM
Staged Columnar Fixation of Bicondylar Tibial Plateaus: A
Cheaper Alternative to External Fixation
Aaron M. Perdue, MD, Nashville, TN
Jordan C. Apfeld, MD, Nashville, TN
Vasanth Sathiyakumar, Nashville, TN
Young M. Lee, BS, Nashville, TN
Daniel J. Stinner, MD, San Antonio, TX
Hassan R. Mir, MD, Nashville, TN
David J. Polga, MD, Marshfield, WI
William T. Obremskey, MD, MPH, Nashville, TN
Manish K. Sethi, MD, Nashville, TN
PAPER: 081
2:06 PM
Early vs. Delayed External Fixation for High-Energy Tibial
Plateau and Plafond Fractures
Justin Haller, MD, Salt Lake City, UT
David Holt, MD, Salt Lake City, UT
Erik Kubiak, MD, Salt Lake City, UT
Thomas F. Higgins, MD, Salt Lake City, UT
There is no difference in infection rate or number secondary
procedures in early vs. delayed provisional external fixation for
high-energy tibial plateau and plafond fractures.
Discussion 6 Minutes
2:18 PM
PAPER: 082
Management of the Isolated Medial Tibial Plateau Fracture
Steffen Haider, BS, NY City, NY
Roy Davidovitch, MD, New York, NY
Kenneth A. Egol, MD, New York, NY
Isolated medial plateau fractures are heterogeneous with a
low and high-energy pattern with differing management and
outcomes.
2:42 PM
PAPER: 085
Deep Infection After Staged Management of Bicondylar Tibial
Plateau Fractures with Compartment Syndrome
Christian S. Bromfield, MD, Sacramento, CA
Pooya Javidan, MD, Saint Louis, MO
J. Tracy Watson, MD, Saint Louis, MO
The incidence of deep infection with a staged management
protocol of operative fixation after fasciotomy coverage or
closure in 220 bicondylar tibial plateau fractures.
2:48 PM
PAPER: 086
Arthrofibrosis of the Knee After Tibial Plateau Fracture
Justin Haller, MD, Salt Lake City, UT
David Holt, MD, Salt Lake City, UT
Thomas F. Higgins, MD, Salt Lake City, UT
Erik Kubiak, MD, Salt Lake City, UT
High-energy pattern and use of provisional external fixator increase
the risk for arthrofibrosis after tibial plateau fracture. CPM use may
decrease the risk of arthrofibrosis after plateau fracture.
PAPER: 087
2:54 PM
Malunions After Minimally Invasive Percutaneous Plate Fixation
(MIPPF) of Tibia Fractures
Alexandre A. Sitnik, MD, PhD, Minsk, Belarus
Axial malalignments were seen in 28.3% of tibia fractures
treated with MIPPF, deformities more than 5 occurred in 8.3%;
important rotational deformities were noticed in 26.8% of
studied cases.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
2:24 PM
PAPER: 083
Incidence and Management of Tibial Tubercle Fractures in
Bicondylar Fractures of the Tibial Plateau
John A. Scolaro, MD, Irvine, CA
Medardo R. Maroto, MD, Dallas, TX
M. Bradford Henley, MD, MBA, FACS, Seattle, WA
Robert P. Dunbar, MD, Seattle, WA
74
Educational Programs
Tuesday, March 11
3:06 PM
PAPER: 088
Retrograde Nailing of Distal Femur Periprosthetic Fractures:
Malunion by Design?
Benjamin Service, MD, Orlando, FL
William Kang, MD, New Orleans, LA
Nathan Turnbull, MD, Orlando, FL
Joshua Langford, MD, Orlando, FL
George J. Haidukewych, MD, Orlando, FL
Kenneth J. Koval, MD, Belle Isle, FL
This study evaluated how the starting point in retrograde femoral
nailing is affected by TKA femoral prosthesis design. Implants
with deeper trochlear grooves can displace the starting point.
PAPER: 089
3:12 PM
Open, Intra-Articular, Distal Femur Fractures: A Limb
Threatening Injury
Adam Sassoon, MD, Saint Louis, MO
Jeffrey Petrie, MD, Orlando, FL
John Riehl, MD, Louisville, KY
Joshua Langford, MD, Orlando, FL
Kenneth J. Koval, MD, Belle Isle, FL
George J. Haidukewych, MD, Orlando, FL
Tuesday
SYMPOSIUM
4:00 PM 6:00 PM
La Nouvelle Ballroom
Complex Shoulder Instability: Around the World in 120
Minutes (F)
Moderator: Pascal Boileau, MD, Nice, France
An international panel will discuss the current state and the
evolving treatment options for complex shoulder instability.
Additionally, the challenges and management options for
patients with failed instability surgery will be reviewed.
I.
IV.
V.
VI.
VII.
VIII.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
75
Tuesday, March 11
4:00 PM 6:00 PM
Theater C
SYMPOSIUM
II.
III.
4:00 PM 6:00 PM
Theater B
Common Fracture Treatment, Whats the Evidence? (H)
Moderator: Paul Tornetta III, MD, Boston, MA
A realistic synopsis of the current evidence for the treatment
of common fractures. Each talk will be a very concise eight
minutes of evidence and a few tips.
I. Clavicle Fractures: Which Ones REALLY should be
operated on?
Andrew H. Schmidt, MD, Minneapolis, MN
II. Proximal humerus fractures in the older patient: Op vs
Nonop
Andrew Jawa, MD, Cambridge, MA
III. Distal Radius Fractures: ORIF vs Ex fix, Which to Do When
Thomas F. Varecka, MD, Minneapolis, MN
IV.
V. Intertrochanteric Fractures:
When to Plate and When to Nail
Robert A. Probe, MD, Temple, TX
TICKET
Room
260
Room
221
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
SYMPOSIUM
IX.
76
Educational Programs
Tuesday, March 11
163
TICKET
IEF
167
TICKET
Tuesday
165
TICKET
Room
215 Review
166
TICKET
Room
218
Improving Orthopaedic Operating Room Efficiency Strategies to Improve Throughout and Patient Safety
Moderator: Naven Duggal, MD, Manlius, NY
Ryan Graue, Cambridge, MA
A number of strategies can be utilized to improve
orthopaedic operating room efficiency and patient safety.
Learn how to use these principles in the preoperative,
intraoperative and postoperative settings to improve
throughput and safety in your operating room.
Room
208
168
TICKET
TICKET
Through presentation by lecture, video and case
Room
discussion, registrants will learn a safe and effective
207
technique of unconstrained and reverse shoulder
arthroplasty.
169
Surgical Management of Cervical Spondylotic
Myelopathy
Moderator: James Kang, MD, Pittsburgh, PA
Joon Y. Lee, MD, Pittsburgh, PA
Room
Clinton J. Devin, MD, Nashville, TN
347
Chris A. Cornett, MD, Omaha, NE
TICKET
276
171
TICKET
Room
356
Educational Programs
77
Tuesday, March 11
172
TICKET
Room
352
PAPER PRESENTATION
4:00 PM 6:00 PM
Theater A
Spine I: Deformity
Moderator(s):Norman B. Chutkan, MD, Augusta, GA
Mark D. Rahm, MD, Temple, TX
4:00 PM
PAPER: 091
Evaluating the Extent of Clinical Variability Among Treatment
Options for Patients with Adult Spinal Deformity
Philippe T. Phan, MD, Ottawa, ON, Canada
Avraam L. Ploumis, MD, PHD, Thessaloniki, Greece
Kathryn Hess, Boston, MA
Kirkham B. Wood, MD, Boston, MA
4:06 PM
PAPER: 092
The Value of Surgical Pathology in Revision Posterior
Instrumented Spine Surgery
Jia-Wei Kevin Ko, MD, Portland, OR
Alexander C. Ching, MD, Portland, OR
Penelope Barnes, MBBS, PhD, Portland, OR
PAPER: 093
4:12 PM
Adult Spinal Deformity: Clinical and Radiological Analysis using
Community-based Cohort
Tetsuya Kobayashi, Asahikawa, Japan
PAPER: 096
4:36 PM
Satisfaction after Adult Spinal Deformity Surgery is Not Driven
by HRQoL Scores or Curve Correction
D. Kojo Hamilton, Portland, OR
Jayme Hiratzka, MD, Portland, OR
Christopher I. Shaffrey, MD, Charlottesville, VA
Robert S. Bess, MD, Castle Rock, CO
Christopher Ames, MD, San Francisco, CA
Gregory M. Mundis, MD, San Diego, CA
Virginie Lafage, PhD, New York, NY
Robert A. Hart, MD, Portland, OR
International Spine Study Group, Brighton, CO
Discussion 6 Minutes
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
4:24 PM
PAPER: 094
Antifibrinolytics in Adult Spinal Deformity Surgery: A
Prospective Randomized Controlled Trial
Thomas Cheriyan, New York, NY
Kseniya Slobodyanyuk, BA, New York, NY
Austin Peters, BS, NY City, NY
Kushagra Verma, MD, Philadelphia, PA
Frank J. Schwab, MD, New York, NY
Christian M. Hoelscher, MD, Philadelphia, PA
T. Kate Huncke, New York, NY
Baron Lonner, MD, New York, NY
Thomas J. Errico, MD, New York, NY
78
Educational Programs
Tuesday, March 11
4:48 PM
PAPER: 097
Adult
Spinal
Deformity
Patients
Treated
with
rhBMP-2
Have
Tuesday
5:12 PM
PAPER: 100
Biomechanical Demands on Posterior Fusion Instrumention
During Lordosis Restoration Procedures
Calvin Kuo, MD, Louisville, KY
Connor J. Telles, MD, Fresno, CA
Audrey Martin, Torrance, CA
Jeremi M. Leasure, MS, San Francisco, CA
Christopher Ames, MD, San Francisco, CA
Dimitriy G. Kondrashov, MD, San Francisco, CA
The goal of this study is to investigate the forces placed on
posterior fusion instrumentation by three commonly used
techniques to restore lumbar lordosis.
PAPER: 101
5:18 PM
Suitability of Stand-alone ALIF as Replacement for
Supplemental Posterior Fixation in Long Fusion Constructs
Morsi Khashan, Jaffa Tel Aviv, Israel
William Camisa, MS, San Francisco, CA
Sigurd H. Berven, MD, San Francisco, CA
Jeremi M. Leasure, MS, San Francisco, CA
We hypothesized that in long L1-S1 fusion, ALIF cages reduce
strain on S1 screws comparably to bilateral iliac fixation.
PAPER: 102
5:24 PM
Anterior Column Realignment (ACR) has Similar Results to PSO
in Adult Spinal Deformity
Gregory M. Mundis, MD, San Diego, CA
Behrooz A. Akbarnia, MD, La Jolla, CA
Nima Kabirian, MD, San Diego, CA
Jeff Pawelek, La Jolla, CA
Robert K. Eastlack, MD, San Diego, CA
Christopher I. Shaffrey, MD, Charlottesville, VA
Eric O. Klineberg, MD, Sacramento, CA
Virginie Lafage, PhD, New York, NY
International Spine Study Group, Brighton, CO
ACR was equally as effective in correcting lumbar lordosis,
T1 pelvic angle, more effective in correcting pelvic tilt when
compared to PSO. ACR had less EBL than PSO and an equal
complication profile.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
79
Tuesday, March 11
5:36 PM
PAPER: 103
rhBMP-2
Use
in
Adult
Spinal
Deformity
Does
Not
Increase
PAPER: 105
5:48 PM
Analysis of Mechanical Failure Associated with Reoperation in
Long Fusion to Sacrum in Adult Spinal Deformity
Shinichi Inoue, MD, San Francisco, CA
Sigurd H. Berven, MD, San Francisco, CA
Morsi Khashan, Jaffa Tel Aviv, Israel
Takahito Fujimori, MD, MSc, Osaka, Japan
Vedat Deviren, MD, San Francisco, CA
Shane Burch, MD, San Anselmo, CA
Bobby Tay, MD, San Francisco, CA
Serena S. Hu, MD, Redwood City, CA
We investigated retrospectively that the incidence, risk factors,
and clinical outcomes of mechanical failure associated with
reoperation in 76 patients who underwent long fusion to the
sacrum.
4:00 PM 6:00 PM
Room 245
Foot and Ankle I: Forefoot and Outcomes
Moderator(s):Jamal Ahmad, MD, Philadelphia, PA
Brian Toolan, MD, Chicago, IL
4:00 PM
PAPER: 106
Long-Term Patient Perceived and Radiographic Outcomes of the
Scarf Bunionectomy: A Cross Sectional Study
Erin E. Klein, DPM, MS, Grayslake, IL
Lowell S. Weil, DPM, Lake Forest, IL
Adam Fleischer, DPM, MPH, North Chicago, IL
Mitchell B. Sheinkop, MD, Chicago, IL
The scarf bunionectomy is an effective procedure where high
patient perceived outcome scores are maintained over time but
lack correlation with radiographic outcomes.
4:06 PM
PAPER: 107
Crossed Screw Provides Greater Gapping Resistance Than
Compression Locking Plate for Lapidus Procedure
Sriniwasan Mani, BS, New York, NY
Jeremy Y. Chan, BS, New York, NY
Ettore Vulcano, MD, Varese, Italy
Josh R. Baxter, PhD, New York, NY
Scott Ellis, MD, New York, NY
Crossed lag screws were found to provide greater stiffness and
gapping resistance at the first TMT joint when compared to
compression locking plates in a cadaveric model.
PAPER: 108
4:12 PM
Union Rates of First Tarsometatarsal Arthrodesis (Lapidus
Procedure) Using Calcaneal Bone Graft
Eric W. Lloyd, MD, Boca Raton, FL
Matthew Roberts, MD, New York, NY
David S. Levine, MD, Bedford, NY
Sriniwasan Mani, BS, New York, NY
Scott Ellis, MD, New York, NY
The use of careful technique and calcaneal bone graft can
effectively decrease the rate of nonunion during a Lapidus
procedure for hallux valgus.
Discussion 6 Minutes
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
PAPER PRESENTATION
80
Educational Programs
Tuesday, March 11
4:24 PM
PAPER: 109
Clinical and Radiographic Testing in Second
Metatarsophalangeal Joint High Grade Plantar Plate Tears
Erin E. Klein, DPM, MS, Grayslake, IL
Adam Fleischer, DPM, MPH, North Chicago, IL
Lowell S. Weil, DPM, Lake Forest, IL
Lowell S. Weil, DPM, Des Plaines, IL
Mitchell B. Sheinkop, MD, Chicago, IL
Michael J. Coughlin, MD, Boise, ID
A positive drawer test and pain for >2 years coupled with a
transverse plane deviation of the 3rd MTP joint strongly suggests
a 2nd MTP joint plantar plate tear.
PAPER: 110
4:30 PM
Effect of Operation for Lessor Toes Deformity Concomitant with
Hallux Valgus on Clinical Outcomes
Byung-Ki Cho, MD, Cheongju, Republic of Korea
Yong-Min Kim, MD, Cheongju, Republic of Korea
Hyun-Chul Shon, MD, Cheongju, Republic of Korea
Kyoung Jin Park, MD, Cheongju, Republic of Korea
Tuesday
4:48 PM
PAPER: 112
Clinical Outcomes of Distal Metatarsal Osteotomy using
Biocompression Screw for Advanced Hallux Rigidus
Byung-Ki Cho, MD, Cheongju, Republic of Korea
Yong-Min Kim, MD, Cheongju, Republic of Korea
Hyun-Chul Shon, MD, Cheongju, Republic of Korea
Kyoung Jin Park, MD, Cheongju, Republic of Korea
4:54 PM
PAPER: 113
Detection of In-Vivo Foot and Ankle Implants by Walk-Through
Metal Detectors
Sriniwasan Mani, BS, New York, NY
Jeremy Y. Chan, BS, New York, NY
Phillip Williams, MD, New York, NY
Matthew Roberts, MD, New York, NY
David S. Levine, MD, Bedford, NY
Jonathan T. Deland, MD, New York, NY
Scott Ellis, MD, New York, NY
Due to the increased use of metal detectors in airports, we studied
the detection rate of common foot and ankle implants in vivo and
found that all implants studied went undetected.
5:00 PM
PAPER: 114
Cigarette Smoking Increases Complication Rate in Forefoot
Surgery
Clayton C. Bettin, MD, Memphis, TN
Susan N. Ishikawa, MD, Cordova, TN
Garnett A. Murphy, MD, Germantown, TN
David R. Richardson, MD, Memphis, TN
Erin M. Dean, MD, Hudson, OH
Kelly R. McCormick, MD, Salem, OR
Kellen H. Gower, BS, Lewisburg, TN
Cigarette smokers were found to have a significantly higher
complication rate (36.4%) in forefoot surgery than patients who
previously (16.5%) or never (8.5%) smoked in this retrospective
review.
Discussion 6 Minutes
5:12 PM
PAPER: 115
Validation of the Foot and Ankle Outcome Score for Hallux
Rigidus
MaCalus Hogan, MD, Wexford, PA
Sriniwasan Mani, BS, New York, NY
Jeremy Y. Chan, BS, New York, NY
Huong Do, MA, New York, NY
Stephen Lyman, PhD, New York, NY
Jonathan T. Deland, MD, New York, NY
Scott Ellis, MD, New York, NY
A valid and reliable patient-centered outcome assessment for
hallux rigidus is needed. In this study the FAOS is validated for
hallux rigidus.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
81
Tuesday, March 11
5:18 PM
PAPER: 116
SF36 PF vs. PF CAT vs. LE CAT: Time for a Paradigm Shift with
Outcomes Measurement
Man Hung, PhD, Salt Lake City, UT
Jeremy D. Franklin, Salt Lake City, UT
Shirley Hon, Salt Lake City, UT
Christine Cheng, Salt Lake Cty, UT
Jillian Conrad, BS, Salt Lake City, UT
Charles L. Saltzman, MD, Salt Lake City, UT
5:42 PM
PAPER: 119
Validity of the Self-reported Foot and Ankle Score (SEFAS) in
Patients with Forefoot, Hindfoot and Ankle Disorders
Maria C. Coster, MD, Kalmar, Sweden
Ann Bremander, PT, PhD, Oskarstrm, Sweden
Bjorn Rosengren, MD, PhD, Malmo, Sweden
Hakan Magnusson, Malmo, Sweden
Ake S. Carlsson, MD, PhD, Malmo, Sweden
Magnus Karlsson, MD, Malmo, Sweden
5:24 PM
PAPER: 117
Comparison of the PROMIS Physical Function CAT with the FFI
and FAAM for Foot and Ankle Disorders
Man Hung, PhD, Salt Lake City, UT
Judith F. Baumhauer, MD, MPH, Rochester, NY
Timothy R. Daniels, MD, FRCSC, Toronto, ON, Canada
Scott Ellis, MD, New York, NY
Jeremy D. Franklin, Salt Lake City, UT
Daniel Latt, MD, PhD, Tucson, AZ
Nelson F. SooHoo, MD, Los Angeles, CA
Charles L. Saltzman, MD, Salt Lake City, UT
Kenneth Hunt, MD, Redwood City, CA
PAPER: 120
5:48 PM
Foot and Ankle Complication Rates of First-Time Board
Certification Applicants Versus Recertification Applicants
Joshua Hunter, MD, Rochester, NY
Sara L. Miniaci, MD, Rochester, NY
Judith F. Baumhauer, MD, MPH, Rochester, NY
Our study evaluates the American Board of Orthopaedic
Surgeons case lists from orthopaedic foot and ankle surgeons
seeking initial board certification and recertification.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Tuesday
5:36 PM
PAPER: 118
Validation of Two Foot and Ankle Scores - SEFAS (Self-reported
Foot And Ankle Score) and AOFAS
Maria C. Coster, MD, Kalmar, Sweden
Ann Bremander, PT, PhD, Oskarstrm, Sweden
Bjorn Rosengren, MD, PhD, Malmo, Sweden
Hakan Magnusson, Malmo, Sweden
Ake S. Carlsson, MD, PhD, Malmo, Sweden
Magnus Karlsson, MD, Malmo, Sweden
82
Educational Programs
Wednesday, March 12
SYMPOSIUM
8:00 AM 10:00 AM
La Nouvelle Ballroom
Wednesday
II.
III.
IV.
V.
VI.
VII.
VIII.
IX.
X.
XI.
XII.
XIII.
SYMPOSIUM
8:00 AM 10:00 AM
Theater C
Common Tendon Disorders Around the Foot and Ankle (J)
Moderator: Steven L. Haddad, MD, Glenview, IL
Explore tendon disorders and disruption about the foot and
ankle. Explore sports injuries and degenerative conditions, and
how they influence normal tendon function, and the options
following failure. Cutting edge technology will undergo critical
review, and need for simultaneous realignment procedures
explored. Registrant will have a comprehensive understanding
of tendon pathology in the foot and ankle.
I. Tendons: Why Do They Fail? The Pathophysiology of
Tendon Function
Gregory C. Berlet, MD, Westerville, OH
II. Posterior Tibial Tendon Dysfunction: Restoring the
Flatfoot
Robert B. Anderson, MD, Charlotte, NC
III. Achilles Tendon Disorders: Sorting Through PRP,
Percutaneous vs Open Repair, and Chronic Ruptures,
Evidence Based Medicine
J. Chris Coetzee, MD, Edina, MN
IV.
SYMPOSIUM
8:00 AM 10:00 AM
Theater B
How Do You Know It Is True? Integrity in Research and
Publications (K)
Moderator: Regis J. OKeefe, MD, Rochester, NY
The current high stakes research environment can lead to
plagiarism, data manipulation, bias, and improper statistics.
Professional societies and orthopaedic leaders can ensure
scientific integrity in the development of evidence-based
practices.
I. Stretching the Truth in Research: from the Subtle to the
Obvious and from the Accidental to the Intentional
Joseph A. Buckwalter, MD, Iowa City, IA
II. Professional Societies, Journals, and the Review
Process: Ensuring Accuracy in Research
Vernon T. Tolo, MD, Los Angeles, CA
III.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
83
Wednesday, March 12
206
TICKET
8:00 AM 10:00 AM
201
Room
207
Room
208
TICKET
Room
218
Room
226
271
Rivergate
Room
208
TICKET
Room
276
209
TICKET
Room
356 Provides
210
TICKET
Room
221
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
TICKET
Room
204
84
Educational Programs
Wednesday, March 12
211
TICKET
Room
347
Room
350
213
TICKET
Room
270
Wednesday
Room
262
215
TICKET
Room
349
FD3
Techniques for Internationals Submitting Abstracts
Room and Educational Programming Proposals to US
217
Educational Programs
Moderator: Guido Marra, MD, Chicago, IL
Stefano A. Bini, MD, San Francisco, CA
Joaquin Sanchez-Sotelo, MD, Rochester, MN
Designed to help international orthopaedic surgeons
understand how to adjust or write an abstract or
ICL application in order to increase the likelihood
of acceptance in US literature or US educational
programming. Principles and suggested techniques will
be discussed for writing submissions that are focused,
concise, clear and unbiased.
PAPER PRESENTATION
8:00 AM 10:00 AM
Theater A
Shoulder and Elbow II: Shoulder Instability and Sports Medicine
Moderator(s):Joseph A. Abboud, MD, Philadelphia, PA
Frank Cordasco, MD, New York, NY
8:00 AM
PAPER: 121
What Functional Magnetic Resonance Imaging Tells us About
Complex Shoulder Instability
Anthony Howard, MD, Liverpool, United Kingdom
David Hawkes, MD, Liverpool, United Kingdom
Jo Gibson, Liverpool, United Kingdom
Omid Alizadehkhaiyat, MD, Liverpool, United Kingdom
Margaret M. Roebuck, PhD, Liverpool, United Kingdom
Graham Kemp, DM, Liverpool, United Kingdom
Simon Frostick, MD, Liverpool, United Kingdom
This is the first fMRI study of patients with Polar Type III
Shoulder instability. Given the plasticity of the cortex, the
difference in cortical activation of this group, it could change
treatment.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
85
Wednesday, March 12
8:06 AM
PAPER: 122
A Computational Assessment of Hill-Sachs Defect Size as it
Relates to Glenohumeral Stability
Mark F. Welsh, BS, London, ON, Canada
Ryan Willing, PhD, London, ON, Canada
Josh W. Giles, BESc, London, ON, Canada
George S. Athwal, MD, London, ON, Canada
James A. Johnson, PhD, London, ON, Canada
8:36 AM
PAPER: 126
Arthropathy after the Bristow-latarjet Repair for Shoulder
Instability: A 33-35 Years Follow Up of 31 Shoulders
Lennart Hovelius, MD, Gavle, Sweden
Vladislavs Gordins, MD, Gvle, Sweden
Bjorn Sandstrom, MD, Gavle, Sweden
Hans Rahme, MD, Uppsala State, Sweden
Ulrica Bergstrom, MD, Umea, Sweden
PAPER: 123
8:12 AM
Frequency and Size of Humeral and Glenoid Bone Defects in
Patients with Shoulder Instability
David Cantu Morales, MD, Puebla, Mexico
Michell Ruiz Suarez, MD, MS, Mexico City, Mexico
David Cantu Morales, MD, Puebla, Mexico
Ivan Encalada, MD, Mexico City, Mexico
Fernando Valero, MD, Mexico City, Mexico
Humeral and glnoid defects are frequent in shoulder instability.
Humeral defects are more frequent, but glenoid defects are larger.
Discussion 6 Minutes
8:24 AM
PAPER: 124
Increasing Number and Total Time of Dislocation Affect Surgical
Management of Anterior Shoulder Instability
Patrick J. Denard, MD, Medford, OR
Xuesong Dai, Hangzhou, China
Stephen S. Burkhart, MD, San Antonio, TX
Increasing number and total time of dislocation are associated
with the development of glenoid and humeral head bony lesions
that alter surgical management of anterior shoulder instability.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
8:30 AM
PAPER: 125
Is the Effectiveness of Bristow-latarjet Procedure Related to the
Fate of the Bone-block? A Prospective Study
Antonio Vadala, MD, Rome, Italy
Cristina Rossi, Rome, Italy
Alessandro Ciompi, MD, Roma, Italy
Domenico Lupariello, Matera, Italy
Alessandro Maria Agr, MD, Rome, Italy
Giuseppe Argento, MD, Rome, Italy
Angelo De Carli, MD, Rome, Italy
Andrea Ferretti, MD, Rome, Italy
8:48 AM
PAPER: 127
Return to Sport after Recurrent Shoulder Instability: Open
Latarjet vs. Arthroscopic Bankart Repair
Davide Blonna, MD, Torino, Italy
Francesco Pasquero, Chieri, Italy
Francesco Caranzano, MD, Turin, Italy
Umberto Mariotti, Milan, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Umberto Cottino, Pecetto Torinese, Italy
Davide E. Bonasia, MD, Torino, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Filippo Castoldi, MD, Torino, Italy
86
Educational Programs
Wednesday, March 12
9:12 AM
PAPER: 130
Latarjet Procedure: Biomechanical Evaluation of Coracoid
Fixation
Andrew Green, MD, Providence, RI
Douglas A. Scott, MD, Hilton Head, SC
David Paller, MS, Providence, RI
Latarjet fixation employing fully-threaded screws is
biomechanically superior to partially threaded screws. Better
fixation may improve the healing rate and reduce the risk of
hardware complications.
PAPER: 131
9:18 AM
The Bristow and Latarjet Procedures are Not Equivalent: A
Biomechanical Comparison
Josh W. Giles, BESc, London, ON, Canada
Ryan Degen, MD, London, ON, Canada
James A. Johnson, PhD, London, ON, Canada
George S. Athwal, MD, London, ON, Canada
This biomechanical comparison found that these two procedures
produce equivalent stability when used to treat instability with
preserved glenoid anatomy but the Latarjet is superior in bone
loss situations.
9:24 AM
Neuromonitoring the Latarjet Procedure
Ruth A. Delaney, MD, Boston, MA
Michael T. Freehill, MD, Winston-Salem, NC
David R. Janfaza, MD, Boston, MA
Kamen Vlassakov, MD, Boston, MA
Laurence D. Higgins, MD, Boston, MA
Jon J. Warner, MD, Boston, MA
PAPER: 132
Wednesday
Discussion 6 Minutes
9:36 AM
PAPER: 133
30-Day Morbidity and Mortality Following Elective Shoulder
Arthroscopy: A Review of 9,410 Cases
Christopher T. Martin, MD, Iowa City, IA
Yubo Gao, PhD, Iowa City, IA
Andrew J. Pugely, MD, Iowa City, IA
Brian R. Wolf, MD, Iowa City, IA
We reviewed 9410 cases of shoulder arthroscopy to identify
risk factors for 30-day complications. Smoking history, history
of COPD, operative time >1.5 hrs, and ASA class 3 were
significant.
9:42 AM
PAPER: 134
Histopathologic Analysis of the Extra-Articular Portion of the
Long Head of the Biceps Tendon and Tenosynovium
Samuel Dubrow, MD, Omaha, NE
Jonathan Streit, MD, Cleveland, OH
Yousef Shishani, MD, Cleveland, OH
Stephanie Muh, MD, Birmingham, MI
Mark Rodgers
Reuben Gobezie, MD, Mayfield Heights, OH
We present a histopathologic analysis of the extra-articular biceps
tendon supporting the concept that the pathologic changes are
due to a degenerative process that is seen in other tendinopathies.
PAPER: 135
9:48 AM
Biceps Tenodesis: How Low Do You Go? A Comparison of
Arthroscopic Suprapectoral and Open Subpectoral Techniques
Brian C. Werner, MD, Charlottesville, VA
Matthew L. Lyons, MD, Charlottesville, VA
Eric W. Carson, MD, Charlottesville, VA
David R. Diduch, MD, Charlottesville, VA
Mark D. Miller, MD, Charlottesville, VA
Stephen F. Brockmeier, MD, Charlottesville, VA
Arthroscopic suprapectoral and open subpectoral techniques
result in significantly different locations of biceps tenodesis.
Discussion 6 Minutes
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 245
Practice Management/Rehabilitation I: Quality Improvement
Moderator(s):Thomas Malvitz, MD, Grand Rapids, MI
Paul Saiz, MD, Las Cruces, NM
8:00 AM
PAPER: 136
A PCR Protocol to Test for Methicillin-Resistant S. aureus
Carriage in Orthopaedic Trauma Patients
Richard D. Southgate, MD, Rochester, NY
Holman Chan, MD, Henderson, NV
John P. Ketz, MD, Pittsford, NY
Catherine A. Humphrey, MD, Rochester, NY
Jonathan M. Gross, MD, Rochester, NY
John T. Gorczyca, MD, Rochester, NY
Rapid PCR amplification identified 7.4% of orthopaedic trauma
patients at a single center as MRSA carriers. Results, available
within 4 hours, allowed for tailoring of perioperative antibiotics.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
87
Wednesday, March 12
8:06 AM
PAPER: 137
Efficacy
of
Antifibrinolytics
on
Surgical
Bleeding
in
8:24 AM
PAPER: 139
Incidence of Failure of Continuous Peripheral Nerve Catheters
for Post-operative Analgesia in Orthopaedic Surgery
Zahab Ahsan, BS, Indianapolis, IN
Jeffrey Yao, MD, Redwood City, CA
The potential of postoperative continuous peripheral nerve block
failure and resulting breakthrough pain upon recovery from the
primary nerve block is important to emphasize to patients.
8:48 AM
PAPER: 142
Its Not Just Demographics; Injury Type and Emergency Room
Care of Orthopaedic Patients Influences Follow-Up Rates
Michelle M. Coleman, MD, Charlotte, NC
Laura N. Medford-Davis, MD, Houston, TX
Omar H. Atassi, MD, Houston, TX
Angela Siler-Fisher, MD, Houston, TX
Charles A. Reitman, MD, Houston, TX
This retrospective study of 464 patients highlights distinct
orthopaedic-related factors associated with no-show to
orthopaedic follow-up after Emergency Department visit.
8:54 AM
PAPER: 143
Patients Perception of Care Correlates with Quality of Hospital
Care: A Survey of 4,605 Hospitals
Spencer M. Stein, New York, NY
Michael S. Day, MD, New York, NY
Raj Karia, MPH, New York, NY
Lorraine Hutzler, BA, New York, NY
Joseph A. Bosco III, MD, New York, NY
The patients perception of the care they received is a key
performance metric and is being used to determine payments to
hospitals.
PAPER: 144
9:00 AM
An Orthopaedic-Hospitalist Co-Managed Hip Fracture Service
Reduces Inpatient Length of Stay
Daniel Bracey, MD, Winston Salem, NC
Cynthia L. Emory, MD, Winston Salem, NC
Kamran S. Hamid, MD, MPH, Winston-Salem, NC
Rebecca L. Pareja, BS, Winston-Salem, NC
Johannes F. Plate, MD, Winston Salem, NC
Erik C. Summers, MD, Winston-Salem, NC
Riyaz H. Jinnah, MD, Winston-Salem, NC
Since implementing an orthopaedic-hospitalist co-managed hip
fracture service line at our institution in March 2012, hip fracture
inpatient length of stay has been significantly reduced by 1.41
days.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
8:30 AM
PAPER: 140
Predictors of Musculoskeletal Injury-related Outcome in
American Soldiers: A Prognostic Analysis
Andrew J. Schoenfeld, MD, Ann Arbor, MI
Gens P. Goodman, DO, El Paso, TX
Philip J. Belmont Jr, MD, El Paso, TX
8:36 AM
PAPER: 141
The Effect of Discharge Disposition on Readmission Rates
following Total Joint Arthroplasty
Nicholas Ramos, MD, New York, NY
Raj Karia, MPH, New York, NY
Lorraine Hutzler, BA, New York, NY
Aaron Brandt, New York, NY
James D. Slover, MD, New York, NY
Joseph A. Bosco III, MD, New York, NY
88
Educational Programs
Wednesday, March 12
9:12 AM
PAPER: 145
Development of an Outpatient Total Knee Replacement Pathway
Geoffrey F. Dervin, MD, Ottawa, ON, Canada
Brendan ONeill, MD, Ottawa, ON, Canada
Through a well-coordinated team approach, length of stay
following TKA can be successfully reduced to outpatient without
compromising patient care in selected, healthy patients.
9:18 AM
PAPER: 146
The Impact of Resident Involvement on Post-operative
Morbidity and Mortality Following Orthopaedic Procedures
Andrew J. Schoenfeld, MD, Ann Arbor, MI
Philip J. Belmont Jr, MD, El Paso, TX
Julia O. Bader, PhD, El Paso, TX
8:00 AM 10:00 AM
Room 265
Pediatrics I: Spine
Moderator(s):Anthony A Scaduto, MD, Los Angeles, CA
Suken A. Shah, MD, Wilmington, DE
9:24 AM
PAPER: 147
A Pre-Surgical Questionnaire for Urinary Tract Infections and
Bleeding Disorders in Arthroplasty Patients
Ying-Ying J. Kao, MD, San Francisco, CA
Alicia Kalamas, MD, Piedmont, CA
Kevin J. Bozic, MD, MBA, San Francisco, CA
The purpose of this study was to develop and validate a brief preoperative tool to screen for urinary tract infections and bleeding
disorders in pre-surgical arthroplasty patients.
Discussion 6 Minutes
Wednesday
9:48 AM
PAPER: 150
The Safety of Outpatient Hand and Upper Extremity Surgery - A
Statistical Review of Complications in 28,737 Cases
Sameer Jain, MD, Columbus, OH
Joseph E. Imbriglia, MD, Wexford, PA
9:36 AM
PAPER: 148
Readmission Burden of 30-day Readmissions Following Total
Joint Replacement Among Medicare Beneficiaries
Joseph A. Bosco III, MD, New York, NY
Lorraine Hutzler, BA, New York, NY
Alexa J. Karkenny, BS, Montvale, NJ
James D. Slover, MD, New York, NY
Richard Iorio, MD, New Rochelle, NY
We reviewed the hospital cost burden of 30 day readmissions
following primary and revision total joint arthroplasty (TJA) to
examine the financial implications of the episode of care payment
model.
9:42 AM
PAPER: 149
An Analysis of Cancelled Surgeries: Implications for Clinical
Operations and Resource Utilization
Roshan P. Shah, MD, JD, Chicago, IL
Stuart D. Kinsella, BA, Philadelphia, PA
Craig L. Israelite, MD, Philadelphia, PA
PAPER PRESENTATION
8:00 AM
PAPER: 151
An Evaluation of the Validity of a DNA-Based Prognostic Test for
Adolescent Idiopathic Scoliosis
Benjamin D. Roye, MD, New York, NY
Margaret Wright, BS, New York, NY
Hiroko Matsumoto, MA, New York, NY
Petya Yorgova, MS, Wilmington, DE
Geraldine Neiss, PhD, Wilmington, DE
Joshua E. Hyman, MD, New York, NY
David P. Roye Jr, MD, New York, NY
Suken A. Shah, MD, Wilmington, DE
Michael G. Vitale, MD, MPH, Irvington, NY
This is the first study to independently evaluate the ability of the
Scoliscore, a DNA-based prognostic test, to stratify risk of curve
progression in patients with Adolescent Idiopathic Scoliosis.
8:06 AM
PAPER: 152
Minimum 20-Year Health Related Quality of Life and Surgical
Rates for Treatment of Adolescent Idiopathic Scoliosis
Annalise N. Larson, MD, Rochester, MN
Ali Ashraf, MD, Garland, TX
David W. Polly Jr, MD, Minneapolis, MN
Yaser M. Baghdadi, MD, Rochester, MN
Michael J. Yaszemski, MD, PhD, Rochester, MN
Retrospective survey study of patients who underwent treatment
with surgery, bracing, or observation for the treatment of
adolescent idiopathic scoliosis (AIS) with minimum 20-year
follow-up.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
89
Wednesday, March 12
8:12 AM
PAPER: 153
Symptomatic Operative AIS Patients - Can Their Increased
Perception of Deformity Be Changed?
Anna McClung, RN, Dallas, TX
Daniel J. Sucato, MD, MS, Dallas, TX
Symptomatic patients with operative AIS scored worse on the
SRS-30 compared to non-symptomatic peers. Postoperatively
symptomatic patients scores improved and were comparable to
non-symptomatic.
Discussion 6 Minutes
8:24 AM
PAPER: 154
Clinical and Economic Implications of Early Discharge Following
Posterior Spinal Fusion for AIS
Nicholas D. Fletcher, MD, Atlanta, GA
Nader A. Shourbaji, MD, Atlanta, GA
Phillip Mitchell, MD, Nashville, TN
Timothy S. Oswald, MD, Marietta, GA
Dennis P. Devito, MD, Atlanta, GA
Robert W. Bruce, MD, Atlanta, GA
Early discharge on post operative day 2 or 3 is possible following
PSF for AIS with no increase in complications.
8:30 AM
PAPER: 155
Increasing Hospital Charges in Adolescent Idiopathic Scoliosis
Fusions
Christopher T. Martin, MD, Iowa City, IA
Andrew J. Pugely, MD, Iowa City, IA
Yubo Gao, PhD, Iowa City, IA
Sergio A. Mendoza-Lattes, MD, Iowa City, IA
Ryan M. Ilgenfritz, MD, Iowa City, IA
Stuart L. Weinstein, MD, Iowa City, IA
Implant charges for AIS fusions increased 24% annually, while
physicians charges increased only 1.3%, and all other charges
increased only 7.5%. Implants are the primary drivers of
increased charges.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER: 156
8:36 AM
Axial Rotation Correction in Adolescent Idiopathic Scoliosis with
Pedicle Screw Construct
Arash A. Dini, MD, New Orleans, LA
Mae E. Young, MD, New Orleans, LA
Katherine Faust, MD, New Orleans, LA
Meghan Brashear, MPH, New Orleans, LA
Kristen L. Stupay, BA, New Orleans, LA
James T. Bennett, MD, New Orleans, LA
8:48 AM
PAPER: 157
Safety and Efficacy of Power-Assisted Pedicle Tract Preparation
and Pedicle Screw Placement
Derek A. Seehausen, BA, Los Angeles, CA
Lindsay Andras, MD, Los Angeles, CA
Yashar Javidan, MD, Los Angeles, CA
David L. Skaggs, MD, Los Angeles, CA
90
Educational Programs
Wednesday, March 12
9:12 AM
PAPER: 160
Growing
Rods
vs.
Shilla:
Better
Cobb
Angle
Correction
and T1
S1 Length Increase but More Surgeries
Lindsay Andras, MD, Los Angeles, CA
Elizabeth Joiner, BS, Los Angeles, CA
Richard E. McCarthy, MD, Little Rock, AR
Scott J. Luhmann, MD, Saint Louis, MO
Paul D. Sponseller, MD, Baltimore, MD
John B. Emans, MD, Boston, MA
David L. Skaggs, MD, Los Angeles, CA
Growing Spine Study Group, Milwaukee, WI
In this case matched series, dual growing rods demonstrated a
greater increase in T1- S1 length, better Cobb correction but
more than twice the number of surgeries compared to Shilla.
9:18 AM
PAPER: 161
Traditional
Growing
Rods
vs.
Magnetically
Controlled
Wednesday
9:36 AM
PAPER: 163
Predicting Failure of Iliac Fixation in Neuromuscular Spine
Deformity
Sumeet Garg, MD, Aurora, CO
Courtney A. Holland, MD, El Paso, TX
Jaren Lagreca, BA, Aurora, CO
Bryan McNair, MS, Aurora, CO
Mark A. Erickson, MD, Aurora, CO
From 2001-2009, 27% (27/100) of patients with NM scoliosis
had failure of iliac fixation. Patients with flaccid tone had lower
risk, and use of a distal crosslink trended towards protective
effect.
PAPER: 164
9:42 AM
While Inconvenient, Baclofen Pumps Do Not Complicate
Scoliosis Surgery in Cerebral Palsy Patients
Burt Yaszay, MD, San Diego, CA
James D. Bomar, San Diego, CA
Paul D. Sponseller, MD, Baltimore, MD
Suken A. Shah, MD, Wilmington, DE
Jahangir Asghar, MD, Coral Gables, FL
Amer Samdani, MD, Philadelphia, PA
Tracey Bastrom, MA, San Diego, CA
Peter O. Newton, MD, San Diego, CA
Harms Study Group, San Diego, CA
This study suggests no increased risk of wound complications or
operative time with the presence of a baclofen pump for patients
with Cerebral Palsy who undergo scoliosis correction surgery.
9:24 AM
PAPER: 162
The Fate of the Neuromuscular Hip After Spinal Fusion
Lindsay M. Crawford, MD, Houston, TX
Jose A. Herrera Soto, MD, Orlando, FL
John Ruder, BS, Orlando, FL
Kathryn M. Peck, MD, Indianapolis, IN
Jonathan H Phillips, MD, Orlando, FL
Dennis R. Knapp Jr, MD, Orlando, FL
PAPER: 165
9:48 AM
Are MRSA Nare Cultures Predictors of Infection in Adolescent
Idiopathic and Neuromuscular Scoliosis
Jose A. Herrera Soto, MD, Orlando, FL
Kathryn M. Peck, MD, Indianapolis, IN
Lindsay M. Crawford, MD, Houston, TX
Jonathan H. Wilhite, MD, Indianapolis, IN
Jonathan H Phillips, MD, Orlando, FL
Dennis R. Knapp Jr, MD, Orlando, FL
Brandon A. Ramo, MD, Dallas, TX
Discussion 6 Minutes
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
91
Wednesday, March 12
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 345
Hand and Wrist I: Hand
Moderator(s):Charles F. Leinberry, MD, Chester Springs, MD
John S. Taras, MD, Philadelphia, PA
8:00 AM
PAPER: 166
Patient-Reported Outcome Measures in the Upper Extremity:
DASH vs. PF CAT
Andrew R. Tyser, MD, Salt Lake City, UT
Shirley Hon, Salt Lake City, UT
Jeremy D. Franklin, Salt Lake City, UT
James Beckmann, MD, Salt Lake City, UT
Christine Cheng, Salt Lake Cty, UT
Angela A. Wang, MD, Salt Lake City, UT
Jillian Conrad, BS, Salt Lake City, UT
Man Hung, PhD, Salt Lake City, UT
The PROMIS Physical Function Computerized Adaptive Testing
instrument performs at least as well the DASH in the parameters
reported, and in some cases significantly better.
8:06 AM
PAPER: 167
Pain with Activity is a Significant Predictor of DASH Score in a
Prospective Cohort of Patients with CMC Arthritis
James Lin, MD, New York, NY
Kiran S. Yemul, New York, NY
Melvin P. Rosenwasser, MD, New York, NY
Patients self-reported pain with activity (as measured by VAS)
was the only significant predictor of DASH score in a cohort of
both operative and non-operative CMC arthritis patients.
8:48 AM
PAPER: 172
Open Drainage (OD) versus Closed Catheter Irrigation (CCI) for
Treatment of Purulent Flexor Tenosynovitis
Trevor R. Born, MD, Rochester, MN
Eric R. Wagner, MD, Rochester, MN
Sanjeev Kakar, MD, Rochester, MN
Comparison of open drainage (OD) with closed catheter
irrigation (CCI) showed similar outcomes with regards to pain,
function, and reoperation rates at mean three year follow-up.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER: 168
8:12 AM
Comparison of the Validity of Goniometer and Visual
Assessments of Angular Joint Positions of the Hand and Wrist
Peter M. Murray, MD, Jacksonville, FL
Kimberly McVeigh, OTR/L, Jacksonville, FL
Michael Heckman, MS, Jacksonville, FL
8:24 AM
PAPER: 169
Long Term Follow-up of Four Cases of Osteochondral
Autologous Transplantation for Metacarpal Head Chondral
Defects
Louis Constantinou, BA, Le Claire, IA
Anna L. Walden, BS, DC, Davenport, IA
Tyson K. Cobb, MD, Davenport, IA
92
Educational Programs
Wednesday, March 12
8:54 AM
PAPER: 173
Radiographic Thumb Osteoarthritis Index (ThOA) Correlating to
Clinical Disease Severity
Amy L. Ladd, MD, Palo Alto, CA
Joe Messana, Mountain View, CA
Aaron J. Berger, MD, PhD, Palo Alto, CA
Arnold-Peter C. Weiss, MD, Providence, RI
A thumb osteoarthritis index (ThOA) measured from a Roberts
view alone provides a simple, reproducible, and clinically relevant
means of quantifying the severity of thumb CMC osteoarthritis.
9:24 AM
PAPER: 177
Risks and Outcomes Associated with 382 Consecutive
Intraoperative Periprosthetic Fractures in PIP Arthroplasty
Eric R. Wagner, MD, Rochester, MN
Robert Van Demark, MD, Rochester, MN
Marco Rizzo, MD, Rochester, MN
Intraoperative fractures occur in 5% of PIP arthroplasties, but do
not influence outcomes. Female gender, increasing BMI, RA, and
pyrocarbon implants increase the risk for these fractures.
Discussion 6 Minutes
PAPER: 174
9:00 AM
First Carpometacarpal Arthroplasty with Ligamentous
Reconstruction: A Long-term Follow Up
Mark A. Yaffe, MD, Indianapolis, IN
Bennet Butler, Chicago, IL
Daniel J. Nagle, MD, Chicago, IL
This study demonstrates the clinical, functional, and radiographic
outcomes following a trapeziectomy with FCR suspension
arthroplasty without tendon interposition (LRSA) for advanced
CMC arthritis.
Discussion 6 Minutes
9:12 AM
PAPER: 175
A Comparative Study of Trapeziectomy with Tightrope - Are We
Making A Difference?
Arvind Mohan, MBBS, Epsom, Surrey, United Kingdom
Michael Shenouda, Chertsey, United Kingdom
Hiba Ismail, London/Middlesex, United Kingdom
Tanaya Sarkhel, FRCS, MBBS, Chertsey, Surrey, United Kingdom
Wednesday
9:36 AM
PAPER: 178
Gliding Coefficient Seems to Favor the Use of More Repair
Strands Over the Use of an Epitendinous Suture
Zaneb Yaseen, MD, Rochester, NY
Christopher S. English, MD, Downey, CA
Spencer J. Stanbury, MD, Rochester, NY
Tony Chen, PhD, New York, NY
Hani Awad, PhD, Rochester, NY
John Elfar, MD, Rochester, NY
The gliding coefficient was not greatly affected by the number of
strands in the repair but improved by omitting the epitendinous
suture in both repair groups.
9:42 AM
PAPER: 179
The Biomechanical and Histological Effect of Platelet Rich
Plasma on Rabbit Forepaw Flexor Tendon Repair
Katie Kollitz, BS, Seattle, WA
Erin M. Parsons, MS, Seattle, WA
Matt Weaver, PhD, Seattle, WA
Jerry I. Huang, MD, Seattle, WA
In contrast to other studies, platelet-rich plasma did not improve
ultimate strength or ROM in a rabbit flexor tendon model at 2,
4, or 8 weeks. Minor histologic differences disappeared after 2
weeks.
PAPER: 180
9:48 AM
Repeat Emergency Room Visits for Hand and Upper Extremity
Injuries
Vishnu C. Potini, MD, New York, NY
Walter W. Bratchenko, MS, PA-C, Newark, NJ
Glen Jacob, Morgantown, West VA
Linda Y. Chen, MS, BS, Newark, NJ
Virak Tan, MD, Newark, NJ
Despite having already been evaluated by another emergency
department, most repeat patients presented to our ED during
normal business hours, with diagnoses that did not warrant
urgent treatment.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
93
Wednesday, March 12
SYMPOSIUM
10:30 AM 12:30 PM
La Nouvelle Ballroom
Metal on Metal and Modular Corrosion: Clinical Impact of
Tribocorrosion (L)
Moderator: Young-Min Kwon, MD, PhD, Boston, MA
VI.
Systemic Effects
J M. Wilkinson, MD, Sheffield, United Kingdom
SYMPOSIUM
VI.
Overview of Complications
George V. Russell Jr, MD, Jackson, MS
SYMPOSIUM
10:30 AM 12:30 PM
Theater B
Traumatic and Athletic Disorders of the
Immature Foot and Ankle (N)
Moderator: Vincent S. Mosca, MD, Seattle, WA
Highlight many of the differences to help educate the audience
on the proper assessment and management of injuries and
athletic disorders of the immature foot and ankle.
I.
II.
III.
IV.
Wednesday
10:30 AM 12:30 PM
Theater C
III.
94
Educational Programs
Wednesday, March 12
INSTRUCTIONAL COURSE Lecture
10:30 AM 11:30 AM
FD4
Room
217
Room
207
Wednesday
TICKET
Room
350
TICKET
Room
221
226
215
227
TICKET
Room
276
223
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
95
Wednesday, March 12
228
TICKET
Room
356
229
TICKET
Rotator Cuff
Moderator: Peter J. Millett, MD, MSc, Vail, CO
Stephen S. Burkhart, MD, San Antonio, TX
Jonathan B. Ticker, MD, Merrick, NY
Ken Yamaguchi, MD, Chesterfield, MO
Room
271
Room
226
231
TICKET
Room
270
232
Room
TICKET
Room
262
Room
218
Room
347
PAPER PRESENTATION
10:30 AM 12:30 PM
Theater A
Adult Reconstruction Knee II: Non-Prosthetic/UKA
Moderator(s):Geoffrey F. Dervin, MD, Ottawa, ON, Canada
Alfred J. Tria, MD, Princeton, NJ
10:30 AM
PAPER: 181
Optimal Usage of Unicompartmental Knee Replacement: An
Analysis of 41,986 Cases
Alexander D. Liddle, MBBS, Oxford, United Kingdom
Hemant G. Pandit, FRCS, Oxford, United Kingdom
Andrew Judge, PhD, Oxford, United Kingdom
David W. Murray, MD, Oxford, United Kingdom
A study to define the optimal usage of UKR, comparing broad
and narrow indications in terms of their effect on implant
survival.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
233
96
Educational Programs
Wednesday, March 12
10:36 AM
PAPER: 182
Load Sharing and Ligament Strains After Unicompartmental
Knee Arthroplasty - A Validated Finite Element Analysis
Bernardo Innocenti, PhD, Bruxelles, Belgium
mer F. Bilgen, PhD, MD, Bursa, Turkey
Luc Labey, Leuven, Belgium
Harry Van Lenthe, PhD, Leuven, Belgium
Jos Vander Sloten, Leuven, Belgium
Fabio Catani, MD, Modena, Italy
Even if a medial UKA is aligned and balanced it induces a change
in stiffness in the knee joint that alters the bone stress and the
collateral ligament strain leading to an osteoarthritic progression.
11:06 AM
PAPER: 186
Success of High Tibial Osteotomy in the United States Military
Brian Waterman, MD, El Paso, TX
Jeffrey Hoffmann, MD, El Paso, TX
Matthew Laughlin, DO, El Paso, TX
Courtney A. Holland, MD, El Paso, TX
John M. Tokish, MD, Scottsdale, AZ
Philip J. Belmont Jr, MD, El Paso, TX
High tibial osteotomy is a useful in the treatment of medial
unicompartmental disease and has demonstrated success in an
active US military population at a minimum of 2-year follow-up.
Discussion 6 Minutes
PAPER: 183
10:42 AM
Comparison of Joint Moments of Patients with Medial
Unicompartmental Replacement during Stair Ascent
Yang-Chieh Fu, PhD, University, MS
Kathy J. Simpson, PhD, Athens, GA
Rumit S. Kakar, PT, Athens, GA
Tracy Kinsey, MPH, Athens, GA
Ormonde M. Mahoney, MD, Athens, GA
11:18 AM
PAPER: 187
Meniscal Allograft with or without Osteotomy - A 15-Year
Follow-Up Study
Hussain Kazi, MB, ChB, , Toronto, ON, Canada
Wael Abdelrahman, MD, Toronto, ON, Canada
Philip Brady, MD, Toronto, ON, Canada
John C. Cameron, MD, Toronto, ON, Canada
Discussion 6 Minutes
10:54 AM
PAPER: 184
Osteoarthritis Progression in Untreated Compartment,
Comparing Open Wedge Tibial Osteotomy and Unicondylar
Knee
Kwang J. Oh, MD, Seoul, Republic of Korea
Anshul S. Sobti, MBBS, MS, Navi Mumbai, India
Wednesday
11:24 AM
Fresh Osteochondral Allograft Transplantation for
Osteochondritis Dissecans of the Knee
Kamran N. Sadr, MD, MS, Menlo Park, CA
Pamela A. Pulido, RN, BSN, La Jolla, CA
Julie C. McCauley, MPH, La Jolla, CA
William Bugbee, MD, La Jolla, CA
PAPER: 188
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
97
Wednesday, March 12
11:42 AM
PAPER: 190
Treatment
of
Cartilage
Defects
with
a
Novel
RUNX-1
Inducing
12:12 PM
PAPER: 194
A
Randomized
Clinical
Trial
Comparing
Hyaluronic
Acid for
11:48 AM
12:18 PM
PAPER: 195
Extreme Variability in Posterior Slope of Proximal Tibia: Are We
Accounting for Patients Normal Anatomy in UKA?
Ryan Nunley, MD, Saint Louis, MO
C. Lowry Barnes, MD, Little Rock, AR
Cara L. Petrus, BS, Little Rock, AR
PAPER: 191
Discussion 6 Minutes
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 245
Sports Medicine/Arthroscopy II: Shoulder I
Moderator(s):Christopher Donaldson, MD, Johnstown, PA
Stephen Soffer, MD, Wyomissing, PA
10:30 AM
PAPER: 196
The Effect of Insertion Angle on the Pullout Strength of
Threaded Suture Anchors
Michael J. Beebe, MD, Salt Lake City, UT
Todd A. Clevenger, MD, Medford, OR
Eric J. Strauss, MD, New York, NY
Erik Kubiak, MD, Salt Lake City, UT
An insertion angle of 90 degrees or greater, for threaded metallic
suture anchors, withstands a greater load to failure and provides
a stiffer construct than more acute insertion angles.
Wednesday
12:06 PM
PAPER: 193
Bone Marrow Cell Mobilization by G-CSF may Enhance
Osseointegration? A Prospective Phase II Clinical Trial
Antongiulio Marmotti, MD, Torino, Italy
Filippo Castoldi, MD, Torino, Italy
Roberto Rossi, MD, Torino, Italy
Matteo Bruzzone, MD, Torino, Italy
Federico Dettoni, MD, Torino, Italy
Davide E. Bonasia, MD, Torino, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Gianluca Collo, MD, Torino, Italy
Corrado Tarella, MD, PhD, Torino, Italy
98
Educational Programs
Wednesday, March 12
10:36 AM
PAPER: 197
Single-Row, Double-Row and Transosseous Equivalent Rotator
Cuff Repair Techniques, A Comparative Analysis
Frank McCormick, MD, Ft Lauderdale, FL
Anil Gupta, MD, MBA, Tampa, FL
Benjamin G. Bruce, MD, Providence, RI
Joshua Harris, MD, Bellaire, TX
Geoffrey D. Abrams, MD, Portola Valley, CA
Kristen Hussey, BS, Chicago, IL
Hillary Wilson, BA, Chicago, IL
Brian J. Cole, MD, MBA, Chicago, IL
11:00 AM
PAPER: 200
PRP Augmentation Reduces Re-tear Rates after Repair of Small
and Medium Sized Rotator Cuff Tears
Patrick Vavken, MD, Basel, Switzerland
Patrick Sadoghi, Graz, Austria
Marc A. Mueller, MD, Basel, Switzerland
Claudio Rosso, MD, MSc, Basel, Switzerland
Victor Valderrabano, MD, Basel, Switzerland
PAPER: 201
11:06 AM
The Costs of Preoperative Evaluation of Rotator Cuff Tears Prior
to Surgical Repair
Frank Petrigliano, MD, Santa Monica, CA
Michael Yeranosian, MD, Hoboken, NJ
Rodney Terrell, MD, San Jose, CA
Jeffrey Wong, MD, Playa Vista, CA
David R. McAllister, MD, Los Angeles, CA
PAPER: 198
10:42 AM
Arthroscopic Rotator Cuff Repair: The Characterization of
Preoperative and Postoperative Sleep Disturbance
Luke S. Austin, MD, Linwood, NJ
Bradford S. Tucker, MD, Ocean City, NJ
Alvin C. Ong, MD, Linwood, NJ
Brandon Eck, BS, Egg Harbor Township, NJ
Fotios P. Tjoumakaris, MD, Ocean View, NJ
Matthew D. Pepe, MD, Linwood, NJ
Adequate sleep plays a role in postoperative healing and also in
patient satisfaction, it is necessary to investigate and characterize
sleep disturbances in patients undergoing RCR.
Wednesday
Discussion 6 Minutes
10:54 AM
PAPER: 199
Are Platelet Rich Plasma Injections Effective After Arthroscopic
Rotator Cuff Tear Repair?
Francesco Franceschi, MD, Rome, Italy
Rocco Papalia, MD, PhD, Rome, Italy
Edoardo Franceschetti, MD, Roma, Italy
Biagio Zampogna, MD, Rome, Italy
Sebastiano Vasta, MD
Alessio Palumbo, MD, Roma, Italy
Michele Paciotti, MD, Avezzano, Italy
Nicola Maffulli, MD, PhD, London, United Kingdom
Vincenzo Denaro, MD, Rome, Italy
Although PRP application after arthroscopic repair of the rotator
cuff has no effects on clinical recovery and structural integrity, it
reduces the postoperative occurrence of shoulder stiffness.
11:18 AM
PAPER: 202
Shoulder Osteoarthritis in Young Patients: When is Arthroscopic
Management Indicated? A Markov Decision Analysis
Ulrich J. Spiegl, MD, Vail, CO
Scott C. Faucett, MD, Bethesda, MD
Marilee P. Horan, MPH, Vail, CO
Peter J. Millett, MD, MSc, Vail, CO
Arthroscopic management was the preferred treatment strategy
for glenohumeral OA in patients under 65 years old.
11:24 AM
PAPER: 203
Distal Peripheral Neuropathy after Open and Arthroscopic
Shoulder Surgery: An Under-Recognized Complication
Benjamin Thomasson, DO, Mantua, NJ
Luke S. Austin, MD, Linwood, NJ
Brandon Eck, BS, Egg Harbor Township, NJ
Matthew D. Pepe, MD, Linwood, NJ
Bradford S. Tucker, MD, Ocean City, NJ
Jonas L. Matzon, MD, Philadelphia, PA
Distal peripheral neuropathy is an under-reported complication
following total shoulder arthroplasty and arthroscopic rotator
cuff repair.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
99
Wednesday, March 12
11:30 AM
PAPER: 204
Glenohumeral Joint Pathology Associated with High Grade
Acromioclavicular Joint Injuries
Matthew Nugent, MD, Grants Pass, OR
Michael J. Kissenberth, MD, Simpsonville, SC
Thomas R. Carter, MD, Phoenix, AZ
Anikar Chhabra, MD, Paradise Valley, AZ
Evan S. Lederman, MD, Phoenix, AZ
Multicenter study of intra articular pathology of high grade
ACJ injuries. 124 consecutive patients found greater than 50%
incidence of concomitant pathology at the time of diagnostic
arthroscopy.
Discussion 6 Minutes
11:42 AM
PAPER: 205
Analysis of Mechanical Failures after Anatomic
Acromioclavicular Joint Reconstruction
Marcus D. Biggers II, MD, Memphis, TN
Benjamin M. Mauck, MD, Collierville, TN
Frederick M. Azar, MD, Memphis, TN
Richard A. Smith, PhD, Memphis, TN
Thomas (Quin) Throckmorton, MD, Germantown, TN
Multivariate analysis of 14 factors found that interference screw
fixation and distal clavicle excision were protective factors against
failure of anatomic acromioclavicular joint reconstruction.
11:48 AM
PAPER: 206
Evaluation of Risk to the Suprascapular Nerve During
Arthroscopic SLAP Repair: Is a Posterior Portal Safer?
Mark J. Sando, MD, Baltimore, MD
R. Frank Henn III, MD, Ellicott City, MD
James C. Dreese, MD, Monkton, MD
Use of the portal of Wilmington results in a much lower incidence of
glenoid perforation during placement of posterior and far posterior
suture anchors making this a safe method for SLAP repair.
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 265
Spine II: Cervical Spine
Moderator(s):Michael J. Lee, MD, Seattle, WA
Vincent Silvaggio, MD, Pittsburgh, PA
10:30 AM
PAPER: 211
Clinical and Radiographic Analysis of an Artificial Cervical Disc:
Seven-Year Outcomes
J. Kenneth Burkus, MD, Columbus, GA
Vincent C. Traynelis, MD, Chicago, IL
Praveen V. Mummaneni, San Francisco, CA
Regis W. Haid JR, MD, Atlanta, GA
Cervical disc arthroplasty maintained improved clinical outcomes
and segmental motion after implantation at 7 years of follow up.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
11:54 AM
PAPER: 207
Management of the Long Head of the Biceps in Rotator Cuff
Repair: High Versus Subpectoral Tenodesis
Francesco Franceschi, MD, Rome, Italy
Rocco Papalia, MD, PhD, Rome, Italy
Edoardo Franceschetti, MD, Roma, Italy
Stefano Campi, MD, Rome, Italy
Alessio Palumbo, MD, Roma, Italy
Biagio Zampogna, MD, Rome, Italy
Sebastiano Vasta, MD
Nicola Maffulli, MD, PhD, London, United Kingdom
Vincenzo Denaro, MD, Rome, Italy
12:06 PM
PAPER: 208
Biomechanical Comparison of the Interval Throwing Progression
and Baseball Pitching
Nicholas R. Slenker, MD, Los Angeles, CA
Orr Limpisvasti, MD, Los Angeles, CA
Karen J. Mohr, PT, Los Angeles, CA
Neal S. ElAttrache, MD, Los Angeles, CA
100
Educational Programs
Wednesday, March 12
10:36 AM
PAPER: 212
Outcomes of Patients Undergoing Anterior Cervical Fusion in
July; Analysis of the July Effect
Sreeharsha Nandyala, BA, Aurora, IL
Steven Fineberg, MD, Valhalla, NY
Alejandro Marquez-Lara, MD, Chicago, IL
Kern Singh, MD, Chicago, IL
11:06 AM
PAPER: 216
Methods to Eliminate Postoperative Posterior Cervical Wound
Infections: No Matter what the Case
Brian J. Neuman, MD, Baltimore, MD
Kevin R. ONeill, MD, Nashville, TN
Sang D. Kim, MD, Los Angeles, CA
K. Daniel Riew, MD, Saint Louis, MO
This study demonstrated that the start of the academic year was
not associated with an increase in LOS, total hospital costs, or
mortality among July patients following ACF in teaching hospitals.
PAPER: 213
10:42 AM
Revision Strategies in Cervical Disc Arthroplasty Failures
Ronald A. Lehman, MD, Potomac, MD
Daniel Kang, MD, Bethesda, MD
K. Daniel Riew, MD, Saint Louis, MO
Our study found <5% of cervical TDRs required revision.
Regardless of approach, all patients demonstrated neurologic
recovery and relief of symptoms following surgery.
Discussion 6 Minutes
10:54 AM
PAPER: 214
Comparison of RhBMP-2 with Allograft in Single-Level Anterior
Cervical Arthrodesis
J. Kenneth Burkus, MD, Columbus, GA
Randall F. Dryer, MD, Austin, TX
Paul M. Arnold, MD, FACS, Kansas City, KS
Kevin T. Foley, MD, Memphis, TN
Wednesday
Discussion 6 Minutes
11:18 AM
PAPER: 217
Reliability of the Subaxial Cervical Spine Injury Classification
System for Orthopedic Surgeons
Ronald A. Lehman, MD, Potomac, MD
Daniel Kang, MD, Bethesda, MD
Adam Bevevino, MD, Washington, DC
Robert W. Tracey, MD, Great Falls, VA
The use of SLICS demonstrated excellent intra- and inter-observer
reliability among orthopaedic surgeons of different training levels,
ranging from orthopaedic intern to staff spine surgeon.
11:24 AM
PAPER: 218
Correlation of Cord Signal Change with Physical Exam Findings
in 61 Consecutive Patients with Cervical Myelopathy
Venu Nemani, MD, PhD, New York, NY
Han Jo Kim, MD, New York, NY
Chaiwat Piyaskulkaew, MD, Saint Louis, MO
K. Daniel Riew, MD, Saint Louis, MO
Cord signal change visualized on MRI correlates poorly with
the upper extremity reflex examination in patients with cervical
spondylotic myelopathy.
11:30 AM
Cervical Dural Tears: Risk Factors and Outcomes
Kevin R. ONeill, MD, Nashville, TN
Brian J. Neuman, MD, Baltimore, MD
K. Daniel Riew, MD, Saint Louis, MO
PAPER: 219
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
101
Wednesday, March 12
11:42 AM
PAPER: 220
Evaluation of Spinal Cord Motion in Patients with Normal
Cervical Sagittal Alignment Using Kinetic MRI
Chengjie Xiong JR, Chongqing, China
Michael D. Daubs, MD, Las Vegas, NV
Akinobu Suzuki, MD, PhD, Osaka, Japan
Bayan Aghdasi, MD, Clovis, CA
Trevor Scott, MD, Santa Monica, CA
Kevin Phan, BS, Irvine, CA
Monchai Ruangchainikom, MD, Bangkok, Thailand
Jeffrey C. Wang, MD, Sherman Oaks, CA
With normal lordotic alignment, the spinal cord shifts posteriorly
away from the spinal column with flexion and toward the
anterior column with extension.
PAPER: 221
11:48 AM
Effect of Global Cervical Sagittal Imbalance on Postural
Compensation and Cervical Mechanics
Avinash G. Patwardhan, PhD, Maywood, IL
Robert Havey, Hines, IL
Muturi Muriuki, PhD, Forest Park, IL
Leonard Voronov, PhD, Hines, IL
Saeed Khayatzadeh, MSc, Hines, IL
Gerard Carandang, Hines, IL
Alexander J. Ghanayem, MD, Maywood, IL
Ngoc-Lam Nguyen, MD, Maywood, IL
William Sears, FRACS, Sydney, Australia
First study establishing a cause-&-effect relationship between
radiographic measures of FHP, T1 tilt and spine mechanics and
illustrates how biomechanical data can be useful in pre-treatment
planning.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER: 222
11:54 AM
Challenging the Norm: Further Psychometric Investigation of
the Neck Disability Index
Man Hung, PhD, Salt Lake City, UT
Jeremy D. Franklin, Salt Lake City, UT
Shirley Hon, Salt Lake City, UT
Brandon D. Lawrence, MD, Salt Lake Cty, UT
Christine Cheng, Salt Lake Cty, UT
Ashley Woodbury, BS, Salt Lake City, UT
Jillian Conrad, BS, Salt Lake City, UT
Darrel S. Brodke, MD, Salt Lake City, UT
12:06 PM
PAPER: 223
Vertebral Artery Anomalies at the Craniovertebral Junction in
the U.S. Population
Courtney M. ODonnell, MD, Seattle, WA
Zachary A. Child, MD, Albuquerque, NM
Quynh Nguyen, MHS, PA-C, Seattle, WA
Paul A. Anderson, MD, Madison, WI
Michael J. Lee, MD, Seattle, WA
102
Educational Programs
Wednesday, March 12
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 345
Tumor/Metabolic Disease I: Sarcoma and Metastatic Disease
Moderator(s):Jeffrey S. Kneisl, MD, Charlotte, NC
Felasfa M. Wodajo, MD, Arlington, VA
10:30 AM
PAPER: 226
What is the Best Method of Staging Sarcomas, Enneking or
TNM?
Krista Goulding, MD, Birmingham, United Kingdom
Lee Jeys, FRCS, Droitwich, United Kingdom
Robert J. Grimer, FRCS, Worcester, United Kingdom
The TNM staging system is a superior prognostication system
compared to Enneking staging for bone and soft tissue sarcoma.
10:36 AM
PAPER: 227
Multiple Primary Malignancies with High Grade Soft Tissue
Sarcoma in Patients Over 45 Years
Eiji Kozawa, MD, Nagoya, Japan
Yoshihiro Nishida, Nagoya, Japan
Satoshi Tsukushi, MD, Nagoya, Japan
Hiroshi Urakawa, Nagoya, Japan
Eisuke Arai, Nagoya, Japan
Hideshi Sugiura, MD, Nagoya City, Japan
Naohisa Futamura, MD, Aichi, Japan
Naoki Ishiguro, MD, Nagoya, Japan
Wednesday
10:54 AM
PAPER: 229
Impact of Peroxisome Proliferator-activated Receptor Gamma
Expression on Outcome of Myxoid Liposarcoma
Akihiko Takeuchi, MD, Kanazawa, Japan
Norio Yamamoto, MD, Kanazawa, Ishikawa, Japan
Toshiharu Shirai, MD, Kanazawa, Japan
Hideji Nishida, MD, Kanazawa City, Japan
Katsuhiro Hayashi, MD, Nagoya, Japan
Hiroaki Kimura, MD, PhD, Kanazawa, Japan
Shinji Miwa, MD, Ishikawa, Japan
Kentaro Igarashi, Kanazawa, Japan
Hiroyuki Tsuchiya, MD, Kanazawa, Japan
The low expression of PPAR significantly correlated with
the better metastasis-free survival in patients with myxoid
liposarcoma, suggesting its usefulness as a prognostic marker.
11:00 AM
Desmoid Tumors of the Upper Extremity
Matthew Houdek, MD, Rochester, MN
Peter S. Rose, MD, Rochester, MN
Sanjeev Kakar, MD, Rochester, MN
PAPER: 230
11:18 AM
PAPER: 232
Factors Affecting Wound Healing in Soft Tissue Sarcomas of the
Anterior Thigh
Tessa Balach, MD, Farmington, CT
Robert Kulwin, Chicago, IL
Mark Cote, PT, Farmington, CT
Terrance D. Peabody, MD, Chicago, IL
Rex Haydon, MD, Chicago, IL
In soft tissue sarcomas of the anterior thigh, both neoadjuvant and
adjuvant chemotherapy are significant risk factors for both wound
healing complications and additional surgery to treat them.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
103
Wednesday, March 12
11:24 AM
PAPER: 233
The Effect of Radiation Therapy in the Treatment of Adult Soft
Tissue Sarcomas of the Extremities
Chad Ferguson, MD, Charlotte, NC
Jeffrey S. Kneisl, MD, Charlotte, NC
Michael D. Bates, MD, Charlotte, NC
Jim Symanowski, PhD, Charlotte, NC
Anthony Crimaldi, MD, DDS, Charlotte, NC
Will Ahrens, MD, Charlotte, NC
Franklin Gettys, MD, Charlotte, NC
Joshua C. Patt, MD, Charlotte, NC
Edward Kim, MD, Charlotte, NC
Radiation therapy treatment of adult extremity soft tissue
sarcomas results in decreased local recurrence without survival
improvement for high grade tumors. Radiation incurs high
complication rates.
11:48 AM
PAPER: 236
The Endogenous Peptide Angiotensin-(1-7) Prevents RadiationInduced Muscle Fibrosis: An In Vivo Murine Model
Daniel Bracey, MD, Winston Salem, NC
Jeffrey Willey, PhD, Winston-Salem, NC
Ann Tallant, PhD, Winston-Salem, NC
Patricia Gallagher, PhD, Winston-Salem, NC
Walter F. Wiggins, PhD, Winston-Salem, NC
Michael F. Callahan, PhD, Columbia, MO
Thomas L. Smith, PhD, Winston-Salem, NC
Cynthia L. Emory, MD, Winston Salem, NC
Prophylactic Angiotensin-(1-7) treatment prior to radiation
therapy may prevent the development of fibrosis in muscles
exposed to high dose radiation during sarcoma treatment.
11:30 AM
PAPER: 234
Preoperative CRP, ESR and NLR are Reliable Predictors of
Survival in Soft Tissue Sarcomas
Eun Seok Choi, Seoul, Republic of Korea
Han-Soo Kim, MD, PhD, Seoul, Republic of Korea
Wanlim Kim, Seoul, Republic of Korea
Ilkyu Han, MD, Seoul, Republic of Korea
Seungcheol Kang, MD, Seoul, Republic of Korea
PAPER: 237
11:54 AM
Eight-year Experience of a Bone Metastasis MDT at an Acute
Teaching Hospital and its Impact on Patient Care
Raghu Raman, FRCS, North Ferriby, United Kingdom
Rasheed Afinowi, FRCS, North Ferriby, United Kingdom
Howard Widdall, Swanland, United Kingdom
Geoffrey V. Johnson, FRCS, North Ferriby, United Kingdom
Keith Jackson, Swanland, United Kingdom
Christopher J. Shaw, MD, East Yorkshire, United Kingdom
Helen Cattermole, FRCS, North Ferriby, United Kingdom
Discussion 6 Minutes
Discussion 6 Minutes
11:42 AM
PAPER: 235
Total Lesion Glycolysis by 18F-FDG PET/CT is a Reliable
Predictive Value of Soft Tissue Sarcoma
Eun Seok Choi, Seoul, Republic of Korea
Han-Soo Kim, MD, PhD, Seoul, Republic of Korea
Ilkyu Han, MD, Seoul, Republic of Korea
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
12:06 PM
PAPER: 238
Intramedullary Nail Stabilization without Cementation and
Curettage for Impending Pathologic Fractures
Alexandria O. Starks, BA, Philadelphia, PA
Brandon J. Shallop, BS, Philadelphia, PA
Alan H. Lee, MD, Brookline, MA
Simon Greenbaum, BA, Bronx, NY
David S. Geller, MD, New York, NY
Marco Ferrone, MD, Boston, MA
John E. Ready, MD, Boston, MA
John A. Abraham, MD, Philadelphia, PA
104
Educational Programs
Wednesday, March 12
12:12 PM
PAPER: 239
Intramedullary Nailing for Pathologic Fracture of the Proximal
Humerus
Eun Seok Choi, Seoul, Republic of Korea
Ilkyu Han, MD, Seoul, Republic of Korea
Wanlim Kim, Seoul, Republic of Korea
Han-Soo Kim, MD, PhD, Seoul, Republic of Korea
Seungcheol Kang, MD, Seoul, Republic of Korea
Proximal interlocked nail with cement augmentation appears
to be a reliable treatment option for pathological or impending
fracture of the proximal humerus in selected patients with
metastatic tumors,
PAPER: 240
12:18 PM
Indications of Reverse Total Shoulder Arthroplasty in
Musculoskeletal Oncology: Preliminary Results
Pietro Ruggieri, MD, Bologna, Italy
Andrea Angelini, MD, Bologna, Italy
Matteo Romantini, MD
Marco Maraldi, Cesentico, Italy
Giulia Trovarelli, Bologna, Italy
Teresa Calabr, Bologna, Italy
Reverse total shoulder arthroplasty for tumors, with correct
surgical indications, is a reasonable reconstructive option
at short-term.It restores function and is associated with low
complication rate.
Discussion 6 Minutes
Wednesday
IV.
V.
VI.
VII.
VIII.
IX.
How I Cement
Thomas P. Sculco, MD, New York, NY
X.
XI.
SYMPOSIUM
1:30 PM 3:30 PM
Theater C
III.
XIV.
XV.
XVI.
XX.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
105
Wednesday, March 12
SYMPOSIUM
242
1:30 PM 3:30 PM
Theater B
TICKET
Room
356
II.
III.
243
Room
276
TICKET
226
244
TICKET
Room
221
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
1:30 PM 3:30 PM
241
Outpatient Arthroplasty: Same Day, Home Safe
Moderator: Keith R. Berend, MD, New Albany, OH
Michael E. Berend, MD, Mooresville, IN
Richard A. Berger, MD, Chicago, IL
Room
Mark A. Hartzband, MD, Franklin Lakes, NJ
TICKET
I.
106
Educational Programs
Wednesday, March 12
246
TICKET
Contemporary Management of
Dupuytrens Contracture
Moderator: Marco Rizzo, MD, Rochester, MN
Prosper Benhaim, MD, Los Angeles, CA
Lawrence C. Hurst, MD, Stony Brook, NY
Peter J. Stern, MD, Cincinnati, OH
250
TICKET
Room
218
TICKET
Room
215
248
Wednesday
TICKET
Session will focus on developing market responsive
Room
strategies to attract patients, referrals and managed care
208
subscribers. Understanding how to develop market
responsive strategic plans along with recognizing what
physicians, patients, and other customers are buying
from your organization is essential in an evolving health
care market. As health care moves from a fee-forservice to managed care market, the strategies involving
promotion, pricing, and distribution of services must
also be refined and will be reviewed. Identify market
needs, understand how physicians and patients
make choices among organizations, determine your
marketplace differential. Learn strategies for market
research, pricing and advertising. Develop methods
for controlling patient flow and enhancing bargaining
strategy.
249
TICKET
Room
353
Room
271
Shoulder Instability
Moderator: April D. Armstrong, MD, Hershey, PA
Brian R. Wolf, MD, Iowa City, IA
Anand M. Murthi, MD, Baltimore, MD
Robert Z. Tashjian, MD, Salt Lake City, UT
251
TICKET
247
Room
260
Room
207
Room Establishing a
347
avoid surgical
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
107
Wednesday, March 12
255
TICKET
Room
352
PAPER PRESENTATION
1:30 PM 3:30 PM
Theater A
1:30 PM
PAPER: 241
Randomized Controlled Trial Comparing Wear of Oxinium and
Cobalt-Chrome on Standard and Cross-Linked Polyethylene
Zachary Morison, MSc
Sunit Patil, FRCS, Toronto, ON, Canada
Emil H. Schemitsch, MD, Toronto, ON, Canada
James P. Waddell, MD, Toronto, ON, Canada
1:54 PM
PAPER: 244
Radiostereometric Analysis of Femoral Head Penetration in
Cross-Linked Polyethylene in THR Patients
David C. Ayers, MD, Worcester, MA
Anthony Porter Jr, MD, Worcester, MA
Benjamin M. Snyder, MD, Worcester, MA
Marie E. Walcott, MD, Worcester, MA
Michelle Aubin, MD, Worcester, MA
Jacob M. Drew, MD, Charlotte, NC
Meridith E. Greene, Boston, MA
Henrik Malchau, MD, Boston, MA
Charles R. Bragdon, PhD, Boston, MA
In young, active THR patients highly crosslinked polyethylene
liners demonstrated less wear than conventional liners by RSA
analysis, and had outstanding clinical outcomes at 5 years.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
1:36 PM
PAPER: 242
Oxidized Zirconium Femoral Heads in Total Hip Arthroplasty: A
Five-Year Follow Up using Radiostereometric Analysis
Benedikt A. Jonsson, MD, Bergen, Norway
Thomas Kadar, MD, Bergen, Norway
Leif I. Havelin, MD, Bergen, Norway
Kristin Haugan, MA, Trondheim, Norway
Birgitte Espehaug, PhD, Bergen, Norway
Terje Stokke, Flaktveit, Norway
Kari Indrekvam, MD, Bergen, Norway
Ove N. Furnes, MD, Bergen, Norway
Geir Hallan, MD, Bergen, Norway
108
Educational Programs
Wednesday, March 12
2:00 PM
PAPER: 245
Wear Rates of Highly Cross Linked Polyethylene with 36mm
Femoral Heads - A Prospective Study With Five-Year Follow Up
Elango Selvarajah, ChB, MB, Christchurch, New Zealand
Gary J. Hooper, MD, Christchurch, New Zealand
Kyle C. Grabowski, Christchurch, New Zealand
Grahame S. Inglis, MD, Christchurch, New Zealand
Tim Woodfield, MSc, PhD, Christchurch, New Zealand
Chris Frampton, Christchurch, New Zealand
Prospective study of 100 total hip arthroplsties, shows 0.1mm/
year steady state wear rate in highly cross linked polyethylene
when used with 36mm femoral heads.
PAPER: 246
2:06 PM
Fixation and Wear with Contemporary Acetabular Components
and Cross-linked Polyethylene at 10 Years
Nicholas Bedard, MD, Iowa City, IA
John J. Callaghan, MD, Iowa City, IA
Michael Stefl, MD, Santa Monica, CA
Tyler J. Willman, BS, Iowa City, IA
Steve S. Liu, MD, Iowa City, IA
Yubo Gao, PhD, Iowa City, IA
Devon D. Goetz, MD, West Des Moines, IA
At minimum 10 year follow-up using a contemporary cementless
acetabular construct and moderately cross-linked polyethylene
liner, excellent fixation and low bearing surface wear has been
demonstrated.
Wednesday
Discussion 6 Minutes
2:18 PM
PAPER: 247
Twelve-Year Comparative Assessment of Metal-on-metal vs.
Ceramic-on-polyethylene Small Head THA
Anne Lubbeke-Wolff, MD, DSc, Geneva , Switzerland
Amanda Gonzalez, Geneva, Switzerland
Guido Garavaglia, MD, Maggia, Switzerland
Constantinos Roussos, MD
Alexis Bonvin, MD, Geneve , Switzerland
Laurent-Panayiotis Christofilopoulos, Geneve, Switzerland
Richard E. Stern, MD, Geneva, Switzerland
Robin E. Peter, MD, Geneva, Switzerland
Pierre J. Hoffmeyer, MD, Geneve, Switzerland
We found similar results for the MoM and CoP bearings up to
ten years postoperative. However, after ten years MoM bearing
small head THAs had a significantly higher risk for all-cause
revision.
2:24 PM
PAPER: 248
Effect of Bearing Surface on Mid-term Survivalship of
Total Hip Replacement
Eric R. Bohm, MD, Winnipeg. MB, Canada
Nicole De Guia, MSc, Toronto, ON, Canada
Michael Dunbar, MD, Halifax, NS, Canada
Vivian T. Poon, MSc, Toronto, ON, Canada
Michael Terner, MSc, Toronto, ON, Canada
Using registry data, we did not find evidence that new THA
bearing designs (cross linked poly, ceramic, metal or resurfacing)
improves 5 year survival. Large head metal on metal decreases
survival.
PAPER: 249
2:30 PM
3-Year Multicenter RSA Evaluation Vitamin E Diffused Highly
Cross-linked Poly Liners and Acetabular Cup Stability
Nanna Sillesen, MD, Boston, MA
Meridith E. Greene, Boston, MA
Audrey Nebergall, Boston, MA
Mogens B. Laursen, MD, PhD, Aalborg, Denmark
Anders Troelsen, MD, PhD, Koege, Denmark
Henrik Malchau, MD, Boston, MA
Multicenter results show little to no wear of vitamin E diffused
highly cross-linked polyethylene liners with metal or ceramic 32mm
heads and stable porous-titanium coated acetabular cups at 3 years.
Discussion 6 Minutes
2:42 PM
PAPER: 250
Wear of Large Metal on Highly Cross-Linked Polyethylene
Articulations Measured by RSA
Stuart A. Callary, BS, Adelaide, Australia
Oksana Holubowycz, PhD, MPH, Adelaide, Australia
Donald Howie, MD, PhD, Adelaide, Australia
This study, the first randomized study using RSA to compare wear
between 36 and 28 mm metal on HXLPE articulations, found no
difference in proximal wear at 2 years after total hip arthroplasty.
2:48 PM
PAPER: 251
10-year Follow Up of Highly Cross-linked Polyethylene Using
Radiostereometric Analysis (RSA)
Audrey Nebergall, Boston, MA
Meridith E. Greene, Boston, MA
Harry E. Rubash, MD, Boston, MA
Janet Dorrwachter, MSN,ANP-BC, Boston, MA
Charles R. Bragdon, PhD, Boston, MA
Henrik Malchau, MD, Boston, MA
The RSA results show no change in femoral head penetration into
or steady state wear of highly cross-linked polyethylene (HXLPE)
liners with 28 or 36mm femoral heads over 10 years in vivo.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
109
Wednesday, March 12
2:54 PM
PAPER: 252
Volumetric Wear of Highly Cross-linked Polyethylene in Total Hip
Arthroplasty - A Ten Year Double-blind RCT using RSA
Geraint E. Thomas, MA, MBBS, Oxford, United Kingdom
Patrick Garfjeld Roberts, MBBS, Oxford, United Kingdom
Antony Palmer, MA, BMBCh, Oxford, United Kingdom
Barbara Marks, Oxford, United Kingdom
Adrian Taylor, MBBS, FRCS, Oxford, United Kingdom
Peter McLardy-Smith, FRCS, Oxford, United Kingdom
David W. Murray, MD, Oxford, United Kingdom
Sion Glyn-Jones, MA MBBS, Oxford, United Kingdom
In a ten year double-blind randomised controled trial using
radiostereometric analysis, wear of HXLPE is significantly lower
than that of conventional UHMWPE.
Discussion 6 Minutes
3:06 PM
PAPER: 253
Osteolysis and Wear of Large and Standard Metal on Highly
Cross-Linked Polyethylene Articulations
Oksana Holubowycz, PhD, MPH, Adelaide, Australia
Donald Howie, MD, PhD, Adelaide, Australia
Lucian B. Solomon, MD, Hyde Park, Australia
Caroline R. Moran, BS, Adelaide, Australia
Seven years after THA with a metal on HXLPE articulation,
8 of 101 patients with no pre-existing acetabular cysts had
periacetabular osteolytic lesions >1cm3 in the absence of
significant HXLPE wear.
3:12 PM
PAPER: 254
Epidemiology of Total Hip Arthroplasty Bearing Surfaces Used
in the United States, 2007 - 2011
James E. Ho, MD, Chicago, IL
Yu Ho, PhD, Chicago, IL
Samuel J. Chmell, MD, Chicago, IL
3:18 PM
PAPER: 255
Trends in Total Hip Arthroplasty Implant Utilization in the
United States
Kevin J. Bozic, MD, MBA, San Francisco, CA
Mandeep Lehil, San Francisco, CA
THA implant usage trends favor cementless fixation, metalon-polyethylene or ceramic-on-polyethylene bearings, modular
acetabular cups, and large diameter femoral heads.
Discussion 6 Minutes
1:30 PM 3:30 PM
Room 245
Foot and Ankle II: Tendons, OCD, and More
Moderator(s):Eric Giza, MD, Sacramento, CA
Sandra E. Klein, MD, Saint Louis, MO
1:30 PM
PAPER: 256
Achilles Tendon Rupture: A Biomechanical Evaluation of Varying
the Number of Loops in a Physiological Model
Qais Naziri, MD, Brooklyn, NY
Preston W. Grieco, BA, Thornwood, NY
Westley Hayes, MS, Brooklyn, NY
David B. Frumberg, MD, Brooklyn, NY
Maxwell Weinberg, BS, Scarsdale, NY
Jaime A. Uribe, MD, Albertson, NY
David J. Hip-Flores, MD, Rockville, MD
We sought to determine the effect of suturing the frayed ends of a
ruptured tendon in an in-vitro Achilles model. Additional sutures
in the frayed segment didnt augment the biomechanical strength.
1:36 PM
PAPER: 257
Acute Achilles Tendon Ruptures: Results of Minimally Invasive
Approach and Early Rehabilitation
Nirmal C. Tejwani, MD, New York, NY
James Lee, ME, New York, NY
A review of 41 Achilles tendon ruptures repaired using a
minimally invasive approach with an accelerated rehabilitation
and weight bearing program showed no re-ruptures and excellent
outcome.
1:42 PM
Treatment of Acute Insertional Achilles Ruptures
Jamal Ahmad, MD, Philadelphia, PA
Kennis Jones, BA, Philadelphia, PA
Steven M. Raikin, MD, Philadelphia, PA
PAPER: 258
1:54 PM
PAPER: 259
A New Technique for Reconstruction of the Neglected Achilles
Tendon Rupture
Vipin Asopa, MRCS, Surrey, United Kingdom
James Clayton, Adelaide, Australia
Robert Douglas, Adelaide, Australia
We describe a free-flap modification of the Lindholm technique of
repair that eliminates the bulk and demonstrates excellent clinical
results.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER PRESENTATION
110
Educational Programs
Wednesday, March 12
2:00 PM
PAPER: 260
The Use of an Achilles Tendon Turndown to Treat Chronic
Achilles Ruptures with Large Defects
Jamal Ahmad, MD, Philadelphia, PA
Steven M. Raikin, MD, Philadelphia, PA
Our method of Achilles reconstruction of chronic ruptures with
large defects results in a high rate of improved patient function
and pain relief.
2:06 PM
PAPER: 261
Reconstruction of Chronic Achilles Tendon Ruptures Using Scar
Tissue Located Between the Tendon Stumps
Toshito Yasuda, MD, Takatsuki City, Japan
Ryuzo Okuda, MD, Kyoto, Japan
Tsuyoshi Jotoku, MD, Takatsuki, Osaka, Japan
Hiroaki Shima, MD, Takatsuki City, Japan
Takashi Hida, MD, Osaka, Japan
Masashi Neo, Takatsuki, Japan
Our newly devised surgical procedure using scar tissue between
stumps was effective for reconstruction of chronic Achilles tendon
ruptures without sacrificing normal autologous tissue.
Discussion 6 Minutes
Wednesday
2:18 PM
PAPER: 262
Outcomes of Surgical Treatment for Insertional Achilles
Tendinopathy Using a Central Tendon Splitting Approach
Elizabeth A. Martin, MD, Rochester, NY
Ruth Chimenti, DPT, Rochester, NY
Andrew Hollenbeck, BS, Candor, NY
Sara L. Miniaci, MD, Rochester, NY
Josh Tome, MS, Rochester, NY
John P. Ketz, MD, Pittsford, NY
Jeff R. Houck, PhD, PT, Rochester, NY
Adolph S. Flemister Jr, MD, Rochester, NY
The central tendon splitting approach for insertional Achilles
tendinopathy afforded excellent functional outcomes, good
pain relief and high satisfaction despite decreased plantarflexion
strength.
2:24 PM
PAPER: 263
Flexor Hallucis Longus Transfer for Insertional Achilles
Tendinopathy: A Prospective, Randomized Study
Kenneth Hunt, MD, Redwood City, CA
Carroll P. Jones, MD, Charlotte, NC
Bruce E. Cohen, MD, Charlotte, NC
W H. Davis, MD, Charlotte, NC
Robert B. Anderson, MD, Charlotte, NC
Compared to Achilles debridement alone, FHL augmentation
resulted in greater ankle plantarflexion strength and similar
clinical outcome, without loss of hallux strength, in patients age
50 and over.
2:30 PM
PAPER: 264
Comparison of Surgical Outcome in Peroneal Tendon
Dislocations with and without Fibular Groove Deepening
Jae Ho Cho, MD, Seoul, Republic of Korea
Woo Chun Lee, Seoul, Republic of Korea
Hong Joon Choi, MD, Seoul, Republic of Korea
Chulhyun Park, MD, Daegu, Republic of Korea
Dong-Il Chun, Seoul, Republic of Korea
Kang Lee, MD, Seoul, Republic of Korea
Tae Keun Ahn, MD, Seoul, Republic of Korea
Young Yi, MD, Seoul, Republic of Korea
Jiyong Ahn, MD, Seoul, Republic of Korea
This study confirms the previous reported results of the isolated
repair of retinaculum without fibular groove deepening with
cohort study.
Discussion 6 Minutes
2:42 PM
PAPER: 265
Characterizing the Molecular Biology of Pain and Degeneration
in Posterior Tibial Tendon Dysfunction
David M. Tainter, BSE, Durham, NC
Selene G. Parekh, MBA, MD, Cary, NC
Richard Bell, BS, Durham, NC
James A. Nunley II, MD, Durham, NC
Mark E. Easley, MD, Durham, NC
Liufang Jing, Durham, NC
Janet L. Huebner, Durham, NC
Virginia B. Kraus, PhD, Durham, NC
Samuel B. Adams Jr, MD, Durham, NC
The purpose of this study was to characterize the inflammatory
cytokine, matrix metalloprotease, and pain neurotransmitter
profiles in the diseased posterior tibial tendon and tendon insertion.
2:48 PM
PAPER: 266
Functional Outcomes of Suture Bridge vs. Bone Tunnel
Technique for Chronic Ankle Instability in Athletes
Byung-Ki Cho, MD, Cheong-Ju, Republic of Korea
Yong-Min Kim, MD, Cheongju, Republic of Korea
Hyun-Chul Shon, MD, Cheongju, Republic of Korea
Kyoung Jin Park, MD, Cheongju, Republic of Korea
Both suture bridge and bone tunnel technique are good surgical
methods for ankle instability in athletes. Suture bridge technique
has advantage of more mechanical stability in rehabilitation period
2:54 PM
PAPER: 267
New Option of the Treatment for Osteonecrosis of the Talus
Narihito Kodama, MD, Shiga, Japan
Yoshitaka Matsusue, Otsu, Shiga, Japan
New option of the treatment for osteonecrosis of the talus, with
vascularized bone graft (VBG) using one of the pedicle divided
from the tibial arterial arch, was considered.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
111
Wednesday, March 12
3:06 PM
PAPER: 268
Clinical and MRI Outcomes After Arthroscopic Microfracture of
Osteochondral Lesions of the Distal Tibial Plafond
Keir A. Ross, McKinney, TX
Charles P. Hannon, BS, New York, NY
Timothy W. Deyer, MD, New York, NY
Niall A. Smyth, MD, South Miami, FL
MaCalus Hogan, MD, Wexford, PA
Huong Do, MA, New York, NY
John G. Kennedy, MD, New York, NY
Arthroscopic microfrature of 32 tibial osteochondral lesions
resulted in improved clinical outcomes and repair tissue inferior
to normal cartilage on MRI. Outcomes may decline with
increasing age.
PAPER: 269
3:12 PM
Evaluation of Pain, Activity and Patient-reported Outcomes of
Percutaneous Drilling to Treat Ankle Osteonecrosis
Qais Naziri, MD, Brooklyn, NY
Kimona Issa, MD, Baltimore, MD
Bhaveen Kapadia, MD, Baltimore, MD
Bradley M. Lamm, DPM, Luthvle Timonimonium, MD
Lynne C. Jones, PhD, Baltimore, MD
Michael A. Mont, MD, Baltimore, MD
Improvements in pain and activity levels as well as patientreported outcomes of percutaneous drilling to treat early-stage
osteonecrosis of the distal tibia and talus are encouraging.
1:30 PM 3:30 PM
Room 265
1:54 PM
PAPER: 274
The Cost-Effectiveness of Prophylactic Intramedullary Nailing
for Bisphosphonate Associated Femoral Fractures
Kenneth A. Egol, MD, New York, NY
James Lee, ME, New York, NY
Michelle Abghari, BS, Detroit, MI
Zehava Sadka Rosenberg, New York, NY
Nirmal C. Tejwani, MD, New York, NY
Discussion 6 Minutes
PAPER PRESENTATION
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER: 270
3:18 PM
Functional and MRI Outcomes after Microfracture with Bone
Marrow Aspirate for Talar Osteochondral Lesions
Charles P. Hannon, BS, New York, NY
Keir A. Ross, McKinney, TX
Christopher D. Murawski, Stroudsburg, PA
Timothy W. Deyer, MD, New York, NY
Niall A. Smyth, MD, South Miami, FL
Huong Do, MA, New York, NY
MaCalus Hogan, MD, Wexford, PA
John G. Kennedy, MD, New York, NY
1:30 PM
PAPER: 271
An Evidence Based Warfarin Management Protocol Reduces
Surgical Delay in Hip Fracture Patients
Muhammed A. Khan, MBBS, MRCS Ed, London,
United Kingdom
Iftikhar Ahmed, MBBS, MSc, Kingston Upon Hull,
United Kingdom
Amr Mohsen, FRCS, FRCS, , Hull, United Kingdom
112
Educational Programs
Wednesday, March 12
2:00 PM
PAPER: 275
Symptomatic Atypical Femoral Fractures are Related to
Underlying Hip Geometry
David P. Taormina, MS, New York, NY
Alejandro Marcano, MD, New York, NY
Kenneth A. Egol, MD, New York, NY
Nirmal C. Tejwani, MD, New York, NY
We compared hip anatomy of symptomatic bisphosphonate
users to those without and found significantly more varus at the
femoral neck.
2:30 PM
PAPER: 279
The Effects of Diabetes Medications on Post-operative Long
Bone Fracture Healing
Christopher M. Simpson, MBChB, Leeds, United Kingdom
Suribabu Gudipati, MBBS, MRCS, Carmarthen, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
Diabetic medications have a significant impact on the fracture
healing process including the timescale and the eventual outcome
of union vs. non-union.
Discussion 6 Minutes
2:06 PM
Atypical Femur Fractures in Patients on Chronic
Bisphosphonates: Does Geometry Matter?
Jennifer E. Hagen, MD, Baltimore, MD
James C. Krieg, MD, Philadelphia, PA
Susan Ott, MD, Seattle, WA
Timothy B. Alton, MD, Seattle, WA
PAPER: 276
Wednesday
2:18 PM
PAPER: 277
The Effect of the RIA on the Volume of Embolic Load during
Intramedullary Nailing of Femoral Shaft Fractures
Jeremy Hall, MD, FRCS MEd, Toronto, ON, Canada
Michael D. McKee, MD, Toronto, ON, Canada
Zachary Morison, MSc
Niloofar Dehghan, MD, Toronto, ON, Canada
Milena Vicente, RN, Toronto, ON, Canada
Christine Schemitsch, Toronto, ON, Canada
Brad Petrisor, MD, Hamilton, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
Emil H. Schemitsch, MD, Toronto, ON, Canada
Using a randomized clinical trial, we sought to determine if
the use of the RIA resulted in a decreased amount of emboli
compared to standard reaming.
2:24 PM
PAPER: 278
Impact of Surrounding Canal Size on Time to Union Following
Femoral Intramedullary Nailing: Does Size Really Matter?
Daniel Seigerman, MD, Hackensack, NJ
Richard S. Yoon, MD, New York, NY
Mark Gage, MD, New York, NY
Philip Lim, BS, MD, Northridge, CA
John Koerner, MD, Philadelphia, PA
Neeraj M. Patel, MD, MPH, MBS, New York, NY
Derek J. Donegan, MD, Philadelphia, PA
Frank A. Liporace, MD, Englewd Clfs, NJ
In the treatment of diaphyseal femur fractures, increasing canal
size surrounding a 10mm nail does not impact time to union,
independent of patient and/or fracture characteristics.
2:42 PM
PAPER: 280
Locked Plating vs. Retrograde Nailing for Distal Femur Fractures:
A Multicenter Randomized Trial
Paul Tornetta III, MD, Boston, MA
Kenneth A. Egol, MD, New York, NY
Janos P. Ertl, MD, Carmel, IN
Brian Mullis, MD, Indianapolis, IN
Cory A. Collinge, MD, Fort Worth, TX
Robert F. Ostrum, MD, Chapel Hill, NC
The purpose of this study was to evaluate the radiographic,
functional and physical outcomes of locked plates vs retrograde
nails in an IRB approved randomized controlled trail.
2:48 PM
PAPER: 281
Dynamic Fixation of Distal Femur Fractures using Far Cortical
Locking Screws: A Prospective Observational Study
Michael Bottlang, PhD, Portland, OR
Kirk Hansen, BS, Portland, OR
Richard E. Gellman, MD, Portland, OR
Daniel C. Fitzpatrick, MD, Eugene, OR
Corey J. Vande Zandschulp, MD, Portland, OR
Daniel V. Sheerin, MD, Eugene, OR
Erik Kubiak, MD, Salt Lake City, UT
Steven M. Madey, MD, Portland, OR
This study demonstrated that dynamic fixation of a locking
plate with Far Cortical Locking (FCL) screws provides reliable
stabilization and may improve healing compared to standard
locked plating.
PAPER: 282
2:54 PM
Dynamic Locked Plating of Comminuted Distal Femur
Fractures: A Matched Cohort Study
Michael J. Gardner, MD, Saint Louis, MO
Patricia Babb, Saint Louis, MO
Christopher McAndrew, MD, Saint Louis, MO
William M. Ricci, MD, Saint Louis, MO
Dynamic locked plating of distal femur fractures, by allowing
slight toggle between the plate and bone, is safe and increases
callus formation.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
113
Wednesday, March 12
3:06 PM
PAPER: 283
Long Bone Defects Managed with the Induced Membrane
Technique: Treatment Protocol and Clinical Outcomes
Suribabu Gudipati, MBBS, MRCS, Carmarthen, United Kingdom
Paul Harwood, MD, Leeds, United Kingdom
Nikolaos K. Kanakaris, MD, Leeds, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
The induced membrane technique appears to be an alternative
good option for the treatment of large bone defects secondary to
acute bone loss or as a result of chronic infected non-unions
PAPER: 284
3:12 PM
Can Reamer-irrigator-aspirator Replace the Iliac Autografting in
Diaphyseal Long Bones Nonunion?
Xavier Flecher, Marseille, France
Jean-Philippe Vivona, Les Pennes Mirabeau, France
Sebastian Parratte, MD, Marseille, France
Jean-Noel A. Argenson, MD, Marseille, France
Autologous anterior iliac crest (AIC) bone graft remains the gold
standard for treating tibial or femoral shaft nonunions despite its
morbidity.
3:18 PM
PAPER: 285
Management of Long Bone Non-union with the Diamond
Concept - Our Institutional Experience
Suribabu Gudipati, MBBS, MRCS, Carmarthen, United Kingdom
Nikolaos K. Kanakaris, MD, Leeds, United Kingdom
Peter Giannoudis, MD, FRCS, MBBS, BS, Leeds, United Kingdom
Diamond concept has allowed restoration of optimal mechanical
and biological environment and facilitated fracture healing and
high success rate of union in the current study.
Discussion 6 Minutes
1:36 PM
PAPER: 287
Crossed Wires versus Two Lateral Wires in Management of
Supracondylar Fracture of the Humerus in Children
Ahmed Hosny, Cairo, Egypt
Mahmoud Abdel Karim, MBBCh, MSc, Cairo, Egypt
M. Hani Mohamadi, Cairo, Egypt
The crossed pin configuration showed more statistically
significant difference in stability than lateral pin configuration (P
value ; 0.031) in management of supracondylar humeral fracture
in children.
PAPER: 288
1:42 PM
Rotation and Coronal Displacement Predict Outcomes in
Pediatric Supracondylar Humerus Fractures
Michael A. Flierl, MD, Aurora, CO
Patrick Carry, Aurora, CO
Frank A. Scott, Aurora, CO
Gaia Georgopoulos, MD, Aurora, CO
Nancy H. Miller, MD, Aurora, CO
Sagittal plane rotation and coronal plane displacement on presurgical radiographs predict adverse events following the closed
reduction and percutaneous pinning of pediatric supracondylar
fractures.
Discussion 6 Minutes
1:54 PM
PAPER: 289
The Effect of C-Arm Orientation on Radiation Exposure during
Supracondylar Humerus Fracture Fixation
Raymond Y. Hsu, MD, Providence, RI
Craig R. Lareau, MD, Providence, RI
Jeomsoon Kim, Providence, RI
Sarath C. Koruprolu, MS, Providence, RI
Christopher T. Born, MD, Providence, RI
Jonathan R. Schiller, MD, Providence, RI
This study compares surgeon radiation exposure from upright
and inverted C-arm orientations during fixation of pediatric
supracondylar humerus fractures.
PAPER PRESENTATION
2:00 PM
PAPER: 290
Fracture of the Medial Humeral Epicondyle in Children: A
Comparison of Operative and Nonoperative Management
Marcus D. Biggers II, MD, Memphis, TN
Timothy M. Bert, MD, Phoenix, AZ
Alice Moisan, BSN, RN, CCRP, Memphis, TN
David D. Spence, MD, Memphis, TN
William C. Warner Jr, MD, Germantown, TN
James H. Beaty, MD, Memphis, TN
Jeffrey R. Sawyer, MD, Germantown, TN
Derek M. Kelly, MD, Memphis, TN
Review of Medial Epicondyle Fractures revealed similar union
rate and functional outcome between operative and non-operative
treatment; but high rate of distal humeral deformity and valgus
instability.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
1:30 PM 3:30 PM
Room 345
114
Educational Programs
Wednesday, March 12
2:06 PM
PAPER: 291
Operative versus Non-operative Treatment of Displaced
Proximal Humeral Physeal Fractures: A Matched Cohort
George W. Chaus, MD, Aurora, CO
Azin Kheirandish Pishkenari, Aurora, CO
Patrick Carry, Aurora, CO
Nancy H. Miller, MD, Aurora, CO
Patients matched by age and fracture patterns had similar clinical
outcomes regardless of whether they underwent operative or nonoperative treatment for a displaced proximal humeral physeal
fracture.
Discussion 6 Minutes
2:18 PM
PAPER: 292
Radiographic Evaluation of Pediatric Distal Radius Fractures:
Implications on Clinical Care and Cost
Gaurav A. Luther, MD, Boston, MA
Patricia Miller, MS, Boston, MA
Peter M. Waters, MD, Boston, MA
Donald S. Bae, MD, Boston, MA
The week 4 x-ray adds little value to clinical decision making,
and its elimination would result in a savings of 4.8% to 11.9% in
the overall cost of non-operative fracture care.
2:24 PM
PAPER: 293
Long Arm Cast Versus Double Sugar Tong Splint for Treatment of
Pediatric Distal Forearm Fractures
Jay B. Cook, MD, Kailua, HI
Justin J. Ernat, MD, Tripler AMC, HI
Daniel Song, MD, APO, AE
Jeffrey Levy, DO, Fort Eustis, VA
Wednesday
2:42 PM
PAPER: 295
Open versus Closed Reduction of Fully Displaced Pediatric
Femoral Neck Fractures
Joseph D. Stone, MD, Atlanta, GA
Mary K. Hill, BA, Aurora, CO
Eduardo N. Novais, MD, Aurora, CO
Open reduction of fully displaced pediatric femoral neck fractures
results in improved quality of reduction and fewer complications,
including osteonecrosis (ON), than closed reduction.
2:48 PM
PAPER: 296
Association Between Femoral Shaft and Ipsilateral Femoral Neck
Fractures in the Pediatric Population
Lindsey Caldwell, MD, Rochester, NY
James O. Sanders, MD, Rochester, NY
John T. Gorczyca, MD, Rochester, NY
Charles Chan, MD, Irvine, CA
The incidence of ipsilateral femoral shaft and neck fractures is
significantly lower in the pediatric trauma population than in
adults.
PAPER: 297
2:54 PM
Non-accidental Fractures in Children: An Evaluation of Age and
Seasonal Variation
William L. Hennrikus Jr, MD, Hershey, PA
Laura Carbone, BS, Elizabethtown, PA
This study confirms the findings of previous authors that fractures
in children age < 1 year are at a greater risk for abuse than at age
1-2 years.
Discussion 6 Minutes
3:06 PM
PAPER: 298
Epidemiology, Diagnosis and Treatment of Pericapsular
Pyomyositis of the Hip in Children
Megan Mignemi, MD, Nashville, TN
Travis J. Menge, MD, Nashville, TN
Heather Cole, Nashville, TN
Christopher M. Stutz, MD, Nashville, TN
Jeffrey E. Martus, MD, MS, Nashville, TN
Steven A. Lovejoy, MD, Nashville, TN
Gregory A. Mencio, MD, Nashville, TN
Jonathan G. Schoenecker, MD, Nashville, TN
Pericapsular pyomyositis is twice as common as septic arthritis in
children and can be best diagnosed using a combination of CRP,
temperature, physical exam, effusion size on ultrasound and MRI.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
115
Wednesday, March 12
3:12 PM
PAPER: 299
Diagnosing Acute Rheumatic Fever or Septic Arthritis in
Children: The Value of Serological Inflammatory Markers
Matthew J. Boyle, MD, Durham, NC
Raakhi M. Mistry, MBBS, Auckland, New Zealand
Diana Lennon, Auckland, New Zealand
Karel Chivers, MD, Wellington South, New Zealand
Wesley P. Bevan, MD, Auckland, New Zealand
Chris Frampton, Christchurch, New Zealand
Haemish A. Crawford, MBChB, FRACS, Auckland, New Zealand
In this retrospective analysis of 114 children with acute rheumatic
fever (ARF) and 111 children with acute septic arthritis, a high
serum ESR and low serum WCC on presentation was predictive
of ARF.
PAPER: 300
3:18 PM
Management of Pediatric Synovial Fluid WBC Values Between
25,000-75,000 Following Aspiration
Benton E. Heyworth, MD, Boston, MA
Benjamin J. Shore, MD, FRCSC, Boston, MA
Catherine A. Suppan, BA, Boston, MA
Aubrey M. Wasser, MPH, Boston, MA
Mininder S. Kocher, MD, MPH, Boston, MA
Michael P. Glotzbecker, MD, Boston, MA
A substantial percentage of children with synovial fluid WBC
values of 25-75K are ultimately diagnosed with culture-positive
septic arthritis requiring surgical I&D.
Discussion 6 Minutes
Room
221
263
TICKET
Room
356
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
116
Educational Programs
Wednesday, March 12
265
TICKET
269
Room
Room
226 Overview
266
TICKET
Room
218
267
TICKET
Wednesday
Session will focus on developing market responsive
Room
strategies to attract patients, referrals and managed
347
care
TICKET
271
TICKET
Room
276
270
TICKET
Room
208
271
TICKET
272
TICKET
Room
262
273
Room
350
Room
353
TICKET
268
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
117
Wednesday, March 12
PAPER PRESENTATION
4:00 PM 6:00 PM
Theater A
Adult Reconstruction Hip III: Complications
Moderator(s):Kevin L. Garvin, MD, Omaha, NE
William B. Kurtz, MD, Nashville, TN
4:00 PM
PAPER: 301
Total Hip Arthroplasty Survival Stratified According to Body
Mass Index
Eric R. Wagner, MD, Rochester, MN
Atul F. Kamath, MD, Massapequa, NY
Kristin Fruth, BS, Rochester, MN
William Harmsen, MS, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
The rate of revision surgery after THA is associated with BMI,
increasing in a sigmoidal fashion for BMIs <27 and >32. This
study adds to the debate of impact of BMI on the outcomes after
primary THA.
4:06 PM
PAPER: 302
Percent Body Fat More Associated with Perioperative Outcomes
After Total Joint Arthroplasty than BMI
Cameron K. Ledford, MD, Durham, NC
Ramon R. Thiele, MS, Durham, NC
Robert J. Butler, DPT, PhD, PT, Durham, NC
John S. Appleton Jr, MD, Dallas, TX
Robin M. Queen, PhD, Durham, NC
Samuel S. Wellman, MD, Durham, NC
David E. Attarian, MD, Durham, NC
Michael P. Bolognesi, MD, Durham, NC
Percent body fat may be a more effective measure to use in
determining perioperative risks and outcomes associated with
total joint arthroplasty, especially those performed in obese
patients.
This study aimed to look at the effect of Body Mass Index (BMI)
on outcomes after total joint arthroplasty.
Discussion 6 Minutes
4:48 PM
PAPER: 307
Characterization of Periprosthetic Femur Fractures in 32,644
Primary Total Hip Arthroplasties
Matthew P. Abdel, MD, Eagan, MN
Chad Watts, MD, Rochester, MN
David G. Lewallen, MD, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
Intraoperative fractures are most common in women over
65 treated with an uncemented stem; cumulative risk of
postoperative femoral fracture at 25 years was 4.7%.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
PAPER: 303
4:12 PM
The Effect of Body Mass Index on Outcomes in Total Joint
Arthroplasty
Hasham M. Alvi, MD, Chicago, IL
Rachel E. Mednick, MD, Chicago, IL
Lauren Mioton, BS, Nashville, TN
Varun Krishnan, BA, Chicago, IL
David W. Manning, MD, Chicago, IL
4:24 PM
PAPER: 304
Do Functional Gain and Pain Relief After Total Hip Replacement
Differ By Patient Obese Status?
Wenjun Li, PhD, Worcester, MA
David C. Ayers, MD, Worcester, MA
Leslie Harrold, MD, MPH, Worcester, MA
Jeroan Allison, MD, Worcester, MA
Courtland G. Lewis, MD, Farmington, CT
Thomas R. Bowen, MD, Danville, PA
Patricia Franklin, MD, MBA, MPH, Worcester, MA
118
Educational Programs
Wednesday, March 12
4:54 PM
PAPER: 308
MRI Findings Associated with Recalled Modular Neck Femoral
Implants
Christopher P. Walsh, MD, Northville, MI
Joseph P. Nessler, MD, Sartell, MN
David C. Markel, MD, Southfield, MI
Retrospective review of prospectively collected data of modular
neck femoral stems showing an increased revision rate with
findings of synovitis, effusion, tendinopathy, and elevated metal
ion levels.
PAPER: 309
5:00 PM
Time to Surgery for Definitive Fixation of Hip Fractures: A Look
at Outcomes Based Upon Delay
Hasham M. Alvi, MD, Chicago, IL
Rachel E. Mednick, MD, Chicago, IL
Varun Krishnan, BA, Chicago, IL
Mary J. Kwasny, PhD, Chicago, IL
David W. Manning, MD, Chicago, IL
This study aims to look at outcomes in patients with hip fractures
based upon time from admission to definitive surgical fixation.
Discussion 6 Minutes
5:12 PM
PAPER: 310
Pre-Admission Chlorhexidine Reduces Infections in Joint
Arthroplasty: A Prospective, Randomized, Level I Study
Bhaveen Kapadia, MD, Baltimore, MD
Mark J. McElroy, BS, MS, Monroeville, PA
Kimona Issa, MD, Baltimore, MD
Samik Banerjee, MBBS, MS, Baltimore, MD
Sreenath Jagannathan, BS, Baltimore, MD
Michael A. Mont, MD, Baltimore, MD
Wednesday
5:24 PM
PAPER: 312
A Randomized Controlled Trial of Triclosan-Coated Sutures in
2,547 Lower Limb Arthroplasty Operations
Cyrus D. Jensen, MBBS, FRCS, Newcastle Upon Tyne, United
Kingdom
Andy Sprowson, MD, Warwickshire, United Kingdom
Paul F. Partington, MD, Corbridge, United Kingdom
Ian Carluke, MB ChB, Ashington, United Kingdom
Kevin Emmerson, FRCS Orth, Newcastle Upon Tyne, United
Kingdom
Seif S. Asaad, Tyne & Wear, United Kingdom
Roland Pratt, MB, FRCS, North Shields, United Kingdom
Scott Muller, MBBS MD, FRCS, Northumberland, United Kingdom
Mike R. Reed, MBBS MD, Northumberland, United Kingdom
The use of triclosan-coated absorbable sutures resulted in no
difference in the surgical site infection rate following lower limb
arthroplasty, when compared to an uncoated version of the same
suture.
Discussion 6 Minutes
5:36 PM
PAPER: 313
Thirty-day Outcomes in Insulin-Dependent and Non-Insulin
Dependent Diabetics After Lower Extremity Arthroplasty
Francis Lovecchio, BA, Chicago, IL
David W. Manning, MD, Chicago, IL
Alexei Mlodinow, BA, Chicago, IL
Lalit Puri, MD, Glenview, IL
John Kim, MD, Chicago, IL
A retrospective review comparing nationwide thirty-day
arthroplasty complications in diabetics under different forms of
glucose control.
5:42 PM
PAPER: 314
The Validity of Patient-Reported Short-Term Complications
following Total Hip and Knee Arthroplasty
Leslie Harrold, MD, MPH, Worcester, MA
David C. Ayers, MD, Worcester, MA
Regis J. OKeefe, MD, Rochester, NY
Courtland G. Lewis, MD, Farmington, CT
Vincent D. Pellegrini, MD, Charleston, SC
Patricia Franklin, MD, MBA, MPH, Worcester, MA
Given the new public reporting requirements of all post-TJA
discharge complications, patient reported post-operative events
may augment current hospital-specific surveillance procedures.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
119
Wednesday, March 12
5:48 PM
PAPER: 315
Is it Reasonable to Hold Surgeons Legally Accountable for Leg
Length Discrepancy after THA?
Carl A. Deirmengian, MD, Wynnewood, PA
Adam Sadler, DO, Philadelphia, PA
Jenny Cai, Philadelphia, PA
Gregory K. Deirmengian, MD, Broomall, PA
William J. Hozack, MD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
Matthew Austin, MD, Philadelphia, PA
Alvin C. Ong, MD, Linwood, NJ
Given that a LLD greater than 1cm occurs in 10% of THAs
among fellowship-trained surgeons, and is due to several
complex factors, it appears unreasonable to hold surgeons legally
accountable.
4:12 PM
PAPER: 318
Mechanically Assisted Taper Corrosion in Modular Total Knee
Arthroplasty
Christina M. Arnholt, Philadelphia, PA
Daniel MacDonald, Philadelphia, PA
Mariya Tohfafarosh, BS, Philadelphia, PA
Jeremy Gilbert, PhD, Syracuse, NY
Gregg R. Klein, MD, Paramus, NJ
Michael A. Mont, MD, Baltimore, MD
Javad Parvizi, MD, FRCS, Philadelphia, PA
Clare M. Rimnac, PhD, Cleveland, OH
Steven M. Kurtz, PhD, Philadelphia, PA
The purpose of this study was to characterize the prevalence of
taper damage in modular components for TKA.
Discussion 6 Minutes
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 245
Adult Reconstruction Knee III: Revision TKA
Moderator(s):David Backstein, Toronto, ON, Canada
William L. Griffin, MD, Charlotte, NC
4:00 PM
PAPER: 316
Does Speed Kill? Revision Rates and Functional Outcomes in
TKA in Relation to Duration of Surgery
Simon Young, MD, Scottsdale, AZ
John Mutu-Grigg, MD, London, ON, Canada
Chris Frampton, Christchurch, New Zealand
John C. Cullen, MD, Auckland, New Zealand
Surgical Duration less than 40 minutes was associated with
poorer outcomes in TKA.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
4:06 PM
PAPER: 317
Mortality Following Revision Total Knee Arthroplasty: A
Matched Cohort Study of Septic versus Aseptic Revision
Horim Choi, MD, Boston, MA
Hany S. Bedair, MD, Boston, MA
4:24 PM
PAPER: 319
Malrotation of the Tibial Component in Total Knee
Replacements: The Impact of Implant Design and Surgical
Experience
Sabir Ismaily, Houston, TX
Jonathan Gold, BS, Houston, TX
Stephen J. Incavo, MD, Houston, TX
Michael P. Bolognesi, MD, Durham, NC
Philip C. Noble, PhD, Houston, TX
120
Educational Programs
Wednesday, March 12
4:48 PM
PAPER: 322
Primary and Revision Arthroplasty: Monocyte Recruitment and
Scores
Simon Frostick, MD, Liverpool, United Kingdom
Amanda Williams, Research Nurse, Liverpool, United Kingdom
Haiyi Wang, Liverpool, United Kingdom
Alasdair Santini, Liverpool, United Kingdom
Viju Peter, MD, Merseyside., United Kingdom
Joanne Banks, FRCS), MB, Liverpool, United Kingdom
John Davidson, FRCS, ChB, Liverpool, United Kingdom
Margaret M. Roebuck, PhD, Liverpool, United Kingdom
Richard Jackson, Liverpool, Merseyside, United Kingdom
5:18 PM
PAPER: 326
How Much of Cement Depth Guarantees Stem Stability in
Revision Knee Arthroplasty with Hybrid Fixation Technique?
Duhyun Ro, MD., Seoul, Republic of Korea
Joon Kyu Lee, MD, Seoul, Republic of Korea
Yool Cho, MD, Seoul, Republic of Korea
Kee Yun Chung, MD, Seoul, Republic of Korea
Seong Hwan Kim, MD, Daehak-Ro, Republic of Korea
Sahnghoon Lee, MD, PhD, Seoul, Republic of Korea
Sang C. Seong, MD, Seoul, Republic of Korea
Young Min Lee, MD, Seoul, Republic of Korea
Myung C. Lee, MD, Seoul, Republic of Korea
4:54 PM
PAPER: 323
Incidence of Patella Clunk Syndrome in a Fixed Versus Mobile
Bearing Posterior-Stabilized Total Knee Arthroplasty
Nimrod Snir, MD, New York, NY
Ran Schwarzkopf, MD, Irvine, CA
Mathew Hamula, BA, BS, New York, NY
Richelle C. Takemoto, MD, Pittsburgh, PA
Brian Diskin, New York, NY
Patrick A. Meere, MD, New York, NY
5:24 PM
PAPER: 327
Distal Femoral Valgus is Highly Variable in Patients Undergoing
Total Knee Arthroplasty
William Bugbee, MD, La Jolla, CA
Luke Aram, MS, Warsaw, IN
Alex J. Schenher, Warsaw, IN
Wednesday
PAPER: 324
5:00 PM
Radiographic and Technical Factors Associated with Patellar
Clunk Syndrome in Total Knee Arthroplasty
James A. Costanzo, MD, Philadelphia, PA
John Peters, BS, Clarks Summit, PA
Daniel M. Kopolovich, BA, Philadelphia, PA
Michael C. Aynardi, MD, Philadelphia, PA
James J. Purtill, MD, Philadelphia, PA
Patellar component size, increase in posterior femoral offset, and
preoperative valgus alignment are associated with patellar clunk
syndrome in posterior stabilized total knee arthroplasty.
Discussion 6 Minutes
5:12 PM
PAPER: 325
Rotating Hinge Versus Constrained Condylar Knee Replacement:
Which One is More Constrained? A Finite Element Study
Saeid Samiezadeh, PhD, Toronto, ON, Canada
Mansour Abolghasemian, MD, Tehran, Iran
Darryl D. DLima, MD, La Jolla, CA
David Backstein, MD, Toronto, ON, Canada
5:36 PM
PAPER: 328
Porous Tantalum Tibial Cones in Revision Total Knee
Arthroplasty: Minimum Five-Year Follow Up
Atul F. Kamath, MD, Massapequa, NY
Arlen D. Hanssen, MD, Rochester, MN
David G. Lewallen, MD, Rochester, MN
At 5-9 year follow-up, porous tantalum cones for severe tibial
bone loss demonstrate durable clinical results and radiographic
fixation. Revision-free survival of the tibial cone component was
95.4%.
5:42 PM
PAPER: 329
Does Increased Topside Conformity in Modular Total Knee
Arthroplasty Lead to Increased Backside Wear?
Ran Schwarzkopf, MD, Irvine, CA
Evan M. Carlson, MS, Hanover, NH
John H. Currier, MS, Hanover, NH
Richard D. Scott, MD, Boston, MA
The study results confirm the hypothesis that the more
conforming tibial inserts experienced a higher backside wear rate
than the flatter designs.
Educational Programs
121
Wednesday, March 12
5:48 PM
PAPER: 330
The Epidemiology of Revision Total Knee Arthroplasty in the
United States
Kevin J. Bozic, MD, MBA, San Francisco, CA
Atul F. Kamath, MD, Massapequa, NY
Edmund Lau, MS, Menlo Park, CA
Kevin Ong, PhD, Philadelphia, PA
Steven M. Kurtz, PhD, Philadelphia, PA
Vanessa Chan, MPH, San Francisco, CA
Harry E. Rubash, MD, Boston, MA
Daniel J. Berry, MD, Rochester, MN
Thomas P. Vail, MD, San Francisco, CA
The burden of revision TKA is growing. PJI and mechanical
loosening are the most common causes of revision TKA.
4:12 PM
PAPER: 333
Ulnar Styloid Fracture in Association with Distal Radius Fracture
Portends Poorer Outcome
Omri Ayalon, MD, New York, NY
Alejandro Marcano, MD, New York, NY
Nader Paksima, DO, New York, NY
Kenneth A. Egol, MD, New York, NY
Presence of an ulnar styloid fracture with a distal radius fracture
is associated with worse pain and lower function than those
without.
Discussion 6 Minutes
4:00 PM 6:00 PM
Room 265
4:24 PM
PAPER: 334
Factors Associated with Complex Regional Pain Syndrome I in
Patients with Surgically Treated Distal Radius Fracture
Young Hak Roh, Incheon, Republic of Korea
Beom Koo Lee, Incheon, Republic of Korea
Do Hyun Moon, Incheon, Republic of Korea
Jong Ryoon Baek, Incheon, Republic of Korea
Jung Ho Noh, MD, PhD, Chuncheon-Si, Republic of Korea
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM
PAPER: 331
Early Versus Late Motion Following Volar Plating of Distal Radius
Fractures
David G. Dennison, MD, Rochester, MN
Char Blanchard, Rochester, MN
Bassem T. Elhassan, MD, Rochester, MN
Steven L. Moran, MD, Rochester, MN
Alexander Yong Shik Shin, MD, Rochester, MN
Following volar plating for distal radius fractures, early motion
favored only better 6 week motion and outcome scores while
delayed motion also resulted in similar outcome at one year.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
4:06 PM
PAPER: 332
Complications of Volar Locked Plating for Distal Radius
Fractures
David M. Brogan, MD, Rochester, MN
Alexander Yong Shik Shin, MD, Rochester, MN
David G. Dennison, MD, Rochester, MN
Hillary A. Becker, MD, Sioux Falls, SD
Ashley C. Walker, NP, MS, Rochester, MN
4:30 PM
PAPER: 335
No Difference Between Anatomical Position and Amount of
Osteoarthritis 15 Years After a Distal Radius Fracture
Mark V. Van Outeren, MD, The Hague, Netherlands
David Arashvand, Rotterdam, Netherlands
Gerald Kraan, MD, Delft, Netherlands
122
Educational Programs
Wednesday, March 12
4:48 PM
PAPER: 337
Computer Assisted Surgical Planning for Distal Radius
Malunion: A Randomized Controlled Trial
Natalie Leong, MD, Los Angeles, CA
Geert Buijze, MD, PhD, Boston, Netherlands
Peter M. Axelsson, MD, Gteborg, Sweden
Rodrigo Moreno, MD, Louisville, KY
Filip Stockmans, MD, PhD, Heule-Kortrijk, Belgium
Jesse B. Jupiter, MD, Boston, MA
This prospective randomized controlled trial compares patient
outcomes after corrective osteotomy for distal radius malunion
with and without computer-assisted planning and peri-operative
patient-specific surgical guides.
4:54 PM
PAPER: 338
Long-term Outcomes After Radiocarpal Dislocation: A
Prospective Review
Brandon J. Yuan, MD, Rochester, MN
David G. Dennison, MD, Rochester, MN
Bassem T. Elhassan, MD, Rochester, MN
Sanjeev Kakar, MD, Rochester, MN
Early recognition and treatment of radiocarpal dislocations with
open reduction, internal fixation and repair of ligaments results in
improved long-term functional outcome scores.
Wednesday
5:00 PM
PAPER: 339
Perilunate Dislocation and Fracture-dislocation of the Wrist:
Retrospective Evaluation of 65 Cases
Pierre Mansat, MD, PhD, Toulouse, France
Dan Israel, MD, Toulouse, France
Nicolas Bonnevialle, MD, Toulouse Cedex, France
Michel Rongieres, MD, Blagnac, France
Michel F. Mansat, MD, Toulouse Cedex, France
Philippe Chiron, MD, Toulouse Cedex, France
Paul Bonnevialle, MD, Toulouse, France
Perilunate dislocation and fracture-dislocation are severe
wrist trauma with often numerous sequelae with follow-up.
Early diagnosis and anatomic reduction are prerequisite to a
satisfactory functional result.
Discussion 6 Minutes
5:12 PM
PAPER: 340
Proximal Row Carpectomy Considerations for Maximizing Longterm Outcomes; A Longitudinal Study of 144 Cases
Eric R. Wagner, MD, Rochester, MN
Dalibel M. Bravo, San Juan, PR
Bassem T. Elhassan, MD, Rochester, MN
Steven L. Moran, MD, Rochester, MN
5:18 PM
Locked Intramedullary Total Wrist Arthrodesis
Jorge L. Orbay, MD, Miami, FL
Eric Feliciano, BS, Miami, FL
Maria-Carolina Orbay, BS, Coral Gables, FL
Michael R. Mijares, MD, Pinecrest, FL
PAPER: 341
5:36 PM
PAPER: 343
Comparison of Compression Screw and Perpendicular Clamp
in Ulnar Shortening Osteotomy
Daniel Martin, MD, Walnut Creek, CA
Dan A. Zlotolow, MD, Philadelphia, PA
Stephanie Russo, Philadelphia, PA
Scott H. Kozin, MD, Philadelphia, PA
When compared with compression screw technique in ulnar
shortening osteotomy, perpendicular clamp placement
significantly increased force across the osteotomy in this cadaveric
biomechanical study.
5:42 PM
PAPER: 344
Bilateral Total Wrist Arthrodesis Improves Long-term Pain and
Function
Eric R. Wagner, MD, Rochester, MN
Bassem T. Elhassan, MD, Rochester, MN
Sanjeev Kakar, MD, Rochester, MN
Bilateral total wrist arthrodesis improves pain, function, and
quality of life in patients with severe carpal arthrosis. This
procedure is a salvage option for patients with severe bilateral
disease.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
123
Wednesday, March 12
5:48 PM
PAPER: 345
Percutaneous Fixation Leads to Consolidation in Selected Cases
of Delayed Union of the Scaphoid Waist
Matthias Vanhees, MD, Stabroek, Belgium
Roger P. van Riet, MD, Wilrijk, Belgium
Frederik Verstreken, MD, Deurne, Belgium
Percutaneous, transtrapezial fixation without bone graft leads to
consolidation in selected cases of delayed union of the scaphoid
waist.
Discussion 6 Minutes
4:12 PM
PAPER: 348
The Effect of Peroneus Brevis Tendon Anatomy on Stability of
Fractures at the Fifth Metatarsal Base
Parisa Morris, MD, Phoenix, AZ
Annie-Lourdes G. Francois, MD, Tucson, AZ
Randall E. Marcus, MD, Cleveland, OH
Lutul D. Farrow, MD, Garfield Heights, OH
The peroneus brevis tendon exerts a greater deforming force on
Jones fracures than avulsion injuries.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 345
Foot and Ankle III: Fractures and Flatfoot
Moderator(s):Patrick Ebeling, MD, Burnsville, MN
Naren G. Gurbani, MD, Capistrano Beach, CA
4:00 PM
PAPER: 346
Epidemiology of Fifth Metatarsal Fractures: A Retrospective
Review
Justin M. Kane, MD, Coatesville, PA
Kristin Brown, Philadelphia, PA
Heather L. Saffel, BS, MS, Elkins, West VA
Anthony Albanese, BA, BS, MEd, Philadelphia, PA
Michael C. Aynardi, MD, Philadelphia, PA
Steven M. Raikin, MD, Philadelphia, PA
David I. Pedowitz, MD, Penn Valley, PA
A retrospective chart review of 772 fifth metatarsal fractures was
undertaken. An attempt was made to establish trends towards
different fractures and risk factors in the general US population.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
4:06 PM
PAPER: 347
Incidence and Long-term Outcome of Nonoperative
Management of Dancers Fractures
Michael C. Aynardi, MD, Philadelphia, PA
David I. Pedowitz, MD, Penn Valley, PA
Christine C. Piper, Philadelphia, PA
Heather L. Saffel, BS, MS, Elkins, West VA
Steven M. Raikin, MD, Philadelphia, PA
4:24 PM
PAPER: 349
Balloon Assisted Reduction, Pin Fixation and Tricalcium
Phosphate Augmentation for Calcanear Fracture
Giovanni Vicenti Jr, MD, Altamura, Italy
Gianni Caizzi, Bari, Italy
Donato Vittore, Bari, Italy
Marco Dilonardo, Taranto, Italy
Antonella Abate Jr, Bari, Italy
Biagio Moretti, Bari, Italy
124
Educational Programs
Wednesday, March 12
4:36 PM
PAPER: 351
Integrated Orthotic and Rehabilitation Initiative Results in
Rapid Improvement
Katherine M. Bedigrew, MD, Fort Sam Houston, TX
Jeanne C. Patzkowski, MD, San Antonio, TX
Jason M. Wilken, PhD, PT, Fort Sam Houston, TX
Johnny Owens, San Antonio, TX
Ryan Blanck, Fort Sam Houston, TX
Daniel J. Stinner, MD, San Antonio, TX
LTC Kevin L. Kirk, DO, Skillman, NJ
Joseph R. Hsu, MD, Charlotte, NC
Subjects enrolled in the Return to Run clinical pathway
demonstrated significant improvements in validated functional
measures and patient based outcomes in eight weeks.
Discussion 6 Minutes
4:48 PM
PAPER: 352
Glycaemic Control in Diabetic Patients and Ankle Fracture
Healing
Waseem Jerjes, MD, PhD, West Yorkshire, United Kingdom
Hiang Boon Tan, MBBS, Leeds, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
Diabetic patients have slight increase in time to union when
compared to the normal population.
4:54 PM
PAPER: 353
Effect of Chronic Heavy Smoking on Ankle Fracture Healing
Waseem Jerjes, MD, PhD, West Yorkshire, United Kingdom
Hiang Boon Tan, MBBS, Leeds, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
Wednesday
5:12 PM
The Fate of the Fixed Syndesmosis over Time
Scott Koenig, MD, Irvine, CA
Elisabeth Gennis, MD, Wayland, MA
Deirdre Rodericks, Boston, MA
Peters T. Otlans, BA, MA, Boston, MA
Paul Tornetta III, MD, Boston, MA
PAPER: 355
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
125
Wednesday, March 12
5:36 PM
PAPER: 358
A Plantar Closing Wedge Osteotomy of the Medial Cuneiform in
Flatfoot Reconstruction
Keir A. Ross, McKinney, TX
Jeff Ling, MD, New York, NY
Charles P. Hannon, BS, New York, NY
Niall A. Smyth, MD, South Miami, FL
Christopher J. Egan, PA-C, Westbury, NY
John G. Kennedy, MD, New York, NY
A new technique for residual forefoot supination in flatfoot
reconstruction is described. Clinical outcomes and radiographic
measures were improved postoperatively.
PAPER: 359
5:42 PM
Outcomes of the Calcaneal Scarf Ostetotomy for Surgical
Correction of the Adult Acquired Flatfoot
Catherine A. Feuerstein, DPM, Des Plaines, IL
Lowell S. Weil, DPM, Lake Forest, IL
Lowell S. Weil, DPM, Des Plaines, IL
Erin E. Klein, DPM, MS, Grayslake, IL
Nicholas Argerakis, DPM, Des Plaines, IL
Mitchell B. Sheinkop, MD, Chicago, IL
Usman Akram, DPM, Glendale, WI
The results of the current study demonstrate that the CSO
significantly changes clinical and radiographic exam parameters
while obtaining high outcome scores in patients.
PAPER: 360
5:48 PM
Biomechanical Analysis of a Flatfoot Model and Lateral Column
Lengthening Technique
Jeffrey Mercer, MD, PhD, Lake Oswego, OR
Nathanael D. Heckmann, MD, Long Beach, CA
Lawrence C. Wang, Orange, CA
Michelle H. McGarry, MD, Long Beach, CA
Steven D. Ross, MD, Orange, CA
Thay Q. Lee, PhD, Long Beach, CA
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Wednesday
126
Educational Programs
Thursday, March 13
INSTRUCTIONAL COURSE Lecture
305
8:00 AM 10:00 AM
301
TICKET
Room
207
TICKET
306
TICKET
Room
262
308
TICKET
Room
353
Will examine the financial and operational impact ICD10 and meaningful use stage 2 regulations will have
on orthopaedic practices. The organization of ICD-10,
cross walk from ICD-9 to ICD-10 and steps needed
for successful conversion will be discussed. Significant
changes proposed in Meaningful use 2 regulations and
compliance risks posed by these regulations will also be
discussed.
Thursday
Room
208
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
127
Thursday, March 13
309
TICKET
Room
226
Room
221
Room
215
Room
271
Room
218
TICKET
Room
347
315
Room
352
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
314
128
Educational Programs
Thursday, March 13
INSTRUCTIONAL COURSE Lecture
8:00 AM 12:00 PM
901
TICKET
Rivergate
Room
TeamSTEPPS
Moderator: Harpal S. Khanuja, MD, Cockeysville, MD
Dwight W. Burney III, MD, Albuquerque, NM
Mary I. OConnor, MD, Jacksonville, FL
Kristy L. Weber, MD, Philadelphia, PA
PAPER PRESENTATION
8:00 AM 10:00 AM
Theater A
Adult Reconstruction Knee IV: Complications
Moderator(s):Thomas J. Blumenfeld, MD, Sacramento, CA
Michael A. Kelly, MD, Hackensack, NJ
Gregg Klein, MD, Paramus, NJ
8:00 AM
PAPER: 361
Patients with Rheumatoid Arthritis are at Increased Risk for
Complications Following Total Joint Arthroplasty
Bheeshma Ravi, MD, Toronto, ON, Canada
Ruth Croxford, MSc, Toronto, ON, Canada
Benjamin Escott, MBBS, Toronto, ON, Canada
Simon Hollands, MSc, BS, Toronto, ON, Canada
Michael Paterson, Toronto, ON, Canada
Earl R. Bogoch, MD, Toronto, ON, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
Gillian Hawker, MD, Toronto, ON, Canada
8:24 AM
PAPER: 364
Ninety-Day Morbidity in Patients Undergoing Primary TKA with
Discontinuation of Warfarin and Bridging with LMWH
Emmanuel Gibon, MD, Paris, France
Nicolas Barut, MD, Paris, France
Jean-Pierre Courpied, PhD, Paris, France
Philippe Anract, MD, Paris, France
Moussa Hamadouche, PhD, Paris, France
This paper evaluates the 90-day complications rate following
primary TKA in patients under chronic anticoagulation managed
with warfarin discontinuation and bridged with LMWH.
8:30 AM
PAPER: 365
Recent National Trends and Outcomes for Pulmonary Embolism
after Total Knee Arthroplasty in the United States
Vincent M. Moretti, MD, Berwyn, IL
Ritesh Shah, MD, Glenview, IL
Pulmonary embolism (PE) after total knee arthroplasty can have
a significant impact on patient outcomes and healthcare costs.
Recent efforts to decrease PE have not altered its occurrence.
Thursday
8:06 AM
PAPER: 362
Rheumatoid Arthritis Does Not Increase Perioperative
Complications Following Same-day Bilateral TKA
Lazaros A. Poultsides, MD, New York, NY
Stavros G. Memtsoudis, MD, PhD, New York, NY
Huong Do, MA, New York, NY
Thomas P. Sculco, MD, New York, NY
Mark P. Figgie, MD, New York, NY
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
129
Thursday, March 13
8:36 AM
PAPER: 366
The Embolic Load After Total Knee Replacement is a Function of
the Tourniquet Time
Rajesh Malhotra, MS, New Delhi, India
Vijay Kumar, MD, New Delhi,India, India
Amit Singla, MBBS, MS, New Delhi, India
Vishwas Malik, Delhi, India
Dr. Chandralekha, New Delhi, India
Ganesan Karthikeyan, MBBS, MD, New Delhi, India
Dr.. Rajni B. Safaya, New Delhi, India
Emboli load is dependent on tourniquet time regardless of
whether intramedullary canal is breached or not.
Discussion 6 Minutes
8:48 AM
PAPER: 367
Implications of Outpatient vs. Inpatient Total Joint Arthroplasty
on Hospital Readmission Rates
David N. Vegari, MD, Philadelphia, PA
Jeffrey G. Mokris, MD, Charlotte, NC
Susan M. Odum, PhD, Charlotte, NC
Bryan D. Springer, MD, Charlotte, NC
In properly selected patients, the outcomes of outpatient TJA
are comparable to inpatient arthroplasty without increasing
readmission rates and financially penalizing hospitals.
8:54 AM
PAPER: 368
In-Hospital Complications and UTIs Increased in Obese Patients
Undergoing TKA
Matthew P. Abdel, MD, Eagan, MN
Michael P. Ast, MD, New York, NY
Yuo-Yu Lee, MS, New York, NY
Stephen Lyman, PhD, New York, NY
Alejandro Gonzalez Della Valle, MD, New York, NY
Obese patients undergoing primary TKA are at increased risk for
all-cause in-house complications, ARF, and UTI and perioperative
management should take BMI into account.
Discussion 6 Minutes
9:00 AM
PAPER: 369
Thirty Day Readmission Rates are Not Inferior for 2 vs. 3 Day
Lengths of Stay in 23635 Primary Total Knee Arthroplasties
Stefano A. Bini, MD, San Francisco, CA
Maria C. Inacio, MS, San Diego, CA
Guy Cafri, PhD, La Jolla, CA
9:12 AM
PAPER: 370
Effects of Various Factors on the Incidence Manipulation Under
Anesthesia after Primary Total Knee Arthroplasty
Kimona Issa, MD, Baltimore, MD
Aiman Rifai, DO, Clifton, NJ
Qais Naziri, MD, Brooklyn, NY
Harpal S. Khanuja, MD, Cockeysville, MD
Vincent K. McInerney, MD, New Vernon, NJ
Mark A. Kester, PhD, Mahwah, NJ
Mark A. Kester, PhD, Mahwah, NJ
Michael A. Mont, MD, Baltimore, MD
Younger age (<50 years), non-Caucasians background, diabetes,
tobacco smoking,osteonecrosis, and lower pre-TKA range-ofmotion were associated with a higher incidence of knee stiffness
after TKA.
PAPER: 371
9:18 AM
Risk Factors for Manipulation After Total Knee Arthroplasty: A
Pooled Electronic Health Record Database Study
Kiel J. Pfefferle, MD, Akron, OH
Scott T. Shemory, MD, Akron, OH
Matthew F. Dilisio, MD, Chestnut Hill, MA
Stephen Fening, PhD, Akron, OH
Ian M. Gradisar, MD, Akron, OH
African American race, female sex and nicotine dependence
are statistically significant risk factors for manipulation under
anesthesia after TKA.
PAPER: 372
9:24 AM
Low-dose Dexamethasone Further Reduces Postoperative
Emesis and Pain in a Current Multimodal Regime Following TKA
In Jun Koh, MD, Gyeonggi-Do, Republic of Korea
Tae Kyun Kim, MD, Seongnam-si, Republic of Korea
Chong Bum Chang, MD, PhD, Seongnamsi, Republic of Korea
Moon Jong Chang, MD, Seoul, Republic of Korea
Young Gon Na, Seongnam-Si, Republic of Korea
Sanghwa Eom, MD, Seongnamsi, Republic of Korea
Seok Jin Kim, MD, Gyeonggi-Do, Republic of Korea
Yeon Gwi Kang, MD, Seongnam-Si, Republic of Korea
Byung June Chung, MD, Seoul, Republic of Korea
Concomitant use of dexamethasone further reduces postoperative
emesis and pain after TKA without increased risks for wound
complications in patients managed using a contemporary
multimodal regimen.
Discussion 6 Minutes
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
130
Educational Programs
Thursday, March 13
9:36 AM
PAPER: 373
Is Tourniquet Use in Total Knee Arthroplasty Safe in Patients
with Radiographic Evidence of Vascular Calcification?
Steven Koehler, MD, New York, NY
Adam C. Fields, BA, New York, NY
Naudereh Noori, San Luis Obispo, CA
Calin S. Moucha, MD, New York, NY
Michael J. Bronson, MD, New York, NY
In this study, we show that total knee arthroplasty can be safely
performed with a tourniquet in patients who have preoperative
radiographic evidence of calcification in the arteries of the knee.
9:42 AM
PAPER: 374
Femoral Nerve Catheters Associated with High Fall Risk in Total
Knee Arthroplasty
Christopher Pelt, MD, Salt Lake City, UT
Mike Anderson, MS, ATC, Salt Lake City, UT
Christin A. Van Dine, PA-C, Salt Lake Cty, UT
Christopher L. Peters, MD, Salt Lake City, UT
Consideration of alternative multimodal pain management
strategies that preserve muscle strength and minimize required
added precautions but maintain adequate pain relief and
outcomes is needed.
PAPER: 375
9:48 AM
The Effect of Statin Therapy on Venous Thromboembolism After
Hip or Knee Arthroplasty
Anne Bass, MD, NY City, NY
Yuo-Yu Lee, MS, New York, NY
Stephen Lyman, PhD, New York, NY
Geoffrey H. Westrich, MD, New York, NY
Brian F. Gage, MD, MSc, Saint Louis, MO
In a study of 16183 patients prospectively enrolled in the HSS
hip and knee arthroplasty registry, statins reduced the risk
of postoperative pulmonary embolism but not total venous
thromboembolism.
Thursday
PAPER: 828
9:54 AM
An Alternative for Pulmonary Embolism Prophylaxis After
Arthroplasty?
Ibrahim Raphael, MD, Philadelphia, PA
Eric H. Tischler, BA, Philadelphia, PA
Ronald Huang, MD, Philadelphia, PA
Richard H. Rothman, MD, Philadelphia, PA
William J. Hozack, MD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
We compared the rates of thromboembolism and adverse effects
of aspirin and warfarin after total joint arthroplasty. Aspirin
offers suitable prophylaxis against symptomatic PE in selected
patients.
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 245
Pediatrics III: Hip and Sports Medicine
Moderator(s):Tim Schrader, MD, Atlanta, GA
Kevin G. Shea, MD, Boise, ID
8:00 AM
PAPER: 376
Pavlik Harness Treatment May Not be Necessary for All
Newborns with Ultrasonic Hip Dysplasia
Harry K. Kim, MD, Dallas, TX
Brigid N. Maloney, MS, Tucson, AZ
Adriana De La Rocha, MS, Dallas, TX
Erica Flores, RN MSN, Dallas, TX
Case E. Brabham, Dallas, TX
Chan-Hee Jo, PhD, Dallas, TX
Based on this study, not all patients with ultrasonic dysplasia need
to be treated with a Pavlik harness. Further studies are needed to
define which patients need to be treated and which do not.
8:06 AM
PAPER: 377
Hip Dysplasia Follow-up After Six Months: Why Order X-rays
Later if Ultrasound has Normalized?
Eric J. Sarkissian, BS, Philadelphia, PA
John M. Flynn, MD, Philadelphia, PA
Wudbhav N. Sankar, MD, Wynnewood, PA
Notable incidences of residual dysplasia in infants after previous
normalization of DDH may warrant radiographic follow-up
at 6 and 12 months of age to allow timely diagnosis and early
intervention.
PAPER: 378
8:12 AM
Residual Dysplasia After Treatment with Pemberton vs. Salter
Osteotomy for DDH: Mean 10-year Follow Up
Daniel J. Sucato, MD, MS, Dallas, TX
Adriana De La Rocha, MS, Dallas, TX
Chester J. Donnally III, BS, El Paso, TX
Brigid N. Maloney, MS, Tucson, AZ
David A. Podeszwa, MD, Dallas, TX
Lori A. Karol, MD, Dallas, TX
At a mean 10 yr follow-up, there were no differences in the
rates of residual dysplasia after treatment with a Pemberton or
Salter osteotomy, however Salter patients require subsequent pin
removal.
Discussion 6 Minutes
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
131
Thursday, March 13
8:24 AM
PAPER: 379
Long-term Outcomes of Operative and Nonoperative Treatment
of Congenital Coxa Vara
David W. Roberts, MD, Winnetka, IL
Yavuz Saglam, MD, Dallas, TX
Adriana De La Rocha, MS, Dallas, TX
Brigid N. Maloney, MS, Tucson, AZ
Harry K. Kim, MD, Dallas, TX
Forty-seven hips with CCV showed satisfactory outcomes at
mean 10 year follow-up, but abnormal growth may lead to
recurrence, and many have persistently abnormal gait at longterm follow-up.
PAPER: 380
8:30 AM
Combined Surgical Hip Dislocation and Proximal Femoral
Osteotomy for Severe Hip Deformities
Stephen T. Duncan, MD, Lexington, KY
Geneva Baca, Saint Louis, MO
Angela D. Keith, MS, Saint Louis, MO
Gail Pashos, Saint Louis, MO
Perry L. Schoenecker, MD, Saint Louis, MO
John C. Clohisy, MD, Saint Louis, MO
Combined surgical hip dislocation and proximal femoral
osteotomy is an effective treatment option with improved hip
function and low conversion rate to THA in patients with severe
hip deformities.
PAPER: 381
8:36 AM
A Concomitant Arthrotomy Does Not Improve Outcome for
Adolescents with Hip Dysplasia Undergoing a PAO
Daniel J. Sucato, MD, MS, Dallas, TX
David A. Podeszwa, MD, Dallas, TX
Adriana De La Rocha, MS, Dallas, TX
John C. Clohisy, MD, Saint Louis, MO
Ernest L. Sink, MD, New York, NY
Ira Zaltz, MD, Royal Oak, MI
Michael B. Millis, MD, Boston, MA
Young Jo Kim, MD, PhD, Boston, MA
Young Jo Kim, MD, PhD, Boston, MA
Performing an arthrotomy in combination with a PAO is may not
be routinely indicated for adolescents and young adults less than
25 years of age with hip dysplasia.
Discussion 6 Minutes
8:48 AM
PAPER: 382
Subcapital Realignment versus In-situ Fixation for Severe Stable
Slipped Capital Femoral Epiphysis
Eduardo N. Novais, MD, Aurora, CO
Mary K. Hill, BA, Aurora, CO
Travis C. Heare, MD, Aurora, CO
Joseph D. Stone, MD, Atlanta, GA
Patrick Carry, Aurora, CO
Ernest L. Sink, MD, New York, NY
Severe stable slipped capital femoral epiphysis (SCFE) treatment
methods were compared. Subcapital realignment led to greater
anatomic restoration and fewer secondary procedures than in-situ
fixation.
8:54 AM
PAPER: 383
Idiopathic Cam Morphology is Not Caused by Subclinical
Slipped Capital Femoral Epiphysis: A MRI and CT Study
Shafagh Monazzam, MD, Sacramento, CA
James D. Bomar, San Diego, CA
Andrew T. Pennock, MD, San Diego, CA
The growth plate tilt of hips with cam morphology secondary
to SCFE and idiopathic cam morphology significantly differ
suggesting subclinical SCFEs are not the cause of idiopathic cam
morphology.
9:00 AM
PAPER: 384
Intermediate Results of the Bernese Periacetabular Osteotomy
for the Treatment of Perthes-like Hip Deformities
Stephen T. Duncan, MD, Lexington, KY
Angela D. Keith, MS, Saint Louis, MO
Gail Pashos, Saint Louis, MO
Geneva Baca, Saint Louis, MO
Perry L. Schoenecker, MD, Saint Louis, MO
John C. Clohisy, MD, Saint Louis, MO
At intermediate term follow-up, patients with Perthes-like
deformity following periacetabular osteotomy demonstrated good
clinical results and an acceptable conversion rate to total hip
arthroplasty.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
9:12 AM
PAPER: 385
Acute Complications of Pediatric and Adolescent Knee
Arthroscopy
Ali Ashraf, MD, Garland, TX
Christy M. Christophersen, Saint Paul, MN
Lindsay R. Hunter, Rochester, MN
Diane L. Dahm, MD, Rochester, MN
Amy L. McIntosh, MD, Rochester, MN
132
Educational Programs
Thursday, March 13
9:18 AM
PAPER: 386
Gene Expression Differences in Young Male and Female
Ruptured Anterior Cruciate Ligaments
Susan M. Moen, MD, Akron, OH
Jeffrey S. Johnson, MD, Rock Springs, WY
Robin Jacquet, Akron, OH
Melanie Morscher, Akron, OH
Christopher J. Klonk, Akron, OH
Kerwyn Jones, MD, Akron, OH
William J. Landis, Akron, OH
Microarray comparison of young female and male ruptured ACL
tissue demonstrated significant gene expression differences that
may contribute to the increased frequency of such injuries in
females.
PAPER: 387
9:24 AM
Meniscal Tears in Adolescents with Anterior Cruciate Ligament
Rupture: Relation to Medical Insurance Type
Richard E. Bowen, MD, Los Angeles, CA
Seth C. Gamradt, MD, Los Angeles, CA
Peter Wang, BS, Granada Hills, CA
Kristin Toy, MS, San Dimas, CA
This study shows increased irrepairable meniscal tears and lower
preoperative Lysholm scores in adolescent patients with anterior
cruciate ligament ruptures and government versus commercial
insurance.
Discussion 6 Minutes
9:36 AM
PAPER: 388
Efficacy of the Modified Brstrom Repair for Adolescent Patients
Suffering from Chronic Lateral Ankle Instability
Jared T. Lee, MD, Vail, CO
Adam Nasreddine, BS, MA, Boston, MA
Nicole J. Stenquist, Brookline, MA
Mininder S. Kocher, MD, MPH, Boston, MA
The purpose of this study was to report on the outcomes of the
modified Brostrom technique in the pediatric and adolescent
population for chronic lateral ankle instability.
Thursday
9:42 AM
PAPER: 389
Indirect Shoulder Magnetic Resonance Arthrography: A
Technique for Identifying Labral Pathology in Young Patients
Andrew J. Razzano Jr, DO, Massillon, OH
Melanie Morscher, Akron, OH
Richard Steiner, PhD, Akron, OH
Kerwyn Jones, MD, Akron, OH
Azam Eghbal, Akron, OH
Indirect MR arthrography may be a less invasive, cost effective
alternative to direct MR arthrography for detecting shoulder
labral pathology in young patients with comparable sensitivity
(94%).
9:48 AM
PAPER: 390
Digital Radiography in Adolescent Patellar Instability: Is MRI
Really Necessary?
Richard E. Bowen, MD, Los Angeles, CA
Scott Montgomery, MD, Venice, CA
Kristin Toy, MS, San Dimas, CA
While digital radiography gives useful information regarding
patellar height and trochlear dysplasia, MRI is essential to measure
the most important factors in adolescent patellar dislocation.
Discussion 6 Minutes
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 265
Practice Management/Rehabilitation II: Health Care Policy and
Evaluation
Moderator(s):Catherine G. Hawthorne, MD, Gallup, NM
Frederick N. Meyer, MD, Mobile, AL
8:00 AM
PAPER: 391
Assessing the Value of Work Done by an Orthopaedic Resident
During Call
William Huntington, MD, Charlotte, NC
Steven L. Frick, MD, Orlando, FL
James B. Jackson, MD, Salt Lake Cty, UT
The clinical call work performed by residents substantiates that
Medicare is getting its moneys worth from residents, in addition
to supporting the education of the next generation of surgeons.
8:06 AM
PAPER: 392
Does State-Wide Restriction Affect MRI Ordering Patterns in
Orthopaedic Surgeons?
Thomas Barrett, MD, Albany, NY
Nilay Patel, BS, Albany, NY
Richard Uhl, MD, Albany, NY
Jared T. Roberts, MD, Watervliet, NY
A comparative 3,600 patient retroactive analysis of MRI tests
ordered per patient encounter in large orthopaedic practices before
and after the ban on ownership legislation took place in MD.
8:12 AM
PAPER: 393
Value in Care Coordination: Orthopaedic Surgeon Virtual
Consults for MRI Imaging Requests
Alexandra E. Page, MD, La Jolla, CA
Anshuman Singh, MD, San Diego, CA
David Buccigrossi, MD, San Diego, CA
Dustin W. Helvey, DPT, San Diego, CA
Through EMR review orthopaedic surgeons were able to
demonstrate improved utilization of musculoskeletal MRI,
identifying non-value-added studies and recommending
appropriate conservative treatment.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
133
Thursday, March 13
8:24 AM
PAPER: 394
The Institutional Burden of Emergent Hip Arthroplasty
Atul F. Kamath, MD, Massapequa, NY
Daniel Austin, BA, Bryn Mawr, PA
Peter Derman, MD, New York, NY
Craig L. Israelite, MD, Philadelphia, PA
Emergent arthroplasty is most often carried out for femoral
fractures and prosthetic dislocations and are associated with more
complicated and expensive clinical courses.
8:30 AM
PAPER: 395
Prevalence and Costs of Rehabilitation and Physical Therapy
After Primary Total Joint Arthroplasty
Kevin Ong, PhD, Philadelphia, PA
Paul A. Lotke, MD, Gladwyne, PA
Edmund Lau, MS, Menlo Park, CA
Michael T. Manley, PhD, Wyckoff, NJ
Steven M. Kurtz, PhD, Philadelphia, PA
Physical therapy is utilized extensively, and in aggregate, costs the
Medicare system more than $648 million a year. Many of the PT
modalities utilized remain without substantive outcome data.
8:36 AM
PAPER: 396
The Potential Effect of Regionalization Strategies on Care
Delivery for Elective Total Joint Replacement
Christopher J. Dy, MD, New York, NY
Robert G. Marx, MD, New York, NY
Hassan Ghomrawi, PhD, New York, NY
Trevor Banka, MD, New York, NY
Ting-Jung Pan, MPH, New York, NY
Huong Do, MA, New York, NY
Geoffrey H. Westrich, MD, New York, NY
Stephen Lyman, PhD, New York, NY
Selecting a high volume hospital is ideal given the increased
complication risk with other choices. However, patients from
vulnerable groups are less likely to have access to these optimal
choices.
8:54 AM
PAPER: 398
The Role of Present on Admission Indicators on TKA
Complication Rates in Medicare Claims Data
Peter Cram, MD, MBA, Iowa City, IA
John J. Callaghan, MD, Iowa City, IA
Xin Lu, MS, Iowa City, IA
Yue Li, PhD, Rochester, NY
The objective of our study was to examine how present on
admission indicators in Medicare data might enhance estimates of
complication rates after primary and revision TKA.
PAPER: 399
9:00 AM
Has Best Available Evidence Changed the Treatment of Femoral
Neck Fractures? A Look at ABOS Part 2 Examinees
Benjamin J. Miller, MD, Iowa City, IA
Nicolas O. Noiseux, MD, Iowa City, IA
Matthew D. Karam, MD, North Liberty, IA
John L. Marsh, MD, Iowa City, IA
John J. Callaghan, MD, Iowa City, IA
The trends in the treatment of femoral neck fractures in ABOS
Part 2 candidates demonstrate an increase in the utilization of
THA, most evident in patients <65 years and adult reconstruction
examinees.
Discussion 6 Minutes
9:12 AM
PAPER: 400
Shared Medical Decision Making in Patients with Osteoarthritis
of the Hip and Knee: Results of a RCT
Kevin J. Bozic, MD, MBA, San Francisco, CA
Jeff Belkora, San Francisco, CA
Vanessa Chan, MPH, San Francisco, CA
Jiwon Youm, BS, MS, San Jose, CA
Tianzan Zhou, BA, La Jolla, CA
John Dupaix, MD, Honolulu, HI
Angela N. Bye, MA, ATC, Redwood City, CA
Clarence H. Braddock III, MD, MPH, Stanford, CA
James I. Huddleston III, MD, Redwood City, CA
We found that decision and communication aids used in
orthopaedic practice had benefits for both patients and surgeons.
Discussion 6 Minutes
8:48 AM
PAPER: 397
Cost of Zero Event Complications Associated with Common
Orthopaedic Procedures
Robert A. Hart, MD, Portland, OR
Garrett Waagmeester, BS, Portland, OR
Paul A. Anderson, MD, Madison, WI
Melanie Arthur, PhD, Fairbanks, AK
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
Zero event complications (DVT, PE, SSI) increase the cost after
orthopaedic procedures substantially, which must be anticipated
as the risk burden of such events shifts from payers to providers.
9:18 AM
PAPER: 401
Surgical Skills Curriculum: Development of Orthopaedic
Training Modules
Adam Brooks, MD, Alameda, CA
William Camisa, MS, San Francisco, CA
Jeremi M. Leasure, MS, San Francisco, CA
Dimitriy G. Kondrashov, MD, San Francisco, CA
William A. McGann, MD, San Francisco, CA
134
Educational Programs
Thursday, March 13
9:24 AM
PAPER: 402
The Effect of Orthopaedic Advertising and Self Promotion on a
Nave Population
Stephen Mohney, BA, Rochester, NY
Peter Quartararo, MD, Rochester, NY
John Elfar, MD, Rochester, NY
A study of Internet based surgeon biographies categorized as selfpromoting and non-self-promoting and their impact on patient
and colleague perceptions.
Discussion 6 Minutes
9:36 AM
PAPER: 403
Blood and Body Fluid Exposures in Orthopaedics: Decreasing
the Incidence with an Evidence-Based Protocol
Simon L. Amsdell, MD, Rochester, NY
Richard D. Southgate, MD, Rochester, NY
John T. Gorczyca, MD, Rochester, NY
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 345
Sports Medicine/Arthroscopy III: Hip/Pelvis
Moderator(s):Greg J. Folsom, MD, Lenexa, KS
Eric Pifel, MD, Pewaukee, WI
8:00 AM
PAPER: 406
Prevalence of Femoroacetabular Impingement Imaging
Findings in Asymptomatic Volunteers: A Systematic Review
Jonathan M. Frank, MD, Chicago, IL
Joshua Harris, MD, Bellaire, TX
Brandon Erickson, MD, Chicago, IL
William Slikker III, MD, Chicago, IL
Michael Salata, MD, Cleveland, OH
Shane J. Nho, MD, Chicago, IL
9:42 AM
PAPER: 404
Computer-Simulated Arthroscopic Knee Surgery: Effects of
Distraction
James Cowan, MD, Ann Arbor, MI
Mark Seeley, MD, Ann Arbor, MI
Todd A. Irwin, MD, Ann Arbor, MI
Michelle S. Caird, MD, Ann Arbor, MI
8:06 AM
PAPER: 407
Can Bracing Affect Altered Gait Patterns in Femoroacetabular
Impingement
Marc Safran, MD, Redwood City, CA
Jonathan Rylander, PhD, San Antonio, TX
Beatrice Shu, MD, Atlanta, GA
Thomas P. Andriacchi, PhD, Stanford, CA
Bracing can alter hip motion patterns that often result in hip
impingement (flexion, adduction and IR) in patients with FAI,
with selected activities such as walking, jogging, and stair
climbing.
9:48 AM
PAPER: 405
The Influence of Comorbidities on Hospital Costs and Length of
Stay Following Total Knee Arthroplasty
Andrew J. Pugely, MD, Iowa City, IA
Yubo Gao, PhD, Iowa City, IA
Christopher T. Martin, MD, Iowa City, IA
John J. Callaghan, MD, Iowa City, IA
8:12 AM
PAPER: 408
Validation of a Computer-Assisted Dynamic Simulation for
Treatment of Symptomatic Femoroacetabular Impingement
Olusanjo O. Adeoye, MD, Chantilly, VA
Asheesh Bedi, MD, Ann Arbor, MI
Bryan T. Kelly, MD, New York, NY
Discussion 6 Minutes
Thursday
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
135
Thursday, March 13
8:24 AM
PAPER: 409
The Effect of Acetabular Rim Recession on Anterior Coverage: A
Cadaveric Study Using the False Profile Radiograph
Scott Kling, MD, Cleveland, OH
Michael Karns, MD, Cleveland, OH
Jeremy Gebhart, MD, Cleveland, OH
Mark R. Robbin, MD, Cleveland, OH
Christos Kosmas, MD, Cleveland, OH
Shane J. Nho, MD, Chicago, IL
Michael Salata, MD, Cleveland, OH
The anterior center edge angle, as measured on the false profile
radiograph, is a superior index of anterior rim recession for
pincer lesions compared to the lateral center edge angle.
8:30 AM
PAPER: 410
Arthroscopic Management of Femoroacetabular Impingement
(FAI) in Adolescents
JW Thomas Byrd, MD, Nashville, TN
Kay S. Jones, RN, Nashville, TN
This controlled study demonstrates favorable outcomes
for arthroscopic management of FAI in adolescents with
improvement more than comparable to that of an adult
population and higher absolute scores.
PAPER: 411
8:36 AM
Three to Seven Year Outcome and Survivorship Following Hip
Arthroscopy in Dysplastic Hips
Jack G. Skendzel, MD, Woodbury, MN
Karen K. Briggs, MPH, Vail, CO
Peter Goljan, MD, Boylston, MA
Marc J. Philippon, MD, Vail, CO
In this difficult patient population, hip arthroscopy can help
restore function in some patients.
Discussion 6 Minutes
8:48 AM
PAPER: 412
Predictors of Poor Clinical Outcome Following Hip Arthroscopy
for Developmental Dysplasia of the Hip
Soshi Uchida, MD, PhD, Kitakyushu, Japan
Hajime Utsunomiya, MD, Kitakyushu, Japan
Tsuyoshi Furuko, MD, Kitakyusyu, Japan
Toshiharu Mori, MD, PhD, Kitakyushu, Japan
Akinori Sakai, MD, PhD, Kitakyushu, Japan
Tomonori Taketa, MD, Kitakyusyu-shi, Japan
Toshitaka Nakamura, Kitakyushu, Japan
9:12 AM
PAPER: 415
Arthroscopic Acetabular Labral Reconstruction in FAI: A
Matched-Pair Controlled Study with Two-year Follow Up
Benjamin G. Domb, MD, Oak Brook, IL
Timothy J. Jackson, MD, Studio City, CA
Anthony P. Trenga, Charlottesville, VA
Christine E. Stake, MA, Naperville, IL
Youssef El Bitar, MD, Springfield, IL
The purpose of this matched-pair controlled study is to compare
the clinical outcomes of arthroscopic labral reconstruction and
resection in patients with FAI of the hip.
9:18 AM
PAPER: 416
Arthroscopic Hip Revision Surgery for Residual FAI: Surgical
Outcomes
Christopher M. Larson, MD, Edina, MN
M. Russell Giveans, PhD, Eden Prairie, MN
Asheesh Bedi, MD, Ann Arbor, MI
Kathryn Samuelson, BS, Edina, MN
Rebecca M. Stone, ATC, Edina, MN
Arthroscopic hip revision surgery for residual FAI led to
significantly improved outcome measures; however, outcomes
were inferior to those after primary arthroscopic FAI corrective
surgery.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
8:54 AM
PAPER: 413
Arthroscopic Surgery for Global versus Focal Pincer
Femoroacetabular Impingement: Are the Outcomes Different?
Dean K. Matsuda, MD, Los Angeles, CA
Nikhil Gupta, BA, Fullerton, CA
Bantoo Sehgal, MD, West Fargo, ND
Bantoo Sehgal, MD, West Fargo, ND
Raoul Burchette, MA MS, Pasadena, CA
136
Educational Programs
Thursday, March 13
9:24 AM
PAPER: 417
Short-term Complications and Survival Analyses of Hip
Arthroscopies Performed in the UK NHS-A Review of 6,395 Cases
Ajay Malviya, MD, Newcastle Upon Tyne, United Kingdom
Simon Jameson, Stockton-on-Tees, United Kingdom
Ali Raza, MBBS, MS, Northumberland, United Kingdom
Philip James, PhD, Alcester, Warwickshire, United Kingdom
Mike R. Reed, MBBS MD, Northumberland, United Kingdom
Paul F. Partington, MD, Corbridge, United Kingdom
We have reviewed the outcomes of hip arthroscopy performed
in the English National health service from 2005 to 2012 to
look at the short term complications and conversion to total hip
arthroplasty.
9:48 AM
PAPER: 420
Functional Outcomes of Acute & Chronic Proximal Hamstring
Ruptures: Repair versus Allograft Reconstruction
David A. Rust, MD, Duluth, MN
M. Russell Giveans, PhD, Eden Prairie, MN
Rebecca M. Stone, ATC, Edina, MN
Kathryn Samuelson, BS, Edina, MN
Christopher M. Larson, MD, Edina, MN
Both direct proximal hamstring repair & allograft reconstruction
had favorable results for ADLs; for patients who desire to
return to sports or higher demand activities, acute repair is
recommended.
Discussion 6 Minutes
Discussion 6 Minutes
9:36 AM
PAPER: 418
Arthroscopic Reduction Versus Open Reduction in Femoral Head
Fractures
Sun Jung Yoon, MD, Jeonju, Republic of Korea
Myung-Sik Park, MD, Jeonju, Republic of Korea
Hongman Cho, MD, Gwangju, Republic of Korea
Young-Jae Moon, Jeonju, Republic of Korea
Seung-Min Choi, Jeonju, Republic of Korea
An arthroscopic approach results in stable fixation and early
joint motion, thereby effectively treating displaced femoral head
fractures in a minimally invasive manner.
9:42 AM
PAPER: 419
Delayed Gadolinium-Enhanced MRI of Cartilage Predicts the
Pattern of Hip Osteoarthritis Progression at Five Years
Antony Palmer, MA, BMBCh, Oxford, United Kingdom
Scott J. Fernquest, BA, MBBS, Newport, United Kingdom
Tom Pollard, MD, Oxford, United Kingdom
Helen L. Vigar, Oxford, United Kingdom
Hamish G. Lowdon, Warwickshire, United Kingdom
Eugene McNally, MD, Oxford, United Kingdom
David R. Wilson, PhD, Vancouver, BC, Canada
Andrew J. Carr, FRCS, Headington Oxford, United Kingdom
Sion Glyn-Jones, MA MBBS, Oxford, United Kingdom
Individuals with FAI morphology and a low dGEMRIC ratio may
represent those most likely to benefit from FAI lesion debridement
for osteoarthritis prevention.
Room
208
Room
226
Thursday
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
137
Thursday, March 13
324
328
TICKET
TICKET
Room
353
TICKET
IEF
Room
215 Surgical
327
TICKET
IEF
Room
260
329
TICKET
330
TICKET
Room
350
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
325
138
Educational Programs
Thursday, March 13
333
TICKET
Room
347
334
TICKET
Room
210
Room
218
Thursday
PAPER PRESENTATION
10:30 AM 12:30 PM
Theater A
Adult Reconstruction Hip IV: Revision THA
Moderator(s):George F. Chimento, MD, Metarie, LA
Bassam Masri, MD, FRCSC, Vancouver, BC, Canada
Scott M. Sporer, MD, Wheaton, IL
10:30 AM
PAPER: 421
Preoperative Radiographic Evaluation of Patients with Pelvic
Discontinuity
John R. Martin, MD, Rochester, MN
Ian J. Barrett, Rochester, MN
Rafael J. Sierra, MD, Rochester, MN
David G. Lewallen, MD, Rochester, MN
Daniel J. Berry, MD, Rochester, MN
The diagnostic accuracy of standard and additional views for
pelvic discontinuity have been examined, with excellent sentivity
noted with a combination of AP and judet films.
10:36 AM
PAPER: 422
Outcomes of Revision Total Hip Arthoplasty: Analysis of a U.S.
Total Joint Registry
Monti Khatod, MD, Santa Monica, CA
Guy Cafri, PhD, La Jolla, CA
Maria C. Inacio, MS, San Diego, CA
Alan L. Schepps, San Diego, CA
Liz Paxton, MA, San Diego, CA
Stefano A. Bini, MD, San Francisco, CA
When evaluating patient, implant, surgical and hospital factors at
time of revision THA: age, surgeon experience, implant fixation,
and bearing surfaces had significant impact on risk of re-revision.
PAPER: 423
10:42 AM
Specific Screening of Metal-on-Metal Hip Patients will
Significantly Increase their Revision Surgery
Olli Lainiala, MB, Tampere, Finland
Antti Eskelinen, MD, PhD, Tampere, Finland
Petra Elo, MD, PhD, Tampere, Finland
Aleksi Reito, MD, Tampere, Finland
Jorma Pajamki, MD, PhD, Tampere, Finland
Timo J. Puolakka, MD, PhD, Tampere, Finland
Teemu Moilanen, MD, Tampere, Finland
Screening with blood metal ion measurements and targeted crosssectional imaging revealed several new cases of adverse reaction
to metal debris among MoM THRs with previously good midterm results.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
139
Thursday, March 13
10:54 AM
PAPER: 424
Trabecular Metal Cups - A Safe Option in Cup Revision Surgery
Maziar Mohaddes, MD, Molndal, Sweden
Ola Rolfson, MD, PhD, Gothenburg, Sweden
Johan N. Karrholm, MD, Molndal, Sweden
Analysis of 2,490 revisions, with a mean follow-up of 3.7 years,
from the Swedish hip arthroplasty register show that trabecular
metal cups can be used safely in first time cup revisions.
11:00 AM
PAPER: 425
RSA of the Migration of Porous Tantalum Components Used to
Reconstruct Major Acetabular Deficiencies
Donald Howie, MD, PhD, Adelaide, Australia
Stuart A. Callary, BS, Adelaide, Australia
John M. Abrahams, Malvern, Australia
Lucian B. Solomon, MD, Hyde Park, Australia
Most porous-tantalum acetabular reconstructions for severe
acetabular deficiencies were stable. Migration >3mm at 3 months
is associated with symptomatic ongoing migration leading to
revision surgery.
PAPER: 426
11:06 AM
Medicare Fails to Compensate Time/Effort Associated with
Revision Arthroplasty; Is Patient Access to Care at Risk?
Gregory K. Deirmengian, MD, Broomall, PA
Anthony T. Tokarski, BS, Philadelphia, PA
Paul M. Lichstein, MD, Philadelphia, PA
Carl A. Deirmengian, MD, Wynnewood, PA
Matthew Austin, MD, Philadelphia, PA
The time and effort employed for primary and revision
arthroplasty procedures was assessed to determine if Medicare
reimbursement rates compensate for the additional time and
effort required for revision.
Discussion 6 Minutes
11:18 AM
PAPER: 427
Determination of Serum Deoxypyridinoline Allows Diagnosis of
Aseptic Loosening after Total Joint Replacement
Stefan Landgraeber, MD, Essen, Germany
Sebastian Warwas, Essen, Germany
Marcel Haversath, MD, Essen, Germany
Henning Quitmann, MD, Essen, Germany
Axel Marx, Sommerfeld, Germany
Marcus Jager, MD, PhD, Essen, Germany
11:24 AM
PAPER: 428
Polyethylene Wear and Osteolysis is Associated with High
Revision Rate of the Bantam AML Femoral Component in DDH
Patrick Murray, MD, Charleston, SC
James I. Huddleston III, MD, Redwood City, CA
Katherine Hwang, MS, Redwood City, CA
Sussanna Imrie, PT, Stanford, CA
Stuart B. Goodman, MD, Redwood City, CA
The long term results of primary total hip arthroplasty with
a Bantam AML femoral stem in DDH patients showed a high
complication and revision rate.
11:30 AM
PAPER: 429
Revision of Recalled Modular Neck Femoral Implants
Christopher P. Walsh, MD, Northville, MI
Joseph P. Nessler, MD, Sartell, MN
David C. Markel, MD, Southfield, MI
Retrospective review of modular neck femoral stems shows
elevated rates of tissue necrosis, synovitis, bony erosion, stemneck corrosion, chronic inflammatory changes and osteotomy at
revision.
Discussion 6 Minutes
11:42 AM
PAPER: 430
Early
Results
of
Metal-on-Metal
Hip
Revisions
for
Adverse
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
140
Educational Programs
Thursday, March 13
11:54 AM
PAPER: 432
Quantifying the Burden of Periprosthetic Joint Infection in
Revision Total Hip and Knee Arthroplasty
Kevin J. Bozic, MD, MBA, San Francisco, CA
Edmund Lau, MS, Menlo Park, CA
Kevin Ong, PhD, Philadelphia, PA
Atul F. Kamath, MD, Massapequa, NY
Vanessa Chan, MPH, San Francisco, CA
Thomas P. Vail, MD, San Francisco, CA
Steven M. Kurtz, PhD, Philadelphia, PA
Harry E. Rubash, MD, Boston, MA
Daniel J. Berry, MD, Rochester, MN
The burden of PJI following THA and TKA is immense.
Epidemiologic differences exist in the rank, severity and
population of patients who undergo RTHA and RTKA for PJI.
Discussion 6 Minutes
12:06 PM
PAPER: 433
Periprosthetic Joint Infections Treated with Two-Stage Revision
over 14 Years: An Evolving Microbiology Profile
Benjamin Bjerke-Kroll, MD, New York, NY
Alexander Christ, MD, New York, NY
Alexander S. McLawhorn, MD, MBA, New York, NY
Peter K. Sculco, MD, New York, NY
Dorothy Marcello, BA, New York, NY
Barry D. Brause, MD, New York, NY
Kethy Jules-Elysee, MD
Thomas P. Sculco, MD, New York, NY
We identified temporal trends in PJI pathogens in series of 785
patients from one institution. There were significant increases in
the rates of primary MRSA, S. viridans, and P. acnes.
12:12 PM
PAPER: 434
The Outcome of Unexpected Positive Intraoperative Cultures in
Presumed Aseptic Revision Hip and Knee Arthroplasty
Anas Saleh, MD, Beachwood, OH
Kevin J. Bloom, BA, South Euclid, OH
Mark Hebeish, DDS, Cleveland, OH
Mario Farias-Kovac, MD, Cleveland, OH
Carlos A. Higuera, MD, Lakewood, OH
Wael K. Barsoum, MD, Cleveland, OH
This is a descriptive study that reports the rate of unexpected
positive intraoperative cultures in revision THA and TKA
performed for aseptic indications and the long-term implications.
12:18 PM
PAPER: 435
An Accurate Diagnosis of Periprosthetic Joint Infection: Are We
There Yet?
Benjamin Zmistowski, BS, Philadelphia, PA
Camilo Restrepo, MD, Philadelphia, PA
Dana Geiser, BS, Philadelphia, PA
Mitchell Maltenfort, PhD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
A model provided by recursive partitioning had greater accuracy
(96%) in diagnosing periprosthetic joint infection than a rigid
diagnostic algorithm (90%) or surgeon judgment (94%).
Discussion 6 Minutes
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 245
Shoulder and Elbow III: Shoulder Arthroplasty
Moderator(s):Mark A. Frankle, MD, Temple Terrace, FL
Samer S. Hasan, MD, Cincinnati, OH
10:30 AM
PAPER: 436
Shoulder Registry Five Year Outcomes Analysis
Richard S. Page, MD, FRACS, Geelong, Australia
Stephen Graves, MD, Adelaide, Australia
Richard De Steiger, MD, Richmond, Australia
David Davidson, MD, University Of Adelaide, Australia
Robyn Vial, MSc, Adelaide, Australia
Elizabeth C. Griffith, BA, Adelaide, Australia
Kara Cashman, BSc (HONS), Adelaide, Australia
Yen-Liang Liu, Adelaide, Australia
Michelle Lorimer, Adelaide, Australia
Registry data reporting outcomes of shoulder arthroplasty
are helping to guide surgical selection, improving outcomes,
informing choice for surgeons, and reducing revision burden and
cost.
10:36 AM
PAPER: 437
Minimum 20-Year Follow Up of Neer Shoulder Arthroplasty in
Patients Less than 50 Years
Bradley S. Schoch, MD, Rochester, MN
John W. Sperling, MD, MBA, Rochester, MN
Robert H. Cofield, MD, Rochester, MN
Cathy D. Schleck, Rochester, MN
Thursday
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
141
Thursday, March 13
10:42 AM
PAPER: 438
Driving Performance after Total Shoulder Arthroplasty
Garret Garofolo, BS, Commack, NY
Mathew Hamula, BA, BS, New York, NY
Joseph D. Zuckerman, MD, New York, NY
The present study findings suggest that patients undergoing total
shoulder replacement show improvement in driving performance
with the mitigation of shoulder pain and discomfort.
Discussion 6 Minutes
10:54 AM
PAPER: 439
Does Preoperative Rotator Cuff Fatty Infiltration Affect Outcome
After Shoulder Arthroplasty?
Peter Lapner, MD, Ottawa, ON, Canada
Lianfu Jiang, Wenzhou, China
Tinghua Zhang, MSc, Ottawa, ON, Canada
George S. Athwal, MD, London, ON, Canada
Associations were identified that correlated greater degrees of fat
infiltration and atrophy to poorer functional results after shoulder
arthroplasty.
11:00 AM
PAPER: 440
Factors that Predict Postoperative Motion in Patients Treated
with Reverse Shoulder Arthroplasty
Mark A. Frankle, MD, Temple Terrace, FL
Daniel G. Schwartz, MD, Chicago, IL
Benjamin J. Cottrell, BS, Tampa, FL
Matthew J. Teusink, MD, Omaha, NE
Rachel Clark, BA, Tampa, FL
Katheryne Downes, MPH, Rockville, MD
Maximizing intraoperative motion can ensure patients have a
much greater likelihood of improvement in their final active
motion.
PAPER: 441
11:06 AM
Shoulder Muscle Parameters as Predictors of Outcome
Following Reverse Total Shoulder Arthroplasty
Brett P. Wiater, MD, Birmingham, MI
James E. Moravek Jr, MD, Palos Hills, IL
Daphne Pinkas, MD, Pleasant Rdg, MI
Denise Koueiter, Royal Oak, MI
Tristan Maerz, MS, Royal Oak, MI
Samuel Yonan, Royal Oak, MI
David Marcantonio, MD
J. Michael Wiater, MD, Beverly Hills, MI
Deltoid size impacts functional outcomes following RTSA.
11:42 AM
PAPER: 445
Radiostereometric and Radiographic Analysis of Glenoid
Component Motion After Total Shoulder Arthroplasty
Jonathan Streit, MD, Cleveland, OH
Yousef Shishani, MD, Cleveland, OH
Meridith E. Greene, Boston, MA
Audrey Nebergall, Boston, MA
Charles R. Bragdon, PhD, Boston, MA
Henrik Malchau, MD, Boston, MA
Reuben Gobezie, MD, Mayfield Heights, OH
The early motion of glenoid components in our cohort was
greatest in rotation, and the presence of radiolucencies appears to
be associated with high levels of early rotational motion.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
Discussion 6 Minutes
11:18 AM
PAPER: 442
Radiographs and CT Show Similar Observer Agreement When
Classifying Glenoid Morphology in Glenohumeral Arthritis
Jessica G. Aronowitz, MD, Bangor, ME
William Harmsen, MS, Rochester, MN
Cathy D. Schleck, Rochester, MN
Joaquin Sanchez-Sotelo, MD, Rochester, MN
John W. Sperling, MD, MBA, Rochester, MN
Robert H. Cofield, MD, Rochester, MN
142
Educational Programs
Thursday, March 13
11:48 AM
PAPER: 446
Scapular Neck Length Measurement and Distribution in the
Reverse Shoulder Arthroplasty (RSA) Patient Population
Peter Simon, PhD, Tampa, FL
Miguel Diaz, BS, Tampa, FL
Daniel G. Schwartz, MD, Chicago, IL
Brandon G. Santoni, PhD, Tampa, FL
Mark A. Frankle, MD, Temple Terrace, FL
12:18 PM
PAPER: 450
Outcome of Resurfacing Total Shoulder Arthroplasty at Two to
Seven Years
Rupen Dattani, MD, FRCS, Middlesex, United Kingdom
Vijayraj Ramasamy, High Wycombe, United Kingdom
Gavin Brigstocke, Surrey, United Kingdom
David R. Boardman, FRCS, MBBS, Epsom, United Kingdom
Vipul Patel, MBBS, MS, Surrey, United Kingdom
11:54 AM
PAPER: 447
Wear Characteristics of Vitamin E-infused Polyethylene in a
Reverse Shoulder Arthroplasty Model
Thomas (Quin) Throckmorton, MD, Germantown, TN
John W. Sperling, MD, MBA, Rochester, MN
Hani Haider, PhD, Omaha, NE
Vitamin E-infused polyethylene produces less volumetric wear
than highly cross-linked polyethylene.
Discussion 6 Minutes
12:06 PM
PAPER: 448
Feasibility of an Osteochondral Allograft for Biologic Glenoid
Resurfacing
Gregory L. Cvetanovich, MD, Chicago, IL
Peter N. Chalmers, MD, Chicago, IL
Adam B. Yanke, MD, Chicago, IL
Anil Gupta, MD, MBA, Tampa, FL
Emma L. Klosterman, MA, Chicago, IL
Nikhil N. Verma, MD, Chicago, IL
Anthony A. Romeo, MD, Chicago, IL
We used three-dimensional computed tomography modeling of
cadaveric glenoids to determine that most glenoids could support
center-based osteochondral allografts of 16-20mm diameter at
depth of 4mm.
12:12 PM
PAPER: 449
Revision Rate and Reasons for Revision Following Resurfacing
Shoulder Replacement in Patients with Osteoarthritis
Jeppe Rasmussen, MD, Brondby, Denmark
Stig Brorson, PhD, Copenhagen, Denmark
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 265
Sports Medicine/Arthroscopy IV: Knee I
Moderator(s):Peter G. Gerbino, MD, Monterey, CA
Rick W. Wright, MD, St. Louis, MO
10:30 AM
PAPER: 451
Arthroscopic Meniscal Allograft Transplantation in Male
Professional Soccer Players
Giulio Maria Marcheggiani Muccioli, MD, Bologna, Italy
Stefano Zaffagnini, MD, Bologna, Italy
Alberto Grassi, MD, Bologna, Italy
Tommaso Bonanzinga, MD, Bologna, Italy
Stefano Della Villa, MD, Bologna, Italy
Maurilio Marcacci, MD, Bologna, Italy
Arthroscopic Meniscal Allograft Transplantation in professional
soccer players allowed returning to play at the same level (Tegner
10) in 75% of the cases at 36-month follow-up.
10:36 AM
PAPER: 452
Risk Factors for 30-Day Morbidity and Mortality Following Knee
Arthroscopy: A Review of 12,271 Patients
Christopher T. Martin, MD, Iowa City, IA
Andrew J. Pugely, MD, Iowa City, IA
Yubo Gao, PhD, Iowa City, IA
Brian R. Wolf, MD, Iowa City, IA
We reviewed 12,271 cases of knee arthroscopy to identify risk
factors for 30-day complications. Recent surgery, operative
time > 1.5 hrs, black race, ASA class, and age over 40 yrs were
significant.
Thursday
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
143
Thursday, March 13
10:42 AM
PAPER: 453
Analysis of Failure and Subsequent Surgery after Unsatisfactory
Medial Patellofemoral Ligament Reconstruction
Manfred Nelitz, MD, Oberstdorf, Germany
Sean R. Williams, MBBS, Oberstdorf, Germany
Sabine Lippacher, MD, Ulm, Germany
Errors in patient selection, technical problems and nonconsideration of additional risk factors were found to be the
reasons for revision surgery after MPFL reconstruction.
Discussion 6 Minutes
10:54 AM
PAPER: 454
The Relationship of the Medial Patellofemoral Ligament (MPFL)
Attachment to the Femoral Physis
Lutul D. Farrow, MD, Garfield Heights, OH
Vincent Alentado, BS, Cleveland Heights, OH
Zakaria Abdulnabi, BS, Cleveland, OH
Raymond W. Liu, MD, Cleveland, OH
Allison Gilmore, MD, Shaker Heights, OH
The MPFL attachment is distal to the medial aspect of the
femoral physis but is juxtaposed to the concave undulation of the
posterior physis.
11:00 AM
PAPER: 455
Two-year
Follow
Up
of
Randomized
Controlled
Trial
of
11:18 AM
PAPER: 457
Meniscal Allograft Transplantation: Survival, Re-operation Rates
and Analysis of Failures
Frank McCormick, MD, Ft Lauderdale, FL
Joshua Harris, MD, Bellaire, TX
Geoffrey D. Abrams, MD, Portola Valley, CA
Kristen Hussey, BS, Chicago, IL
Hillary Wilson, BA, Chicago, IL
Rachel M. Frank, MD, Chicago, IL
Anil Gupta, MD, MBA, Tampa, FL
Bernard R. Bach Jr, MD, River Forest, IL
Brian J. Cole, MD, MBA, Chicago, IL
This study quantifies the survival for meniscus allograft
transplantation in 200 consecutive cases and reports the findings
at re-operation.
PAPER: 458
11:24 AM
The Effect of ACL In Situ Graft Force on the Biologic Healing
Response of the ACL Graft-Tunnel Interface
S. Richard Ma, MD, Columbia, MO
Michael Schaer, MD, New York, NY
Clifford Voigt, MD, Pittsburgh, PA
Katherina Y. Chen, MS, Flushing, NY
Marco L. Sisto, BA, New York, NY
Lilly Ying, VBS, New York, NY
Xiang-Hua Deng, MD, New York, NY
Scott A. Rodeo, MD, New York, NY
Elevated in situ ACL graft forces impair the biological healing of
the ACL graft in a preclinical model of ACL reconstruction.
PAPER: 459
11:30 AM
The Effect of Microfracture on Meniscal Healing in a Goat (Capra
hircus) Model; Sports Animal Model
William Howarth, MD, Monument, CO
Brian F. Grogan, MD, Temple, TX
Kevin S. Borchard, MD, USAF Academy, CO
Warren R. Kadrmas, MD, Helotes, TX
Bone marrow stimulation by subchondral microfracture effect on
meniscal healing in a goat model.
Discussion 6 Minutes
11:42 AM
PAPER: 460
Gonarthrosis: Comparison between Hyaluronic Acid and
Platelet-Rich Plasma Obtained with Two Different Methods
Stefano Carni, MD, Roma, Italy
Alessandro Carcangiu, Rome, Italy
Fabio Cerza, Velletri, Italy
Purpose of this study is to compare clinical outcomes in patients
treated with injections of Hyaluronic Acid and Platelet Rich
Plasma (obtained by two different methods) in gonarthrosis.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
11:06 AM
PAPER: 456
Outcomes of Magnetic Resonance Imaging of the Knee by
Provider Training and Predictors of Positive Findings
James Wylie, MD, Holladay, UT
Zachary Working, MD, Salt Lake City, UT
Robert L. Schmidt, MD, PhD, MBA, Salt Lake City, UT
Robert T. Burks, MD, Salt Lake City, UT
Julia R. Crim, MD, Salt Lake City, UT
144
Educational Programs
Thursday, March 13
11:48 AM
PAPER: 461
Long
Term
Results
after
Matrix
Associated
Chondrocyte
12:18 PM
PAPER: 465
The Risk of Knee Arthroplasty Following Cruciate Ligament
Reconstruction: A Population-Based Matched Cohort Study
Timothy S. Leroux, MD, Toronto, ON, Canada
Darrell J. Ogilvie-Harris, MD, Toronto, ON, Canada
Tim Dwyer, MBBS, Toronto, ON, Canada
Jaskarndip Chahal, MD, Toronto, ON, Canada
Amir Khoshbin, MD, Toronto, ON, Canada
Rajiv Gandhi, MD, Toronto, ON, Canada
Nizar Mahomed, MD, Toronto, ON, Canada
David Wasserstein, MD, MSc, North York, ON, Canada
The first long term results after MACT of the knee demonstrate
that is an effective surgical therapy for full-thickness cartilage
defects with good long term results, in particular for simple
defects.
PAPER: 462
11:54 AM
Autograft vs. Allograft ACL Reconstructions: A Prospective,
Randomized Clinical Study with Min. 10-Year Follow Up
Craig R. Bottoni, MD, Honolulu, HI
Eric L. Smith, MD, Boston, MA
Sarah G. Raybin, BA, Honolulu, HI
James S. Shaha, MD, Kailua, HI
John M. Tokish, MD, Scottsdale, AZ
Douglas J. Rowles, MD, Aiea, HI
A long-term clinical comparison of allografts and autografts for
primary ACL reconstructions in a young, athletic population
showed a 3X greater failure rate with allografts.
Discussion 6 Minutes
12:06 PM
PAPER: 463
Comparison of Outcomes Following ACL Reconstruction Using
Patellar-Tendon Autograft Versus Allograft
Lauren M. Matheny, Vail, CO
Ryan J. Warth, MD, Vail, CO
Jason M. Hurst, MD, New Albany, OH
Karen K. Briggs, MPH, Vail, CO
J R. Steadman, MD, Vail, CO
Thursday
Discussion 6 Minutes
PAPER PRESENTATION
10:30 AM 12:30 PM
Room 345
Practice Management/Rehabilitation III: Risk Management and
Quality Improvement II
Moderator(s):Kevin P. Black, MD, Hershey, PA
John D. Campbell, MD, Bozeman, MT
10:30 AM
PAPER: 466
ASA Score as a Predictor of 90-Day Readmission in Patients with
Isolated Orthopaedic Trauma Injuries
Vasanth Sathiyakumar, Nashville, TN
Aaron M. Yengo-Kahn, BS, Nashville, TN
Harrison F. Kay, BS, Nashville, TN
R Adams Cowley, Baltimore, MD
Young M. Lee, BS, Nashville, TN
Jesse Ehrenfeld, MD, MPH, Nashville, TN
William T. Obremskey, MD, MPH, Nashville, TN
Manish K. Sethi, MD, Nashville, TN
ASA score is highly correlated with postoperative readmission rates
for patients presenting with isolated orthopaedic trauma injuries,
and could be used to help hospitals target at-risk individuals.
10:36 AM
PAPER: 467
Thrombogenicity and Platelet Function in Lower Extremity Total
Joint Arthroplasty: A Prospective Randomized Study
Bhaveen Kapadia, MD, Baltimore, MD
Mark J. McElroy, BS, MS, Monroeville, PA
Kevin Bliden, MBA, BS, Baltimore, MD
Martin G. Gesheff, BS, Baltimore, MD
Christopher J. Franzese, BS, Baltimore, MD
Samik Banerjee, MBBS, MS, Baltimore, MD
Udaya S. Tantry, PhD, Baltimore, MD
Paul Gurbel, MD, Baltimore, MD
Michael A. Mont, MD, Baltimore, MD
The primary aim of this study was to assess potential changes in
thrombogenicity by using measures of coagulability and platelet
reactivity following elective surgery for lower extremity arthroplasty.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
145
Thursday, March 13
10:42 AM
PAPER: 468
Pre-Operative Bleeding Risk Predictability for Lower Extremity
Joint Arthroplasty: Prospective Randomized Study
Bhaveen Kapadia, MD, Baltimore, MD
Mark J. McElroy, BS, MS, Monroeville, PA
Kimona Issa, MD, Baltimore, MD
Kevin Bliden, MBA, BS, Baltimore, MD
Martin G. Gesheff, BS, Baltimore, MD
Christopher J. Franzese, BS, Baltimore, MD
Udaya S. Tantry, PhD, Baltimore, MD
Paul Gurbel, MD, Baltimore, MD
Michael A. Mont, MD, Baltimore, MD
11:18 AM
PAPER: 472
Do Surgeons Know the Cost of Orthopaedic Implants? A
Multicenter Study of 503 Orthopaedic Surgeons
Kanu M. Okike, MD, Honolulu, HI
Robert V. OToole, MD, Baltimore, MD
Julius A. Bishop, MD, Palo Alto, CA
Christopher McAndrew, MD, Saint Louis, MO
Samir Mehta, MD, Philadelphia, PA
William W. Cross III, MD, Rochester, MN
Grant Garrigues, MD, Chapel Hill, NC
Mitchel B. Harris, MD, Boston, MA
Christopher T. LeBrun, MD, Ellicott City, MD
Discussion 6 Minutes
10:54 AM
PAPER: 469
The Ottawa and Pittsburgh Rules for Selective Radiography
Following Acute Knee Injury
Sujith Konan, London, United Kingdom
Fares S. Haddad, FRCS, London, United Kingdom
The Ottawa and the Pittsburgh rules have a high sensitivity for
the detection of knee fractures. Use of these rules can aid efficient
clinical evaluation.
11:00 AM
PAPER: 470
Operative Intervention for Geriatric Hip Fracture: Does Type of
Surgery Impact Length of Stay?
Vasanth Sathiyakumar, Nashville, TN
Anna E. Garcia, BS, Nashville, TN
Young M. Lee, BS, Nashville, TN
William T. Obremskey, MD, MPH, Nashville, TN
Amir A. Jahangir, MD, Nashville, TN
Jesse Ehrenfeld, MD, MPH, Nashville, TN
Manish K. Sethi, MD, Nashville, TN
This study shows that type of surgery is a significant predictor
of post-operative LOS and the related inpatient hospital costs
following operative fixation of a low energy geriatric hip fracture.
Thursday
PAPER: 471
11:06 AM
Unnecessary Magnetic Resonance Imaging of Hips: Economic
Burden to Patients and Healthcare System
Kimona Issa, MD, Baltimore, MD
Bhaveen Kapadia, MD, Baltimore, MD
Samik Banerjee, MBBS, MS, Baltimore, MD
Robert Pivec, MD, Baltimore, MD
Michael A. Mont, MD, Baltimore, MD
PAPER: 473
11:24 AM
Foley Catheters are Unnecessary and Result in More Urological
Complications in Total Joint Arthroplasty
Antonia Chen, MD, MBA, Philadelphia, PA
Benjamin Rothrauff, BA, Pittsburgh, PA
Peter Z. Xu, BA, Pittsburgh, PA
Brooke Klatt, DPT, PT, Pittsburgh, PA
Brian A. Klatt, MD, Pittsburgh, PA
146
Educational Programs
Thursday, March 13
11:42 AM
PAPER: 475
Malnourished Primary Total Joint Arthroplasty Patients Have
Increased Transfusion and Infection Rates
Antonia Chen, MD, MBA, Philadelphia, PA
Peter Z. Xu, BA, Pittsburgh, PA
Benjamin Rothrauff, BA, Pittsburgh, PA
Jonathan Waters, MD, Pittsburgh, PA
Brian A. Klatt, MD, Pittsburgh, PA
Total joint arthroplasty patients who were malnourished (low
protein, low albumin and low iron) were more likely to receive
postoperative transfusions and subsequently become infected.
11:48 AM
PAPER: 476
The Importance of Risk Adjustment in Reporting Total Joint
Replacement Outcomes
Nelson F. SooHoo, MD, Los Angeles, CA
Zhongmin Li, PhD, Sacramento, CA
Kevin J. Bozic, MD, MBA, San Francisco, CA
Adequate risk adjustment is a key element in objective
comparison of surgeons, hospitals, and devices using TJR registry
data.
PAPER: 477
11:54 AM
Financial Impact of a Multi-Disciplinary Pre-Operative Risk
Stratification Program for Joint Arthroplasty
Neil L. Duplantier, MD, New Orleans, LA
David Briski, Mequon, WI
J L. Ochsner Jr, MD, New Orleans, LA
Mark S. Meyer, MD, Destrehan, LA
Daryl F. Stanga, PA-C, Madisonville, LA
George F. Chimento, MD, Metairie, LA
12:12 PM
PAPER: 479
A Comparison of 30-day Readmissions Following Orthopedic
Procedures and Medical Admissions
Jed I. Maslow, New York, NY
Lorraine Hutzler, BA, New York, NY
James D. Slover, MD, New York, NY
Joseph A. Bosco III, MD, New York, NY
The causes of readmissions following orthopedic surgery
and medical admissions are different and strategies to reduce
orthopedic readmissions should focus on preventing perioperative
complications.
12:18 PM
PAPER: 480
Impact of Preoperative Medical Clearance on the Time to
Definitive Surgical Management of Hip Fractures
Fred L. Speck, MD, Galveston, TX
Randal Morris, Galveston, TX
Jillian K. McAngus, BS, TX City, TX
Nikoletta M. Leontaritis Carayannopoulos, DO, Galveston, TX
Ronald W. Lindsey, MD, Galveston, TX
Many experts recommend performing surgery within 24 to 48
hours of admission in older hip fracture patients. Some diagnostic
procedures significantly increase time to definitive surgery.
Discussion 6 Minutes
Thursday
12:06 PM
PAPER: 478
Convergent Validity of the Lower Extremity Computerized
Adaptive Testing in Adult Reconstruction Patients
Christopher Pelt, MD, Salt Lake City, UT
Mike Anderson, MS, ATC, Salt Lake City, UT
Man Hung, PhD, Salt Lake City, UT
Angela P. Presson, PhD, Salt Lake Cty, UT
Christopher L. Peters, MD, Salt Lake City, UT
The LE CAT may be a valuable PRO in the assessment of adult
reconstruction patients but we recommend a more in depth
analysis including detailed psychometric analysis prior to
widespread use.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
147
Thursday, March 13
SYMPOSIUM
SYMPOSIUM
1:30 PM 3:30 PM
La Nouvelle Ballroom
1:30 PM 3:30 PM
Theater C
VIII.
I.
II.
III.
IV.
V.
VI.
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
148
Educational Programs
Thursday, March 13
SYMPOSIUM
1:30 PM 3:30 PM
Theater B
Hand Surgery Update: Treatment Recommendations for
Common Hand and Wrist Injuries and Afflictions (S)
Moderator: John S. Taras, MD, Philadelphia, PA
Designed for the hand and upper extremity surgeon and
the general orthopedist. Case presentations will focus on
common conditions such as carpal tunnel syndrome, distal
radius fractures, digital tendon and nerve lacerations, CMC
arthritis, Dupuytrens contracture, and the circumstances that
can disrupt an ideal course of recovery. Newly introduced
treatment methods will be presented and compared and
contrasted to traditional standards. The course format consists
of case presentations by the faculty followed by a question and
answer session.
I. Introduction
John S. Taras, MD, Philadelphia, PA
II.
III.
IV.
343
TICKET
Room
208
TICKET
Thursday
Room
260
Room
347
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
149
Thursday, March 13
345
TICKET
Room
262
Room
271
Room
352
348
TICKET
Room
215
349
TICKET
Room
221
Shoulder Instability
Moderator: Patrick J. McMahon, MD, Pittsburgh, PA
Mark D. Lazarus, MD, Philadelphia, PA
Jon K. Sekiya, MD, Ann Arbor, MI
Andrew S. Rokito, MD, New York, NY
Hussein A. Elkousy, MD, Houston, TX
Room
207
351
TICKET
Room
218
Room
356
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
150
Educational Programs
Thursday, March 13
353
TICKET
Room
353
Room
276
Room
350
TeamSTEPPS
Moderator: Harpal S. Khanuja, MD, Cockeysville, MD
Dwight W. Burney III, MD, Albuquerque, NM
Rivergate
Mary I. OConnor, MD, Jacksonville, FL
Room
Kristy L. Weber, MD, Philadelphia, PA
Thursday
TICKET
PAPER PRESENTATION
1:30 PM 3:30 PM
Theater A
Adult Reconstruction Knee V: Infection
Moderator(s):Robert A. Malinzak, MD, Mooresville, IN
Alexander P. Sah, MD, Fremont, CA
1:30 PM
PAPER: 481
Is Regional Anesthesia Safe in Patients Undergoing Surgery for
Treatment of Periprosthetic Joint Infection?
Mohammad R. Rasouli, MD, Philadelphia, PA
Hasan H. Ceylan, Istanbul, Turkey
Camilo Restrepo, MD, Philadelphia, PA
Eugene R. Viscusi, MD, Philadelphia, PA
Javad Parvizi, MD, FRCS, Philadelphia, PA
Epidural abscess following neuraxial anesthesia during revision
surgery for treatment of PJI is rare. Thus, the benefits of neuraxial
anesthesia may outweigh the small risk of epidural abscess.
1:36 PM
PAPER: 482
Does Operative Time Affect Infection Rate Following Primary
Total Knee Arthroplasty?
Sameer Naranje, MBBS, MS, Minneapolis, MN
Lisa Lendway, PhD, Saint Paul, MN
Susan C. Mehle, Saint Paul, MN
Terence J. Gioe, MD, Apple Valley, MN
Prolongation of the operative time increases the hazard of TKA
revision due to infection independent of age, sex, BMI and
comorbidities.
PAPER: 483
1:42 PM
The Role of Surgical Dressing in Total Joint Arthroplasty: Level I
Randomized Clinical Trial
Bryan D. Springer, MD, Charlotte, NC
Walter B. Beaver, MD, Charlotte, NC
William L. Griffin, MD, Charlotte, NC
J. Bohannon Mason, MD, Charlotte, NC
Susan M. Odum, PhD, Charlotte, NC
An occlusive antimicrobial surgical dressing showed significant
reduction in wound complications, blisters, number of dressing
changes/exposure and patient satisfaction compared to standard
gauze dressing.
Discussion 6 Minutes
1:54 PM
PAPER: 484
Do Space Suits Increase Contamination & Deep Infection in Total
Joint Arthroplasty? A Systematic Review
Simon Young, MD, Scottsdale, AZ
Mark Zhu, Auckland, New Zealand
In contrast to charnley type exhaust suits, modern space suits do
not lower and may increase deep infection rates.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
151
Thursday, March 13
2:00 PM
PAPER: 485
Joint Aspiration during Two Stage Septic Knee Revision Surgery
is Inadequate for Detection of Infection Persistence
Bernd Preininger, MD, Berlin, Germany
Viktor Janz, MD, Berlin, Germany
Philipp Von Roth, MD, Berlin, Germany
Tobias Winkler, MD, Berlin, Germany
Tilman Pfitzner, MD, Berlin, Germany
Andrej Trampuz, MD, Berlin, Germany
Carsten Perka, MD, Berlin, Germany
Joint aspiration does not accurately exclude persistence of
infection; therefore other parameters should be used to determine
the correct timing for total knee arthroplasty reimplantation.
2:06 PM
PAPER: 486
An in vivo Assessment of the Bacterial Susceptibility of Porous
Tantalum
Alexandra Stavrakis, MD, Los Angeles, CA
Jared Niska, MD, Los Angeles, CA
Amanda Loftin, Santa Monica, CA
Lloyd Miller, MD, PhD, Baltimore, MD
Louis M. Kwong, MD, Torrance, CA
Fabrizio Billi, PhD, Los Angeles, CA
Nicholas Bernthal, MD, Venice, CA
Using an established mouse model of post-arthroplasty infection
to compare the susceptibility to infection among porous
tantalum, stainless steel, and titanium implants.
Discussion 6 Minutes
2:18 PM
PAPER: 487
Articulating vs. Static Antibiotic Spacers in Revision Total Knee
Arthroplasty for Sepsis - A Meta-analysis
George N. Guild III, MD, Atlanta, GA
Baohua Wu, Duluth, GA
Giles R. Scuderi, MD, New York, NY
Articulating spacers provided superior range of motion, improved
infection rates for simple and complex patients, facilitated
reimplantation, and developed less bone loss than did static
spacers.
2:42 PM
PAPER: 490
Younger Age is Associated with a Higher Risk of Periprosthetic
Infection and Aseptic Failure After TKA
John P. Meehan, MD, Sacramento, CA
Richard H. White, MD, Sacramento, CA
Beate Danielson, PhD
Sunny H. Kim, PhD, Sacramento, CA
Amir A. Jamali, MD, Sacramento, CA
Patients younger than 50 years had a significantly higher risk of
undergoing revision joint surgery because of both periprosthetic
joint infection and aseptic mechanical failure one year after TKA.
2:48 PM
PAPER: 491
The Economics of Unplanned Readmissions Following TKA and
the Potential Consequences of Healthcare Reform
R Clement Carter, BSE, Durham, NC
Michael M. Kheir, BS, Philadelphia, PA
Peter Derman, MD, New York, NY
Rebecca Speck, Philadelphia, PA
David N. Flynn, MD, MBA, Philadelphia, PA
L. Scott Levin, MD, Philadelphia, PA
Lee A. Fleisher, MD, Philadelphia, PA
Review of 3,224 TKAs reveals that unplanned readmissions
generate a positive contribution margin but are not profitable
in the long run. New policies will likely accelerate efforts to
eliminate them.
PAPER: 492
2:54 PM
Optimal Irrigation and Debridement of Infected Total Joint
Implants with Chlorhexidine Gluconate
Daniel C. Smith, MD, New York, NY
Richard Maiman, BA, Bronx, NY
Evan Schwechter, MD, Scarsdale, NY
Sun Jin Kim, MD, New York, NY
David M. Hirsh, MD, Bronx, NY
An in vitro comparison of scrubbing biofilm from a total joint
implant analog with different chlorhexidine gluconate solutions
demonstrated significant biofilm eradication at 4% and 2%
concentrations.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
2:24 PM
PAPER: 488
Ceftazidime-Vancomycin Impregnated Cement Spacers in Twostage Revision for Infected TKA
Michael Drexler, MD, Toronto, ON, Canada
Tim Dwyer, MBBS, Toronto, ON, Canada
Paul R. Kuzyk, MD, FRCSC, Toronto, ON, Canada
Rajesh Chakravertty, MD, Toronto, ON, Canada
Mansour Abolghasemian, MD, Tehran, Iran
Benjamin Lozano, MD
David Backstein, MD, Toronto, ON, Canada
2:30 PM
PAPER: 489
Sonication for the Enhanced Diagnosis of Prosthetic Joint
Infection
Curtis W. Hartman, MD, Omaha, NE
Angela Hewlett, MD, MS, Omaha, NE
Derrick T. Antoniak, MD, Omaha, NE
Beau S. Konigsberg, MD, Omaha, NE
Kevin L. Garvin, MD, Omaha, NE
152
Educational Programs
Thursday, March 13
3:06 PM
PAPER: 493
Levels of Evidence in Knee Surgery: Progress Over the Last
Decade?
Kamrul Hasan, MBBS, PhD, London, United Kingdom
Aadhar Sharma, MBBS, Hertfordshire, United Kingdom
Alison Carter, London, United Kingdom
Razi Zaidi, Stanmore, United Kingdom
Mudussar Ahmad, MBBS, London, United Kingdom
Suzie Cro, MSc, BS, London, United Kingdom
Zameer Shah, MBBS, FRCS, London, United Kingdom
Andy Goldberg, Middox, United Kingdom
There has been a trend towards higher levels of evidence in Knee
Surgery over a decade but the differences did not reach statistical
significance.
PAPER: 494
3:12 PM
Are There Identifiable Risk Factors or Causes Associated with
Unplanned Readmission Following TKA?
R Clement Carter, BSE, Durham, NC
Michael M. Kheir, BS, Philadelphia, PA
Peter Derman, MD, New York, NY
Rebecca Speck, Philadelphia, PA
David N. Flynn, MD, MBA, Philadelphia, PA
L. Scott Levin, MD, Philadelphia, PA
Lee A. Fleisher, MD, Philadelphia, PA
Review of 3,224 TKAs reveals that increased length of stay and
revision surgery are associated with unplanned readmissions,
most commonly cause by infection, confusion or hematoma.
PAPER: 495
3:18 PM
Success of Different Knee Arthrodesis Techniques After Failed
Total Knee Arthroplasty
Ran Schwarzkopf, MD, Irvine, CA
Timothy L. Kahn, BA, Irvine, CA
Julien Succar, MD, Boston, MA
John E. Ready, MD, Boston, MA
The fusion rates of those using IMN were consistent with previous
reports. Recurrence of infection was relatively high and could be
related to the high proportion of history of infected TKA.
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 245
Trauma IV: Pelvis/Acetabulum
Moderator(s):James C. Krieg, MD, Seattle, WA
Edward Perez, MD, Memphis, TN
1:30 PM
PAPER: 496
Computed Tomography Generated versus Conventional Plain
Radiographs for the Diagnosis of Pelvic Ring Injury
Adham Abdelfattah, MD, Saint Louis, MO
Berton R. Moed, MD, Saint Louis, MO
John A. Boudreau, MD, Saint Louis, MO
CT-generated 2D virtual radiographs are very beneficial for
inexperienced surgeons and as useful as conventional plain
radiographs for experienced surgeons in accurately classifying
pelvic ring injury.
1:36 PM
PAPER: 497
The Ongoing Relevance of Acetabular Fracture Classification
Jonathan R. Hutt, BA, MBBS, FRCS, London, United Kingdom
Martin Bircher III, FRCS, Ashtead Surrey, United Kingdom
Mark Rickman, MD, London, United Kingdom
Changing patient demographics and injury mechanisms have
led to altered acetabular fracture patterns that may require
modifications to the currently accepted classification system.
PAPER: 498
1:42 PM
Femoral Head Impaction Predicts Early Failure after Central
Fracture-dislocation of the Acetabulum
Gregory Y. Blaisdell, MD, Tampa, FL
Chris James, MD, Columbia, MO
Henry C. Sagi, MD, Tampa, FL
Superolateral femoral head impaction lesions associated with
central fracture-dislocations of the acetabulum were highly
correlated with femoral head collapse and early conversion to
arthroplasty.
Thursday
Discussion 6 Minutes
PAPER: 830
3:24 PM
Vancomycin plus Rifampin Therapy has Enhanced Efficacy
Against aStaphylococcus aureusImplant Infection
Jared Niska, MD, Los Angeles, CA
Jonathan Shahbazian, Baltimore, MD
Romela Ramos, MS, Los Angeles, CA
Kevin Francis, Alameda, CA
Nicholas Bernthal, MD, Venice, CA
LLyod Miller, MD, PhD, Baltimore, MD
1:54 PM
PAPER: 499
The Pararectus Approach for Anterior Fixation of Acetabular
Fractures - Outcome at Two Years
Marius Keel, MD, Berne, Switzerland
Salvatore Tomagra, Bern, Switzerland
Harald M. Bonel, MD, Bern, Switzerland
Klaus Siebenrock, MD, Bern, Switzerland
Johannes D. Bastian, MD, Bern, Switzerland
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
153
Thursday, March 13
2:00 PM
PAPER: 500
Outcome Following Fixation of Comminuted Quadrilateral Plate
Fracture-Single Surgeons Experience
Suribabu Gudipati, MBBS, MRCS, Carmarthen, United Kingdom
Peter Giannoudis, MD, FRCS, Leeds, United Kingdom
Nikolaos K. Kanakaris, MD, Leeds, United Kingdom
Grace White, Leeds, United Kingdom
Laszlo Toth, Leeds, UK, United Kingdom
Open reduction internal fixation of medial wall acetabulum
fractures using a spring plate has been effective in reducing
the risk of post-traumatic arthritis and maintaining the joint
congruity.
PAPER: 501
2:06 PM
Simultaneous Fixation and Joint Arthroplasty for Osteoporotic
Acetabular Fractures to Allow Full Weight-bearing
James A. Young, FRCS, London, United Kingdom
Rachel Pearce, Tooting London, United Kingdom
Mark Hamilton, London, United Kingdom
Alex Trompeter, Farnham, Surrey, United Kingdom
Mark Rickman, MD, London, United Kingdom
We present 24 consecutive cases of osteoporotic acetabular
fracture treated with simultaneous fixation and hip arthroplasty
and immediate full weight-bearing with good mid-term results.
2:30 PM
PAPER: 504
Indication and Outcomes of the INFIX in Pelvic Ring Fractures? A
Prospective Comparison of Surgical Techniques
John Stammers, MBBS, BSc, Newark/Nottinghamshire,
United Kingdom
Edward Massa, MD, MSc, London, United Kingdom
Edward M. Britton, London, United Kingdom
Paul Culpan, FRCS, London, United Kingdom
Peter Bates, FRCS, MBBS, Kent, United Kingdom
A comparison between the Subcutaneous Internal Fixator
versus open reduction internal fixation in Anterior Pelvic Ring
Fractures. Our Experience, Indications, Radiological and Clinical
Outcomes.
Discussion 6 Minutes
2:42 PM
PAPER: 505
Predictive Value of Radiographic Fracture Characteristics to
Determine Operative Indication in LC-1 Fractures
James Beckmann, MD, Salt Lake City, UT
Angela P. Presson, PhD, Salt Lake Cty, UT
Stuart H. Curtis, BS, Cottonwood Heights, UT
Ami Stuart, Salt Lake Cty, UT
Thomas F. Higgins, MD, Salt Lake City, UT
Erik Kubiak, MD, Salt Lake City, UT
Predictive Value of Specific Radiographic Fracture Characteristics
to Determine Operative Indication in LC-1 Type Fractures.
Discussion 6 Minutes
2:18 PM
PAPER: 502
Fixation of the Anterior Pelvic Ring through the Modified
Stoppa Approach - Focus on the Outcome in Relation to Age
Johannes D. Bastian, MD, Bern, Switzerland
Alexandre Ansorge JR, MA, Bern, Switzerland
Salvatore Tomagra, Bern, Switzerland
Lorenz Buchler, MD, Bern, Switzerland
Lorin M. Benneker, MD, Bern, Switzerland
Klaus Siebenrock, MD, Bern, Switzerland
Marius Keel, MD, Berne, Switzerland
Surgical treatment with open reduction and internal fixation
of the anterior pelvic ring in type B- and C- pelvic ring injuries
appears to be an adequate technique even in the elderly.
2:24 PM
PAPER: 503
Risk of Spermatic Cord Injury During Anterior Pelvic Ring and
Acetabular Surgery: An Anatomic Study
Reza Firoozabadi, MD, Seattle, WA
Paul R. Stafford, MD, Tulsa, OK
Milton L. Routt Jr, MD, Houston, TX
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
2:48 PM
PAPER: 506
Percutaneous
Lumbopelvic
Instrumentation
for
Highly
154
Educational Programs
Thursday, March 13
3:06 PM
PAPER: 508
Functional Outcomes of Isolated Tile Type B Pelvic Ring Injuries
Fixed with Percutaneous Posterior-only Fixation
Matthew P. Sullivan, MD, Philadelphia, PA
John A. Scolaro, MD, Irvine, CA
Samir Mehta, MD, Philadelphia, PA
Posterior only percutaneous fixation of partially unstable pelvic
ring injuries results in near excellent functional recovery and that
bilateral fixation correlates with the best functional outcomes.
3:12 PM
PAPER: 509
Gait Abnormalities after Closed Reduction and Percutaneous
Pinning for Posterior Pelvic Ring Disruption
Pooria Salari, MD, MD Heights, MO
Berton R. Moed, MD, Saint Louis, MO
Lisa K. Cannada, MD, Saint Louis, MO
3:18 PM
PAPER: 510
Diagnosis and Treatment of Sacroiliac Joint Pain using Anterior
Compression Plating: A Retrospective Outcome Study
Russell D. Goode, MD, Mobile, AL
Martha George, MD, Birmingham, AL
Jorge Alonso, MD, Mobile, AL
1:42 PM
PAPER: 513
Fluoroquinolones Impair Tendon-Bone Healing in a Rat Rotator
Cuff Repair Model
Alice J. Fox, MSc, New York, NY
Michael Schaer, MD, New York, NY
Florian Wanivenhaus, MD, Zrich, Switzerland
Tony Chen, PhD, New York, NY
Erik Attia, BS, New York, NY
Nikolaus B. Binder, MD PhD, NY City, NY
Miquel Otero, PhD, New York, NY
Russell F. Warren, MD, New York, NY
Scott A. Rodeo, MD, New York, NY
Discussion 6 Minutes
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 265
Shoulder and Elbow IV: Rotator Cuff
Moderator(s):Wesley Nottage, Laguna Hills, CA
Kaveh R. Sajadi, MD, Lexington, KY
Thursday
1:36 PM
PAPER: 512
The
Effect
of
Granulocyte
Colony
Stimulating
Factor
on Rat
1:30 PM
PAPER: 511
Oxidative Stress Induced Degenerative Changes of Rotator Cuff
and the Antioxidant Attenuated the Changes in Mice
Daichi Morikawa, MD, Tokyo, Japan
Yoshiaki Itoigawa, MD, Rochester, MN
Hidetoshi Nojiri, MD, PhD, Tokyo, Japan
Hirotaka Sano, MD, PhD, Sendai, Japan
Eiji Itoi, MD, Sendai, Japan
Yoshifumi Saijo, MD, PhD, Sendai, Japan
Kazuo Kaneko, MD, Tokyo, Japan
Takahiko Shimizu, PhD, Chiba, Japan
Discussion 6 Minutes
1:54 PM
PAPER: 514
Prostaglandins Mediate the Beneficial Effects of Atorvastatin
During the Early Phase of Rotator Cuff Healing
Oleg Dolkart, PhD, Tel Aviv, Israel
Yankel Gabet, DDS, PhD, Tel Aviv, Israel
Ofir Chechik, MD, Ramat Hasharon, Israel
Fadi Y. Alhajajra SR, Tel Aviv, Israel
Tamar Liron, Tel Aviv, Israel
Eran Maman, MD, Tel Aviv, Israel
Although chronic inflammation contributes to the development of
tendinopathy, our results advocate for a positive role of PGE-2 in
tendon healing during the acute inflammatory phase that follows
tendon surgical repair.
Educational Programs
155
Thursday, March 13
2:00 PM
PAPER: 515
Are the Symptoms of Calcific Tendonitis Due to Neoinnervation
and/or Neovascularization?
Lisa Hackett, Sonographer, Coogee, Australia
Neal L. Millar, MD, Glasgow, United Kingdom
Patrick H. Lam, PhD, Sydney, Australia
George A. Murrell, MD, Kogarah, Australia
This study shows a very significant concomitant eight (8) fold
increase in mast cells, macrophages, and neo-neurovascular
infiltration in the tendons of patients with calcific tendonitis.
PAPER: 516
2:06 PM
Gene Expression in Human Rotator Cuff Pathology
Alexander Choo, MD, San Diego, CA
Meagan M. McCarthy, MD, San Diego, CA
Rajeswari Pichika, PhD, San Diego, CA
Eugene J. Sato, MS, San Diego, CA
Richard L. Lieber, PhD, La Jolla, CA
Simon Schenk, PhD, La Jolla, CA
John G. Lane, MD, San Diego, CA
Samuel R. Ward, PhD, La Jolla, CA
Quantification of gene expression in human rotator cuff muscle
demonstrates varied gene expression in fibrotic/adipogenic/
myogenic programs in response to different types of pathology.
Discussion 6 Minutes
2:18 PM
PAPER: 517
Botulinum Toxin is Detrimental to Repair of a Chronic Rotator
Cuff Tear in a Rabbit Model
Mohit Gilotra, MD, Baltimore, MD
Thao Nguyen, MD, Baltimore, MD
Matthew Christian, MD, Baltimore, MD
Derik L. Davis, MD, Baltimore, MD
R. Frank Henn III, MD, Ellicott City, MD
Syed A. Hasan, MD, Fulton, MD
In a chronic rotator cuff repair model, botulinum toxin impairs
rotator cuff healing.
2:24 PM
PAPER: 518
The Infraspinatus is an Active Humeral Head Depressor; the
Supraspinatus is Not - An in vivo Study
Peggy Kuhnel, MD, London, ON, Canada
Clement Werner, MD, Zurich, Switzerland
Stephan Blumenthal, Zurich, Switzerland
Sebastian Guenkel, DMed, Zurich, Switzerland
Christian Gerber, MD, Zurich, Switzerland
2:42 PM
PAPER: 520
A Prospective Follow Up of Patients Treated Surgically or NonSurgically for Full-thickness Rotator Cuff Tears
Joel J. Gagnier, PhD, Ann Arbor, MI
Hanna Oltean, MPH, Ann Arbor, MI
Bruce S. Miller, MD, MS, Assoc Prof, Ann Arbor, MI
Our Shoulder Registry was used to compare the efficacy of
surgical versus non-surgical management of full-thickness rotator
cuff tears and to detect variables that predict success within each
group.
2:48 PM
PAPER: 521
Rotator Cuff Repair: What Predicts Anatomic and Clinical
Outcomes? A Systematic Review of 8,240 Cases
Matthew D. McElvany, MD, Santa Rosa, CA
Erik McGoldrick, MD, Arcata, CA
Albert O. Gee, MD, Seattle, WA
Moni B. Neradilek, MS, Seattle, WA
Frederick A. Matsen III, MD, Seattle, WA
The integrity of a rotator cuff repair at followup is most closely
associated with patient age, tear size, and the degree of fatty
infiltration, rather than repair method.
PAPER: 522
2:54 PM
Is Arthroscopic Rotator Cuff Repair Justified in Patients Older
than 70 Years Old? A Prospective Multicenter Study
Philippe Valenti, MD, Paris Cedex 16, France
Constantina Moraiti, MD, Paris, France
Pablo E. Valle, Crdoba, Argentina
Ali Maqdes, MBBS, MD, Paris, France
Denis Katz, Ploemeur, France
Kamil Elkholti, Villeurbanne, France
Jean Kany, Toulouse, France
Arthroscopic rotator cuff repair seems to be justified in
symptomatic patients over 70 years old.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
2:30 PM
PAPER: 519
Prospective Longitudinal Analysis of the Risk of Tear
Progression for Asymptomatic Degenerative Rotator Cuff Tears
Jay D. Keener, MD, Saint Louis, MO
Leesa M. Galatz, MD, Saint Louis, MO
GA Stobbs Cucchi, RN, Saint Louis, MO
Rebecca Patton, MA, Saint Louis, MO
Sharlene A. Teefey, MD, Saint Louis, MO
Karen Steger-May, MD, Saint Louis, MO
Aaron M. Chamberlain, MD, Saint Louis, MO
Ken Yamaguchi, MD, Chesterfield, MO
156
Educational Programs
Thursday, March 13
3:06 PM
PAPER: 523
Prevalence of Rotator Cuff Repairs With and Without
Concomitant Subacromial Decompressions
Daniel D. Buss, MD, Edina, MN
Leroy P. McCarty III, MD, Edina, MN
Steven H. Stern, MD, Northfield, IL
Ned Tervola, MA, ATC, Edina, MN
Mitchell Schoen, BA, Edina, MN
M. Russell Giveans, PhD, Eden Prairie, MN
The rate of rotator cuff repairs performed with subacromial
decompression is significantly higher than RCR without SAD in
all age groups, and is not decreasing with time.
PAPER: 524
3:12 PM
Does Arthroscopic Subacromial Decompression Influence the
Functional Outcome of Calcific Tendonitis?
Nicholas D. Clement, MRCS Ed, Edinburgh, United Kingdom
Julie M. McBirnie, MD, Edinburgh, United Kingdom
Subacromial decompression used as part of the arthroscopic
management of acute calcific tendonitis does not influence to
functional outcome of the patient.
PAPER: 525
3:18 PM
Rotator Cuff Lesions in Patients with Frozen Shoulder: An
Analysis of 300 Stiff Shoulders
Yusuke Ueda, MD, Tokyo, Japan
Hiroyuki Sugaya, MD, Chiba, Japan
Norimasa Takahashi, MD, Funabashi, Japan
Nobuaki Kawai, MD, Chiba, Japan
Morihito Tokai, MD, Funabashi,Chiba, Japan
Kazutomo Onishi, MD, Chiba, Japan
Motoki Tanaka, Fukuoka City, Japan
Rotator cuff lesions in 300 stiff shoulders were prospectively
evaluated using MRI or ultrasonography in order to elucidate
relationship between cuff lesions and severity of stiffness.
Thursday
Discussion 6 Minutes
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 345
Spine III: Scoliosis
Moderator(s):William Donaldson, MD, Pittsburgh, PA
Kern Singh, MD, Chicago, IL
1:30 PM
PAPER: 526
Gait Improvement After Fusion for AIS is Influenced by Measures
in Coronal and Sagittal Planes
Justin Paul, MD, New York, NY
Ashish Patel, MD, Brooklyn, NY
Ellen M. Godwin, PT, PhD, Brooklyn, NY
Kristina Bianco, New York, NY
Charles R. Spero, MD, Pomona, NY
Nicholas H. Post, MD, Brooklyn, NY
Thomas J. Errico, MD, New York, NY
Virginie Lafage, PhD, New York, NY
Carl B. Paulino, MD, Brooklyn, NY
The interaction between COM and COP suggests that fusion
surgery for AIS improves gait by correcting measures in the
coronal and sagittal planes.
PAPER: 527
1:36 PM
Transverse Process Hooks at Upper Instrumented Vertebra
Provide More Gradual Motion Transition than Pedicle Screws
Dinesh Thawrani, MD, Richlands, VA
David Glos, Research Eng, Cincinnati, OH
Matthew Coombs, Cincinnati, OH
Donita Bylski-Austrow, Cincinnati, OH
Peter F. Sturm, MD, Cincinnati, OH
Transverse process hooks at upper instrumented vertebra
provided more gradual transition to normal motion compared
to pedicle screws in long posterior spinal fusion constructs in
biomechanical tests.
PAPER: 528
1:42 PM
EOS Imaging System is Available for Early Onset Scoliosis and
Can Reduce Ionizing Radiation Exposure
Burt Yaszay, MD, San Diego, CA
Nima Kabirian, MD, San Diego, CA
Gregory M. Mundis, MD, San Diego, CA
Jeff Pawelek, La Jolla, CA
Carrie Bartley, MA, San Diego, CA
Behrooz A. Akbarnia, MD, La Jolla, CA
The novel EOS Imaging system can significantly reduce emitted
ionizing radiation in early onset scoliosis patients as young as 3
years old.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
157
Thursday, March 13
1:54 PM
PAPER: 529
Comparison of Typical Thoracic Curves and Atypical Thoracic
Curves within the Lenke 1 Classification
Takahito Fujimori, MD, MSc, Osaka, Japan
Tracey Bastrom, MA, San Diego, CA
Carrie Bartley, MA, San Diego, CA
Peter O. Newton, MD, San Diego, CA
Harms Study Group, San Diego, CA
Significant differences exist between Lenke 1 curves when
one considers the location of the apex, which may introduce
unintended bias to a study population when utilizing only the
Lenke 1 designation.
PAPER: 530
2:00 PM
Evolution of the Surgical Correction of Scoliosis in Patients with
Duchenne Muscular Dystrophy
Brian Scannell, MD, Charlotte, NC
Burt Yaszay, MD, San Diego, CA
Carrie Bartley, MA, San Diego, CA
Tracey Bastrom, MA, San Diego, CA
Peter O. Newton, MD, San Diego, CA
Scott J. Mubarak, MD, San Diego, CA
Operative treatment of scoliosis in Duchenne Muscular
Dystrophy was evaluated. Both pedicle screw and Luque
instrumentation had high complication rates, with more implant
failure in the Luque group.
PAPER: 531
2:06 PM
Single Stage Vertebral Column Resection (VCR) of
Hemivertebrae in Children under the Age of 10 Years
Mohammad M. El-Sharkawi, MD, Assiut, Egypt
Wael Koptan, MD, Cairo, Egypt
Yasser H. El Miligui, MD, FRCS, Cairo, Egypt
Mohamed Omar A. Soliman, Prof., Cairo, Egypt
In a prospective study of 31 children with a lumbar hemivertebra,
single stage posterior VCR and short segment posterior
instrumentation achieved adequate correction and satisfactory
clinical outcome.
Discussion 6 Minutes
2:18 PM
PAPER: 532
A Multicenter Inter-observer Reliability Study of Radiographic
Characteristics of Dystrophic Scoliosis in NF1
Charles Gerald T. Ledonio, MD, Minneapolis, MN
David W. Polly Jr, MD, Minneapolis, MN
Ann M. Brearley, PhD, MS, Minneapolis, MN
Alvin H. Crawford, MD, Cincinnati, OH
Daniel J. Sucato, MD, MS, Dallas, TX
Leah Y. Carreon, MD, Louisville, KY
Annalise N. Larson, MD, Rochester, MN
David Stevenson, Salt Lake City, UT
8.This multicenter radiographic assessment study shows that
there is good reliability to detect dystrophic scoliosis in NF1
patients by assessing radiographic characteristics of dystrophic
modulation.
PAPER: 533
2:24 PM
Modeling Thoracic Volume to Predict Pulmonary Function in
Scoliosis, Pectus and Combined Deformity
David W. Polly Jr, MD, Minneapolis, MN
Ben E. Rosenstein, BS, Minneapolis, MN
Charles Gerald T. Ledonio, MD, Minneapolis, MN
Annalise N. Larson, MD, Rochester, MN
David J. Nuckley, PhD, Minneapolis, MN
A computational model for thoracic volume measurement using
patient specific spine & chest wall deformity has been validated
with a maximal error of 4.1%.
PAPER: 534
2:30 PM
A Systematic Review of All Smart Phone Applications
Specifically Aimed for use as a Scoliosis Screening Tool
Qais Naziri, MD, Brooklyn, NY
Jadie E. De Tolla, BS, Brooklyn, NY
Chibuikem Akamnonu, MD, Brooklyn, NY
Ardalan A. Nourian, MD, New York, NY
Dante M. Leven, DO, Brooklyn, NY
Westley Hayes, MS, Brooklyn, NY
Katherine Stiene, Northport, NY
Andrew A. Merola, MD, Brooklyn, NY
Carl B. Paulino, MD, Brooklyn, NY
New Smart phone apps can be useful in screening and diagnosis
of scoliosis. We systematically reviewed all apps that fit this
description to determine the most accurate ones compared to
scoliometer.
Discussion 6 Minutes
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
158
Educational Programs
Thursday, March 13
2:42 PM
PAPER: 535
A Novel Animal Model for Congenital Scoliosis in Chicken
Embryos
Andrea Ketschek, PhD, Philadelphia, PA
Mirela Spillane, PhD, Philadelphia, PA
Wenhai Wang, PhD, Philadelphia, PA
Giuseppe Orlando, MD, Palmi, Italy
Amer Samdani, MD, Philadelphia, PA
Randal R. Betz, MD, Philadelphia, PA
Joshua Pahys, MD, Wynnewood, PA
Gianluca Gallo, PhD, Philadelphia, PA
Patrick J. Cahill, MD, Philadelphia, PA
The induction of congenital scoliosis in chicken embryos through
in ovo electroporation may represent a new model for studying
the etiology, consequences, and therapies for congenital scoli in
humans.
2:48 PM
PAPER: 536
Thoracic Volume Predicts Pulmonary Function Recovery in
Scoliosis Patients
David W. Polly Jr, MD, Minneapolis, MN
Ben E. Rosenstein, BS, Minneapolis, MN
Charles Gerald T. Ledonio, MD, Minneapolis, MN
Charles E. Johnston II, MD, Dallas, TX
David J. Nuckley, PhD, Minneapolis, MN
3:12 PM
PAPER: 539
Radiation Exposure During Posterior Instrumented Fusion for
Idiopathic Scoliosis
Courtney M. ODonnell, MD, Seattle, WA
Viviana Bompadre, PhD, Seattle, WA
Walter F. Krengel III, MD, Seattle, WA
This retrospective review demonstrates decreased radiation
exposure for pediatric posterior instrumented fusion cases using
fluoroscopy as compared to published values for CT-guided
technology.
PAPER: 540
3:18 PM
The Effect of Increasing Pedicle Screw Diameter on Thoracic
Spinal Canal Dimensions
Samuel K. Cho, MD, Palisades Park, NJ
Young Lu, BA, New York, NY
Lawrence G. Lenke, MD, Saint Louis, MO
pedicle screw size caused pedicle expansion laterally but did not
alter spinal canal dimensions. When there was an osseous breach,
most were lateral and did not involve the spinal cavity.
Discussion 6 Minutes
Thursday
Discussion 6 Minutes
3:06 PM
PAPER: 538
Understanding Direct Vertebral Rotation: Developing a
Multisegmental Biomechanical Model and Evaluation Factors
Siddharth Badve, MD, MBBS, MS, Cleveland, OH
Nathaniel R. Ordway, Syracuse, NY
Yushek Pun, Sandy Hook, CT
Stephen A. Albanese, MD, East Syracuse, NY
William F. Lavelle, MD, East Syracuse, NY
Screw placement and direction of derotation force are important.
Bi-cortical pedicle screws provided an advantage due to higher
threshold for failure and potential for improved deformity
correction.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
159
Thursday, March 13
SYMPOSIUM
SYMPOSIUM
4:00 PM 6:00 PM
La Nouvelle Ballroom
4:00 PM 6:00 PM
Theater C
IV.
VII.
VIII.
IX.
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
160
Educational Programs
Thursday, March 13
XIII. Tips and Tricks to Improve the Results of Lateral UKA
with Off-the-Shelf Implants
Keith R. Berend, MD, New Albany, OH
SYMPOSIUM
4:00 PM 6:00 PM
Theater B
II.
Room
271
Thursday
362
TICKET
Room
226
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
161
Thursday, March 13
363
TICKET
Room
262
364
TICKET
Room
207
Room
221
IEF
Room
218
Room
276
368
TICKET
Room
350
Room
208
Room
260
An alphabetical faculty financial disclosure list can be found starting on page 312.
Thursday
367
162
Educational Programs
Thursday, March 13
372
TICKET
Room
356
Room
353
PAPER PRESENTATION
4:00 PM 6:00 PM
Theater A
Adult Reconstruction Hip V: Primary THR II
Moderator(s): James I. Huddleston III, MD, Redwood City, CA
Steven T. Woolson, MD, Palo Alto, CA
4:00 PM
PAPER: 541
Low Surgeon Volume is Associated with Increased
Complications Following THA, After Accounting for Experience
Bheeshma Ravi, MD, Toronto, ON, Canada
Peter Austin, Toronto, ON, Canada
Benjamin Escott, MBBS, Toronto, ON, Canada
Ruth Croxford, MSc, Toronto, ON, Canada
Richard Jenkinson, MD, Toronto, ON, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
Gillian Hawker, MD, Toronto, ON, Canada
Low surgeon volume is associated with increased complications
following total hip arthroplasty.
Thursday
4:06 PM
PAPER: 542
Trends in Total Hip Arthroplasty in the United States: The Shift
to a Younger Demographic
Jacob M. Drew, MD, Charlotte, NC
Jeffrey K. Lange, MD, Worcester, MA
Virginia Briggs, PhD, Worcester, MA
Patricia Franklin, MD, MBA, MPH, Worcester, MA
David C. Ayers, MD, Worcester, MA
4:12 PM
PAPER: 543
The Utility of a Total Joint Registry in Quality Improvement
Thomas C. Barber, MD, Oakland, CA
Liz Paxton, MA, San Diego, CA
Maria C. Inacio, MS, San Diego, CA
Christopher F. Ake, PhD, San Diego, CA
Eric J. Yue, MD, Sacramento, CA
Monti Khatod, MD, Santa Monica, CA
Robert S. Namba, MD, Corona Del Mar, CA
Tadashi T. Funahashi, MD, Irvine, CA
In a US integrated healthcare system with over 9 million
members, a total joint replacement registry (TJRR) has
implemented a comprehensive reporting program to support
quality improvement.
Discussion 6 Minutes
4:24 PM
PAPER: 544
HIV Infection and Risk of Perioperative Complications Following
Total Hip Arthroplasty
Qais Naziri, MD, Brooklyn, NY
Matthew R. Boylan, Brooklyn, NY
Kimona Issa, MD, Baltimore, MD
Harpal S. Khanuja, MD, Cockeysville, MD
Michael A. Mont, MD, Baltimore, MD
This study compared the cost, length and risk of short-term
complications during admission among HIV-positive and HIVnegative patients admitted for primary total hip arthroplasty
(THA).
4:30 PM
PAPER: 545
Factors Affecting Readmission Rates Following Primary Total
Hip Arthroplasty
Rachel E. Mednick, MD, Chicago, IL
Hasham M. Alvi, MD, Chicago, IL
Hasham M. Alvi, MD, Chicago, IL
Varun Krishnan, BA, Chicago, IL
Francis Lovecchio, BA, Chicago, IL
David W. Manning, MD, Chicago, IL
The risk of readmission following total hip arthroplasty is
increased in patients with a BMI>40, a history of chronic steroid
use, and in patients with a low preoperative serum albumin.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
163
Thursday, March 13
4:36 PM
PAPER: 546
Bisphosphonates Reduce the Risk of Revision Following Total
Hip Arthroplasty
Monti Khatod, MD, Santa Monica, CA
Maria C. Inacio, MS, San Diego, CA
Richard M. Dell, MD, Cypress, CA
Stefano A. Bini, MD, San Francisco, CA
Liz Paxton, MA, San Diego, CA
Robert S. Namba, MD, Corona Del Mar, CA
5:12 PM
PAPER: 550
Is Closed Suction Drainage Effective in Recovery of Hip Joint
Function After Total Hip Arthroplasty?
Gaku Koyano, MD, PhD, Tokyo, Japan
Tetsuya Jinno, MD, PhD, Tokyo, Japan
Daisuke Koga, MD, Tokyo, Japan
Chisato Hoshino, Tokyo, Japan
Takeshi Muneta, MD, Tokyo, Japan
Atsushi Okawa, Tokyo, Japan
Discussion 6 Minutes
4:48 PM
PAPER: 547
Timing of Pharmacologic Thromboprophylaxis on Venous
Thromboembolism and Surgical Site Infection following TJA
Zhong Wang, PhD, Bethesda, MD
Frederick A. Anderson, PhD, Worcester, MA
Michael M. Ward, MD, Bethesda, MD
Timothy Bhattacharyya, MD, Bethesda, MD
LMWH prophylaxis closer to the surgical time reduced VTE
risk, was associated with higher incidences of bleeding and, more
importantly, surgical site infections.
4:54 PM
PAPER: 548
Topical Versus Intravenous Tranexamic Acid in Total Hip
Arthroplasty: A Double-Blind, Randomized Controlled Trial
Wayne T. North, MD, Berkley, MI
Nima Mehran, MD, Royal Oak, MI
Michael W. Laker, MD, Birmingham, MI
Kaiser Shah, BA, Oak Brook, IL
Craig Silverton, DO, Detroit, MI
Robb M. Weir, MD, Novi, MI
Jason J. Davis, MD, Commerce Township, MI
Lige Kaplan, MD, Royal Oak, MI
Intravenous TA reduces blood loss and transfusion requirements
in THA. This double blind, RCT demonstrates that topical TA is
equivalent in its ability to reduce blood transfusions in THA.
Thursday
PAPER: 549
5:00 PM
Wound Complications with Therapeutic Anticoagulation after
Total Joint Arthroplasty
Ryan Nunley, MD, Saint Louis, MO
James A. Keeney, MD, Saint Louis, MO
John C. Clohisy, MD, Saint Louis, MO
Staci Johnson, M.Ed, Saint Louis, MO
Douglas J. McDonald, MD, Webster Groves, MO
Robert L. Barrack, MD, Saint Louis, MO
5:18 PM
PAPER: 551
Rivaroxaban versus Enoxaparin for Venous Thromboembolism
Prophylaxis after Hip and Knee Arthroplasty
Nicholas B. Frisch, MD, MBA, Bloomfield Hills, MI
Michael A. Charters, MD, Detroit, MI
Nolan M. Wessell, MD, Detroit, MI
Jakub A. Sikora-Klak, BS, Bloomfield Hills, MI
Stephen Yu, BS, Garden City, MI
James J. Jeffries JR, Detroit, MI
Clifford M. Les, DVM, Detroit, MI
Craig Silverton, DO, Detroit, MI
Michael W. Laker, MD, Birmingham, MI
164
Educational Programs
Thursday, March 13
5:36 PM
PAPER: 553
The Painful Reality of Hip Stem Modularity - Catastrophic
Adverse Tissue Responses in a Series of 216 Cases
Danyal Nawabi, MD, FRCS (Orth), New York, NY
Brett Lurie, MBBS, New York, NY
Allison Ruel, BA, New York, NY
Giorgio Perino, New York, NY
Hollis Potter, MD, New York, NY
Geoffrey H. Westrich, MD, New York, NY
A cobalt-chrome on titanium, modular neck-stem hip design
has shown a poor survivorship of only 76.6% at 2 years. The
majority (93%) of the revisions are due to ALTR.
PAPER: 554
5:42 PM
Medicaid Patients Have Higher Complication Rates and Costs
After Primary TJA - A Matched-Control Study
Michele R. DApuzzo, MD, New York, NY
Wendy Novicoff, PhD, Charlottesville, VA
James A. Browne, MD, Charlottesville, VA
Medicaid patients have a significantly higher risk for select
postoperative complications and increased costs when matched
for age, gender and comorbid medical condition.
PAPER: 555
5:48 PM
Distributed Analysis of Hip Implants Using Five International
Registries: Pioneering Study of Bearing Surfaces
Ove N. Furnes, MD, Bergen, Norway
Guy Cafri, PhD, La Jolla, CA
Liz Paxton, MA, San Diego, CA
Stephen Graves, MD, Adelaide, Australia
Barbara Bordini, MD, Bologna, Italy
Thomas K. Comfort, MD, Stillwater, MN
Samprit Banerjee, PhD, New York, NY
Danica Marinac-Dabic, MD, PhD, Rockville, MD
Art Sedrakyan, PhD, MD, New York, NY
Younger patients with large size but not small size metal on
metal implants are at higher risk of revision compared to crosslink polyethylene bearing in worldwide distributed study of five
registries.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 245
Sports Medicine/Arthroscopy V: Shoulder II
Moderator(s):Richard Angelo, Woodinville, WA
Michael A. Kuhn, MD, Cape Carteret, NC
4:00 PM
PAPER: 556
Increased Rate of Posterior Instability in Young Active Patients
Jay B. Cook, MD, Kailua, HI
Daniel Song, MD, APO, AE
Douglas J. Rowles, MD, Aiea, HI
Craig R. Bottoni, MD, Honolulu, HI
Steve Shaha, Draper, UT
John M. Tokish, MD, Scottsdale, AZ
The rate of posterior instability our young, active population is
greater than double that previously reported.
4:06 PM
PAPER: 557
Footprint Contact Restoration Between the Biceps-labrum
Complex and the Glenoid Rim in SLAP Repair
Sung-Jae Kim, MD, Seoul, Republic of Korea
Sung-Hwan Kim, MD, Seoul, Republic of Korea
Yun-Rak Choi, MD, PhD, Seoul, Republic of Korea
Seong-Hun Kim, Goyang-Si, Republic of Korea
Min Jung, MD, Seoul, Republic of Korea
Su Keon A. Lee, MD, Seoul, Republic of Korea
Jae-Ho Yang, Seoul, Republic of Korea
Yong-Min Chun, MD, PhD, Seoul, Republic of Korea
Although two single-loaded anchors with simple suture resulted in the
largest pressurized contact dimension in SLAP repair, this approach
showed suboptimal contact area just below the biceps anchor.
PAPER: 558
4:12 PM
Arthroscopic Latarjet Procedure for Anterior Shoulder
Instability: Five-Year Minimum Follow Up
Guillaume D. Dumont, MD, Boston, MA
Simon Fogerty, FRCS, North Yorkshire, United Kingdom
Laurent Lafosse, MD, Annecy, France
Evaluation of the rate of recurrent instability and patient
outcomes after shoulder stabilization using the arthroscopic
Latarjet procedure a minimum of five years after surgery.
Thursday
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
165
Thursday, March 13
4:24 PM
PAPER: 559
Biomechanical Analysis of the Modified Bristow Procedure: Is
the Bone Block Necessary?
Curtis J. Kephart, MD, Delray Beach, FL
Michael Abdulian, MD, Studio City, CA
Michelle H. McGarry, MD, Long Beach, CA
James E. Tibone, MD, Los Angeles, CA
Thay Q. Lee, PhD, Long Beach, CA
Glenohumeral instability due to a bony Bankart lesion was restored
with a modified Bristow procedure where only the conjoint tendon
without the bone block was transferred to the glenoid.
4:30 PM
PAPER: 560
A Randomized Controlled Trial Comparing Arthroscopic and
Open Bankart Repair for Anterior Shoulder Dislocations
Steven J. Svoboda, MD, West Point, NY
Kenneth L. Cameron, PhD, West Point, NY
Karen Y. Peck, ATC, MEd, West Point, NY
Thomas M. DeBerardino, MD, Farmington, CT
Bradley J. Nelson, MD, Minneapolis, MN
Dean C. Taylor, COL, MD, Durham, NC
Joachim Tenuta, MD, Albany, NY
John M. Uhorchak, MD, Cornwall, NY
Brett D Owens, MD, West Point, NY
In a young, high-demand military cadet population, open and
arthroscopic shoulder stabilization procedures were found to
have similar clinical outcomes.
4:54 PM
PAPER: 563
Redefining Critical Bone Loss in Shoulder Instability:
Functional Outcomes Worsen with Subcritical Bone Loss
James S. Shaha, MD, Kailua, HI
Jay B. Cook, MD, Kailua, HI
Daniel Song, MD, APO, AE
Craig R. Bottoni, MD, Honolulu, HI
Douglas J. Rowles, MD, Aiea, HI
Steve Shaha, Draper, UT
John M. Tokish, MD, Scottsdale, AZ
Subcritical glenoid bone loss above 13.4% led to a clinically
significant decrease in WOSI scores consistent with an
unacceptable outcome.
5:00 PM
PAPER: 564
A Prospective Outcome Evaluation of Humeral Avulsions of the
Glenohumeral Ligament (HAGL) Tears
CDR (ret) Matthew T. Provencher, MD, Boston, MA
Frank McCormick, MD, Ft Lauderdale, FL
Lance E. LeClere, MD, San Diego, CA
Tistia Gaston, PA-C, Boston, MA
Daniel J. Solomon, MD, Novato, CA
Christopher B. Dewing, MD, San Diego, CA
After surgery, patients demonstrated statistically and clinically
significant improved outcomes, a predictable return to activity
and patient satisfaction.
Discussion 6 Minutes
PAPER: 561
4:36 PM
Hill-Sachs Remplissage: Two to 10-year Follow Up and Incidence
of Recurrence
Eugene M. Wolf, MD, San Francisco, CA
Afshin Arianjam, MD, San Francisco, CA
This paper presents the results of arthroscopic remplissage used in
the treatment of traumatic anterior shoulder instability in patients
with both glenoid bone loss and a Hill Sachs lesion.
Discussion 6 Minutes
4:48 PM
PAPER: 562
3-D Modeling of Humeral Head Defects in Glenohumeral
Instability: Implications of the Glenoid Track
Jaicharan Iyengar, MD, Lodi, CA
5:12 PM
PAPER: 565
Arthroscopic Subdeltoid Transfer of the Long Head of the Biceps
Tendon: Outcomes at Two to 10 Years Follow Up
Samuel A. Taylor, MD, New York, NY
Peter D. Fabricant, MD, MPH, New York, NY
Nikolas Baret, New York, NY
Ashley M. Newman, BS, Syracuse, NY
Nicole Sliva, BA, New York, NY
Stephen J. OBrien, MD PLLC, New York, NY
Arthroscopic subdeltoid transfer of the long head of the
biceps tendon is a safe, reliable intervention for chronic biceps
tendinopathy with favorable 2-10 year outcomes.
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
166
Educational Programs
Thursday, March 13
5:18 PM
PAPER: 566
Graft Position Determines Stability in Free Bone Graft
Augmentation Procedures of the Anterior Glenoid
Laurent B. Willemot, MD, Rochester, MN
Alexander W. Hooke, MA, Rochester, MN
Andrew Thoreson, MD
Philippe Debeer, MD, Herent, Belgium
Jan M. Victor, MD, GENT, Belgium
Kai-Nan An, PhD, Rochester, MN
Olivier Verborgt, MD, PhD, Wilrijk, Belgium
This study found improved stability for free bone graft
augmentation when compared to standard labral repair;
furthermore, it stresses the importance of bone graft positioning
in the sagittal plane.
PAPER: 567
5:24 PM
Arthroscopic Repair Versus Conservative Treatment in Acute
Shoulder Dislocation: A Prospective Case Control Study
Angelo De Carli, MD, Rome, Italy
Luigi Mossa, Rome, Italy
Antonio Vadala, MD, Rome, Italy
Alessandro Ciompi, MD, Roma, Italy
Riccardo Maria Lanzetti, Roma, Italy
Domenico Lupariello, Matera, Italy
Carlo Iorio, MD
Andrea Ferretti, MD, Rome, Italy
Primary repair of Bankart lesion after first time shoulder
dislocation in young active people offers better clinical and
functional results then conservative treatment.
Discussion 6 Minutes
5:36 PM
PAPER: 568
The Arthroscopic Latarjet Procedure - An Update
Claudio Rosso, MD, MSc, Basel, Switzerland
Vito Bongiorno, MD, Annecy, France
Simon Fogerty, FRCS, North Yorkshire, United Kingdom
Simon Boyle, York, United Kingdom
Laurent Lafosse, MD, Annecy, France
Thursday
5:48 PM
PAPER: 570
Glenoid Bone Loss in Posterior Shoulder Instability: Prevalence
and Implications in Arthroscopic Treatment
Adam C. Hines, MD, Kailua, HI
Jay B. Cook, MD, Kailua, HI
James S. Shaha, MD, Kailua, HI
Kevin Krul, MD, Kailua, HI
John M. Tokish, MD, Scottsdale, AZ
While anterior glenoid bone loss is known to significantly affect
outcomes for anterior shoulder instability, posterior glenoid bone
loss may not have as direct a correlation with patient outcomes.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 265
Hand and Wrist III: Nerve, Soft Tissue Reconstruction, & Pediatric
Hand
Moderator(s): Mark E. Baratz, MD, Washington PA,
Amy L. Ladd, MD, Palo Alto, CA
4:00 PM
PAPER: 571
Posterior Elbow Soft-tissue Reconstruction Using a Flexor Carpi
Ulnaris Muscle Turnover Flap
Christopher O. Bayne, MD, Rochester, MN
Jianjun Ma, MD, Springfield, IL
William Slikker III, MD, Chicago, IL
Fraser J. Leversedge, MD, Durham, NC
Mark S. Cohen, MD, Chicago, IL
Robert W. Wysocki Jr, MD, Chicago, IL
This study reports the outcomes of using a flexor carpi ulnaris
muscle turnover flap for reconstruction of posterior elbow softtissue defects.
4:06 PM
PAPER: 572
Radialization vs. Centralization Procedures for High Grade
Radial Club Hand: A Randomized Trial
Bhavuk Garg, MS Ortho, New Delhi, India
Prakash Kotwal, MS, New Delhi, India
Samarth Mittal, MBBS, New Delhi, India
Vijay Kumar, MD, New Delhi,India, India
According to our study radialization has shown better results as
compared to centralization in terms of clinical and radiological
outcome but no significant difference in functional outcome was
seen.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
167
Thursday, March 13
4:12 PM
PAPER: 573
Long-Term Results Following Surgical Treatment of Wrist Flexion
Deformity in Patients with Cerebral Palsy
Christopher J. Dy, MD, New York, NY
Morgan M. Swanstrom, MD, New York, NY
Krystle Hearns, MA, New York, NY
Lorene Janowski, DPS OTR/L MS, New York, NY
Michelle G. Carlson, MD, New York, NY
We report our long-term results of FCU to ECRB transfer, ECU
to ECRB transfer, and FCU lengthening to treat wrist flexion
deformity in patients with cerebral palsy.
Discussion 6 Minutes
4:24 PM
PAPER: 574
The Impact of Perioperative Warfarin in Patients Undergoing
Surgery of the Hand and Wrist
Ljiljana Bogunovic, MD, Saint Louis, MO
Richard H. Gelberman, MD, Clayton, MO
Charles A. Goldfarb, MD, Saint Louis, MO
Martin I. Boyer, MD, Saint Louis, MO
Ryan P. Calfee, MD, Saint Louis, MO
The perioperative continuation of Warfarin therapy is safe in
patients undergoing surgery of the hand and wrist.
4:30 PM
PAPER: 575
Novel Polymer Scaffold for MSC Engineering and Biologic
Enhancement of Ligament Differentiation
Eric R. Wagner, MD, Rochester, MN
Dalibel M. Bravo, San Juan, PR
Michael J. Yaszemski, MD, PhD, Rochester, MN
Sanjeev Kakar, MD, Rochester, MN
aMSCs attach, proliferate and differentiate into ligamentous
phenotypes along the porous PCLF scaffold. This novel scaffold
has potential in stem cell engineering and ligament regeneration.
4:36 PM
PAPER: 576
A Comparison of Ultrasound and Electrodiagnostic Testing for
the Diagnosis of Carpal Tunnel Syndrome
John R. Fowler, MD, Gibsonia, PA
Richard J. Tosti, MD, Philadelphia, PA
William C. Hagberg, MD, Wexford, PA
Joseph E. Imbriglia, MD, Wexford, PA
While US will not replace EDX in complicated cases, in a select
group of patients with a positive CTS-6, US can be used to
confirm the diagnosis of carpal tunnel syndrome.
4:48 PM
PAPER: 577
Ulnar Nerve Stability Based Approach for Patients with Cubital
Tunnel Syndrome: A Prospective Cohort Study
Yun-Rak Choi, MD, PhD, Seoul, Republic of Korea
Ho-Jung Kang, MD, PhD, Seoul, Republic of Korea
Yong-Min Chun, MD, PhD, Seoul, Republic of Korea
Il-Hyun Koh, Gyenggi-Do, Republic of Korea
An ulnar nerve stability-based approach to surgery selection
for cubital tunnel syndrome was effective based on two-year
followup data.
PAPER: 578
4:54 PM
Redefining the Supraclavicular Anatomy of the Brachial Plexus
Sophia Leung, MD, Baltimore, MD
Dan A. Zlotolow, MD, Philadelphia, PA
Scott H. Kozin, MD, Philadelphia, PA
Joshua M. Abzug, MD, Timonium, MD
In the infant brachial plexus, a trifurcation is seen invariably at
the upper trunk, with the suprascapular nerve being the most
lateral structure, which questions standard depictions of the
plexus.
5:00 PM
PAPER: 579
An Evaluation of Inflammation, Histology and Function in Nerve
Regeneration
Peter Tang, MD, New York, NY
Ken Nakayama, MD, Shizuoka, Japan
Hyunwoo P. Kang, BS, MA, New York, NY
Derek Smith, MD, Lake Oswego, OR
Francis Y. Lee, MD, PhD, New York, NY
Nerve regeneration in the setting of segmental peripheral nerve
defects continues to be a challenge. Inflammation plays a key role
in histologic and functional recovery.
Discussion 6 Minutes
5:12 PM
PAPER: 580
Allograft Nerve Reconstruction for Digital Nerve Loss
John S. Taras, MD, Philadelphia, PA
Nirav H. Amin, MD, Cleveland, OH
Nimit A. Patel, MD, Philadelphia, PA
Lucy McCabe, Philadelphia, PA
The data suggest that processed nerve allograft provides a safe
and effective option for the reconstruction of peripheral sensory
nerve deficits in the hand measuring up to 30 mm.
Discussion 6 Minutes
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
168
Educational Programs
Thursday, March 13
5:18 PM
PAPER: 581
Optimal Axon Counts for Brachial Plexus Nerve Transfers
Joseph Schreiber, MD, New York, NY
Mahmoud M. Khair, MD, New York, NY
Lauren Rosenblatt, BS, San Antonio, TX
David J. Byun, BS, New York, NY
Steve K. Lee, MD, New York, NY
Scott W. Wolfe, MD, New York, NY
Based on axon counts of historically successful nerve transfers,
our findings suggest that a donor to recipient axon count
ratio of greater than 1:1 may be the goal in brachial plexus
reconstructions.
PAPER: 582
5:24 PM
Axon Counts Yield Multiple Options for Triceps to Axillary Nerve
Transfer
Mahmoud M. Khair, MD, New York, NY
Joseph Schreiber, MD, New York, NY
Lauren Rosenblatt, BS, San Antonio, TX
David J. Byun, BS, New York, NY
Steve K. Lee, MD, New York, NY
Scott W. Wolfe, MD, New York, NY
This study evaluates the possibility of restoring deltoid muscle
function in patients with upper brachial plexus injuries by
transferring divisions of the radial nerve to the axillary nerve.
Discussion 6 Minutes
5:36 PM
PAPER: 583
Assessment of the Role of Nerve Transfer for Management of
Upper Extremity Peripheral Nerve Injuries
Asser Sallam, MD, Ismailia, Egypt
Adel Abdelkafy, Ismailia, Egypt
Ahmed M. Metwally, MD, Suez, Egypt
Khaled Aboelnasr, Ismailia, Egypt
Khaled Salama, MD, Ismaillia, Egypt
Nerve transfers offer a surgical alternative for restorationof
function by providing expendable axons close to the end organ
and thereby minimizing the time required for re-innervation.
Thursday
5:42 PM
PAPER: 584
Does Pre-operative Donor Nerve Electromyography Predict
Nerve Transfer Outcomes?
Joseph Schreiber, MD, New York, NY
Joseph Feinberg, MD, New York, NY
David J. Byun, BS, New York, NY
Steve K. Lee, MD, New York, NY
Scott W. Wolfe, MD, New York, NY
5:48 PM
PAPER: 585
Early Surgical Outcomes of Targeted Muscle Reinnervation
Aaron E. Barrow, MD, Fort Sam Houston, TX
Chad A. Krueger, MD, San Antonio, TX
Mickey S. Cho, MD, San Antonio, TX
This paper reports on the early surgical outcomes for TMR,
including a low rate of post-operative complications and a high
rate myoprosthetic fitting.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 345
Spine IV: Lumbar/Miscellaneous
Moderator(s):Ronald A. Lehman, MD, Potomac, MD
F.Todd Wetzel, MD, Wilmington, DE
4:00 PM
PAPER: 586
The Anti-inflammatory Effects of Perioperative
Methylprednisolone on Soft Tissue Inflammation Induced by
rhBMP-2
Chengjie Xiong JR, Chongqing, China
Michael D. Daubs, MD, Las Vegas, NV
Haijun Tian, MD, Shanghai, China
Scott Montgomery, MD, Venice, CA
Bayan Aghdasi, MD, Clovis, CA
Akinobu Suzuki, MD, PhD, Osaka, Japan
Trevor Scott, MD, Santa Monica, CA
Kevin Phan, BS, Irvine, CA
Jeffrey C. Wang, MD, Sherman Oaks, CA
A very low dose of methylprednisolone was equally sufficient as a
pharmacological dose to decrease rhBMP-2 induced inflammation
and edema in a rat model.
4:06 PM
PAPER: 587
Epidemiological Trends in the Use of Bone Morphogenetic
Protein in Spinal Fusions from 2002-2010
Sreeharsha Nandyala, BA, Aurora, IL
Steven Fineberg, MD, Valhalla, NY
Alejandro Marquez-Lara, MD, Chicago, IL
Kern Singh, MD, Chicago, IL
Increasing trend in use of BMP for spinal fusion surgery in the
United States between 2002-2010.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
169
Thursday, March 13
4:12 PM
PAPER: 588
Contrast Enhanced CT of the Intervertebral Disc Using
Equilibrium Partitioning of an Ionic Contrast Agent (epic) CT
Kraig A. Kristof, MD, Sylvania, OH
Tristan Maerz, MS, Royal Oak, MI
Michael D. Newton, BS, Warren, MI
Olesya Motovylyak, BS, West Bloomfield, MI
Vishal C. Patel, MD, Dallas, TX
Daniel K. Park, MD, Bloomfield Hills, MI
Kevin C. Baker, PhD, Royal Oak, MI
EPIC-CT is a contrast-enhancing CT method sensitive to
temporal and spatial differences in sulfated glycosaminoglycans in
in vitro and in vivo models of disc degeneration in a rabbit.
4:36 PM
PAPER: 591
Occipitocervical Fusion in Skeletal Dysplasia: A New Surgical
Technique
Prakash Sitoula, MD, Wilmington, DE
Suken A. Shah, MD, Wilmington, DE
Laurens Holmes, PhD, DrPH, Wilmington, DE
Kenneth J. Rogers, PhD, Wilmington, DE
Colleen P. Ditro, NP, Wilmington, DE
William G. Mackenzie, MD, Wilmington, DE
This study describes a new technique for occipitocervical fusion
in children with skeletal dysplasia when the posterior elements
are not of a size or quality for other types of instrumentation.
Discussion 6 Minutes
Discussion 6 Minutes
4:24 PM
PAPER: 589
The Effect of Vitamin D Deficiency on Spinal Fusion in an Aged
Rat Model Using BMP2
Michael D. Daubs, MD, Las Vegas, NV
Kevin Phan, BS, Irvine, CA
Chengjie Xiong JR, Chongqing, China
Tetsuo Hayashi, MD, Fukuoka, Japan
Raed M. Alobaidaan, MBBS, Los Angeles, CA
Haijun Tian, MD, Shanghai, China
Trevor Scott, MD, Santa Monica, CA
Chelsea B. Fan, San Ramon, CA
Jeffrey C. Wang, MD, Sherman Oaks, CA
Vitamin D deficiency did not affect fusion healing rates in young
or aged rats.
4:30 PM
PAPER: 590
The Change of Mechanical Properties After Rod Contouring on
Different Spinal Constructs
Satoru Demura, MD, Kanazawa, Japan
Hideki Murakami, MD, Kanazawa, Japan
Satoshi Kato, MD, Kanazawa, Japan
Katsuhito Yoshioka, MD, Kanazawa, Japan
Hiroyuki Hayashi, MD, Kanazawa, Japan
Kazuya Shinmura, MD, Ishikawa, Japan
Noriaki Yokogawa, MD, Ishikawa, Japan
Takayoshi Ishii, MD, Kanazawa, Japan
Hiroyuki Tsuchiya, MD, Kanazawa, Japan
4:48 PM
PAPER: 592
Prevention of Surgical Site Infection Using Iodine-supported
Spinal Instruments in Total Spondylectomy
Hiroyuki Hayashi, MD, Kanazawa, Japan
Hiroyuki Tsuchiya, MD, Kanazawa, Japan
Hideki Murakami, MD, Kanazawa, Japan
Satoru Demura, MD, Kanazawa, Japan
Toshiharu Shirai, MD, Kanazawa, Japan
Satoshi Kato, MD, Kanazawa, Japan
Katsuhito Yoshioka, MD, Kanazawa, Japan
Kazuya Shinmura, MD, Ishikawa, Japan
Noriaki Yokogawa, MD, Ishikawa, Japan
We newly developed iodine-supported instruments. Iodinesupported spinal instruments were effective for prevention of
SSI. In addition, there were no cytotoxicity and adverse effects
detected.
4:54 PM
Predictors of Dynamic Instability in Degenerative
Spondylolisthesis
William Slikker III, MD, Chicago, IL
Joe Lee, MD, Arcadia, CA
Krzysztof B. Siemionow, MD, Chicago, IL
Alejandro Espinoza, PhD, Chicago, IL
Howard S. An, MD, Chicago, IL
PAPER: 593
Thursday
An alphabetical faculty financial disclosure list can be found starting on page 312.
170
Educational Programs
Thursday, March 13
5:00 PM
PAPER: 594
The Prognostic Value of Pre-operative Activity Level on Postoperative Outcomes Following Lumbar Microdiscectomy
Ravi Ramachandran, MD, Sacramento, CA
Rachel M. Deering, MPH, BS, Boston, MA
Christopher M. Bono, MD, Boston, MA
Mitchel B. Harris, MD, Boston, MA
Kirkham B. Wood, MD, Boston, MA
This study seeks to elucidate which, if any, activities of daily
living give us insight on the postoperative course of a patient after
lumbar discectomy.
5:36 PM
PAPER: 598
Sacral Screw Strain in a Long Posterior Spinal Fusion Construct
with Sacral Alar-Iliac (S2AI) versus Iliac Fixation
Daniel Kang, MD, Bethesda, MD
Ronald A. Lehman, MD, Potomac, MD
Robert W. Tracey, MD, Great Falls, VA
Rachel E. Gaume, BS
Khaled M. Kebaish, MD, Baltimore, MD
Lawrence G. Lenke, MD, Saint Louis, MO
Both S2AI and Iliac fixation provide significant reduction in S1
sacral screw strain compared to sacral fixation alone. Bilateral S2AI
fixation is a viable and biomechanically comparable alternative.
Discussion 6 Minutes
5:12 PM
PAPER: 595
An Efficacy Study of Institutional Protocol for Deep Vein
Thrombosis Associated with Spinal Surgery
Norihiko Takegami, Tsu, Japan
Koji Akeda, MD, PhD, Tsu, Japan
Takao Imanishi, MD, Tsu-Shi Mie-Ken, Japan
Koichiro Murata, Tsu City, Japan
Masahiro Hasegawa, MD, Mie, Japan
Toshihiko Sakakibara, MD, Mie Pref, Japan
Yuichi Kasai, MD, Mie Prefecture, Japan
Akihiro Sudo, Prof., Tsu City, Mie, Japan
11% of patients who underwent spinal surgery had DVT perioperatively. More than 90% of these DVTs improved with proper
perioperative management without chemical prophylaxis.
5:18 PM
Selective Densitometry of the Lumbar Spine
Bryant Chu, BS, San Francisco, CA
Jeremi M. Leasure, MS, San Francisco, CA
Dimitriy G. Kondrashov, MD, San Francisco, CA
PAPER: 596
Thursday
PAPER: 599
5:42 PM
Medical vs. Surgical Treatment of Spinal Epidural Abscesses in
Patients with Normal Neurology or Radicular Deficit
Rojeh Melikian, MD, Cambridge, MA
Sang D. Kim, MD, Los Angeles, CA
Kevin L. Ju, MD, Boston, MA
David Zurakowski, PhD, Boston, MA
Christopher M. Bono, MD, Boston, MA
Mitchel B. Harris, MD, Boston, MA
Comparison of medical vs surgical treatment of SEA in patients with
no deficit or radicular deficits showed higher failure rates in medical
group but no difference in final outcomes or complications.
PAPER: 600
5:48 PM
Expression of Vascular Endothelial Growth Factor in
Hypertrophic Ligamentum Flavum of Lumbar Spinal Stenosis
Sittisak Honsawek, MD, PhD, Bangkok, Thailand
Worawat Limthongkul, MD, Bangkok, Thailand
Wicharn Yingsakmongkol, MD, Bangkok, Thailand
Vinai Parkpian, MD, Bangkok, Thailand
The increased expression of VEGF was associated with the
degenerative changes of hypertrophic LF, suggesting that VEGF
could contribute to pathogenesis in lumbar spinal stenosis.
PAPER: 829
5:54 PM
Oxy133: Activation Of Hedgehog Signaling And Osteogenesis
Through Smoothened Binding
Scott Montgomery, MD, Venice, CA
Taya Nargizyan, Los Angeles, CA
Sigrid Nachtergaele, Palo Alto, CA
Haijun Tian, Shanghai, China
Gil Weintraub, Encino, CA
Elisa Atti, Los Angeles, CA
Jeffrey Wang, Sherman Oaks, CA
Farhad Parhami, Los Angeles, CA
Oxy133 stimulates endochondral bone formation via Hedgehog
signaling by direct binding to smoothened.
Discussion 6 Minutes
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
171
Friday, March 14
SYMPOSIUM
8:00 AM 10:00 AM
La Nouvelle Ballroom
8:00 AM 10:00 AM
Theater C
I.
II.
III.
I.
VI.
VIII.
IX.
Faculty
Peter B. MacDonald, MD, Winnipeg. MB, Canada
X.
Faculty
Joel L. Boyd, MD, Minneapolis, MN
XI.
Faculty
Daniel Whelan, MD, Toronto, ON, Canada
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
SYMPOSIUM
172
Educational Programs
Friday
Friday, March 14
SYMPOSIUM
8:00 AM 10:00 AM
Theater B
Can We Improve Surgical Outcomes for Orthopaedic Patients?
A Compelling Need for Change. (Y)
Moderator: James H. Herndon, MD, Boston, MA
Educate surgeons and surgical team members regarding the
importance of surgical safety and impact on orthopaedic
outcomes including adverse orthopaedic events reported to
the Joint Commission and American Board of Orthopaedic
Surgery. The aligned perspectives of the surgical patients,
hospitals, payers, orthopaedic surgeons and orthopaedic
community will be presented calling for collaboration. Safety
solutions including regular use of effective surgical team
communication, reliable safety processes and systematic safety
data collection with analysis will be outlined - all requiring
orthopaedic surgeon leadership.
I. Patients Perspectives of Orthopaedic Surgical Safety.
Expanding roles of the the American Board of Medical
Specialties and AmericanBoard of Orthopaedic Surgery.
Lloyd Morgan, Winnetka, IL
II. Hospital and Healthcare System Perspectives
ofOrthopaedic Surgical Safety. Joint Commission
Understanding of Surgical Errorsand System-based
Solutions.
Mark Chassin, MD, MPH, Oakbrook Terrace, IL
III. Payer Perspectives of Orthopaedic SurgicalSafety. Costs
and Economic Incentives for Improvement.
Steven H. Stern, MD, Northfield, IL
IV. Orthopaedic Surgeon and Team Member Perspectives
ofOrthopaedic Surgical Safety. Critical role of Surgeon
Leadership.
David C. Ring, MD, Boston, MA
V. Scientific Perspectives of Orthopaedic Surgical Safety.
Utilization of Reliable Validated Effective Surgical
Communication and Processto Reduce Surgical Errors.
John S. Webster, MD, MBA, La Mesa, CA
VI. AAOS Perspectives of Orthopaedic surgical Safety.
Commitment to Improve Orthopaedic Patient Safety
and Care
William J. Robb III, MD, Wnnetka, IL
Room
271
Room
215
Room
221
Educational Programs
173
Friday, March 14
TICKET
Room
276
405
Room
353
408
TICKET
Room
356
409
TICKET
Room
208
Room
352
TICKET
Room
226
412
TICKET
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
404
174
Educational Programs
Friday
Friday, March 14
413
TICKET
Room
260
414
TICKET
Room
350
415
TICKET
Room
207
Room
210
PAPER PRESENTATION
8:00 AM 10:00 AM
Theater A
Adult Reconstruction Hip VI: Metal on Metal
Moderator(s):Kevin B. Fricka, MD, Alexandria, VA
Michael A. Mont, MD, Baltimore, MD
8:00 AM
PAPER: 601
Systematic Screening for Adverse Soft Tissue Reactions in
Patients Operated on with Birmingham Hip Resurfacing
Aleksi Reito, MD, Tampere, Finland
Timo J. Puolakka, MD, PhD, Tampere, Finland
Petra Elo, MD, PhD, Tampere, Finland
Jorma Pajamki, MD, PhD, Tampere, Finland
Antti Eskelinen, MD, PhD, Tampere, Finland
We implemented a systematic screening program including whole
blood metal ion analysis, clinical evaluation and targeted crosssectional imaging to identify possible ARMeD in patients with
BHR.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
175
Friday, March 14
8:30 AM
PAPER: 605
Histological Reaction Around Metal-Metal Total Hips is Not
Dependent on Dosage of Wear Debris
Patricia A. Campbell, PhD, Los Angeles, CA
Edward Ebramzadeh, PhD, Los Angeles, CA
Sophia Sangiorgio, PhD, Los Angeles, CA
Zhen Lu, Los Angeles, CA
Sang-Hyun Park, PhD, Los Angeles, CA
Tim Tan, BS, Los Angeles, CA
Scott D. Nelson, MD, Santa Monica, CA
Koen A. DeSmet, MD, Gent, Belgium
Using multivariate analysis, we found weak correlations between
histological features and implant wear in 118 failed metalon-metal hips. Wear alone does not explain the variation in
histological features.
PAPER: 606
8:36 AM
High Prevalence of Adverse Reactions to Metal Debris in Smallheaded ASR Hips
Aleksi Reito, MD, Tampere, Finland
Timo J. Puolakka, MD, PhD, Tampere, Finland
Petra Elo, MD, PhD, Tampere, Finland
Olli Lainiala, MB, Tampere, Finland
Jorma Pajamki, MD, PhD, Tampere, Finland
Antti Eskelinen, MD, PhD, Tampere, Finland
We observed a high prevalance of adverse soft tissue reactions
in patients with ASR hip replacement with femoral diameter less
than 50 mm.
Discussion 6 Minutes
Discussion 6 Minutes
8:24 AM
PAPER: 604
Influence of Physical Activity on Metal Concentrations and
Pseudotumor Formation in Patients with MoM Arthroplasty
Jetse Jelsma, MSc, Maastricht, Netherlands
Rachel Senden, PhD, Heerlen, Netherlands
Ide Heyligers, Heerlen, Netherlands
Bernd P. Grimm, PhD, Aachen, Germany
This first study to measure patient physical activity and correlate
it with blood ion levels suggests that metal-on-metal wear may be
more influenced by the intensity than the quantity of activity.
8:48 AM
PAPER: 607
Pseudotumor After Large Head Metal-on-metal Stemmed
Total Hip Replacement. Risk Factors, Time Course and Revisions
Bart Hans Bosker, MD, Zwolle, Netherlands
Harmen B. Ettema, Lierderholthuis, Netherlands
Marloes Van Rossum, MD, Zwolle, Netherlands
Martijn F. Boomsma, MD, Zwolle, Netherlands
Boudewijn Kollen, Groningen, Netherlands
Mario Maas, Amsterdam, Netherlands
Cees Verheyen, PhD, Zwolle, Netherlands
This study shows a very high incidence of pseudotumors in
patients treated with large-head MoM THAs, although we
confirm several well known risk factors the most important risk
factor is time.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
8:06 AM
PAPER: 602
Does Gender or Head Size Affect Blood Metal Ion Concentrations
Following Metal-on-Metal Hip Resurfacing?
Gulraj Matharu, BSc, Birmingham, United Kingdom
Fiona Berryman, PhD, Birmingham, United Kingdom
Lesley Brash, MSc, RN, Birmingham, United Kingdom
Paul Pynsent, PhD
Ronan Treacy, Worcestershire, United Kingdom
David J. Dunlop, MD, Stourbridge, United Kingdom
176
Educational Programs
Friday
Friday, March 14
8:54 AM
PAPER: 608
Longitudinal MRI Analysis of Soft Tissue Lesions Around Metal
on Metal Total Hip Arthroplasties
Toby Briant-Evans, FRCS, Winchester, United Kingdom
Nicola Lyle, FRCS, MBBS, Basingstoke, United Kingdom
Jennifer Hauptfleisch, Oxford, United Kingdom
Andrea R. Pearce, Basingstoke, United Kingdom
Richard Harker, MA, FRCS, Hampshire, United Kingdom
Kevin Conn, FRCS, Basingstoke, United Kingdom
John M. Britton, Hampshire, United Kingdom
Geoffrey Stranks, FRCS, Tadley, United Kingdom
Serial Metal Artefact Reduction Sequence MRI scans performed
on 94 MoM THAs demonstrated that the majority of soft tissue
lesions enlarge over time, but this is not correlated with patient
symptoms.
PAPER: 609
9:00 AM
Natural History of Pseudotumours in Metal-on-Metal Hip
Replacements: A Longitudinal MARS MRI Study
Young-Min Kwon, MD, PhD, Boston, MA
Kshitijkumar Agrawal, Arlington, MA
Andrew A. Freiberg, MD, Boston, MA
Harry E. Rubash, MD, Boston, MA
Henrik Malchau, MD, Boston, MA
The natural history of cystic pseudotumours appears to be nonprogressive in the majority of MoM patients with no or minimal
symptoms. MRI features of complex cysts are associated with
progression.
9:18 AM
PAPER: 611
Metal Ions from Well-functioning Hip Resurfacings Decline
Significantly at Ten Years
Catherine Van Der Straeten, MD, Ghent, Belgium
Damien A. Van Quickenborne, Laarne, Belgium
Bart De Roest, Deurle, Belgium
Jan M. Victor, MD, Gent, Belgium
Koen A. DeSmet, MD, Gent, Belgium
In well-functioning MoM hip resurfacings ion levels are low even
after 10 years in situ. There is a significant decrease of ion levels
with time. In 25% of patients ions were undetectable at 10 years.
9:24 AM
PAPER: 612
Cancer Incidence and Cause-specific Mortality Among Patients
with Metal-on-metal Hip Replacements
Keijo Makela, MD, Turku, Finland
Tuomo I. Visuri, Espoo, Finland
Pekka Pulkkinen, PhD, Helsinki, Finland
Antti Eskelinen, MD, PhD, Tampere, Finland
Ville M. Remes, MD, Helsinki, Finland
Petri Virolainen, MD, Littoinen, Finland
Mika Junnila, Turku, Finland
Eero Pukkala, Helsinki, Finland
Overall risk of cancer and risk of death is decreased after metalon-metal hip replacement due to healthy patient effect. However,
metal-on-metal hip implants should not be considered safe until
more data is available.
Discussion 6 Minutes
Discussion 6 Minutes
9:12 AM
PAPER: 610
Which Factors Determine the Volume of Material Lost from the
Taper Junctions of Metal-on-Metal Hip Replacements?
Ashley Matthies, BSc, London, United Kingdom
Suzie Cro, MSc, BS, London, United Kingdom
Paul J. Bills, PhD, MSc, Huddersfield, United Kingdom
Radu Racasan, PhD, Huddersfield, United Kingdom
Liam Blunt, PhD, Huddersfield, United Kingdom
Gordon W. Blunn, MD, Middlesex, United Kingdom
Johann Henckel, MD, London, United Kingdom
John Skinner, FRCS, London, United Kingdom
Alister Hart, FRCS, London, United Kingdom
Multiple linear regression analysis of fifteen factors showed that
bearing surface design was the most significant predictor of high
taper material loss in retrieved metal-on-metal hip replacements.
9:36 AM
PAPER: 613
Analysis of the Taper Supports Retention of a Well-fixed Stem in
Revision Surgery of Metal-on-Metal Hip Replacements
Ashley Matthies, BSc, London, United Kingdom
Paul J. Bills, PhD, MSc, Huddersfield, United Kingdom
Radu Racasan, PhD, Huddersfield, United Kingdom
Liam Blunt, PhD, Huddersfield, United Kingdom
Gordon W. Blunn, MD, Middlesex, United Kingdom
John Skinner, FRCS, London, United Kingdom
Alister Hart, FRCS, London, United Kingdom
Retrieval analysis of metal-on-metal hip stems showed negligible
wear (<1mm3) of the male taper surface in all cases. This
supports retention of a well-fixed, undamaged stem during
revision surgery.
9:42 AM
PAPER: 614
Variables Influencing Tribo-corrosion of Modular Junctions in
Metal-on-Polyethylene THR?
Iustin Moga, BA, Toronto, ON, Canada
Melvyn A. Harrington, MD, Bellaire, TX
Philip C. Noble, PhD, Houston, TX
Increased bearing torque of large head Metal-on-Metal heads
leads to increased wear, release of metal ions and corrosion in the
taper junction compared to Metal-on-Polyethylene THR.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
177
Friday, March 14
8:12 AM
PAPER: 618
Poor Utility of Serum Interleukin-6 Levels to Predict Indolent
Periprosthetic Shoulder Infections
Matthew Grosso, BS, Cleveland, OH
Salvatore J. Frangiamore, MD, MS, Cleveland, OH
Anas Saleh, MD, Beachwood, OH
Mario Farias-Kovac, MD, Cleveland, OH
Eric T. Ricchetti, MD, Cleveland, OH
Thomas W. Bauer, MD, PhD, Cleveland, OH
Joseph P. Iannotti, MD, PhD, Cleveland, OH
Perioperative serum interleukin-6 levels are not a sensitive marker
of infection for indolent periprosthetic shoulder infections.
Discussion 6 Minutes
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 245
Shoulder and Elbow V: Shoulder Complications
Moderator(s):Joshua Dines, MD, Great Neck, NY
Gordon I. Groh, MD, Asheville, NC
8:00 AM
PAPER: 616
Adverse Events Associated with Biodegradable LactideContaining Suture Anchors
Andres F. Cobaleda Aristizabal, MD, Mexico City, Mexico
Eric J. Sanders, BS, Plano, TX
F. Alan Barber, MD, Plano, TX
2 of 370 procedures (0.5%)demonstrated anchor specific adverse
events. No instances of inflammatory reactions were documented
in these PLLA based anchors.
8:06 AM
PAPER: 617
Propionibacterium Acnes Infection as an Etiology of Pain After
Shoulder Arthroscopy
John G. Horneff, MD, Philadelphia, PA
Pramod B. Voleti, MD, Philadelphia, PA
Jason Hsu, MD, Saint Louis, MO
Judith ODonnell, MD, Philadelphia, PA
G. Russell Huffman, MD, Philadelphia, PA
Propionibacterium acnes infection in revision shoulder
arthroscopy should be considered in cases of refractory
postoperative pain.
8:24 AM
PAPER: 619
Early Versus Late Culture Growth Characteristics inP.
AcnesPositive Periprosthetic Shoulder Infections
Salvatore J. Frangiamore, MD, MS, Cleveland, OH
Matthew Grosso, BS, Cleveland, OH
Anas Saleh, MD, Beachwood, OH
Bashar Alolabi, MD, Toronto, ON, Canada
Thomas W. Bauer, MD, PhD, Cleveland, OH
Joseph P. Iannotti, MD, PhD, Cleveland, OH
Eric T. Ricchetti, MD, Cleveland, OH
In revision shoulder arthroplasty, the early growth of P. acnes in
intraoperative cultures (< 7 days) is more likely to represent a true
infection as opposed to a false-positive result.
8:30 AM
PAPER: 620
Propionibacterium Acnes in Shoulder Surgery: False Positive,
Commensal Organism or Pathogen?
William R. Mook, MD, Durham, NC
Grant Garrigues, MD, Chapel Hill, NC
The reported incidences of true positive P. acnes cultures at the
time of shoulder arthroplasty may be overestimated based on the
rate of false positive control specimens identified in our study.
8:36 AM
PAPER: 621
Serum Interleukin-6 as a Marker of Periprosthetic Shoulder
Infection
Diego C. Villacis, MD, Los Angeles, CA
Jarrad A. Merriman, MPH, Pasadena, CA
Raj Yalamanchili, Los Angeles, CA
Reza Omid, MD, Los Angeles, CA
John M. Itamura, MD, Los Angeles, CA
George F. Hatch III, MD, Los Angeles, CA
A prospective cohort study of patients having undergone revision
shoulder surgery concluding that interleukin-6 is not an effective
screening tool for periprosthetic shoulder infection.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
9:48 AM
PAPER: 615
What is the Prevalence of Pseudotumors in Total Hip
Arthroplasty Patients with Dual Taper Modular Femoral Stem?
Young-Min Kwon, MD, PhD, Boston, MA
William A. Leone, MD, Lighthouse Point, FL
Tsung-Yuan Tsai, PhD, Boston, MA
Guoan Li, PhD, Boston, MA
Andrew A. Freiberg, MD, Boston, MA
Harry E. Rubash, MD, Boston, MA
178
Educational Programs
Friday
Friday, March 14
8:48 AM
PAPER: 622
Intraoperative Periprosthetic Fractures in Revision Reverse
Shoulder Arthroplasty: 132 Consecutive Cases
Eric R. Wagner, MD, Rochester, MN
Matthew Houdek, MD, Rochester, MN
Robert H. Cofield, MD, Rochester, MN
Joaquin Sanchez-Sotelo, MD, Rochester, MN
John W. Sperling, MD, MBA, Rochester, MN
Intraoperative humeral fractures occur in 10% of revision
surgeries, but when stabilized, have no effect on overall final
outcome. The risk is higher for females, cemented, and multiply
operated.
PAPER: 623
8:54 AM
The Incidence of Humeral Stem Loosening in Reverse Total
Shoulder Arthroplasty
Andres M. Alvarez, MD, Weston, FL
Gregory J. Gilot, MD, Davie, FL
Edward G. Benton JR, MD, Waco, TX
Sherif Dabash, MBBS, MD, Weston, FL
Incidence of aseptic loosening of the humeral component in
Reverse Total Shoulder Arthroplasty.
PAPER: 624
9:00 AM
What Biomechanical and Patient Factors Influence Fretting
Corrosion in Total Shoulder Replacement?
Judd Day, PhD, Philadelphia, PA
Daniel MacDonald, Philadelphia, PA
Christina M. Arnholt, Philadelphia, PA
Gerald R. Williams Jr, MD, Philadelphia, PA
Charles L. Getz, MD, Newton Square, PA
Matthew J. Kraay, MD, Cleveland, OH
Clare M. Rimnac, PhD, Cleveland, OH
Steven M. Kurtz, PhD, Philadelphia, PA
This study investigates the prevalence of fretting assisted
corrosion in modular total shoulder replacements. Also, evaluates
how patient and implant factors are associated with corrosion.
Discussion 6 Minutes
9:12 AM
PAPER: 625
Results of Closed Management of Acute Dislocation Following
Reverse Shoulder Arthroplasty
Matthew J. Teusink, MD, Omaha, NE
Ioannis P. Pappou, MD, PhD, Palm Harbor, FL
Daniel G. Schwartz, MD, Chicago, IL
Mark A. Frankle, MD, Temple Terrace, FL
This study examined the outcomes of patients that dislocated
postoperatively and were treated with nonoperative, closed
reduction.
9:18 AM
PAPER: 626
Retrieved Reverse Total Shoulder Systems: An Analysis of
Damage, Imaging, Clinical and Outcomes Data
Brett P. Wiater, MD, Birmingham, MI
James E. Moravek Jr, MD, Palos Hills, IL
Erin A. Baker, MS, Royal Oak, MI
Meagan Salisbury, BS, Royal Oak, MI
Daphne Pinkas, MD, Pleasant Rdg, MI
J M. Wiater, MD, Beverly Hills, MI
The study objective was to explore trends in clinical failure of
reverse total shoulder, through analyses of retrieved implants,
clinical records, radiographs and functional outcomes data.
PAPER: 627
9:24 AM
Failure After Reverse Total Shoulder Arthroplasty - What is the
Success of Component Revision?
Eric M. Black, MD, Philadelphia, PA
Susanne M. Roberts, MD, Boston, MA
Elana J. Siegel, BA, Boston, MA
Paul F. Yannopoulos, BA, Boston, MA
Laurence D. Higgins, MD, Boston, MA
Jon J. Warner, MD, Boston, MA
This study looks at the success and failures of patients with failed
reverse shoulder arthroplasty undergoing revision to an additional
reverse shoulder arthroplasty. We also analyze salvage measures.
Discussion 6 Minutes
9:36 AM
PAPER: 628
Patient Specific Risk Factors Associated with Deep Infection
after Primary Shoulder Arthroplasty
Jason P. Richards, MD, Pocatello, ID
Maria C. Inacio, MS, San Diego, CA
Michael P. Beckett, MD, Santa Monica, CA
Ronald A. Navarro, MD, Rolling Hills, CA
Anshuman Singh, MD, San Diego, CA
Mark T. Dillon, MD, Sacramento, CA
Lawrence Hsu, MD, Bakersfield, CA
Edward Yian, MD, Newport Coast, CA
This study utilizes data from a regional shoulder arthroplasty
registry to quantify several identifiable risk factors for postsurgical infection after primary shoulder arthroplasty.
9:42 AM
PAPER: 629
The Relationship Between Patient Characteristics, Complications
and Outcomes after Total Shoulder Arthroplasty
Oke A. Anakwenze, MD, Philadelphia, PA
Evan ODonnell, BA, New York, NY
Charles M. Jobin, MD, New York, NY
William N. Levine, MD, New York, NY
Christopher S. Ahmad, MD, New York, NY
Peri-operative complications following total shoulder arthroplasty
occur in over 10% of patients. These complications are predictive
of poor patient outcomes.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
179
Friday, March 14
8:12 AM
PAPER: 633
Age at Walking in Infants Treated with Idiopathic Clubfoot
Davida Packer, MD, Bonita Springs, FL
Lewis E. Zionts, MD, Pacific Palisades, CA
Sophia Sangiorgio, PhD, Los Angeles, CA
Edward Ebramzadeh, PhD, Los Angeles, CA
Jennifer Hall, Los Angeles, CA
Discussion 6 Minutes
Discussion 6 Minutes
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 265
Pediatrics IV: Potpourri
Moderator(s):Kristan Pierz, MD, Hartford, CT
Harold J. Van Bosse, MD, Wynnewood, PA
8:00 AM
PAPER: 631
Re-operation Following Tarsal Coalition Resection: A PopulationBased Study
Amir Khoshbin, MD, Toronto, ON, Canada
Timothy S. Leroux, MD, Toronto, ON, Canada
Maryse Bouchard, MD, FRCSC, Seattle, WA
David Wasserstein, MD, MSc, North York, ON, Canada
Peggy W. Law, MSc, Toronto, ON, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
Timothy R. Daniels, MD, FRCSC, Toronto, ON, Canada
James G. Wright, MD, Toronto, ON, Canada
Re-operation Following Tarsal Coalition Resection: A
Population-Based Study.
8:06 AM
PAPER: 632
Amniotic Band Syndrome and Clubfoot: Effectiveness of Ponseti
Casting
Aaron M. Carpiaux, MD, Lexington, KY
Pooya Hosseinzadeh, MD, Huntington, West VA
Ryan D. Muchow, MD, Lexington, KY
Vishwas R. Talwalkar, MD, Lexington, KY
Todd A. Milbrandt, MD, Lexington, KY
Janet Walker, MD, Lexington, KY
Henry J. Iwinski, MD, Lexington, KY
Ponseti casting is effective in treatment of clubfeet associated with
amniotic band syndrome.
8:24 AM
PAPER: 634
Clubfoot Treatment Responsive Patients are Anatomically
Distinct from Those Who Require More Treatment
Daniel K. Moon, MD, Saint Louis, MO
Paul Commean, Saint Louis, MO
Marilyn J. Siegel, MD, Saint Louis, MO
Christina A. Gurnett, MD, PhD, Webster Groves, MO
Matthew B. Dobbs, MD, Saint Louis, MO
Clubfoot patients with initial success after proper Ponseti treatment
had quantitative and qualitative differences in soft tissue composition
distinct from patients who required additional treatments.
8:30 AM
PAPER: 635
Residual Forefoot Adductus Predicts the Need for Future
Surgery Clubfeet Treated by Ponseti Casting
Pooya Hosseinzadeh, MD, Huntington, West VA
Erik D. Peterson, MD, Toledo, OH
Janet Walker, MD, Lexington, KY
Ryan D. Muchow, MD, Lexington, KY
Henry J. Iwinski, MD, Lexington, KY
Vishwas R. Talwalkar, MD, Lexington, KY
Todd A. Milbrandt, MD, Lexington, KY
Residual forefoot adductus is associted with increased need for
future surgery in clubfeet treated by Ponseti casting.
PAPER: 636
8:36 AM
Clubfoot Recurrence after Tibialis Anterior Tendon Transfer in
Patients Treated with Ponseti Casting
Matthew R. Luckett, MD, Lexington, KY
Pooya Hosseinzadeh, MD, Huntington, West VA
Philip A. Ashley, MD, Lexington, KY
Ryan D. Muchow, MD, Lexington, KY
Todd A. Milbrandt, MD, Lexington, KY
Janet Walker, MD, Lexington, KY
Vishwas R. Talwalkar, MD, Lexington, KY
Henry J. Iwinski, MD, Lexington, KY
Philip A. Ashley, MD, Lexington, KY
Patients who undergo Tibialis Anterio tendon transfer at early
age are at high risk for recurrence.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
9:48 AM
PAPER: 630
Effects of Morbid Obesity on RSA: A Case Control Study on
Outcomes, Complications, Disposition and Cost
Mark A. Frankle, MD, Temple Terrace, FL
Ioannis P. Pappou, MD, PhD, Palm Harbor, FL
Rachel Clark, BA, Tampa, FL
Nazeem Virani, MD
180
Educational Programs
Friday
Friday, March 14
8:48 AM
PAPER: 637
Idiopathic Genu Valgum: Correlation with Obesity and Vitamin
D Deficiency
Pooya Hosseinzadeh, MD, Huntington, West VA
Kevin A. Murr, MD, Lexington, KY
Ryan D. Muchow, MD, Lexington, KY
Henry J. Iwinski, MD, Lexington, KY
Vishwas R. Talwalkar, MD, Lexington, KY
Todd A. Milbrandt, MD, Lexington, KY
Janet Walker, MD, Lexington, KY
Vitamin D deficiency is present in majority of patients with
idiopathic genu valgum.
PAPER: 638
8:54 AM
A Comparison of Hemiepiphysiodesis Implants for Late-Onset
Tibia Vara: The Staple Revisited
Shawn S. Funk, MD, Nashville, TN
Megan Mignemi, MD, Nashville, TN
Jonathan G. Schoenecker, MD, Nashville, TN
Steven A. Lovejoy, MD, Nashville, TN
Gregory A. Mencio, MD, Nashville, TN
Jeffrey E. Martus, MD, MS, Nashville, TN
Treatment of late-onset tibia vara with hemiepiphysiodesis has
evolved from staples to physeal plates; however, this study noted
no difference in surgical success rates despite greater implant
costs.
PAPER: 639
9:00 AM
Association of Hypertension with Blounts and Slipped Capital
Femoral Epiphysis
Jonathan G. Schoenecker, MD, Nashville, TN
K. Patrick Powell, MD, Fort Worth, TX
Heather Cole, Nashville, TN
Vishwas R. Talwalkar, MD, Lexington, KY
Henry J. Iwinski, MD, Lexington, KY
Janet Walker, MD, Lexington, KY
Todd A. Milbrandt, MD, Lexington, KY
Although it is estimated that only 3-5% of all children has
hypertension; these results clearly indicate a higher incidence
(>60%) of hypertension in patients with SCFE or Blounts
disease.
9:18 AM
PAPER: 641
Outcomes of Dynamic Splinting in Patients with Stiffness After
Knee Surgery
James L. Pace, MD, Hawthorne, CA
Adam Nasreddine, BS, MA, Boston, MA
Michael K. Simoni, BA, Boston, MA
David Zurakowski, PhD, Boston, MA
Mininder S. Kocher, MD, MPH, Boston, MA
Investigate the outcomes of dynamic splinting of the
arthrofibrotic knee in the pediatric population in terms of
increased range of motion and reducing the need for lysis of
adhesion surgery.
PAPER: 642
9:24 AM
Hemoglobin to Hematocrit Ratio: The Strongest Predictor of
Avascular Necrosis in Children with Sickle Cell Disease
Douglas M. Worrall, Philadelphia, PA
Lawrence Wells, MD, Philadelphia, PA
Kimberly Smith-Whitley, MD, Philadelphia, PA
High blood pressure, elevated Hb/Hematocrit, elevated
weight(SS), and elevated Hb(SS) are clinically useful tools to
predict femoral head AVN risk in children with SCD promoting
earlier intervention.
Discussion 6 Minutes
9:36 AM
PAPER: 643
A Multicenter Longitudinal Study of Osteogenesis Imperfecta:
Baseline Observations
Ronak Patel, BS, Houston, TX
David Cuthbertson, MS, Tampa, FL
Jeffrey Krischer, PhD, Tampa, FL
Jay R. Shapiro, MD, Baltimore, MD
Peter A. Smith, MD, Chicago, IL
Francis H. Glorieux, MD, PhD, Montreal, Canada
Brendan Lee, MD, PhD, Houston, TX
Vernon R. Sutton, MD, Houston, TX
Linked Clinical Res Ctrs Osteogenesis Imperfecta, Houston, TX
Baseline observations of the largest cohort of osteogenesis
imperfecta patients to date. The prevalence of clinical features,
rodding, fracture rates and BMD are presented.
Discussion 6 Minutes
9:12 AM
PAPER: 640
Comparison of Internal and External Fixation for Limb
Lengthening Patients Who Have Experienced Both
John E. Herzenberg, MD, Baltimore, MD
Shawn C. Standard, MD, Baltimore, MD
Vikrant Landge, MBBS, Baltimore, MD
Stacy C. Specht, MPA, Baltimore, MD
Limb lengthening with a new, internal, magnetically controlled
device results in a high rate of satisfaction, when compared to
external fixation.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
181
Friday, March 14
8:06 AM
PAPER: 647
Acetabular Reconstructions for Metastatic Disease in the Era of
Cost Containment
Nicholas Bernthal, MD, Venice, CA
Shawn L. Price, MD, Louisville, KY
Brandon G. Wilkinson, BS, Provo, UT
Kevin B. Jones, MD, Salt Lake Cty, UT
R L. Randall, MD, Salt Lake City, UT
8:12 AM
PAPER: 648
Prognostic Factors in the Operative Management of Sacral
Chordomas
Babar Kayani, MBBS BSc, Herts, United Kingdom
Sammy A. Hanna, MRCS, London, United Kingdom
William Aston, FRCS, Stanmore, Middlesex, United Kingdom
Rob Pollock, FRCS, Middx, United Kingdom
John Skinner, FRCS, London, United Kingdom
Stephen R. Cannon, FRCS, Buckinghamshire, United Kingdom
Asif Saifuddin, MBBS, Stanmore, United Kingdom
Tim Briggs, FRCS, Middlesex, United Kingdom
PAPER: 645
9:48 AM
Long-Term Results Following Surgical Treatment of Elbow
Deformity in Patients with Cerebral Palsy
Christopher J. Dy, MD, New York, NY
Morgan M. Swanstrom, MD, New York, NY
Krystle Hearns, MA, New York, NY
Christian A. Pean, MS, New York, NY
Lorene Janowski, DPS OTR/L MS, New York, NY
Michelle G. Carlson, MD, New York, NY
Carefully selected soft tissue releases of the elbow, guided
by preoperative contracture, can significantly improve active
extension and flexion posture during ambulation in patients with
CP.
8:24 AM
PAPER: 649
The Role of Spinopelvic Reconstruction after Amputative
Sacrectomy
Grigoriy Arutyunyan, MD, Rochester, MN
Peter S. Rose, MD, Rochester, MN
Franklin H. Sim, MD, Rochester, MN
Michael J. Yaszemski, MD, PhD, Rochester, MN
Discussion 6 Minutes
PAPER PRESENTATION
8:00 AM 10:00 AM
Room 345
Tumor/Metabolic Disease II: Spine and Pelvic Tumors/
Periprosthetic Issues
Moderator(s):Tim Briggs, FRCS, Middelsex, United Kingdom
Thomas J. Scharschmidt, MD, Westerville, OH
8:00 AM
PAPER: 646
Percutaneous Acetabuloplasty Compared with Surgery for High
Grade Periacetabular Carcinoma Metastases
Matthew Colman, MD, Salt Lake Cty, UT
Syed M. Karim, BS, Boston, MA
Vinil Shah, MD, Boston, MA
Albert Yoo, MD, Boston, MA
Joshua A. Hirsch, MD, Boston, MA
Joseph H. Schwab, MD, Boston, MA
Francis J. Hornicek, MD, Boston, MA
Kevin A. Raskin, MD, Boston, MA
Friday
9:42 AM
PAPER: 644
Conflict of Interest in the Assessment of Botulinum Toxin A
Injections in Patients with Cerebral Palsy
Moon Seok Park, MD, Sungnam, Republic of Korea
Kyoung Min Lee, MD, Sungnam, Republic of Korea
Ki Hyuk Sung, MD, Kyungki, Republic of Korea
Seung Yeol Lee, MD, Seongnam, Republic of Korea
Young Choi, MD, Busan, Republic of Korea
In H. Choi, MD, Seoul, Republic of Korea
Tae-Joon Cho, Seoul, Republic of Korea
Won Joon Yoo, MD, Seoul, Republic of Korea
Chin Y. Chung, MD,PhD, Seongnam, Republic of Korea
182
Educational Programs
Friday
Friday, March 14
8:36 AM
PAPER: 651
The Effect of Supplemental Bone Grafting in Periarticular Bone
Tumors
Joseph Benevenia, MD, Newark, NJ
Jeffrey Moore, Califon, NJ
Kathleen S. Beebe, MD, Montclair, NJ
Francis R. Patterson, MD, Newark, NJ
9:00 AM
PAPER: 654
Cortical Atrophy Related with Tumor Prosthesis in Skeletally
Immature Osteosarcoma Patients
Wanlim Kim, Seoul, Republic of Korea
Ilkyu Han, MD, Seoul, Republic of Korea
Seungcheol Kang, MD, Seoul, Republic of Korea
Han-Soo Kim, MD, PhD, Seoul, Republic of Korea
Discussion 6 Minutes
8:48 AM
PAPER: 652
Treatment of Nonunion with Autologous Bone Marrow Aspirate;
Demineralized Bone Matrix and Bone Morphogenic Protein
Pingal A. Desai, MD, Parsippany, NJ
Saad M. Hasan, BA, New York, NY
Vishal Hegde, BA, New York, NY
Joseph Nguyen, MPH, New York, NY
Parth A. Vyas, MD, New York, NY
Lester Zambrana, BA, New York, NY
Joseph M. Lane, MD, New York, NY
Bone Morphogenic Protein and Demineralized Bone Matrix
are equally effective as Osteoinductors when mixed with
concentrated autologous Iliac crest bone marrow aspirate for the
treatment of nonunion.
8:54 AM
PAPER: 653
The Relationship between Solitary Pulmonary Micronodules at
Presentation and Survival in Young Sarcoma Patients
Cara A. Cipriano, MD, Palo Alto, CA
Lauren Brockman, BS, Chicago, IL
Jeff Ording, BS, Chicago, IL
Jason T. Romancik, BS, Chicago, IL
Curt Ginder, BS, Chicago, IL
Robert G. Hartemayer, Chicago, IL
Joel Krier, MD, Jamaica Plain, MA
Steven Gitelis, MD, Chicago, IL
Paul Kent, MD, Chicago, IL
In our cohort of 121 sarcoma patients <50 years of age, solitary
<5mm pulmonary nodules detected on CT at time of initial
diagnosis did not adversely affect survival at mean 47.2 month
follow up.
9:12 AM
PAPER: 655
Gait Outcomes Post Lower Extremity Tumor Resection and
Endoprosthetic Reconstruction
Eileen Fowler, PhD, Los Angeles, CA
Nicholas Bernthal, MD, Venice, CA
Marcia B. Greenberg, MS, PT, Los Angeles, CA
Kent Heberer, MS, Los Angeles, CA
Susan V. Bukata, MD, Los Angeles, CA
Jeffrey J. Eckardt, MD, Los Angeles, CA
Laboratory and community gait outcomes post lower extremity
endoprosthetic reconstruction following tumor resection
demonstrate a higher level of function than previously reported.
9:18 AM
Is There a Role for Knee Arthrodesis with Modular
Endoprostheses for Tumor and Revision of Failed
Endoprostheses?
Pietro Ruggieri, MD, Bologna, Italy
Eric Henderson, MD, Hanover, NH
Giulia Trovarelli, Bologna, Italy
Elisa Pala, MD, Bologna, Italy
Teresa Calabr, Bologna, Italy
Andrea Angelini, MD, Bologna BO, Italy
PAPER: 656
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
183
Friday, March 14
SYMPOSIUM
10:30 AM 12:30 PM
La Nouvelle Ballroom
II.
III.
IV.
V.
VI.
XI.
XII.
XIII.
XIV.
XV.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
9:36 AM
PAPER: 658
Infected Tumor Prostheses: A Single Institution Experience
Pietro Ruggieri, MD, Bologna, Italy
Andrea Angelini, MD, Bologna BO, Italy
Teresa Calabr, Bologna, Italy
Giulia Trovarelli, Bologna, Italy
Gabriele Drago, MD, Bologna, Italy
Matteo Romantini, MD
Elisa Pala, MD, Bologna, Italy
184
Educational Programs
Friday
Friday, March 14
XII. Posterior Shoulder Atrophy in a 23-Year-Old Thrower:
Release of the Suprascapular Nerve
Kevin D. Plancher, MD, MS, FACS, New York, NY
SYMPOSIUM
SYMPOSIUM
10:30 AM 12:30 PM
Theater B
Controversies in Pediatric Sports Medicine: Update in 2014 (BB)
Moderator: Jennifer M. Weiss, MD, Los Angeles, CA
Case-based debate examining treatment options for four
common pediatric sports injuries: shoulder dislocation, tibial
spine fractures, management of osteochondritis dessicans as an
incidental finding, and discoid meniscus.
I.
II.
III.
IV.
10:30 AM 12:30 PM
Theater C
V. Full Thickness Large Rotator Cuff Tear in a 65-YearOld: Pro Repair and Double Row Technique
Brian J. Cole, MD, MBA, Chicago, IL
VI. Full Thickness Large Rotator Cuff Tear in a 65-YearOld: Pro Single Row Technique
Felix H. Savoie III, MD, New Orleans, LA
VII. Full Thickness Large Rotator Cuff Tear in a 65-YearOld: Con, Dont Fix it
Robert T. Burks, MD, Salt Lake City, UT
VII.
Discoid Meniscus
Lawrence Wells, MD, Philadelphia, PA
VIII.
Discoid Meniscus
Jennifer M. Weiss, MD, Los Angeles, CA
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
185
Friday, March 14
TICKET
10:30 AM 11:30 AM
FD12 Getting Your Great Ideas Supported - Effective
Techniques for Women in Orthopaedics
Room
217
Moderator: Mary I. OConnor, MD, Jacksonville, FL
Will help you understand the information which
different types of people want in order to support your
proposals; how to achieve buy-in and counter efforts
to sink your next great idea. We will also discuss
perceptions of women leaders as well as corresponding
tactics for you to counter negative bias and improve
your effectiveness.
Room
276
425
TICKET
Room
262
10:30 AM 12:30 PM
421
Room
226
423
TICKET
Room
352
Room
350
427
TICKET
Room
347
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
424
186
Educational Programs
Friday
Friday, March 14
428
TICKET
Room
221
432
TICKET
Room
353
Room
260
Room
271
431
Moderator: Mark B. Dekutoski, MD, Phoenix, AZ
Norman B. Chutkan, MD, Augusta, GA
John R. Dimar II, MD, Louisville, KY
IEF
John C. France, MD, Morgantown, West VA
James D. Schwender, MD, Minneapolis, MN
William R. Stevens, MD, Phoenix, AZ
Room
Adam L. Wollowick, MD, New York, NY
433
TICKET
Room
356
Room
210
PAPER PRESENTATION
TICKET
270
10:30 AM 12:30 PM
Theater A
Adult Reconstruction Knee VI: Outcomes/Results
Moderator(s):Jeffrey A. Geller, MD, New York, NY
Geoffrey H. Westrich, MD, New York, NY
10:30 AM
PAPER: 661
Recent National Trends and Outcomes for Unilateral and
Bilateral Total Knee Arthroplasty in the United States
Vincent M. Moretti, MD, Berwyn, IL
Alexander C. Gordon, MD, Prospect Heights, IL
Bilateral TKA is becoming less popular in the United States. Its use
is associated with longer hospital stays, more blood transfusions,
more pulmonary embolism, and more rehabilitation requirements.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
187
Friday, March 14
10:54 AM
PAPER: 664
Five-year Prospective Longitudinal Study of Activity Levels After
TKA Stratified by Demographic Comorbid Factors
Michael A. Mont, MD, Baltimore, MD
Robert Pivec, MD, Baltimore, MD
Kimona Issa, MD, Baltimore, MD
Samik Banerjee, MBBS, MS, Baltimore, MD
Kirby Hitt, MD, Temple, TX
Steven F. Harwin, MD, New York, NY
Kenneth A. Greene, MD, Akron, OH
Kristin Given, MS, Mahwah, NJ
Mark A. Kester, PhD, Mahwah, NJ
Activity levels significantly drop relative to pre-op levels at <3
months post op. Scores reach a peak at 1 year and remain stable
up to 5 years.
11:00 AM
PAPER: 665
Functional Recovery After Total Knee Arthroplasty: A
Prospective Randomized Trial Between Two Surgical
Approaches
Wayne E. Moschetti, MD, MS, Jamaica Plain, MA
Ivan M. Tomek, MD, Lebanon, NH
Stephen R. Kantor, MD, Lebanon, NH
Luanne A. Cori, BA, Enfield Center, NH
Kevin F. Spratt, PhD, Lebanon, NH
Tamara S. Morgan, MA, Lebanon, NH
Patient-reported functional outcomes in the first 8 weeks after
total knee arthroplasty: A randomized, blinded trial comparing
a quadriceps-sparing subvastus versus medial parapatellar
approach.
PAPER: 666
11:06 AM
The Effect of Total Knee Arthroplasty on Pain and Function in
End Stage Knee OA: A Subscale Analysis of 55,706 Patients
Luke Jones, MRCS, Oxford, UK, United Kingdom
Derfel Williams, MBChB, MRCS, Oxford, United Kingdom
Kristina Harris, MSc, Oxford, United Kingdom
Ines Rombach, MSc, Oxford, United Kingdom
David J. Beard, MA, MSc, PhD, Oxford, United Kingdom
Andrew J. Price, FRCS, Oxford, United Kingdom
The PROMS and HES databases were used to identify the
outcome of 55.706 patients who underwent primary knee
arthroplasty and outcomes were determined in terms of pain and
function.
Discussion 6 Minutes
11:18 AM
PAPER: 667
Economic Benefit to the Society at Large of TKA in the Young
Patient: A Markov Analysis
Hany S. Bedair, MD, Boston, MA
Thomas D. Cha, MD, Boston, MA
Viktor Hansen, MD, Boston, MA
A Markov state-transition decision model was used to model the
overall average cost of TKA and non-operative treatment in a
50-year-old patient with severe knee OA.
11:24 AM
PAPER: 668
A Cost-Utility Analysis of Knee Arthroplasty Using Data from
Three National Registries
Barry Andrews, MBChB, FRCS, London, United Kingdom
Charles Anthony Willis-Owen, FRCS, MA, London,
United Kingdom
Adeel Aqil, MBChB, MRCS Ed, London, United Kingdom
Justin P. Cobb, MD, London, United Kingdom
Cost-utility analysis of UKA vs. TKA, using three national
registries, demonstrated dominance of UKA over TKA, with an
ICER of -$2010/QALY. UKA is both cheaper and more effective.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
10:36 AM
PAPER: 662
Trends in Total Knee Arthroplasty in the U.S.: Understanding the
Shift to a Younger Demographic
Jacob M. Drew, MD, Charlotte, NC
Virginia Briggs, PhD, Worcester, MA
Patricia Franklin, MD, MBA, MPH, Worcester, MA
David C. Ayers, MD, Worcester, MA
188
Educational Programs
Friday
Friday, March 14
11:30 AM
PAPER: 669
Simultaneous Bilateral Knee Arthroplasty in Octogenarians: A
Safe and Effective Option for Selected Patients?
Catherine W. Cahill, MD, Houston, TX
Richard D. Scott, MD, Boston, MA
Ran Schwarzkopf, MD, Irvine, CA
Sumi Sinha, BS, Nashua, NH
Simultaneous bilateral knee arthroplasty for selected
octogenarians can be a safe and effective treatment option for
bilateral knee arthritis.
Discussion 6 Minutes
11:42 AM
PAPER: 670
Increased Accuracy of MRI-based Versus CT-based Patient
Specific Instrumentation in Total Knee Arthroplasty
Tilman Pfitzner, MD, Berlin, Germany
Carsten Perka, MD, Berlin, Germany
Hagen Hommel, Eggersdorf, Germany
PSI improve accuracy in component alignment. In absence of
contraindications MRI-based PSI should be favoured over CTbased PSI because of the increased accuracy.
11:48 AM
PAPER: 671
Total Knee Arthroplasty With or Without Patellar Resurfacing for
Patients with Patellofemoral Osteoarthritis
Jong-Keun Seon, MD, Hwasungun, Republic of Korea
Eun K. Song, MD, Hwasun-Gun, Republic of Korea
Hasung Kim, Hwasun, Republic of Korea
This study suggested that TKA without patellar resurfacing
is a good treatment option even in patients with high grade
osteoarthritis of the patellofemoral joint.
11:54 AM
PAPER: 672
Fifteen Year Results of All-Polyethylene Tibial Components in
Total Knee Arthroplasty
Donald L. Pomeroy, MD, Louisville, KY
Lucas J. Burton, MD, Nashville, TN
Janene A. Empson, RN, ONC, Louisville, KY
Jessica S. Olson, BS, Louisville, KY
Carla M. Baumgartner, Louisville, KY
12:06 PM
PAPER: 673
At Five Years Highly-Porous-Metal Tibial Components were
Durable and Reliable: A Randomized Trial of 389 Patients
Luis Pulido, MD, Rochester, MN
Matthew P. Abdel, MD, Eagan, MN
David G. Lewallen, MD, Rochester, MN
Michael J. Stuart, MD, Rochester, MN
Joaquin Sanchez-Sotelo, MD, Rochester, MN
Arlen D. Hanssen, MD, Rochester, MN
Mark W. Pagnano, MD, Rochester, MN
In this large RCT, highly porous metal tibias provided durable
fixation and reliable clinical outcomes at 5 years.
PAPER: 674
12:12 PM
Evaluation of Mobile Bearing TKA Using a Harmonized
Distributed Analyses of Four National Registries
Robert S. Namba, MD, Corona Del Mar, CA
Guy Cafri, PhD, La Jolla, CA
Liz Paxton, MA, San Diego, CA
Stephen Graves, MD, Adelaide, Australia
Otto Robertsson, MD, PhD, Reykjavik, Iceland
Danica Marinac-Dabic, MD, PhD, Rockville, MD
Samprit Banerjee, PhD, New York, NY
Susan Stea, BS, Bologna, Italy
Art Sedrakyan, PhD, MD, New York, NY
An advanced harmonized distributed analyses of four national
total joint registries calculated log hazard ratios. Mobile bearing
knees had a higher risk of revision with HR 1.46 ( 95% CI
1.33,1.61).
PAPER: 675
12:18 PM
Liposomal Bupivicaine: The First 1,000 Cases in a New Era
John W. Barrington, MD, Plano, TX
Roger H. Emerson Jr, MD, Dallas, TX
This prospective case-control study comparing the first 1,000
cases utilizing a novel extended-release liposomal bupivacaine to
a control group demonstrated improved overall mean VAS pain
scores.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
189
Friday, March 14
10:30 AM 12:30 PM
Room 245
Trauma V: Upper Extremity
Moderator(s):Gil Ortega, Scottsdale, AZ
Ivan S. Tarkin, MD, Pittsburgh, PA
10:30 AM
PAPER: 676
The Floating Flail Chest: Treating an Injury Combination of the
Flail Chest and Floating Shoulder
Brian Cunningham, MD, Phoenix, AZ
Gilbert R. Ortega, MD, Scottsdale, AZ
Anthony S. Rhorer, MD, Scottsdale, AZ
Ryan McLemore, PhD, Phoenix, AZ
Kelly Jackson, NP, Scottsdale, AZ
Operative treatment of the floating shoulder helps improve
outcomes in patients with a floating flail chest and may decrease
hospital length of stay and home oxygen requirements.
10:36 AM
PAPER: 677
The Rising Incidence of Operative Fixation of Acute Mid-shaft
Clavicle Fractures
Alan J. Micev, MD, Chicago, IL
Derek Hsu, BA, Chicago, IL
Sara L. Edwards, MD, Chicago, IL
Guido Marra, MD, Chicago, IL
Matthew D. Saltzman, MD, Chicago, IL
The purpose of this study is to evaluate whether the incidence of
operative treatment of mid-shaft clavicle fractures has increased
in recent years.
PAPER: 678
10:42 AM
Re-operation Following Open Reduction Internal Fixation of
Midshaft Clavicle Fractures in ON, Canada
Timothy S. Leroux, MD, Toronto, ON, Canada
David Wasserstein, MD, MSc, North York, ON, Canada
Patrick Henry, MD, Portland, ME
Amir Khoshbin, MD, Toronto, ON, Canada
Tim Dwyer, MBBS, Toronto, ON, Canada
Darrell J. Ogilvie-Harris, MD, Toronto, ON, Canada
Nizar Mahomed, MD, Toronto, ON, Canada
Christian Veillette, MD, Toronto, ON, Canada
Re-operation following open reduction internal fixation of
midshaft clavicle fractures in Ontario Canada.
11:18 AM
PAPER: 682
Results of Humeral Shaft Fracture Treatment in 296 Patients
Edward Westrick, MD, New Castle, PA
Benjamin Hamilton, MS, Cleveland Heights, OH
M. Bradford Henley, MD, MBA, Seattle, WA
Reza Firoozabadi, MD, Seattle, WA
This study of humeral shaft fractures demonstrates a higher
nerve palsy rate for operative and non-operative treatment, and
a higher nonunion rate for non-operative management than
previously reported.
Discussion 6 Minutes
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
10:54 AM
PAPER: 679
Comparison Study of Different Approach for Proximal Humeral
Fractures
Jinmyoung Dan, MD, Kyeung-Buk
Seung-Hee Kim, Gumisi
Yoon Seok Lee, Gumi
Byoung-Gook Kim, Gumi
PAPER PRESENTATION
190
Educational Programs
Friday
Friday, March 14
11:24 AM
PAPER: 683
Iatrogenic Radial Nerve Injury during Open Reduction Internal
Fixation (ORIF) of Humeral Shaft Fractures
Thomas LaPorta, MD, New Hyde Park, NY
Ariel Goldman, MD, Roslyn Heights, NY
Sara Merwin, MPH, New Hyde Park, NY
Myriam Kline, PhD, Manhasset, NY
Our study is a review of local data of humeral shaft fractures
following ORIF to quantify, describe and analyze factors that
may contribute to iatrogenic nerve palsies sustained during the
procedure.
11:30 AM
PAPER: 684
Comparison of Nonsurgical and Surgical Treatment in Humeral
Shaft Fractures: Our Experience
Antonio Vadala, MD, Rome, Italy
Andrea Gatti, MD, Rome, Italy
Pierluigi Serlorenzi, MD, Rome, Italy
Alessandro Maria Agr, MD, Rome, Italy
Carlo Iorio, MD
Angelo De Carli, MD, Rome, Italy
Andrea Ferretti, MD, Rome, Italy
Comparison Of Nonsurgical And Surgical Treatment In Humeral
Shaft Fractures: Our Experience.
Discussion 6 Minutes
11:54 AM
PAPER: 687
Open Fractures of the Proximal Ulna Have Similar Injury
Patterns and Outcomes as Closed Fractures
Paul H. Yi, BA, Chicago, IL
Sangmin R. Shin, MD, Jamaica Plain, MA
Alexander Weening, MD, Amsterdam, Netherlands
Paul Tornetta III, MD, Boston, MA
David C. Ring, MD, Boston, MA
Andrew Jawa, MD, Cambridge, MA
Open fractures of the proximal ulna present with similar injury
patterns and have similar final outcomes and postoperative
complication rates as closed fractures.
Discussion 6 Minutes
12:06 PM
PAPER: 688
Salvage of Upper Extremities with Humeral Fracture and
Associated Brachial Artery Injury
Ebrahim Paryavi, MD, MPH, Baltimore, MD
Raymond A. Pensy, MD, Brinklow, MD
Thomas F. Higgins, MD, Salt Lake City, UT
W. Andrew Eglseder, MD, Baltimore, MD
Salvage of the upper extremity with humeral fracture and
associated brachial artery injury is not dependent on type of
fixation or time to reperfusion. Flap coverage is correlated with
amputation.
11:42 AM
PAPER: 685
Outcomes after Plating of Olecranon Fractures: A Multicenter
Evaluation
Anthony De Giacomo, MD, Boston, MA
Paul Tornetta III, MD, Boston, MA
Brent J. Sinicrope, MD, Louisville, KY
Patrick Cronin, Boston, MA
Peter L. Althausen, MD, Reno, NV
Timothy J. Bray, MD, Reno, NV
Michael S. Kain, MD, Burlington, MA
Andrew J. Marcantonio, DO, Wellesley, MA
Henry C. Sagi, MD, Tampa, FL
12:12 PM
PAPER: 689
A Comparison of Health Outcomes of Upper Limb Combat
Amputees and Non-Amputees with Serious Upper Extremity
Injuries
Ted Melcer, San Diego, CA
Jay Walker, BA, San Diego, CA
Vernon F. Sechriest, MD, San Diego, CA
Michael R. Galarneau, MS, San Diego, CA
PAPER: 690
12:18 PM
Characterization and Outcomes of Upper Extremity
Amputations
David J. Tennent, MD, San Antonio, TX
Joseph C. Wenke, PhD, San Antonio, TX
Chad A. Krueger, MD, San Antonio, TX
11:48 AM
PAPER: 686
Post-operative Complications of Olecranon Fractures:
Comparing Outcomes of Various Plate Fixation
Jessica L. Traver, MD, Saint Louis, MO
Heidi Israel, PhD, RN, Saint Louis, MO
Lisa K. Cannada, MD, Saint Louis, MO
J. Tracy Watson, MD, Saint Louis, MO
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
191
Friday, March 14
10:30 AM 12:30 PM
Room 265
Spine V: Spine Trauma
Moderator(s):Patrick J. Cahill, MD, Philadelphia, PA
Theodore J. Choma, MD, Columbia, MO
10:30 AM
PAPER: 691
National Trends in the Surgical Management of Pediatric
Cervical Spine Trauma
Samuel K. Cho, MD, Palisades Park, NJ
The rate of cervical spine surgery for trauma in the pediatric
population has reMEd steady over the past decade. The majority
of cases were caused by motor vehicle accidents.
10:36 AM
PAPER: 692
Blunt Cerebrovascular Injury in Cervical Spine Fractures - Are
More Liberal Screening Criteria Warranted?
Ryan Robertson, MD, Columbia, SC
Gregory Grabowski, MD, Columbia, SC
Cervical spine injuries meeting Biffl criteria have a higher
incidence of BCVI(19%) but a significant incidence of 11% also
exists with non-Biffl fractures meaning more liberal screening
may be needed.
PAPER: 693
10:42 AM
Osteoporosis in Acute Fractures of the Cervical Spine: The Role
of Opportunistic Computed Tomography Screening
Osa Emohare, MBBS, PhD, Saint Paul, MN
Amanda Cagan, BA, Saint Paul, MN
Alison J. Dittmer, BA, Plymouth, MN
Martin Asis, MD, Minneapolis, MN
Julie A. Switzer, MD, Saint Paul, MN
David W. Polly Jr, MD, Minneapolis, MN
It is now possible to diagnose osteoporosis using incidental
abdominal CT scans; applying this approach to fractures of the
cervical spine demonstrates levels of osteoporosis in patients over
65.
Discussion 6 Minutes
10:54 AM
PAPER: 694
Questioning the Need for Extensive Instrumentation in Thoracic
Fractures: A Biomechanical Analysis
Robert F. McLain, MD, Cleveland, OH
Tiffany G. Perry, Shaker Heights, OH
Mageswaran Prasath, PhD, Cleveland, OH
Robb Colbrunn, PhD, Cleveland, OH
Tara F. Bonner, BS, MSc, Cleveland, OH
Thomas E. Mroz, MD, Cleveland, OH
11:18 AM
PAPER: 697
Assessment of the Rapid Increase in Incidence and Cost of
Treating C2 Fractures in the United States from 2000-2010
Alan H. Daniels, MD, Providence, RI
Sean Esmende, MD, Providence, RI
Melanie Arthur, PhD, Fairbanks, AK
Hari Vigneswaran, BS, Providence, RI
Mark A. Palumbo, MD, Providence, RI
The incidence and cost of treating C2 fractures has increased
dramatically from 2000 to 2010. The estimated yearly cost of
inpatient care for C2 fractures was over 1.6 billion US dollars in
2010.
11:24 AM
PAPER: 698
How Often are Interfacility Transfers of Spine Injury Patients
Truly Necessary?
Jesse E. Bible, MD, MHS, Nashville, TN
Rishin Kadakia, Nashville, TN
Harrison F. Kay, BS, Nashville, TN
Chi Zhang, BA, Nashville, TN
Geoffrey E. Casimir, BS, Nashville, TN
Clinton J. Devin, MD, Nashville, TN
There is an overutilization of interfacility transfers of spine
injuries that can easily be treated with and without an orthotic
device and appropriate outpatient follow-up.
An alphabetical faculty financial disclosure list can be found starting on page 312.
PAPER: 696
Friday
11:00 AM
PAPER: 695
Burst C2 Fractures Combined with Traumatic Spondylolisthesis:
Single-Session Single-Incision Approach
Yasser M. Assaghir, MD, Naser City, Egypt
PAPER PRESENTATION
192
Educational Programs
Friday
Friday, March 14
11:30 AM
PAPER: 699
The Relationship Between MRI Features and Neurological
Prognosis in Patients with Cervical Spinal Cord Injury
Akinobu Matsushita, MD, Fukuoka, Japan
Takeshi Maeda, Iizuka, Japan
Eiji Mori, MD, Fukuoka, Japan
Itaru Yugue, MD, Iizuka Fukuoka, Japan
Osamu Kawano, MD
Tsuneaki Takao, MD, Iizuka, Japan
Hiroaki Sakai, MD
Keiichiro Shiba, MD, Iizuka, Japan
12:06 PM
PAPER: 703
Does Spinal Canal Stenosis Affect the Neurological Outcomes
after Spinal Cord Injury without Major Bony Injury?
Tsuneaki Takao, MD, Iizuka, Japan
Yuichiro Morishita, MD, PhD, Iizuka, Japan
Takeshi Maeda, Iizuka, Japan
Eiji Mori, MD, Fukuoka, Japan
Itaru Yugue, MD, Iizuka Fukuoka, Japan
Osamu Kawano, MD
Hiroaki Sakai, MD
Keiichiro Shiba, MD, Iizuka, Japan
Discussion 6 Minutes
11:42 AM
PAPER: 700
Nonfusion Method in Thoracolumbar and Lumbar Spinal
Fractures
Yong-Min Kim, MD, Cheongju, Republic of Korea
Dong-Soo Kim, MD, Cheongju, Republic of Korea
Hyun-Chul Shon, MD, Cheongju, Republic of Korea
Kyoung Jin Park, MD, Cheongju, Republic of Korea
Byung-Ki Cho, MD, Cheong-Ju, Republic of Korea
Eun M. Lee, MD, Cheongju, Republic of Korea
Nonfusion Method in Thoracolumbar and Lumbar Spinal Fractures.
11:48 AM
PAPER: 701
The Provocative Radiographic Traction Test for Diagnosing
Occipito-cervical Dissociation
Zachary A. Child, MD, Albuquerque, NM
Carlo Bellabarba, MD, Seattle, WA
Michael J. Lee, MD, Seattle, WA
Richard J. Bransford, MD, Seattle, WA
Randal P. Ching, Seattle, WA
Jens R. Chapman, MD, Seattle, WA
Daniel Rau, MD, Berlin, Germany
A cadaveric biomechanical study was performed to better define
the test in equivocal cases of occipito-cervical instability.
PAPER: 704
12:12 PM
Evaluation of Spinal Cord Motion in Patients with Abnormal
Sagittal Cervical Alignment Using Kinetic MRI
Chengjie Xiong JR, Chongqing, China
Michael D. Daubs, MD, Las Vegas, NV
Akinobu Suzuki, MD, PhD, Osaka, Japan
Bayan Aghdasi, MD, Clovis, CA
Trevor Scott, MD, Santa Monica, CA
Kevin Phan, BS, Irvine, CA
Monchai Ruangchainikom, MD, Bangkok, Thailand
Jeffrey C. Wang, MD, Sherman Oaks, CA
With kyphotic sagittal cervical alignment there is paradoxical
motion of the spinal cord with increased anterior translation in
flexion at the C5-6 level.
PAPER: 705
12:18 PM
Comparing the Osteogenic Potential of Mesenchymal Stem Cells
Isolated from Multiple Lumbar Fusion Bone Graft Sites
Sarina Sinclair, PhD, Salt Lake City, UT
Darrel S. Brodke, MD, Salt Lake City, UT
Brandon D. Lawrence, MD, Salt Lake Cty, UT
This work aimed to isolate and compare the osteogenic potential,
cellular and growth factors, of mesenchymal stem cells from
multiple lumbar fusion bone graft sites.
Discussion 6 Minutes
PAPER: 702
11:54 AM
Comparison of Methods of Halo Vest Application: A
Biomechanical Study
Mark L. Prasarn, MD, Bellaire, TX
Caleb J. Behrend, MD, Roanoke, VA
MaryBeth Horodyski, EdD, ATC, LAT, Gainesville, FL
Bryan P. Conrad, Gainesville, FL
Glenn R. Rechtine II, MD, Pinellas Park, FL
We propose a new method for application of the halo vest that
results in less motion at an unstable upper cervical spine injury,
possibly resulting in improved protection of the spinal cord.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
193
Friday, March 14
10:30 AM 12:30 PM
Room 345
Foot and Ankle IV: Arthritis in Ankles
Moderator(s):Michael S. Aronow, MD, West Hartford, CT
David I. Pedowitz, MD, Penn Valley, PA
10:30 AM
PAPER: 706
Long-Term Clinical and Functional Outcomes Following Bilateral
Ankle Arthrodesis
Matthew Houdek, MD, Rochester, MN
Benjamin Wilke, MD, Rochester, MN
Daniel B. Ryssman, MD, Rochester, MN
Norman S. Turner III, MD, Rochester, MN
Bilateral ankle arthrodesis provides patients with a reliable
treatment for bilateral end-stage ankle arthritis with good clinical
and functional outcomes.
10:36 AM
PAPER: 707
Arthrodesis is Preferred to Re-Arthroplasty after a Failed Ankle
Prosthesis - The Swedish Ankle Register
Ilka Kamrad, MD, Malmo, Sweden
Bjorn Rosengren, MD, PhD, Malmo, Sweden
Anders S. Henricson, MD, Falun, Sweden
Hakan Magnusson, Malmo, Sweden
Jan-Ake Nilsson, BSc, Malmo, Sweden
Magnus Karlsson, MD, Malmo, Sweden
Ake S. Carlsson, MD, PhD, Malmo, Sweden
Since exchanging failed ankle prostheses resulted in a new
revision rate of 56 % and since the outcome was similar to
secondary fusion we question the value of exchanging a failed
ankle prosthesis.
PAPER: 708
10:42 AM
Outcomes of Tibiotalocalcaneal/Pantalar Fusion versus Total
Ankle Replacement with Subtalar Fusion
Maryse Bouchard, MD, FRCSC, Seattle, WA
Mara Jones, MD, Toronto, ON, Canada
Syndie Singer, MD, Vaughan, ON, Canada
Ellie Pinsker, Toronto, ON, Canada
Kevin J. Wing, MD, Vancouver, BC, Canada
Alastair S E. Younger, MD, Vancouver, BC, Canada
Murray J. Penner, MD, Vancouver, BC, Canada
Timothy R. Daniels, MD, FRCSC, Toronto, ON, Canada
Both total ankle replacement with subtalar fusion and
tibiotalocalcaneal/pantalar fusion significantly improve pain and
disability from ankle/hindfoot arthritis, with no difference in
complications.
Discussion 6 Minutes
10:54 AM
PAPER: 709
Salvage Arthrodesis after Failed Total Ankle Replacement vs.
Primary Ankle Arthrodesis
Stefan Rahm, MD, St. Gallen, Switzerland
Georg Klammer, MD, Zurich, Switzerland
Emanuel Benninger, Effretikon, Switzerland
Mazda Farshad, MD, Zurich, Switzerland
Fabienne A. Gerber, Zumikon, Switzerland
Norman Espinosa, MD, Zurich, Switzerland
This matched case control study shows significantly better clinical
results and less complications in primary arthrodesis compared to
salvage arthrodesis after failed total ankle replacement.
PAPER: 710
11:00 AM
Risks to the Blood Supply of the Talus after Four Methods of
Total Ankle Arthroplasty: A Cadaveric Injection Study
Joshua N. Tennant, MD, Chapel Hill, NC
Chamnanni Rungprai, MD, Iowa City, IA
Marc Pizzimenti, PhD, Iowa City, IA
Jessica Goetz, PhD, Iowa City, IA
Phinit Phisitkul, MD, Iowa City, IA
John E. Femino, MD, Iowa City, IA
Annunziato Amendola, MD, Iowa City, IA
The extraosseous talar blood supply is assessed in relation to
surgical resection for 4 current TAA methods. CT scan and
non-dissection debridement were used. Risks exist for all implant
systems.
PAPER: 711
11:06 AM
Variations in Talar Morphology Affect Implant Fit in Total Ankle
Arthroplasty
Christopher E. Talbot, MS, Biddeford, ME
Shana N. Miskovsky, MD, Shaker Heights, OH
Brian Schmotzer, Cleveland, OH
Using measured trochlear aspect ratios from osseous specimens,
models of talar implant fit revealed that, in cases with proper
anterior fit, an average of 50% did not fit with respect to length.
Discussion 6 Minutes
11:18 AM
PAPER: 712
Subtalar Articular Facet Involvement during Intramedullary
Guidance of Total Ankle Arthroplasty
Shyler L. DeMill, DO, Yakima, WA
Jaymes Granata, MD, Lewis Center, OH
Jeffrey E. McAlister, DPM, Westerville, OH
Gregory C. Berlet, MD, Westerville, OH
Christopher Hyer, DPM, Westerville, OH
The purpose of this cadaveric anatomic evaluation was to
quantify the frequency and amount of posterior subtalar facet
joint involvement during intrameduallary guidance to the tibial
canal and evalualuate the relational anatomy.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
PAPER PRESENTATION
194
Educational Programs
Friday
Friday, March 14
11:24 AM
PAPER: 713
Short to Mid-term Clinical Evaluation of a Cementless Fixed
Bearing Total Ankle Prosthesis
Scott Nodzo, MD, Buffalo, NY
Michael Miladore, MD, Buffalo, NY
Nathan B. Kaplan, MD, Rochester, NY
Christopher Ritter, MD, Buffalo, NY
11:54 AM
PAPER: 717
Bony Contact of a Straight versus a Curved Tibiotalocalcaneal
Arthrodesis Intramedullary Nail
Shelton A. McKenzie, MD, Silver Spring, MD
Domingo Molina IV, MS, Dickinson, TX
Randal Morris, Galveston, TX
Vinod K. Panchbhavi, MD, FACS, Galveston, TX
11:30 AM
PAPER: 714
Total Ankle Replacement - A Population-based Study on 714
Cases from the Finnish Arthroplasty Register
Eerik T. Skytta, MD, PhD, Tampere, Finland
Holger Kneer, MD, Tampere, Finland
Pirjo Honkanen, MD, Ylojarvo, Finland
Antti Eskelinen, MD, PhD, Tampere, Finland
Ville M. Remes, MD, Helsinki, Finland
10-year survival of total ankle replacements was 77%, and
selected prosthesis,patients age, sex and diagnosis had no effect
on survival.
Discussion 6 Minutes
11:42 AM
PAPER: 715
Outcomes after Total Ankle Replacement in Association with
Ipsilateral Hindfoot Arthrodesis
John S. Lewis Jr, MD, Durham, NC
Samuel B. Adams Jr, MD, Durham, NC
Robin M. Queen, PhD, Durham, NC
James K. DeOrio, MD, Durham, NC
James A. Nunley II, MD, Durham, NC
Mark E. Easley, MD, Durham, NC
Total ankle replacement (TAR) performed with ipsilateral
hindfoot arthrodesis results in significant improvements in pain
and functional status, but outcome may be inferior to that of
isolated TAR.
11:48 AM
PAPER: 716
Clinical Performance and Minimal Clinically Important
Difference in the Ankle Osteoarthritis Scale
Marcus P. Coe, MD, Enfield, NH
Jason M. Sutherland, PhD, Vancouver, BC, Canada
Murray J. Penner, MD, Vancouver, BC, Canada
Alastair S E. Younger, MD, Vancouver, BC, Canada
Kevin J. Wing, MD, Vancouver, BC, Canada
Preoperative AOS and comorbidities affected improvement in the
AOS after surgery for ankle arthritis. Average improvement in
AOS (31.7 points) was greater than the estimated MCID of 26.1
points.
Discussion 6 Minutes
12:06 PM
PAPER: 718
Improvement in Gait Following Combined Ankle and Subtalar
Arthrodesis
Shay A. Tenenbaum, MD, Herzliya, Israel
Scott Coleman, MS, MBA, Dallas, TX
James W. Brodsky, MD, Dallas, TX
In patients with severe ankle and hindfoot arthritis, combined
ankle and subtalar arthrodesis with an intramedullary retrograde
nail produces objective improvements in quantifiable parameters
of gait.
12:12 PM
PAPER: 719
The Treatment of Osteomyelitis Following Fractures About the
Ankle: A Comparison of Two Fusion Methods
Jeffrey Moore, Califon, NJ
Manuel H. Lee, BS, Newark, NJ
Wayne S. Berberian, MD, Paramus, NJ
We compare two methods of fusion used in the treatment of
traumatic ankle fractures complicated by chronic osteomyelitis.
12:18 PM
PAPER: 720
The Impact of Obesity on the Outcome of Total Ankle
Replacement
Maryse Bouchard, MD, FRCSC, MSc, Seattle, WA
Amit Amin, FRCS, Harrow, UK, United Kingdom
Ellie Pinsker, Toronto, ON, Canada
Ryan Khan, Toronto, ON, Canada
Erisa Deda, Toronto, ON, Canada
Timothy R. Daniels, MD, FRCSC, Toronto, ON, Canada
Total ankle replacement significantly and similarly improves
pain and disability in obese and non-obese patients with ankle
arthritis, with no significant difference in complication rate.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
195
Friday, March 14
SYMPOSIUM
1:30 PM 3:30 PM
Theater C
1:30 PM 3:30 PM
Theater B
I.
II.
I.
II.
III. Pediatrics
Ken J. Noonan, MD, Madison, WI
IV. Spine
Norman B. Chutkan, MD, Augusta, GA
V.
Sports Medicine/Arthroscopy
Dean K. Matsuda, MD, Los Angeles, CA
VI. Trauma
Ivan S. Tarkin, MD, Pittsburgh, PA
VII.
Tumor/Metabolic Disease
Jeffrey S. Kneisl, MD, Charlotte, NC
VIII.
Practice Management/Rehabilitation
Thomas Malvitz, Grand Rapids, MI
IX.
X.
XI.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
SYMPOSIUM
196
Educational Programs
Friday
Friday, March 14
INSTRUCTIONAL COURSE Lecture
446
1:30 PM 3:30 PM
441
TICKET
Room
221
442
TICKET
Room
207
Room
208
218
Room
347
Room
353
IEF
Room
356
Room
276 Cover
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
197
Friday, March 14
TICKET
Room
350
Room
352
452
TICKET
Room
271
Room
260
454
TICKET
Room
226
PAPER PRESENTATION
1:30 PM 3:30 PM
LaNouvelle
Game Changers Paper Session
Moderator(s):Brian J. Cole, MD, Chicago, IL
Michael J. Stuart, MD, Rochester, MN
1:30 PM
PAPER: 002
Allogenic Blood Transfusion in Total Hip Arthroplasty: Results
from the Nationwide Inpatient Sample, 2000-2009
Anas Saleh, MD, Beachwood, OH
Travis Small, DO, Meadville, PA
Aiswarya Lekshmi Pillai Chandran Pillai, MD, MS,
Cleveland, OH
Nicholas K. Schiltz, BS, Cleveland, OH
Alison K. Klika, MS, Cleveland, OH
Wael K. Barsoum, MD, Cleveland, OH
Allogenic blood transfusion after total hip arthroplasty has a
considerable burden on patients and healthcare institutions,
increasing length of stay, admission costs, and acute
complications.
1:36 PM
PAPER: 545
Factors Affecting Readmission Rates Following Primary Total
Hip Arthroplasty
Rachel E. Mednick, MD, Chicago, IL
Hasham M. Alvi, MD, Chicago, IL
Hasham M. Alvi, MD, Chicago, IL
Varun Krishnan, BA, Chicago, IL
Francis Lovecchio, BA, Chicago, IL
David W. Manning, MD, Chicago, IL
The risk of readmission following total hip arthroplasty is
increased in patients with a BMI>40, a history of chronic steroid
use, and in patients with a low preoperative serum albumin.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
450
198
Educational Programs
Friday
Friday, March 14
1:42 PM
PAPER: 191
Autologous Adipose Tissue derived Mesenchymal Stem Cells for
the Treatment of Osteoarthritis of the Knee
Chris H. Jo, MD, Seoul, Republic of Korea
Lee Young-Gil, Chunbuk Kunsan, Republic of Korea
Won Hyoung Shin, Seoul, Republic of Korea
Ji Sun Shin, BS, Seoul, Republic of Korea
Hyang Kim, PhD, Seoul, Republic of Korea
Kang Sup Yoon, MD, Seoul, Republic of Korea
The intra-articular injection of AD MSCs into the osteoarthritic
knee improved function and pain without causing adverse
events, and reduced cartilage defects by regeneration of articular
cartilage.
Discussion 6 minutes
1:54 PM
PAPER: 117
Comparison of the PROMIS Physical Function CAT with the FFI
and FAAM for Foot and Ankle Disorders
Man Hung, PhD, Salt Lake City, UT
Judith F. Baumhauer, MD, MPH, Rochester, NY
Timothy R. Daniels, MD, FRCSC, Toronto, ON, Canada
Scott Ellis, MD, New York, NY
Jeremy D. Franklin, Salt Lake City, UT
Daniel Latt, MD, PhD, Tucson, AZ
Nelson F. SooHoo, MD, Los Angeles, CA
Charles L. Saltzman, MD, Salt Lake City, UT
Kenneth Hunt, MD, Redwood City, CA
The PROMIS PF CAT is a valid tool that performed well in terms
of reliability, time for completion, and responsiveness.
2:00 PM
PAPER: 179
The Biomechanical and Histological Effect of Platelet Rich
Plasma on Rabbit Forepaw Flexor Tendon Repair
Katie Kollitz, BS, Seattle, WA
Erin M. Parsons, MS, Seattle, WA
Matt Weaver, PhD, Seattle, WA
Jerry I. Huang, MD, Seattle, WA
In contrast to other studies, platelet-rich plasma did not improve
ultimate strength or ROM in a rabbit flexor tendon model at 2, 4,
or 8 weeks. Minor histologic differences disappeared after 2 weeks.
PAPER: 576
2:06 PM
A Comparison of Ultrasound and Electrodiagnostic Testing for
the Diagnosis of Carpal Tunnel Syndrome
John R. Fowler, MD, Gibsonia, PA
Richard J. Tosti, MD, Philadelphia, PA
William C. Hagberg, MD, Wexford, PA
Joseph E. Imbriglia, MD, Wexford, PA
While US will not replace EDX in complicated cases, in a select
group of patients with a positive CTS-6, US can be used to
confirm the diagnosis of carpal tunnel syndrome.
2:18 PM
PAPER: 151
An Evaluation of the Validity of a DNA-Based Prognostic Test for
Adolescent Idiopathic Scoliosis
Benjamin D. Roye, MD, New York, NY
Margaret Wright, BS, New York, NY
Hiroko Matsumoto, MA, New York, NY
Petya Yorgova, MS, Wilmington, DE
Geraldine Neiss, PhD, Wilmington, DE
Joshua E. Hyman, MD, New York, NY
David P. Roye Jr, MD, New York, NY
Suken A. Shah, MD, Wilmington, DE
Michael G. Vitale, MD, MPH, Irvington, NY
This is the first study to independently evaluate the ability of the
Scoliscore, a DNA-based prognostic test, to stratify risk of curve
progression in patients with Adolescent Idiopathic Scoliosis.
PAPER: 138
2:24 PM
Early Results of CMS Bundled Payment Initiative for a 90-day
Total Joint Replacement Episode of Care
Richard Iorio, MD, New Rochelle, NY
James D. Slover, MD, New York, NY
Andrew J. Clair, BA, New York, NY
Joseph D. Zuckerman, MD, New York, NY
Early results from this CMS bundled payment initiative
demonstrate decreased length of stay and increased discharge
to home, with stable readmissions, suggesting significant costsavings with no loss.
PAPER: 520
2:30 PM
A Prospective Follow Up of Patients Treated Surgically or NonSurgically for Full-thickness Rotator Cuff Tears
Joel J. Gagnier, PhD, Ann Arbor, MI
Hanna Oltean, MPH, Ann Arbor, MI
Bruce S. Miller, MD, MS, Ann Arbor, MI
Our Shoulder Registry was used to compare the efficacy of
surgical versus non-surgical management of full-thickness rotator
cuff tears and to detect variables that predict success within each
group.
Discussion - 6 minutes
2:42 PM
PAPER: 216
Methods to Eliminate Postoperative Posterior Cervical Wound
Infections: No Matter what the Case
Brian J. Neuman, MD, Baltimore, MD
Kevin R. ONeill, MD, Nashville, TN
Sang D. Kim, MD, Los Angeles, CA
K. Daniel Riew, MD, Saint Louis, MO
Despite the type of posterior cervical procedure, comorbidities or
body habitus, our protocol for preparation, exposure and closure
has decreased the risk of posterior cervical wound infections.
Discussion 6 minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
199
Friday, March 14
3:06 PM
PAPER: 063
A Randomized Controlled Trial of Early vs Delayed
Weightbearing After Surgical Fixation of Unstable Ankle
Fractures
Niloofar Dehghan, MD, Toronto, ON, Canada
Richard Jenkinson, MD, Toronto, ON, Canada
Michael D. McKee, MD, Toronto, ON, Canada
Aaron Nauth, MD, Toronto, ON, Canada
Emil H. Schemitsch, MD, Toronto, ON, Canada
Jeremy Hall, MD, FRCS, Toronto, ON, Canada
David J. Stephen, MD, Toronto, ON, Canada
Hans J. Kreder, MD, Toronto, ON, Canada
There is no difference with regards to time to return to work,
however the early group has improved ankle function and health
outcome scores early on, with no increase in rate of complication/
failure.
3:12 PM
PAPER: 069
Does Ankle Syndesmosis Screw Removal Affect Patient
Outcomes? A Prospective, Randomized, Controlled Trial
Matthew J. Boyle, MD, Durham, NC
Ryan Gao, Auckland, New Zealand
Brendan Coleman, MD, Wellington, New Zealand
3:18 PM
PAPER: 826
Can All Tibial Shaft Fractures Weight Bear Following
Intramedullary Nailing? A Randomized Clinical Trial
Steven C. Gross, MD, Charlotte, NC
David P. Taormina, MS, New York, NY
David Galos, MD, New York, NY
Kenneth A. Egol, MD, New York, NY
Nirmal C. Tejwani, MD, New York, NY
This prospective randomized study was designed to examine the
potential benefits or risks associated with postoperative weightbearing versus non-weight-bearing.
Discussion 6 minutes
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 245
Adult Reconstruction Hip VII: Other/Complications
Moderator(s):Paul E. Beaule, MD, Ottawa, ON, Canada
William B. Macaulay, MD, Columbia, NY
1:30 PM
PAPER: 721
What is the Fate of Malpositioned Acetabular Components
When Evaluated in the Standing Position?
John V. Tiberi, MD, Torrance, CA
Selami Cakmak, MD, Istanbul, Turkey
Dov Goldvasser, MSc, Boston, MA
Tsung-Yuan Tsai, PhD, Boston, MA
Jing-Sheng Li, PT, MS, Boston, MA
Andrew A. Freiberg, MD, Boston, MA
Henrik Malchau, MD, Boston, MA
Harry E. Rubash, MD, Boston, MA
Young-Min Kwon, MD, PhD, Boston, MA
Nearly half of conventionally malpositioned cups were wellpositioned while standing. This difference in orientation may,
in part, explain why many malpositioned cups are wellfunctioning.
1:36 PM
PAPER: 722
Effect of Lumbosacral Spine on Pelvic Orientation and Cup
Positioning
Morteza Meftah, MD, New York, NY
Joseph D. Lipman, MS, New York, NY
Amar S. Ranawat, MD, New York, NY
Chitranjan S. Ranawat, MD, New York, NY
There is a significant change in pelvic tilt from standing to sitting.
In the majority of patients, the functional anteversion increases
with sitting.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
2:48 PM
PAPER: 411
Three to Seven Year Outcome and Survivorship Following Hip
Arthroscopy in Dysplastic Hips
Jack G. Skendzel, MD, Woodbury, MN
Karen K. Briggs, MPH, Vail, CO
Peter Goljan, MD, Boylston, MA
Marc J. Philippon, MD, Vail, CO
200
Educational Programs
Friday
Friday, March 14
1:42 PM
PAPER: 723
Bariatric Orthopaedics: Total Hip Arthroplasty in Patients Who
are Super-obese (BMI>50 kg/m2)
Kimona Issa, MD, Baltimore, MD
Steven F. Harwin, MD, New York, NY
Arthur L. Malkani, MD, Louisville, KY
Bhaveen Kapadia, MD, Baltimore, MD
Aiman Rifai, DO, Clifton, NJ
Vincent K. McInerney, MD, New Vernon, NJ
Michael A. Mont, MD, Baltimore, MD
The clinical and patient-reported outcomes of primary total hip
arthroplasty were lower in the super-obese patients compared to
patients with normal body mass index.
Discussion 6 Minutes
1:54 PM
PAPER: 724
Weight Change after Hip and Knee Arthroplasty: Incidence,
Predictors and Effects on Clinical Outcomes
Michael P. Ast, MD, New York, NY
Matthew P. Abdel, MD, Eagan, MN
Alexandra Gorab, BS, New York, NY
Yuo-Yu Lee, MS, New York, NY
Allison Ruel, BA, New York, NY
Stephen Lyman, PhD, New York, NY
Geoffrey H. Westrich, MD, New York, NY
This series of 6900 patients demonstrates that while the
majority of patients maintain their weight after lower extremity
arthroplasty, those who lose weight demonstrate superior clinical
outcomes.
2:00 PM
PAPER: 725
Pre- and Post-Operative Weight Patterns of TJA Patients and
Characteristics Associated with Weight Change
Maria C. Inacio, MS, San Diego, CA
Donna Kritz-Silverstein, PhD, La Jolla, CA
Rema Raman, PhD, La Jolla, CA
Caroline A. Macera, PhD, San Diego, CA
Jeanne Nichols, La Jolla, CA
Richard Shaffer, PhD, San Diego, CA
Donald C. Fithian, MD, El Cajon, CA
This study describes weight changes of 30,632 patients
undergoing TJA and evaluates patient characteristics associated
with different weight patterns one year pre- and one year postTJA.
2:06 PM
PAPER: 726
Osteoarthritis and Function: Inflammation and Obesity
Simon Frostick, MD, Liverpool, United Kingdom
Amanda Williams, Research Nurse, Liverpool, United Kingdom
Haiyi Wang, Liverpool, United Kingdom
Alasdair Santini, Liverpool, United Kingdom
Viju Peter, MD, Merseyside., United Kingdom
Joanne Banks, FRCS, MB, Liverpool, United Kingdom
John Davidson, FRCS, ChB, Liverpool, United Kingdom
Margaret M. Roebuck, PhD, Liverpool, United Kingdom
Richard Jackson, Liverpool, Merseyside, United Kingdom
Reduction in inflammation following arthroplasty surgery in
lower limb patients with osteoarthritis indicates inflammatory
drivers within joint tissues contribute to systemic levels of
inflammation.
Discussion 6 Minutes
2:18 PM
PAPER: 727
Direct Anterior Hip Yields Faster Voluntary Cessation of All
Walking Aids in a Randomized Trial
J. Bohannon Mason, MD, Charlotte, NC
Michael J. Taunton, MD, Rochester, MN
Bryan D. Springer, MD, Charlotte, NC
Susan M. Odum, PhD, Charlotte, NC
In a randomized prospective trial patients undergoing total hip
arthroplasty via direct anterior approach voluntarily quit use of
all walking aids on average 12 days earlier than patients with a
mini-incision posterior approach.
2:24 PM
PAPER: 728
Risk of Stem Undersizing in Anterior Approach for Total Hip
Arthroplasty
Fabrizio Rivera, MD, Torino, Italy
Francesco Leonardi, MD, Savigliano, Italy
Andrea Evangelista, MSc, Turin, Italy
High level of difficulty of femoral surgical exposition significantly
increases risk of stem undersizing in anterior hip approach.
PAPER: 729
2:30 PM
Unsealed Holes in the Cup Risk Factor for Acetabular Osteolysis
Volker T. Otten, MD, Umea, Sweden
Sead Crnalic, MD, Umea, Sweden
Per Soderlund, Umea, Sweden
Kjell G. Nilsson, MD, Umea, Sweden
In a RCT of 4 different modes of uncemented hip cup fixation
CT analysis 15 years postop. revealed that acetabular osteolysis
typically emanates from unsealed holes. Seal cup holes or use nohole cups.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
201
Friday, March 14
3:06 PM
PAPER: 733
Assessment of Durability and Function at Minimum 35-year
Follow Up of THR in Patients 50 and Under
Lucian C. Warth, MD, Iowa City, IA
John J. Callaghan, MD, Iowa City, IA
Steve S. Liu, MD, Iowa City, IA
Alison L. Klaassen, MA, Iowa City, IA
Devon D. Goetz, MD, West Des Moines, IA
Richard C. Johnston, MD, Iowa City, IA
At minimum 35 year follow-up of Charnley cemented THR in
patients age 50 and under, 63.5% of original hips continued to
function or the patients had died with the original prosthesis in
place.
3:12 PM
PAPER: 734
Digital Tomosynthesis Effectively Confirms Biological Fixation of
Cementless Total Hip Arthoplasty
Tamon Kabata, MD, Kanazawa, Japan
Toru Maeda, MD, PhD, Kanazawa, Japan
Yoshitomo Kajino, MD, Kanazawa, Japan
Shintaro Iwai, MD, Kanazawa, Japan
Kazunari Kuroda, MD, Kanazawa-Shi, Japan
Kenji Fujita, MD, Kanazawa, Japan
Kazuhiro Hasegawa, MD, Kanazawa, Japan
Hiroyuki Tsuchiya, MD, Kanazawa, Japan
Digital tomosynthesis is more effective and safer than plain
X-rays for evaluating the biological fixation of cementless THA,
due to its high resolution, low dose exposure, and minimum
artifacts.
PAPER: 735
3:18 PM
Variations in the Trunnion Surface Topography between 11
Different Commercially Available Hip Replacement Stems
Selin Munir, Wollstonecraft, Australia
Arjuna M. Imbuldeniya, MBBS, Sydney, Australia
William L. Walter, MD, PhD, North Sydney, Australia
The quantitative analysis of the surface topography of 11
commercial trunnions.
Discussion 6 Minutes
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 265
Shoulder and Elbow VI: Shoulder Trauma and Miscellaneous
Injuries
Moderator(s):John G. Costouros, MD, San Francisco, CA
Patrick J. McMahon, MD, Pittsburgh, PA
1:30 PM
PAPER: 736
Incidence and Risk Factors for Acute Infection After Proximal
Humeral Fractures: A Multicenter Study
Davide Blonna, MD, Torino, Italy
Nicola Barbasetti Di Prun, MD, Turin, Italy
Stefano Marenco, Torino, Italy
Valter Trombetta, Mezzomerico, Italy
Bruno Battiston, MD
Enrico Bellato, MD, Torino, Italy
Alessandro Masse, MD, Orbassano, Italy
Marco Assom, MD, Rivoli-Turin, Italy
Filippo Castoldi, MD, Torino, Italy
This study suggests that washing the shoulder with chlorhexidine
gluconate and avoiding the use of first generation cephalosporin
are effective at reducing the risk for infection.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
2:42 PM
PAPER: 730
Is Hip or Knee Joint Replacement Appropriate for Patients in
their 90s?
Melissa Levering, Tampa, FL
Thomas L. Bernasek, MD, Tampa, FL
Grant E. Flammer, Tampa, FL
Christine E. Hilliard, Tampa, FL
Corey C. Engel, Tampa, FL
202
Educational Programs
Friday
Friday, March 14
1:36 PM
PAPER: 737
Early Outcomes Following Nonbridging External Fixation for
Proximal Humerus Fractures
David Kovacevic, MD, Cleveland, OH
Eric T. Ricchetti, MD, Cleveland, OH
Peter J. Evans, MD, PhD, Cleveland, OH
Early outcomes following surgical treatment of proximal humerus
fractures with a nonbridging external fixator provides reliable
pain relief, excellent motion, and negligible reoperation rates.
1:42 PM
PAPER: 738
Open Reduction and Internal Fixation Versus Hemiarthroplasty
in the Management of Proximal Humerus Fractures
Robert J. Thorsness, MD, Rochester, NY
James C. Iannuzzi, MD, MPH, Rochester, NY
Katia Noyes, PhD, MPH, Rochester, NY
Stephen L. Kates, MD, Rochester, NY
Ilya Voloshin, MD, Rochester, NY
The purpose of this study was to use a nationally representative
database to determine differences in 30-day outcomes based on
procedure choice for management of proximal humerus fractures.
Discussion 6 Minutes
1:54 PM
PAPER: 739
Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty
for the Treatment of Acute Proximal Humerus Fractures
Cyrus M. Press, MD, Alexandria, VA
Hussein A. Elkousy, MD, Houston, TX
Daniel P OConnor, PhD, Houston, TX
Gary M. Gartsman, MD, Houston, TX
Thomas B. Edwards, MD, Houston, TX
Clinical results following proximal humerus fractures treated
either with reverse shoulder arthroplasty or hemiarthroplasty
with minimum 2 years follow-up.
2:00 PM
PAPER: 740
Percutaneous Intramedullary K-wire Fixation Versus Plate
Fixation for Displaced Midshaft Clavicular Fractures
Kawakami Takeshi, MD, Osaka, Japan
Teruhisa Mihata, MD, PhD, Takatsuki, Japan
Takeshi Kawakami, Osaka, Japan
Muneaki Abe, Osaka, Japan
Chisato Watanabe, MD, PhD, Osaka, Japan
Masashi Neo, Takatsuki, Japan
Intramedullary K-wire fixation and plate fixation for displaced
midshaft clavicular fractures provided high rates of radiographic
union. Intramedullary K-wire fixation decreased time to bone
union compared with plate fixation.
2:06 PM
PAPER: 741
Biomechanical Analysis of Intramedullary vs. Superior Plate
Fixation of Transverse Midshaft Clavicle Fractures
David J. Wilson, MD, Lacey, WA
Kyong S. Min, MD, Lakewood, WA
William F. Scully III, MD, Fort Benning, GA
DeWayne L. Weaver, MD, Tacoma, WA
Josef K. Eichinger, MD, Gig Harbor, WA
Edward D. Arrington, MD, University Place, WA
Biomechanical analysis of a new intramedullary fixation device
vs. superior plate fixation using fourth generation SawBones
models tested under combined axial compression and torsion.
Discussion 6 Minutes
2:18 PM
PAPER: 742
Intra- and Inter- Observer Agreement in the Classification and
Treatment of Distal Third Clavicle Fractures
Julie Y. Bishop, MD, Columbus, OH
Grant L. Jones, MD, Columbus, OH
Brian Lewis, MD, Dayton, OH
Angela D. Pedroza, MPH, Columbus, OH
MOON Shoulder Group, BA, Nashville, TN
Our study has shown that when evaluating distal clavicle fracture
patterns on radiographs, the intra- and inter- agreement was
highest for determination of fragment stability.
2:24 PM
PAPER: 743
Correlation of Functional and Radiographic Outcomes After
Acromioclavicular Joint Reconstruction
Gregory N. Lervick, MD, Minneapolis, MN
M. Russell Giveans, PhD, Eden Prairie, MN
Kathryn Samuelson, BS, Edina, MN
Suture fixation (with or without allograft augmentation) of
grade III-V AC separations resulted in a high success rate when
measured both functionally as well as radiographically.
2:30 PM
PAPER: 744
Short-term Failure Rates after Acromioclavicular Joint
Reconstruction
Lawrence Hsu, MD, Bakersfield, CA
Hillard T. Spencer, MD, Anaheim, CA
Jeffrey F. Sodl, MD, Newport Beach, CA
Jason P. Richards, MD, Pocatello, ID
Edward Yian, MD, Newport Coast, CA
Short-term Failure Rates after Acromio-Clavicular Joint
Reconstruction: A Comparison of Anatomic and Non-Anatomic
Surgical Techniques.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
203
Friday, March 14
3:06 PM
PAPER: 748
Outcome Assessment of Long Thoracic Nerve Decompression at
the Axillary Region
Ahmed Al Mandhari, MD, Liverpool, United Kingdom
Omid Alizadehkhaiyat, MD, Liverpool, United Kingdom
Alexandros Kyriakos, MD, Liverpool, United Kingdom
Simon Frostick, MD, Liverpool, United Kingdom
3:12 PM
PAPER: 749
Pectoralis Major Transfer with its Bony Insertion Stabilizes
Scapular Winging via Enhanced Bone-Bone Healing
Eric R. Wagner, MD, Rochester, MN
Bassem T. Elhassan, MD, Rochester, MN
Transfer of the sternal head of the pectoralis major with its bony
insertion to the inferior pole of the scapula does stabilize and
restore the function to the scapula in patients with winging.
3:18 PM
PAPER: 750
Assessing Knowledge Translation in Orthopaedic Surgery Using
Time-series Analysis of Clavicle Fracture Treatment
David Wasserstein, MD, MSc, North York, ON, Canada
Timothy S. Leroux, MD, Toronto, ON, Canada
Patrick Henry, MD, Portland, ME
Michael Paterson, Toronto, ON, Canada
Michael D. McKee, MD, Toronto, ON, Canada
Bheeshma Ravi, MD, Toronto, ON, Canada
Darrell J. Ogilvie-Harris, MD, Toronto, ON, Canada
Nizar Mahomed, MD, Toronto, ON, Canada
Christian Veillette, MD, Toronto, ON, Canada
Using time-series analysis we demonstrated a statistical
association between an increase in clavicle fracture surgery that
corresponded with published high level evidence supporting that
change.
Discussion 6 Minutes
PAPER PRESENTATION
1:30 PM 3:30 PM
Room 345
Sports Medicine/Arthroscopy VI: Knee II
Moderator(s):David Diduch, MD, Charlottesville, VA
Christopher C. Kaeding, MD, Columbus, OH
1:30 PM
PAPER: 751
Tunnel Collisions During Simultaneous Anterior Cruciate
Ligament and Posterolateral Corner Reconstruction
Julio C. Gali, MD, Sorocaba, Brazil
Phelipe Cintra, Sorocaba, Brazil
Marco Almagro, Sorocaba, Brazil
Adilio Bernardes, Sorocaba, Brazil
Ildefonso Mora Neto, Votorantim, Brazil
Thiago Ferreira, Sorocaba, Brazil
Edie Caetano, Sorocaba, Brazil
Julio C. Gali, MD, Sorocaba, Brazil
Tunnel collision on anterior cruciate ligament and posterolateral
corner reconstruction can be minimized by drilling popliteus
tendon/fibular collateral ligament tunnels at 20 axial/20 coronal
angle.
Friday
2:42 PM
PAPER: 745
Suture Technique Influences the Biomechanical Integrity of
Pectoralis Major Repairs
James M. Gregory, MD, Saint Louis, MO
Emma L. Klosterman, MA, Chicago, IL
Jacqueline M. Thomas, BS, Des Plaines, IL
James E. Hammond, DO, Suffolk, VA
Deepti Gupta, MD, Chicago, IL
Elizabeth Shewman, MS, Chicago, IL
Vincent Wang, Chicago, IL
Nikhil N. Verma, MD, Chicago, IL
Anthony A. Romeo, MD, Chicago, IL
204
Educational Programs
Friday
Friday, March 14
1:36 PM
PAPER: 752
Adolescent Anterior Cruciate Ligament Reconstruction:
Autograft versus Allograft
Michael T. Busch, MD, Atlanta, GA
Mackenzie M. Herzog, BA, Atlanta, GA
Keith May, ATC, DPT, Atlanta, GA
Will Mansour, BS, Lagrange, GA
Jonathan C. Riboh, MD, Durham, NC
Melissa Leake, MS, ATC, Atlanta, GA
Meagan M. Fernandez, DO, Hummelstown, PA
Samuel C. Willimon, MD, Atlanta, GA
The purpose of this study was to compare failure rates and
clinical outcomes following ACL reconstruction using hamstring
tendon autograft compared to posterior tibialis tendon allograft.
PAPER: 753
1:42 PM
Risk Factors of Subsequent Operations after Primary Anterior
Cruciate Ligament Reconstruction
Rick P. Csintalan, MD, Irvine, CA
Maria C. Inacio, MS, San Diego, CA
Tadashi T. Funahashi, MD, Irvine, CA
Gregory B. Maletis, MD, Baldwin Park, CA
Overall short-term re-operation rates after ACLR are relatively
low. Risk factors for subsequent surgery vary depending on the
type of surgery evaluated. Some of the risk factors observed for
re-operations.
Discussion 6 Minutes
1:54 PM
PAPER: 754
The Association between Cruciate Ligament Injury and
Development of Post-traumatic Osteoarthritis
Richard Nordenvall, MD, Stockholm, Sweden
Shahram Bahmanyar, PhD, MD, Stockholm, Sweden
Johanna Adami, Stockholm, Sweden
Ville Mattila, Stockholm, Sweden
Li Fellander-Tsai, MD, Stockholm, Sweden
The association between Cruciate Ligament injury and
development of post-traumatic osteoarthritis, a population based
nationwide study in Sweden, 1987-2009.
2:00 PM
PAPER: 755
Anterior Cruciate Ligament Reconstruction with Autologous
Ruptured Tissue
Tomoyuki Matsumoto, MD., PhD, Kobe, Japan
Ryosuke Kuroda, MD, Kobe, Japan
Takehiko Matsushita, MD, Kobe, Japan
Daisuke Araki, MD, PhD, Pittsburgh, PA
Yohei Kawakami, MD, Hyogo, Japan
Koji Takayama, MD, PhD, Kobe, Japan
Yuichi Hoshino, MD, Kobe, Japan
Kouki Nagamune, PhD, Fukui, Japan
Masahiro Kurosaka, MD, Kobe, Japan
Despite of no differences found in clinical outcomes, the use of
the ruptured tissue showed the superiority in tunnel enlargement
for ACL reconstruction.
PAPER: 756
2:06 PM
Prevention Programs for Anterior Cruciate Ligament Injuries: A
Cost-Effectiveness Analysis
Eric F. Swart, MD, New York, NY
Lauren H. Redler, MD, New York, NY
Peter D. Fabricant, MD, MPH, New York, NY
Bert Mandelbaum, MD, Santa Monica, CA
Christopher S. Ahmad, MD, New York, NY
Claire Wang, MD, PhD, New York, NY
Cost effectiveness analysis of prevention and screening strategies
for ACL injuries in young athletes. Prevention is cost effective
under current protocols, while current screening strategies are
not.
Discussion 6 Minutes
2:18 PM
PAPER: 757
Value of Arthroscopic Partial Meniscectomy in Treatment of
Symptomatic Patients with Meniscal Tears and Knee OA
Elena Losina, MD, Boston, MA
A. David Paltiel, PhD, New Haven, CT
Elizabeth E. Dervan, BA, Boston, MA
Yan Dong, PhD, Boston, MA
Kurt P. Spindler, MD, Nashville, TN
Lisa A. Mandl, MD, MPH, New York, NY
Morgan H. Jones, MD, Cleveland Heights, OH
Robert J. Wright, MD, Boston, MA
Jeffrey N. Katz, MD, Brookline, MA
We estimated value of arthroscopic partial meniscectomy in
symptomatic persons with meniscal tears and knee OA and
assessed whether future reserach is warranted in this population.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
205
Friday, March 14
PAPER: 759
2:42 PM
PAPER: 760
Arthroscopic Partial Meniscectomy Versus Sham Surgery for a
Degenerative Meniscus Tear
Teppo L. Jarvinen, MD, PhD, Helsinki, Finland
Raine T. Sihvonen, MD, Tampere, Finland
Mika P. Paavola, MD, Helsinki, Finland
Antti Malmivaara, Helsinki, Finland
Ari Itala, PhD, Turku, Finland
Antti Joukainen, MD, PhD, Kuopio, Finland
Hekki T. Nurmi SR, MD, Jyvskyl, Finland
Juha Kalske, Espoo, Finland
In this controlled trial the outcomes after arthroscopic partial
meniscectomy were no better than those after a sham procedure.
2:48 PM
PAPER: 761
A
Tissue
Engineered
Load
Sharing
Scaffold
for
Meniscal
Regeneration
Brian M. Culp, MD, NB, NJ
Aaron R. Merriam, Milltown, NJ
Charles J. Gatt Jr, MD, Somerset, NJ
Michael G. Dunn, NB, NJ
This study demonstrates the feasibilty of a tissue engineered
meniscal replacement that has the potential to prevent post
mensicectomy degenerative arthritis.
2:54 PM
PAPER: 762
Gene Expression Profile of Synovial Fluid following Meniscal
Injury; Osteoarthritis Markers Found
Danica D. Vance, BS, Miami, FL
Liyong Wang, PhD, Miami, FL
Evadnie Rampersaud, PhD, Miami, FL
Bryson P. Lesniak, MD, Miami, FL
Jeffery Vance, MD, PhD, Miami, FL
Margaret A. Pericak-Vance, PhD, Miami, FL
Lee D. Kaplan, MD, Miami, FL
Gene Expression profile of synovial fluid following meniscal
injury show expresson of OA markers.
Discussion 6 Minutes
3:06 PM
PAPER: 763
Degenerative Meniscal Extrusion in the Development of OA
Knee - A Nested Case Control Study of 941 Knees. Data from OAI.
Luke Jones, MRCS, Oxford, UK, United Kingdom
Jonathan Palmer, MBBS, London, United Kingdom
Muhammad Javaid, Oxford, UK, United Kingdom
George A. Grammatopoulos, MRCS, Oxford, United Kingdom
Paul Monk, MRCS, Oxford, United Kingdom
David J. Beard, MA, MSc, Oxford, United Kingdom
Andrew J. Price, FRCS, Oxford, United Kingdom
This study examines the role of degenerative mensical extrusion
in the development of knee OA using a nested case control design
and data from the OAI.
3:12 PM
PAPER: 764
Risk of Re-injury at Two Years: A Randomized Clinical Trial
Comparing Three Graft Types for ACL Reconstruction
Nick G. Mohtadi, MD, Calgary, Canada
Denise S. Chan, MBT, MSc, Calgary, Canada
Rhamona Humphrey, Calgary, Canada
Elizabeth Oddone Paolucci, PhD, Calgary, Canada
Risk and predictive factors of graft re-injury at 2-years are
evaluated in patients with patellar tendon, quadruple-stranded
or double-bundle hamstring ACL reconstructions in this doubleblind RCT.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
2:24 PM
PAPER: 758
The Effect of Lateral Meniscal Root Injuries on the Stability of
the Anterior Cruciate Ligament Deficient Knee
Charles Vega, MD, Lake Jackson, TX
Jebran Haddad III, BS, Houston, TX
Jerry W. Alexander, Houston, TX
Jonathan Gold, BS, Houston, TX
Theodore Shybut, MD, Houston, TX
Philip C. Noble, PhD, Houston, TX
Walter R. Lowe, MD, Houston, TX
206
Educational Programs
Friday
Friday, March 14
SYMPOSIUM
3:18 PM
PAPER: 765
What is the Safe Penetration Depth for All-Inside Meniscal
Repairs?
Jeffrey Lue, MD, Plano, TX
Hugh L. Jones, Houston, TX
Jesal N. Parekh, PhD, Houston, TX
Philip C. Noble, PhD, Houston, TX
Patrick C. McCulloch, MD, Houston, TX
4:00 PM 6:00 PM
Theater B
Translational Biologics (EE)
Moderator: Matthias PG Bostrom, MD, New York, NY
Brian J. Cole, MD, MBA, Chicago, IL
Discussion 6 Minutes
SYMPOSIUM
I.
II.
III.
IV.
V.
VI.
VII.
VIII.
3:45 PM 5:45 PM
Theater C
Knee
Craig J. Della Valle, MD, Chicago, IL
II. Shoulder
Thomas (Quin) Throckmorton, MD, Germantown, TN
III.
Sports Medicine
Christopher D. Harner, MD, Pittsburgh, PA
IV. Trauma
Andrew H. Schmidt, MD, Minneapolis, MN
V. Hand
A. Lee Osterman, MD, Philadelphia, PA
Room
276
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
207
Friday, March 14
TICKET
Room
356
467
TICKET
Room
353
463
468
TICKET
Room
221
TICKET
Room
218
464
469
TICKET
Room
260
465
TICKET
Room
208
466
TICKET
Room
350
TICKET
Room
226
Room
271
Friday
462
208
Educational Programs
Friday
Friday, March 14
471
TICKET
Room
207
4:12 PM
PAPER: 768
Relationship between Years of Participation and Neurocognitive
Function among Adolescent Football Athletes
Gregory W. Stewart, MD, New Orleans, LA
Leann Myers, PhD, New Orleans, LA
Roberta Bell, Metairie, LA
Hagar T. Elgendy, BS, MS, New Orleans, LA
Jenifer Juengling, PhD, Laplace, LA
Felix H. Savoie III, MD, New Orleans, LA
Correlation between years of playing football and digit symbol
substitution does not support the hypothesis that participation in
collision sport negatively affects neurocognitive function.
Discussion 6 Minutes
4:24 PM
PAPER: 769
Arthroscopic Treatment of Anterior Ankle Impingement: A
Prospective Study of 46 Patients With Five-Year Follow Up
Stewart J. Walsh, MD, Auckland, New Zealand
Bruce C. Twaddle, FRACS, Auckland, New Zealand
Michael Rosenfeldt, MD, Parnell Auckland, New Zealand
Matthew J. Boyle, MD, Durham, NC
472
TICKET
Room
347
PAPER PRESENTATION
4:00 PM 6:00 PM
Theater A
Sports Medicine/Arthroscopy VII: Head, Foot, Miscellaneous
Moderator(s):John R. Trey Green, MD, Seattle, WA
Anil S. Ranawat, MD, New York, NY
4:00 PM
PAPER: 766
Incidence of Head and Neck Injuries in Extreme Sports
Vinay K. Sharma, Portage, MI
Juan N. Rango, BS, Belmont, MI
Alexander Connaughton, Wayland, MA
Vani J. Sabesan, MD, Kalamazoo, MI
Approximately 40,000 head and neck injuries are reported per year
due to participation in extreme sports, a greater awareness regarding
incidence and consequences of these types of injuries is needed.
4:06 PM
PAPER: 767
Early Results of Oculomotor Testing in Evaluating Sports
Concussions
Sam Akhavan, MD, Sewickley, PA
Alexander Kiderman, PhD, Pittsburgh, PA
Edward D. Snell, MD, Pittsburgh, PA
Patrick J. DeMeo, MD, Pittsburgh, PA
Kevin M. Kelly, MD, PhD, Pittsburgh, PA
Matthew R. Quigley, MD, Pittsburgh, PA
4:30 PM
PAPER: 770
Arthroscopic Treatment of Osteochondral Lesions of the Talus in
Children: A Minimum Two-year Follow Up
Tomasz T. Antkowiak, MD, MS, Van Nuys, CA
Michael J. Carlson, MD, Provo, UT
Gregory R. Applegate, MD, Van Nuys, CA
Richard D. Ferkel, MD, Van Nuys, CA
Arthroscopic treatment of symptomatic osteochondral lesions of
the talus in patients 18 and under demonstrated high functional
outcomes and satisfaction rates at a minimum of 2 years
followup.
4:36 PM
PAPER: 771
Biomechanical Comparison of Anterior Talofibular Ligament
Allograft Reconstruction to the Intact Ligament
Thomas O. Clanton, MD, Vail, CO
Nicholas A. Viens, MD, Lexington, KY
Kevin J. Campbell, BS, Vail, CO
Robert F. LaPrade, MD, PhD, Vail, CO
Coen A. Wijdicks, PhD, Vail, CO
Anatomic allograft reconstruction of the ATFL demonstrated
similar strength and stiffness to the native ligament at time zero in
a fresh-frozen cadaveric model.
Discussion 6 Minutes
Educational Programs
209
Friday, March 14
5:18 PM
PAPER: 776
Follistatin-like 3 (FSTL3) Mediates Exercise-Driven Bone
Formation
Derrick Knapik, Columbus, OH
Priyangi Perera, MSc, Round Rock, TX
Jin Nam, PhD, Riverside, CA
David C. Flanigan, MD, Columbus, OH
Sudha Agarwal, PhD, Columbus, OH
We identified a novel molecular mechano-responsive protein,
Follistatin-like 3 (FSTL3), integral for mediating exercisedependent bone formation, strengthening and remodeling.
5:24 PM
PAPER: 777
Adipose-derived Stem Cells Promote Meniscus Regeneration
Tatsuhiro Toratani, MD, Kanazawa, Japan
Junsuke Nakase, MD, Kanazawa, Japan
Masahiro Kosaka, MD, Kanazawa, Japan
Yoshinori Ohashi, MD, Kanazawa, Japan
Hiroyuki Tsuchiya, MD, Kanazawa, Japan
The results of our study suggest that in the future, allogeneic
adipose-derived stem cells may play an important role as a tool
for meniscus regeneration.
Discussion 6 Minutes
PAPER: 774
5:00 PM
Preventive Effect of Eccentric Training on Acute Hamstring
Injury in Professional Baseball
Richard A. Seagrave III, MD, Kansas City, KS
Luis Perez, MS, Kirkwood, MO
Sean McQueeney, ATC, DPT, Surprise, AZ
Vincent H. Key, MD, Kansas City, KS
E. Bruce Toby, MD, Kansas City, KS
Joshua D. Nelson, MD, Kansas City, KS
A prospective study targeting the effects of eccentric training on
acute hamstring muscle injury in professional baseball players
show eccentric training may decrease hamstring injury.
Discussion 6 Minutes
5:12 PM
PAPER: 775
Effect of Muscle Weakness and Joint Inflammation on the Onset
and Progression of Osteoarthritis in the Rabbit Knee
Christian Egloff, MD, Zurich, Switzerland
Andrew Sawatsky, MSc, Calgary, Canada
Timothy R. Leonard, Calgary, Canada
Victor Valderrabano, MD, Basel, Switzerland
David A. Hart, PhD, Calgary, Canada
Walter Herzog, Calgary, Canada
5:36 PM
PAPER: 778
Platelet-Rich Plasma is More Effective than Cortisone for Severe
Chronic Hip Burisitis
Raymond R. Monto, MD, Nantucket, MA
Platelet-rich plasma treatment for severe chronic greater
trochanteric bursitis provided more effective and durable clinical
results than cortisone injection in this prosepective randomized
study.
5:42 PM
PAPER: 779
Improving Arthroscopic Knee Surgery Residency Training Using
a Virtual Reality Simulator
W. Dilworth Cannon Jr, MD, Sausalito, CA
Donald G. Eckhoff, MD, Denver, CO
William E. Garrett Jr, MD, Bahama, NC
Robert E. Hunter, MD, Salida, CO
Howard J. Sweeney, MD, Northbrook, IL
Orthopaedic third year residents trained on a high fidelity virtual
reality arthroscopic knee simulator performed a live surgery with
significantly greater surgical skill than a control group when
subsequently performing a live surgery.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
4:48 PM
PAPER: 772
Earlier Return to Sport after Lateral Ankle Ligament Injury
Treated with Platelet-Rich Plasma
Michael Stanton, MD, Rochester, NY
Russell LaFrance, MD, Hamilton, NY
Brian D. Giordano, MD, Pittsford, NY
Ilya Voloshin, MD, Rochester, NY
John P. Goldblatt, MD, Rochester, NY
Michael D. Maloney, MD, Rochester, NY
210
Educational Programs
Friday
Friday, March 14
5:48 PM
PAPER: 780
Orthopedic eRehab - A Multiple Case Study Analysis
Jonathan J. Paul, MD, Charlotte, NC
Kasey Rolfes, ATC, Charlotte, NC
Bryan R. Herron, MD, Prince Frederick, MD
Kenneth M. Fine, MD, Rockville, MD
We propose the use of the Internet to deliver and monitor
orthopedic home exercise programs to improve orthopedic
patient outcomes and reduce health care costs.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 245
Adult Reconstruction Knee VII: Miscellaneous
Moderator(s):Thomas H. Eickmann, MD, Longmont, CO
Stephen M. Howell, MD, Sacramento, CA
4:00 PM
PAPER: 781
Radiographic and Operative Outcome for PSG Compared to
Conventional Instrumentation in TKA: A Multicenter RCT
Bert Boonen, MD, Weert, Netherlands
Walter A. van der Weegen, MD, Geldrop, Netherlands
Nanne Pieter Kort, PhD, Roosteren, Netherlands
Martijn Schotanus, Sittard-Geleen, Netherlands
Bart Kerens, MD, Sittard Geleen, Netherlands
Alignment results did not differ between PSG and conventional
instrumentation. A small reduction in operation time and blood
loss was found with the PSG system, but is unlikely of clinical
significance.
4:06 PM
PAPER: 782
No Functional Benefit after TKA Performed with Patient Specific
Instrumentation
Sebastian Parratte, MD, Marseille, France
Guillaume Blanc, Marseille, France
Matthieu Ollivier, Marseille, France
Jean-Noel A. Argenson, MD, Marseille, France
The results of this prospective randomized study showed that
patient specific instrumentation does not confer any substantial
advantage in early function after TKA.
PAPER: 783
4:12 PM
Prospective Comparison of Flexion Stabilities after TKA Using
the Measured Resection and Balanced Gap Techniques
Jong-Keun Seon, MD, Hwasungun
Eun K. Song, MD, Hwasun-Gun, Jeollanam-Do
Hasung Kim, Hwasun
4:24 PM
PAPER: 784
Barbed vs. Standard Sutures for Closure in TKA: A Multicenter
Prospective Randomized Trial
Jeremy Gililland, MD, Salt Lake Cty, UT
Lucas Anderson, MD, Salt Lake City, UT
Jacob Barney, BS, Salt Lake City, UT
Hunter Ross, BS, Salt Lake City, UT
Christopher R. Jones, MD, Durham, NC
Clint D. Barnett, MD, Belton, TX
Keith R. Berend, MD, New Albany, OH
Christopher Pelt, MD, Salt Lake City, UT
Christopher L. Peters, MD, Salt Lake City, UT
Barbed suture provides a reasonable option for closure in
TKA, as it is associated with less closure time, lower cost, and
no difference in complications, clinical outcomes, or patient
satisfaction.
4:30 PM
PAPER: 785
Application of Barbed Sutures in the Closure of Knee
Arthroplasty: A Comparative Study
Abigail Campbell, New York, NY
David A. Patrick Jr, BS, New York, NY
Barthelemy Liabaud, New York, NY
Jeffrey A. Geller, MD, New York, NY
Due to a higher risk of incision related complications, barbed
sutures for superficial closure after knee arthroplasty should be
avoided.
4:36 PM
Topical versus Intravenous Tranexamic Acid in
Total Knee Arthroplasty
Brian R. Hamlin, MD, Pittsburgh, PA
Anthony M. DiGioia III, MD, Pittsburgh, PA
Anton Y. Plakseychuk, MD, Pittsburgh, PA
Timothy J. Levison, MS, Pittsburgh, PA
PAPER: 786
4:48 PM
PAPER: 787
Weighted versus Uniform Dose of Tranexamic Acid in Total Knee
Arthroplasty: A Randomized Controlled Trial
Mark Belkin, Glenview, IL
Zachary H. Goldstein, BA, South Bend, IN
Brett R. Levine, MD, Chicago, IL
A prospective, randomized, controlled trial to evaluate the
effectiveness of a uniform versus weighted dose of tranexamic
acid in primary total knee arthroplasty.
Educational Programs
211
Friday, March 14
5:24 PM
PAPER: 792
Highly Cross-linked UHMWPE Oxidation: An Improvement Over
Conventional Gamma-sterilized?
Barbara H. Currier, MChE, Hanover, NH
John H. Currier, MS, Hanover, NH
John P. Collier, DE, Hanover, NH
Michael B. Mayor, MD, Hanover, NH
Steven D. Reinitz, BA, Hanover, NH
Rayna Levine, BA, Hanover, NH
Douglas Van Citters, PhD, Hanover, NH
Oxidation in HXL tibial inserts is a concern, given oxidationrelated loss of polyethylene toughness that led to fatigue damage
in conventional gamma-sterilized tibial inserts.
Discussion 6 Minutes
5:36 PM
PAPER: 793
The Outcome of Cross Linked and Standard Polyethylene in
Primary Total Knee Replacement
Stephen Graves, MD, Adelaide, Australia
Richard De Steiger, MD, Richmond, Australia
David Davidson, MD, University Of Adelaide, Australia
Robyn Vial, MSc, Adelaide, Australia
Ann Tomkins
Elizabeth C. Griffith, BA, Adelaide, Australia
Kara Cashman, BSc (HONS), Adelaide, Australia
Yen-Liang Liu, Adelaide, Australia
Michelle Lorimer, Adelaide, Australia
This study demonstrated a lower rate of revision for cross linked
polyethylene in primary total knee replacement, however the
midterm outcomes were prosthesis specific.
5:12 PM
PAPER: 790
Correlation of Oxidative Stress, Vitamin E and Antioxidant
Capacity in Primary Knee Osteoarthritis Patients
Sittisak Honsawek, MD, PhD, Bangkok, Thailand
Aree Tanavalee, MD, Bangkok, Thailand
Saran Tantavisut, Bangkok, Thailand
Srihatach G. Ngarmukos, MD, Bangkok, Thailand
Vinai Parkpian, MD, Bangkok, Thailand
5:42 PM
PAPER: 794
Extramedullary Guides versus Portable Navigation for Tibial
Component Alignment: A Randomized, Controlled Trial
Denis Nam, MD, Saint Louis, MO
Elizabeth Cody, MD, New York, NY
Joseph Nguyen, MPH, New York, NY
Mark P. Figgie, MD, New York, NY
David J. Mayman, MD, New York, NY
5:18 PM
PAPER: 791
Particles from Vitamin E-diffused HXL UHMWPE Induce Less
Osteolysis Compared to Virgin HXL UHMWPE Particles In Vivo
David A. Bichara, MD, Boston, MA
Erik P. Malchau, Frederiksberg, Denmark
Nanna Sillesen, MD, Boston, MA
Selami Cakmak, MD, Istanbul, Turkey
Orhun K. Muratoglu, PhD, Boston, MA
This in vivo study suggests that VE-UHMWPE particles have
reduced osteolysis potential in vivo when compared to virgin,
highly cross-linked UHMWPE in a murine calvarial bone model.
5:48 PM
PAPER: 795
No Gender Differences Exist in Posterior Condylar Offsets of the
Knee
Pramod B. Voleti, MD, Philadelphia, PA
Jason W. Stephenson, MD, Madison, WI
Paul A. Lotke, MD, Gladwyne, PA
Gwo-Chin Lee, MD, Philadelphia, PA
Using novel 3D reconstructions of MRI scans, normal male and
female knees exhibit a similar ratio of posterior condylar offset
to total condylar height at both the medial and lateral femoral
condyles.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
4:54 PM
PAPER: 788
Practical Issues for the Use of Tranexamic Acid in Total Knee
Arthroplasty: A Systematic Review
In Jun Koh, MD, Gyeonggi-Do, Republic of Korea
Tae Kyun Kim, MD, Seongnam-si, Republic of Korea
Chong Bum Chang, MD, PhD, Seongnamsi, Republic of Korea
Moon Jong Chang, MD, Seoul, Republic of Korea
Young Gon Na, Seongnam-Si, Republic of Korea
Seok Jin Kim, MD, Gyeonggi-Do, Republic of Korea
Sanghwa Eom, MD, Seongnamsi, Republic of Korea
Yeon Gwi Kang, MD, Seongnam-Si, Republic of Korea
Byung June Chung, MD, Seoul, Republic of Korea
212
Educational Programs
Friday
Friday, March 14
5:54 PM
PAPER: 827
Muscle Viability Revisited: Are We Removing Normal Muscle? A
Critical Evaluation of Dogmatic Debridement
Adam Sassoon, MD, Saint Louis, MO
John Riehl, MD, Louisville, KY
Amy Rich, MD, Orlando, FL
Joshua Langford, MD, Orlando, FL
George J. Haidukewych, MD, Orlando, FL
Gary Pearl, Orlando, FL
Kenneth J. Koval, MD, Belle Isle, FL
Surgeons are unable to predict muscle viability by assessment
of color, consistency, contractility, and capacity to bleed.
Histopathologic findings of biopsies differed from surgeon
assessment in 72%.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 265
Trauma VI: Social Responsibility
Moderator(s):Bogadi R. Prashanth, MD, Karnataka, India
Frederic Wilson, MD, Phoenix, AZ
4:00 PM
PAPER: 796
Complications and Patient Reported Outcome after Hip
Fracture - A Consecutive Annual Cohort Study of 664 Patients
Susanne Hansson, MD, Malm, Sweden
Kristina Akesson, MD, PhD, Malmo, Sweden
Olof Leonardsson, MD, Malmo, Sweden
Ola Rolfson, MD, PhD, Gothenburg, Sweden
Cecilia Rogmark, MD, PhD, Malmo, Sweden
Still poor outcome in function and HRQoL after hip fractures,
but patients satisfied, indicating low demands. Medical and
hip complications main cause for inferior PROM, and must be
avoided.
4:06 PM
PAPER: 797
Implementation of a Novel Musculoskeletal Emergency Center
Reduces Time to Care for Extremity Injuries
Kamran S. Hamid, MD, MPH, Winston-Salem, NC
Benedict U. Nwachukwu, MD, Boston, MA
Jason E. Lang, MD, Winston-Salem, NC
Ralph B. DAgostino, PhD, Winston Salem, NC
Emily Gower, PhD, Winston-Salem, NC
Zhongyu J. Li, MD, Winston-Salem, NC
Eben A. Carroll, MD, Winston Salem, NC
Gary G. Poehling, MD, Winston-Salem, NC
L A. Koman, MD, Winston-Salem, NC
A novel Musculoskeletal Emergency Center care model was
implemented at a major level 1 trauma center and demonstrated
reduced time to care in its first month of implementation.
4:12 PM
PAPER: 798
Solving the Pediatric Lower Extremity Vascular Trauma
Dilemma: Improved Care with a Vascular Trauma Protocol
Itai Gans, BS, Philadelphia, PA
Keith D. Baldwin, MD, Sicklerville, NJ
L. Scott Levin, MD, Philadelphia, PA
Michael L. Nance, MD, Philadelphia, PA
John M. Flynn, MD, Philadelphia, PA
To improve the timeliness of vascular care and better match the
skills of the practitioner to the injury, pediatric centers should
consider implementation of our lower extremity vascular protocol.
Discussion 6 Minutes
4:24 PM
PAPER: 799
The Effect of Education on Orthopaedic Surgery Residents
Ability to Evaluate a Simulated Compartment Syndrome
Michael Morris, MD, Berkley, MI
Benjamin L. Harper, MD, Grand Rapids, MI
Scott Hetzel, MS, Madison, WI
Michael B. Shaheen, MD, BS, Stanford, CA
Alan Davis, Grand Rapids, MI
Blaise A. Nemeth, Madison, WI
Matthew A. Halanski, MD, Madison, WI
Orthopaedic surgery residents make fewer technical and
measurement errors in objective analysis of a simulated
compartment syndrome after a formal didactic, and this
improvement is retained over time.
4:30 PM
PAPER: 800
Simulation Training Significantly Improves Performance in
Virtual Reality Hip Fracture Fixation
Kashif Akhtar, MBBS, MEd, FRCS, Buckinghamshire,
United Kingdom
Kapil Sugand, MBBS, London, United Kingdom
Chetan Khatri, Preston, United Kingdom
Alvin Chen, MBBS, MSc, FRCS, London, United Kingdom
Justin P. Cobb, MD, London, United Kingdom
Chinmay Gupte, PhD, FRCS, London, United Kingdom
Practising hip fracture fixation on a VR simulator results in
significant improvements in metrics of time taken, number of
guide wire insertion attempts, number of radiographs and TipApex distance.
PAPER: 801
4:36 PM
Attempted Ankle Fracture Reduction by Emergency and
Orthopaedic Doctors: Junior Versus Senior Trainees
Waseem Jerjes, MD, PhD, West Yorkshire, United Kingdom
Hiang Boon Tan, MBBS, Leeds, United Kingdom
Peter Giannoudis, MD, FRCS, MBBS, BS, Leeds, United Kingdom
Senior orthopaedic trainees are better in improving the position
of ankle fractures.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
213
Friday, March 14
5:18 PM
PAPER: 806
Implant Cost Awareness of Analogous Intramedullary and Plate
Devices Among Orthopaedic Surgeons
Abraham Kim, MD, Santa Monica, CA
Edward Ebramzadeh, PhD, Los Angeles, CA
Benjamin C. Bengs, MD, Santa Monica, CA
Orthopedic surgeons are aware of the higher cost of
intramedullary devices compared to their equivalent plate
constructs but significantly underestimate the actual cost of
intramedullary devices.
PAPER: 807
5:24 PM
A Cost Effectiveness Analysis of Fixation Options for
Intertrochanteric Hip Fractures
Eric F. Swart, MD, New York, NY
Eric C. Makhni, MD, NY City, NY
William B. Macaulay, MD, New York, NY
Melvin P. Rosenwasser, MD, New York, NY
Kevin J. Bozic, MD, MBA, San Francisco, CA
This cost effectiveness analysis of IT hip fracture fixation
options suggests that for fractures with questionable stability,
intramedullary nails may be the more cost effective strategy.
Discussion 6 Minutes
PAPER: 804
5:00 PM
Does Malnutrition in Patients Presenting with Fractures Predict
Lower Quality Measures?
Kenneth A. Egol, MD, New York, NY
James Lee, ME, New York, NY
Lorraine Hutzler, BA, New York, NY
Brandon Shulman, BA, New York, NY
Raj Karia, MPH, New York, NY
Malnourished patients treated for fractures were nearly twice
as likely to acquire some combination of infection, DVT, PE, or
other reason for readmission than those of normal nutritional
status.
Discussion 6 Minutes
5:12 PM
PAPER: 805
Can an Evidence-Based Treatment Algorithm for
Intertrochanteric Hip Fractures Maintain Quality at a Reduced
Cost?
Kenneth A. Egol, MD, New York, NY
Alejandro Marcano, MD, New York, NY
Lambert Lewis, MS, BS, Syracuse, NY
Nirmal C. Tejwani, MD, New York, NY
Toni M. McLaurin, MD, New York, NY
Roy Davidovitch, MD, New York, NY
An evidence-based algorithm for implant selection based on
the AO/OTA classification of intertrochanteric hip fractures
effectively reduced costs at our institutions while maintaining
quality of care.
5:36 PM
PAPER: 808
Sleep Disturbance Following Fracture is Related to Emotional
Well Being Rather than Functional Result
Brandon Shulman, BA, New York, NY
Frank A. Liporace, MD, Englewd Clfs, NJ
Roy Davidovitch, MD, New York, NY
Raj Karia, MPH, New York, NY
Kenneth A. Egol, MD, New York, NY
At one year follow-up from acute fracture treatment, poor sleep
was independently associated with poor emotional status, but not
associated with poor functional status.
5:42 PM
PAPER: 809
Prospective Evaluation of Posttraumatic Stress Disorder in
Injured Patients with and without Orthopaedic Injury
Alan L. Jones, MD, Dallas, TX
Ann Marie Warren, PhD, Dallas, TX
Megan C. Reynolds, MS, Dallas, TX
Michael L. Foreman, MD, MS, Dallas, TX
Kenleigh Roden-Foreman, BA, Dallas, TX
Monica Bennett, PhD, Dallas, TX
Stephanie D. Agtarap, BA, Denton, TX
Approximately one third of 282 patients had severe PTSD
symptoms at 3 and 6 months, with orthopaedic patients showing
some trend toward severity improvement.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
4:48 PM
PAPER: 802
The Relationship of Obesity to Increasing Healthcare Burden in
the Setting of Orthopedic Polytrauma
Heather L. Licht, MD, Temple, TX
John Vassaur, BA, Temple, TX
Mark Murray, Temple, TX
Daniel Jupiter, PhD, Temple, TX
Justin L. Regner, MD, Temple, TX
Christopher D. Chaput, MD, Temple, TX
214
Educational Programs
Friday
Friday, March 14
5:48 PM
PAPER: 810
Professional Demands and Stress in Orthopaedic Trauma: An
Orthopaedic Trauma Association Member Survey
Brian Cunningham, MD, Phoenix, AZ
Gilbert R. Ortega, MD, Scottsdale, AZ
Hrayr Basmajian, MD, Loma Linda, CA
Kelly Jackson, NP, Scottsdale, AZ
Orthopedic trauma surgeons across experience levels and practice
type continue to face challenges in managing stress and family
while maintaining career satisfaction.
Discussion 6 Minutes
PAPER PRESENTATION
4:00 PM 6:00 PM
Room 345
Spine VI: Lumbar/Miscellaneous II
Moderator(s):Hyun W. Bae, MD, Los Angeles, CA
Scott Boden, MD, Atlanta, GA
4:00 PM
PAPER: 811
Development of a Biomechanical Model for Sacroiliac Range of
Motion
William Camisa, MS, San Francisco, CA
Bruce I. Condez, Millbrae, CA
Jeremi M. Leasure, MS, San Francisco, CA
Jenni M. Buckley, PhD, San Francisco, CA
Christopher Ames, MD, San Francisco, CA
Dimitriy G. Kondrashov, MD, San Francisco, CA
The double leg potting technique inhibits the opening of the
pelvic ring which is important to the normal range of motion of
the SI joint.
4:06 PM
PAPER: 812
Prevalence of Myelomalacia in Cervical Spine MRIs According to
Physician Specialties
Sang D. Kim, MD, Los Angeles, CA
Yihua Zhou, MD, PhD, Saint Louis, MO
Katie Vo, Saint Louis, MO
K. Daniel Riew, MD, Saint Louis, MO
We present the largest series of MRIs evaluated for prevalence
of myelomalacia in patients who present to different physician
specialties.
4:12 PM
PAPER: 813
The Effect of Increasing Cobb Angle and Sagittal Contour on
Pulmonary Function in Adolescent Idiopathic Scoliosis
Ivana Ninkovic, MPH, MS, Minneapolis, MN
Jennifer K. Wozniczka, MD, Minneapolis, MN
Charles Gerald T. Ledonio, MD, Minneapolis, MN
David W. Polly Jr, MD, Minneapolis, MN
David J. Nuckley, PhD, Minneapolis, MN
Ben E. Rosenstein, BS, Minneapolis, MN
We wanted to define the effect of sagittal contour and Cobb angle
on thoracic volume in scoliosis patients using computer modeling
to obtain volume measurements from two-dimensional x-ray
images.
Discussion 6 Minutes
4:24 PM
PAPER: 814
Biomechanical Analysis of Lumbar Segmental Motion in Cases
of Lumbosacral Transitional Vertebrae
Hidetoshi Nojiri, MD, PhD, Tokyo, Japan
Alejandro Espinoza, PhD, Chicago, IL
Howard S. An, MD, Chicago, IL
Gunnar B. Andersson, MD, Chicago, IL
Nozomu Inoue, MD, Chicago, IL
We demonstrated an adjacent level effect in cases of lumbosacral
transitional vertebrae, tied to biomechanical hypermobility of the
segment immediately above the lumbosacral transitional vertebra.
4:30 PM
PAPER: 815
Spondylolisthesis Model: Study of Posterior Element Instability
Guy R. Fogel, MD, San Antonio, TX
Biomechanical explanation of complications in treatment of
degenerative spondylolisthesis.
4:36 PM
PAPER: 816
Kinematic Analysis of Diseased and Adjacent Segments in
Degenerative Lumbar Spondylolisthesis
Kevin Phan, BS, Irvine, CA
Michael D. Daubs, MD, Las Vegas, NV
Asher Kupperman, MD, Los Angeles, CA
Trevor Scott, MD, Santa Monica, CA
Jeffrey C. Wang, MD, Sherman Oaks, CA
There is compensatory motion at adjacent levels in patients with
unstable degenerative spondylolisthesis at L3-4 and L4-5.
Discussion 6 Minutes
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
215
Friday, March 14
5:12 PM
PAPER: 820
Cortical Screw as Rescue for Failed Lumbar Pedicle Screw
Construct: A Biomechanical Analysis
Graham Calvert, MD, Madison, MS
Amir Abtahi, MD, Salt Lake City, UT
Kent N. Bachus, PhD, Salt Lake City, UT
Brandon D. Lawrence, MD, Salt Lake Cty, UT
Darrel S. Brodke, MD, Salt Lake City, UT
5:18 PM
PAPER: 821
Efficacy of BMP2 for the Treatment of Lumbar Pseudarthrosis in
a Rodent Spine Model
Jing Li, Changsha, China
Michael D. Daubs, MD, Las Vegas, NV
Kevin Phan, BS, Irvine, CA
Tetsuo Hayashi, MD, Fukuoka, Japan
Akinobu Suzuki, MD, PhD, Osaka, Japan
Haijun Tian, MD, Shanghai, China
Trevor Scott, MD, Santa Monica, CA
Jeffrey C. Wang, MD, Sherman Oaks, CA
A higher dose of BMP2 appears to be necessary when attempting
to obtain a successful fusion with an established pseudarthrosis.
5:24 PM
PAPER: 822
Is Surgery Effective for Lumbar Stenosis and Degenerative
Spondylolisthesis in the Octogenarian Population?
Jeffrey A. Rihn, MD, Media, PA
Alan S. Hilibrand, MD, Philadelphia, PA
Wenyan Zhao, PhD, Hanover, NH
Jonathan Lurie, MD, Lebanon, NH
Alexander Vaccaro, MD, PhD, Gladwyne, PA
Todd J. Albert, MD, Philadelphia, PA
James N. Weinstein, DO, MS, Lebanon, NH
The surgical treatment of SpS and DS in patients 80 offers
significant benefit compared to nonoperative treatment with no
difference in the complication rate compared to patients <80.
Discussion 6 Minutes
5:36 PM
PAPER: 823
Ex-vivo Genetic and Signaling Studies of the Intervertebral Disc:
Methods, Modeling and Investigations
Dominic Pelle, MD, Grand Rapids, MI
Jacqueline D. Peacock, PhD, Grand Rapids, MI
Scott S. Russo, MD, Grand Rapids, MI
Kenneth Easton, MD, Ada, MI
Matthew R. Steensma, MD, Byron Center, MI
We have developed a novel ex-vivo organ culture model of intact
murine intervertebral discs (IVD) and optimized ex-vivo genetic
recombination to investigate mechanisms of degenerative disc
disease.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Friday
4:48 PM
PAPER: 817
Impact of Lumbar Fusion on Healthcare Resource Utilization
Curtis Mina, MD, Louisville, KY
Leah Y. Carreon, MD, Louisville, KY
Steven D. Glassman, MD, Louisville, KY
216
Educational Programs
Friday
Friday, March 14
5:42 PM
PAPER: 824
The Effect of Aging on Healing of Posterolateral Lumbar Fusion
in a Rodent Model Using BMP2
Michael D. Daubs, MD, Las Vegas, NV
Tetsuo Hayashi, MD, Fukuoka, Japan
Akinobu Suzuki, MD, PhD, Osaka, Japan
Kevin Phan, BS, Irvine, CA
Haijun Tian, MD, Shanghai, China
Trevor Scott, MD, Santa Monica, CA
Kunal Sukhija, Los Angeles, CA
Bryan A. Bean, BS, Los Angeles, CA
Jeffrey C. Wang, MD, Sherman Oaks, CA
Age delays fusion healing time when utilizing BMP2 in a rodent
model.
PAPER: 825
5:48 PM
Insulin-mimetic
Local
Therapeutic
Adjuncts
for
Enhancing
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Video and Multimedia Award Programs and Selections
Video and multimedia programs are identified by viewing station
number. Stations are grouped by area of anatomy. Program
offerings will change on Thursday. Self-Service Stations are
available near the Feature Presentation Theater.
217
Award Programs
Stations 1-8
Stations 9-12
Station 13
Stations 14-15
Pediatrics
Station 16
Stations 17-22
Spine
Station 23
Stations 24-35
OVT34...................................................................... Station 4
Open Latarjet with Modified Bankart Repair in Collision
Athletes
Trauma
Station 36
Tumors
Station 37
Academy Hall E
March 11-14
The Featured Presentation Theater will offer Annual Meeting
participants the opportunity to meet with authors, who will be
available to answer questions regarding their area of interest and
provide insights into their own techniques. Principal authors
will share their views on why their topic is of interest, and is
important to them and to the field of orthopaedics. You will
be able to view the program and participate in a question and
answer session.
Tuesday - Wednesday
Award Programs
OVT29 ..................................................................... Station 1
Shoulder Arthrodesis: Surgical Technique
Ryan Warth, MD, Vail, CO
Peter J. Millett, MD, MSc, Vail, CO
This surgical video demonstrates a technique for shoulder
arthrodesis using modern fixation methods and implants.
(Product no. V14001, DVD-Video, 11 mins.)
218
Educational Programs
OVT15...................................................................... Station 7
Ultrasound-guided Plantar Fascia Release: A New
Ultraminimally Invasive Surgical Technique
OVT68...................................................................... Station 8
A Surgical Technique for Medial Patellofemoral Ligament
Reconstruction in the Skeletally Immature
Henry B. Ellis Jr, MD, Dallas, TX
Philip L. Wilson, MD, Dallas, TX
This is a technical description with short-term outcomes
following anatomic reconstruction of the medial patellofemoral
ligament in skeletally immature patients with patellar instability.
(Product no. V14008, DVD-Video, 11 mins.)
Tuesday - Wednesday
ADULT RECONSTRUCTION HIP
OVT01 ..................................................................... Station 9
A Simple Method to Perform the Real Acetabulum in
Chronic Dislocated Hips
Nicolas Restrepo Giraldo, MD, Pasto, Colombia
This video shows a reproducible and easy technique to find and
prepare the acetabulum in Crowe III or IV dysplastic hips.
(Product no. V14009, DVD-Video, 14 mins.)
OVT03.................................................................... Station 11
Behavior of the Ultra-Short Anatomic Cementless Femoral
Stem in Young and Elderly Patients
Young-Hoo Kim, MD, Seoul, Korea, Republic of
An ultra-short, anatomic cementless stem in 100 younger patients
(43.9 mean years) and 100 elderly patients (78.9 mean years)
provided stable fixation without diaphyseal fixation at 7.6-year
follow-up.
(Product no. V14011, DVD-Video, 10 mins.)
Tuesday - Wednesday
ADULT RECONSTRUCTION KNEE
OVT10 ................................................................... Station 13
Balancing a Total Knee Arthroplasty with a Navigation
System
Jean-yves Jenny, MD, Illkirch, France
The navigation system used provides a virtual simulation of knee
reconstruction during TKR and allows choosing the best fitted
procedure between measured resections and ligament balancing.
of the bone for a revision knee replacement.
(Product no. V14017, DVD-Video, 14 mins.)
Tuesday - Wednesday
FOOT AND ANKLE
OVT13.................................................................... Station 14
Endoscopic Gastrocnemius Recession
Phinit Phisitkul, MD, Iowa City, IA
Chamnanni Rungprai, MD, Iowa City, IA
Annunziato Amendola, MD, Iowa City, IA
This video presents indications, contraindications, surgical
technique, post-operative care, and outcomes of endoscopic
gastrocnemius recession in 278 consecutive patients at the
University of Iowa.
(Product no. V14020, DVD-Video, 6 mins.)
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
219
Tuesday - Wednesday
PEDIATRICS
OVT67 ................................................................... Station 16
Open Reduction and Internal Fixation of Displaced
Pediatric Lateral Condyle Fractures of the Humerus
Tamir Bloom, MD, Newark, NJ
John Koerner, MD, Philadelphia, PA
Sanjeev Sabharwal, MD, MPH, Newark, NJ
Tuesday - Wednesday
SHOULDER AND ELBOW
OVT18 ................................................................... Station 17
Ulnar Nerve Transposition at the Elbow
Randy R. Bindra, MD, FRCS, Clarendon Hills, IL
Ryan Sullivan, MD, Chicago, IL
This video features pearls and pitfalls of anterior transposition of
the ulnar nerve that will not jeopardize vascular supply.
(Product no. V14024, DVD-Video, 16 mins.)
OVT24.................................................................... Station 21
Shoulder Hemiarthroplasty in Complex Humeral
Fractures: How to Replace Anatomy and Function
Antonio Pastrone, MD, Torino, Italy
Andrea Cimino, MD, San Mauro Torino, Italy
Michel Jean Cal, MD, Torino, Italy
Stefano Mortera, MD, Collegno, Torino, Italy
Monica Cicirello, MD, Torino, Italy
Davide Blonna, MD, Torino, Italy
Antongiulio Marmotti, MD, Torino, Italy
Filippo Castoldi, MD, Torino, Italy
This step-by-step video features the key points so surgeons can
understand the fracture and prepare for the procedure and plan
for it based on the images. By following the surgical procedure,
viewers can focus on the main aspects surgeons must handle to
attain reconstruction f the anatomy of the proximal humerus
around the prosthesis.
(Product no. V14031, DVD-Video, 13 mins.)
Tuesday - Wednesday
SPINE
OVT36 ................................................................... Station 23
Fixation of Odontoid Fractures with an Anterior Screw:
Surgical Technique
Manuel Valencia, MD, Santiago, Chile
Paulina De La Fuente, MD, Santiago, Chile
Selim Abara, MD, Santiago, Chile
Felipe Novoa, MD, Santiago, Chile
Andres Leiva, MD, Santiago, Chile
Arturo Olid, MD, Santiago, Chile
The goal of this video is to show the surgical technique of
anterior screw fixation in odontoid fractures.
(Product no. V14040, DVD-Video, 14 mins.)
An alphabetical faculty financial disclosure list can be found starting on page 312.
220
Educational Programs
Tuesday - Wednesday
SPORTS MEDICINE AND ARTHROSCOPY
OVT64.................................................................... Station 26
Simultaneous Unicondylar Osteoarticular Allograft and
High Tibial Osteotomy: Case Presentation and Technique
Guillem Gonzalez-Lomas, MD, Jersey City, NJ
Dylan Lowe, BA, New York, NY
Alan Wayne McGee Jr, MD, BS, Leo, IN
Theodore S. Wolfson, BS, New York, NY
Eric J. Strauss, MD, New York, NY
Laith M. Jazrawi, MD, Brooklyn, NY
Concomitant osteotomy and unicondylar allograft is a safe and
efficient solution that prevents patients from undergoing multiple
procedures to address multiple issues.
(Product no. V14068, DVD-Video, 10 mins.)
OVT65.................................................................... Station 27
Distal Femoral Osteotomy and Subchondroplasty: Case
Presentation and Surgical Technique
Laith M. Jazrawi, MD, Brooklyn, NY
Dylan Lowe, BA, New York, NY
Mathew Hamula, BA, BS, New York, NY
OVT33.................................................................... Station 28
Persistant Olecranon Physis in an Athlete
Matthias Vanhees, MD, Stabroek, Belgium
Frederik Verstreken, MD, Schoten, Belgium
Roger P. van Riet, MD, Wilrijk, Belgium
This video shows a technique to fix a persistent olecranon physis
that allows for immediate return to sports.
(Product no. V14039, DVD-Video, 20 mins.)
OVT40.................................................................... Station 30
Meniscal Allograft Transplantation
Salvatore Bisicchia, MD, Iowa City, IA
Federica Rosso, MD, Torino, Italy
Annunziato Amendola, MD, Iowa City, IA
Postoperative management can vary according to associated
procedures. Clinical improvement is observed in most patients
with a slow decrease in function over time. Associated procedures
should be performed as necessary. Based on a literature review,
the overall complication rate averages 21%, and the failure rate
is about 10%. There is only a slight loss of joint space in the
majority of patients.
(Product no. V13044, DVD-Video, 16 mins.)
OVT43.................................................................... Station 31
Open Subpectoral Biceps Tenodesis: Reliable Treatment
for All Biceps Tendon Pathology
Patrick Kane, MD, Philadelphia, PA
Philip Hsiao, BA, Philadelphia, PA
Bradford S. Tucker, MD, Egg Harbor Township, NJ
Kevin B. Freedman, MD, Bryn Mawr, PA
This video demonstrates the authors preferred treatment for
open subpectoral biceps tenodesis using bone tunnel and suture
fixation to manage the long head of the biceps tendon pathology.
(Product no. V14047, DVD-Video, 17 mins.)
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
OVT47.................................................................... Station 32
Arthroscopic-Assisted Core Decompression of the Femoral
Head for Osteonecrosis
Rachel M. Frank, MD, Chicago, IL
Anil Gupta, MD, MBA, Chicago, IL
Joshua Harris, MD, Chicago, IL
Frank McCormick, MD, Chicago, IL
Richard C. Mather III, MD, Durham, NC
Shane J. Nho, MD, Chicago, IL
OVT48.................................................................... Station 33
Allograft Hip Capsulolabral Spacer for the Treatment of
Capsulolabral Adhesions
Fernando Ferro, MD, Vail, CO
Marc J. Philippon, MD, Vail, CO
Jeffrey Nepple, MD, Avon, CO
Tuesday - Wednesday
TRAUMA
OVT71.................................................................... Station 36
Distal Radius Fractures Open Reduction Internal Fixation:
Case Presentation and Surgical Technique
Kenneth A. Egol, MD, New York, NY
Carlos Uquillas, MD, New York, NY
Dylan Lowe, BA, New York, NY
Mathew Hamula, BA, BS, New York, NY
Siddharth A. Mahure, BS, Sarasota, FL
This video presents the advantages of surgical fixation of distal
radius fractures over nonsurgical management, as surgery reliably
restores normal anatomy.
(Product no. V14071, DVD-Video, 7 mins.)
Tuesday - Wednesday
TUMORS
OVT49.................................................................... Station 34
A Simple Lateral Tenodesis for Severe Rotatory Instability
in ACL Deficient Knee
Fabio Conteduca, MD, Rome, Italy
Raffaele Iorio, MD, Rome, Italy
Cosma Calderaro, MD, Rome, Italy
Daniele Mazza, MD, Fiumicino, Italy
Carmelo DArrigo, MD, Rome, Italy
Andrea Ferretti, MD, Rome, Italy
OVT73.................................................................... Station 37
Chondrosarcoma of the Proximal Femur Limb-Sparing
Resection and Reconstruction with Modular Segmental
Proximal Femur Tumor Prosthesis
Peter Gold, BA, New York, NY
Adem Abrham, New York, NY
Eric Feit, BA, New York, NY
Camilo E. Villalobos, MD, New York, NY
Rodolfo A. Zamora SR, MD, New York, NY
James C. Wittig, MD, New York, NY
Radical resection and prosthetic reconstruction is a safe and
reliable method for the treatment of a nondisplaced pathological
fracture attributable to low-grade primary chondrosarcoma.
(Product no. V14073, DVD-Video, 11 mins.)
Thursday - Saturday
Award Programs
OVT50.................................................................... Station 35
Surgical Treatment of the Segonds Fracture
An alphabetical faculty financial disclosure list can be found starting on page 312.
221
222
Educational Programs
OVT34...................................................................... Station 4
Open Latarjet with Modified Bankart Repair in Collision
Athletes
Robert A. Arciero, MD, Farmington, CT
Augustus D. Mazzocca, MD, Farmington, CT
In this video, a technique for the open Latarjet coracoid transfer
procedure will be highlighted.
(Product no. V14004, DVD-Video, 19 mins.)
OVT15...................................................................... Station 7
Ultrasound-guided Plantar Fascia Release: A New
Ultraminimally Invasive Surgical Technique
Manuel Villanueva, MD, PhD, Madrid, Spain
Alvaro Iborra, DPM, Madrid, Spain
Felipe Benito Del Carmen, MD, Madrid, Spain
Angel G De La Rubia, DPM, Madrid, Spain
The authors believe that ultrasound-guided release of the plantar
fascia is safe, precise, it can be learned quickly, and it is not
necessary to be an expert on skeletal ultrasonography.
(Product no. V14007, DVD-Video, 13 mins.)
OVT68...................................................................... Station 8
A Surgical Technique for Medial Patellofemoral Ligament
Reconstruction in the Skeletally Immature
Henry B. Ellis Jr, MD, Dallas, TX
Philip L. Wilson, MD, Dallas, TX
This is a technical description with short-term outcomes
following anatomic reconstruction of the medial patellofemoral
ligament in skeletally immature patients with patellar instability.
(Product no. V14008, DVD-Video, 11 mins.)
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
223
OVT07.................................................................... Station 12
Approaches to the Hip: Minimally Invasive Direct Lateral
Total Hip Arthroplasty
Thursday - Saturday
ADULT RECONSTRUCTION HIP
OVT06 ..................................................................... Station 9
Approaches to the Hip: Minimally Invasive Direct Anterior
Total Hip Arthroplasty
OVT09.................................................................... Station 11
Partial Two-stage Exchange for Infected Total Hip
Arthroplasty
Adolph V. Lombardi Jr, MD, New Albany, OH
Timothy Ekpo, DO, Grand Blanc, MI
Keith R. Berend, MD, New Albany, OH
Michael J. Morris, MD, New Albany, OH
Joanne B. Adams, BFA, CMI, New Albany, OH
Thursday - Saturday
ADULT RECONSTRUCTION KNEE
OVT11 ................................................................... Station 13
Medial Mobile-Bearing UKA with Twin-Peg Femoral
Design and Enhanced Instrumentation
Keith R. Berend, MD, New Albany, OH
Adolph V. Lombardi Jr, MD, New Albany, OH
Jason M. Hurst, MD, New Albany, OH
Michael J. Morris, MD, New Albany, OH
Joanne B. Adams, BFA, CMI, New Albany, OH
Keri L. Satterwhite, New Albany, OH
Michael A. Sneller, BS, New Albany, OH
At 2.8-year mean follow-up, a medial mobile-bearing UKA with a
twin-peg femoral component had a lower manipulation rate and
higher Knee Society score improvement than the earlier single-peg
design.
(Product no. V14018, DVD-Video, 18 mins.)
An alphabetical faculty financial disclosure list can be found starting on page 312.
224
Educational Programs
Thursday - Saturday
FOOT AND ANKLE
OVT16.................................................................... Station 14
Peroneal Tendoscopy: An Innovative Perspective for
Peroneal Tendon Patology
Antongiulio Marmotti, MD, Torino, Italy
Margherita Germano, MD, Torino, Italy
Rainero Del Din, MD, Perosa Argentina, Italy
Filippo Castoldi, MD, Torino, Italy
Federico Dettoni, MD, Torino, Italy
Roberto Rossi, MD, Torino, Italy
Davide Blonna, MD, Torino, Italy
Davide E. Bonasia, MD, Torino, Italy
Fabrizio Trucchi, MD, Collegno, Italy
Giuseppe Peretti, MD, Milan, Italy
Peroneal tendoscopy is a minimally invasive procedure for tendon
visualization from the myotendinous junction to the peroneal
tubercle and for the treatment of early stages of different diseases.
(Product no. V14022, DVD-Video, 13 mins.)
Thursday - Saturday
Thursday - Saturday
SHOULDER AND ELBOW
OVT26.................................................................... Station 17
Total Shoulder Arthroplasty (Technical Note and Results)
Thomas W. Wright, MD, Gainesville, FL
Gonzalo Samitier Solis, MD, PhD, Annecy, France
Aimee Struk, MEd, MBA, ATC, Gainesville, FL
This is a detailed video-demonstration of the TSA surgical
technique for shoulder OA used at the University of Florida.
(Product no. V14033, DVD-Video, 16 mins.)
OVT27.................................................................... Station 18
Reconstruction of Chronic Distal Biceps Ruptures: Surgical
Anatomy and Operative Technique
Jared T. Lee, MD, Edwards, CO
Max P. Michalski, MSc, Vail, CO
Peter J. Millett, MD, MSc, Vail, CO
The surgical anatomy and technique of distal biceps tendon
reconstruction with allograft is presented through a case example.
PEDIATRICS
OVT30.................................................................... Station 20
Reverse Total Shoulder Arthoplasty: Surgical Technique
Jack Skendzel, MD, Vail, CO
Ryan Warth, MD, Vail, CO
Peter J. Millett, MD, MSc, Vail, CO
The surgical indications, technique and outcomes of reverse total
shoulder arthroplasty are presented.
(Product no. V14036, DVD-Video, 15 mins.)
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
225
OVT53.................................................................... Station 25
ACL Reconstruction in Patient with Open Physis
OVT54.................................................................... Station 26
Arthroscopic Absorbable Suture Fixation for Tibial Spine
Fractures: 24 months of Follow Up
Michele Verdano, MD, Parma, Italy
Andrea Pellegrini, MD, Rimini, Italy
Davide Aliani, MD, Parma, Italy
Enricomaria Lunini, Podenzano, Italy
Francesco Ceccarelli, MD, Parma, Italy
Repair using this arthroscopic technique provides a significant
advantage in the treatment of type III and type IV fractures of the
tibial eminence by obtaining optimal arthroscopic fixation.
Thursday - Saturday
SPINE
OVT37.................................................................... Station 23
Surgical Treatment of Spondylolisthesis by Posterolateral
Arthrodesis and Instrumentation
Antonello Montanaro, MD, Rome, Italy
Francesco Turturro, MD, Rome, Italy
Cosma Calderaro, MD, Rome, Italy
Luca Labianca, MD, Rome, Italy
Vincenzo Di Sanzo, MD, PhD, Rome, Italy
Pierpaolo Rota, MD, Rome, Italy
Alessandro Carducci, MD, Rome, Italy
Andrea Ferretti, MD, Rome, Italy
The posterolateral arthrodesis with pedicle screw fixation, and
associated laminectomy, is an effective surgical procedure to treat
spondylolisthesis with a slip below 50% (Grade I and II).
(Product no. V14041, DVD-Video, 9 mins.)
Thursday - Saturday
SPORTS MEDICINE AND ARTHROSCOPY
OVT52.................................................................... Station 24
Circumferential Rotator Cuff Repair Utilizing the N+4,
Subclavian and High Posteromedial Portals
Keith D. Nord, MD, Jackson, TN
Maher W. Khan, MD, Jackson, TN
Garth B. Wright, MD, Jackson, TN
Jonathon B. Taylor, BS, Jackson, TN
OVT55.................................................................... Station 27
Arthroscopic Preparation and Internal Fixation of an
Unstable Osteochondritis Dissecans Lesion of the Knee
Christopher L. Camp, MD, Rocherster, MN
Aaron J. Krych, MD, Rochester, MN
Michael J. Stuart, MD, Rochester, MN
This video describes a novel technique for arthroscopic treatment
of OCD lesions by hinging open the lesion, thoroughly preparing
the base, and obtaining multipoint fixation to maximize stability.
(Product no. V14059, DVD-Video, 7 mins.)
OVT57.................................................................... Station 28
Surgical Technique for Combined Arthroscopic Bankart Hill-Sachs Remplissage
Walter B. McClelland, MD, Atlanta, GA
Pascal Boileau, MD, Nice, France
Charles Bessiere, MD, Nice, France
The combined procedure of arthroscopic Bankart-Hill-Sachs
remplissage is safe, reliable, and valuable for patients with
recurrent glenohumeral instability.
(Product no. V14061, DVD-Video, 17 mins.)
OVT58.................................................................... Station 29
Trasnosseous Equivalent Pectoralis Major Tendon Repair
An alphabetical faculty financial disclosure list can be found starting on page 312.
226
Educational Programs
OVT61..................................................................Station 32b
Reconstruction of the Posterolateral Corner with Achilles
Tendon Allograft
OVT41..................................................................Station 30b
Labral Reconstruction: Iliotibial Autograft Knotless
Technique
Carl Wierks, MD, Holland, MI
Labral reconstruction of the hip using ITB autograft secured with
a knotless suture-anchor technique reduces pain and improves
function.
(Product no. V14045, DVD-Video, 14 mins.)
OVT46..................................................................Station 31b
Peritrochanteric Access and Gluteus Medius Repair
J W Thomas Byrd, MD, Nashville, TN
This emerging technique video presents entry and development
of the eritrochanteric space with a systematic approach to repair
gluteus medius tears; outside and inside views of the technique
are illustrated.
(Product no. V14050, DVD-Video, 9 mins.)
OVT42..................................................................Station 33b
Arthroscopic ACL Reconstruction: Using Autogenous BonePatellar Tendon Graft -Remnant Preserving Technique
Sung-Jae Kim, MD, Seoul, Korea, Republic of
Sung-Hwan Kim, MD, Seoul, Korea, Republic of
Se Won Lee, MD, Seoul, Korea, Republic of
Min Jung, MD, Seoul, Korea, Republic of
Jae-Hoo Lee, MD, Seoul, Korea, Republic of
Hak-Soo Kim, MD, Seoul, Korea, Republic of
Su Keon A. Lee, MD, Seoul, Korea, Republic of
We present a novel technique of remnant preserving ACL
reconstruction using autogenous bone patellar tendon graft
without a tibial bone block to decrease postoperative anterior
knee pain at kneeling.
(Product no. V14046, DVD-Video, 12 mins.)
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
OVT56..................................................................Station 34b
Arthroscopic Distal Tibia Allograft for Management of
Posterior Glenoid Bone Loss
227
Thursday - Saturday
TUMORS
OVT74.................................................................... Station 37
Treating a Fracture of the Pathologic Femur with the
IlluminOSS Photodynamic Bone Stabilization System
OVT60..................................................................Station 35b
Arthroscopic Repair of a Posterior Bony Bankart Lesion
Kirsten L. Poehling-Monaghan, MD, Rochester, MN
Aaron Krych, MD, Rochester, MN
Diane Dahm, MD, Rochester, MN
This video describes a technique for the arthroscopic fixation of a
posterior bony Bankart lesion using modified portal placement to
facilitate direct fracture reduction and proper suture placement.
(Product no. V14064, DVD-Video, 6 mins.)
Thursday - Saturday
TRAUMA
OVT72.................................................................... Station 36
Distal Humerus Fractures Open Reduction Internal
Fixation: Case Presentation and Surgical Technique
Kenneth A. Egol, MD, New York, NY
Carlos Uquillas, MD, New York, NY
Dylan Lowe, BA, New York, NY
Mathew Hamula, BA, BS, New York, NY
Distal humerus fractures, particularly when intra-articular
extension is present, have better outcomes when open reduction
and internal fixation is employed.
(Product no. V14072, DVD-Video, 10 mins.)
Feature Presentation
An alphabetical faculty financial disclosure list can be found starting on page 312.
228
Educational Programs
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
11:30 AM Peroneal Tendoscopy: An Innovative Perspective
for Peroneal Tendon Patology
Antongiulio Marmotti, MD, Margherita Germano,
MD, Rainero Del Din, MD, Filippo Castoldi,
MD, Federico Dettoni, MD, Roberto Rossi, MD,
Davide Blonna, MD, Davide E. Bonasia, MD,
Fabrizio Trucchi, MD, Giuseppe Peretti, MD
1:00 PM All-Arthroscopic Allograft Labral Reconstruction
of the Hip
Dominic S. Carreira, MD
1:45 PM
8:30 AM
ACL Reconstruction in Patient with Open Physis
Stefano Zaffagnini, MD, Alberto Grassi, MD,
Giulio Maria Marcheggiani Muccioli, MD,
Maurilio Marcacci, MD
An alphabetical faculty financial disclosure list can be found starting on page 312.
229
230
Educational Programs
Scientific Exhibits
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Scientific Exhibit SE08
Spine
Scientific Exhibit SE15
An alphabetical faculty financial disclosure list can be found starting on page 312.
Scientific Exhibits
Highly Porous Metals in Cementless Acetabular Fixation Whats the Current Evidence?
Samik Banerjee, MBBS, MS, Baltimore, MD
Kimona Issa, MD, Baltimore, MD
Robert Pivec, MD, Baltimore, MD
Bhaveen Kapadia, MD, Baltimore, MD
Mark J. McElroy, BS, MS, Monroeville, PA
Harpal S. Khanuja, MD, Cockeysville, MD
Arthur L. Malkani, MD, Prospect, KY
Michael A. Mont, MD, Baltimore, MD
231
232
Educational Programs
Scientific Exhibits
Trauma
Educational Programs
control diagnosis and treatment in polytraumatized patients with
pelvic injuries associated with spinal fractures.
Pediatrics
Scientific Exhibit SE28
An alphabetical faculty financial disclosure list can be found starting on page 312.
Scientific Exhibits
233
234
Educational Programs
Scientific Exhibits
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Scientific Exhibit SE41
An alphabetical faculty financial disclosure list can be found starting on page 312.
Scientific Exhibits
235
236
Educational Programs
Scientific Exhibits
Basic Research
Scientific Exhibit SE53
Tumor
Scientific Exhibit SE55
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Scientific Exhibit SE57
Practice Management
Scientific Exhibit SE62
An alphabetical faculty financial disclosure list can be found starting on page 312.
Scientific Exhibits
237
238
Educational Programs
Scientific Exhibits
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Scientific Exhibit SE73
An alphabetical faculty financial disclosure list can be found starting on page 312.
Scientific Exhibits
239
240
Educational Programs
Scientific Exhibits
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
The Alternate Paper designation indicates that this poster has
been selected to be given as a paper in the event that one of the
papers in the chosen session has to be withdrawn.
241
Longitudinal study assessed pseudotumor size after metal-onmetal total hip arthroplasty using magnetic resonance imaging.
Among the 20 hips, six pseudotumors increased in size whereas
five decreased.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
242
Educational Programs
Posters
Educational Programs
Poster No. P016
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
243
244
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P033
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
245
246
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P050
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
247
248
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P069
Posters
249
250
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P086
251
Total Hip Arthroplasty with Porous Metal Implants for PostTraumatic Arthritis After Acetabular Fracture
Brandon J. Yuan, MD, Rochester, MN
Jonathon Spanyer, MD, Louisville, KY
Arthur L. Malkani, MD, Louisville, KY
David G. Lewallen, MD, Rochester, MN
Arlen D. Hanssen, MD, Rochester, MN
Although infection and instability remain significant concerns,
porous metal components offer excellent mid-term mechanical
durability in the treatment of post-traumatic OA after acetabular
fracture.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
252
Educational Programs
Who Belongs in the Unit? Predictors of the Need for Critical Care
after Total Joint Arthroplasty
Paul M. Courtney, MD, Philadelphia, PA
Colin Whitaker, Philadelphia, PA
Jacob T. Gutsche, MD, Philadelphia, PA
Eric L. Hume, MD, Wynnewood, PA
Gwo-Chin Lee, MD, Philadelphia, PA
Risk stratification algorithms for ICU admission after total joint
arthroplasty must include both intraoperative and preoperative
risk factors in order to be fully predictive.
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P102
We investigated the biomechanic behavior of cementless taperedwedge stems implanted in femurs with various canal geometries.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
253
254
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P120
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
255
256
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P140
257
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
258
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P156
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
After accounting for factors associated with acute pain after knee
and hip arthroplasty, the American College of Rheumatology
survey independently predicted increased postoperative opioid
consumption.
259
260
Educational Programs
The Flexion Gaps and the Femoral Component Rotations are All
Different among Various Gap Balancing Technique
Young Min Lee, MD, Seoul, Republic of Korea
Sahnghoon Lee, MD, PhD, Seoul, Republic of Korea
Joon Kyu Lee, MD, Seoul, Republic of Korea
Kee Yun Chung, MD, Seoul, Republic of Korea
Yool Cho, MD, Seoul, Republic of Korea
Seong Hwan Kim, MD, Daehak-Ro, Republic of Korea
Duhyun Ro, MD., Seoul, Republic of Korea
Myung C. Lee, MD, Seoul, Republic of Korea
Sang C. Seong, MD, Seoul, Republic of Korea
Different gap techniques results in unequal flexion gaps and the
femoral component rotations.
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P172
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
261
262
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P190
263
Posters
264
Educational Programs
Does Bone Quality Alter Mechanical Performances of AllPolyethylene and Metal-Backed TKA Tibial Component?
Jean M. Brilhault, MD, Tours, France
Silvia Pianigiani, MS, Milano, Italy
Alessandro Navacchia, MSc, Cesena, Italy
Luc Labey, Leuven, Belgium
Walter Pascale, MD, Milano, Italy
Vincenzo Parenti Castelli, Bologna, Italy
Bernardo Innocenti, PhD, Bruxelles, Belgium
Generally, AP solution presents worse performance with respect
to MB implants in terms of stress distribution in the bone and
micromotions.
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P208
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
265
266
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P227
267
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
268
Educational Programs
Posters
Pediatrics
Poster No. P241
Educational Programs
269
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
270
Educational Programs
Pediatrics
Poster No. P255
Practice Management/Rehabilitation
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P264
Increasing Medical Student Exposure to Orthopaedics Developing an Orthopaedic Surgery Interest Group
Dayne T. Mickelson, MD, Seattle, WA
Philip Louie, BS, Kirkland, WA
Alex W. Farnand, MD, Chicago, IL
Lauren Meyer, MD, Seattle, WA
Jens R. Chapman, MD, Seattle, WA
An Orthopaedic Surgery Interest Group was established. This
resulted in developing student confidence in the musculoskeletal
system, increasing interest in Orthopaedics and improving match
results.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
271
272
Educational Programs
Posters
The orthopaedic job market in the United States has changed over
the last decade with decreasing demand for spine, trauma and
hand and increasing practice opportunities in academics.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P282
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
273
274
Educational Programs
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P298
275
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
276
Educational Programs
Posters
The Deep Layer of the Rotator Cuff Tendon Becomes Stiffer with
Age: A Possible Cause of Cuff Tear
Nobuyuki Yamamoto, MD, Sendai, Japan
Takashi Hayakawa, Fukushima, Japan
Takayuki Muraki, PhD, Sendai, Japan
Hirotaka Sano, MD, PhD, Sendai, Japan
Eiji Itoi, MD, Sendai, Japan
The rotator cuff tendons of 210 shoulders volunteers in their 10s
to 70s were examined with use of ultrasound elastography. The
deep layer of the rotator cuff tendons became stiffer with age.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P317
Lower Trapezius Tendon Transfer for Irreparable PosteriorSuperior Rotator Cuff Tears
Ryan P. Donegan, MD, Lexington, KY
Charles M. Jobin, MD, New York, NY
Aaron M. Chamberlain, MD, Saint Louis, MO
Surena Namdari, MD, MSc, Philadelphia, PA
Chi-Tsai Tang, MD, Saint Louis, MO
Leesa M. Galatz, MD, Saint Louis, MO
This study describes the technique and sonographic,
electromyographic and functional results of lower trapezius
tendon transfer with achilles allograft in patients with irreparable
rotator cuff tears.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
277
278
Educational Programs
Posters
Educational Programs
Poster No. P336
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
279
280
Educational Programs
Spine
Poster No. P346
Posters
A Longitudinal In Vivo Study of Lumbar Spine Degeneration Disc Height and Facet Joint Space Width
Hidetoshi Nojiri, MD, PhD, Tokyo, Japan
Yusuke Oshita, MD, PhD, Yokohama Kanagawa, Japan
Alejandro Espinoza, PhD, Chicago, IL
Howard S. An, MD, Chicago, IL
Gunnar B. Andersson, MD, Chicago, IL
Nozomu Inoue, MD, Chicago, IL
This 5-year longitudinal study showed decreases measured in
vivo of 7.3% in disc height and 6.8% in facet joint space width
showcasing the morphological changes brought on by spine
degeneration.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P354
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
281
282
Educational Programs
Spine
Poster No. P362
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P370
Effectiveness of Postoperative Wound Drains in One- and TwoLevel Cervical Spine Fusion
Caroline Poorman, BA, New York, NY
Peter G. Passias, MD, Brooklyn, NY
Kristina Bianco, New York, NY
Michael C. Gerling, MD, Brooklyn, NY
Postoperative cervical drains are associated with longer hospital
stays and operative times for one- and two-level cervical fusions
with no difference in complication rates.
The improved discectomy seen with the suction curette device can
potentially improve the clinical fusion rate and decrease the rate
of intraoperative complications with the fewer number of passes.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
283
284
Educational Programs
Spine
Poster No. P380
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P387
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
285
286
Educational Programs
Spine
Poster No. P397
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P404
287
Sports Medicine/Arthroscopy
Poster No. P406
Posters
288
Educational Programs
Sports Medicine/Arthroscopy
Poster No. P414
Posters
Educational Programs
Poster No. P424
289
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
290
Educational Programs
Sports Medicine/Arthroscopy
Poster No. P432
Posters
Educational Programs
Poster No. P440
291
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
292
Educational Programs
Sports Medicine/Arthroscopy
Poster No. P448
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P456
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
293
294
Educational Programs
Sports Medicine/Arthroscopy
Poster No. P464
Trauma
Poster No. P466
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P472
295
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
296
Educational Programs
Trauma
Poster No. P481
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P490
When Do Distal Radius Fractures Most Likely Displace: Longterm Follow Up of Closed Reduction and Casting
Andrew Jawa, MD, Cambridge, MA
Joey LaMartina II, MD, Boston, MA
Paul Tornetta III, MD, Boston, MA
Using regression analysis of a large dataset of radiographic
measurements, we found the majority of displacement in distal
radius fractures occurs in the first 6 weeks, but continues for up
to 1 year.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
297
298
Educational Programs
Trauma
Poster No. P498
Posters
Educational Programs
Poster No. P508
Cemented vs. Cementless Hip Hemiarthroplasties with WellDesigned Stems: A Case Control Matched Study
George A. Grammatopoulos, MRCS, Oxford, United Kingdom
Hannah A. Wilson, MA, Reading, United Kingdom
Benjamin J. Kendrick, MBBS, FRCS
Claire Pulford, MBBS, Oxford, United Kingdom
Janet Lippett, Reading, United Kingdom
Mark Deakin, Freeland, Oxfordshire, United Kingdom
Antonio J. Andrade, MBBS, MSc, Berkshire, United Kingdom
Gregoris Kambouroglou, MD, London, United Kingdom
299
Posters
300
Educational Programs
Trauma
Poster No. P517
Posters
Outcomes of Operative Treatment of Unstable Ankle Fracture Metallic vs. Biodegradable Implants
Jung Ho Noh, MD, PhD, Gangwon-Do, Republic of Korea
Young Hak Roh, MD, Incheon, Republic of Korea
Moo Kyung Oh, MD, Chuncheon, Republic of Korea
Jun Suk Lee, MD, Seoul, Republic of Korea
The outcomes of biodegradable implants for ankle fracture were
inferior to those of metallic implant.
Tumor/Metabolic Disease
Poster No. P526
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
301
Posters
302
Educational Programs
Tumor/Metabolic Disease
Poster No. P536
Does a Golf Ball Affect the Route to Diagnosis for Soft Tissue
Tumors?
Krista Goulding, MD, Birmingham, United Kingdom
Robert J. Grimer, FRCS, Worcester, United Kingdom
Posters
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P544
303
The current findings indicate that obesity does not modulate the
production of adiponectin in OA cartilage.
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
304
Educational Programs
ORS Posters
Poster No. P556
Posters
Effect Of The Horizontal Extension Technique On The CrossSectional Area Of The Carpal Tunnel
Shouta Kaneko, OTR, MSc, Eniwa, Japan
Sadako Tsubota, OTR, Eniwa, Japan
Takako Chikenji, OTR, PhD, Eniwa, Japan
Yoshikazu Ikemoto, MD, PhD, Eniwa, Japan
Yuki Saito, RPT, Eniwa, Japan
Yukihiro Osanami, OTR, Eniwa, Japan
Eiichi Uchiyama, MD, PhD, Eniwa, Japan
Horizontal extension technique (HET) changed carpal tunnel
structure. Flexibility of the structure may be affected by HET.
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
Poster No. P562
BOS Posters
Poster No. P563
An alphabetical faculty financial disclosure list can be found starting on page 312.
Posters
305
306
Educational Programs
Nurses
A total of 32 contact hours are being offered through NAON;
4.0 contact hours for each NUR course and for the CAST1
and CAST2 courses. Each session is provider approved by the
California Board of Registered Nursing, Provider Number
CEP3432, for 4.00 contact hours for each NUR course and
8.00 contact hours each for the CAST1 and CAST2 courses.
The National Association of Orthopaedic Nurses is accredited
as a provider of continuing nursing education by the American
Nurses Credentialing Centers Commission on Accreditation
Orthopaedic Technologists
Applying to the National Board for Certification of Orthopaedic
Technologists for approval of a total of 32 contact hours or 4
contact hours for each NUR session and 8 contact hours each for
the CAST1 and CAST2 courses.
Physician Assistants
Applying to the American Academy of Physician Assistants
(AAPA) for Category 1 CME credit from the AOA Council
on Continuing Medical Education, Prescribed credit from the
AAFP and AMA Category 1 CME credit for the PRA from
organizations accredited by the ACCME. Total number of contact
hours: 32.
Orthopaedic Physician Assistants
Applying to the National Board for Certification of Orthopaedic
Physician Assistants for approval of a total of 32 contact hours
for orthopaedic physician assistants or 4 contact hours for
each NUR session and 8 contact hours each for the CAST1 and
CAST2 courses.
General
Certificates for sessions will be available online once a participant
completes a session. A link to the evaluation will be distributed
to participants via email following each session. Please be sure to
give your correct e-mail address when registering for the courses.
Once participants complete the evaluation, a contact hour
certificate will be available to print. To receive any certificate
other than nursing, please visit the registration counter in front
of the session. For credit that may be acceptable to state medical
associations, specialty societies or state boards of medical
licensure, please contact those organizations. NAON, AAOS
and NAOT make every effort to have the course approved for
credit prior to the course dates. It is not always possible to obtain
approval in advance of a program.
Overview
This course will feature presentations about innovations in
immobilization, casting complication causes and solutions, and
the casting procedure. Demonstration and return demonstration
will include application and removal of a short arm cast,
thumbspica cast, short leg cast, and a sugar tong splint.
Program
8:15 AM
Casting Complications
Sean Conkle, OTC
8:45 AM
9:05 AM
9:30 AM
Break
1:30 PM
5:45 PM
Adjournment
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
CAST2 Casting and Splinting Advanced
Overview
This course will feature presentations about necessary supplies
and procedures for advanced casting. Demonstration and return
demonstration will include Meunster, PTB, Pediatric Hip Spica,
and Ponsetti Serial Casts.
Program
8:15 AM
Break
1:30 PM
Break
3:45 PM
4:15 PM
Hands-On Workshop
Cynthia Henderson, OTC, CO
Sean Conkle, OTC
Nicole Williams, OTC, MBA
Robyn Masseth, OTC
Kristie Woolems, OTC
5:45 PM
Adjournment
Break
9:45 AM
Adjournment
An alphabetical faculty financial disclosure list can be found starting on page 312.
307
308
Educational Programs
3:45 PM
Break
5:00 PM
Introductions
Nadine Trznadel, MSN, RN, CNS, ONC
Steven Mardjetko, MD
7:45 AM
8:15 AM
8:45 AM
9:15 AM
9:45 AM
Break
Adjournment
Adjournment
The FDA has not cleared the drug and/or medical device for the use described in this presentation (i.e. the drug or medical device is being discussed for an off label use). For full information refer to page 15.
Educational Programs
309
Overview
Surgery is an important management option for many
orthopaedic conditions. A variety of procedures will be
addressed, including those for hip conditions, injuries requiring
replantation, shoulder conditions, pediatric cervical spine issues,
anterior cruciate ligament tears, and sports injuries in adolescents.
Program
1:30 PM
Welcome
Jan Foecke, MS, RN, ONC
NAON Director of Programs
NAON Administrator, Approver and
Provider Units
Harpal S. Khanuja, MD
AAOS Allied Health Program Director
Pam Cupec, MS, RN, ONC, CRRN, ACM
2013-2014 NAON President
Introductions
Lynn D. Burkett, RN, BSN, MBA, ONC
Gary C. Canner, MD
1:45 PM
3:30 PM
4:00 PM
Break
4:15 PM
4:45 PM
5:30 PM
6:00 PM
Adjournment
An alphabetical faculty financial disclosure list can be found starting on page 312.
ATTENTION SUBMITTERS:
DISCLOSURE RULES
www.aaos.org/annual
2014 Disclosures
312
Disclosures
Why Disclosure?
As an accredited provider of continuing medical education (CME),
the Academy is required by the Accreditation Council for Continuing
Medical Education (ACCME) to obtain and share with participants of
any AAOS CME activity any potential conflicts of interest by faculty,
program developers, and CME planners.
The ACCME Standards of Commercial Support, Standard 2 states the
requirements:
2.1 The provider must be able to show that everyone who is in a position to control the content of an education activity has disclosed
all relevant financial relationships with any commercial interest to
the provider.
Disclosures
2.2 An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of,
or responsibility for, the development, management, presentation
or evaluation of the CME activity.
The AAOS Mandatory Disclosure Policy for Governance Groups (except Board of Directors), Continuing Medical Education Contributors,
Senior Management Team Members, and Others requires that faculty
submit all financial relationships with industry occurring within the
past 12 months.
Board of Directors
Joshua J. Jacobs, MD, President: 4
Implant Protection; 5 Medtronic
Sofamor Danek, Nuvasive, Zimmer
Frederick M. Azar, MD, 1st Vice
President: 4 - Pfizer; 7 - Elsevier
David D. Teuscher, MD, 2nd Vice
President: ........................................n
Andrew N. Pollak, MD, Treasurer:
1 - Zimmer; 5 Smith & Nephew;
7 - AAOS
John R. Tongue, MD, Past President: .n
Wilford K. Gibson, MD, Chair,
Board of Councilors: .......................n
John J. McGraw, MD, Chair, Elect
Board of Councilors: 3B Amedisys
Home Health Care
David J. Mansfield, MD,
Secretary, Board of Councilors:
2 Alcon Pharmaceutical, Astra
Council on Education
Edward Akelman, MD, Chair:
1 Integra; 2 Auxilium
Pharmaceuticals; 3B Wright
Medical Technology, Inc.
Gregory Charles Berlet, MD,
MemberAtLarge: 1 Bledsoe Brace,
Wright Medical Technology, Inc.;
2 Wright Medical Technology, Inc.;
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Lippincott Williams & Wilkins
Thomas J. Grogan, MD, Member:
4 BAZI, BristolMyers Squibb,
Johnson & Johnson
Thomas B. Hughes Jr., MD,
Member: ..........................................n
Young Jo Kim, MD, PhD, Member:
2 Synthes; 3B Smith & Nephew;
3C, 6 Siemens Heath Care
Erik C. B.King, MD, Member: ........n
Valerae O. Lewis, MD,
MemberAtLarge: 5 Stryker
Jay R. Lieberman, MD, Member:
3B DePuy, A Johnson & Johnson
Company; 5 Amgen Co., Arthrex,
Inc.
John J. McGraw, MD, Member: 3B
Amedisys Home Health Care
Vincent J. Sammarco, MD, Member:
2, 3B Extremity Medical
Exhibits Committee
Merck
Central Instructional
Courses Committee
Craig J. Della Valle, MD, Chair:
3B Biomet, Convatec, DePuy, A
Johnson & Johnson Company, Smith
& Nephew; 4 CD Diagnostics;
5 Biomet, CD Diagnostics, Smith
& Nephew, Stryker; 7 Journal of
Bone and Joint Surgery American,
SLACK Incorporated
Col. Tad L. Gerlinger, MD,
Member: ..........................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
313
314
Disclosures
Disclosures
Pediatrics Instructional
Course Committee
Spine Instructional
Course Committee
Robert V. Dawe, MD, Chair: 4
Spinewave
Charles J. Banta II, MD, Member: 1
Biomet; 3B Biomet, Spinal USA
Practice Management
Instructional Course
Committee
A. Herbert Alexander, MD, Chair: ..n
Robert H. Blotter, MD, Member: ....n
J. Abbott Byrd III, MD, Member: 1
Biomet; 3C, 4 CoAlign Spine
Stanley H. Dysart, MD, Member: 2,
3B Ferring Pharmaceuticals
Erick M. Santos, MD, PhD, Member:
4 DePuy, A Johnson & Johnson
Company, Pfizer
Tumor Instructional
Course Committee
Carol D. Morris, MD, MS, Chair: ...n
Joseph Benevenia, MD, Member:
2 Musculoskeletal Transplant
Foundation; 3C Merete, NJOS; 5
Biomet, Musculoskeletal Transplant
Foundation, Synthes
David S. Geller, MD,
Member: ..........................................n
Michael P. Mott, MD, Member: ......n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Nutriceutcals; 5 Convatec; 7
American Journal of Orthopedics,
Clinical Orthopaedics and Related
Research, Journal of Arthroplasty,
Journal of Bone and Joint Surgery
American
Kipling P. Sharpe, MD, Member: 2
Stryker, Pacira; 3B, 5 Stryker
James D. Slover, MD, Member: 5
Biomet, DJO LLC
Scott M. Sporer, MD, Member: 3B
Smith & Nephew, Zimmer; 5
Central DuPage Hospital, Zimmer;
7 SLACK Incorporated
Andrew M. Star, MD, Member: 2,
3B, 5 DePuy, A Johnson & Johnson
Company; 3A, 4 Johnson &
Johnson
Edward J. Stolarski, MD, Member:
2 Biometric, Biomet; 3B Biomet,
Medacta; 4 OSI; 5 Gulfcoast
Research
Pediatrics Program
Committee
Practice Management/
Rehabilitation Program
Committee
Thomas A. Malvitz, MD, Chair: .....n
Catherine G. Hawthorne, MD,
Member: ..........................................n
Paul Saiz, MD, Member: 2, 3B
Zimmer, Amedica
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
315
316
Disclosures
Disclosures
Sports Medicine/Arthroscopy
Program Committee
Dean K. Matsuda, MD, Chair: 1
Arthrocare, Smith & Nephew
Richard L. Angelo, MD, Member: 2,
3B DePuy, A Johnson & Johnson
Company
Champ Baker III, MD, Member: 4
Arthrex, Inc.
David R. Diduch, MD, Member:
1 Arthrocare; 3B Mitek; 5
Genzyme, Mitek, Zimmer, Moximed,
Arthrex, Inc.
Christopher T. Donaldson, MD,
Member: ..........................................n
Greg J. Folsom, MD, Member: 4
Abbott, Johnson & Johnson
Peter G. Gerbino II, MD, Member: .n
Thomas James Gill, MD, Member:
3B ConMed Linvatec, VisionScope
Technologies; 4 VisionScope
Technologies; 7 SLACK
Incorporated
John R. Trey Green III, MD,
Member: 6 Pacific Medical, Stryker
Christopher C. Kaeding, MD,
Member: 3B Biomet
Michael A. Kuhn, MD, Member: 2,
3B Arthrex, Inc.
Christian Lattermann, MD, Member:
2 Sanofi/Genzyme; 3B Sanofi/
Genzyme, Isto; 5 Smith & Nephew
Eric Bruce Pifel, MD, Member:
4 Midwest Orthopedic Specialty
Hospital
Scott Evan Powell, MD, Member: 3B
Smith & Nephew
Anil S. Ranawat, MD, Member:
1 DePuy, A Johnson & Johnson
Company, Stryker; 2 MAKO,
ConforMIS, Nova, DePuy, A Johnson
& Johnson Company, Stryker; 3B
MAKO, DePuy, Stryker, ConforMIS,
Mitek, DePuy, Linvatech; 3C
ConforMIS; 4 ConforMIS, Nova
Surgical; 5 MAKO, DePuy, Stryker;
6, 7 DePuy, Stryker
Stephen R. Soffer, MD, Member: ....n
Armando Felipe Vidal, MD, Member:
2 Stryker; 3B Arthrocare, Stryker;
6 Stryker, Smith & Nephew
Rick W. Wright, MD, Member:
3B Flexion Therapeutics, ISTO
Technologies; 5 National Institutes
of Health (NIAMS & NICHD),
Smith & Nephew; 7 Wolters
Kluwer Health Lippincott Williams
& Wilkins
Muneaki Abe...................................n
Mark F. Abel, MD............................n
Michelle Abghari, BS.......................n
Khaled Aboelnasr.............................n
Mansour Abolghasemian, MD.........n
Adem Abrham..................................n
Faculty
Adel Abdelkafy................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Alessandro Maria Agr, MD............n
Stryker, Aesculap/B.Braun; 3B
- Medtronic, Stryker, DePuy; 4 TranS1, Visualase, Doctors Research
Group; 5 - TranS1
Amit Amin, FRCS (Ortho)...............n
Nirav Hasmukh Amin, MD.............n
Jeonghoon Ahn................................n
Jerry W. Alexander...........................n
Matthew Anderle.............................n
Marudeen Aivaz...............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
317
318
Disclosures
7 - Elsevier
Patricia Babb....................................n
Geneva Baca....................................n
Eisuke Arai.......................................n
David Arashvand.............................n
Michael T. Archdeacon, MD: 3B Stryker; 7 - SLACK Incorporated
Kristin Archer, PhD..........................n
Robert A. Arciero, MD: 2 - Arthrex,
Inc., Mitek; 3B - Biomet, Mitek, Soft
Tissue Regeneration; 4 - Soft Tissue
Regeneration; 5 - Arthrex, Inc.
Disclosures
Antoine Babinet...............................n
Anchal Bansal..................................n
F. Alan Barber, MD: 1 - DePuyMitek; 2 - ConMed Linvatec, DePuyMitek; 4 - Johnson & Johnson; 5
- Arthrex, Inc., ConMed Linvatec,
DePuy-Mitek, Smith & Nephew
Endoscopy, Stryker Endoscopy
Peter Austin......................................n
Matteo Baldassarri...........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Kelly-Anne Barr, RN, BS..................n
Robert L. Barrack, MD: 1, 3B
- Stryker; 5 - Biomet, Medical
Compression Systems, National
Institutes of Health (NIAMS &
NICHD), Smith & Nephew, Stryker,
Wright Medical Technology, Inc.;
6 - Stryker; 7 - The McGraw-Hill
Companies Inc., Wolters Kluwer
Health - Lippincott Williams &
Wilkins
Rajbir N. Batra................................n
Paolo Baudi......................................n
Carla M. Baumgartner.....................n
Rita Baumgartner, BS.......................n
Roberta Bell.....................................n
Hamed Benghuzzi............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
319
320
Disclosures
Inc.
Disclosures
Sanofi-Aventis
Franois Bonnel, Prof.......................n
Tara Francesca Bonner, BS, MSc......n
Nicolas Bonnevialle, MD.................n
Paul Bonnevialle, MD......................n
Daniel Bonny, BS.............................n
Christopher M. Bono, MD: 6 Harvard Clinical Research Institute,
Intrinsic Therapeutics, United
HealthCare; 7 - Wolters Kluwer
Health - Lippincott Williams &
Wilkins
James V. Bono, MD: 1 - Stryker,
Sectra; 2, 3B - Stryker; 7 - Springer
Peter M. Bonutti, MD: 1 - Stryker,
Joint Active Systems, Inc.; 2 - Stryker;
3B - Stryker, Biomet; 4 - Joint Active
Systems, Inc.
Alexis Bonvin, MD..........................n
Martijn Franklin Boomsma, MD.....n
Bert Boonen, MD.............................n
Robert E. Booth Jr., MD: 1, 2, 3B Zimmer; 4 - CD Diagnostics, Zimmer
Kevin S. Borchard, MD....................n
Timothy Borden, MD......................n
Barbara Bordini, MD.......................n
Raffaele Borghi, MD........................n
Sean L. Borkowski, MS....................n
Christopher T. Born, MD: 2, 5 Stryker; 3B - Stryker, Illuminoss,
DeRoyal; 3C - Biointraface; 4 Biointraface, Illuminoss
Trevor R. Born, MD........................n
Kyle Borque, MD.............................n
Ellis Bos...........................................n
Joseph A. Bosco III, MD: 5 - 3M,
MAKO
Adele L. Boskey, PhD: 3C
- Skelescan; 4 - Amgen Co.,
Bristol-Myers Squibb, DePuy, A
Johnson & Johnson Company, Eli
Lilly, GE Healthcare, Genzyme,
GlaxoSmithKline, Johnson &
Johnson, Norvartis, Sanofi-Aventis,
Wyeth, Zimmer
Capt. (ret) Michael J. Bosse, MD: 4 Orthopaedic Implant Company
Mathias P. G. Bostrom, MD: 3B, 5 Smith & Nephew
Arjan G.J. Bot, MD: 6 - Prins
Bernhardt Cultuurfonds/Stichting
Banning-de Jong Fonds
Michael Bottlang, PhD: 1, 2, 3B Synthes, Zimmer
Craig R. Bottoni, MD: 2, 3B Arthrex, Inc.; 5 - Arthrex, Inc.,
Musculoskeletal Transplant
Foundation
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Jad Bou Monsef, MD.......................n
PA-C................................................n
Dalibel M. Bravo.............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
321
322
Disclosures
Disclosures
Gianni Caizzi...................................n
Selami Cakmak, MD........................n
Teresa Calabr.................................n
Carlotta Calamelli, MD...................n
Cosma Calderaro.............................n
Lindsey Caldwell, MD.....................n
Ryan Patrick Calfee, MD: 3B Synthes; 5 - Medartis
John J. Callaghan, MD: 1, 3B
- DePuy, A Johnson & Johnson
Company; 7 - Wolters Kluwer Health
- Lippincott Williams & Wilkins,
Journal of Arthroplasty
Charles D. Callahan, PhD, MBA......n
Michael F. Callahan, PhD: 3A, 4 Tensive Controls, Inc., Animal Health
Specialties, LLC
Suzanne Cassel.................................n
Scott Carney.....................................n
Abigail Campbell.............................n
Pilar Camacho..................................n
Saunders/Mosby-Elsevier
Paola Capra.....................................n
Gerard Carandang...........................n
Paolo Caravaggi...............................n
Leo Carroll.......................................n
Megan Carroll Paulus, MD..............n
Patrick Carry....................................n
Sasha Carsen, MD, MBA.................n
Eric Ward Carson, MD: 3C, 4 - KFx
Aaron Carter, MD............................n
Alison Carter....................................n
Cordelia Wheeler Carter, MD..........n
R. Clement Carter, BSE....................n
Alessandro Carcangiu......................n
Aron Chacko....................................n
Sanghoon Chae................................n
Jaskarndip Chahal, MD...................n
Rajesh Chakravertty, MD................n
Bill Champion..................................n
Charles Chan, MD...........................n
Daniel Steven Chan, MD: 3B Biomet
Denise S. Chan, MBT, MSc..............n
Ferdinand J. Chan, MD....................n
Gilbert Chan, MD............................n
Holman Chan, MD..........................n
Jeremy Yangshi Chan, BS.................n
Newton Chan...................................n
Vanessa Chan, MPH........................n
Dr. Rajesh Chandralekha.................n
Aiswarya Lekshmi Pillai Chandran
Pillai, MD, MS.................................n
Chong Bum Chang, MD, PhD: 2 Pfizer, DePuy, A Johnson & Johnson
Company, GlaxoSmithKline; 5 Smith & Nephew
Eric Y. Chang, MD...........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
James Chang, MD: 3B, 4 - Zone II
Surgical
Dong-Il Chun...................................n
Yun-Jin Choi....................................n
Tae-Joon Cho...................................n
Monica Cicirello..............................n
Andrea Cimino.................................n
Philippe Cinquin..............................n
Phelipe Cintra..................................n
Alessandro Ciompi, MD..................n
Cara Cipriano, MD..........................n
Carolina Civitenga, MD...................n
Andrew James Clair, BA: 3B Medtronic, Boston Scientific Inc.,
Endologix, Bard Medical, Covidien
Medical, Gore Medical;
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
323
324
Disclosures
Heather Cole....................................n
Disclosures
5 - Sanofi-Aventis
Robert Cope.....................................n
Frank A. Cordasco, MD: 1 - ConMed
Linvatec; 3B - Arthrex, Inc.
Luanne A. Cori, BA.........................n
Chris Alan Cornett, MD..................n
Lara Cristiano..................................n
Sead Crnalic, MD.............................n
Suzie Cro, MSc, BS..........................n
John R. Crockarell Jr., MD: 7 Elsevier
Patrick Cronin..................................n
Lynn A. Crosby, MD: 1, 2, 3B, 5 Exactech, Inc.
R. Adams Cowley............................n
Socorro Cortes.................................n
Alexander Connaughton..................n
Gregory Cunningham.......................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Arthrosurface; 3B - Aperion
Biologics, Flexion Therepeutics,
Ceterix; 4 - Arthrosurface
Richard S. Davidson, MD: 1, 2,
3B - Biomet; 3C - Medsonics;
4 - Abbott, Bristol-Myers Squibb,
GlaxoSmithKline, Merck, Pfizer,
Zimmer Holdings Inc.
Alan Davis.......................................n
Bruce Davis......................................n
Bart De Roest...................................n
Mark Deakin....................................n
Erin M. Dean, MD...........................n
John T. Dearborn, MD....................n
Kevin Frederick Deasy, BS................n
Philippe Debeer, MD........................n
Thomas M. DeBerardino, MD:
2 - Musculoskeletal Transplant
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Erisa Deda........................................n
325
326
Disclosures
Surgery
MBA: 7 - Springer
Robert Dorman................................n
Disclosures
Brian Diskin.....................................n
Robert Douglas................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Inc.
Petra Elo, MD, PhD.........................n
Mohammad Mostafa El-Sharkawi,
MD..................................................n
Erin E. Ely........................................n
John B. Emans, MD: 1 - Synthes;
3B, 3C - Medtronic Sofamor Danek,
Synthes
Roger H. Emerson Jr., MD: 1,
5 - Biomet; 2 - Medtronic, Biomet,
Pacira; 3B - Medtronic, Biomet; 4 Pacira
Li Fellander-Tsai, MD......................n
Francesca Fissore..............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
327
328
Disclosures
Grant E. Flammer............................n
Kevin P. Francis................................n
Disclosures
Ryan Gao.........................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Richard H. Gelberman, MD: 1 Medartis; 7 - Wolters Kluwer Health
- Lippincott Williams & Wilkins
David Samuel Geller, MD................n
Jeffrey A. Geller, MD: 3B - Smith &
Nephew
Richard Evan Gellman, MD.............n
Elisabeth Gennis, MD......................n
Martha George, MD........................n
Anastasos Georgoulis.......................n
Amanda Gonzalez............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
329
330
Disclosures
Disclosures
ANCHOR Group.............................n
Moon Group: 5 - Smith & Nephew
Gary S. Gruen, MD: 3B - Smith &
Nephew
Yu Gu, BS........................................n
Anthony Gualtieri, BA.....................n
Suribabu Gudipati, MBBS, MRCS...n
Victor R. Guevara............................n
Pierre Guigui....................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Charles Patrick Hannon, BS.............n
Bart Hans Bosker, MD.....................n
Dane C. Hansen, DO: 4 - Shire
Kirk Hansen, BS...............................n
Viktor Hansen, MD.........................n
Arlen D. Hanssen, MD: 1, 5 Stryker; 7 - Elsevier
Walter Herzog..................................n
Kathryn Hess...................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
331
332
Disclosures
Nephew
Shirley Hon......................................n
Disclosures
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Life Sciences; 7 - Jaypee Medical
Publishers
- Acumed, LLC
Simon Jameson.................................n
Allison Janda, BA.............................n
Eun Jin Jang.....................................n
Lorene Janowski, DPS OTR/L MS...n
Kyle Jansson.....................................n
Nancy M. Jackson............................n
Glen Jacob.......................................n
Richard Jackson...............................n
Marion Jenkins................................n
Skylar Johnson.................................n
Staci Johnson, MEd..........................n
Timothy S. Johnson, MD: 2 Arthrex, Inc.
Charles Eugene Johnston II, MD:
1 - Medtronic Sofamor Danek; 7 Saunders/Mosby-Elsevier
Richard C. Johnston, MD................n
Elizabeth Joiner, BS..........................n
Alan L. Jones, MD: 3C - Medtronic
Carroll Payne Jones, MD: 1 Arthrex, Inc., Wright Medical
Technology, Inc.; 2, 3B - Wright
Medical Technology, Inc., Amniox; 5
- Orthofix, Inc., Biomimetic, Wright
Medical Technology, Inc., Zimmer
Christopher Robert Jones, MD........n
Clifford B. Jones, MD, FACS...........n
Grant L. Jones, MD: 3C - Arthrotek;
5 - Biomet, Genzyme
Hugh L. Jones..................................n
Kay S. Jones, RN..............................n
Kennis Jones, BA..............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Helen Ingoe......................................n
333
334
Disclosures
Disclosures
Lee Josephs......................................n
Tsuyoshi Jotoku, MD.......................n
Antti Joukainen, MD, PhD...............n
Jean-Yves Jouzeau, PharmD, PhD....n
David Joyce, MD.............................n
Patrick Wakefield Joyner, MD..........n
Mika Junnila....................................n
Denis Katz: 1, 2, 3B - FH
Orthopedics
Rishin Kadakia.................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Vincent H. Key, MD.........................n
Myung Ku Kim................................n
Linda A. Koester..............................n
Yong-Gon Koh.................................n
Chetan Khatri..................................n
Omar Kherad...................................n
Michael Khoo, MBBS......................n
Amir Khoshbin, MD........................n
W. Benjamin Kibler, MD: 3C, 4 Alignmed
Alexander Kiderman, PhD...............n
Sieh Kiew.........................................n
Hiroaki Kijima, MD.........................n
Kazuhiko Kikugawa, MD, PhD........n
Patrick Kilmartin, BS, MS: 3A - CD
Diagnostics
Abraham Kim, MD..........................n
Byoung-Gook Kim...........................n
Dong-Soo Kim, MD.........................n
Yeun Ho Kim...................................n
Yongjung J. Kim, MD......................n
Yong-Min Kim, MD.........................n
Young Jo Kim, MD, PhD: 2 Synthes; 3B - Smith & Nephew; 3C,
6 - Siemens Heath Care
Young-Hoo Kim, MD: 1 - DePuy, A
Johnson & Johnson Company
Yumi Kim, MD................................n
Yunjung Kim, MPH.........................n
Hiroaki Kimura, MD, PhD..............n
Graham J. W. King, MD: 1, 3B Wright Medical Technology, Tornier
Inc.
Stuart D. Kinsella, BA......................n
Derrick Knapik................................n
Sujith Konan....................................n
Boudewijn Kollen.............................n
Hasung Kim.....................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Wanlim Kim.....................................n
Il-Hyun Koh.....................................n
Morsi Khashan.................................n
335
336
Disclosures
Denise Koueiter................................n
Disclosures
William J. Landis.............................n
John G. Lane, MD: 2 - Genzyme;
3B - MicroAire Surgical Instruments
LLC; 4 - Parcus, Alignmed
Joseph M. Lane, MD: 2 - Eli Lilly;
3B - Amgen Co., Bone Therapeutics,
Inc., CollPlant, Zimmer; 4 - Dfine,
CollPlant; 5 - Amgen Co.
Jason Edward Lang, MD: 5 - DePuy,
A Johnson & Johnson Company,
Smith & Nephew
Joshua Langford, MD: 2 - Smith &
Nephew; 3B - Innovative Medical
Device Solutions, Stryker; 4 - Core
Orthopaedics, Institute for Better
Bone Health, LLC
Gunasekaran Kumar........................n
Sita Kumar.......................................n
Robert Kulwin.................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
William Francis Lavelle, MD: 2 Stryker; 5 - DePuy, A Johnson &
Johnson Company
Carlos J. Lavernia, MD: 1, 5 MAKO Surgical Corp.; 3B - MAKO
Surgical Corp, J&J, DePuy; 4
- Johnson & Johnson, Zimmer,
MAKO Surgical Corp., Stryker,
Wright, Symmetry Medical
Peggy W. Law, MSc..........................n
Brandon D. Lawrence, MD..............n
Allison Lax, MD..............................n
Lionel E. Lazaro, MD......................n
Vu H. Le, MD..................................n
Andres Leiva....................................n
Randall Lee......................................n
Diana Lennon..................................n
Trevor Lentz, PT..............................n
Timothy Robert Leonard.................n
Francesco Leonardi, MD..................n
Olof Leonardsson, MD....................n
William A. Leone, MD: 1 - Stryker;
2 - MAKO Surgical; 3B - MAKO
Surgical, Stryker
Natalie Leong, MD..........................n
Nikoletta M. Leontaritis
Carayannopoulos, DO.....................n
Seth S. Leopold, MD........................n
Darren Lepere, BS............................n
Daniel M. Lerman, MD...................n
Timothy Sean Leroux, MD..............n
Michelle Leroux-Williams, PhD: 3A,
4 - Osiris Therapeutics
Gregory Neal Lervick, MD: 2, 3B Tornier
Clifford M. Les, DVM, PhD.............n
Bryson Patrick Lesniak, MD............n
G. Douglas Letson, MD: 3B - Stryker
Sophia Leung, MD...........................n
Melissa Levering..............................n
Mandeep Lehil.................................n
Ronald Arthur Lehman, MD............n
Jin Ho Lee........................................n
Cynthia Lichtefeld............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
337
338
Disclosures
Jane Liu............................................n
Jet Jianqing Liu, MD........................n
Raymond W. Liu, MD: 6 Orthopediatrics
Spencer Liu, MD: 3B - Pacira
Steve S. Liu, MD..............................n
Yen-Liang Liu..................................n
Adolfo M. Llinas, MD: 2 - Zimmer;
3B - Bayer; 7 - Innnomed
Eric W. Lloyd, MD...........................n
Manuel Llusa-Perez, MD, PhD.........n
Amanda Loftin.................................n
Disclosures
Zhen Lu...........................................n
Daniel MacDonald...........................n
Daniel Lubelski................................n
Enricomaria Lunini..........................n
Lorraine Lipscombe.........................n
Janet Lippett....................................n
Michelle Lorimer..............................n
Tamar Liron.....................................n
Inc.; 3B - Stryker; 3C - DJ
Orthopaedics
Takashi Maeda................................n
Toru Maeda, MD, PhD....................n
Tristan Maerz, MS...........................n
Barbara Maestri, MD.......................n
Domenico Lupariello........................n
Erin Magennis..................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Richard Maiman, BA.......................n
339
Yoshitaka Matsusue.........................n
Ville Mattila.....................................n
Jonas Leif Matzon, MD...................n
Sara Martinez-Martos......................n
Vishwas Malik.................................n
Axel Marx........................................n
Laurence Marck...............................n
Antti Malmivaara.............................n
Brigid N. Maloney, MS....................n
Michael Dennis Maloney, MD: 2, 3B
- Arthrex, Inc.; 4 - Telephus
William J. Maloney, MD: 1 - Wright
Medical Technology, Inc.; 3B Pipeline Orthopaedics; 4 - Abbott,
Gillead, ISTO Technologies, Johnson
& Johnson, Merck, Moximed, Pfizer,
Pipeline Orthopaedics, TJO
Mitchell Maltenfort, PhD.................n
Stefano Marenco..............................n
Blandine Marion..............................n
Umberto Mariotti............................n
Barbara Marks.................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
340
Disclosures
Disclosures
Joe Messana.....................................n
Aaron R. Merriam...........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Nancy H. Miller, MD.......................n
Shinichi Miyazaki.............................n
Young-Jae Moon..............................n
Jeffrey Moore...................................n
Yu Mochizuki, MD..........................n
341
Kenneth Milligan.............................n
Amir S. Mohamed............................n
Alexandre Moreau-Gaudry..............n
Lloyd Morgan..................................n
Michael T. Milone...........................n
Byung-Woo Min, MD......................n
Noriki Miyamoto.............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
342
Disclosures
Sigrid Nachtergaele..........................n
Tomoko Nagano..............................n
Audrey Nebergall.............................n
Christopher D. Murawski................n
Jeanne Nichols.................................n
Disclosures
Yoshihiro Nakamura........................n
Toshitaka Nakamura.......................n
Edward Nickerson...........................n
Dominic Nielsen...............................n
Tuukka T. Niinimaki, MD...............n
Jan-Ake Nilsson, BSc.......................n
Kjell G. Nilsson, MD: 2 - DePuy,
A Johnson & Johnson Company,
Link Orthopaedics, Ossur, Smith
& Nephew, Zimmer, Hereaus; 4 RSA Biomedical; 5 - Eli Lilly, Link
Orthopaedics, Zimmer
Akimoto Nimura, MD.....................n
Ivana Ninkovic, MPH, MS...............n
Hideji Nishida, MD.........................n
Yoshihiro Nishida: 3B - Seikagaku;
5 - Pfizer
Takashi Nishii..................................n
Jared Niska, MD..............................n
Mikko J. Nissi, PhD.........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Nicolas Oliver Noiseux, MD: 3B Wright Medical Technology, Inc.;
5 - DePuy, A Johnson & Johnson
Company, Zimmer
Hidetoshi Nojiri, MD, PhD: 6 - NIHNCCAM
Issei Nomura....................................n
Tomohiro Nomura, MD..................n
Ken J. Noonan, MD: 1, 3B, 5 Biomet
Hilali H. Noordeen, FRCS: 2 - K2M,
Ellipse Technologies, KSpine; 3B Baxter, K2M, Ellipse Technologies,
Kspine
Naudereh Noori...............................n
Jeong-Hwan Oh...............................n
Moo Kyung Oh................................n
Se Heang Oh....................................n
Arturo Olid......................................n
Khalid Odeh.....................................n
Johnny Owens..................................n
Mika P. Paavola, MD.......................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
343
344
Disclosures
MAKO
Alexandra Elizabeth Page, MD........n
Richard Samuel Page, MD, FRACS:
5 - DePuy-Synthes, A Johnson &
Johnson Company, Integra Life
Gherardo Pagliazzi...........................n
Mark W. Pagnano, MD: 1 - DePuy,
A Johnson & Johnson Company,
MAKO, Stryker; 5 - Zimmer; 7 Clinical Orthopaedics and Related
Research
Mark Pahuta, MD............................n
Joshua Pahys, MD: 3B - DePuy, A
Johnson & Johnson Company
Jorma Pajamki, MD, PhD: 3B Zimmer
Nader Paksima, DO: 2, 5 - Stryker;
3B - IMDS, Stryker; 4 - SBI
Elisa Pala, MD.................................n
Disclosures
Gary Pearl........................................n
Efthymios Papasoulis.......................n
Murray J. Penner, MD: 1, 3B Wright Medical Technology, Inc.; 2 Integra LifeSciences, Wright Medical
Technology, Inc., Arthrex, Inc.; 5
- Integra LifeSciences; 6 - Arthrex,
Inc., Biomimetic, ConMed Linvatec,
Synthes, Wright Medical Technology,
Inc., Cartiva
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
345
Mahesh Polavarapu..........................n
Eero Pukkala....................................n
Claire Pulford, MBBS......................n
Luis Pulido, MD...............................n
Pamela A. Pulido, RN, BSN.............n
Pekka Pulkkinen, PhD......................n
Stephanie Pun, MD..........................n
Yushek Pun......................................n
Camilla Pungetti, MD......................n
Timo J.S. Puolakka, MD, PhD:
5 - Smith & Nephew; 6 - DePuy, A
Johnson & Johnson Company
Lalit Puri, MD: 1 - Innomed; 3B Stryker, Salient Surgical, Kinamed
James J. Purtill, MD.........................n
Matthew D. Putnam, MD: 3B,
3C - Dynamic Clinical Systems;
4 - Eli Lilly, Merck; 5 - Acumed,
LLC, DePuy, A Johnson & Johnson
Company, Stryker, Synthes
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
346
Disclosures
Orthopaedics, Stryker
Matthew R. Quigley, MD................n
Stephen Matthew Quinnan, MD:
2 - Smith & Nephew, Orthofix;
3B - DePuy, A Johnson & Johnson
Company, Smith & Nephew,
Orthofix, Inc.
Martin Quirno, MD.........................n
Henning Quitmann, MD..................n
Sheeraz Qureshi, MD: 1 - Zimmer;
2 - Medtronic, Stryker, Zimmer;
3B - Stryker, Zimmer, Medtronic,
Orthofix, Inc.
Radu Racasan, PhD.........................n
Mark D. Rahm, MD: 1 - SpineSmith;
2 - Medtronic Sofamor Danek; 5 K2M
Stefan Rahm, MD............................n
Zain Rahman, MA...........................n
Disclosures
Rishikesan Ramaesh.........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Daniel S. Robertson, MD.................n
Ryan Robertson, MD.......................n
Otto Robertsson, MD, PhD: 4 AstraZeneca
Elizabeth Robinson..........................n
Deirdre Rodericks............................n
Jeffrey A. Rodgers, MD....................n
Mark Rodgers..................................n
Catalina Rodriguez..........................n
Edward Rodriguez, MD: 1 - Zimmer;
4 - MXO Orthopedics
Jose A. Rodriguez, MD: 3B - DePuy,
A Johnson & Johnson Company,
Exactech, Inc., Medacta, Smith &
Nephew; 5 - Exactech, Inc., Wright
Medical Technology, Inc., Smith
& Nephew, DePuy, A Johnson &
Johnson Company
Justin Roebert, MB, ChB.................n
Margaret M. Roebuck, PhD: 1 Biomet; 2 - Biomet, Boerhinger
Ingelheim, Bristol-Myers Squibb,
Pfizer; 3B - Biomet, BoerhingerIngelheim; 3C - DePuy, A Johnson
& Johnson Company; 5 - DePuy,
A Johnson & Johnson Company,
Johnson & Johnson
Kenneth J. Rogers, PhD....................n
Marc Sabourin.................................n
Pierpaolo Rota.................................n
Andrew H. Rotstein.........................n
Jason Rotstein, MD: 6 - Stryker
Stephanie Russo...............................n
David A. Rust, MD..........................n
Scott P. Ryan, MD............................n
Jonathan Rylander, PhD...................n
Daniel B. Ryssman, MD...................n
Ho-Young Ryu, MD.........................n
Robert Ryu......................................n
Shiraz Sabah, MD............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Andrew Rosenberg...........................n
347
348
Disclosures
Vasanth Sathiyakumar.....................n
Keri L. Satterwhite...........................n
Disclosures
Alan L. Schepps................................n
Anthony Alberto Schepsis, MD:
2 - Arthrex, Inc., Arthrosurface,
DePuy, A Johnson & Johnson
Company, Arthrocare, DePuy Mitek,
Smith & Nephew; 3B - Smith &
Nephew, Mitek, Arthrosurface;
5 - Arthrosurface; 6 - Arthrex,
Arthrosurface; 7 - Wolters Kluwer
Health - Lippincott Williams &
Wilkins
Susan A. Scherl, MD: 7 - Wolters
Kluwer Health - Lippincott Williams
& Wilkins
Jonathan R. Schiller, MD: 3B DePuy, A Johnson & Johnson
Company
Kevin Schiller, BS: 3A - CD
Diagnostics
Nicholas K. Schiltz, BS.....................n
Cathy D. Schleck..............................n
Theodore F. Schlegel, MD: 1 - DJ
Orthopaedics; 3B - Arthrocare,
Rotation Medical; 4 - Cayenne
Medical, Caymus
Ryne Sample Schlitz, BS...................n
Andrew H. Schmidt, MD: 1 - Smith
& Nephew, CFI Medical Solutions;
3B - Acumed, LLC, Medtronic,
St. Jude Medical; 3C - Twin Star
Medical, Conventus Orthopaedics;
4 - Conventus Orthopaedics, Epien,
Epix VAN, International Spine and
Orthopaedic Instititute, Twin Star
Medical; 5 - Twin Star Medical; 7 Thieme, Inc.
Andrew H. Schmidt, MD: 1 - Smith
& Nephew, CFI Medical Solutions;
3B - Acumed, LLC, Medtronic,
St. Jude Medical; 3C - Twin Star
Medical, Conventus Orthopaedics;
4 - Conventus Orthopaedics, Epien,
Epix VAN, International Spine and
Orthopaedic Institute, Twin Star
Medical; 5 - Twin Star Medical; 7 Thieme, Inc.
Ann Marie Schmidt..........................n
Robert L. Schmidt, MD, PhD, MBA.n
Brian Schmotzer...............................n
Jennifer Schneider, MS: 3A, 4 - Titan
Spine
Bradley S. Schoch, MD....................n
Mitchell Schoen, BA.........................n
Jonathan G. Schoenecker, MD: 5 ISIS Pharmaceuticals
Perry L. Schoenecker, MD................n
Andrew J. Schoenfeld, MD...............n
Lew C. Schon, MD: 1 - DJ
Orthopaedics, Arthrex, Inc., Darco,
Tornier, Zimmer; 2 - Tornier, Biomet,
Zimmer, Biomimetics; 3B - Arthrex
Inc., Zimmer, Tornier, Biomet,
Biomimetics, Guidepoint Global,
Gerson Lehrman Group, Spinesmith
Holdings; 3C - Royer Biomedical,
Inc., Carestream Health; 4 - Tornier,
Royer Biomedical, Inc., Bioactive
Surgical, Inc., Healthpoint Capital;
5 - Zimmer, Tornier, Arthrex, Inc.,
Spinesmith Holdings, Biomimetics,
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Biomet; 6 - Bioactive Surgical Inc.,
Concepts in Medicine LLC, Smith
Nephew Endoscopy, Orthohelix,
Chesapeake Surgical Biocomposites,
Olympus; 7 - Elsevier
Martijn Schotanus............................n
349
Christa Schueller..............................n
Vinay K. Sharma..............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
350
Disclosures
Disclosures
Dalia Somjen....................................n
R. M. Smith, MD.............................n
Rebecca Speck..................................n
Tim D. Spector, MD: 2 - Norvartis,
Pfizer; 3B - Ono, Expanscience; 5 Pfizer
Edwin E. Spencer Jr., MD: 1, 3B,
4 - Tornier; 5 - DePuy, A Johnson &
Johnson Company, Tornier
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Dempsey S. Springfield, MD: 4 Johnson & Johnson, Merck
Andy Sprowson, MD.......................n
Murray D. Spruiell, MD...................n
Katherine Stiene...............................n
Dongsuk Suh....................................n
Kunal Sukhija...................................n
Donald Nicholas Sullivan, MD........n
Eileen F. Sullivan, BS, RN................n
Matthew Patrick Sullivan, MD.........n
Ryan Sullivan, MD...........................n
Erik Christian Summers, MD...........n
Dan Sun, BS.....................................n
Toru Sunagawa................................n
Sarah A. Sund, BS............................n
Ki Hyuk Sung, MD..........................n
Catherine A. Suppan, BA.................n
American Board of Orthopaedic
Surgery Surgical Skills Task Force
(SSTF)..............................................n
David Surprenant.............................n
Jason M. Sutherland, PhD................n
Werasak Sutipornpalangkul, MD.....n
Fayyaz S. Sutterwala, MD, PhD.......n
Vernon Reid Sutton, MD.................n
Akinobu Suzuki, MD, PhD..............n
Steven James Svoboda, MD..............n
Girish Nanjunda Swamy, MBBS......n
Morgan Marie Swanstrom, MD.......n
Eric F. Swart, MD............................n
Howard J. Sweeney, MD: 3C, 4 - Life
Spine, Inc.
Pat Sweeney, BA...............................n
Alan Swenson, MD, BS....................n
F. Craig Swenson, MD: 4 Bristol-Myers Squibb, Pfizer,
GlaxoSmithKline
Marc F. Swiontkowski, MD: 2
- Pfizer China; 3B - Eli Lilly; 7 Saunders/Mosby-Elsevier, Wolters
Kluwer Health - Lippincott Williams
& Wilkins
Paul Switaj, MD...............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
351
352
Disclosures
Salvatore Tomagra...........................n
Disclosures
Francesco Tentoni............................n
Ann Tomkins...................................n
Laszlo Toth......................................n
Masamitsu Tomioka........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Valter Trombetta..............................n
Alex Trompeter................................n
Robert T. Trousdale, MD: 1, 3B
- DePuy, A Johnson & Johnson
Company, Wright Medical
Technology, Inc., MAKO
Giulia Trovarelli...............................n
Hiroshi Urakawa.............................n
Alex Uhr..........................................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
353
354
Disclosures
Anthony Viste..................................n
Tuomo Ilmari Visuri.........................n
Michael G. Vitale, MD, MPH: 1
- Biomet; 3B - Biomet, Stryker; 5 Synthes
Brantley P. Vitek Jr., MD..................n
Donato Vittore.................................n
Michael Vives, MD: 2 Musculoskeletal Transplant
Foundation; 3B - Zimmer; 4 Accelalox, NOC2 Healthcare
Katie Vo...........................................n
Chao Wang......................................n
Sebastian Warwas............................n
Jean-Philippe Vivona........................n
Disclosures
Yong Wang.......................................n
Keith K. Wannomae.........................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Brian C. Werner, MD.......................n
Clement Werner, MD: 2, 3B Medtronic
Robert Paul Wessel III......................n
Nolan Michael Wessell, MD............n
Philippe Wicart................................n
Howard Widdall: 3A - JRI
Norbert Wiegand.............................n
Douglas M. Worrall.........................n
Baohua Wu......................................n
Minfei Wu........................................n
Thomas H. Wuerz, MD...................n
Jorgen Wullems, MSc: 3B - Biomet
Erin Wylie, BA.................................n
James Wylie, MD.............................n
Robert W. Wysocki Jr., MD.............n
Ding Xia, MSc.................................n
Chengjie Xiong Jr.............................n
Peter Zihao Xu, BA..........................n
Kohei Yabuno, MD..........................n
Mark Aaron Yaffe, MD...................n
Tomonoro Yagi, MD........................n
Madhusudhan R. Yakkanti, MD:
6 - Synthes
Raj Yalamanchili..............................n
Shin Yamada, MD............................n
Ken Yamaguchi, MD: 1 - Tornier,
Zimmer
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Disclosures
Madeleine Willegger.........................n
355
356
Disclosures
Jae-Ho Yang.....................................n
Disclosures
Rebecca Zhu....................................n
Katarzyna Zienkiewicz.....................n
Lee Young-Gil..................................n
Deng Zhao.......................................n
Wenyan Zhao, PhD..........................n
William Yeo.....................................n
Razi Zaidi........................................n
Thomas Zumbrunn..........................n
Justin Zumsteg, MD.........................n
Samuel Yonan..................................n
Rami R. Zanoun..............................n
Faculty disclosure listed as entered in the AAOS Disclosure Database as of October 1, 2013.
The codes after the name are identified as 1 Royalties; 2 Speakers Bureau/paid presentations; 3a. Employee; 3b. Paid consultant; 3c. Unpaid consultant; 4 Stock or stock options;
5 Research or institutional support as a principal investigator has been received; 6 Other financial or material support; 7 Royalties, financial or material support from publishers; n No conflicts to disclose
Technical
Exhibits
Hours:
Wednesday and Thursday
9:00 AM 5:00 PM
Friday
9:00 AM 4:00 PM
358
Technical Exhibits
Technical Exhibits
Beverage Breaks
Food Service
Enjoy complimentary food and beverage items supplied by
many of the exhibitors in their booth. Food service areas
located throughout the exhibit hall will offer a variety of
food and beverage options for purchase.
AAOS Bistro
The AAOS Bistro provides a comfortable setting for
exhibitors and attendees to eat, meet and network. Located
directly on the show floor with an all-inclusive buffet lunch
and available table reservations, Wednesday through Friday
from 11:00 AM to 2:30 PM. Tickets can be purchased in
Lobby G.
Arthrex, Inc.
Biomet
Bioventus
DePuy Synthes
DJO, LLC
Lilly USA, LLC
Maquet
Otto Bock Healthcare
Seating Areas
Park benches are placed throughout the exhibit hall and
additional seating is available at the food service areas and in
the Academy Lounge located in Exhibit Hall G.
Technical Exhibits
AAOS EXHIBITS COMMITTEE
The Exhibits Committee is responsible for evaluating the companies
that exhibit at the annual meeting. The committee also reviews the
exhibits on-site for content, presentation and compliance with FDA
guidelines. During the annual meeting, Joseph T. Moskal, MD,
chair of the committee, can be reached onsite at the AAOS Exhibits
Office located in Room 235 of Morial Convention Center.
Joseph T. Moskal, MD, Roanoke, VA, Chair
Dennis B. Brooks, MD, Pepper Pike, OH
Jonathan J. Carmouche, MD, Roanoke, VA
Karen S. Duane, MD, Newberry, FL
Benjamin Goldberg, MD, Chicago, IL
Donald H. Lee, MD, Nashville, TN
John Walter Mann III, MD, Roanoke, VA
James V. Nepola, MD, Iowa City, IA
Rick F. Papandrea, MD, Waukesha, WI
John M. Schwartz, MD, FACS, New York, NY
John R. Tenny, MD, Dallas, TX
Scott D. Weiner, MD, Akron, OH
EXHIBITOR LISTINGS
AdvaMed and PhRMA
The product code ADVA following an exhibit company listing
indicates that the exhibitor is a member of the Advanced Medical
Technology Association and subscribes to its Code of Ethics that
govern member relationships with health care professionals,
including orthopaedic surgeons. AdvaMed is the worlds largest
trade association representing manufacturers of medical devices,
equipment, diagnostic products and health information systems.
AdvaMed members produce nearly ninety percent of the health
care technology purchased annually in the U.S. and more than
fifty percent purchased annually around the world. AdvaMed is
a leader in compliance. Its Code of Ethics on Interactions with
Health Care Professionals provides ethical and legal standards
that are critical to the medical device industrys ability to continue
its collaboration with health care professionals. This Code of
Ethics went into effect in January 2004. The AdvaMed Code of
Ethics may be found at www.aaos.org/IndustryRelationships or
http://www5.aaos.org/industryrelationships/standards.cfm
PRODUCT LISTINGS
For your convenience, the technical exhibiting companies are
listed alphabetically and the products/services they offer are
identified by the following codes.
ADVA
AdvaMed Member
AM
Anatomical Model
AO
Allied Organizations
AS
Arthroscopic Systems
Blood Products
BLD
BNE
Bone Products
BB
Business to Business/OEM
CS
Casting Supplies & Equipment
COM
Computer Hardware/Software
DEV Devices
Diagnostic Equipment
DI
EDU
Education Patient and Physician
EMR
Electronic Medical Records
FPD
Facility Planning & Design
FIN
Financial Planning/Investments
FRST
First-Time Exhibitor
Image Guiding/Navigation Systems
IMG
I Implants
Market Research Services
MKT
MS
Medical Supplies
MRI MRI
O Orthoses
OTH Other
PH Pharmaceuticals
PHRM
PhRMA Member
PR
Physician Recruitment
PM
Practice/Office Management
P Prostheses
PUB Publishers
Rehabilitation/Exercise Equipment
REHB
SF
Shoes & Foot Supplies
SG
Soft Goods (Supports)
SURG
Surgical Equipment
Surgical Instruments
SI
T
Tissue Products
XRAY X-Ray
Technical Exhibits
359
360
Technical Exhibits
Technical Exhibits
Wednesday, March 12
Managing your Internet Reputation
9:30 - 10:15 AM
Thursday, March 13
9:30 - 10:15 AM
Office Websites: How to Save Time and Money
Wednesday, March 12
10:15 - 11:30 AM
Social Media for the Orthopaedic Surgeon
Thursday, March 13
Defending Your Internet Reputation
10:30 - 11:15 AM
Wednesday, March 12
Killer Apps
Thursday, March 13
11:30 AM - 12:15 PM
Educational iPad Apps for Orthopaedic Surgeons
11:30 AM - 12:15 PM
Wednesday, March 12
1:30 - 2:15 PM
Filmless Radiography: PACS & the Totally Electronic Office
Presenter: A. Herbert Alexander, MD
Discuss components of filmless radiology (FR), the importance
PACS, office design, conversion issues and importance of
integrating the practice manager, EHR, and PACS.
Wednesday, March 12
2:30 - 3:15 PM
Implementation and Utilization of Voice-Recognition
Software: A Study in Patience, Persistence and Payoff
Presenter: Michael A. Rauh, MD
Participants will understand the cost and times associated with
traditional transcription; and learn costs and techniques of
implementation of voice recognition software.
Wednesday, March 12
3:30 - 4:15 PM
Four Apps That Will Change the Way You Practice
Presenter: John P. Andrawis, MD
Four mobile health apps that will improve the doctor-patient
relationship, interaction with staff, education, and ultimately
improve patient care and satisfaction.
Thursday, March 13
1:30 - 2:15 PM
Must-have Smartphone Apps for Orthopaedic Surgeons
Presenter: Orrin Franko, MD
Attend this live demonstration of the must-have apps for your
practice for clinics, education, and productivity.
Thursday, March 13
2:30 - 3:15 PM
Innovations in Digital Media Presentation
Presenter: Andrew J. Pastor, MD
Learn how to enhance your academic lectures by using new and
exciting presentation format known as Prezi.
Thursday, March 13
3:30 - 4:15 PM
Search Engine Marketing for Your Practice
Presenter: Christian Veillette, MD
Learn key search engine marketing techniques to make sure you
are getting the most targeted traffic from your office website.
Technical Exhibits
Friday, March 14
9:30 - 10:15 AM
Useful iPhone/iPad Apps in Your Practice and Life
Presenter: Scott F. M. Duncan, MD, MPH, MBA
A review of real life scenarios in how surgeons can utilize certain
Apps on the iPhone and iPad in their professional and personal
lives. Live demonstration of Epic EMR client, Dictamus and
Dragon dictation options, Dr. Goniometer, FRAX, MedCalc Pro,
AO surgery reference, PubMed App, Tripit, and more.
Friday, March 14
10:30 - 11:15 AM
Five Secrets to Getting New Patients with Your Website
Presenter: C. Noel Henley, MD
Is your website bringing in new patients each month? Can you
honestly claim your website pays for itself every year? Five
concrete ways your orthopaedic practice website can and should
be bringing in new patients every month.
361
Friday, March 14
1:30 - 2:15 PM
Movies Speak a Million Words - Take Your Movie from
Camera to PowerPoint
Presenter: Randipsingh R. Bindra, MD
Live demonstration of the key steps of editing and encoding
your captured video into a slick movie that can be inserted into a
PowerPoint presentation.
Friday, March 14
2:30 - 3:15 PM
Maintaining Privacy: Navigating HIPAA in Medical Health
App Implementation
Presenters: John P. Andrawis, MD and Michaela Bantilan
HIPAA basics to avoid unanticipated exposure of risk and
liabilities when implementing medical health apps and
smartphones into your practice.
Friday, March 14
11:30 AM - 12:15 PM
On the Horizon: iPads and Smartphones to Enhance Your
Practice
Presenter: Orrin Franko, MD
Learn about cutting edge technologies to enhance patient care,
sync data between medical devices, and expand your virtual
practice network.
Technical Exhibits
362
Technical Exhibits
Topic
Experts
Wednesday, March 12
10:30 11:15 AM
11:30 AM 12:15 PM
HIP
SPINE
1:30 2:15 PM
2:30 3:15 PM
3:30 4:15 PM
TRAUMA
Todd J. Albert, MD
Sheeraz Qureshi, MD
David L. Nelson, MD
David C. Ring, MD
Pierre J. Hoffmeyer, MD
Steven A. Stuchin, MD
Fernando de la Huerta, MD
Lawrence X. Webb, MD
Robert T. Trousdale, MD
Thursday, March 13
9:30 10:15 AM
KNEE
10:30 11:15 AM
SHOULDER
Carl J. Basamania, MD
Christian Gerber, MD
HIP
Thorsten Gehrke, MD
1:30 2:15 PM
TUMOR
Edward Y. Cheng, MD
Ilya Iofin, MD
2:30 3:15 PM
Lew C. Schon, MD
3:30 4:15 PM
David G. Lewallen, MD
9:30 10:15 AM
SPORTS MEDICINE
Michael D. Maloney, MD
10:30 11:15 AM
HAND
Edward Diao, MD
Technical Exhibits
11:30 AM 12:15 PM
Friday, March 14
11:30 AM 12:15 PM
PEDIATRIC
Stuart L. Weinstein, MD
1:30 2:15 PM
SHOULDER
Scott P. Steinmann, MD
Joseph D. Zuckerman, MD
2:30 3:15 PM
Daniel J. Berry, MD
Technical Exhibits
CompAny
Booth
No.
Exhibitor Listing as of January
14, 2014.
The American Academy of Orthopaedic
Surgeons invites you to visit the
technical exhibits as a part of your
educational experience at the annual
meeting. The products displayed in the
technical exhibits area and the uses
suggested by the manufacturer do not
represent an endorsement nor imply
that the products have been evaluated
or approved by the American Academy
of Orthopaedic Surgeons.
Company
Booth No.
Pelham, AL 35124
Phone: (205)987-0935
Web: www.3dmedicalconcepts.com
Product Codes: FRST, SF, SI
Stevensville, MD 21666
Phone: (410)604-6393
Web: www.3pointproducts.com
Product Codes: MS, O, REHB, SG
450
5131
Washington, DC 20002
Phone: (202)548-4150
Web: www.aaos.org
Product Codes: EDU, OTH
4213
Berlin, 12099
Germany
Phone: 49-30750190
Web: www.aap.de
Product Codes: BB, BNE, I, SI, T
1049
Acell, Inc.
5021
Aesculap, Inc.
1249
ACIGI Relaxation/Fujiiryoki
1241
6122
6049
1340
Columbia, MD 21046
Phone: (800)826-2926
Web: www.acell.com
Product Codes: DEV
Fremont, CA 94538
Phone: (510)651-9088
Web: www.drfuji.com
Product Codes: REHB
Memphis, TN 38120
Phone: (901)762-0352
Web: www.activeimplants.com
Product Codes: DEV, I
Advanced Biologics
Advanced Endoscopy
Devices, Inc.
3832
1557
Alignmed 1541
Santa Ana, CA 92705
Phone: (866)987-5433
Web: www.ebilife.com
Product Codes: OTH, SG
533
Acton, MA 01720
Phone: (800)433-5774
Web: www.allenmedical.com
Product Codes: AS, DEV, SURG
4720
AlloSource 1441
Aerobiotix 7020
Centennial, CO 80111
Phone: (720)873-0213
Web: www.allosource.org
Product Codes: BNE, OTH, T
6812
2639
Bothell, WA 98021
Phone: (425)949-4900
Web: www.alpinionusa.com
Product Codes: DI, FRST, OTH
1341
AllMeds 4641
AdvancedMD Software
Miamisburg, OH 45342
Phone: (937)416-1977
Web: www.aerobiotix.com
Product Codes: FRST, OTH, SURG
Tokyo, 105-0012
Japan
Phone: 81-364358358
Web: www.ai-medic.co.jp
Product Codes: I, SI
Cheshire, CT 06410
Phone: (230)271-6499
Product Codes: BNE, FRST, PH
5349
Alpha Listings
Brea, CA 92821
Phone: (888)933-9991
Web: www.novitasmedical.com
Product Codes: BB, DEV, MS, O, OTH
Alexion 6815
Advanced Orthopaedic
Solutions, Inc.
Torrance, CA 90501
Phone: (310)533-9966
Web: www.aosortho.com
Product Codes: DEV, I, SI
Abrexis 641
AccelLAB Inc.
3037
Booth No.
2131
Fairfield, OH 45014-2200
Phone: (513)984-4112
Web: www.accutektesting.com
Product Codes: OTH
Carlsbad, CA 92008
Phone: (800)272-0267
Web: www.advancedbiologics.com
Product Codes: BNE, DEV
Rosemont, IL 60018
Phone: (800)626-6726
Web: www.aaos.org
Product Codes: EDU, PM, PUB
Company
Hillsboro, OR 97124
Phone: (888)627-9957
Web: www.acumed.net
Product Codes: ADVA, I, SI
aap Implantate AG
Booth No.
Acumed 5549
A
AAOS Advocacy Booth
Company
363
364
Technical Exhibits
Company
Booth No.
AME/Orthotec International
3331
American 3B Scientific
4322
Miami, FL 33155
Phone: (305)662-2855
Web: www.artroscopia.net
Product Codes: AS, I, SI, SURG
Tucker, GA 30084
Phone: (888)326-6335
Web: www.3bscientific.com
Product Codes: AM, EDU, REHB, SG
Indianapolis, IN 46240
Phone: (800)247-9699
Web: www.aaoe.net
Product Codes: PM
American Imaging
4421
2738
841
Doral, FL 33122
Phone: (305)436-0599
Web: www.endoscopia.com
Product Codes: AS, BNE, DEV, I, P, SI, SURG
Alpha Listings
American Society of
Orthopaedic Assistant
Indianapolis, IN 46240
Phone: (800)280-2390
Web: www.asopa.org
Product Codes: AO
Amniox Medical
Marietta, GA 30067
Phone: (888)709-2140
Web: www.amnioxmedical.com
Product Codes: I, T
4119A
5842
Amplitude 1571
Valence, 26000
France
Phone: 33-623612061
Web: www.amplitude-ortho.com
Product Codes: I, IMG
Booth No.
ARGOmedical AG
1331
7130
4519
4412
Nashville, TN 37215
Phone: (615)665-1283
Web: www.amsurg.com
Product Codes: BB, EDU, FPD, FRST, MKT,
OTH, PR
Guangzhou, 511356
China
Phone: 86-2082986918 x112
Web: www.apexitool.net
Product Codes: DEV, FRST, I, MS, SI, SURG
632
1734
Arthrex, Inc.
6029
Hopkinton, MA 01748
Phone: (508)497-8950
Web: www.arteriocyte.com
Product Codes: BLD, DEV, SI
Applied Medical
1356
4530
ArthroCare 1130
6013
ArthroPlastics, Inc.
1942
Aptiv Solutions
7019
Arthrosurface, Inc.
6529
Arcam AB
4072
Parsippany, NJ 07054
Phone: (973)290-8228
Web: www.amjorthopedics.com
Product Codes: PUB
Company
AMSURG 4633
Highland, IL 62249
Phone: (217)663-8892
Web: www.apexnetworkpt.com
Product Codes: OTH, PM, REHB
American Journal of
Orthopedics 5719
American Medical
Endoscopy, Inc.
Booth No.
Hanover, MD 21076
Phone: (800)300-5433
Web: www.anatomygifts.org
Product Codes: AM, BNE, EDU, FRST, T
Company
Carrollton, TX 75006
Phone: (866)960-6890
Web: www.aprima.com
Product Codes: EMR, PM
Dayton, OH 45405
Phone: (937)278-6547
Web: www.apsbiomedical.com
Product Codes: I, OTH
Reston, VA 20190
Phone: (703)483-6400
Web: www.aptivsolutions.com
Product Codes: ADVA, DEV, FRST, OTH, PH
Molndal, SE 431 37
Sweden
Phone: 46-317103200
Web: www.arcam.com
Product Codes: BNE, I
Arcamed, LLC
Indianapolis, IN 46241
Phone: (317)375-7733
Web: www.arcamed.com
Product Codes: BB, DEV, SURG
Naples, FL 34108
Phone: (239)643-5553
Web: www.arthrex.com
Product Codes: AS, BLD, DEV, EDU, I, IMG,
SI, SURG, T
Austin, TX 78735
Phone: (512)391-3900
Web: www.arthrocare.com
Product Codes: ADVA, DEV, I, SI
Franklin, MA 02038
Phone: (866)261-9294
Web: www.arthrosurface.com
Product Codes: ADVA, AS, BNE, DEV, I, P, SI,
SURG
Arzzt 4853
Napoles, DF 03810
Mexico
Phone: 52-5590001335
Web: www.arzzt.com
Product Codes: BNE, DEV, I, SI
6520
Asociacion Argentina de
Ortopedia y Traumatologia
Buenos Aires, 1018
Argentina
Phone: 54 11 4801-8532
Web: www.aaot.org.ar
Product Codes: AO
4123A
Technical Exhibits
CompAny
Booth No.
Roma, 00173
Italy
Phone: 39-863517956
Web: www.assuteurope.com
Product Codes: DEV, I, O, SURG
3231
5737
331
6053
Avalign Technologies
837
2141
Marietta, GA 30066
Phone: (770)429-8477
Web: www.bauerfeindusa.com
Product Codes: O, P, SF, SG
Raleigh, NC 27615
Phone: (919)800-0020
Web: www.baxanosurgical.com
Product Codes: ADVA, DEV, I, SI
930
6918
1635
Bacterin 6641
Beijing, 100021
China
Phone: 86-1058611761
Web: www.clzd.com
Product Codes: DEV, I, P
Beijing, 101204
China
Phone: 86-01060999862
Web: www.fulekeji.com
Product Codes: BNE, I, MS, O, P, SI
Benvenue Medical
7212
Berkeley Advanced
Biomaterials, Inc.
1433
Berkeley, CA 94710
Phone: (510)883-0500
Web: www.ostetic.com
Product Codes: BNE, DEV, I, T
357
Memphis, TN 38103
Phone: (614)551-9543
Web: www.bwcrutches.com
Product Codes: DEV, FRST, REHB
BioAccess 2554
Baltimore, MD 21224
Phone: (410)675-8586
Web: www.bioaccess.com
Product Codes: SI, SURG
Biocomposites 6521
4431
3949
Wilmington, NC 28405
Phone: (910)350-8015
Web: www.biocomposites.com
Product Codes: BNE, DEV, I
BioD, LLC
4932
Biodynamic Research
Corporation (BRC)
7221
6148
Memphis, TN 38120
Phone: (901)417-7868
Web: www.biodlogics.com
Product Codes: T
Ocala, FL 34482
Phone: (352)304-5149
Web: www.biologictherapies.com
Product Codes: BB, BNE, DEV, OTH, SI,
SURG, T
Alpha Listings
5818
Troy, MI 48083
Phone: (800)521-2192
Web: www.beckerorthopedic.com
Product Codes: O
Booth No.
Deerfield, IL 60015
Phone: (224)948-2913
Web: www.baxterbiosurgery.com
Product Codes: BNE, DEV
Albany, NY 12203
Phone: (888)450-4225
Web: www.bblmedicalfacilities.com
Product Codes: FPD
Company
Becker Orthopedic
B
Belgrade, MT 59714
Phone: (406)388-0480
Web: www.bacterin.com
Product Codes: BNE, DEV
Puteaux, 92800
France
Phone: 33-147784600
Web: www.avicenne.com
Product Codes: I, MKT, P, SI, SURG
Alachua, FL 32615
Phone: (888)296-4361
Web: www.axogeninc.com
Product Codes: I, T
Zurich, 8050
Switzerland
Phone: 41-443058000
Web: www.fisso.com
Product Codes: DEV, MS, SURG
AVICENNE 3164
AxoGen, Inc.
Baitella AG
Westerville, OH 43082
Phone: (800)428-2847
Web: www.bankofamerica.com
Product Codes: FIN, PM
Akron, OH 44308
Phone: (330)572-1673
Web: www.abiakron.org
Product Codes: AM, BB, EDU, FRST, OTH
Booth No.
Autocam Medical
Company
365
366
Technical Exhibits
Company
Booth No.
Biomatlante 2967
Vigneux de Bretagne, 44360
France
Phone: 33-228020009
Web: www.biomatlante.com
Product Codes: BB, BNE, I
Biomet 1749
Warsaw, IN 46581
Phone: (574)267-6639
Web: www.biomet.com
Product Codes: ADVA, BLD, BNE, DEV, EDU,
I, PM, SI, T
BioPro, Inc.
Bioretec Ltd
Tampere, 33720
Finland
Phone: 358-207789500
Web: www.bioretec.com
Product Codes: DEV, I
BIOTECK S.p.A.
Arcugnano, VI 36057
Italy
Phone: 39-0444289366
Web: www.bioteck.com
Product Codes: BNE
2041
2130
3330
Durham, NC 27703
Phone: (800)396-4325
Web: www.bioventusglobal.com
Product Codes: DEV
1235
1531
Alpha Listings
Seoul, 135-270
Korea, Republic of
Phone: 82-25712500
Web: www.bkmeditech.com
Product Codes: I, SI
Booth No.
735
Plymouth, MN 55441
Phone: (763)452-4950
Web: www.bluebelttech.com
Product Codes: I, IMG, SURG
5929
BLOXR 2538
Salt Lake City, UT 84123
Phone: (801)590-9880
Web: www.bloxr.com
Product Codes: DEV, FRST, OTH, XRAY
Company
Booth No.
Brasseler USA
Savannah, GA 31419
Phone: (800)569-6738
Web: www.brasselerusa.com
Product Codes: BNE, SI, SURG
1841
5820
Breg 1649
7031
Brownmed 4313
Irving, TX 75063
Phone: (214)647-6161
Web: www.bluestarimaging.com
Product Codes: OTH
BME 6534
San Antonio, TX 78245
Phone: (210)881-0018
Web: www.bme-tx.com
Product Codes: DEV, I
Bodycote 6719
Bioventus 5819
Eagan, MN 55121
Phone: (651)683-8089
Web: www.birdcronin.com
Product Codes: O, REHB, SF, SG, SI
Company
Carlsbad, CA 92010
Phone: (800)897-2734
Web: www.breg.com
Product Codes: ADVA, DEV, O, P, PM, SG
BSN Medical
1735
1931
Charlotte, NC 28209
Phone: (800)552-1157
Web: www.bsnmedical.com
Product Codes: CS, SG
5613
3955
Nogent, 52800
France
Phone: 33-325027289
Web: www.c2f-implants.com
Product Codes: I, P, SI
Bonutti Technologies
1941
Cannuflow, Inc.
4230
Effingham, IL 62401
Phone: (217)342-3412
Web: www.bonuttitechnologies.com
Product Codes: DEV, I, O, REHB, SURG
5913
6512
Kenosha, WI 53144
Phone: (262)925-1374
Web: www.bradshaw-medical.com
Product Codes: SI
Westchester, IL 60154
Phone: (708)409-1343
Web: www.brainlab.com
Product Codes: DEV, IMG, SI
Churubusco, IN 46723
Phone: (260)693-2167
Web: www.catool.com
Product Codes: BB, DEV, I, P, SI
C2F Implants
Plymouth, MN 55447
Phone: (763)559-1830
Web: www.bonefoam.com
Product Codes: SURG
Brainlab
3869, 3973
Jupiter, FL 33477
Phone: (877)772-5571
Web: www.captivaspine.com
Product Codes: BB, BNE, DEV, I, SI
3436
167
241
Technical Exhibits
CompAny
Booth No.
Company
CARE 4512
Ceterix Orthopaedics
CareCloud 4413
CG Bio
Miami, FL 33126
Phone: (305)775-1195
Web: www.carecloud.com
Product Codes: EMR, FRST, PM
CareCredit 4423
Costa Mesa, CA 92626
Phone: (800)300-3046
Web: www.carecredit.com
Product Codes: FRST, OTH
CareFusion 1136
San Diego, CA 92130
Phone: (888)876-4287
Web: www.carefusion.com
Product Codes: MS, OTH, SI
Case Medical
Mahwah, NJ 07430
Phone: (201)831-0005
Web: www.casesbysource.com
Product Codes: BB, MS
Cayenne Medical
Scottsdale, AZ 85260
Phone: (480)502-3661
Web: www.cayennemedical.com
Product Codes: AS, DEV, I
Floresville, TX 78114
Phone: (512)940-5989
Web: www.cdcdesigninc.com
Product Codes: AM
Cerapedics, Inc.
Westminster, CO 80021
Phone: (303)974-6275
Web: www.cerapedics.com
Product Codes: BNE, DEV
1536
1430
1549
7123
Changzhou, 213164
China
Phone: 86-51986522226
Web: www.wastonmedical.com
Product Codes: BB, BNE, I, MS, SI
ChartLogic, Inc.
Cleveland, OH 44122
Phone: (877)478-9106
Web: www.checkpointsurgical.com
Product Codes: ADVA, DEV, SI, SURG
261
3757
ChoiceSpine, LP
Knoxville, TN 37919
Phone: (865)246-3333
Web: www.choicespine.net
Product Codes: I
4136
Citieffe S.r.l.
1663
7213
Bologna, 40012
Italy
Phone: 39-3666446930
Web: www.citieffe.com
Product Codes: DEV, I, SI
CME/1st-Dragon 4657
4331
1334
4441
6055
Chinese Orthopaedic
Association 4218A
Booth No.
Brea, CA 92821
Phone: (800)566-9687
Web: www.clinicalresolution.com
Product Codes: BLD, DEV, FRST, T
Beijing, 1018
China
Web: www.coachina.org
Product Codes: AO
2270
Company
6113
St Petersburg, FL 33704
Phone: (813)928-7166
Web: www.1st-dragon.com
Product Codes: COM, FRST,
3234
Collect Rx
4756
4623
651
Oakland, NJ 07436
Phone: (201)405-1477
Web: www.collagenmatrix.com
Product Codes: DEV
Rockville, MD 20850
Phone: (301)230-2440
Web: www.collectrx.com
Product Codes: FIN, PM
Franklin, TN 37067
Phone: (800)367-6813
Web: www.chsmedcareers.com
Product Codes: PR
Kettering, OH 45420
Phone: (800)684-7783
Web: www.communitytissue.org
Product Codes: T
Compulink Business
Systems, Inc.
4568
ConforMIS 149
Bedford, MA 01730
Phone: (781)345-9001
Web: www.conformis.com
Product Codes: I
132
ConMed 2249
Utica, NY 13502
Phone: (800)237-0169
Web: www.conmed.com
Product Codes: AS, COM, DEV, EDU, I, SI,
SURG, T
Alpha Listings
Booth No.
367
368
Technical Exhibits
Company
Booth No.
Consensus Orthopedics
5835
ContainMed, Inc.
1034
Booth No.
Booth No.
4049
4049
Cybertech Medical
5657
DeRoyal 4041
Cytonics Corporation
5830
3035
1141
Devicix, LLC
3630
DGIMed Ortho
1333
2838
3438
DJO Global
1349
Speedway, IN 46224
Phone: (317)487-8800
Web: www.containmed.com
Product Codes: SURG
773
CORFLEX INC.
3148
1543
Company
Cleveland, OH 44106
Phone: (216)445-0814
Web: www.customorthopaedics.com
Product Codes: AM, EDU, IMG, SI
La Verne, CA 91750
Phone: (800)220-4224
Web: www.cybertechmedical.com
Product Codes: O
Jupiter, FL 33458
Phone: (561)575-4451
Web: www.cytonics.com
Product Codes: BLD, OTH
D
Danco Anodizing
1840
Darco International
1741
Covidien 3749
5223
Mansfield, MA 02048
Phone: (800)962-9888
Web: www.covidien.com
Product Codes: ADVA, DEV, MS, SI, SURG
Manchester, NH 03109
Phone: (603)623-3344
Web: www.corflex.com
Product Codes: O, SG
Corin Group
Geneva, IL 60134
Phone: (630)232-2510
Web: www.curasurgical.com
Product Codes: MS
Alpha Listings
Company
Arcadia, CA 91006
Phone: (626)445-3303
Web: www.danco.net
Product Codes: DEV, DI, I, SI, SURG
2949
Huntington, WV 25701
Phone: (304)522-4883
Web: www.darcointernational.com
Product Codes: SF, SG
3073
Curexo Technology
Corporation 3859
Fremont, CA 94539
Phone: (510)249-2300
Web: www.robodoc.com
Product Codes: SURG
5520
Bloomingdale, IL 60108
Phone: (800)800-6006
Web: www.delmedical.com
Product Codes: DI, XRAY
Delphi of TeamHealth
Morrisville, NC 27560
Phone: (866)885-5522
Web: www.delphihp.com
Product Codes: PR
Raynham, MA 02767
Phone: (508)880-8100
Web: www.depuyspine.com
Product Codes: SI, SURG
Powell, TN 37849
Phone: (888)938-7828
Web: www.deroyal.com
Product Codes: I, MS, REHB, SG
Ronkonkoma, NY 11779
Phone: (631)585-3300
Web: www.DesignsForVision.com
Product Codes: SURG
Minnetonka, MN 55343
Phone: (952)582-6700
Web: www.dgimedortho.com
Product Codes: DEV, I, SI, SURG
2534
Arnold, MD 21012
Phone: (410)421-5550
Web: www.ultrasoundmsk.com
Product Codes: DI, IMG
4736
Pflugerville, TX 78660
Phone: (512)520-6802
Web: www.directedmfg.com
Product Codes: DEV, I, SI, SURG
Vista, CA 92081
Phone: (760)734-3125
Web: www.djoglobal.com
Product Codes: DEV, I, MS, P, REHB, SF, SG,
SI, SURG
Technical Exhibits
CompAny
Booth No.
DragonBio Implants
7029
Shenzhen, 518057
China
Phone: 86-75581886815
Web: www.dragonbio.com
Product Codes: BB, BNE, FRST, I, IMG, MRI,
SI, SURG, XRAY
Wilmington, NC 28405
Phone: (910)791-0009
Web: www.drycorp.com
Product Codes: CS, MS, P
DryCast, LLC
Mahwah, NJ 07430
Phone: (646)561-2881 EXT 101
Web: www.drycast.com
Product Codes: CS, FRST, MS, SF
DSM Biomedical
Exton, PA 19341
Phone: (484)713-2100
Web: www.dsm.com/medical
Product Codes: OTH
DTC Healthcom
5252
6154
3133
7022
7222
Irvine, CA 92618
Phone: (949)837-3600
Web: www.ellipse-tech.com
Product Codes: FRST, I
4634
635
2449
Baldwin, NY 11510
Phone: (516)277-9000
Web: www.elliquence.com
Product Codes: DEV, SURG
Elsevier
7235
5213, 5315
Philadelphia, PA 19103
Phone: (215)239-3900
Web: www.us.elsevierhealth.com
Product Codes: PUB
Ebone 3131
6955
eClinicalWorks 4734
Endolab GmbH
Thansau/Rohrdorf, 83101
Germany
Phone: 49-80312313230
Web: www.endolab.org
Product Codes: BB, I, OTH
Endotec Inc.
Irvine, CA 92618
Phone: (800)323-9890
Web: www.endotec.com
Product Codes: DEV, I
Washington, PA 15301
Phone: (724)746-6050
Web: www.ensinger-ind.com
Product Codes: SI, SURG
6213
EOS Imaging
2335
Novi, MI 48377
Phone: (248)306-0143
Web: www.eos.info
Product Codes: AM, BB, CS, DEV, I, O, P, SI,
SURG
Cambridge, MA 02138
Phone: (678)564-5400
Web: www.eos-imaging.com
Product Codes: DI, XRAY
Aventura, FL 33180
Phone: (305)776-8837
Web: www.ergoactives.com
Product Codes: DEV, MS
Ermi, Inc.
6015
5449
5731
4241
Ensinger 3135
Atlanta, GA 30324
Phone: (404)687-0505
Web: www.getmotion.com
Product Codes: DEV
359
2231
Etex Corporation
3034
Eurocoating S.p.A.
1530
Indianapolis, IN 46250
Phone: (800)428-4374
Web: www.esaoteusa.com
Product Codes: DI, IMG, MRI
Cambridge, MA 02139
Phone: (617)577-7270
Web: www.etexcorp.com
Product Codes: BNE, T
Alpha Listings
Kenosha, WI 53144
Phone: (262)553-2111
Web: www.medicalties.com
Product Codes: EDU, OTH
Booth No.
Ergoactives 535
Madison, WI 53715
Phone: (608)270-6400
Web: www.emdat.com
Product Codes: COM, FRST, PM
Emovi, Inc.
Company
Emdat 4632
Westborough, MA 01581
Phone: (508)836-2700
Web: www.eclinicalworks.com
Product Codes: EMR, PM
Element Orthopedics
Elliquence LLC
Booth No.
ElliptiGO Inc.
Company
369
370
Technical Exhibits
Company
Booth No.
Evonik Corporation
1350
Exactech, Inc.
2261
Parsippany, NJ 07054
Phone: (973)929-8000
Web: www.evonik.com
Product Codes: BB, I, OTH
Gainesville, FL 32653
Phone: (800)392-2832
Web: www.exac.com
Product Codes: ADVA, BLD, BNE, DEV, I,
IMG, SI, T
Exscribe, Inc.
4549
1035
Bethlehem, PA 18015
Phone: (610)419-2050
Web: www.exscribe.com
Product Codes: COM, EMR, PM
Parsippany, NJ 07054
Phone: (973)588-8980
Web: www.extremitymedical.com
Product Codes: DEV, I
Ferring Pharmaceuticals
Parsippany, NJ 07054
Phone: (973)796-1600
Web: www.euflexxa.com
Product Codes: DEV, PHRM
FH Orthopedics
Heimsbrunn, 68990
France
Phone: 33-389819092
Web: www.fhorthopedics.com
Product Codes: I, P
Alpha Listings
Fidia Pharma
Parsippany, NJ 07054
Phone: (908)342-5281
Web: www.hyalgan.com
Product Codes: DEV, PHRM
4134
3767
Horsham, PA 19044
Phone: (215)394-8909
Web: www.flowerortho.com
Product Codes: FRST, I
Flow-FX LLC
5834
Footmaxx, Inc.
5852
Mokena, IL 60448
Phone: (219)670-0410
Product Codes: DEV, I
Roanoke, VA 24035
Phone: (800)779-3668
Web: www.footmaxx.com
Product Codes: O
6051
Stamford, CT 06902
Phone: (203)324-2000
Web: www.fujiprivatepractice.com
Product Codes: DI, XRAY
2239
973
436
Roselle, IL 60172
Phone: (630)815-4818
Web: www.fusiononeinc.com
Product Codes: EMR
Fx Solutions
VIRIAT, 01440
France
Phone: 33-474553555
Web: www.fxsolutions.fr
Product Codes: DEV, I, P, SI
Game Ready
Concord, CA 94520
Phone: (888)426-3732
Web: www.gameready.com
Product Codes: ADVA, DEV, REHB
GE Healthcare
2837
Gensco Laboratories
4066
Milwaukee, WI 53201
Phone: (262)544-3011
Web: www.gehealthcare.com
Product Codes: DEV, DI, EMR, MRI, PM,
SURG, XRAY
GermedUSA 4950
4323
Globus Medical
6849
Audubon, PA 19403
Phone: (610)930-1800
Web: www.globusmedical.com
Product Codes: ADVA, DEV, I, SI
GPI Prototype
6120
GraMedica 1630
1537
Macomb, MI 48042
Phone: (586)677-9600
Web: www.gramedica.com
Product Codes: I
Greatbatch Medical
7015
5557
Grafton, WI 53024
Phone: (866)546-0010
Web: www.gauthierbiomedical.com
Product Codes: SI
GMReis 2455
FusionOne Electronic
Healthcare 4637
3535
Fairfield, NJ 07004
Phone: (973)227-6882
Web: www.gibraltarlabsinc.com
Product Codes: FRST, OTH
541
Neenah, WI 54956
Phone: (920)486-5147
Web: www.fi-3d.com
Product Codes: FRST, SURG
Booth No.
Company
Miramar, FL 33027
Phone: (855)743-6726
Web: www.genscolabs.com
Product Codes: PH
Fused Innovation
Warren, NJ 07059
Phone: (888)633-5843
Web: www.flagshipsurgical.com
Product Codes: AS, BB, DEV, MS, SF, SG, SI,
SURG
Flower Orthopedics
Booth No.
F
FCS Medical
Company
6541
Minneapolis, MN 55441
Phone: (763)951-8207
Web: www.greatbatchmedical.com
Product Codes: ADVA, I, SI
1363
Technical Exhibits
CompAny
Booth No.
Company
Booth No.
4537
Groupe Lepine
1669
Seattle, WA 98109
Phone: (206)448-6192
Web: www.grouphealthphysicians.org
Product Codes: PR
Genay, 69727
France
Phone: 33-472330295
Web: www.groupe-lepine.com
Product Codes: I, P, SG, T
GS Medical
Soquel, CA 95073
Phone: (831)477-1307
Web: www.gsmedicalusa.com
Product Codes: ADVA, DEV, I, SI
gSource, LLC
Emerson, NJ 07630
Phone: (201)599-2277
Web: www.gsource.com
Product Codes: BB, SI
Twinsburg, OH 44087
Phone: (800)800-3106
Web: www.hitachimed.com
Product Codes: DI, IMG, MRI
1041
Boston, MA 02142
Phone: (425)418-2774
Web: www.halifaxbiomedical.com
Product Codes: DI, FRST, SI, XRAY
Hames Orthotech
Florence, AL 35630
Phone: (256)766-3338
Web: www.hamesorthotech.com
Product Codes: FRST, O, SG
3734
1551
4064
2435
458
4135
4054
Bedford, MA 01730
Phone: (781)999-7300
Web: www.hologic.com
Product Codes: BNE, DEV, DI, MRI, XRAY
5714
I
I.T.S. GmbH/I.T.S. USA
6219
6818
iCRco, Inc.
2743
Maitland, FL 32751
Phone: (407)971-8054
Web: www.its-implant.com
Product Codes: I
1064
Warsaw, IN 46582
Phone: (574)269-4266
Web: www.iconacy.com
Product Codes: I
1730
Torrance, CA 90505
Phone: (310)921-9559
Web: www.icrcompany.com
Product Codes: DI
5139
Hologic 2341
Booth No.
6118
IlluminOss Medical
4232
457
Ft Worth, TX 76177
Phone: (407)770-0272
Web: www.imds.net
Product Codes: AS, BB, CS, DEV, I, SI, SURG,
T
1634
1732
Changhua, 51446
Taiwan
Phone: 886-48819638
Web: www.supports.com.tw
Product Codes: O, REHB
Implanet 3965
Martillac, 33650
France
Phone: 33-557995555
Web: www.implanet.com
Product Codes: DEV, FRST, I, P
Implantcast-USA 6429
Arlington, TX 76013
Phone: (817)226-9900
Product Codes: I
Alpha Listings
Hapad, Inc.
Sacramento, CA 95825
Phone: (916)923-5076
Web: www.handbiolab.com
Product Codes: DEV
Holmed Corporation
939
HNM Medical
Miami, FL 33179
Phone: (866)291-8498
Web: www.hnmmedical.com
Product Codes: AS, SI
H
Halifax Biomedical Inc.
Plymouth, MA 02360
Phone: (508)732-7500
Web: www.harvesttech.com
Product Codes: BLD, BNE, DEV
Company
371
372
Technical Exhibits
Company
Booth No.
IMT-USA, LLC
Plymouth, MN 55447
Phone: (952)591-2543
Web: www.insorb.com
Product Codes: DEV, OTH, SI
Industrias Medicas
Sampedro S.A.S
5729
3936
3332
Niles, IL 60714
Phone: (847)674-2595
Web: www.inexsurgical.com
Product Codes: AS, DEV, DI, O, SI, SURG
Infinite Therapeutics
Kingston, NH 03848
Phone: (603)347-6006
Web: www.infinitymassagechairs.com
Product Codes: OTH, REHB
Inion Inc
Weston, FL 33327
Phone: (954)659-9224
Web: www.inion.com
Product Codes: DEV, I, SI
Innomed, Inc.
Savannah, GA 31404
Phone: (912)236-0000
Web: www.innomed.net
Product Codes: CS, SI, SURG
452
6729
1065
Alpha Listings
Booth No.
Instratek, Inc.
Houston, TX 77058
Phone: (281)892-8020
Web: www.instratek.com
Product Codes: DEV, I, SI
Memphis, TN 38103
Phone: (901)375-1109
Web: www.intech-medical.com
Product Codes: BB, DEV, I, SI, SURG
Northglenn, CO 80234
Phone: (303)404-2221
Web: www.titanium.org
Product Codes: FRST, OTH
Intralign 4430
Scottsdale, AZ 85251
Phone: (508)916-2628
Web: www.intralign.com
Product Codes: FRST, OTH
Intrauma SRL
Rivoli, TO 10098
Italy
Phone: 39-0119539496
Web: www.intrauma.com
Product Codes: I, SI
Intrepid Orthopedics
Memphis, TN 38132
Phone: (901)370-5700
Web: www.innovisionus.com
Product Codes: DEV, I, SURG
3337
Conshohocken, PA 19428
Phone: (484)342-6004
Web: www.invibio.com
Product Codes: BB, DEV, I, OTH
Booth No.
4418
6749
Houston, TX 77043
Phone: (409)658-1017
Web: www.iotiot.com
Product Codes: SI, SURG
J
6300 N River Rd
Rosemont, IL 60018
Phone: (800)626-6726
Web: www.jaaos.org
Product Codes: PUB
4522
4048
Alpharetta, GA 30022
Phone: (800)272-2707
Web: www.jacksoncoker.com
Product Codes: PM
Raritan, NJ 08869
Phone: (908)218-6000
Web: www.janssenpharmaceuticalsinc.com
Product Codes: PH, PHRM
6914
3935
Invivolink 4731
Nashville, TN 37212
Phone: (866)478-8981
Web: www.invivolink.com
Company
JAAOS 5519
International Titanium
Association 337
Innovision, Inc.
649
Plainsboro, NJ 08536
Phone: (609)275-0500
Web: www.integralife.com
Product Codes: ADVA, BNE, DEV, I, SI,
SURG, T
6349
4930
Integra 567
Cleveland, OH 44124
Phone: (440)646-1286
Web: www.therma-zone.com
Product Codes: DEV, FRST, MS, OTH, REHB
Plainville, CT 06062
Phone: (800)467-4944
Web: www.impmedical.com
Product Codes: DEV, MS, SG, SI, SURG
4234
Austin, TX 78759
Phone: (512)318-2980
Web: www.insurgical.com
Product Codes: BNE, DEV, OTH, SI, SURG
Intech Medical
4036
Medellin,
Colombia
Phone: 57-43013939
Web: www.imsampedro.com
Product Codes: AM, BB, BNE, DEV, I, SI, SURG
Company
Panama City
Panama
Phone: 507-3010496
Web: www.jphmedical.com
Product Codes: PUB
3166
Jewel Precision
4037
Seoul, 152-728
South Korea
Phone: 82-28503898
Web: www.jeilmed.co.kr
Product Codes: I
Technical Exhibits
CompAny
Booth No.
JJ International Instruments
Raleigh, NC 27613
Phone: (919)264-4292
Web: www.myjjonline.com
Product Codes: SI
5848
2268
2264
6949
Leesburg, VA 20175
Phone: (703)777-3155
Web: www.k2m.com
Product Codes: ADVA, BNE, DEV, I, SI, SURG
7129
KareOutcomes 4469
Company
Booth No.
Miami, FL 33126
Phone: (305)262-8980
Product Codes: FRST
Moorpark, CA 93021
Phone: (805)529-0825
Web: www.korosusa.com
Product Codes: SI
KYOCERA Medical
Corporation 4033
Kasios 4040
El Segundo, CA 90245
Phone: (800)421-0832
Web: www.karlstorz.com
Product Codes: AS, COM, DEV, SI, SURG
LUnion, 31240
France
Phone: 33-534273323
Web: www.kasios.com
Product Codes: BNE, I
Keeler Instruments
Broomall, PA 19008
Phone: (610)353-4350
Web: www.keelerusa.com
Product Codes: SI
Coldwater, MI 49036
Phone: (517)279-9000
Web: www.kilgoreinternational.com
Product Codes: AM, EDU
Camarillo, CA 93012
Phone: (805)384-2748
Web: www.kinamed.com
Product Codes: DEV, I, SI, SURG
Albuquerque, NM 87110
Phone: (855)488-8273
Web: www.kinesiotaping.com
Product Codes: EDU, FRST, MS, REHB
1348
LDR 2034
LH Medical Corporation
Fort Wayne, IN 46804
Phone: (260)432-5670
Web: www.lhindustries.com
Product Codes: I, SI
2941
138
4533
6019
748
531
Braintree, MA 02184
Phone: (781)849-0109
Web: www.lifeinstruments.com
Product Codes: SI, SURG
Noblesville, IN 46060
Phone: (317)225-5956
Web: www.eliteseat.com
Product Codes: DEV, REHB
440
Austin, TX 78750
Phone: (512)344-3300
Web: www.ldrspine.com
Product Codes: DEV
Wayne, NJ 07470
Phone: (973)633-1500
Web: www.medical.konicaminolta.us
Product Codes: DI
Osaka, 532-0003
Japan
Phone: 81-663501059
Web: kyocera-md.jp
Product Codes: DEV, I, MS, P
630
1031
Tampa, FL 33634
Phone: (800)683-2400
Web: www.lifelinktb.org
Product Codes: BNE, T
LifeNet Health
6119
4341
LimaCorporate Spa
1371
Indianapolis, IN 46285
Phone: (317)276-2000
Web: www.lilly.com
Product Codes: PH, PHRM
Alpha Listings
Taichung, 43444
Taiwan
Phone: 886-426308728
Web: www.softguards.com
Product Codes: O, REHB, SG
Booth No.
Kinamed, Inc.
K
K2M, Inc.
Company
373
374
Technical Exhibits
Company
Booth No.
Booth No.
Company
Booth No.
4335
MedCure, Inc.
4433
235
Medical Compression
Systems, Inc.
873
Barcelona, 08907
Spain
Phone: 34-932649623
Web: www.llambrich.com
Product Codes: SI
Alpharetta, GA 30005
Phone: (877)562-8656
Web: www.locumleaders.com
Product Codes: BB, EDU, FRST, PR
Alpharetta, GA 30009
Phone: (800)562-8663
Web: www.locumtenens.com
Product Codes: PR
Lumitex MD
1431
Strongsville, OH 44136
Phone: (440)243-8401
Web: www.lumitexmd.com
Product Codes: BB, DEV, MS, OTH, SI, SURG
M
M.J. Markell Shoe Co., Inc.
Yonkers, NY 10701
Phone: (914)963-2258
Web: www.markellshoe.com
Product Codes: O, SF, SG
1842
1073
Kalamazoo, MI 49007
Phone: (800)319-2122
Web: www.meetmaestro.com
Product Codes: BB, EDU
Hangzhou, 311106
China
Phone: 86-15658166600
Web: www.rejoin-medical.com
Product Codes: DEV, I, SI
6823
MAQUET 548
5135
Materialise 6839
Leuven, 3001
Belgium
Phone: (734)259-6445
Web: www.materialise.com/ortho
Product Codes: AM, COM, DEV, OTH, SI
Bettlach, 2544
Switzerland
Phone: 41-326441258
Web: www.mathysmedical.com
Product Codes: I, P, SI
Lakeland, FL 33811
Phone: (484)598-3291
Web: www.maxxhealthinc.com
Product Codes: DEV, I
McGinley Orthopaedic
Innovations, LLC
Wayne, NJ 07470
Phone: (888)880-2874
Web: www.maquet.com
Product Codes: ADVA, SI, SURG
Maestro 5713
Hialeah, FL 33016
Phone: (305)823-8300
Web: www.maramed.com
Product Codes: AS, O, P, SF
Denver, CO 80203
Phone: (303)832-2887
Web: www.mahca.com
Product Codes: FPD
LocumTenens.com 4555
Alpha Listings
Company
3431
3440
Duluth, GA 30097
Phone: (770)497-1560
Web: www.mdlogic.com
Product Codes: COM, EMR
Medacta International
Castel San Pietro, CH-6874
Switzerland
Phone: 41-916966060
Web: www.medacta.com
Product Codes: I, P
Medartis, Inc.
Exton, PA 19341
Phone: (610)961-6101
Web: www.medartis.com
Product Codes: I
Alexandria, VA 22302
Phone: (703)589-3525
Web: www.mcsmed.com
Product Codes: DEV, MS
Golden, CO 80401
Phone: (888)273-5344
Web: www.medicalmodeling.com
Product Codes: AM
4541
765
6621
3631
Tucson, AZ 85719
Phone: (520)398-5467
Web: www.medfix.com
Product Codes: BB, DEV, I, MS, SI, SURG
Casper, WY 82604
Phone: (877)621-2355
Web: www.mcginleyorthopaedicinnovations.com
Product Codes: DEV, FRST, SI, SURG
MD Logic EHR
Portland, OR 97230
Phone: (866)560-2525
Web: www.medcure.org
Product Codes: T
Burnsville, MN 55337
Phone: (952)277-1259
Web: www.m-p-r.com
Product Codes: SG, SI, SURG
734
2030
MedicMicro 5735
Sainte-Croix, 1450
Switzerland
Phone: 41-245577583
Web: www.medicmicro.ch
Product Codes: DEV, SI
Medin Corporation
1641
1940
Passaic, NJ 07055
Phone: (973)779-2400
Web: www.medin.com
Product Codes: BB, OTH
Technical Exhibits
CompAny
Booth No.
Medmix Systems AG
Rotkreuz, 6343
Switzerland
Phone: 41-417980680
Web: www.medmix.ch
Product Codes: BB, DEV, MS, PH, SI, T
MedNet Technologies
Melville, NY 11747-4989
Phone: (516)285-2200
Web: www.mednet-tech.com
Product Codes: COM, PM
MedShape, Inc.
Atlanta, GA 30318
Phone: (877)343-7016
Web: www.medshape.com
Product Codes: DEV, I
Medstrat, Inc
634
4540
Merge Healthcare
7218
1135
441
Arlington, TN 38002
Phone: (901)867-4681
Web: www.microport.com.cn/english
Product Codes: I
5812
Bellaire, TX 77402
Phone: (713)664-4707
Web: www.microsurgeryusa.com
Product Codes: SI, SURG
2973
MiMedx 1173
4649
6913
3437 3539
4722
5751
4737
MTF 4141
3152
Metasurg 7228
Houston, TX 77084
Phone: (281)398-5656
Web: www.metasurg.com
Product Codes: FRST, I, SI
1358
1267
Marietta, GA 30062
Phone: (770)691-9100
Web: www.mimedx.com
Product Codes: T
Edison, NJ 08837
Phone: (800)433-6576
Web: www.mtf.org
Product Codes: BNE, I, T
Louisville, KY 40291
Phone: (502)291-8899
Web: www.myrehabpro.com
Product Codes: COM, FRST, OTH
6553
4621
2548
4049
National Association of
Orthopaedic Nurses
5219
Raynham, MA 02767
Phone: (508)880-8100
Web: www.depuymitek.com
Product Codes: MS, SURG
Austin, TX 78749
Phone: (512)301-3888
Web: www.ronadro.com
Product Codes: OTH
Chicago, IL 60611
Phone: (800)289-6266
Web: www.orthonurse.org
Product Codes: EDU
Alpha Listings
Fitchburg, MA 01420
Phone: (978)602-1482
Web: www.micronproducts.com
Product Codes: CS, I, SI
Booth No.
Mizuho OSI
Micron Products
Company
Microport 665
Chicago, IL 60654
Phone: (312)565-6868
Web: www.merge.com
Product Codes: COM, DI, EMR, IMG, PM
Metal Craft
Miami Anatomical
Research Center
Charlottesville, VA 22911
Phone: (434)975-8000
Web: www.microaire.com
Product Codes: SI
Memphis, TN 38132
Phone: (800)876-3133
Web: www.medtronic.com
Product Codes: ADVA, DEV, I, IMG, SI, SURG
Booth No.
Miami, FL 33172
Phone: (305)716-0966
Web: www.marctraining.com
Product Codes: FRST, OTH
Medtronic 5249
Medyssey Spine
Company
375
376
Technical Exhibits
Company
Booth No.
Neoligaments 3735
West Yorkshire, LS19 7UE
United Kingdom
Phone: 44-1132387202
Web: www.neoligaments.com
Product Codes: P
NEOSTEO 659
Reze, 44400
France
Phone: 33-0236569670
Web: www.neosteo.com
Product Codes: I
NeuMed 1934
West Trenton, NJ 08628
Phone: (609)896-3444
Web: www.neumedinc.com
Product Codes: DEV, O
4038
Alpha Listings
Neurotech 2135
Minnetonka, MN 55343
Phone: (952)582-6719
Web: www.neurotech.us
Product Codes: O, REHB
NewClip USA
6739
Nextech 4749
Tampa, FL 33609
Phone: (813)425-9200
Web: www.nextech.com
Product Codes: COM, EMR, PM
Company
Booth No.
NextGen Healthcare
Information Systems, Inc.
Horsham, PA 19044
Phone: (215)657-7010
Web: www.nextgen.com
Product Codes: COM, EMR, PM
4449
Company
Booth No.
O
Oberd 4757
Columbia, MO 65201
Phone: (573)442-7101
Web: www.oberd.com
Product Codes: COM, FRST, MKT, PM
6921
3835
7118
Tampa, FL 33610
Phone: (813)443-4905
Web: www.ODI-NA.com
Product Codes: I, SI
5220
OH MY Products
Nordson Micromedics
2238
1437
Oiservice CT & MR
2631
1251
Olive Medical
3969
NovoSource, Inc.
7219
Nueterra 4659
Leawood, KS 66211
Phone: (913)387-0510
Web: www.nueterra.com
Product Codes: FPD, PM, PR
NuTech 6855
OMNI 4939
Opedix 7035
Bethesda, MD 20892
Phone: (800)624-2663
Web: www.bones.nih.gov
Product Codes: BNE, OTH
Alachua, FL 32615
Phone: (386)462-7660
Web: www.novabone.com
Product Codes: BNE, DEV, I
Dayton, OH 45402
Phone: (800)668-6165
Web: www.novosource.net
Product Codes: FRST, I
Birmingham, AL 35216
Phone: (205)290-2158
Web: www.nutechmedical.com
Product Codes: BNE, I, T
Edgewood, MD 21040
Phone: (800)925-5187
Web: www.nutramaxlabs.com
Product Codes: OTH
4031
Fishers, IN 46040
Phone: (317)731-3669
Web: www.ohmyproducts.com
Product Codes: FRST, OTH
969
Grandville, MI 49418
Phone: (866)503-1470
Web: www.hemaclear.com
Product Codes: BLD, DEV, SURG
Hopkinton, MA 01748
Phone: (508)416-5200
Web: www.olympusbiotech.com
Product Codes: BNE
Scottsdale, AZ 85250
Phone: (480)513-8345
Web: www.opedix.com
Product Codes: FRST, REHB, SG
Technical Exhibits
CompAny
Booth No.
Operating Room
Innovations, Inc.
7136
Coronado, CA 92118
Phone: (619)261-9526
Web: www.orinnovations.com
Product Codes: FRST, MS
4115B
OrthAlign, Inc.
Ortho Development
Ortho Executive
Savannah, GA 31406
Phone: (888)463-5803
Web: www.ortho-circle.com
Product Codes: FRST, SI
Lewisville, TX 75056
Phone: (800)527-0404
Web: www.orthofix.com
Product Codes: ADVA, DEV
Portland, OR 97202
Phone: (503)234-9691
Web: www.orthomedinc.com
Product Codes: I, MS, SI, SURG
Orthopaedics Overseas
5813
Washington, DC 20036
Phone: (202)296-0928
Web: www.hvousa.org
Product Codes: AO
5141
6920
448
4123B
341
Ramsey, NJ 07446
Phone: (201)880-2243
Web: www.odtmag.com
Product Codes: PUB
OrthoScan 2531
Orthosensor, Inc.
6929
OrthoView 5238
Jacksonville, FL 32256
Phone: (800)318-0923
Web: www.orthoview.com
Product Codes: COM, DEV, I, OTH, P
Warsaw, IN 46582
Phone: (877)268-6339
Web: www.orthopediatrics.com
Product Codes: DEV, I, SI
637
OrthoPediatrics 3834
2959
5919
Scottsdale, AZ 85250
Phone: (480)503-8010
Web: www.orthoscan.com
Product Codes: DEV, DI, IMG, SURG, XRAY
Decines, 69150
France
Phone: 33-472025696
Web: www.my-osc.eu
Product Codes: I, P, SI
ORTHOWORLD Inc.
5416
6528
7217
Ossur Americas
3239
Columbia, MD 21046
Phone: (443)545-1800
Web: www.osiris.com
Product Codes: T
OsteoMed 3049
Addison, TX 75001
Phone: (972)677-4600
Web: www.osteomed.com
Product Codes: ADVA, BNE, DEV, I, SI
1257
Alpha Listings
Draper, UT 84020
Phone: (801)553-9991
Web: www.odev.com
Product Codes: DEV, I
OrthoCircle 140
Booth No.
Raytown, MO 64138
Phone: (800)821-1303
Web: www.orthocare.com
Product Codes: CS, SG
Company
Ortho-Care 3059
OrthoMed, Inc.
Chicago, IL 60606
Phone: (800)358-6443
Web: www.originhs.com
Product Codes: COM, FRST, OTH, PM
Booth No.
Orthofix 4929
6829
Company
377
378
Technical Exhibits
Company
Booth No.
5657
P
P & M Corporate Finance
Southfield, MI 48076
Phone: (248)223-3300
Web: www.pmcf.com
Product Codes: BB, FIN, MKT
Honolulu, HI 96815
Phone: (808)941-8880
Web: www.pacificinstruments.biz
Product Codes: BB, DEV, SI
4636
5828
7135
Panasonic 2930
Newark, NJ 07102
Phone: (201)293-9799
Web: www.panasonic.com/healthcare
Product Codes: AS, IMG, OTH
Paradigm BioDevices
Rockland, MA 02370
Phone: (781)982-9950
Web: www.paradigmbiodevices.com
Product Codes: BNE, SI
Paragon Medical
Alpha Listings
Pierceton, IN 46562
Phone: (574)594-2140
Web: www.paragonmedical.com
Product Codes: I, SI, SURG
6648
3339
3430
Company
Booth No.
PCC Structurals
5149
PCI HealthDev
4754
PracticeLink.com 4630
3230
PracticeMatch Services
4415
Pro-Dex Inc.
3773
Promimic AB
7237
2542
Pulse Lavage AB
1936
Purac Biomaterials
2139
Pivot Medical
5840
Puracon GmbH
7134
Planmed, Inc.
2834
Pyxidis 2163
Portland, OR 97206
Phone: (503)794-2099
Web: www.pccstructurals.com
Product Codes: DEV, I, SI
Dallas, TX 75225
Phone: (866)936-3089
Web: www.healthdev.com
Product Codes: FIN, FPD, OTH
5230
Phoenix Ortho
4518
Physician Assistants in
Orthopaedic Surgery
5516
Ovilla, TX 75154
Phone: (800)843-8179
Web: www.phoenixortho.net
Product Codes: EMR
Bakersfield, CA 93301
Phone: (281)558-5240
Product Codes: FPD, PM
Sarasota, FL 34243
Phone: (941)755-7965
Web: www.parcusmedical.com
Product Codes: AS, I, SI, SURG
Booth No.
Glendale, AZ 85318
Phone: (800)804-7267
Web: www.paos.org
Product Codes: OTH
Company
Sunnyvale, CA 94089
Phone: (408)774-1452 EXT 106
Web: www.pivotmedical.com
Product Codes: DEV, I
Roselle, IL 60172
Phone: (630)894-2200
Web: www.planmed.com
Product Codes: DI, XRAY
Norcross, GA 30092
Phone: (678)983-0229
Web: www.practiceflowsolutions.com
Product Codes: FPD, PM
4730
Hinton, WV 25951
Phone: (800)776-8383
Web: www.practicelink.com
Product Codes: EDU, PR, PUB
Irvine, CA 92614
Phone: (949)769-3200
Web: www.pro-dex.com
Product Codes: AS, DEV, SI, SURG
Gothenburg, 41292
Sweden
Phone: 46-317728022
Web: www.promimic.com
Product Codes: BNE, DEV, FRST, I, OTH
Cincinnati, OH 45213
Phone: (513)229-7115
Web: www.proscan.com
Product Codes: OTH
Uppsala, 752 29
Sweden
Phone: 46-18555505
Web: www.pulselavage.com
Product Codes: SI
Tucker, GA 30084
Phone: (470)545-7100
Web: www.puracbiomaterials.com
Product Codes: BB, I, PH
Rosenheim, 83026
Germany
Phone: 49-80319005870
Web: www.puracon.com
Product Codes: FRST, OTH
Doylestown, PA 18902
Phone: (215)230-7307
Web: www.pyxidis-medical.com
Product Codes: BB, DEV, OTH
Technical Exhibits
CompAny
Booth No.
Q
QAL Medical
Marinette, WI 54143
Phone: (888)430-1625
Web: www.qalmedical.com
Product Codes: DEV, REHB
6822
4614
Quinn Medical
Quintus Composites
1535
5749
Residency Select
5121
Manalapan, NJ 07726
Phone: (888)409-2468
Web: www.residencyselect.com
Product Codes: EDU, FRST, PR
Booth No.
Sanatmetal Ltd.
1565
4714
Eger, 3300
Hungary
Phone: 36-36512900
Web: www.sanatmetal.com
Product Codes: I, P, SI
Princeton, NJ 08540
Phone: (908)229-5365
Product Codes: COM, FRST
1364
RISystem AG
6919
SBM Inc.
rms Surgical
3634
Edgewater, NJ 07020
Phone: (201)203-5773
Web: www.responseortho.com
Product Codes: COM, DEV, I, OTH, SI
Anoka, MN 55303
Phone: (763)427-4161
Web: www.junoinc.com
Product Codes: I, SI, SURG
Dallas, NC 28034
Phone: (704)884-3506
Web: www.roechling-plastics.us
Product Codes: MS, SI, SURG
1335
Company
RTI Surgical
Alachua, FL 32615
Phone: (386)418-8888
Web: www.rtibiologics.com
Product Codes: ADVA, BNE, I, T
349
4534
5937
SAGE 5412
Thousand Oaks, CA 91320
Phone: (805)410-7239
Web: www.sagepub.com
Product Codes: PUB
Winchester, MA 01890
Phone: (781)369-1782
Web: www.s-b-m.us
Product Codes: BNE, I
2171
141
Seabrook International
4058
SH Medical Corp.
1631
Cincinnati, OH 45226
Phone: (513)561-2241
Web: www.schaerermedicalusa.com
Product Codes: SURG
Seabrook, NH 03874
Phone: (603)760-1520
Web: www.seabrookinternational.com
Product Codes: DEV, FRST, I, SI
Miami, FL 33122
Phone: (305)406-2222
Web: www.shmedical.com/
Product Codes: AS, DI, SI, SURG
267
Vashon, WA 98070
Phone: (206)463-5551
Web: www.sawbones.com
Product Codes: AM, AS, EDU
161
Alpha Listings
4319
Phoenix, AZ 85034
Phone: (480)940-1310
Web: www.researchforlife.org
Product Codes: T
Gardena, CA 90248
Phone: (310)808-6586
Web: www.radlink.com
Product Codes: DI, FRST
Regen Lab
Radlink 2740
Booth No.
Company
379
380
Technical Exhibits
Company
Booth No.
Booth No.
Skeletal Dynamics
Torrance, CA 90502
Phone: (800)228-1429
Web: www.shimadzu.com/medical
Product Codes: DI
4839
Waxhaw, NC 28173
Phone: (704)512-0000
Web: www.shoulderoptions.com
Product Codes: I, SI
1937
Shukla Medical
2035
SI-BONE, Inc.
4921
Piscataway, NJ 08854
Phone: (732)474-1770
Web: www.shuklamedical.com
Product Codes: SI
SICOT 4218B
Brussels, BE 1050
Belgium
Phone: 32-26486823
Web: www.sicot.org
Product Codes: AO
Siemens Healthcare
4821
Malvern, PA 19355
Phone: (610)219-6300
Web: www.siemens.com
Product Codes: ADVA, AS, COM, DI, EDU,
FPD, IMG, MRI, PHRM, SURG, XRAY
Alpha Listings
Company
Richland, WA 99354
Phone: (509)371-1104
Web: www.signfracturecare.org
Product Codes: AO
4214B
Cleveland, OH 44103
Phone: (216)229-2040
Web: www.simbionix.com
Product Codes: AM, COM, EDU, OTH
3633
Lutz, FL 33558
Phone: (877)323-7373
Web: www.singlesourcesurgical.com
Product Codes: FRST, T
Miami, FL 33176
Phone: (305)596-7585
Web: www.skeletaldynamics.com
Product Codes: DEV, EDU, I, P, SI
SLACK Incorporated
Thorofare, NJ 08086
Phone: (856)848-1000
Web: www.Healio.com
Product Codes: PUB
965
6313
Company
Booth No.
Socrates Ortho
4435
6513
Memphis, TN 38119
Phone: (855)214-1860
Web: www.solanasurgical.com
Product Codes: ADVA, I, SI, T
7220
Solvay 4131
Alpharetta, GA 30005
Phone: (800)621-4557
Web: www.solvayspecialtypolymers.com
Product Codes: OTH
5421
2248
Centennial, CO 80112
Phone: (303)790-9411
Web: www.sontecinstruments.com
Product Codes: SI
5229
4219
Cordova, TN 38016
Phone: (901)396-2121
Web: www.smith-nephew.com
Product Codes: ADVA, AS, DEV, EDU, I, SI,
SURG
Soothe 7113
4514
Southern Spine
7018
5229
N Dartmouth, MA 02747
Phone: (508)985-2112
Web: www.southcoast.org
Product Codes: FRST, PR
Macon, GA 31201
Phone: (478)745-0000
Web: www.southernspine.net
Product Codes: FRST, I
Bradenton, FL 34209
Phone: (941)792-2688
Web: www.soothepharmacy.com
Product Codes: BB, EDU, FRST, MS, PH
Lenexa,KS 66214
Phone: (913)451-4414
Web: www.spinalsimplicity.com
Product Codes: DEV, I, SI
936
6419
Baltimore, MD 21215
Phone: (410)601-9000
Web: www.rubininstitute.com
Product Codes: COM, EDU, PR, PUB
Technical Exhibits
CompAny
Booth No.
2739
Company
Booth No.
Company
381
Booth No.
SurgCenter Development
Ecully, 69130
France
Phone: 33-472770152
Web: www.spineway.com
Product Codes: I, P
STERIS Corporation
Spiracur 4948
Houston, TX 77007
Phone: (713)521-4220
Web: www.spinepaininc.com
Product Codes: COM, DI, EDU, FRST, XRAY
Spineway 3057
Mentor, OH 44060
Phone: (800)548-4873
Web: www.steris.com
Product Codes: ADVA, FPD, SURG
Sunnyvale, CA 94089
Phone: (408)701-5300
Web: www.spiracur.com
Product Codes: DEV, SI
Springer 5721
New York, NY 10013
Phone: (212)460-1500
Web: www.springer.com
Product Codes: PUB
Montvale, NJ 07645
Phone: (201)802-1300
Web: www.srssoft.com
Product Codes: COM, EMR, IMG, PM
Nashville, TN 37203
Phone: (855)267-5551
Web: www.stabilitybio.com
Product Codes: BNE, T
Irving, TX 75063
Phone: (800)876-0500
Web: www.staffcare.com
Product Codes: PR
6518
7131
Stelkast 431
Stryker Endoscopy
2169
740
Sacramento, CA 95814
Phone: (916)441-0400
Web: www.samgi.com
Product Codes: PR
3065
3737
363
Athens, GA 30601
Phone: (866)640-2875
Web: www.surgicaldevices.com
Product Codes: SURG
2549
2549
Kalamazoo, MI 49001
Phone: (800)253-3210
Web: www.stryker.com
Product Codes: ADVA, BLD, CS, DEV, IMG,
MS, SI, SURG
Warsaw, IN 46582
Phone: (574)267-8207
Web: www.surgicalpower.com
Product Codes: SI, SURG
3156
Surgical Specialties
Corporation 2151
Reading, PA 19606
Phone: (877)991-1110
Web: www.quilldevice.com
Product Codes: DEV, SI
Stryker MAKO
2549
SurgiMate 4631
Stryker Orthopaedics
2549
Surgionix Ltd.
Mahwah, NJ 07430
Phone: (201)831-5000
Web: www.stryker.com
Product Codes: ADVA, AS, BLD, BNE, DEV,
EDU, I, OTH, PM, SI
Auckland, 0757
New Zealand
Phone: 64-94769246
Web: www.surgionix.com
Product Codes: DEV, SI, SURG
SunMedica, Inc.
6555
1535
Redding, CA 96003
Phone: (530)229-1600
Web: www.sunmedica.com
Product Codes: DEV, MS, SG
Cincinnati, OH 45246
Phone: (513)772-6635
Web: www.sdbiocoatings.com
Product Codes: BNE, DEV, I
6423
Alpha Listings
Mc Murray, PA 15317
Phone: (724)941-6368
Web: www.stelkast.com
Product Codes: DEV, I
StrenuMed Inc.
Stryker Instruments
4615
3141
Ridgefield, CT 06877
Phone: (203)244-6300
Web: www.steutemeditech.com
Product Codes: AS, DI, IMG, MRI, SI, SURG,
XRAY
Ventura, CA 93003
Phone: (805)477-1000
Web: www.strenumed.com
Product Codes: BB, SI, SURG
SRSsoft 4457
Stability Biologics
Zurich, 8048
Switzerland
Phone: 41-491719789699
Web: www.stemcup.ch
Product Codes: I
382
Technical Exhibits
Company
Booth No.
6820
Swarm Interactive
4453
4949
Zhangjiagang, 215625
China
Phone: 86-51258100786
Product Codes: FRST, I, SI
4655
4130
5829
6249
Tasarimmed Medical
Equipments 7121
Istanbul, 34055
Turkey
Phone: 90-2126742244
Web: www.tasarimmed.com.tr
Product Codes: DEV, FRST, I, MS, SI, SURG
3730
4034
3067
6530
Windsor, CO 80550
Phone: (970)674-3032
Web: www.medcomgroup.com
Product Codes: FRST, MS, REHB
4119B
ThermoTek, Inc
2155
2031
5512
Thortex 5153
5850
Terason 2830
Burlington, MA 01803
Phone: (781)270-4143
Web: www.terason.com
Product Codes: DI
5321
Needham, MA 02492
Phone: (781)449-9780
Web: www.jbjs.org
Product Codes: EDU, PUB
Durham, NC 27709
Phone: (866)246-6990
Web: www.teleflex.com
Product Codes: BNE, DEV, SI
Gurnee, IL 60031
Phone: (847)596-3100
Web: www.teleflexmedicaloem.com
Product Codes: BB, OTH
Booth No.
LUnion, 31240
France
Phone: 33-534251060
Web: www.teknimed.com
Product Codes: BNE, DEV, I, P
Company
Teleflex 3069
Alpha Listings
Tekscan, Inc.
Cullman, AL 35058
Phone: (256)739-1398
Web: www.systemedxortho.net
Product Codes: COM, EMR, PM
Teknimed 5248
Systemedx Healthcare
Technology 4535
1253
Wilmington, MA 01887
Phone: (978)642-2400
Web: www.tecomet.com
Product Codes: BB, DEV, I, SI, SURG
Tecres Spa
Chamberet, 19370
France
Phone: 33-555983138
Web: www.synimed.com
Product Codes: BNE, I, P
Addison, IL 60101
Phone: (800)322-2844
Web: www.tmsmed.net
Product Codes: I, SI
Tecomet 1834
Bozeman, MT 59715
Phone: (406)581-8899
Web: www.synergysurgicalists.com
Product Codes: FRST, PM, PR
Booth No.
Technicality, Inc.
Warsaw, IN 46582
Phone: (574)267-8700
Web: www.symmetrymedical.com
Product Codes: AS, BB, DEV, I, SI, SURG
Synergy Surgicalists
Company
Portland, OR 97230
Phone: (503)654-5726
Web: www.thortexinc.com
Product Codes: DEV, FRST, I, SI
6755
6729
Tianjin, 301609
China
Phone: 86-2268660777
Web: www.walkman.com.cn
Product Codes: BNE, FRST, I, SI
Beijing, 100082
China
Phone: 86-1082292929
Web: www.ztmed.cn
Product Codes: I, SI
Technical Exhibits
CompAny
Booth No.
Tiemann Surgical
Hauppauge, NY 11788
Phone: (800)843-6266
Web: www.georgetiemann.com
Product Codes: SI, SURG
Tissue Regenix
Tracy, CA 95304
Phone: (866)592-0488
Web: www.topshelforthopedics.com
Product Codes: O, REHB, SG
3841
Townsend Design
Bakersfield, CA 93313
Phone: (661)837-1795
Web: www.townsenddesign.com
Product Codes: O, REHB
7013
4068
Croydon, NH 03773
Phone: (603)863-1079
Web: www.truetoolinnovations.com
Product Codes: BB, BNE, FRST
Chesterfield, MO 63005
Phone: (800)519-0268
Web: www.ulrichmedicalusa.com
Product Codes: DEV, SI
741
1038
Philadelphia, PA 19107
Phone: (215)521-3004
Web: www.unionsurgical.com
Product Codes: I, SI
United Endoscopy
3639
Corona, CA 92879
Phone: (951)270-3400
Web: www.endoscope.com
Product Codes: AS, DI, MS, SI, SURG
United Ortho
4550
3235
7023
5741
6922
Venel 4552
Omaha, NE 68138
Phone: (402)763-8725
Web: www.venel.com
Product Codes: EDU, MKT, OTH
4758
Vilex, Inc.
4938
Virtamed AG
6713
Deerfield, IL 60015
Phone: (847)607-8577
Web: www.arthritis-health.com
Product Codes: BB, EDU, PUB
3837
Mc Minnville, TN 37110
Phone: (800)521-5002
Web: www.vilex.com
Product Codes: DEV, I, SI
831
4849
VirtualScopics 2842
Taipei, 23452
Taiwan
Phone: 886-229294567
Web: www.uoc.com.tw
Product Codes: I, P, SI
US Orthopedics, Inc.
Reno, NV 89503
Phone: (775)851-3420
Web: www.understand.com
Product Codes: COM, EDU, PM
Booth No.
Rochester, NY 14625
Phone: (585)249-6231
Web: www.virtualscopics.com
Product Codes: DI, IMG, MRI, XRAY
VisionScope Technologies
2540
Vivorte, Inc.
6821
Littleton, MA 01460
Phone: (888)808-8357
Web: www.myvsi.com
Product Codes: AS, DI
5413
Louisville, KY 40204
Phone: (270)307-5266
Web: www.vivorte.com
Product Codes: FRST, I, T
Alpha Listings
Company
Knoxville, TN 37996
Phone: (865)974-1772
Web: www.pemba.utk.edu
Product Codes: EDU
Understand.com 4536
4513
Triangle 7128
TriMed, Inc.
U&I Corporation
Bloomington, MN 55437
Phone: (952)426-7600
Web: www.tornier.com
Product Codes: ADVA, AS, DEV, I, P, SI
Kalamazoo, MI 49004
Phone: (260)489-3656
Web: www.totalplastics.com
Product Codes: BB, DEV, I, O, P, SI
Booth No.
Tyy Consulting
462
Tornier 5849
Total Plastics
Company
383
384
Technical Exhibits
Company
Booth No.
7223
VQ OrthoCare
6319
Booth No.
Whale Imaging
2439
Irvine, CA 92614
Phone: (800)266-6969
Web: www.vqorthocare.com
Product Codes: ADVA, BNE, DEV, EDU, MS,
O, REHB, SG
7214
VSMPO-Tirus, US
Chandler, AZ 85226
Phone: (480)921-4948
Web: www.procellera.com
Product Codes: DEV, FRST
Leetsdale, PA 15056
Phone: (724)251-9400
Web: www.vsmpo-tirus.com
Product Codes: BB, I
351
W
Waldemar Link GmbH &
Co. KG
Hamburg, 22339
Germany
Phone: 49-539950
Web: www.linkhh.de
Product Codes: DEV, I, P, SI
Weatherby Healthcare
3849
4548
Hsinchu, 31053
Taiwan
Phone: 886-35828999
Product Codes: FRST, I
Philadelphia, PA 19103
Phone: (215)521-8300
Web: www.lww.com
Product Codes: PUB
4337
Madison, WI 53717
Phone: (800)960-4118
Web: www.wellbe.me
Product Codes: BB, COM, EDU, FRST
Lenni, PA 19052
Phone: (610)459-1000
Web: www.westlakeplastics.com
Product Codes: BB
1835
3531
756
Miamisburg, OH 45342
Phone: (937)847-8400
Web: www.x-spine.com
Product Codes: I
6939
Y
Your Practice Online, LLC
4437
Z
Ziehm Imaging
2539
4833
Orlando, FL 32811
Phone: (407)615-8560 EXT 164
Web: www.ziehm.com
Product Codes: SURG, XRAY
Logan, UT 84321
Phone: (435)757-4956
Web: www.ziggdesign.com
Product Codes: AS, BB, DEV, I, SI, SURG
Zimmer 3149
5513
749
Wuhu, 241000
China
Phone: 86-5535905318
Web: www.whruijin.com
Product Codes: DEV, FRST, SURG
Freehold, NJ 07728
Phone: (732)409-1005
Web: www.wynnpharm.com
Product Codes: PH
Booth No.
933
Wynn Pharm
Company
Irvine, CA 92612
Phone: (877)388-8569
Web: www.yourpracticeonline.net
Product Codes: BB, COM, EDU, PM
Niles, IL 60714
Phone: (847)470-9300
Web: www.whitneymedicalsolutions.com
Product Codes: DEV, MS, SI
Wellbe.me 7122
Westlake Plastics
Somerville, MA 02145
Phone: (617)776-1365
Product Codes: PUB
Weigao Orthopaedic
Device Co., Ltd.
Alpha Listings
Company
Warsaw, IN 46580
Phone: (800)613-6131
Web: www.zimmer.com
Product Codes: ADVA, BLD, BNE, DEV, EDU,
I, IMG, MS, SG, SI, SURG
6813
ZyDoc Transcription
4714
Campbell, CA 95008
Phone: (405)684-0747
Web: www.ziplinemedical.com
Product Codes: DEV, FRST, MS, SURG
Islandia, NY 11749
Phone: (631)273-1963
Web: www.zydoc.com
Product Codes: EMR, PM
1648
X
X-NOV Medical Technology
Porrentruy, 2900
Switzerland
Phone: 33-624625046
Web: www.xnov.com
Product Codes: FRST, I, P, SI
7120
Technical Exhibits
AdvaMed Member - ADVA
Allied Organization - AO
American Society of Orthopaedic
Assistant........................................4119A
Asociacion Argentina de Ortopedia y
Traumatologia................................4123A
Chinese Orthopaedic Association....4218A
European Federation of Orthopaedics and
Traumatology (EFORT)..................4115A
National Association of Orthopaedic
Technologists - NAOT.................. 4222B
Operation Walk USA...................... 4115B
Orthopaedics Overseas................... 4123B
SICOT............................................ 4218B
SIGN Fracture Care International... 4214B
Sociedad Colombiana de Cirugia
Ortopedica y Traumatolgia
SCCOT.........................................4222A
Sociedade Brasileira de Ortopedia e
Traumatologia - SBOT..................4212A
The Perry Initiative.........................4119A
Anatomical Models - AM
Arthroscopic Systems - AS
Advanced Endoscopy Devices, Inc...... 533
Allen Medical Systems...................... 1341
AME/Orthotec International............. 3331
American Medical Endoscopy, Inc...... 841
Arthrex, Inc...................................... 6029
ArthroPlastics, Inc............................. 1942
Arthrosurface, Inc............................. 6529
Case Medical.................................... 6721
Cayenne Medical.............................. 1430
ConMed............................................ 2249
Devicix, LLC..................................... 3630
Flagship Surgical, LLC...................... 3535
HNM Medical.................................. 4135
IHI Ionbond Inc................................ 6118
IMDS - Innovative Medical Device
Solutions........................................... 457
INEX Surgical Inc............................. 3332
Karl Storz Endoscopy-America, Inc... 1057
Maramed Orthopedic Systems.......... 6723
Orthopedic Sciences, Inc................... 5919
Panasonic.......................................... 2930
Parcus Medical, LLC......................... 3430
Pro-Dex Inc....................................... 3773
Razek Equipamentos Ltda................ 1335
Sawbones/Pacific Research Labs........ 3134
SH Medical Corp.............................. 1631
Siemens Healthcare........................... 4821
Smith & Nephew Inc........................ 5229
Steute Meditech, Inc.......................... 3065
Stryker Endoscopy............................ 2549
Stryker Orthopaedics........................ 2549
Symmetry Medical Inc...................... 4949
Tornier.............................................. 5849
United Endoscopy............................... 831
Velocity Orthopedics, Inc.................. 6922
VisionScope Technologies................. 2540
Product Listings
Acumed............................................. 5549
Aesculap Implant Systems................. 1049
Aptiv Solutions................................. 7019
ArthroCare....................................... 1130
Arthrosurface, Inc............................. 6529
Baxano Surgical, Inc......................... 1635
Biomet.............................................. 1749
Breg.................................................. 1649
Ceterix Orthopaedics........................ 7123
Checkpoint Surgical, LLC................. 6055
Consensus Orthopedics..................... 5835
Corin Group..................................... 2949
Covidien........................................... 3749
DePuy Synthes Joint Reconstruction. 4049
Exactech, Inc..................................... 2261
Game Ready..................................... 6541
Globus Medical................................. 6849
Greatbatch Medical.......................... 1363
GS Medical....................................... 3734
Integra................................................ 567
K2M, Inc.......................................... 6949
MAQUET........................................... 548
Medtronic......................................... 5249
OrthAlign, Inc................................... 5813
Orthofix............................................ 4929
OsteoMed......................................... 3049
Pega Medical, Inc.............................. 3230
RTI Surgical...................................... 5937
Siemens Healthcare........................... 4821
Small Bone Innovations, Inc.............. 2248
Smith & Nephew Inc........................ 5229
Solana Surgical, LLC......................... 6513
STERIS Corporation......................... 3141
Stryker Instruments........................... 2549
Stryker Orthopaedics........................ 2549
Tornier.............................................. 5849
VQ OrthoCare.................................. 6319
Zimmer............................................. 3149
385
Product Listings
386
Technical Exhibits
Kasios............................................... 4040
LifeLink Tissue Bank........................... 531
LifeNet Health.................................. 6119
Millstone Medical Outsourcing........... 657
MTF................................................. 4141
NIH Osteoporosis & Related Bone
Diseases........................................... 5220
NovaBone Products LLC.................. 1251
NuTech............................................. 6649
Olympus Biotech Corporation.......... 2935
Oriental Resources Development
Limited............................................ 6819
Ortho Solutions Limited................... 6613
Orthorebirth Co., Ltd......................... 637
OsteoMed......................................... 3049
Paradigm BioDevices, Inc.................. 6648
Promimic AB..................................... 7237
RTI Surgical...................................... 5937
SBM Inc............................................ 2171
Shanghai Bojin Electric Instrument
& Device Co., Ltd........................... 3731
Skye Orthobiologics LLC.................. 7220
Sonoma Orthopedic Products........... 2254
Stability Biologics.............................. 6518
Stryker Orthopaedics........................ 2549
Surface Dynamics, LLC..................... 1534
Suzhou Sunan Zimmered Medical
Instrument Co., Ltd........................... 456
Synergie Ingenierie Medicale
(synimed)........................................ 6435
Tecres Spa......................................... 5829
Teknimed.......................................... 5248
Teleflex.............................................. 3069
Tianjin Walkman Biomaterial
Co., Ltd........................................... 6755
Tissue Banks International.................. 462
Toby Orthopaedics, Inc..................... 4068
True Tool Innovations....................... 7023
VQ OrthoCare.................................. 6319
Zimmer............................................. 3149
Business to Business/OEM - BB
aap Implantate AG............................ 3037
Abrexis............................................... 641
AccelLAB Inc.................................... 3832
AMSURG......................................... 4633
Arcamed, LLC.................................. 6520
Austen BioInnovation Institute in
Akron.............................................. 3967
Autocam Medical.............................. 6053
Bal Seal Engineering, Inc................... 2141
Biologic Therapies, Inc...................... 6148
Biomatlante....................................... 2967
C&A Tool Engineering, Inc.............. 3436
Captiva Spine, Inc............................. 6512
Cases By Source, Inc......................... 1536
Changzhou Waston Medical
Appliance Co., Ltd.......................... 1334
DragonBio Implants.......................... 7029
Endolab GmbH................................. 5731
EOS Electro Optical Systems............. 6213
Computer Hardware/
Software - COM
CARE............................................... 4512
CareCloud........................................ 4413
ChartLogic, Inc................................. 4441
CME/1st-dragon............................... 4657
Compulink Business Systems, Inc...... 4568
ConMed............................................ 2249
Devicix, LLC..................................... 3630
DTC Healthcom............................... 4634
Emdat............................................... 4632
EPM Endo Plant Muller GmbH........ 3934
Exscribe, Inc..................................... 4549
KareOutcomes.................................. 4469
Karl Storz Endoscopy-America, Inc... 1057
KM Medical Software Ltd................ 4533
Materialise........................................ 6839
MD Logic EHR................................. 4541
MedNet Technologies....................... 4540
Merge Healthcare............................. 4649
Millstone Medical Outsourcing........... 657
Mobile Workforce Inc....................... 4722
Modernizing Medicine, Inc............... 4737
My Rehab Pro, LLC.......................... 6553
Nextech............................................ 4749
NextGen Healthcare Information
Systems, Inc..................................... 4449
Oberd............................................... 4757
Origin Healthcare Solutions ............. 4612
Ortech Data Centre Inc..................... 4557
OrthoView ....................................... 5238
Response Ortho LLC 1364
SanDance Technology, LLC.............. 7112
Siemens Healthcare........................... 4821
Simbionix USA Corporation............. 3633
Sinai Hospital of Baltimore, Rubin
Inst. for Advanced Orthopedics....... 5615
Socrates Ortho.................................. 4435
Spine Pain Management, Inc............. 2739
SRSsoft............................................. 4457
Stryker Endoscopy............................ 2549
Swarm Interactive............................. 4453
Systemedx Healthcare Technology.... 4535
Tekscan, Inc...................................... 4034
Understand.com................................ 4536
Virtamed AG..................................... 6713
Wellbe.me......................................... 7122
Your Practice Online, LLC................ 4437
Devices - DEV
Abrexis............................................... 641
AccelLAB Inc.................................... 3832
Acell, Inc........................................... 5021
Active Implants Corporation............. 6049
Technical Exhibits
Devicix, LLC..................................... 3630
DGIMed Ortho................................. 1333
Directed Manufacturing, Inc............. 3438
DJO Global....................................... 1349
Element Orthopedics......................... 7022
ElliptiGO Inc...................................... 635
Elliquence LLC................................. 2449
Emovi, Inc......................................... 6015
Endotec Inc....................................... 4241
EOS Electro Optical Systems............. 6213
Ergoactives.......................................... 535
Ermi, Inc............................................. 359
Exactech, Inc..................................... 2261
Extremity Medical, LLC................... 1035
Ferring Pharmaceuticals.................... 3767
Fidia Pharma USA............................... 973
Flagship Surgical, LLC...................... 3535
Flow-FX LLC.................................... 5834
Francis Lamont Innovations Ltd....... 6715
Fx Solutions...................................... 1537
Game Ready..................................... 6541
GE Healthcare.................................. 2837
Globus Medical................................. 6849
GPI Prototype................................... 6120
Gruppo Bioimpianti SRL.................. 1041
GS Medical....................................... 3734
Hand Biomechanics Lab, Inc............. 1265
Harvest Technologies Corp................. 939
Hologic............................................. 2341
I-Flow, LLC, a Kimberly-Clark
Health Care Company.................... 6449
IHI Ionbond Inc................................ 6118
IMDS - Innovative Medical
Device Solutions................................ 457
Implanet............................................ 3965
IMT-USA, LLC................................. 5729
Incisive Surgical, Inc.......................... 3936
Industrias Medicas Sampedro S.A.S.. 4036
INEX Surgical Inc............................. 3332
Inion Inc........................................... 6729
Innovative Medical Equipment, LLC.7119
Innovative Medical Products............. 6349
Innovision, Inc.................................. 3337
Instratek, Inc..................................... 4234
INSURGICAL Power Tools.............. 4930
Intech Medical................................... 649
Integra................................................ 567
Intrepid Orthopedics......................... 6914
Invibio Biomaterial Solutions............ 3935
ISTO Technologies, Inc..................... 6749
Jewel Precision.................................. 4037
Joined Orthopaedic Innovators
Netherlands..................................... 7021
Joint Restoration Foundation............ 6021
Joslin Orthopedic Gear..................... 2268
K2M, Inc.......................................... 6949
Karl Storz Endoscopy-America, Inc... 1057
Kinamed, Inc..................................... 2941
Kneebourne Therapeutic LLC........... 3941
KYOCERA Medical Corporation..... 4033
LDR.................................................. 2034
LimaCorporate Spa........................... 1371
Product Listings
387
Product Listings
388
Technical Exhibits
Diagnostic Equipment - DI
AccelLAB Inc.................................... 3832
Alpinion Medical Systems................. 2639
American Imaging............................. 2738
Danco Anodizing.............................. 1840
Del Medical, Inc................................ 2534
Devicix, LLC..................................... 3630
Diagnostic Instruments, Inc............... 2838
EOS Imaging..................................... 2335
Esaote North America....................... 2231
FUJIFILM Medical Systems USA,
Inc................................................... 2239
GE Healthcare.................................. 2837
Hitachi Medical Systems
America, Inc.................................... 2435
Hologic............................................. 2341
iCRco, Inc......................................... 2743
INEX Surgical Inc............................. 3332
Konica Minolta Medical Imaging...... 2641
Medstrat, Inc...................................... 441
Merge Healthcare............................. 4649
Oiservice CT & MR......................... 2631
OrthoScan......................................... 2531
Paramed Medical Systems, Inc.......... 2831
Technical Exhibits
Image Guiding/Navigation
Systems - IMG
AccelLAB Inc.................................... 3832
Aesculap Implant Systems................. 1049
AIP Precision Machining................... 1340
Amplitude......................................... 1571
Arthrex, Inc...................................... 6029
Blue Belt Technologies........................ 735
Brainlab.................................. 3869, 3973
Custom Orthopaedic Solutions......... 6441
Devicix, LLC..................................... 3630
Diagnostic Instruments, Inc............... 2838
DragonBio Implants.......................... 7029
Esaote North America....................... 2231
Exactech, Inc..................................... 2261
Hitachi Medical Systems
America, Inc.................................... 2435
Medtronic......................................... 5249
Merge Healthcare............................. 4649
Olive Medical................................... 3969
OMNI............................................... 4939
OrthAlign, Inc................................... 5813
OrthoScan......................................... 2531
Orthosensor, Inc................................ 6929
Panasonic.......................................... 2930
Siemens Healthcare........................... 4821
SRSsoft............................................. 4457
Steute Meditech, Inc.......................... 3065
Stryker Endoscopy............................ 2549
Stryker Instruments........................... 2549
Surgical Planning Associates, Inc....... 2232
Tenex Health, Inc.............................. 5850
VirtualScopics................................... 2842
Zimmer............................................. 3149
Implants - I
aap Implantate AG............................ 3037
AccelLAB Inc.................................... 3832
Active Implants Corporation............. 6049
Acumed............................................. 5549
Advanced Orthopaedic Solutions,
Inc................................................... 5349
Aesculap Implant Systems................. 1049
Ai-Medic Co., Ltd............................. 6122
AIP Precision Machining................... 1340
AME/Orthotec International............. 3331
American Medical Endoscopy, Inc...... 841
Amniox Medical............................... 5842
Amplitude......................................... 1571
Apex Tools and Orthopedics............. 4412
APS Materials, Inc............................ 6013
Arcam AB......................................... 4072
ARGOmedical AG............................ 1331
Arthrex, Inc...................................... 6029
ArthroCare....................................... 1130
Arthrosurface, Inc............................. 6529
Arzzt................................................. 4853
Assut Europe s.p.a............................ 5737
Product Listings
389
Product Listings
390
Technical Exhibits
Technical Exhibits
Medical Supplies - MS
3-Point Products Inc.......................... 5131
Abrexis............................................... 641
Apex Tools and Orthopedics............. 4412
ArthroPlastics, Inc............................. 1942
Baitella AG......................................... 837
Bledsoe Brace Systems....................... 5929
CareFusion........................................ 1136
Case Medical.................................... 6721
Cases By Source, Inc......................... 1536
MRI - MRI
AccelLAB Inc.................................... 3832
DragonBio Implants.......................... 7029
Esaote North America....................... 2231
GE Healthcare.................................. 2837
Hitachi Medical Systems America,
Inc................................................... 2435
Hologic............................................. 2341
Oiservice CT & MR......................... 2631
Paramed Medical Systems, Inc.......... 2831
Siemens Healthcare........................... 4821
Steute Meditech, Inc.......................... 3065
VirtualScopics................................... 2842
Orthoses - O
3-Point Products Inc.......................... 5131
Abrexis............................................... 641
Aspen Medical Products.................... 3231
Assut Europe s.p.a............................ 5737
Bauerfeind USA, Inc............................ 930
Becker Orthopedic............................ 3949
Bird & Cronin.................................. 1235
Bonutti Technologies......................... 1941
Breg.................................................. 1649
Brownmed........................................ 4313
CORFLEX INC................................ 3148
Cybertech Medical............................ 5657
Dynamic Techno Medicals Pvt. Ltd... 7235
East Coast Orthotic and Prosthetic
Corporation...................................... 931
EOS Electro Optical Systems............. 6213
Footmaxx, Inc................................... 5852
Hames Orthotech................................ 458
I-Ming Sanitary Materials Co., Ltd... 1732
INEX Surgical Inc............................. 3332
Kao Chen Enterprise Co., Ltd........... 5836
M.J. Markell Shoe Co., Inc............... 1842
Mammon International Corp............ 1650
Maramed Orthopedic Systems.......... 6723
Meditech Group, LLC....................... 1940
NeuMed............................................ 1934
Neurotech......................................... 2135
Ossur Americas................................. 3239
Span Link International, LLC............. 936
Suzhou Sunan Zimmered Medical
Instrument Co., Ltd........................... 456
Tekscan, Inc...................................... 4034
Top Shelf Orthopedics....................... 4434
Total Plastics..................................... 1038
Townsend Design.............................. 3639
United Ortho.................................... 4849
VQ OrthoCare.................................. 6319
Other - OTH
AAOS Advocacy Booth..................... 4213
Abrexis............................................... 641
Accutek Testing Laboratory.............. 2131
Aerobiotix......................................... 7020
AIP Precision Machining................... 1340
Alignmed.......................................... 1541
AlloSource........................................ 1441
Alpinion Medical Systems................. 2639
AMSURG......................................... 4633
ApexNetwork Physical Therapy........ 4656
APS Materials, Inc............................ 6013
Aptiv Solutions................................. 7019
Austen BioInnovation Institute in
Akron.............................................. 3967
Bal Seal Engineering, Inc................... 2141
Biologic Therapies, Inc...................... 6148
BLOXR............................................. 2538
Blue Star Radiology.......................... 5820
Bodycote........................................... 6719
Product Listings
391
Product Listings
392
Technical Exhibits
CARE............................................... 4512
CareCredit........................................ 4423
CareFusion........................................ 1136
Cytonics Corporation....................... 5830
DSM Biomedical............................... 3133
Ebone................................................ 3131
ElliptiGO Inc...................................... 635
Empirical Testing Corp..................... 5449
Endolab GmbH................................. 5731
Evonik Corporation.......................... 1350
FCS Medical..................................... 4134
FORE - Foundation For Orthopaedic
Research and Education.................... 5712
Gibraltar Laboratories Inc................ 4323
Incisive Surgical, Inc.......................... 3936
Infinite Therapeutics........................... 452
Innovative Medical Equipment, LLC.7119
INSURGICAL Power Tools.............. 4930
International Titanium Association..... 337
Intralign............................................ 4430
Invibio Biomaterial Solutions............ 3935
Lumitex MD..................................... 1431
Materialise........................................ 6839
Medin Corporation........................... 1641
MEDS Management Group.............. 7218
Miami Anatomical Research Center.. 5417
Millstone Medical Outsourcing........... 657
Musculoskeletal Clinical Regulatory
Advisers, LLC................................... 4318
My Rehab Pro, LLC.......................... 6553
Nadia International, Inc.................... 2548
National Athletic Trainers
Association...................................... 5415
NIH Osteoporosis & Related Bone
Diseases............................................ 5220
Nutramax Laboratories, Inc.............. 4031
OH MY Products.............................. 7118
Orchid Orthopedic Solutions............ 6829
Origin Healthcare Solutions.............. 4612
Ortho Executive................................ 6920
Orthopedic Analysis LLC.................... 341
OrthoView........................................ 5238
Panasonic.......................................... 2930
PCI HealthDev.................................. 4754
Phillips Precision Medicraft............... 5230
Promimic AB..................................... 7237
ProScan Reading Services.................. 2542
Puracon GmbH................................. 7134
Pyxidis.............................................. 2163
Quintus Composites.......................... 5749
Response Ortho LLC........................ 1364
Simbionix USA Corporation............. 3633
Solvay............................................... 4131
STAT Design, LLC............................ 7131
Stryker Orthopaedics........................ 2549
Tekscan, Inc...................................... 4034
Teleflex Medical OEM...................... 3067
THI - Total Healthcare Innovation
GmbH............................................. 2031
Venel................................................. 4552
White Towel Services Inc................... 7214
Pharmaceuticals - PH
AccelLAB Inc.................................... 3832
Alexion............................................. 6815
Aptiv Solutions................................. 7019
Auxilium Pharmaceuticals, Inc.... 134, 135
Gensco Laboratories......................... 4066
ISTO Technologies, Inc..................... 6749
Janssen Pharmaceuticals, Inc............. 4048
Lilly USA, LLC................................. 4341
Medmix Systems AG........................... 634
Pacira Pharmaceuticals, Inc............... 7135
Purac Biomaterials............................ 2139
Soothe............................................... 7113
Tyy Consulting.................................. 4513
Wynn Pharm..................................... 1648
Physician Recruitment - PR
AAOS Now....................................... 5519
AMSURG......................................... 4633
Army Medical Recruiting.................. 4519
ARP Wave LLC................................... 632
Biodynamic Research Corporation
(BRC).............................................. 7221
Community Health Systems.............. 4623
Delphi of TeamHealth....................... 4736
Francis Lamont Innovations Ltd....... 6715
Group Health Permanente................ 4537
JAAOS.............................................. 5519
Locum Leaders, Inc........................... 4433
LocumTenens.com............................ 4555
Medical Consultants Network.......... 4732
Ministry Health Care........................ 4621
Nueterra........................................... 4659
PracticeLink.com.............................. 4630
PracticeMatch Services...................... 4415
QTC Medical Services, a Lockheed
Martin Co....................................... 4614
Residency Select................................ 5121
Sinai Hospital of Baltimore, Rubin
Inst. for Advanced Orthopedics....... 5615
Southcoast Hospitals Group............. 4514
Staff Care, Inc................................... 4615
SurgCenter Development.................... 740
Surgical Affiliates Management
Group, Inc....................................... 4712
Synergy Surgicalists........................... 4655
Weatherby Healthcare....................... 4548
Practice/Office Management - PM
AAOS Exhibit Hall Resource Center.5519
AAOS Now....................................... 5519
AdvancedMD Software..................... 4720
AllMeds............................................ 4641
American Association of
Orthopaedic Executives................... 4654
ApexNetwork Physical Therapy........ 4656
Aprima Medical Software................. 4530
Bank of America Practice Solutions... 4658
Biomet.............................................. 1749
Breg.................................................. 1649
CARE............................................... 4512
CareCloud........................................ 4413
ChartLogic, Inc................................. 4441
Collect Rx......................................... 4756
Compulink Business Systems, Inc...... 4568
eClinicalWorks.................................. 4734
Emdat............................................... 4632
Exscribe, Inc..................................... 4549
GE Healthcare.................................. 2837
Jackson & Coker.............................. 4522
Jiangsu Ideal Medical Science &
Technology Co., Ltd........................ 6854
KareOutcomes.................................. 4469
MedNet Technologies....................... 4540
MEDS Management Group.............. 7218
Merge Healthcare............................. 4649
Mobile Workforce Inc....................... 4722
Nextech............................................ 4749
NextGen Healthcare Information
Systems, Inc..................................... 4449
Nueterra........................................... 4659
Oberd............................................... 4757
Origin Healthcare Solutions.............. 4612
Ortech Data Centre Inc..................... 4557
Ossur Americas................................. 3239
Physician Owned Surgery Centers..... 4531
Practice Flow Solutions..................... 4730
Rosemont Media, LLC...................... 4534
Socrates Ortho.................................. 4435
SRSsoft............................................. 4457
Stryker Orthopaedics........................ 2549
SurgiMate......................................... 4631
Synergy Surgicalists........................... 4655
Systemedx Healthcare Technology.... 4535
Understand.com................................ 4536
White Towel Services Inc................... 7214
Your Practice Online, LLC................ 4437
ZyDoc Transcription......................... 4714
Prosthesis - P
American Medical Endoscopy, Inc...... 841
Arthrosurface, Inc............................. 6529
AVICENNE...................................... 3164
Bauerfeind USA, Inc............................ 930
Beijing AKEC Medical Co., Ltd........ 6112
Beijing Chunlizhengda Medical
Instruments Co., Ltd....................... 3732
Breg.................................................. 1649
C&A Tool Engineering, Inc.............. 3436
C2F Implants...................................... 167
DJO Global....................................... 1349
Dry Corp, LLC................................. 5252
Dynamic Techno Medicals Pvt. Ltd... 7235
Technical Exhibits
Publisher - PUB
AAOS Exhibit Hall Resource Center.. 5519
AAOS Now....................................... 5519
American Journal of Orthopedics..... 5719
Bone & Joint Journal
(formerly JBJS (Br))......................... 5613
Data Trace Publishing....................... 5223
Elsevier................................... 5213, 5315
JAAOS.............................................. 5519
Jaypee Highlights Medical Publisher.5123
Orthopedic Design & Technology
Magazine........................................ 5317
ORTHOWORLD Inc....................... 5416
PracticeLink.com.............................. 4630
SAGE................................................ 5412
Sinai Hospital of Baltimore, Rubin
Inst. for Advanced Orthopedics....... 5615
SLACK Incorporated........................ 5421
Springer............................................ 5721
The Journal of Bone and
Joint Surgery, Inc............................. 5321
Thieme Publishers, Inc...................... 5512
Veritas Health LLC........................... 4758
Webb Dordick, Rare Medical Books... 5313
Wolters Kluwer Health..................... 5513
Rehabilitation/Exercise
Equipment - REHB
3-Point Products Inc.......................... 5131
ACIGI Relaxation/Fujiiryoki............. 1241
American 3B Scientific...................... 4322
ApexNetwork Physical Therapy........ 4656
ARP Wave LLC................................... 632
Better Walk Inc................................... 357
Bird & Cronin.................................. 1235
Bonutti Technologies......................... 1941
DeRoyal............................................ 4041
DJO Global....................................... 1349
Dynamic Techno Medicals Pvt. Ltd... 7235
ElliptiGO Inc...................................... 635
Emovi, Inc......................................... 6015
Game Ready..................................... 6541
I-Ming Sanitary Materials Co., Ltd... 1732
Infinite Therapeutics........................... 452
Innovative Medical Equipment, LLC.7119
Kao Chen Enterprise Co., Ltd........... 5836
Kinesio Holding Corporation.............. 138
Kneebourne Therapeutic LLC........... 3941
Magnus Magnetica, LLC.................. 6823
Neuro Resource Group..................... 4038
Neurotech......................................... 2135
Opedix.............................................. 7035
QAL Medical.................................... 6822
Tekscan, Inc...................................... 4034
The Medcom Group, Ltd.................. 6530
ThermoTek, Inc................................. 2155
Top Shelf Orthopedics....................... 4434
Townsend Design.............................. 3639
VQ OrthoCare.................................. 6319
Brownmed........................................ 4313
BSN Medical..................................... 1735
CORFLEX INC................................ 3148
Custom Fab, Inc................................ 1543
Darco International........................... 1741
DeRoyal............................................ 4041
DJO Global....................................... 1349
Dynamic Techno Medicals Pvt. Ltd... 7235
Flagship Surgical, LLC...................... 3535
Groupe Lepine.................................. 1669
Hames Orthotech................................ 458
Hapad, Inc........................................ 1730
Innovative Medical Products............. 6349
Joslin Orthopedic Gear..................... 2268
Kao Chen Enterprise Co., Ltd........... 5836
M.J. Markell Shoe Co., Inc............... 1842
Mammon International Corp............ 1650
Medical Products Resource............... 2030
Meditech Group, LLC....................... 1940
Mizuho OSI............................ 3437, 3539
Opedix.............................................. 7035
Ortho-Care....................................... 3059
Ossur Americas................................. 3239
Span Link International, LLC............. 936
Stryker Endoscopy............................ 2549
SunMedica, Inc................................. 6555
Top Shelf Orthopedics....................... 4434
United Ortho.................................... 4849
VQ OrthoCare.................................. 6319
Zimmer............................................. 3149
Product Listings
393
Product Listings
394
Technical Exhibits
Surgical Instruments - SI
3D Medical ExFix, LLC...................... 450
aap Implantate AG............................ 3037
Acumed............................................. 5549
Advanced Endoscopy Devices, Inc...... 533
Advanced Orthopaedic
Solutions, Inc.................................. 5349
Aesculap, Inc..................................... 1249
Ai-Medic Co., Ltd............................. 6122
AIP Precision Machining................... 1340
Allotech Co., Ltd.............................. 6812
AME/Orthotec International............. 3331
American Medical Endoscopy, Inc...... 841
Apex Tools and Orthopedics............. 4412
Applied Medical................................ 1356
Arteriocyte Medical Systems............. 1734
Arthrex, Inc...................................... 6029
ArthroCare....................................... 1130
ArthroPlastics, Inc............................. 1942
Arthrosurface, Inc............................. 6529
Arzzt................................................. 4853
Autocam Medical.............................. 6053
Avalign Technologies......................... 4231
AVICENNE...................................... 3164
BAUI Biotech Co., Ltd...................... 6918
Baxano Surgical, Inc......................... 1635
BioAccess.......................................... 2554
Biologic Therapies, Inc...................... 6148
Biomet.............................................. 1749
Technical Exhibits
Parcus Medical, LLC......................... 3430
PCC Structurals................................ 5149
Pega Medical, Inc.............................. 3230
Phillips Precision Medicraft............... 5230
Pro-Dex Inc....................................... 3773
Pulse Lavage AB................................ 1936
Quadrant Engineering Plastic
Products.......................................... 4831
Quintus Composites.......................... 5749
Razek Equipamentos Ltda................ 1335
Response Ortho LLC........................ 1364
rms Surgical...................................... 3634
Rochling Engineering Plastics............ 1068
Rose Micro Solutions.......................... 349
Sanatmetal Ltd.................................. 1565
Seabrook International...................... 4058
SH Medical Corp.............................. 1631
Shandong Hangwei Orthopedics
Medical Instrument Co., Ltd........... 3172
Shoulder Options, Inc....................... 4839
Showa Ika Kohgyo Co., Ltd.............. 1937
Shukla Medical................................. 2035
Skeletal Dynamics............................. 6313
Smith & Nephew Inc........................ 5229
Solana Surgical, LLC......................... 6513
Sontec Instruments, Inc..................... 4219
Spiracur............................................ 4948
STAT Design, LLC............................ 7131
Steute Meditech, Inc.......................... 3065
StrenuMed Inc.................................. 3737
Stryker Endoscopy............................ 2549
Stryker Instruments........................... 2549
Stryker Orthopaedics........................ 2549
Surgical Planning Associates, Inc....... 2232
Surgical Power, Inc............................ 3156
Surgical Specialties Corporation........ 2151
Surgionix Ltd.................................... 6423
Surgitel/General Scientific Corp......... 2230
Suzhou Sunan Zimmered Medical
Instrument Co., Ltd........................... 456
Suzhou Xinrong Best Medical
Instrument Co., Ltd......................... 6820
Symmetry Medical Inc...................... 4949
Syntec Scientific Corporation............ 4130
Tasarimmed Medical Equipments..... 7121
Technicality, Inc................................ 1253
Tecomet............................................ 1834
Teleflex.............................................. 3069
Tenex Health, Inc.............................. 5850
ThermoTek, Inc................................. 2155
Thortex............................................. 5153
Tianjin Walkman Biomaterial
Co., Ltd........................................... 6755
Tianjin ZhengTian Medical
Instrument Co., Ltd......................... 6729
Tiemann Surgical.............................. 3841
Toby Orthopaedics, Inc..................... 4068
Tornier.............................................. 5849
Total Plastics..................................... 1038
Triangle............................................. 7128
U&I Corporation................................ 741
Ulrich Medical USA.......................... 3235
Tissue Products - T
aap Implantate AG............................ 3037
AccelLAB Inc.................................... 3832
AlloSource........................................ 1441
Amniox Medical............................... 5842
Anatomy Gifts Registry..................... 7130
Arthrex, Inc...................................... 6029
Berkeley Advanced Biomaterials, Inc..1433
BioD, LLC........................................ 4932
Biologic Therapies, Inc...................... 6148
Biomet.............................................. 1749
Cellright Technologies, LLC.............. 2270
Ceterix Orthopaedics........................ 7123
CG Bio................................................ 261
Clinical Resolution Lab, Inc.............. 7213
Community Tissue Services................. 651
ConMed............................................ 2249
Etex Corporation.............................. 3034
Exactech, Inc..................................... 2261
Groupe Lepine.................................. 1669
Hans Biomed USA, Inc...................... 1064
IHI Ionbond Inc................................ 6118
IMDS - Innovative Medical
Device Solutions................................ 457
Integra................................................ 567
Joined Orthopaedic Innovators
Netherlands...................................... 7021
Joint Restoration Foundation............ 6021
LifeLink Tissue Bank........................... 531
LifeNet Health.................................. 6119
MedCure, Inc.................................... 3631
Medmix Systems AG........................... 634
Millstone Medical Outsourcing........... 657
MiMedx............................................ 1173
MTF................................................. 4141
NuTech............................................. 6649
Osiris Therapeutics, Inc.................... 6528
Research for Life, LLC...................... 4319
RTI Surgical...................................... 5937
Single Source Surgical, LLC................ 965
Skye Orthobiologics LLC.................. 7220
Solana Surgical, LLC......................... 6513
Stability Biologics.............................. 6518
Stellen Medical, LLC......................... 2169
Stryker Endoscopy............................ 2549
Product Listings
395
Product Listings
396
Technical Exhibits
X-Ray - XRAY
AccelLAB Inc.................................... 3832
AIP Precision Machining................... 1340
BLOXR............................................. 2538
Del Medical, Inc................................ 2534
DragonBio Implants.......................... 7029
EOS Imaging..................................... 2335
FUJIFILM Medical Systems
USA, Inc.......................................... 2239
GE Healthcare.................................. 2837
Hologic............................................. 2341
OrthoScan......................................... 2531
Planmed, Inc..................................... 2834
Quadrant Engineering Plastic
Products.......................................... 4831
Quantum Medical Imaging, LLC...... 2443
Shanghai Bojin Electric
Instrument & Device Co., Ltd......... 3731
Siemens Healthcare........................... 4821
Spine Pain Management, Inc............. 2739
Steute Meditech, Inc.......................... 3065
VirtualScopics................................... 2842
Ziehm Imaging.................................. 2539
Beverage Breaks
Food Service
Enjoy complimentary food and beverage items supplied by many of the exhibitors
in their booth. Food service areas located throughout the exhibit hall will offer a
variety of food and beverage options for purchase.
AAOS Bistro
The AAOS Bistro provides a comfortable setting for exhibitors and attendees to eat,
meet and network. Located directly on the show floor with an all-inclusive buffet
lunch and available table reservations, Wednesday through Friday from 11:00 AM to
2:30 PM. Tickets can be purchased in Lobby G.
Seating Areas
Park benches are placed throughout the exhibit hall and additional seating is
available at the food service areas and in the Academy Lounge located in Exhibit
Hall G.
Stop at Internet Connections kiosks located in the lobby areas to view a listing of
all exhibitors, their contact and product information, and create and print your
personal My Expo Plan.
Pick up an updated floor plan and exhibitor listing at the You Are Here signs
located at delect entrances to the Exhibit Hall. These signs and maps are color
coded to help you find your way around the exhibit hall.
Booth numbers are located on the aisle carpet and aisle numbers are on signs
hanging overhead.
Theres no need to tote a bulging bag or cram papers in your suitcase when you
leave. Simply present your badge to exhibitors whose literature you want to
receive. After scanning the bar code, exhibitors will be able to mail materials
directly to you after the meeting, enabling you to spend more time in face-to-face
discussions with vendors.
About our
Members and
Volunteers
398
Thursday, March 13
6:30 - 8:00 AM
Hilton Riverside
Versailles Ballroom
Monday, March 10
12:00 - 5:00 PM
Hilton Riverside
Grand Salon 9 & 12
Meeting
Wednesday, March 12
7:00 - 7:45 AM
Morial Convention Center
Room 279
Wednesday, March 12
11:30 AM - 3:30 PM
Morial Convention Center
Room 224
Wednesday, March 12
4:00 - 6:00 PM
Morial Convention Center
Room 223
Saturday, March 15
7:30 - 9:30 AM
Morial Convention Center
Room 279
Thursday, March 13
6:00 - 8:00 AM
Morial Convention Center
Room 220
Friday, March 14
6:00 - 8:00 AM
Morial Convention Center
Room 220
Board of Councilors
Executive Committee
Tuesday, March 11
3:30 - 6:00 PM
Morial Convention Center
Room 224
Orientation Meeting
Wednesday, March 12
2:00 - 5:00 PM
Hilton Riverside
Grand Salon 9 & 12
Thursday, March 13
3:30 - 5:30 PM
Morial Convention Center
Room 224
Committee on State
Legislative and Regulatory
Issues Business Meeting
Thursday, March 13
4:30 - 6:30 PM
Hilton Riverside
Versailles Ballroom
Business Meeting
Friday, March 14
7:00 - 11:30 AM
Hilton Riverside
Grand Ballroom A
State Orthopaedic
Societies Committee
Friday, March 14
1:30 - 3:30 PM
Hilton Riverside
Versailles Ballroom
Thursday, March 13
6:00 - 8:00 AM
Hilton Riverside
Oak Alley
Research Committee
Thursday, March 13
6:00 - 8:00 AM
Hilton Riverside
Belle Chasse
Business Meeting
Friday, March 14
6:00 - 8:00 AM
Hilton Riverside
Grand Ballroom B
Thursday, March 13
6:30 - 8:30 AM
Morial Convention Center
Room 223
Thursday, March 13
12:00 - 1:30 PM
Morial Convention Center
Room 214
Saturday, March 15
11:30 AM - 1:00 PM
Morial Convention Center
Room 278
Communications Cabinet
Meeting
Thursday, March 13
2:00 - 4:00 PM
Hilton Riverside
Jefferson
Business Meeting
Breakfast Meeting
Wednesday, March 12
6:30 - 9:30 AM
Morial Convention Center
Great Hall B
Friday, March 14
7:00 - 8:00 AM
Morial Convention Center
Room 223
Friday, March 14
12:00 - 2:00 PM
Morial Convention Center
Room 223
Friday, March 14
12:00 PM - 1:30 PM
Morial Convention Center
Room 214
Friday, March 14
6:00 - 8:00 AM
Hilton Riverside
Grand Salon 15 & 18
Wednesday, March 12
11:30 AM - 12:30 PM
Hilton Riverside
Grand Salon 21 & 24
Alumni Reception
Friday, March 14
6:00 - 7:00 PM
Hilton Riverside
Grand Salon 9 & 12
Evaluation Leadership
Meeting and Lunch
Meeting
Meeting
Wednesday, March 12
1:00 - 4:00 PM
Hilton Riverside
Grand Salon 21 & 24
Exhibits Committee
Meeting
Tuesday, March 11
4:00 - 6:00 PM
Morial Convention Center
Room 278
Breakfast Meeting
Meeting
Wednesday, March 12
6:30 - 9:00 AM
Morial Convention Center
Room 278
Breakfast Meeting
Wednesday, March 12
7:30 - 9:30 AM
Morial Convention Center
Room 274
Friday, March 14
7:00 - 9:00 AM
Morial Convention Center
Room 212
Thursday, March 13
10:00 AM - 12:00 PM
Morial Convention Center
Room 274
Thursday, March 13
12:00 - 2:30 PM
Morial Convention Center
Room 224
PAC Luncheon
International Committee
Meeting
Wednesday, March 12
1:30 - 3:30 PM
Morial Convention Center
Room 223
Luncheon
Saturday, March 15
6:30 - 8:30 AM
Morial Convention Center
Room 223
Wednesday, March 12
11:30 AM - 1:30 PM
Morial Convention Center
Great Hall B
399
400
Thursday, March 13
7:00 AM - 9:00 AM
Morial Convention Center
Room 274
Wednesday, March 12
6:00 AM - 8:00 AM
Morial Convention Center
Room 220
Periodicals
Reception
Friday, March 14
6:00 - 8:00 PM
Hilton Riverside
Grand Salon 15 & 18
Friday, March 14
11:00 AM - 1:00 PM
Morial Convention Center
Room 224
Photo courtesy of Jen Amato, New Orleans Convention & Visitors Bureau
Luncheon
Thursday, March 13
12:00 - 2:00 PM
Windsor Court
Gallery
Officers Meeting
Tuesday, March 11
3:00 - 4:00 PM
Hilton Riverside
Ascot
Abbott Society
Reception
Thursday, March 13
6:00 - 9:00 PM
Antoines Restaurant
713 Rue St. Louis Street
Wednesday, March 12
9:00 - 10:30 AM
Hilton Riverside
Eglinton and Winton
Wednesday, March 12
5:30 - 8:30 PM
Hilton Riverside
Grand Salon 3 & 6
Academic Leadership
Wednesday, March 12
Committee Meeting
12:30 - 2:00 PM
Hilton Riverside
Windsor
Communication Committee
Saturday, March 15
12:00 - 1:00 PM
Morial Convention Center
Room 213
EBM Committee
Saturday, March 15
12:00 - 1:00 PM
Morial Convention Center
Room 220
Membership Committee
Saturday, March 15
12:00 - 1:00 PM
Morial Convention Center
Room 223
Development Committee
Meeting
Publications Committee
Saturday, March 15
12:00 - 1:00 PM
Morial Convention Center
Room 224
Nominating Committee
Wednesday, March 12
Meeting
4:00 - 6:00 PM
Hilton Riverside
Chequers
HP Committee
Saturday, March 15
12:00 - 1:00 PM
Morial Convention Center
Room 279
Fellowships Alumni
Reception
Wednesday, March 12
6:00 - 7:00 PM
Hilton Riverside
Jefferson Ballroom
Thursday, March 13
7:00 - 8:00 AM
Hilton Riverside
Prince of Wales
Friday, March 14
12:00 - 2:00 PM
Hilton Riverside
Grand Salon 15 & 18
Wednesday, March 12
4:00 - 6:00 PM
Hilton Riverside
Prince of Wales
Thursday, March 13
Critical Issues Committee
Meeting
11:00 AM - 2:00 PM
Hilton Riverside
Magnolia
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Sheraton New Orleans
Evergreen
401
402
Leadership Development
Thursday, March 13
1:30 - 3:00 PM
Committee Meeting
Hilton Riverside
Newberry
Education Committee
Friday, March 14
7:00 - 8:00 AM
Hilton Riverside
Grand Salon 3 & 6
Fellowships Coordinating
Thursday, March 13
Committee Meeting
2:00 - 2:45 PM
Hilton Riverside
Ascot
CPT/RUC Committee
Friday, March 14
8:15 - 9:15 AM
Hilton Riverside
Grand Salon 3 & 6
Friday, March 14
8:15 - 9:15 AM
Hilton Riverside
Grand Salon 7 & 10
Friday, March 14
CORD Accreditation &
10:30 AM - 12:00 PM
Compliance Committee
Meeting
Hilton Riverside
Ascot
Friday, March 14
11:00 AM - 12:30 PM
Hilton Riverside
Grand Salon 3 & 6
Friday, March 14
1:00 - 2:00 PM
Hilton Riverside
Grand Salon 7 & 10
Friday, March 14
CORD Governing
12:00 - 1:30 PM
Committee Meeting
Hilton Riverside
Ascot
Friday, March 14
10:00 - 11:00 AM
Hilton Riverside
Grand Salon 7 & 10
Friday, March 14
3:00 - 4:00 PM
Hilton Riverside
Grand Salon 3 & 6
Friday, March 14
4:00 - 6:00 PM
Hilton Riverside
Grand Salon 3 & 6
Saturday, March 15
6:00 - 7:00 AM
Morial Convention Center
Room 208-209
Member Reception
Saturday, March 15
5:00 - 7:00 PM
Morial Convention Center
Great Hall B Pre-Function
Friday, March 14
7:00 - 10:00 AM
Hilton Riverside
Grand Ballroom D
Thursday, March 13
3:00 - 4:00 PM
Hilton Riverside
Grand Salon 3 & 6
Thursday, March 13
4:00 - 5:00 PM
Hilton Riverside
Grand Salon 7 & 10
Thursday, March 13
4:00 - 5:00 PM
Hilton Riverside
Grand Salon 3 & 6
Thursday, March 13
2:00 - 3:00 PM
Hilton Riverside
Grand Salon 3 & 6
Humanitarian Services
Committee
Thursday, March 13
3:00 - 4:00 PM
Hilton Riverside
Grand Salon 7 & 10
Thursday, March 13
12:00 - 1:00 PM
Hilton Riverside
Eglinton and Winton
2014 American Academy of Orthopaedic Surgeons
Thursday, March 13
12:00 - 1:30 PM
Hilton Riverside
Prince of Wales
Education &
Thursday, March 13
Industry Relations Committee 12:30 - 1:30 PM
Hilton Riverside
Chequers
Fellowship Directors
Council of Delegates
Thursday, March 13
12:30 - 2:00 PM
Hilton Riverside
Grand Salon 9 & 12
Enduring Education
Friday, March 14
3:00 - 5:00 PM
Committee
Hilton Riverside
Chequers
Fellowship Match
Committee
Thursday, March 13
1:00 - 2:00 PM
Hilton Riverside
Marlborough B
Public Relations
Committee
Thursday, March 13
2:00 - 3:00 PM
Hilton Riverside
Eglinton and Winton
Education Committee
Thursday, March 13
2:00 - 4:00 PM
Hilton Riverside
Marlborough A
Traveling Fellowship
Committee
Friday, March 14
7:00 - 8:30 AM
Hilton Riverside
Marlborough A
PICME Committee
Friday, March 14
8:00 - 9:30 AM
Hilton Riverside
Chequers
Nominating Committee
Friday, March 14
9:00 - 10:30 AM
Hilton Riverside
Cambridge
STOP Outreach
Committee
Friday, March 14
10:30 AM - 12:00 PM
Hilton Riverside
Marlborough A
OKO Committee
Friday, March 14
10:30 - 11:30 AM
Hilton Riverside
Chequers
Friday, March 14
1:30 - 3:00 PM
Hilton Riverside
Grand Salon 19 & 22
Friday, March 14
6:00 - 7:30 PM
Hilton Riverside
Grand Salon 21 & 24
Andrews Institute
Reception
Friday, March 14
6:00 - 8:00 PM
Ritz-Carlton
Broadmoor
Thursday, March 13
7:00 - 10:00 PM
The House of Blues
225 Decatur Street
Research Committee
Thursday, March 13
2:00 - 4:00 PM
Hilton Riverside
Melrose
403
404
Thursday, March 13
7:00 - 8:00 AM
Hilton Riverside
Eglinton and Winton
AANA/ISAKOS Lunch
Thursday, March 13
12:00 - 2:00 PM
Hilton Riverside
Grand Salon 15
International Committee
Meeting
Thursday, March 13
12:00 - 2:00 PM
Hilton Riverside
Grand Salon 18
Council on Education
Thursday, March 13
4:00 - 5:00 PM
Hilton Riverside
Marlborough B
Friday, March 14
12:00 - 2:00 PM
Hilton Riverside
Marlborough A
Tuesday, March 11
8:00 AM - 1:00 PM
New Orleans Marriott
Mardi Gras C
Reception
Tuesday, March 11
6:00 PM - 9:00 PM
New Orleans Marriott
Mardi Gras A-B
Wednesday, March 12
6:00 AM - 2:00 PM
New Orleans Marriott
Mardi Gras A-C
Wednesday, March 12
7:00 AM - 5:00 PM
New Orleans Marriott
Mardi Gras D
Thursday, March 13
6:00 AM - 2:00 PM
New Orleans Marriott
Mardi Gras A-C
Thursday, March 13
7:00 AM - 5:00 PM
New Orleans Marriott
Mardi Gras D
Friday, March 14
6:00 AM - 2:00 PM
New Orleans Marriott
Mardi Gras A-C
Friday, March 14
7:00 AM - 4:00 PM
New Orleans Marriott
Mardi Gras D
Thursday, March 13
12:00 - 3:00 PM
Astor Crowne Plaza
Astor Ballroom III
Friday, March 14
7:00 - 9:00 PM
Westin Canal Place
Magnolia II
Friday, March 14
6:00 - 9:00 PM
Royal Sonesta Hotel, Regal Suite
300 Bourbon Street
Thursday, March 13
6:00 - 9:00 PM
Windsor Court
Gallery C
Georgetown Alumni
Alumni Reception
Reception
Thursday, March 13
6:00 - 9:00 PM
Westin Canal
Plimsoll Club
Friday, March 14
6:00 - 8:00 PM
Hyatt Place New Orleans
Meeting Place 1 & 2
Cleveland Clinic
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Harrahs
Fulton Street I-II
Reception
Alumni Reception
Thursday, March 13
6:00 - 7:30 PM
New Orleans Marriott
Galvez
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Arnauds Restaurant,
Counts Ballroom
813 Rue Bienville
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Astor Crowne Plaza
Toulouse B
Saturday, March 15
11:30 AM - 1:30 PM
Morial Convention Center
Room 349
Foot Club
Luncheon
Saturday, March 15
12:00 - 1:30 PM
Hyatt Place New Orleans
Meeting Place 1 & 2
Freiberg Society
Reception
Thursday, March 13
6:30 - 9:00 PM
Hyatt Place New Orleans
Meeting Place 2
Friday, March 14
6:30 - 8:30 PM
Westin Canal Place
Executive Room
Friday, March 14
6:00 - 8:00 PM
Windsor Court
La Chinoiserie B
Hip Society
Board of Directors Meeting
Thursday, March 13
6:00 - 8:00 AM
Morial Convention Center
Room 224
Friday, March 14
4:30 - 5:30 PM
The Pelican Club
312 Exchange Place
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
The Pelican Club
312 Exchange Place
Hughston Society
Reception
Friday, March 14
6:00 - 8:00 PM
Ritz-Carlton
Broadmoor
405
406
Indiana University
Alumni & Friends Reception Thursday, March 13
6:00 - 8:00 PM
Renaissance Arts
Lobby Art Gallery
700 Tchoupitoulas Street
Wednesday, March 12
4:00 - 8:00 PM
Hyatt Place New Orleans
Meeting Place 2
Friday, March 14
6:00 - 9:00 PM
New Orleans Marriott
Balcony N
Thursday, March 13
6:00 - 10:00 AM
Hilton Riverside
Grand Salon 19 & 22
Annual Luncheon
Thursday, March 13
1:00 - 3:00 PM
Hilton Riverside
Grand Ballroom D
Thursday, March 13
3:30 - 5:30 PM
Hilton Riverside
Grand Salon 21 & 24
Thursday, March 13
6:00 - 7:30 PM
Hilton Riverside
Grand Salon 15 & 18
Trilogy Breakfast
Friday, March 14
9:00 - 10:30 AM
Hilton Riverside
Grand Salon 21 & 24
Knee Society
Executive Board Meeting
Friday, March 14
6:00 - 8:00 AM
Morial Convention Center
Room 224
Thursday, March 13
6:00 - 8:30 PM
Hyatt Place New Orleans
Atrium Dining Room
Friday, March 14
6:00 - 7:30 PM
Westin Canal Place
River Room
Thursday, March 13
6:30 - 8:30 PM
Astor Crowne Plaza
Grand Ballroom A-B
Friday, March 14
6:00 - 8:00 PM
Astor Crowne Plaza
Grand Ballroom A
Thursday, March 13
6:00 - 8:00 PM
Galatoires Restaurant
209 Bourbon Street
Wine Room
Cocktail Reception
Friday, March 14
6:00 - 9:00 PM
Windsor Court
La Chinoiserie A
Alumni Reunion
Friday, March 14
6:00 - 9:00 PM
Hilton New Orleans Riverside
River/Port/Starboard
Alumni Reception
Annual Meeting
Friday, March 14
6:00 - 8:00 PM
The Ritz-Carlton
Union Terrace A
Thursday, March 13
6:00 - 7:30 AM
W Hotel New Orleans
Studio 3
Military Committee
Wednesday, March 12
7:00 - 8:00 AM
Hilton Riverside
Marlborough A
Wednesday, March 12
8:00 - 11:00 AM
Hilton Riverside
Grand Salon 13
Research Committee
Wednesday, March 12
9:00 - 10:30 AM
Hilton Riverside
Marlborough A
Think Tank
Wednesday, March 12
10:30 AM - 12:00 PM
Hilton Riverside
Marlborough A
Education Committee
Meeting
Wednesday, March 12
12:00 - 2:00 PM
Hilton Riverside
Grand Salon 3 & 6
Friday, March 14
7:00 - 10:00 PM
Hyatt Place New Orleans
Atrium Dining Room
Thursday, March 13
6:30 - 8:30 PM
W Hotel New Orleans
Studio 56
Alumni Reception
Thursday, March 13
6:00 - 8:00 PM
New Orleans Marriott
Beauregard
Reception
Thursday, March 13
6:30 - 8:30 PM
New Orleans Marriott
Mardi Gras A-C
Wednesday, March 12
4:30 - 5:30 PM
Hilton Riverside
Grand Salon 13
Annual Meeting
407
408
Membership Committee
Thursday, March 13
Meeting
6:30 - 7:30 AM
Hilton Riverside
Newberry
Health Policy
Fellowship Committee
Meeting
Thursday, March 13
9:00 - 10:00 AM
Hilton Riverside
Grand Salon 13 & 16
COTA Meeting
Thursday, March 13
9:00 - 11:00 AM
Hilton Riverside
Melrose
Fellowship Directors Meeting
Thursday, March 13
10:00 - 11:00 AM
Hilton Riverside
Grand Salon 13 & 16
HWB Meeting
Thursday, March 13
11:00 AM - 2:30 PM
Hilton Riverside
Grand Ballroom C
Fund Development
Committee Meeting
Thursday, March 13
12:00 - 1:00 PM
Hilton Riverside
Grand Salon 24
Thursday, March 13
12:00 - 1:00 PM
Hilton Riverside
Grand Salon 21
Disaster Management
Committee Meeting
Thursday, March 13
1:00 - 2:00 PM
Hilton Riverside
Grand Salon 16
COT Meeting
Thursday, March 13
2:00 - 3:00 PM
Hilton Riverside
Grand Salon 13
Thursday, March 13
Practice Management
Committee Meeting
2:00 - 3:00 PM
Hilton Riverside
Elmwood
International Relations
Committee Meeting
Friday, March 14
8:00 - 9:00 AM
Hilton Riverside
Belle Chasse
Humanitarian Committee
Meeting
Friday, March 14
9:00 - 10:00 AM
Hilton Riverside
Belle Chasse
Friday, March 14
12:45 - 1: 45 PM
Hilton Riverside
Prince of Wales
Luncheon
Friday, March 14
12:00 - 2:00 PM
New Orleans Marriott at the
Convention Center
Blaine Kern E-F
Wednesday, March 12
9:00 AM - 3:00 PM
Hilton Riverside
Grand Salon 15 & 18
Tuesday, March 11
12:00 - 3:30 PM
Hilton Riverside
Grand Salon 15 & 18
Tuesday, March 11
5:00 - 9:30 PM
Hilton Riverside
Jefferson Ballroom
Wednesday, March 12
6:30 - 9:00 AM
Hilton Riverside
Jefferson Ballroom
Wednesday, March 12
10:00 AM - 1:00 PM
Hilton Riverside
Belle Chasse
Perry/RJOS Outreach
Workshop
Wednesday, March 12
4:00 - 8:00 PM
Hilton Riverside
Versailles Ballroom
Annual Reception
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
New Orleans Marriott
Jackson
Wednesday, March 12
7:00 - 8:00 AM
Hilton Riverside
Belle Chasse
Friday, March 14
6:30 - 9:30 AM
Omni Royal Orleans
621 St. Louis Street
Executive Committee/
Thursday, March 13
CORR Board of Trustees
11:30 AM - 5:00 PM
Hilton Riverside
Windsor
Friday, March 14
7:00 - 10:00 PM
New Orleans Marriott
Balcony J
CORR Reception
Friday, March 14
7:00 - 10:00 PM
Royal Sonesta
The Fleur de Lis Suite &
Courtyard
Alumni Reception
Thursday, March 13
6:00 - 8:30 PM
Harrahs
Satchmo Room
Reception
Friday, March 14
7:00 - 9:00 PM
Ritz-Carlton
Audubon
Alumni Reception
Friday, March 14
6:00 - 9:00 PM
New Orleans Marriott
Bonaparte
Friday, March 14
7:00 - 9:00 PM
Astor Crowne Plaza
Grand Ballroom B
Thursday, March 13
6:00 - 9:00 PM
New Orleans Marriott
Balcony N
Reception
Thursday, March 13
6:00 - 8:00 PM
New Orleans Marriott
Balcony K
409
410
Alumni Reunion
Thursday, March 13
6:00 - 8:00 PM
New Orleans Marriott
Iberville
Alumni Reception
Thursday, March 13
6:30 - 8:30 PM
New Orleans Marriott
Audubon
University at Buffalo
University of Louisville
Alumni Reception
Friday, March 14
6:30 - 8:30 PM
New Orleans Marriott
Balcony K
University of Arkansas
Alumni Dinner
Thursday, March 13
7:00 - 10:00 PM
The House of Blues
225 Decatur Street
Thursday, March 13
6:00 - 9:00 PM
Antoines Restaurant
713 Rue St. Louis Street
University of Chicago
Alumni Reception
Friday, March 14
6:30 - 8:30 PM
Inter-Continental Hotel
New Orleans
Magnolia
Thursday, March 13
6:30 - 9:30 PM
Pat OBriens, 624 Bourbon Street
Briars Suite
University of Iowa
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Windsor Court
Gallery
University of Kansas
Alumni Dinner
Thursday, March 13
6:30 - 10:00 PM
Red Fish Grill, 115 Bourbon Street
Lake Room
Alumni Reception
Thursday, March 13
6:00 - 8:00 PM
Courtyard New Orleans/
Convention Center
300 Julia Street
Meeting Room A
University of Maryland
Alumni Reception
Thursday, March 13
7:00 - 10:00 PM
W New Orleans
Studio 2
University of Massachusetts
Alumni Reception
Friday, March 14
6:00 - 9:00 PM
Harrahs
Salon 1
University of Miami
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Sheraton New Orleans
Edgewood
University of Minnesota
Alumni Reception
Friday, March 14
6:00 - 8:00 PM
Loews New Orleans
St. Landry
Thursday, March 13
6:00 - 9:00 PM
Mulates Party Hall
201 Julia Street
University of Pennsylvania
Alumni Reception
Friday, March 14
6:00 - 9:00 PM
Windsor Court
Board Room
Alumni Reception
Friday, March 14
7:00 - 10:00 PM
Loews New Orleans
Beauregard
Semi-Annual Meeting
Alumni Reception
Alumni Reception
Thursday, March 13
6:00 - 10:00 PM
New Orleans Marriott
Bacchus
Friday, March 14
6:00 - 9:00 PM
Arnauds Restaurant
813 Rue Bienville
411
Tuesday, March 11
4:00 - 6:00 PM
Harrahs New Orleans
Fulton - Salon I
Alumni Reception
Wednesday, March 12
6:00 - 8:30 PM
Ritz-Carlton
French Quarter Bar
Alumni Reception
Friday, March 14
6:00 - 7:30 PM
Sheraton New Orleans
Oakley
University of Toronto
Alumni Reception
Wednesday, March 12
7:00 - 10:00 PM
Astor Crowne Plaza
Bienville
Alumni Reception
Thursday, March 13
6:00 - 8:00 PM
New Orleans Marriott
Jackson
University of Utah
Alumni Reception
Thursday, March 13
6:00 - 8:30 PM
Arnauds
813 Rue Bienville
Alumni Reception
Friday, March 14
6:30 - 8:30 PM
Hilton Riverside New Orleans
Marlborough
University of Virginia
Alumni Reception
Thursday, March 13
6:30 - 8:30 PM
Astor Crowne Plaza
Astor Ballroom I
University of Wisconsin
Alumni Reception
Thursday, March 13
6:00 - 8:00 PM
W Hotel New Orleans
Studio 1
Friday, March 14
6:30 - 9:00 PM
New Orleans Marriott
Balcony L
Friday, March 14
6:30 - 8:30 PM
Ritz Carlton
Crescent View
Reception
Thursday, March 13
6:00 - 8:00 PM
New Orleans Marriott
Balcony I
University of Texas
412
Active Fellows
A
Sharif Ashanti Abdus-Salaam, MD
Kristopher T. Abeln, MD
Timothy S. Achor, MD
Brent M. Adcox, MD
Jessica Pelow Aidlen, MD
Nauman J. Akhtar, MD, MBA
Omar H. Akhtar, MD
Mir H. Ali, MD, PhD
Basil Jamal Alwattar, MD
Cody Neal Anderson, MD
Scott Allen Anderson, MD
Michael Jonathan Angel, MD
Ivan Josef Antosh, MD
Alexios Apazidis, MD
Amber B. Aragon, MD
Gregory Troy Ardoin, MD
Marshal S. Armitage, MD
Brandon Shane Asbury, MD
Luke Stanford Austin, MD
John B. Ayres, MD
B
Lucas J. Bader, MD
Sepideh Baghian, MD
Babak Barcohana, MD
Joseph Barker, MD
Clint Douglas Barnett, MD
Rahul Basho, MD
Aaron Baxter, MD
Jason R. Baynes, MD
Matthew D. Beal, MD
Hany S. Bedair, MD
S. Samuel Bederman, MD, PhD, FRCSC
Benjamin B. Bedford, MD
Andrew W. Beharrie, MD
Joseph Bellapianta, MD
Julius A. Bishop, MD
Benjamin T. Bissell, MD
Lisa Rose Blackrick, MD
Brian J. Blake, MD
Kenneth S. Bode, MD
Matthew J. Bollier, MD
William Seth Bolling, MD
Rajshri M. Bolson, MD
George Robert Booker, MD
Karen June Boselli, MD
Jesse Cole Botker, MD
Andrea Legath Bowers, MD
Jason J. Boyer, MD
David A. Brcka, MD
Gregory Thomas Brebach, MD
Marcus S. Briones, MD
Kenneth Ryan Brooks, MD
Gabriel Dean Brown, MD
C
Edwin Richard Cadet, MD
Roberto D. Calderon, MD
Briana Lynn Calore, MD
Michael Louis Caravelli, MD
Roy Cardoso, MD
John Carlisle, MD
Brent Dixon Carlson, MD
Emily E. Carmody Soni, MD
Kimberly Carney Young, MD
Jason Joseph Caron, MD
Brian J. Carr, MD
William Joseph Carroll III, MD
Joaquin A. Castaneda, MD
Ryan James Caufield, MD
Robert Christopher Chadderdon, MD
Daniel B. Chan, MD
Daniel Steven Chan, MD
Keith W. Chan, MD
Simon Chao, MD
Adam J. Chase, MD
Saad Chaudhary, MD
Neal C. Chen, MD
Sam Chen, MD
Todd E. Chertow, MD
Sunny C.F. Cheung, MD
Daniel J. Chivas, MD
Robert Hyun Cho, MD
Gene Choi, MD
Jason Craig Clark, MD
Roger Massa Componovo, MD
Augustine H. Conduah, MD
Chad Stephen Conner, MD
Jack A. Conoley, MD
Clayton Bernard Conrad, MD
Nicholas Cook, MD
John Ryan Cotton, MD
William D. Crenshaw, MD
Colin Victor Crickard, MD
William Wood Cross III, MD
Justin S. Cummins, MD
Adnan Cutuk, MD
John K. Czerwein, MD
D
Erica E. Dafford, MD
Jenny Frances, MD
Jeremy Stephen Frank, MD
Juan C. Frisancho, MD
Aileen M. Danko, MD
Jason J. Davis, MD
Joseph P. DeAngelis, MD
Robert C. Decker, MD
Amalia Maria DeComas, MD
Charles Adam DeCook, MD
Gregory K. Deirmengian, MD
John M. Delgado, MD
Javier Delgado-Candelario, MD
Michael L. Fernandez, MD
Justin Michael Ferrara, MD
Craig J. Finlayson, MD
Keith Stephen Flak, MD
Nicholas David Fletcher, MD
John Harris Flint, MD
Jared R. H. Foran, MD
David Michael Foulk, MD
J
Jesu Jacob, DO
Benjamin J. Jacobs, MD
Justin A. Jacobson, MD
Devon Michael Jeffcoat, MD
Casey Jenkins, MD
Timothy Douglas Jenkins, MD
John Andrew Johansen, MD
Brian Douglas Johnson, MD
Clint Weston Johnson, MD
Ericka Johnson, MD
Casey D. Johnston, MD
Benjamin Jay Justice, MD
K
Sanjeev Kakar, MD
Charles F. Kallina IV, MD
Lige Kaplan, MD
Michael Karch, MD
George S. Kardashian, MD
Ravi Arvind Karia, MD
Sina Kasraeian, MD
Julie M. Keller, MD
Todd C. Kelley, MD
Travis Jay Kemp, MD
James Kercher, MD
Jordan Todd Kerker, MD
Zeeshaan I. Khan, MD
Leonard K. Kibuule, MD
Carter D. Kiesau, MD
Stephen Kim, MD
L
Jason Edward Lake, MD
Phillip Raymond Langer, MD
Justin M. LaReau, MD
James Wesley Larson III, MD
Daniel Latt, MD, PhD
Gregory Scott Lavigne, MD
Brandon D. Lawrence, MD
John Todd Rutter Lawrence, MD, PhD
M
Richard Brian Mackey, MD
Ian Anthony Madom, MD
William Thomas Magee, MD
Yariv Maghen, MD
Jonathan R. Maher, MD
John P. Mann, MD
Nicholas T. Mansuetta, DO
Jeffrey Scott Margolis, MD
Medardo Richard Maroto, MD
Nathan A. Marsh, MD
Robert Michael Masella, MD
Sameer Mathur, MD
Ricardo Luis Matos, MD
Christopher James Mattern, MD
Christopher McAndrew, MD
Jeremy Bell McCandless, MD
Jason Paul McConnell, MD
Kevin C. McDaid, MD
Michael Patrick McDermott, MD
Thomas James McDonald, MD
Kevin Michael McGee, MD
Jasmin L. McGinty, MD
Heather McCann McIntosh, MD
Jessica Cole McMichael, MD
Michael J. McNulty IV, MD
Erika Michelle McPhee, MD
Steven W. Meisterling, MD
Deana Mercer, MD
Timothy John Mickel, MD
Chad Micucci, MD
David K. Mikolyzk, MD
Mason Wayne Milburn, MD
Benjamin J. Miller, MD
Matthew David Miller, MD
Carter W. Mitchell, MD
Scott A. Mitchell, MD
Sam Moghtaderi, MD
James Moon Mok, MD
Robert M. Molloy, MD
Keith Oster Monchik, MD
Corey O. Montgomery, MD
Carlos Esteban Moreyra, MD
Joseph Michael Morreale, MD
Matthew Charles Morrey, MD
Michael J. Morris, MD
Richard Grant Mostak, MD
Andrew Wells Moulton, MD
Erin Moyer, MD
Traske McNeil Muir, MD
George K. Myo, MD
N
Joshua Peter Nadaud, MD
Jonathan T. Nassos, MD
John Curtis Neilson, MD
Joshua D. Nelson, MD
Tony K. Nguyen, MD
Clifford C. Novak, MD
Philip Daniel Nowicki, MD
O
Jason Benjamin ODell, MD
Charles Lawton Ogburn III, MD
P
James Paci, MD
Michael Paczas, MD
William Page, MD
Joshua Pahys, MD
Charles Paik, MD
M. Jason Palmer, MD
Rajeev Pandarinath, MD
Matthew Jeffrey Panzarella, MD
SangDo Park, MD
Billy Keith Parsley, MD
Peter Gust Passias, MD
Jayesh K. Patel, MD
Nilpesh Mahesh Patel, MD
Priyesh D. Patel, MD
Ravi Patel, MD
Diane Elizabeth Sedgwick Payne, MD, PT
Q
Albi Qeli, MD
R
Sridhar R. Rachala, MD
Adam Wesley Racusin, MD
Kristen E. Radcliff, MD
Jay H. Rapley, MD
Sudheer C. Reddy, MD
Chandra Shekar K. Reddy, MD
John C. Redfern, MD
Shannah Malia Redmon, MD
Bradley Clay Register, MD
Lee M. Reichel, MD
James Joseph Reid, MD
Justin Scott Reid, MD
William Michael Reisman, MD
Brian K. Reiter, MD
Regis Louis Renard, MD
413
414
Kevin M. Roenbeck, MD
Kevin William Rolfe, MD
James Richard Romanowski, MD
Denise M. Romero, MD
Jason Rotstein, MD
Kasra Rowshan, MD
Francisco Rubio, MD
David E. Ruchelsman, MD
Daniel E. Rueff, MD
Scott D. Ruhlman, MD
Tracy Dawn Rupke, MD
Deirdre Dunn Ryan, MD
S
Coleen S. Sabatini, MD, MPH
Vani Janaki Sabesan, MD
Christopher Kyle Sadlack, MD
Neil Nelson S. Saldua, MD
Thomas L. Salsbury, MD
Babak Samimi, MD
Walter P. Samora III, MD
Hugo Banda Sanchez, MD
Patrick Wesley Sander, MD
Jason Benjamin Sanders, MD
James SanFilippo, MD
Keith John Santiago, MD
Matthew Carl Sardelli, MD
Akhilesh Sastry, MD
Adam Carlton Schaaf, MD
Kathryn Schabel, MD
Alyssa Schaffer, MD
Steven James Schechinger, MD
Matthew R. Schmitz, MD
Mark A. Schwartz, MD
Scott Kevin Schweizer, MD
John Paul Seaberg, MD
Jared Justin Seale, MD
David Marshall Sedory, MD
Nicholas R. Seibert, MD
Ari Douglas Seidenstein, MD
Milan Kumar Sen, MD
Paul Richard Sensiba, MD
Shane Seroyer, MD
Erik Paul Severson, MD
James A. Shaffer, MD
Aakash A. Shah, MD
Brian Shannon, MD
Nael Shanti, MD
Gary Scott Shapiro, MD
Joy V. Sharma, MD
Michael J. Shevlin, MD
Khalid Shirzad, MD
Karl D. Shively, MD
Theodore Shybut, MD
Justin Cain Siebler, MD
Josef B. Simon, MD
Vladimir A. Sinkov, MD
Leslie Elaine Sisco, MD
Anthony F. Skalak, MD
Kshamata Skeete, MD
Vudhi Vudhipoom Slabisak, MD
Harvey E. Smith, MD
Jordan L. Smith, MD
Jon Benjamin Smucker, MD
Jagdeep S. Sodhi, MD
Timothy Davenport Spires, Jr, MD
Ajay Kumar Srivastava, MD
Tom Davis Stanley, MD
Adam Matthew Starr, MD
Michael Paul Stauff, MD
Garen Daxton Steele, MD
Matthew R. Steensma, MD
John Joseph Stefancin, MD
Daniel Robert Stephenson, MD
Kelly C. Stets, MD
Benjamin W. Stevens, MD
James Thomas Stewart, Jr, MD
Matthew Stiebel, MD
Addison Thomas Stone, MD
Eric Strauss, MD
Sara E. Strebe, MD
George B. Sutherland, MD
Karen Michelle Sutton, MD
Megan A. Swanson, MD
Jeremy Paul Swymn, MD
Ishaq Y. Syed, MD
Mark Jonathan Sytsma, MD
T
Ramin Ronald Tabaddor, MD
Thomas Louis Tanous, Jr, MD
Michael J. Taunton, MD
Vijay B. Thangamani, MD
Adrian J. Thomas, MD
Kristen Leigh Thomas, MD
Thomas Jackson Thomasson IV, MD
U
John H. Udall, MD
V
Marlo Oyster Van Steyn, MD
Todd Frederick Vanderheiden, MD
Travis Boyd VanDyke, MD
Vikas Varma, MD
Zackary D. Vaughn, MD
Michael R. Veale, MD
Ryan John Veurink, MD
James Everett Voos, MD
Caleb Vosburg, MD
W
Matthew Kyle Wallace, MD
Michael Jason Wallace, MD
Drew Eugene Warnick, MD
Scott McGiinnis Waterman, MD
Jeffrey Dean Watson, MD
Brian Alexander Weatherby, MD
John C. Weinlein, MD
Kurt Richard Weiss, MD
J. Michael Wells, MD
Matthew David Welsch, MD
Adam Nelson Whatley, MD
Brent William Whited, MD
Otto W. Wickstrom III, MD
Carl Wierks, MD
Jason James Wilcox, MD
Moshe Wilker, MD
Daniel Kaliko Williams, MD
Daniel Mark Williams, MD
Joseph Brian Wilson, MD
Jocelyn Ross Wittstein, MD
Troy Wolter, MD, MS
Ripley William Worman, MD
James Vann Worthen, MD
Robert John Wylie, MD
Y
Jeffrey Jon-Michael Yaste, MD
Daniel J. Yoo, MD
Brett H. Young, MD
Pavel V. Yufit, MD
Z
Lukas Peter Zebala, MD
Lee Michael Zuckerman, MD
Mark Richard Zunkiewicz, MD
Associate Member
Orthopaedic
Antony Kallur Antony, MD
Yasser Farid, MD, PhD
Ryhor Harbacheuski, MD
Bennie G.P. Lindeque, MD
Vinayak Sathe, MD
Jonathan N. Sembrano, MD
Ashish Shah, MD
Bohus Svagr, MD
Vladimir Tress, MD
Associate Member
Osteopathic
Michael Bagley, DO
Randa Bascharon, DO
Daniel J. Brandenstein, DO
William Campbell, DO
Barry L. Clark, DO
Matthew B. Colligan, DO
Christopher Copeland, DO
Richard Lee Crank, DO
Brad A. Cucchetti, DO
Sarang N. Desai, DO
Dana Robert Desser, DO
Carl P. DiLella, DO
Bart L. Eastwood, DO
David Harkins, DO
Meredith C. Heisey, DO
William John Jackson, DO
Mark Krahe, DO
James Lebolt, DO
Rickland Lawrence Likes, DO
Andrew J. Marcantonio, DO
Mark E. McNemar, DO
Anne Marie Meo, DO
Eric Brandon Metz, DO
Charles Orth, DO
Mark Palermo, DO
Ted William Parcel, DO
Donald W. Pennington, DO
Edward P. Petrow, Jr, DO
Michael Quackenbush, DO
Anthony W. Roccisano, DO
Michael Paul Schmidt, DO
Nicholas James Schoch, DO
Brian E. Seng, DO
Michael Shingles, DO
William Bret Smith, DO
Michael P. Swords, DO
Associate Member
Basic Science
Gregory S. Lewis, PhD
Charles M. Turkelson, PhD
New
Membership Desk
at the
Rediscover
Your membership goes beyond Annual Meeting and JAAOS. Are you using all of your
benefits? Discover the many practical services, web resources, and professional
development tools included with your AAOS membership.
Renew
Pay member dues, pick up your membership card and update your account! AAOS
Member Services staff are on site to personally assist you with your membership needs.
8:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 3:00 PM
www.aaos.org/member
Bolivia
Alfredo Pozzo, MD
Hugo Daniel Sagarnaga, MD
Christian Fuentes, Sr, MD
Bosnia and Herzegowina
Semin Becirbegovic, MD
Australia
Anthony J. Spriggins, MD
Brett Kuhnemann, MBBS
David K. Colvin, MD
Ian W. Incoll, FRCS, MBBS
David M. Dickison, MBBS, FRACS
Sunil Gurpur Kini, MS
Christopher T. Jones, MBBS, FRACS
Max Leibenson, MD
Simon Matthews, FRCS (Ortho), MBBS
Munish Rraj Krishnan, MBBS
Thomas Darby Earle Treseder, FRACS
David G. Wood, FRACS
Heinz Matthias Rau, FRACS, MD
Anna Manolopoulos, FRACS, MBBS
Buddhika Balalla, MBBS, FRACS
James Canty, FRCS (Ortho), MBBS
Robert Michael Sharp, MD
Matthew Alfredson, FRACS
Sandeep Tewari, FRACS, MBBS, MS
Peter Hamilton, MD
David James Mitchell, FRACS, MBBS
Gavin Clark, FRACS, MBBS
Austria
Martin Zegner, MD
Regina Hois, MD
Lukas A. Holzer, MD
Brazil
Jose Ricardo Pecora, MD
Leonardo Silva Quialheiro, MD
Walter Ricioli, Jr, MD
Octavio Castro Campos, Jr, MD
Thiago Leonardi Azuaga, MD
Paulo H. Araujo, MD
Marcelo Oliveira, MD
Jorge Luiz Fernandes Oliva, Jr, MD
Marcio Schiefer, MD
Ricardo Lucas Rodrigues, MD
Francisco Robson De Vasconcelos Alves, MD
Plinio Marcos Peloso, MD
Lucio Patro Untura, Sr, MD
Luiz Fernando Guimaraes Amorim, MD
Mauricio Leite Souza, Jr, MD
Noe De Marchi Neto, MD
Nelson Akira Umeki, Sr, MD
Adriano Karpstein, MD
Andre Vilela de Farias, MD
Camilo Partezani Helito, MD
Marcus Valladares Guimaraes, MD
Marilia Maia Gomes, MD
Ricardo Pedrinelli, MD
Ralf Gerhard Klassen, MD
Agnus Welerson Vieira, MD
Eduardo Pimenta Guimaraes, MD
Marcio Rangel Valin, Sr, MD
Cladis Sanches Lopes Filho, MD
Cassio Mauricio Telles, MD
Francisco Jose Carvalho, MD
Alexandre Philippe Boss Jaccard, MD
Plnio Montemor, MD
Fabio De Castro Jorge Racy, MD
Marie Gdalevitch, MD
Bill Ristevski, MD
Michele Angers, MD
Lee Dallas Ekert, MD, FRCSC
Marc-Andre Tremblay, MD
Christopher Lu, MD
Mehdi Sadoughi, MD
Marie-Pier Beaulieu, MD
Michael Blankstein, MD
Simon Fournier-Gosselin, MD
Mehdi Ghorbani, MD
Brent Weatherhead, MD
Julian Sernik, MD
Marie-Lyne Nault, MD
Michael Carbery, MD, FRCSC, PT
Olivier Chemaly, MD, FRCSC
Guillaume Bissonnette, MD
Abdel-Rahman Lawendy, FRCS
Osama Nawara, MS, MBBS
Francois Colin, MD
Hamid Nourhosseini, MD, FRACS
Manoj Bhargava, MD, FRCS
Arash Sepehr Arae, FRCSC
Bassam Zahra, MD, MSc
Saad Abulaziz Altaher, MD
Chile
Felipe Maturana, MD
Claudio Diaz, MD
Alejandro K. Baar, MD
China
Shuxun Hou, MD
Xiaohui Niu, MD
Yunfeng Yang, MD
Li Zhao, MD
Zhen Hui Sun, MD
Cheng Liu, PhD
Yunsheng Hu, MD
Yong Gao, MD
Zhano Zhang Congxiao, MD
Ai Guo Song, MD
Bulgaria
Bahrain
Rashad Abubars, MD
Husain Qasim Ali, MBBS
Bangladesh
Mahbub Hossain, MD
Syed Zakir Hossain, MD
Belgium
Thomas Joachim, MD
Christian P. Delloye, MD
Jan J.J. Malcorps, MD
Colombia
Canada
Trevor Stone, MD
Anthony E. King, MD
Jacqueline Smith, MD
Michelle A. Ghert, MD, FRCSC
Cameron Taylor, MD
Angela Scharfenberger, MD
Debra Bartley, MD
Wade Travis Gofton, BSCH, MD, FRCSC
Robert Koon Wah Chan, MD
Osama Soliman Gharsaa, MD
Costa Rica
Marialaura Chavarria, MD
Alexis Alvarado, MD
Cyprus
Athanasios Papachristou, MD
Czech Republic
Zdenek Kostal, MD
Denmark
Bjarne Szczurek Pedersen, MD
Georg Kejlaa, MD
Michel E. H. Boeckstyns, MD
Henry Coudane, MD
El Mostafa Aboulala, MD
Olivier A. Bringer, MD
Rachid Ghazi, MD
Franois Loubignac, MD
Julien Berhouet, MD
Remi Kohler, MD
Houssam Bouloussa, MD
Mihai Stanciulescu, MD
Patrick De Mauleon, MD
Colin Dujardin, MD
Edouard Fouque, MD
Christine Rigout, MD
Mikheil Shavgulidze, MD
Germany
Karl-Dieter Heller, MD
Ulf Kuhlee, MD
Georg Janda, MD
Mustafa Yucel, MD
Ecuador
Greece
Egypt
Abd El Rahman Afify, MD
Ayman Mohamed Ebied, PhD, FRCS (Orth)
Mohammed Kaddah, MD
Moahmmed Mostafa Kotb, MD
Fouad Zamel Sadek, MD, FRCS (Ortho)
Amr Abdalla Ahmed Elsayed Azzam, MD
Sherif Galal Hassan, MD
Moheb Fadel, MD
Ahmed Elmalt, MD
Honduras
Carlos Huezo, MD
Luis Boquin, MD
Hong Kong
Wai Yuen Cheung, MD
Iceland
Andri Kristinn Karlsson, MD
Ethiopia
Kebret T Kebede, MD
Finland
Rami Madanat, MD
France
Philippe Beaufils, MD
Gilles Walch, MD
Nejib Khouri, MD
Philippe Merloz, MD
Abdelhafid Talha, MD
Thierry Heckel, MD
Olivier Castillo, MD
Laurent Obert, MD
Jamil Machour, MD
Leon Agbonon, MD
Guillaume Demey, MD
Christian Cistac, MD
India
Milind Sawant, MD
Niranjan Deshmukh, MBBS, MS
Tejas Dwarkanath Upasani, MD
Vinod K. Puthumanapully, FRCS
Ashok Nandra, MS
Varun Chouhan, MBBS, MS
Venkatadass Krishnamoorthy, MBBS, MS
Jayanta Jana, MBBS, MD
S. Rastogi, MD
Vishwajit Faldesai, MD
Rajiv Choudhry, MS
Jagadesh Gudaru, MS(Ortho), MCh(Ortho)
Nishant Jaykar Chotai, MD
Jitendra Bhanjibhai Tavri, MBBS, MS
Lavindra Tomar, MS, MBBS
Rashpal Singh, MBBS, MS
Anil Agrawal, MBBS
Georgia
Dominican Republic
417
Yuichi Hoshino, MD
Doi Toshio, MD
Takayasu Ito, MD, PhD
Ken Nakayama, MD
Takahisa Kaneko, MD
Akihiko Hasegawa, MD
Takashi Sono, MD
Indonesia
Jordan
Morocco
Ali El Kohen, MD
Myanmar
Iran
Aliakbar Esmaeilijah, MD
Saeed Kokly, MD
Abdolmohammad Liaghat, MD
Keivan Ahadi, MD
Alireza Variani, MD
Mir Abdollah Hejazifar, MD
Kaveh Bashtishiraz, MD
Alireza Mahmoodi Gharaee, MD
Zaw W. Soe, MD
Myint Thaung, MD
Netherlands
Paul J. A. Schwering, MD
Niels Baas, MD
Haidar Jan, MD
Joost De Bruijn, PhD
Jasper Devries, MD
Roel Hendrickx, MD
Adam Swets, MD
Hubert Jan Oostenbroek, MD
Roy Hoogeslag, MD
Gerald A Booi, MD
Kenya
Neford Oendo Ongaro, MD
Vincent Mutiso, MD
Lebanon
Pierre Gemayel, MD
Lithuania
Iraq
Sarunas Tarasevicius, MD
New Zealand
Macedonia
Mark Wright, MD
Warren B. Leigh, MD
Danica Donchovska, MD
Katerina Kasapinova, MD
Nigeria
Ireland
Jamal Khawaja Nasser, MD
William Quinlan, MD
Murali Krishna Sayana, MD
Sean Dudeney, FRCS
Fergal McGoldrick, FRCS (Ortho)
Israel
Reuben Farber, MD
Ehud Atoun, MD
Nimrod Rahamimov, MD
Italy
Leo Massari, MD
Roberto Civinini, MD
Bruno Magnan, MD
Mario Bortolato, MD
Alessandro Lelli, MD
Antonio Brando, MD
Gianluca Camillieri, MD
Giorgio Zappala, MD
Japan
Yoichi Shimada, MD, PhD
Toshito Yasuda, MD
Nozaka Koji, MD, PhD
Kazuhika Hatayama, MD
Daisuke Mori, MD
Malaysia
Samsudin Cassim, MD
Mexico
Agustin Lazarini Colorado, MD
Marco Sanchez Breton, MD
Efrain Huerta Mena, MD
Alfonso Meza Vernis, MD
Ernesto Davila Fernandez, MD
Juan Antelmo Montes de Oca Gil, Sr, MD
Luis Vadillo Carstensen, Sr, MD
Luis Alexis Martinez Ortiz, MD
Alejandro A. Candia, MD
Angel Edgardo Hernandez, PhD
Jaim Atri-Levy, MD
Luis Rodolfo Garcia Andrade, Sr, MS
Delfino Carranza, MD
Juan Martinez Caamano, MD
Samuel Sebastian Castaon, MD
Alberto R. Chinchilla Hernandez, FRCS, MD
Francisco Gutierrez, MD
Carlos Torres Castro, MD
Jose Jesus Martinez, MD
Celia Osorno, MD
Josefina Molina III, MD
Gustavo Armando Tafoya Arreguin, MD
Luis Gerardo Lpez, MD
Norway
Lars Engebretsen, MD
Sandro Rolle, MD
Oman
Ashim Wokhlu, MS, MBBS
Sivaprasad Kalyanasundaram, MBBS, MS
Pakistan
Shahid Hussain, MS
Mehtab Ahmed Pirwani, MD
Asad Ullah Makhdoom, MBBS
Irshad Ahmed Bhutto, MBBS, MS
Ghulam Mustafa Khan, MD
Muhammad Inam, MBBS, MD
Mian Amjad Ali, MBBS, FRCS (Ortho)
Panama
Ricardo E. Mosquera, MD
South Korea
Tunisia
German A. Vizcarra, MD
Philippines
Marc Anthony Castro, MD
Hermenegildo Go Garcia, Jr
Poland
Michal Mielnik, MD
Portugal
Francisco Oliveira, MD
Spain
Romania
Russian Federation
Eugeny Paklin, MD
Andrey Yanchenko, MD
Mansur Khasanshin, MD
Ivan Radysh, MD
Oleg Goryachev, MD
Yury Postnikov, MD
Sergey Sergienko, MD
Andrey Korytkin, MD
Anatoly Ovsyankin, PhD, MD
Boris Mark Kalinskiy, MD
Igor Piven, MD
Roman Vladimirovich Gladkov, MD
Andrey Kaminsky, MD
Saudi Arabia
Emad E. Soued, MD
Omar Elofi, MD, MBBS, MSc
Eltahir Hussain Eltahir, MD
Saeed Koaban, MD
Hisham Elimam Dolieb, FRCS
Mohammad Ibrahim Altikhais, MD
Francesc Angles, MD
Fernando Avila-Espana, MD
Sandra Catalan, PhD, MD
Miriam Zurron, MD
Raquel Vayas, MD
Victor Manuel De La Cruz, MD
Jose R. Ballesteros-Betancourt, MD
Jordi Colomina, MD
Slovakia
Jozef Almsi, MD
Ukraine
Abakar Y. Magomedov, MD
Stanislav Bondarenko, MD
Illya Gaydarzhy, MD
Sergiy Fedun, MD
United Kingdom
Marcellino Maheson, MD
Jai Shanker, MD
Nick J. London, FRCS
Harold Nwaboku, MD
Andrew J. Price, FRCS
Ganesan Senthil Kumar, FRCS
Abubaker K. Mbogo, MBChB
Attila Kovacs, MD
Rupinderbir S. Deol, MBBS, MSc, FRCS
Jacob Luke Campton, FRCS (Ortho)
Kalid M. Abdlslam, FRCS
Hla Moe Thaya, MD
Haji M. K. Azmi Bin Haji Abd Kadir, MD
Awais Shaikh, MD
Yaganti China Saidaiah, MD
Vishnu Prasad, MD
Gordon MacKay, FRCS
Gregory Packer, MD
David Griffiths, MA, MBBS, FRCS (Ortho)
Simon David Burtt, MBBS, FRCS, FRCS
Ravi Kuppuswamy, FRCS (Ortho), MBBS
Edward Jeans, MRCS, BMBS
Ajay Sharma, MS, MBBS
Stefano Lupparelli, FRCS, MD
Sachin Jadhav, MD
Zakareya E. Gamie, MBBS, MBChB
Sanjay Jain, MD
Azeem Ahmed, MD
Amjad Gulzar Shaikh, FRCS, MSc, MD
Sailesh Jaswantrai Parekh, FRCS, MBBS, MS
B. Varghese, MS, FRCS (Ortho)
Metta Bandara Palipane, FRCS
Ashok Nellikunja, MD
Asif Pardiwala, MD
Sweden
Per Wretenberg, MD, PhD
Annette W. Dahl, PhD
Fredrik Lindberg, MD
Switzerland
Bernard Jost, MD
Lukas Daniel Iselin, MD
Axel Gamulin, MD
Mike Slomczykowski, MD, PhD
Philip Wildisen, MD
Eva H. Kraus, Dr. med
Rolf Luginbuehl, MD
Marie-Rose R Eloy, MD
Marc Saudan, MD
Taiwan
Kuan-Yu Lin, MD
Yang-Hwei Tsuang, MD, PhD
Mingte Cheng, MD, PhD
Chao-Ping Chen, MD
South Africa
Robert A. McLennan-Smith, MD
Theo Le Roux, MD
Ajmal Ikram, MD
Rian Steyn, MD
Kamalesh Naik, MD
Etienne Maritz, FRCS (Ortho)
Olivier Van Der Spuy, MD
Claud Kilian, MD
Fuat Duygulu, MD
Serkan Aykut, MD
Sri Lanka
Singapore
Kanwaljit K. Soin, MD
Turkey
Thailand
Alisara A. Arirachakaran, MD
Pornchai Mulpruek, MD
419
Venezuela
Ramon Canaan, MD
Henry Molina, MD
Oscar A. Hevia, MD
Guillermo Enrique Rangel, MD
Flavio Abbatematteo, MD
Arturo Diaz, Sr, MD
Jhonny Morantes, MD
Jose Rafael Alvarez, Sr, MD
Jose Iglesias, MD
Jesus Ortiz Borges, MD
Luis A. Vargas, MD
Jesus Gonzalez Mata, MD
Leonardo Scarano, MD
Leonardo Pinto, MD
Vietnam
Cong Ngoc Pham, MD
Hien Quoc Vu Le, MD
Khoa Dang Tran, MD
Quan Anh Vo, MD
Trinh Cong Binh, MD
Long Van Pham, MD
Dong Le Tran, MD
Toan Thanh Vo, MD
Tung Thanh Le, MD
Tuan Ngoc Tran, MD
Man Van Vo, MD
FIND IT at the
AAOS Resource Center
Your Source for Lifelong Orthopaedic Learning
Academy Programs
SAVE
10%
ON ORDERS
OF $300
OR MORE
Publications
Surgical Video
Member Benefits
Web Resources
Practice Management
International Membership
CME
MOC
Examinations
Expert Presentations
OKU
OrthoPortal
eBooks
Coding
ICL Handouts
Patient Education
Tuesday
Wednesday Friday
Saturday
8:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 3:00 PM
www.aaos.org/store
422
John Andrawis, MD
James R. Andrews, MD
Jack T. Andrish, MD
Jeffery D. Angel, MD
Michael Edward Angeline, MD
Richard L. Angelo, MD
Marc Angerame, MD
Michele Angers, MD
Jeffrey Anglen, MD, FACS
Chayanin Angthong, MD
Alireza Anissipour, DO
Steven R. Anthony, DO
John Antoniou, MD
Antony Kallur Antony, MD
Iqbal Ansgar Anwar, MD
Adam William Anz, MD
Alan Garvin Anz, MD
Kevin L. Garvin, MD
Stephen K. Aoki, MD
Dillon Arango, MD
Paulo H. Araujo, MD
Michael T. Archdeacon, MD
Michael J. Archibeck, MD
Robert A. Arciero, MD
Elizabeth A. Arendt, MD
Jean-Noel A. Argenson, MD
Evan Henry Argintar, MD
Alexandre Arkader, MD
Sheyan Armaghani, MD
April D. Armstrong, MD
Douglas G. Armstrong, MD
William V. Arnold, MD
Michael S. Aronow, MD
Danny Arora, MD
Amarpal S. Arora, MD
Col. Edward D. Arrington, MD
Diren Arsoy, MD
Grigoriy Arutyunyan, MD
David E. Asprinio, MD
Benjamin Assenmacher, MD
Joseph Assini, MD
Nelson Astur Neto, MD
Alfred Atanda, MD
Abiola Atanda, MD
Kivanc Israel Atesok, MD
Edward A. Athanasian, MD
William Athans, MD
George S. Athwal, MD
Ehud Atoun, MD
Samer Attar, MD
David E. Attarian, MD
Brigham K. Au, MD
Joshua D. Auerbach, MD
Matthew Austin, MD
Luke Stanford Austin, MD
Kristopher Avant, DO
Raffi Stephen Avedian, MD
Michael W. Aversano, MD
Anthony Avery, MD
Olufemi Rolland Ayeni, MD
David Christopher Ayers, MD
Miguel Angel Ayerza, MD
Frederick M. Azar, MD
George Babis, MD
Bernard R. Bach Jr, MD
Casey Bachison, MD
Abdo Bachoura, MD
Kent N. Bachus, PhD
Henry A. Backe Jr, MD
Jeffrey Backes, MD
David Backstein, MD
Semon Bader, MD
Brian L. Badman, MD
Hyun W. Bae, MD
Donald S. Bae, MD
Nicolai Baecher, MD
Geoffrey Scott Baer, MD
Michael S. Bahk, MD
James R. Bailey, MD
Evan Baird, MD
Glen Olsen Baird, MD
Navkirat Singh Bajwa, MD
Champ L. Baker Jr, MD
Champ Baker III, MD
Margaret Mary Baker, MD
B. Sonny Bal, MD
Tessa Balach, MD
Keith D. Baldwin, MD
George Walter Balfour, MD
Todd P. Balog, MD
Robert Alexander Balyk, MD, FRCSC
Kelley E. Banagan, MD
Rahul Banerjee, MD, FACS
Ankit Bansal, MD
Charles J. Banta II, MD
Michael G. Baraga, MD
Mark E. Baratz, MD
Thomas C. Barber, MD
David Barei, MD, FRCSC
Jason Tyler Bariteau, MD
Brian Barlow, MD
Jonathan D. Barlow, MD
C. Lowry Barnes, MD
Steven L. Barnett, MD
Joseph S. Barr Jr, MD
Cameron Barr, MD
Robert L. Barrack, MD
John Patrick Barrett, MD
William P. Barrett, MD
John W. Barrington, MD
O. Alton Barron, MD
Wael K. Barsoum, MD
Craig Scott Bartlett, MD
Asheesh Bedi, MD
Michael S. Bednar, MD
Kathleen S. Beebe, MD
Michael J. Beebe, MD
Benjamin Beecher, MD
Robert Markey Beer, MD
Michael Behr, MD
David F. Beigler, MD
Daphne Michelle Beingessner, MD
Jacques Bejui-Hugues, MD
Eric Belin, MD
Nicole Stephanie Belkin, MD
John-Erik Bell, MD
Robert H. Bell, MD
Carlo Bellabarba, MD
Johan Bellemans, MD
Jack J. Beller, MD
Michael Bellino, MD
Philip J. Belmont Jr, MD
Mark Richard Belsky, MD
Etienne Belzile, MD
John A. Bendo, MD
Joseph Benevenia, MD
Stephen K. Benirschke, MD
Michael T. Benke, MD
Rodney W. Benner, MD
James Michael Bennett, MD
Christopher V. Bensen, MD
Leon S. Benson, MD
Daniel J. Berry, MD
Gregory Berry, MD
Jack M. Bert, MD
Charles J. Bertuch Jr, MD
Sigurd H. Berven, MD
Basil R. Besh, MD
James L. Beskin, MD
Robert Shay Bess, MD
William J. Best
Randal R. Betz, MD
Adam Bevevino, MD
Nikita Bezrukov, MD
Hari Bezwada, MD
Neil Bhamb, MD
Srino Bharam, MD
Husain Bharmal, MD
Nitin N. Bhatia, MD
Timothy Bhattacharyya, MD
Sam J. Biafora, MD
Richard A. Biama, MD
Leela C. Biant, FRCS(Ortho), MS
Jesse E. Bible, MD, MHS
H. Ryan Bicknell Jr, MD
Ryan T. Bicknell, MD
Janet Sybil Biermann, MD
Daniel Scott Biggerstaff, MD
Louis U. Bigliani, MD
Randipsingh R. Bindra, MD
Stefano Alec Bini, MD
John G. Birch, MD
Justin Bird, MD
Michael V. Birman, MD
Shariff K. Bishai, DO
Allen T. Bishop, MD
Julius A. Bishop, MD
Julie Young Bishop, MD
Debdut Biswas, MD
Kevin P. Black, MD
James Clinton Black, MD
Eric M. Black, MD
Aaron K. Black, MD
Sheena R. Black, MD
Andrew J. Blackman, MD
Clint Brian Blackwood, MD
J. David Blaha, MD
Theodore A. Blaine, MD
James Alan Blair, MD
Gregory Yates Blaisdell, MD
Laurel C. Blakemore, MD
John S. Blanco, MD
Alan T. Blank, MD, MS
John Stuart Blankenship, MD
R. Dale Blasier, MD
Philip E. Blazar, MD
Brian J. Blessinger, MD
Charles M. Blitzer, MD
Michael R. Bloomfield, MD
Robert H. Blotter, MD
Eric Michael Bluman, MD
Thomas J. Blumenfeld, MD
Scott L. Blumenthal, MD
John W. Blute Jr, MD
Oheneba Boachie-Adjei, MD
Norman Douglas Boardman, MD
Scott D. Boden, MD
Barry P. Boden, MD
Alex B. Bodenstab, MD
Clifford K. Boese, MD
Friedrich Boettner, MD
Yelena Bogdan, MD
Ljiljana Bogunovic, MD
Donald R. Bohay, MD
Kyle C. Bohm, MD
Frank C. Bohnenkamp, MD
Kamal I. Bohsali, MD
Pascal Boileau, MD
Patrick J. Boland, MD
Matthew J. Bollier, MD
William Seth Bolling, MD
Michael P. Bolognesi, MD
Nicolas Bonnaig, MD
Kevin F. Bonner, MD
Christopher M. Bono, MD
James V. Bono, MD
Peter M. Bonutti, MD
David Warner Boone, MD
Harm-Willem Boons, MD
Robert E. Booth Jr, MD
Christopher T. Born, MD
Joseph Borrelli Jr, MD
Patrick P. Bosch, MD
Joseph A. Bosco III, MD
Capt. (ret) Michael J. Bosse, MD
Mathias P.G. Bostrom, MD
Craig R. Bottoni, MD
Martin Joseph Bouliane, MD
Robert Barry Bourne, MD, CM, FACSC
Francesco Bove, MD
Richard E. Bowen, MD
J. Richard Bowen, MD
Mark K. Bowen, MD
Thomas R. Bowen, MD
Karl Frederick Bowman, MD
Barbara D. Boyan, PhD
Joel L. Boyd, MD
Martin I. Boyer, MD
Robert E. Boykin, MD
Peter Boyle, DO
Melbourne D. Boynton, MD
Kevin John Bozic, MD, MBA
Shahram Bozorgnia, MD
William Braaksma, MD
Paul J. Braaton, MD
Thomas Lane Bradbury, MD
James P. Bradley, MD
Jonathan Patrick Braman, MD
Thomas Branch, MD
Richard Jackson Bransford, MD
Jonathan Todd Bravman, MD
Timothy James Bray, MD
Justin Ryan Brazeal, MD
Thomas F. Breen, MD
Michael L. Brennan, MD
Keith H. Bridwell, MD
Earl Warren Brien, MD
Craig D. Brigham, MD
Brian K. Brighton, MD
Brian E. Brigman, MD
Jean M. Brilhault, MD
Paul Alvin Broadstone, MD
Stephen F. Brockmeier, MD
Darrel S. Brodke, MD
James White Brodsky, MD
Michael James Brody, MD
Henry M. Broekhuyse, MD
David M. Brogan, MD
Daniel Eric Bronsnick, MD
Michael J. Bronson, MD
Dennis B. Brooks, MD
Peter J. Brooks, MD
Jeffrey J. Brooks, MD
Robert H. Brophy, MD
Stephen L. Brotherton, MD
Nicholas Michael Brown, MD
Timothy Desmond Brown, MD
Gregory Alexander Brown, MD, PhD
Haydee C. Brown, MD
David E. Brown, MD
Thomas D. Brown, PhD
Thomas E. Brown, MD
James Andrew Browne, MD
William Timothy Brox, MD
Jeremy Bruce, MD
Richard Franklin Bruch, MD
423
424
Roderick J. Bruno, MD
Lance Michael Brunton, MD
Brandon J. Bryant, MD
Chris Daniel Bryce, MD
Richard G. Buch, MD
Robert William Bucholz, MD
Jacob M. Buchowski, MD, MS
William W. Buckingham Jr, MD
Taylor Buckley, MD
Joseph A. Buckwalter, MD
Jeffrey Evan Budoff, MD
Matthew J. Bueche, MD
Peter J. Buecker, MD
Knute C. Buehler, MD
William Bugbee, MD
Susan V. Bukata, MD
Leonard T. Buller, MD
David B. Bumpass, MD
Andrew D. Bunta, MD
Evalina L. Burger, MD
Ronald C. Burgess, MD
Stephen S. Burkhart, MD
Wayne Z. Burkhead Jr, MD
Robert T. Burks, MD
J. Kenneth Burkus, MD
Dwight W. Burney III, MD
Joseph P. Burns, MD
Travis C. Burns, MD
Douglas C. Burton, MD
Jeff Bury, MD
Matthew L. Busam, MD
Michael T. Busch, MD
Benjamin Thomas Busfield, MD
Charles A. Bush-Joseph, MD
Dale R. Butler, MD
Craig Alan Butler, MD, MBA
R. Bryan Butler, MD
Glenn R. Buttermann, MD
John Buza, MD
Jonathan E. Buzzell, MD
Ian R. Byram, MD
J. Abbott Byrd III, MD
J.W. Thomas Byrd, MD
Miguel E. Cabanela, MD
Edwin Richard Cadet, MD
Jason M. Cage, DO
Patrick John Cahill, MD
James T. Caillouette, MD
E. Lyle Cain Jr, MD
Richard A. Cain Jr, MD
Michelle S. Caird, MD
James Calder, MD
Ryan Patrick Calfee, MD
Jason H. Calhoun, MD
John J. Callaghan, MD
Alexandra Kathleen Callan, MD
Mark C. Callanan, MD
Christine B. Caltoum, MD
James Ian Cameron, MD
Frank P. Cammisa Jr, MD
Christopher L. Camp, MD
John D. Campbell, MD, MBA
John T. Campbell, MD
Kirk A. Campbell, MD
Barbara Jean Campbell, MD
Robert Murray Campbell Jr, MD
Robert Brick Campbell, MD
David R. Campbell, MD
Edmund R. Campion, MD
S. Terry Canale, MD
Lisa K. Cannada, MD
John Cannizzaro, MD
David L. Cannon, MD
Robert V. Cantu, MD
John T. Capo, MD
Giacomo Cappelleti, MD
Adam Michael Caputo, MD
James L. Carey, MD
Michelle Gerwin Carlson, MD
Emily E. Carmody Soni, MD
Jonathan J. Carmouche, MD
Gregory Francis Carolan, MD
Troy H. Caron, DO
Cyrus Theodore Caroom, MD
Joshua T. Carothers, MD
James E. Carpenter, MD
Diana Deane Carr, MD
Eugene Carragee, MD
Dominic S. Carreira, MD
Alexandra Carrer, MD
Charles Carroll IV, MD
Eben A. Carroll, MD
Cordelia Wheeler Carter, MD
Joshua Carter, MD
Danielle Casagrande, MD
Andrew M. Casden, MD
Virginia Fishburne Casey, MD
Kevin Matthew Casey, MD
Paul M. Caskey, MD
Joseph Ralph Cass, MD
Adrian J. Cassar Gheiti, MD, MRCS(Ed)
Xavier Cassard, MD
Ezequiel H. Cassinelli, MD
Pablo Castaneda, MD
Antonio E. Castellvi, MD
Tiffany Castillo, MD
Kyle Allen Caswell, DO
Louis W. Catalano III, MD
Kenneth R. Catallozzi, MD
Paul Celestre, MD
Rebecca Cerrato, MD
Thomas D. Cha, MD
James Chow, MD
John Z. Chrabuszcz, MD
Thomas Christensen, MD
Matthew Christian, MD
Melissa Ann Christino, MD
Constance R. Chu, MD
Alice Chu, MD
Steven C. Chudik, MD
Christopher R. Chuinard, MD, MPH
Christopher Cox, MD
Ian D. Crabb, MD
Edward V. Craig, MD
Charles C. Craig, MD
Robin C. Crandall, MD
Alvin Howell Crawford, MD
Dennis C. Crawford, MD, PhD
Charles Hopkins Crawford III, MD
Haemish Alexander Crawford,
MB(ChB), FRACS
William R. Creevy, MD
Brett D. Crist, MD
Lauren Crocco, MD
Lynn A. Crosby, MD
Samuel Crosby, MD
Colin G. Crosby, MD
Michael B. Cross, MD
John M. Cuckler, MD
Vanessa G. Cuellar, MD
Alberto D. Cuellar, MD
Derek J. Cuff, MD
Quanjun Cui, MD
Randall W. Culp, MD
Judd E. Cummings, MD
Nancy Madsen Cummings, MD
Matthew E. Cunningham, MD, PhD
Frances Cuomo, MD
Anna Vergun Cuomo, MD
Richard Blake Curd, MD
Thomas W. Currey, MD
Bradford L. Currier, MD
Brian M. Curtin, MD
Alan S. Curtis, MD
Joseph F. Curtis Jr, MD
Fred D. Cushner, MD
Gregory L. Cvetanovich, MD
Cory Czajka, MD
Scott D. Daffner, MD
Mark T. Dahl, MD
Brian Phillip Dahl, MD
William John Dahl, MD
Diane Lynn Dahm, MD
Justin Daigre, MD
Elizabeth Ann Dailey, MD
Jean-Claude Gregoire
DAlleyrand, MD
Aaron Daluiski, MD
David F. Dalury, MD
Michael C. Daly, MD
Timothy A. Damron, MD
Alexis Dang, MD
Alan Bao-Chan Dang, MD
Chris John Dangles, MD
Timothy Rudolf Daniels, MD, FRCSC
Alan H. Daniels, MD
Jonathan Danoff, MD
Michele R. DApuzzo, MD
Bruce V. Darden II, MD
Michael Edward Darowish, MD
Manuel F. DaSilva, MD
Michael David Daubs, MD
Joseph P. Davey, MD
Tal S. David, MD
Roy Davidovitch, MD
Jon R. Davids, MD
Kelsey E. Davidson, MD
Richard S. Davidson, MD
Philip A. Davidson, MD
Darin Davidson, MD
Charles M. Davis III, MD
Samuel Morgan Davis, MD
Edward T. Davis, FRCS
Robert V. Dawe, MD
John Rapier Dawson, MD
Charles S. Day, MD, MBA
Michael S. Day, MD
Michael R. Dayton, MD
Richard De Steiger, MD
D. Nicole Deal, MD
John T. Dearborn, MD
Thomas M. DeBerardino, MD
Kevin Debiparshad, MD
James Nicholas DeBritz, MD
Juliet M. DeCampos, MD
Thomas A. DeCoster, MD
Harry A. Demos, MD
Ian J. Dempsey, MD
Patrick J. Denard, MD
Douglas A. Dennis, MD
David G. Dennison, MD
James Keith DeOrio, MD
Peter Derman, MD
Geoffrey Francis Dervin, MD
Allen A. Deutsch, MD
Clinton J. Devin, MD
Jeffrey W. Devitt Jr, MD
Douglas K. Dew, MD, MBA
Christopher J. DeWald, MD
Ashvin Kumar Dewan, MD
Albert DHeurle, MD
Sravan C. Dhulipala, MD
Giovanni Di Giacomo, MD
Alberto Di Martino, MD, PhD
Edward Diao, MD
Jonathan F. Dickens, MD
Crystal M. Dickson, MD
Jacob Didesch, MD
Michael L. DiDonna, MD
David R. Diduch, MD
Brian Dierckman, MD
Gregory Scott DiFelice, MD
Anthony M. DiGioia III, MD
Benedict F. DiGiovanni, MD
Christopher W. DiGiovanni, MD
Matthew F. Dilisio, MD
Jennifer J. Connor, MD
Ernest U. Conrad III, MD
Sheila Ann Conway, MD
James L. Cook, DVM, PhD
Jay B. Cook, MD
Theodore Derek Cooke, FRCSC
Leroy H. Cooley, MD
Thomas M. Coon, MD
Herbert John Cooper, MD
Daniel Roy Cooperman, MD
Lawson A.B. Copley, MD
Jeffrey Miles Coppage, MD
Frank A. Cordasco, MD
Andrew L. Cornelius, MD
Chris Alan Cornett, MD
Brig Gen Kory Cornum, MD
Roger Cornwall, MD
Jacqueline Corona, MD
Kristoff Corten, MD
Andrew J. Cosgarea, MD
Leon N. Costa, MD
Alberto Costantini, MD
John George Costouros, MD
Michael J. Coughlin, MD
Ralph Richard Coughlin, MD
Jean-Pierre Courpied, PhD
425
426
Raymond S. Duffett, MD
Jeffrey R. Dugas, MD
Naven Duggal, MD
Chase A. Dukes, MD
Mark L. Dumonski, MD
Guillaume David Dumont, MD
Robert Paul Dunbar, MD
Michael Dunbar, MD
Norman L. Dunitz, MD
Scott J. Dunitz, MD
James T. Dunlap, MD
John C. Dunn, MD
Warren Dunn, MD, MPH
Jonathan H. Dunn, MD
Allan R. Dunn, MD
James Dunwoody, MD, FRCSC
Neil Leon Duplantier, MD
Thomas Richard Duquin, MD
Xavier A. Duralde, MD
Salim K. Durrani, MD
Paul J. Duwelius, MD
Kevin W. Dwyer, MD
Christopher John Dy, MD
Daryll C. Dykes, MD, PhD
Stanley H. Dysart, MD
Daniel Richard Dziadosz, MD
John L. Eady, MD
John S. Early, MD
Brandon Elizabeth Earp, MD
Janet F. Eary, MD
Mark E. Easley, MD
Jonathan G. Eastman, MD
Patrick Brian Ebeling, MD
Robert Shane Eberly, MD
Craig P. Eberson, MD
Thomas Ebinger, MD
Jason Cecil Eck, DO
Donald G. Eckhoff, MD
Stephen G.J. Eckrich, MD
Eric William Edmonds, MD
Thomas Bradley Edwards, MD
Sara Louise Edwards, MD
Scott G. Edwards, MD
Paul K. Edwards, MD
Natalie Marie Egge, MD
Kenneth A. Egol, MD
Kurt J. Ehlert, MD
Michael G. Ehrlich, MD
Lauren K. Ehrlichman, MD
Thomas Harold Eickmann, MD
Mark Aaron Eilers, MD
Robert E. Eilert, MD, FACS
Thomas A. Einhorn, MD
Eric Eisemon, MD
Frank J. Eismont, MD
Benno Ejnisman, MD
Eugene Ek, MD, PhD
Anders L. Ekelund, MD
Evan F. Ekman, MD
Mostafa Hassib El Dafrawy, MD
Neal S. ElAttrache, MD
Ashraf Elbanna, MD
Mohamed Mahmoud Elfekky Sr,
MSc, FRCS, MD
Bassem T. Elhassan, MD
Jacob Elkins, MD, PhD
Ilia Elkinson, MD
Hussein Adel Elkousy, MD
Scott Ellis, MD
Henry B. Ellis Jr, MD
Brad Ellison, MD
Mohammad Mohammad El-Sharkawi, MD
John B. Emans, MD
Roger H. Emerson Jr, MD
Sanford E. Emery, MD, MBA
Cynthia Lynn Emory, MD
Donald P. Endrizzi, MD
Lars Engebretsen, MD
C. Anderson Engh Jr, MD
Gerard Anderson Engh, MD
Howard R. Epps, MD
Greg Erens, MD
Steven Ericksen, MD
Brandon Erickson, MD
Mark A. Erickson, MD
William B. Ericson Jr, MD
Justin J. Ernat, MD
Thomas J. Errico, MD
William J. Ertl, MD
Benjamin Escott, MBBS
Mark Eskander, MD
Marjorie Eskay-Auerbach, MD
Aidin Eslampour, MD
Christopher Espinoza-Ervin, MD
Max Phillip Esser, MD
David Essig, MD
John Louis Esterhai Jr, MD
Robert J. Esther, MD
Daniel M. Estok II, MD
Andrew R. Evans, MD
John Peter Evans, MD
J. Mark Evans, MD
Jason M. Evans, MD
Clifford John Evans, DO
Richard Parker Evans, MD
Douglas A. Evans, MD
Jesse L. Even, MD
Nathan Everding, MD
Marybeth Ezaki, MD
Ken Faber, MD
David Figueroa, MD
Blair C. Filler, MD
Yale Fillingham, MD
Steven Fineberg, MD
Leslie A. Fink, MD
John G. Finkenberg, MD
Maureen A. Finnegan, MD
Joseph L. Finstein, MD
Reza Firoozabadi, MD
Stuart James Fischer, MD
Charla R. Fischer, MD
Jeffrey S. Fischgrund, MD
David A. Fisher, MD
Donald C. Fithian, MD
Wolfgang Fitz, MD
Kelly V. Fitzpatrick, DO
Jennifer L. FitzPatrick, MD
Michael Joseph Fitzpatrick, MD
Frederick C. Flandry, MD
David Clint Flanigan, MD
Ryan Flanigan, MD
Evan L. Flatow, MD
Thomas B. Fleeter, MD
James E. Fleischli, MD
Adolph Samuel Flemister Jr, MD
Nicholas David Fletcher, MD
Michael Arthur Flippin, MD
Mason Neal Florence, MD
Steven Edward Flores, MD
Stephen A. Flores, MD
Anthony Vatroslav Florschutz, MD
John Calhoun Peterson Floyd, MD
John M. Flynn, MD
Greg J. Folsom, MD
Clary J. Foote, MD
Jared R.H. Foran, MD
Eric D. Fornari, MD
Jonathan Agner Forsberg, MD
Paul T. Fortin, MD
Antonio Maria Foruria de Diego, MD, PhD
W. Stanley Foster, MD
T. Ty Fowler, MD
John R. Fowler, MD
John C. France, MD
Jenny Frances, MD
Salvatore Joseph Frangiamore, MD, MS
Ryan Garcia, MD
EStephan J. Garcia, MD
Michael J. Garcia, MD
Grant Garcia, MD
Eduardo Garcia-Cimbrelo, MD
Michael J. Gardner, MD
Eric J. Gardner, MD
Goran Garellick, MD, PhD
Sumeet Garg, MD
Rohit Garg, MD
Jonathan P. Garino, MD
Matthew Robert Garner, MD
Grant Garrigues, MD
Gary M. Gartsman, MD
Kevin L. Garvin, MD
Joshua L. Gary, MD
Roger Casey Gaskins, MD
Seth I. Gasser, MD
Erich Michael Gauger, MD
Elizabeth Gausden, MD
J. Christopher Gayton, MD
Lauren Elizabeth Geaney, MD
Gregory Paul Gebauer, MD
Mark C. Gebhardt, MD
Matthew J. Geck, MD
Albert Ooguen Gee, MD
Andrew Gregory Geeslin, MD
Laura M. Bruse Gehrig, MD
Andrew H. Glassman, MD
Steven D. Glassman, MD
Mark Glazebrook, MD
Wojciech Glinkowski, MD, PhD
Michael P. Glotzbecker, MD
Reuben Gobezie, MD
Danny Goel, MD, MSc, FRCSC
Wade Travis Gofton, BSCH, MD,
Med, FRCSC
Gloria Gogola, MD
Victor Goldberg, MD
Michael J. Goldberg, MD
Benjamin Goldberg, MD
Robert David Golden, MD
Charles A. Goldfarb, MD
Steven A. Goldstein, PhD
Wayne M. Goldstein, MD
Rachel Y. Goldstein, MD
Jeffrey M. Goldstein, MD
S. Raymond Golish, MD, PhD
M. Mustafa Gomberawalla, MD
Bruce F.C. Gomberg, MD
Jaime A. Gomez, MD
Ricardo A. Gonzales, MD
Mark H. Gonzalez, MD
Wilford K. Gibson, MD
Brett W. Gibson, MD
Thomas V. Giel III, MD
Joseph Andrew Gil, MD
Shawn R. Gilbert, MD
Thomas James Gill, MD
John T. Gill, MD
Corey S. Gill, MD
Robert J. Gillespie, MD
Blake P. Gillette, MD
Craig Gillis, DO
Scott D. Gillogly, MD
Allison Gilmore, MD
Mohit Gilotra, MD
Nicholas John Giori, MD
Paul J. Girard, MD
Federico Pablo Girardi, MD
Robert George Girling, MD
Steven Gitelis, MD
Steven A. Giuseffi, MD
M. Russell Giveans, PhD
Eric Giza, MD
Joseph Pashko Gjolaj, MD
James N. Gladstone, MD
David L. Glaser, MD
John A. Glaser, MD
Diana A. Glaser, PhD
Michele T. Glasgow, MD
Robert R. Glasgow, MD, FRCS
Jonathan L. Glashow, MD
Guillem Gonzalez-Lomas, MD
Hubert Lee Gooch Jr, MD
Mark A. Goodman, MD
Stuart Barry Goodman, MD
Howard J. Goodman, MD
Murray J. Goodman, MD
Gens Pierce Goodman, DO
David Goodwin, MD
Vipool K. Goradia, MD
John T. Gorczyca, MD
J. Eric Gordon, MD
Wade T. Gordon, MD
Alexander C. Gordon, MD
Abbey Gore, MD
Richard A. Gosselin, MD
Michelle Gosselin, MD
Masafumi Gotoh, MD, PhD
Hilton P. Gottschalk, MD
John S. Gould, MD
James A. Goulet, MD
Prasad V. Gourineni, MD
Kanu Goyal, MD
John Grady-Benson, MD
Carl N. Graf, MD
Brent Graham, MD
Gregory D. Gramstad, MD
Jaymes Granata, MD
Kevin D. Grant, MD
Luis Carlos Grau, MD
Jonathan N. Grauer, MD
Stanley C. Graves, MD
Matthew L. Graves, MD
Chancellor Folsom Gray, MD
Robert R. Gray, MD
Benjamin Leo Gray, MD
John J. Grayhack, MD
Gregory Graziano, MD
Andrew Green, MD
Daniel William Green, MD
Thomas M. Green, MD
John R. Trey Green III, MD
Neil E. Green, MD
Stuart A. Green, MD
Steven Marshall Green, MD
Jeffrey A. Greenberg, MD
Walter B. Greene, MD
A. Seth Greenwald, DPhil Oxon
Nelson Victor Greidanus, MD,
MPH, FRCSC
Patrick Greis, MD
Justin K. Greisberg, MD
Ruby Grewal, MD
Michael Griesser, MD
Letha Y. Griffin, MD
William L. Griffin, MD
Chad James Griffith, MD
Joachim Grifka, MD
Kimberly Grillo McLean, DO
Michael B. Grillot, MD
Jerry Speight Grimes, MD
Thomas J. Grogan, MD
Gordon I. Groh, MD
Andrew W. Grose, MD
Richard H. Gross, MD
Jonathan Michael Gross, MD
Steven C. Gross, MD
Christopher Edward Gross, MD
Brian Edward Grottkau, MD
Alexander Gruebl, MD
Gary S. Gruen, MD
Konrad Izumi Gruson, MD
Stephen Gryzlo, MD
Prof. Yu Guangrong
Suribabu Gudipati, MBBS, MRCS
Timothy C. Gueramy, MD
Joseph Guettler, MD
Joseph Johnson Gugenheim Jr, MD
David A. Fuller, MD
Brian C. Fuller, MD
Tadashi Ted Funahashi, MD
Christopher George Furey, MD
Kimberly Lee Furry, MD
Peter G. Gabos, MD
Keith Robert Gabriel, MD
Varun Kashyap Gajendran, MD
Jorge O. Galante, MD
Daniel D. Galat, MD
Leesa M. Galatz, MD
Brian J. Galinat, MD
Stacey Elisa Gallacher, MD
Bethany Gallagher, MD
Gregory G. Gallant, MD, MBA
Robert August Gallo, MD
David Galos, MD
Peter Louis Gambacorta, DO
Steven Gammon, MD
Braden Gammon, MD
Seth C. Gamradt, MD
Axel Gamulin, MD
David John Gandy, MD
Theodore J. Ganley, MD
Tigran Garabekyan, MD
Shawn Brian Garbedian, MD
Alexander C. Garber, MD
427
428
Andrew Gurman, MD
Michael S. Guss, MD
Stuart Trent Guthrie, MD
Daniel Guy, MD
Olivier Guyen, MD
Aaron John Guyer, MD
Richard D. Guyer, MD
Gregory P. Guyton, MD
David E. Gwinn, MD
Michael H. Haak, MD
Steven B. Haas, MD
Donald A. Hackbarth Jr, MD
Jacques Henri Hacquebord, MD
Steven L. Haddad, MD
Fares Sami Haddad, FRCS
Scott R. Hadley, MD
John Christian Hagedorn II, MD
Robert J. Hagen, MD
Warren O. Haggard, PhD
Hani Haider, PhD
George John Haidukewych, MD
Mark Hake, MD
William Michael Hakeos, MD
Adam Dean Hall, MD
Jeremy Hall, MD, FRCS(Ortho), MEd
Justin Hall, MD
Justin Haller, MD
Brian Richard Hallstrom, MD
Lawrence S. Halperin, MD
Jennifer Lynne Halpern, MD
Patrick J. Halpin, MD
David A. Halsey, MD
Matthew Halsey, MD
Jason J. Halvorson, MD
Moussa Hamadouche, PhD
Steven Paul Haman, MD
Reggie C. Hamdy, MD
Nady Hamid, MD
Christopher Lawrence Hamill, MD
James J. Hamilton, MD
William G. Hamilton, MD
Stephen C. Hamilton, MD
Brian R. Hamlin, MD
Eric Mark Hammerberg, MD
Kim W. Hammerberg, MD
James E. Hammond, DO
Sommer Hammoud, MD
Daniel Mark Hampton, MD
Douglas P. Hanel, MD
Edward N. Hanley Jr, MD
Jo A. Hannafin, MD, PhD
Sigvard T. Hansen Jr, MD
Peter B. Hanson, MD
Arlen D. Hanssen, MD
Shane Hanzlik, MD
Robert H. Haralson III, MD, MBA
Steven F. Harwin, MD
Jared Harwood, MD
Samer S. Hasan, MD, PhD
Syed Ashfaq Hasan, MD
J. Stewart Haskin, MD
Hill Hastings II, MD
Kazuhika Hatayama, MD
Armodios Miltiadis Hatzidakis, MD
Bryan Haughom, MD
Michael Hausman, MD
Richard J. Hawkins, MD
Catherine G. Hawthorne, MD
Col. (ret) Roman A. Hayda, MD
James B. Hayden, MD
Brett Hayden, MD
T. David Hayes, MD
Richard Justis Haynes, MD
Peyton Hays, MD
William A. Hazel Jr, MD
John H. Healey, MD, FACS
William L. Healy, MD
Wendell M. Rogan Heard, MD
Travis C. Heare, MD
Thomas M. Hearty, MD
Jonah Hebert-Davies, MD
Paul J. Hecht, MD
Andrew C. Hecht, MD
Robert Kurt Heck Jr, MD
Reed Heckert, MD
James D. Heckman, MD
Nathanael D. Heckmann, MD
Daniel J. Hedequist, MD
Michael J. Heffernan, MD
Michael H. Heggeness, MD
John P. Heiner, MD
David Leonard Helfet, MD
Melvin D. Helgeson, MD
John G. Heller, MD
Michael David Hellman, MD
Robert Andrew Henderson, MD
Steven Talmadge Hendrix, MD
M. Bradford Henley, MD, MBA, FACS
C. Noel Henley, MD
Theresa A. Hennessey, MD
William L. Hennrikus Jr, MD
Patrick Henry, MD
Robert Mikael Henshaw, MD
Robert N. Hensinger, MD
Steven Arthur Herbst, MD
Martin Joseph Herman, MD
James H. Herndon, MD
Jose A. Herrera Soto, MD
Thomas Alan Herschmiller, MD
Dolfi Herscovici Jr, DO
Stuart H. Hershman, MD
Ralph Hertel, MD
John E. Herzenberg, MD
Alfred V. Hess, MD
Carolyn Hettrich, MD, MPH
Benton E. Heyworth, MD
Stephen Vincent Hiatt, MD
Laurie Hiemstra, MD
Laurence D. Higgins, MD
Thomas F. Higgins, MD
Fujio Higuchi, MD
Hiroshi Higuchi, MD
Carlos A. Higuera, MD
Gregory R. Hildebrand, MD
Alan S. Hilibrand, MD
James A. Hill, MD
William D.B. Hiller, MD
Chad Aaron Hills, DO
Beat Hintermann, MD
Jayme Hiratzka, MD
Christopher Ben Hirose, MD
Stuart Hirsch, MD
Brandon P. Hirsch, MD
Kirby Hitt, MD
Christine Ann Ho, MD
Bryant Ho, MD
Sherwin S.W. Ho, MD
James Eric Ho, MD
Bang H. Hoang, MD
Jason P. Hochfelder, MD
Christopher W. Hodgkins, MD
Daniel Patrick Hoeffel, MD
Joseph John Hoegler, MD
Scott A. Hoffinger, MD
Pierre J. Hoffmeyer, MD
Aaron Adam Hofmann, MD
Kurt J. Hofmann, MD
Eric P. Hofmeister, MD
Dirk-Jan Hofstee, MD
Kathleen Anne Hogan, MD
MaCalus Hogan, MD
Justin Hohl, MD
Donald W. Hohman Jr, MD
Courtney Allen Holland, MD
George B. Holmes Jr, MD
Ginger E. Holt, MD
William J. Holt, MD
Lukas A. Holzer, MD
Edward S. Homan Jr, MD
Kelly C. Homlar, MD
William John Hopkinson, MD
Kazuichiro Hori, MD
Bernard David Horn, MD
Phillip Howard Horne, MD
Francis J. Hornicek, MD
MaryBeth Horodyski, EdD, ATC, LAT
Patrick B. Horrigan, MD
Taylor Horst, MD
Daniel Scott Horwitz, MD
Harish Sadanand Hosalkar, MD
Richard A. Hostin, MD
Robert N. Hotchkiss, MD
William R. Hotchkiss, MD
Matthew Houdek, MD
Andrew Howard, MD
Stephen M. Howell, MD
William J. Hozack, MD
Gregory M. Hrasky, MD
Mark Hsiao, MD
Wellington K. Hsu, MD
Stephanie Hsu, MD
Andrew Ray Hsu, MD
Anny Hsu, MD
Joseph R. Hsu, MD
Serena S. Hu, MD
Ronald Huang, MD
Kyle Hubler, DO
Paul M. Huddleston, MD
James I. Huddleston III, MD
Joshua L. Hudgens, MD
Thomas Huff, MD
Stephen J. Huffaker, MD
G. Russell Huffman, MD
Kevin Timothy Hug, MD
Thomas B. Hughes Jr, MD
Catherine A. Humphrey, MD
Marc Wilson Hungerford, MD
Kenneth Hunt, MD
Thomas R. Hunt III, MD
Robert E. Hunter, MD
A. Lee Hunter Jr, MD
Joshua Hunter, MD
Michael H. Huo, MD
Lawrence C. Hurst, MD
Amit Jain, MD
Andre Jakoi, MD
Amir A. Jamali, MD
Michelle A. James, MD
Joseph A. Janicki, MD
Nicholas Jarmon, MD
John J. Jasko, MD
Pooya Javidan, MD
Thomas Keller, MD
Francis Burns Kelly, MD
Bryan T. Kelly, MD
Derek Michael Kelly, MD
Michael Patrick Kelly, MD
Michael A. Kelly, MD
John D. Kelly IV, MD
Cynthia M. Kelly, MD
Jason Kelly, MD
Matthew J. Kelly, MD
John G. Kennedy, MD
Charles W. Kennedy, MD
William T. Kent, MD
Keith Kenter, MD
Louis Keppler, MD
Arash Kermanshahi, MD
Glenn J. Kerr, MD
Michael Kessler, MD
John P. Ketz, MD
Mahmoud Michael Khair, MD
Jad Khalil, MD
Safdar N. Khan, MD
Mansoor A. Khan, MD
A. Jay Khanna, MD
Harpal Singh Khanuja, MD
Omar Nassim Khatib, MD
Monti Khatod, MD
Michael S. Khazzam, MD
Jenniefer Y. Kho, MD
Amal Khoury, MD
Elie Khoury, MD
Sonya Khurana, MD
W. Benjamin Kibler, MD
Douglas W. Kiburz, MD
Thomas R. Kiefhaber, MD
Young Jo Kim, MD, PhD
Stephen Kim, MD
Leslie H. Kim, MD
Harry Kwang-Woo Kim, MD
Jun Shik Kim, MD
Young-Hoo Kim, MD
Raymond H. Kim, MD
Tae Kyun Kim, MD
Han Jo Kim, MD
Suezie Kim, MD
Paul Hyon-Uk Kim, MD
Graham J.W. King, MD
Erik Charles Bennett King, MD
Matthew Carnochan Kinney, MD
John S. Kirchner, MD
Kevin L. Kirk, DO
John S. Kirkpatrick, MD
D. Kay Kirkpatrick, MD
Bernard G. Kirol, MD
Ira H. Kirschenbaum
Alison Kitay, MD
Andrew Jawa, MD
Subramanyan Jayasankar, MD
Laith M. Jazrawi, MD
Clifford L. Jeng, MD
Louis George Jenis, MD
Derek R. Jenkins, MD
Tyler James Jenkins, MD
Richard Jenkinson, MD
Jonathan K. Jennings, MD
Jason Michael Jennings, MD
Jean-Yves Jenny, MD
Ray Byron Jensen, DO
Seth A. Jerabek, MD
Kyle James Jeray, MD
David Jevsevar, MD, MBA
Ramon L. Jimenez, MD
Matthew L. Jimenez, MD
William A. Jiranek, MD
Mark Jeffrey Jo, MD
Charles M. Jobin, MD
Norman A. Johanson, MD
Alun John, MD
Jeffrey Einer Johnson, MD
Darren L. Johnson, MD
Timothy S. Johnson, MD
Paul Johnson, MD
Anthony E. Johnson, MD
Derek R. Johnson, MD
Amanda L. Johnson, MD
Aaron J. Johnson, MD
Peter S. Johnston, MD
Richard C. Johnston, MD
Charles Eugene Johnston II, MD
Tyler Johnston, MD
Clifford B. Jones, MD, FACS
Kevin Bruce Jones, MD
Lynne C. Jones, PhD
Charles Irving Jones, MD
Alan L. Jones, MD
Grant L. Jones, MD
Marci Dara Jones, MD
Kerwyn Jones, MD
Morgan H. Jones, MD
Virginia Mooney Jones, MD
Kristofer Jones, MD
Justin Jones, MD
Daniel A. Jones, MD
Sean Jones-Quaidoo, MD
Charles J. Jordan, MD
Sheeba Joseph, MD
Hans Joseph, DO
Tsuyoshi Jotoku, MD
Nathaniel Jove, MD
Paul J. Juliano, MD
Jesse B. Jupiter, MD
Wael Fayez Kaawach, MD
429
430
Per Kjaersgaard-Andersen, MD
Brian A. Klatt, MD
Gregg R. Klein, MD
Sandra E. Klein, MD
Matthew Kleiner, MD
Steve Klepps, MD
Christopher Klifto, MD
Eric O. Klineberg, MD
Stephen Klinge, MD
Christopher James Kneip, MD
Jeffrey S. Kneisl, MD
Michael Knesek, MD
Justin Ryan Knight, MD
Jeffrey B. Knox, MD
Elisa J. Knutsen, MD
ZaKary A. Knutson, MD
Jih-Yang Ko, MD
Ky Kobayashi, MD
Mininder S. Kocher, MD, MPH
Pradeep Kodali, MD
Daniel Koehler, MD
Melissa D. Koenig, MD
Karl Koenig, MD, MS
Scott Koenig, MD
John Koerner, MD
Jason L. Koh, MD
Eugene Young Koh, MD, PhD
Lawrence Kohan, MD
Patricia A. Kolowich, MD
L. Andrew Koman, MD
Richard D. Komistek, PhD
Elizaveta Kon, MD
Geoffrey Konopka, MD, MPH
Christopher Kontogianis, MD
Theodore Damian Koreckij, MD
Theodore Kostiuk, DO
Konstantin Kotov, MD
Stephen Kottmeier, MD
David Kovacevic, MD
Rudy Kovachevich, MD
Kenneth J. Koval, MD
Marc Stephen Kowalsky, MD
Loukas Koyonos, MD
Michael Kozanek, MD
Scott H. Kozin, MD
Matthew J. Kraay, MD
Kenneth A. Krackow, MD
Paul E. Kraemer, MD
Joan B. Krajca-Radcliffe, MD
Michael Kralovec, MD
Robert C. Kramer, MD
Derek J. Kramer, MD
Dennis E. Kramer, MD
Hans J. Kreder, MD
Philip James Kregor, MD
Jennifer Kreshak, MD
Christian Krettek, MD
Stefan Kreuzer, MD
James C. Krieg, MD
Venkatadass Krishnamoorthy, MBBS, MS
Anil Krishnamurthy, MD
Sumant G. Krishnan, MD
Gregory B. Krivchenia II, MD
Chad A. Krueger, MD
Richard W. Kruse, DO
Robert J. Krushell, MD
Aaron J. Krych, MD
Jeffery Edward Krygier, MD
Erik Kubiak, MD
Bernd Kubista, MD
James Charles Kudrna, MD
John E. Kuhn, MD
Kevin M. Kuhn, MD
Michael A. Kuhn, MD
Michael Kuhne, MD
K. William Kumler, MD, MBA
Herbert L. Kunkle, MD
Andrew Frederic Kuntz, MD
Alfred Chung Kuo, MD
Calvin Kuo, MD
Stanley J. Kupiszewski, MD
Mark F. Kurd, MD
Masahiro Kurosaka, MD
William B. Kurtz, MD
Steven M. Kurtz, PhD
John Kurylo, MD
Peter R. Kurzweil, MD
Sharat Kumar Kusuma, MD
Bradley Randall Kuzel, MD
Paul Robert Kuzyk, MD, FRCSC, MSc
Terry R. Light, MD
Nina R. Lightdale - Miric, MD
Edward Guerrant Lilly III, MD
Moe R. Lim, MD
Orr Limpisvasti, MD
Sheldon S. Lin, MD
Patrick P. Lin, MD
Albert Lin, MD
Michael Y. Lin, MD
Yu-Min Lin, MD
Johnny L. Lin, MD
David L. Lin, MD
Antoinette W. Lindberg, MD
Eric C. Makhni, MD
Neil J. Maki, MD
Stephen Paul Makk, MD, MBA
Henrik Malchau, MD
Farbod Malek, MD
Chaitanya S. Malempati, DO
Gregory B. Maletis, MD
Gautam Malhotra, MD
Robert Andrew Malinzak, MD
Arthur L. Malkani, MD
William J. Mallon, MD
C. Bruce Malone, MD
Kevin J. Malone, MD
William J. Maloney, MD
Thomas A. Malvitz, MD
John Paul Manalo, MD
Peter J. Mandell, MD
John Mangelson, MD
Henry J. Mankin, MD
Michael T. Manley, PhD
Mollie Manley, MD
John Walter Mann III, MD
Jeffrey Adam Mann, MD
Paul A. Manner, MD
David W. Manning, MD
Arthur Manoli II, MD
Pierre Mansat, MD, PhD
David J. Mansfield, MD
Theodore Thomas Manson, MD
Joseph Maratt, MD
Maurilio Marcacci, MD
Matthew S. Marcus, MD
Steven M. Mardjetko, MD
Geoffrey Marecek, MD
David C. Markel, MD
Andrew David Markiewitz, MD
Richard M. Marks, MD
Peter D. McCann, MD
Brian R. McCardel, MD
Joseph C. McCarthy, MD
James J. McCarthy, MD
Mark Andrew McCarthy, MD
Richard E. McCarthy, MD
Moira Margaret McCarthy, MD
Eric Cleveland McCarty, MD
Robert Trigg McClellan, MD
Walter B. McClelland, MD
Michael McClincy, MD
Philip McClure, MD
Stephen M. McCollam, MD
Jeremy J. McCormick, MD
Joseph P. McCormick, MD
Brett William McCoy, MD
Brendan J. McCriskin, MD
Patrick C. McCulloch, MD
Kirk A. McCullough, MD
Erin M. McDermott-Nance, MD
Douglas J. McDonald, MD
Lucas McDonald, MD, MPH
Matthew McDonnell, MD
Gregory S. McDowell, MD
Mitchell A. McDowell, DO
Edward G. McFarland, MD
Sean V. McGarry, MD
William C. McGarvey, MD
Richard Louis McGough, MD
Timothy V. McGrath, MD
John J. McGraw, MD
Brian Joseph McGrory, MD
Robert A. McGuire Jr, MD
Kathleen A. McHale
Amy L. McIntosh, MD
Louis F. McIntyre, MD
Richard F. McKay, MD
Patricia Lee McKay, MD
Todd Owen McKinley, MD
Robert F. McLain, MD
Toni M. McLaurin, MD
Alexander Stewart McLawhorn, MD, MBA
Patrick J. McMahon, MD
William C. McMaster, MD
Edward J. McPherson, MD
Molly Claire Meadows, MD
Clifton Meals, MD
Simon Mears, MD
John B. Meding, MD
Rachel E. Mednick, MD
Michael Medvecky, MD
James E. Meeker, MD
Amir A. Mehbod, MD
Charles T. Mehlman, DO, MPH
Nima Mehran, MD
Samir Mehta, MD
431
432
Siddhant K. Mehta, MD
Joshua W. Meier, MD
Karim Anthony Meijer, MD
Eric G. Meinberg, MD
Robert J. Meislin, MD
Alfonso Mejia, MD
Russell D. Meldrum, MD
J. Mark Melhorn, MD
Menachem M. Meller, MD
James Stuart Melvin III, MD
Gregory A. Mencio, MD
Elliot Mendelsohn, MD
Marco Mendoza, MD
R. Michael Meneghini, MD
Matthew Menet, MD
Emmanuel Nganku Menga, MD
John J. Mercuri, MD, MA
Bradley Robert Merk, MD
Gabriel Merlin, MD
Michael Merrick, MD
David J. Merriman, MD
Andrew Laurance Merritt, MD
Michael Kurt Merz, MD
Addisu Mesfin, MD
J. Wesley Mesko, MD
Michael J. Messina, MD
Paul Christopher Metzger, MD
Matthew J. Meunier, MD
Frederick N. Meyer, MD
Carissa L. Meyer, MD
Lauren Meyer, MD
Laura Leigh Meyers, MD
Alan J. Micev, MD
Lyle J. Micheli, MD
James D. Michelson, MD
Jef Michielsen, MD
Stuart M. Michnick, MD
Charles A. Mick, MD
Theodore Miclau, MD
Kellie Kristin Middleton, MD
Mark A. Mighell, MD
William Michael Mihalko, MD, PhD
Todd A. Milbrandt, MD
Andrew Hill Milby, MD
Matthew Milewski, MD
Richard A. Miller, MD
Mark D. Miller, MD
Gary A. Miller, MD
Anna N. Miller, MD
Justin A. Miller, MD
G. Klaud Miller, MD
Lisa S. Miller, MD
Daniel James Miller, MD
Lawrence S. Miller, MD
Nancy H. Miller, MD
Richard J. Miller, MD
Geoffrey M. Miller, MD
Stuart D. Miller, MD
Assoc. Prof. Bruce Scott Miller, MD, MS
Suzanne L. Miller, MD
Benjamin J. Miller, MD
Doyle Joshua Miller, MD
Peter J. Millett, MD, MSc
Michael B. Millis, MD
William Min, MD
Kyong Su Min, MD
Tom Minas, MD
Bryan Woei Ming, MD
Anthony Miniaci, MD, FRCSC
Sara Lyn Miniaci, MD
Keith P. Minihane, MD
Yukihide Minoda, MD
Hassan Riaz Mir, MD
William M. Mirenda, MD
Sohail K. Mirza, MD, MPH
Faisal Mirza, MD, FRCSC
Amer J. Mirza, MD
Allan K. Mishra, MD
Shana N. Miskovsky, MD
Matthew E. Mitchell, MD
Erika Jasmin Mitchell, MD
Stephen F. Mitros, MD
Morris M. Mitsunaga, MD
Bradley Moatz, MD
Berton R. Moed, MD
Todd Moen, MD
Craig G. Mohler, MD
Jeffrey G. Mokris, MD
Timothy Scott Mologne, MD
Robert D. Monsey, MD
Michael A. Mont, MD
Scott Montgomery, MD
Harvey Montijo, MD
Harvey E. Montijo, MD
Raymond R. Monto, MD
Pekka A. Mooar, MD
William Randolph Mook, MD
Bryan Scott Moon, MD
Daniel K. Moon, MD
James F. Mooney III, MD
Thomas J. Moore, MD
Timothy A. Moore, MD
Richard E. Moore, MD
Drew Douglas Moore, MD
Claude T. Moorman III, MD
James E. Moravek Jr, MD
Jose A. Morcuende, MD
Vincent Michael Moretti, MD
Steven J. Morgan, MD
Jeffrey Scott Morgan, MD, MBA
Ryan Thomas Morgan, MD
Toru Moro, MD
Bernard F. Morrey, MD
Mark E. Morrey, MD
Carol D. Morris, MD, MS
Brent J. Morris, MD
Alan H. Morris, MD
Ryan Morris, DO
Michael J. Morris, MD
Mark Morris, MD
Martin J. Morrison III, MD
Lee Morse, MD
Saam Morshed, MD
Errol Steven Mortimer, MD
Vincent Stephen Mosca, MD
Wayne E. Moschetti, MD, MS
Colin F. Moseley, MD
Michael William Moser, MD
Joseph T. Moskal, MD
Michael J. Moskal, MD
Michael P. Mott, MD
Calin Stefan Moucha, MD
Mark J.R. Moulton, MD
Vasilios Moutzouros, MD
Thomas Francis Moyad, MD, MPH
Kenneth Mroczek, MD
Thomas Edward Mroz, MD
Scott J. Mubarak, MD
Chaitanya S. Mudgal, MD
Benjamin Mueller, MD, PhD
Stephanie Muh, MD
Kevin James Mulhall, MD
Philip Mulieri, MD
Scott M. Mullen, MD
Michael T. Mulligan, MD
Brian Mullis, MD
Kishore Mulpuri, MD
Jacqueline Munch, MD
Gregory Michael Mundis, MD
Richard L. Munk, MD
Mark W. Munro, MD
John Wesley Munz, MD
Raghuveer Muppavarapu, MD
Robert Francis Murphy, MD
Charles P. Murphy, MD
Stephen B. Murphy, MD
Garnett Andrew Murphy, MD
Margaret Siobhan Murphy-Zane, MD
Peter M. Murray, MD
Thomas F. Murray Jr, MD
Kevin R. Murray, MD
Paraic A. Murray, MD
George A.C. Murrell, MD
Daniel Beasley Murrey, MD
Yvonne M. Murtha, MD
Anand M. Murthi, MD
George F. Muschler, MD
Jennifer Mutch, MD
Amar Mutnal, MD
Richard John Mutty, MD
Scott L. Myers, MD
Thomas Myers, MD
Richard Myers, MD
Mark S. Myerson, MD
Karen Sookyung Myung, MD
Peggy L. Naas, MD, MBA
James Nace, DO, PT
Daniel J. Nagle, MD
Rueben Nair, MD
Masatoshi Naito, MD
Charles C. Nalley, MD
Denis Nam, MD
Robert S. Namba, MD
Joshua Namm, MD
Sumon Nandi, MD
George P. Nanos, MD
Unni G. Narayanan, MBBS, MSc, FRCSC
Nader A. Nassif, MD
Ahmad Nassr, MD
Kristen M. Nathe, MD
Douglas Naudie, MD, FRCSC
Aaron Nauth, MD
Ronald Anthony Navarro, MD
Danyal Nawabi, MD,
FRCS(Ortho)
Qais Naziri, MD
Kevin M. Neal, MD
Nathaniel Jonathan Nelms, MD
Fred R.T. Nelson, MD
Charles L. Nelson, MD
David L. Nelson, MD
Bradley J. Nelson, MD
Scott C. Nelson, MD
Kenneth J. Nelson, MD
James V. Nepola, MD
Jeffrey Nepple, MD
Sergiy Nesterenko, MD
Leon Nesti, MD, PhD
Anuj Netto, MD
Philip R. Neubauer, MD
Steven K. Neufeld, MD
Robert J. Neviaser, MD
Andrew Neviaser, MD
William Neway, DO
Erik T. Newman, MD
Peter O. Newton, MD
Duong Nguyen, MD
Mai P. Nguyen, MD
Thao Nguyen, MD
Shane Jay Nho, MD
Gregg Nicandri, MD
Claude E. Nichols III, MD
Gregory P. Nicholson, MD
Dean Papaliodis, MD
Rick F. Papandrea, MD
Hans-Christoph Pape, MD
Steven Ray Papp, MD
Nick D. Pappas, MD
Ioannis P. Pappou, MD, PhD
Wayne Gregory Paprosky, MD
Selene G. Parekh, MBA, MD
Shital N. Parikh, MD
Andrew Park, MD
Myung-Sik Park, MD
Daniel K. Park, MD
Justin J. Park, MD
Min Jung Park, MD, MSc
Kwan Park, MD
Richard D. Parker, MD
Richard W. Parkinson, FRCS
Vinai Parkpian, MD
Michael Lloyd Parks, MD
Christopher Parks, MD
Sebastian Parratte, MD
William M. Parrish, MD
Brian S. Parsley, MD
Bradford O. Parsons, MD
Theodore W. Parsons III, MD, FACS
Michael J. Patzakis, MD
Jeanne C. Patzkowski, MD
E. Scott Paxton, MD
Monica Maria Payares, MD
William Thomas Payne, MD
Theresa Pazionis, MD
Terrance D. Peabody, MD
Michael L. Pearl, MD
Andrew D. Pearle, MD
Albert W. Pearsall IV, MD
Adam Pearson, MD
Walter J. Pedowitz, MD
David Isadore Pedowitz, MD
Robert A. Pedowitz, MD, PhD
Francesco Pegreffi, MD, PhD
Stephane Pelet, MD, PhD
Vincent D. Pellegrini, MD
Christopher Pelt, MD
Brad L. Penenberg, MD
Murray J. Penner, MD
Scott Pennington, MD
Andrew Tennant Pennock, MD
Matthew D. Pepe, MD
Edward Perez, MD
Antonio Javier Perez-Caballer, MD
Carsten Perka, MD
Joseph H. Perra, MD
Brett Perricelli, MD
Kevin I. Perry, MD
Robin E. Peter, MD
Christopher L. Peters, MD
Steve A. Petersen, MD
Joseph Laurence Petfield, MD
Benjamin McVay Petre, MD
Frank Petrigliano, MD
Anthony V. Petrosini, MD
Gabriel L. Petruccelli, MD
Kiel J. Pfefferle, MD
Bernard Andrew Pfeifer, MD
Terrence Philbin, DO
Marc J. Philippon, MD
Donna P. Phillips, MD
Geoffrey I. Phillips, MD
Jonathan H. Phillips, MD
Phinit Phisitkul, MD
Raymond O. Pierce Jr, MD
Christine Walker Pierce, MD
Casey Pierce, MD
Kristan Pierz, MD
Eric Bruce Pifel, MD
Matthew Alan Pifer, MD
Matthew Pigott, MD
Leo A. Pinczewski, FRACS
Gregory J. Pinkowsky, MD
Mark C. Pinto, MD
Michael S. Pinzur, MD
Miguel A. Pirela-Cruz, MD
Joseph Michael Pirolo, MD
J. David Pitcher Jr, MD
Robert Pivec, MD
Peter D. Pizzutillo, MD
Kevin D. Plancher, MD, MS
Avraam L. Ploumis, MD, PhD
David A. Podeszwa, MD
Kornelis Andries Poelstra, MD
Joel Roger Politi, MD
Gregory G. Polkowski II, MD
Andrew N. Pollak, MD
David W. Polly Jr, MD
David R. Polonet, MD
John D. Polousky, MD
Jay F. Pomerance, MD
433
434
Gregory C. Pomeroy, MD
Brent A. Ponce, MD
Karthikeyan E. Ponnusamy, MD
Matthew A. Popa, MD
David James Pope, MD
Richard W. Pope, MD
Debra J. Popejoy, MD
Charles A. Popkin, MD
Scott Edward Porter, MD
Martin A. Posner, MD
Zachary D. Post, MD
William R. Post, MD
Hollis Potter, MD
Michael Potter, MD
Benjamin Kyle Potter, MD
Gorden David Potter III, MD
Aaron Daniel Potts, MD
Michael Pouliot, MD
Sina Pourtaheri, MD
Scott Evan Powell, MD
Mark L. Prasarn, MD
Bogadi R. Prashanth, MD
Cyrus Minoo Press, MD
Chad T. Price, MD
Thomas Edmunds Price, MD
Mark D. Price, MD
Andrew J. Price, FRCS
Maya Pring, MD
Jonathan Printz, MD
James W. Pritchett, MD
Robert A. Probe, MD
Chadwick C. Prodromos, MD
Laura J. Prokuski, MD
Cdr. (ret) Matthew T. Provencher, MD
Gregory H. Rafijah, MD
Mark D. Rahm, MD
Steven M. Raikin, MD
Sean Rajaee, MD
Rajiv Rajani, MD
Raghav Rajgopal, MD
Rakesh Ramakrishnan, MD
Miguel Ramirez, MD
Dipak B. Ramkumar, MD
Matthew Lee Ramsey, MD
Anil S. Ranawat, MD
Amar S. Ranawat, MD
Chitranjan S. Ranawat, MD
R. Lor Randall, MD
Timmothy Ryan Randell, MD
Filippo Randelli, MD
Marc E. Rankin, MD
Raj D. Rao, MD
Timothy Rapp, MD
Kevin A. Raskin, MD
Linda J. Rasmussen, MD
Vijay J. Rasquinha, MD
Karl E. Rathjen, MD
Joshua Ratner, MD
Michael A. Rauh, MD
Raymond B. Raven, MD, MBA
Bheeshma Ravi, MD
Amy Lynn Ravindra, MD
Bernard A. Rawlins, MD
Ghazi M. Rayan, MD
Afshin Razi, MD
John S. Reach, MD
John E. Ready, MD
Brian Rebolledo, MD
Glenn R. Rechtine II, MD
Deepak Reddy, MD
Fred C. Redfern, MD
Lauren H. Redler, MD
Lori K. Reed, MD
Dale Nicholas Reed, MD
Harold Wharton Rees, MD
Stephen Reichard, MD
J. Spence Reid, MD
Sandra Lee Reidel, MD
Mark C. Reilly, MD
Donald T. Reilly, MD, PhD
Keith R. Reinhardt, MD
Charles A. Reitman, MD
Mark S. Rekant, MD
Ville M. Remes, MD
Herbert Resch, MD
Arthur C. Rettig, MD
Peter C. Rhee, MD
Charles Edward Rhoades, MD
Anthony S. Rhorer, MD
Manuel Ribas Fernandez, MD
James R. Roberson, MD
Henri Robert, MD
Craig S. Roberts, MD, MBA
Timothy Roberts, MD
Matthew Roberts, MD
Jason W. Roberts, MD
Jared T. Roberts, MD
Martin William Roche, MD
Scott Alan Rodeo, MD
Craig M. Rodner, MD
Mark W. Rodosky, MD
Juan J. Rodrigo, MD
Stephen W. Rodrigue, MD
Jose A. Rodriguez, MD
Arnaldo I. Rodriguez-Santiago, MD
Michael J. Rogal, MD
Jason Michael Rogers, MD
Rachel Samantha Rohde, MD
Andrew S. Rokito, MD
David M. Romano, MD
James Richard Romanowski, MD
Anthony A. Romeo, MD
Jose A. Romero, MD
David W. Romness, MD
Peter S. Rose, MD
Laurel H. Saliman, MD
Michael F. Schafer, MD
Jonathan L. Schaffer, MD
William W. Schairer, MD
Thomas J. Scharschmidt, MD
Emil H. Schemitsch, MD
Mara Lynne Schenker, MD
Anthony Alberto Schepsis, MD
Susan A. Scherl, MD
Mark S. Schickendantz, MD
Adam Paul Schiff, MD
Eric D. Schiffman, MD
Carl Schillhammer, MD
Harry Schmaltz, MD
Thomas P. Schmalzried, MD
Gregory J. Schmeling, MD
Andrew H. Schmidt, MD
Christopher C. Schmidt, MD
Richard D. Schmidt, MD
Matthew R. Schmitz, MD
Bradley S. Schoch, MD
Perry L. Schoenecker, MD
Jonathan G. Schoenecker, MD
Andrew J. Schoenfeld, MD
Lew C. Schon, MD
Patrick Christopher Schottel, MD
Tim Schrader, MD
Michael J. Schreck, MD
William E. Schreiber, MD
Verena M. Schreiber, MD
Joseph Schreiber, MD
Donald J. Schroeder, MD
Gregory Douglas Schroeder, MD
William C. Schroer, MD
Mark Schrumpf, MD
Dean R. Schueller, MD
Leah M. Schulte, MD
Brian M. Schulz, MD
Steven F. Schutzer, MD
Joseph Hasbrouck Schwab, MD
Joseph M. Schwab, MD
Herbert S. Schwartz, MD
Adam Schwartz, MD
Daniel Grant Schwartz, MD
Jeffrey M. Schwartz, MD, FACS
Alexandra Kay Schwartz, MD
Cary C. Schwartzbach, MD
Ran Schwarzkopf, MD
Richard M. Schwend, MD
James Douglas Schwender, MD
Leslie Ellen Schwindel, MD
Mark Scioli, MD
John Alan Scolaro, MD
Laura Scordino, MD
Douglas Alan Scott, MD
Richard D. Scott, MD
W. Norman Scott, MD
Allison C. Scott, MD
Giles R. Scuderi, MD
Gaetano J. Scuderi, MD
Matthew G. Scuderi, MD
Thomas P. Sculco, MD
Peter Keyes Sculco, MD
Scott Beecher Scutchfield, MD
Richard A. Seagrave III, MD
Benjamin W. Sears, MD
Arjun Sebastian, MD
Vernon Franklin Sechriest, MD
Aaron A. See, DO
Ludwig Seebauer, MD
Mark Seeley, MD
Matthew Seidel, MD
Ari Douglas Seidenstein, MD
William H. Seitz Jr, MD
Jon K. Sekiya, MD
David Seligson, MD
Stephen A. Sems, MD
Milan Kumar Sen, MD
Benjamin Service, MD
Paul Sethi, MD
Manish K. Sethi, MD
Kevin J. Setter, MD
Joseph Milo Sewards, MD
James J. Sferra, MD
Nicholas A. Sgaglione, MD
Gene W. Shaffer, MD
Benjamin Shaffer, MD
Christopher I. Shaffrey, MD
Adam B. Shafritz, MD
Ritesh Shah, MD
Roshan P. Shah, MD, JD
Suken A. Shah, MD
Apurva Shah, MD, MBA
James S. Shaha, MD
Irshad A. Shakir, MD
Raj Harry Shani, MD
Brian David Shannon, MD
Jesse Shantz, MD, FRCSC
Steven L. Shapiro, MD
Matthew S. Shapiro, MD
Steven Aaron Shapiro, MD
Frederic Shapiro, MD
Adam Shar, MD
Alok D. Sharan, MD
Melinda Sharkey, MD
Peter F. Sharkey, MD
Krishn M. Sharma, MD
Kipling P. Sharpe, MD
Mark Shasti, MD
James A. Shaw, MD
Brian A. Shaw, MD
Jeremy Dewitt Shaw, MD, MS
Kevin G. Shea, MD
David Shearer, MD
Shahin Sheibani-Rad, MD
Mitchell B. Sheinkop, MD
K. Donald Shelbourne, MD
Walter R. Shelton, MD
Francis H. Shen, MD
Joseph E. Sheppard, MD
David Morton Sheps, MD, MSc, FRCSC
Justin D. Saliman, MD
Charles L. Saltzman, MD
Matthew D. Saltzman, MD
Paul M. Saluan, MD
Eduardo Agustin Salvati, MD
John P. Salvo, MD
John P. Salvo Jr, MD
Andrew A. Sama, MD
Sanjum Samagh, MD
Chris Sambaziotis, MD
Gonzalo Samitier Solis, MD
Vincent James Sammarco, MD
Julie Samora, MD
Thomas G. Sampson, MD
Eric Michael Samuelson, MD
Thomas P. San Giovanni, MD
Joaquin Sanchez-Sotelo, MD
Linda J. Sandell, PhD
James O. Sanders, MD
Albert E. Sanders, MD
Roy W. Sanders, MD
Thomas Sanders, MD
Abhindrajeet Sandhu, MD
435
436
Gregory H. Sirounian, MD
Peter Siska, MD
Sureshan Sivananthan, MD
David Lee Skaggs, MD
William Skakun, DO
Nathan William Skelley, MD
Nicolas J. Skordas, MD
Eerik Tapio Tuomas Skytta, MD, PhD
Mark A. Slabaugh, MD
Bradley Earl Slagel, MD
Robert R. Slater Jr, MD
Nicholas R. Slenker, MD
Steven Slotkin, MD
James A. Slough, MD
James D. Slover, MD
Kevin Smit, MD
Brian G. Smith, MD
Jeffrey Mark Smith, MD
Wade Russell Smith, MD
Matthew V. Smith, MD
Jeremy T. Smith, MD
Michael Devon Smith, MD
Kevin Smith, MD
Bruce Laron Smith Jr, MD
Joel J. Smith, MD
John Taylor Smith, MD
Peter A. Smith, MD
Michael D. Smith, MD
Eric Louis Smith, MD
Eric B. Smith, MD
Jeremy Scott Smith, MD
Matthew J. Smith, MD
William Bret Smith, DO
Micah Smith, MD
Ian Smithson, MD
Joseph Douglas Smucker, MD
Niall Adair Smyth, MD
Barry J. Snyder, MD
Mark A. Snyder, MD
Brian Snyder, MD, PhD
Stephen J. Snyder, MD
Benjamin Matthew Snyder, MD
Andrew Sobel, MD
Jeffrey F. Sodl, MD
Stephen R. Soffer, MD
Gregory W. Soghikian, MD
David H. Sohn, JD, MD
Gbolabo Olabiyi Sokunbi, MD
Gillian Soles, MD
Daniel Jordan Solomon, MD
Jason Solomon, MD
Alexander P. Soneru, MD
Kit M. Song, MD
Daniel Song, MD
John K. Sontich, MD
Rena Stewart, MD
Robert Stewart, MD
Daniel J. Stinner, MD
Gregory William Stocks, MD
Edward J. Stolarski, MD
Jeffrey Davis Stone, MD
Norman Stone, MD
Jason W. Stoneback, MD
Mark Stouffer, MD
Michael David Stover, MD
Richard E. Strain Jr, MD
William M. Strassberg, MD
Robert J. Strauch, MD
Eric Jason Strauss, MD
Jonathan Streit, MD
Sabrina Strickland, MD
Gregory Strohmeyer, MD
Benjamin Stronach, MD
Benjamin Strong, MD
Louis S. Stryker, MD
Michael J. Stuart, MD
James R. Stubbart, MD
S. David Stulberg, MD
Bernard N. Stulberg, MD
Peter F. Sturm, MD
Edwin P. Su, MD
Daniel J. Sucato, MD, MS
Prof. Akihiro Sudo
Nina Suh, MD
Michael Suk, MD
Atul Sukthankar, MD
Linda Suleiman, MD
J. Andy Sullivan, MD
Robert Terrence Sullivan, MD
Jaron P. Sullivan, MD
Matthew Patrick Sullivan, MD
Michael Sumko, DO
Hobie D. Summers, MD
Jeffrey J. Sundblad, MD
James P. Sutherland Jr, MD
Karen Michelle Sutton, MD
Larry Suva, PhD
Kentaro Suzuki, MD
Steven James Svoboda, MD
Vineeta T. Swaroop, MD
Ishaan Swarup, MD
Marc F. Swiontkowski, MD
Paul Switaj, MD
Elizabeth Ann Szalay, MD
Jan Paul Szatkowski, MD
Benjamin Szerlip, DO
John M. Tabit, DO
Lisa Taitsman, MD
Norimasa Takahashi, MD
Yoshinori Takakura, MD
Masato Takao, MD
Richelle C. Takemoto, MD
Ryan K. Takenaga, MD
Julio Taleisnik, MD
Rajiv V. Taliwal, MD
Carl T. Talmo, MD
Paul Talusan, MD
Vishwas R. Talwalkar, MD
Eric Tan, MD
Virak Tan, MD
Miho Jean Tanaka, MD
Yasuhito Tanaka, MD
Aree Tanavalee, MD
Peter Tang, MD
Edward Tang, MD
Suzanne Tanner, MD
Edward C. Tanner, MD
John C. Tanner III, MD
Oliver O. Tannous, MD
Michael Tanzer, MD
Samih Tarabichi, MD
John S. Taras, MD
Jennifer M. Tareco, MD
T. David Tarity, MD
Ivan Seth Tarkin, MD
Robert Zaray Tashjian, MD
J. Channing Tassone, MD
James P. Tasto, MD
Michael J. Taunton, MD
Bobby Tay, MD
Darren Tay, MBBS, FRCS(Ortho)
Ross Taylor, MD
Benjamin Taylor, MD
Samuel Arthur Taylor, MD
Kenneth F. Taylor, MD
Col. Dean C. Taylor, MD
Michal L. Taylor, MD
David C. Teague, MD
Fernando Techy, MD
Robert Allan Teitge, MD
Nirmal C. Tejwani, MD
Sam G. Tejwani, MD
H. Thomas Temple, MD
David C. Templeman, MD
Kimberly J. Templeton, MD
Joshua N. Tennant, MD
John R. Tenny, MD
Richard M. Terek, MD
Bernardo Terra, MD
Rodney Terrell, MD
Michael A. Terry, MD
David Teuscher, MD
Matthew J. Teusink, MD
Nikhil Anand Thakur, MD
John Theodoropoulos, MD, FRCSC, MSc
Alexander Theologis, MD
Zachary Thielen, MD
Christos Vassos, MD
Zachary Vaupel, MD
Christian Veillette, MD
Shyam Vekaria, MD
Andrea Veljkovic, MD, FRCSC
Olivier Verborgt, MD, PhD
Robin Vereeke West, MD
James R. Verheyden, MD
Nikhil N. Verma, MD
Kushagra Verma, MD
Doug A. Vermillion, MD
Frederik Verstreken, MD
Peter S. Vezeridis, MD
Jan M.K. Victor, MD
Brian N. Victoroff, MD
Armando Felipe Vidal, MD
Jonathan Vigdorchik, MD
Mandeep Virk, MD
Sohrab Virk, MD
Walter W. Virkus, MD
Michael G. Vitale, MD, MPH
Mark A. Vitale, MD
Michael Vives, MD
Dang-Khoa Vo, MD, MS
Clifford Voigt, MD
Ilya Voloshin, MD
Bryan George Vopat, MD
Dagmar Vos, MD
Frank R. Voss, MD
Jason Vourazeris, MD
Mark S. Vrahas, MD
Dharmesh Vyas, MD
Bradford Sutton Waddell, MD
James P. Waddell, MD
Emilio Wagner, MD
Emily Wagstrom, MD
Christopher John Wahl, MD
Gilles Walch, MD
Norman Waldrop III, MD
Richard H. Walker, MD
Peter S. Walker, PhD
Eric J. Wall, MD
Lindley B. Wall, MD
Charles Douglas Wallace, MD
Arthur K. Walling, MD
Brian Walters, MD
Robert L. Waltrip, MD
Jeffrey C. Wang, MD
Angela A. Wang, MD
Ching-Jen Wang, MD
Yongsak Wangroongsub, MD
Tony Wanich, MD
Keith L. Wapner, MD
W. Timothy Ward, MD
Daniel M. Ward, MD
Winston J. Warme, MD
Bryan A. Warme, MD
Jon J.P. Warner, MD
William C. Warner Jr, MD
Russell F. Warren, MD
Gregory Richard Waryasz, MD
Daniel C. Wascher, MD
Eleby R. Washington, MD
Ray C. Wasielewski, MD
Amy Wasterlain, MD
Michael A. Wasylik, MD
Brian Waterman, MD
Peter M. Waters, MD
Troy B. Watkins Jr, MD
Colyn J. Watkins, MD
J. Tracy Watson, MD
Jeffry T. Watson, MD
Anthony D. Watson, MD
Jonathan Watson, MD
James Watt, DO
Tyler Steven Watters, MD
Keith W. Weaver, MD
Michael J. Weaver, MD
Lawrence Xavier Webb, MD
Nicholas Paul Webber, MD
Stephen C. Weber, MD
Kristy L. Weber, MD
Jason Weber, MD
Alexander Weber, MD
John S. Webster, MD, MBA
Kenneth Durham Weeks, MD
Colleen Weeks, MD
Adam Wegner, MD, PhD
Julien Wegrzyn, MD, PhD
David H. Wei, MD
Mark Weidenbaum, MD
Bradley K. Weiner, MD
Scott D. Weiner, MD
Dennis S. Weiner, MD
Lon Weiner, MD
Steven Bennett Weinfeld, MD
Stuart L. Weinstein, MD
James N. Weinstein, DO, MS
Joseph Weinstein, DO
Robb Matthew Weir, MD
Kurt Richard Weiss, MD
Jennifer M. Weiss, MD
Arnold-Peter C. Weiss, MD
David B. Weiss, MD
Jason Scott Weisstein, MD
Joseph K. Weistroffer, MD
Richard B. Welch, MD
Samuel Secord Wellman, MD
David Wellman, MD
Lawrence Wells, MD
Dennis R. Wenger, MD
Glenn D. Wera, MD
Brian C. Werner, MD
Steven B. Wertheim, MD
Hugh S. West Jr, MD
Jennifer J. Westendorf, PhD
Robert W. Westermann, MD
Geoffrey H. Westrich, MD
Nathan Wetters, MD
F. Todd Wetzel, MD
Robert Joseph Wetzel, MD
Joseph L. Whalen, MD
Peter G. Whang, MD
Daniel Whelan, MD
Edward R. White, MD
Klane K. White, MD
Kenneth C. Thomas, MD
John G. Thometz, MD
Terry L. Thompson, MD
Michael A. Thompson, MD
Matthew Michael Thompson, MD
Jeffrey D. Thomson, MD
Brian Thomson, MD
David B. Thordarson, MD
Thomas S. Thornhill, MD
Robert John Thorsness, MD
Thomas (Quin) Throckmorton, MD
James E. Tibone, MD
Jonathan B. Ticker, MD
John F. Tilzey, MD
Edwin M. Tingstad, MD
Fotios Paul Tjoumakaris, MD
E. Bruce Toby, MD
Gregory Tocks, DO
John M. Tokish, MD
Daisaku Tokunaga, MD
Stephen R. Tolhurst, MD
Vernon T. Tolo, MD
Bryan J. Tompkins, MD
Marc Tompkins, MD
John R. Tongue, MD
Pietro M. Tonino, MD
Brian Christopher Toolan, MD
Michael E. Torchia, MD
Joseph S. Torg, MD
Edward A. Toriello, MD
Paul Tornetta III, MD
Paul Justin Tortolani, MD
Laura Lowe Tosi, MD
Alison P. Toth, MD
Patrick Christopher Toy, MD
Peter G. Trafton, MD
Gabriel T. Trainer, MD
Ensor E. Transfeldt, MD
Scott W. Trenhaile, MD
Satoshi Tsukushi, MD
Dominick Tuason, MD
Creighton Collins Tubb, MD
Bradford S. Tucker, MD
Kimberly K. Tucker, MD
Joel A. Tucker, MD
Dmitry Tuder, MD
Douglas R. Turgeon, MD
Norman S. Turner III, MD
Wakenda K. Tyler, MD, MPH
Soshi Uchida, MD, PhD
Aniebiet-Abasi Udofia, MD
Richard Uhl, MD
Slif D. Ulrich, MD
Yuji Umeda, MD
Marc Evan Umlas, MD
Anthony S. Unger, MD
Ekaterina Y. Urch, MD
John William Uribe, MD
Andrew G. Urquhart, MD
Hajime Utsunomiya, MD
Alexander Vaccaro, MD, PhD
Jessica Vachon, MD
Rahul Vaidya, MD
Thomas Parker Vail, MD
Alex Vaisman, MD
Victor Valderrabano, MD
Richard Valenzuela, MD
Heather A. Vallier, MD
Frank Valone III, MD
Harold J.P. Van Bosse, MD
C. Niek Van Dijk, MD
Carola F. Van Eck, MD
Ann E. Van Heest, MD
Geoffrey Van Thiel, MD, MBA
Curtis D. VandenBerg, MD
Kelly L. Vanderhave, MD
C. Thomas Vangsness Jr, MD
John Nicholas Vani, MD
Richard William Vanis, MD
Thomas F. Varecka, MD
437
438
Felasfa M. Wodajo, MD
Marcella Rae Woiczik, MD
Brian R. Wolf, MD
Jennifer Moriatis Wolf, MD
Scott W. Wolfe, MD
Caroline Wolfe, MD
Andrew Barrett Wolff, MD
Philip R. Wolinsky, MD
Adam Laurance Wollowick, MD
Andrew Matthew Wong, MD
Christopher Wong, MD
Montri D. Wongworawat, MD
Kirkham B. Wood, MD
David G. Wood, FRACS
Gary Lewis Woods, MD
Steven T. Woolson, MD
Clint J. Wooten, MD
Jennifer K. Wozniczka, MD
Rick W. Wright, MD
Raymond Dayne Wright Jr, MD
Vonda J. Wright, MD
Patrick Beaumont Wright, MD
Thomas W. Wright, MD
Timothy M. Wright, PhD
Robert John Wright, MD
Geoffrey A. Wright, MD
Chia Heng Wu, MD
Dane K. Wukich, MD
Jay Wunder, MD
Ronald W.B. Wyatt, MD
Douglas J. Wyland, MD
John D. Wyrick, MD
Robert W. Wysocki Jr, MD
Mark Aaron Yaffe, MD
Ken Yamaguchi, MD
Kent Yamaguchi, MD
Suzanne Marie Yandow, MD
Yunfeng Yang, MD
Adam Blair Yanke, MD
Sarah Marie Yannascoli, MD
Jeffrey Yao, MD
Reina Yao, MD
Walid K. Yassir, MD
Toshito Yasuda, MD
Yuji Yasunaga, MD
Burt Yaszay, MD
Michael J. Yaszemski, MD, PhD
Adolph J. Yates Jr, MD
Tameem M. Yehyawi, MD
Yi-Meng Yen, MD
Jin-Sup Yeom, MD
Edward Yian, MD
Marilyn L. Yodlowski, MD, PhD
Michael Christopher Yonz, MD
Brad J. Yoo, MD
S. Tim Yoon, MD, PhD
Patrick Yoon, MD
Richard S. Yoon, MD
Sun Jung Yoon, MD
James J. York, MD
Ichiro Yoshimura, MD
Shinichi Yoshiya, MD
Ari Youderian, MD
Samuel D. Young III, MD
Mae Ewing Young, MD
Ernest Young, MD
Alastair S.E. Younger, MD
Jim A. Youssef, MD
Warren D. Yu, MD
Elizabeth M. Yu, MD
Brandon J. Yuan, MD
Pongsak Yuktanandana, MD
Stefano Zaffagnini, MD
Ira Zaltz, MD
Diego Zanolli, MD
Kevin Zartman, MD
Mark W. Zawadsky, MD
Thomas A. Zdeblick, MD
Lukas Peter Zebala, MD
Daniel Zelazny, MD
Boris A. Zelle, MD
Benjamin S. Zellner, MD
David Steven Zelouf, MD
Michele M. Zembo, MD, MBA
Jiaqian Zhou
Hanbing Zhou, MD
Dean W. Ziegler, MD
200
Educational
Sessions
AL
T DE
BES
All available audio from the 2014 AAOS Annual Meeting - $199
Single session - $25 each
Orthopaedic Review Course - $49
All available audio from the 2014 AAOS Annual Meeting - $249
Single session - $35 each
Orthopaedic Review Course - $59
Tuesday
8:00 AM 6:00 PM
Wednesday Friday 7:00 AM 6:00 PM
Saturday
7:00 AM 3:00 PM
440 In Memoriam
Member Name
Member Name
George S. E. Aitken, MD
2/13/12
Durham, NC
J. Bruce Galloway, MD
5/9/09
Asheville, NC
S. William Allred MD
3/5/13
James A. Ghadially, MD
8/11/12
Houston, TX
Dayton, OH
Robert G. Gitchell, MD
12/18/12
Ames, IA
In Memoriam
Unknown
Franklin Glockner, MD
3/23/11
Hinsdale, MA
George N. Austin, MD
2/8/07
Alexandria, VA
2/1/13
Tucson, AZ
Frederick L. Behling, MD
7/10/13
Portola Vally, CA
George D. Griffin, MD
6/1/12
Palo Alto, CA
Mordecai E. Berkowitz, MD
7/7/13
Gloucester, MA
Kevin D. Harrington, MD
1/7/13
Mill Valley, CA
Frank A. Bersani, MD
3/14/13
Skaneateles, NY
Arthur R. Hartwig, MD
11/14/11
Woodside, CA
Dan R. Bigelow, MD
1/20/12
Felix Heimberg, MD
1/4/13
Lunenburg, MA
Herbert E. Block, MD
1/9/13
Fort Worth, TX
Harry N. Herkowitz, MD
6/7/13
West Bloomfield, MI
Thomas A. Brady, MD
April 2011
Richland, MI
5/28/13
Birmingham, AL
Michael A. Browne, MD
1/5/13
Jupiter, FL
Daniel T. Hinkin, MD
8/5/13
Manhattan, KS
F. Robert Brueckmann, MD
8/20/12
Zionsville, IN
Janaleigh Hoffman, MD
8/25/12
Fremont, CA
Frank S. Bryan, MD
2/18/12
Carlisle, PA
Eugene D. Horrell, MD
10/14/13
Spearfish, SD
J. W. Burnett, MD
5/23/13
Crystal, MN
10/27/12
Littleton, NH
6/20/12
New Orleans, LA
David M. Huibregtse, MD
9/2/13
Janesville, WI
Ruben D. Cabrera, MD
2004
Burke, VA
James M. Hunter, MD
2/16/13
Birchrunville, PA
John N. Callander, MD
6/9/13
San Francisco, CA
Willard S. Hunter, MD
11/21/12
Tempe, AZ
Robert W. Carson, MD
12/22/12
Woodside, CA
Arnold M. Illman, MD
9/20/13
Massapequa, NY
Bennett W. Caughran, MD
1/20/13
Chattanooga, TN
Perry D. Inhofe, MD
11/10/13
Tulsa, OK
Harold H. Chakales, MD
12/13/11
Houston, TX
Paul J. Jorden, MD
4/28/13
Wheaton, IL
D. Robert Chapman, MD
1/28/13
Winnsboro, TX
Arthur D. Kassel, MD
Unknown
Novato, CA
Ronald S. Chassner, MD
5/15/13
Miami, FL
1/18/12
Petaluma, CA
6/24/13
La Jolla, CA
Richard E. Kendrick, MD
11/29/12
Modesto, CA
Bennie J. Clayburgh, MD
1/21/13
Grand Forks, ND
Kenneth W. Kengla, MD
1/7/13
Newport Beach, CA
Jonathan Cohen, MD
2003
Brighton, MA
Daryl L. Kirkby, MD
Unknown
Phoenix, AZ
Michael Collopy, MD
4/16/13
Brookfield, WI
Richard M. Klaus, MD
12/20/12
Atlanta, GA
Thomas G. Colmey, MD
9/19/12
River Forest, IL
Crown Point, IN
William B. Comai, MD
1/23/13
Battle Creek, MI
Daniel F. Klinar, MD
6/6/13
Kingsport, TN
Ray W. Covington, MD
5/14/13
Waco, TX
Thomas A. Koenig, MD
8/23/13
Northport, NY
Scranton, PA
Alfred E. Kristensen, MD
9/10/13
Jacksonville, FL
Tore Dalen, MD
Unknown
Sundsvall, SWE
Melvin G. Kunkel, MD
2/1/13
Kenneth R. Duff, MD
1/28/10
New Braunfels, TX
Howard A. Kurzner, MD
3/26/09
Miami, FL
Thomas S. Dunstan, MD
10/19/12
Ludington, MI
Unknown
Ventura, CA
Selim F. El-Attrache, MD
7/24/13
Mount Pleasant, PA
Joseph T. Leach, MD
2/2/11
Columbus, OH
Charles H. Emich, MD
5/21/13
Alexandria, VA
Ralph T. Lidge, MD
1/26/13
Barrington, IL
Gregory M. Engel, MD
12/6/12
Bellevue, WA
Robert F. Lindberg, MD
4/30/13
Ketchum, ID
Jerry E. Enis, MD
8/14/13
Miami, FL
Robert C. Lockwood, MD
6/1/12
Marcellus, NY
Jaime Escorcia, MD
7/1/13
Bogota, COL
Unknown
Greenacres, WA
Philip M. Evanski, MD
7/29/13
New Hope, PA
Douglas B. Mains, MD
12/9/13
Wheaton, IL
4/10/10
Sacramento, CA
Joseph R. Mariotti, MD
10/5/13
Pinole, CA
1/19/13
Warm Springs, GA
David A. McQueen, MD
2/25/13
Wichita, KS
Gael R. Frank, MD
8/26/12
Kansas City, MO
Ronald K. Miller, MD
1/11/12
Council Bluffs, IA
Richard M. Fry, MD
1/23/13
Gainesville, FL
12/4/11
Anchorage, AK
7/7/13
Altoona, PA
William B. Moore, MD
2012
Santa Fe, NM
William R. Fuqua, MD
8/30/12
Owensboro, KY
Page W. Nelson, MD
4/2/13
Pearland, TX
In Memoriam
441
Member Name
Member Name
William H. Newman, MD
12/28/12
Chicago, IL
Gregory H. Schwab, MD
8/22/13
San Diego, CA
Harold H. Niekamp, MD
1/17/12
Houghton Lake, MI
7/23/12
Atlanta, GA
Jay Nogi, MD
3/21/13
Glen Allen, VA
Harold F. Shuster, MD
2004
Bozman, MD
Fridtjof E. Nussbaumer, MD
12/10/12
Fayetteville, NY
Gene R. Smith, MD
2/27/13
San Antonio, TX
Calvin M. Oba, MD
1/29/13
Scottsbluff, NE
4/2/13
Bethlehem, PA
Robert W. Palmer, MD
5/20/13
Gaithersburg, MD
4/14/13
Canandaigua, NY
Richard F. Pawlowski, MD
Unknown
Scottsdale, AZ
Martin L. Sorger, MD
5/5/13
Montclair, NJ
Maurice F. Perll, MD
1/6/12
Mexico, MO
5/23/13
Mount Dora, FL
Jacquelin Perry, MD
3/11/13
Downey, CA
Mark A. Taylor, MD
Gregory A. Peters, MD
7/20/12
Grand Rapids, MI
Clifford H. Turen, MD
1/16/13
Dover, DE
Rudolf A. Pyka, MD
1/23/13
Redlands, CA
Clifford G. Vernick, MD
2/12/13
Santa Fe, NM
3/29/13
Sausalito, CA
Charles E. Vilmer, MD
5/11/12
Polo, MO
1/4/13
Hamilton, OH
Unknown
Charleston, SC
George I. Raybin, MD
4/11/13
Pilesgrove, NJ
Donald R. Watson, MD
12/8/13
Las Cruces, NM
Thomas A. Redden, MD
7/21/12
11/1/12
Englewood, CO
Phil A. Webb, MD
Henderson, NV
Sonora, CA
Grand Forks, ND
12/3/12
Las Vegas, NV
1/17/13
Greenville, SC
Alan H. Wilde, MD
5/25/12
Broadview Heights, OH
J. Howard Ritchie, MD
2013
Lawrence H. Wilk, MD
5/31/13
Corpus Christi, TX
Thomas D. Rizzo, MD
11/2/10
Sea Island, GA
Jack L. Winters, MD
8/11/13
Metairie, LA
Noel B. Rogers, MD
5/25/11
Jacksonville, NC
E. Paul Woodward, MD
3/2/03
San Diego, CA
12/30/10
Fairport, NY
Richard N. Wrenn, MD
Unknown
Charlotte, NC
Charles J. Ruth, MD
2/7/11
Fremont, CA
Henry A. Yancey, MD
10/17/13
Richmond, VA
Alvina O. Sabanas, MD
1/8/08
Peoria, AZ
Lewis A. Yocum, MD
5/25/13
Los Angeles, CA
Joseph Schlonsky, MD
9/30/12
New Albany, OH
In Memoriam
Santa Monica, CA
442
STANDARDS OF PROFESSIONALISM
Orthopaedic Surgeon-Industry Relationships
Mandatory Standards:
6. An orthopaedic surgeon shall decline subsidies or other
financial support from industry, except that an orthopaedic
surgeon may accept non-monetary items which benefit
patients or serve an educational function and which have a
fair market value of less than $100.
7. An orthopaedic surgeon who has influence in selecting a
particular product or service for an entity shall disclose any
relationship with industry to colleagues, the institution and
other affected entities.
8. An orthopaedic surgeon shall disclose to the patient any
financial arrangements with industry that relate to the
patients treatment, including the receipt of inventor royalties,
stock options or paid consulting arrangements with industry.
9. An orthopaedic surgeon shall accept no direct financial
inducements from industry for utilizing a particular product
or for switching from one manufacturers product to another.
10. An orthopaedic surgeon shall enter into consulting
agreements with industry only when such arrangements are
established in advance and in writing to include evidence:
443
Course
Handouts!
The Four Most Common Types of Cartilage Damage You Will See
in Practice: How We Treat Them and Why (#353)
Rotator Cuff Repair 2014: Current Principles and New Dimensions (#249)
Innovative Techniques in Revision Total Hip Arthroplasty (#301)
And hundreds more!
AAOS Members: Just $55 on-site (or $75 post-meeting), get your flash drive
with more than 200 Instructional Course Handouts plus:
All of the new Technical Skills Courses
Getting Ready for ICD-10 #308
Each individual Course Handout PDF: $15 (Available On-Site Only)
Tuesday:
Wednesday Friday:
Saturday:
8:00 AM 6:00 PM
7:00 AM 6:00 PM
7:00 AM 3:00 PM
SAVE
Get ready to go digital in 2015! Next year, all course handouts will be available only in electronic formats. Print handouts will not be available.
Participants
Index
Index
446
Aguilar, Dino............................... 84
Ahlmann, Elke R....................... 182
Ahmad, Christopher S.... 57, 60-61,
83, 106, 159, 178, 204, 273, 278
Ahmad, Jamal....... 44, 79, 109-110
Ahmad, Mudussar.................... 152
Ahmadinia, Kasra..................... 100
Ahmed, Iftikhar......................... 111
Ahn, Jaimo................ 272, 295-296
Ahn, Jeonghoon....................... 257
Ahn, Jiyong............... 110, 124, 264
Ahn, Tae Keun.. 110, 124, 264, 266
Ahrens, Will.............................. 103
Ahsan, Zahab............................. 87
Aibinder, William....................... 262
Aichmair, Alexander................. 281
Aivaz, Marudeen...................... 257
Ajibade, David.......................... 293
Akada, Takanori........................ 287
Akamnonu, Chibuikem............. 157
Akbar, Michael.......................... 257
Akbarnia, Behrooz A...... 78, 89-90,
156
Ake, Christopher F................... 162
Akeda, Koji............................... 170
Akers, Kevin.............................. 294
Akesson, Kristina...................... 212
Akhavan, Sam.................. 144, 208
Akhtar, Kashif........................... 212
Akinleye, Sheriff D.................... 298
Akita, Keiichi............................... 58
Akram, Usman.......................... 125
Al, Shafic S-Nammari................. 66
Alaia, Michael J........................ 239
Alas, Veronica........................... 145
Albanese, Anthony................... 123
Albanese, Stephen A................ 158
Albers, Christoph E.................. 244
Albert, Todd J.. 46, 54, 75, 77, 149,
174, 215
Aleem, Alexander W................. 269
Alentado, Vincent...................... 143
Alexander, Jerry W................... 205
Alexander, Jerry W.................... 205
Alexiades, Michael M.......... 55, 243
Alhajajra, Fadi Y........................ 154
Aliani, Davide........................... 225
Alizadehkhaiyat, Omid.. 61, 84, 203
Allen, Benjamin J...... 278, 280, 290
Allison, Daniel C....................... 182
Allison, Jeroan.......... 117, 235, 256
Almagro, Marco........................ 203
Al-Nammari, Shafic S................. 66
Alobaidaan, Raed M................. 169
Alolabi, Bashar................... 62, 177
Alonso, Jorge............................ 154
Alosh, Hasson.......................... 263
117, 289
Bendo, John A............................ 54
Benevenia, Joseph.... 45, 159, 182,
236
Benghuzzi, Hamed........... 231, 280
Bengs, Benjamin C................... 213
Benhaim, Prosper..................... 106
Benito Del Carmen, Felipe ..... 218,
222, 228
Benke, Michael T........................ 85
Benneker, Lorin M.................... 153
Benner, Rodney W................... 293
Bennett, James T....................... 89
Bennett, Monica....................... 213
Benninger, Emanuel................. 193
Benson, Leon S........................ 308
Benson, Michael....................... 288
Benton, Edward G.................... 178
Berbari, Elie................................ 64
Berber, Reshid.................. 230, 248
Berberian, Wayne S.......... 186, 194
Berend, Keith R.75, 105, 126, 160,
210, 223, 227, 229, 231
Berend, Michael E....... 56, 94, 105,
160, 207, 252, 264
Berger, Aaron J........................... 92
Berger, Richard A............. 105, 122
Bergeron, Stephane................. 272
Bergmann, Karl.......................... 72
Bergstrom, Ulrica........................ 85
Berkes, Marschall B........... 65, 189
Berkowitz, Eric N.............. 106, 116
Berkowitz, Mark J..................... 136
Berlet, Gregory C......... 82, 94, 193
Berli, Martin.............................. 265
Berman, Michael...................... 289
Bernardes, Adilio...................... 203
Bernasek, Thomas L........ 201, 206
Bernstein, Richard A................ 148
Bernthal, Nicholas............ 151-152,
181-182, 303
Berry, Daniel J.59, 64, 70, 82, 104,
117, 121, 138, 140, 247, 251, 253
Berryman, Fiona....................... 175
Bershadsky, Boris..................... 274
Bert, Jack M............. 126, 174, 186
Bert, Timothy M........................ 113
Bertelsen, Alexander................ 279
Berven, Sigurd H............. 67, 78-79
Bess, Robert S..... 77-79, 127, 137,
173, 282, 286
Bessiere, Charles..................... 225
Betti, Emanuele........................ 271
Bettin, Clayton C......................... 80
Betz, Randal R................. 158, 283
Bevan, Wesley P....................... 115
Bevevino, Adam.78, 100, 280, 283,
Index
447
Index
448
297
Bhandari, Mohit.................. 75, 272
Bhatia, Sanjeev......... 226-228, 240
Bhattacharyya, Timothy............ 163
Bianchi, Arnaud........................ 303
Bianco, Kristina.... 87, 156, 282-283
Biau, David J............................ 245
Bible, Jesse E............. 72, 191, 281
Bichara, David A....................... 211
Bicknell, Ryan T........................ 279
Bierman, Arlene......................... 56
Biggers, Marcus D.............. 99, 113
Bigoni, Marco............................. 99
Bilgen, mer F........................... 96
Billi, Fabrizio............................. 151
Billig, Jessica I.......................... 301
Bills, Paul J............................... 176
Binder, Nikolaus B.................... 154
Bindra, Randipsingh......... 219, 228
Bing, Xinyu............................... 301
Bingham, Joshua...................... 262
Bini, Stefano A..... 47, 84, 115, 129,
138, 163, 257
Bircher, Martin.......................... 152
Bird, Justin.......................... 84, 302
Birnbaum, Jacqueline F.... 189, 297
Bishop, Allen T.......................... 267
Bishop, Julie Y........................... 202
Bishop, Julius A.......... 61, 145, 296
Bisicchia, Salvatore.......... 220, 228
Bisseling, Pepijn....................... 250
Bjerke, Benjamin-Kroll.............. 140
Bjerke, Brian P........................... 57
Black, Eric M............................. 178
Black, Kevin P........................... 144
Blaine, Theodore A..................... 60
Blair, James A.......................... 233
Blaisdell, Gregory Y.................. 152
Blakemore, Laurel C............. 59, 76
Blanc, Guillaume...................... 210
Blanchard, Char....................... 121
Blanck, Ryan.................... 124, 233
Bland, J Martin......................... 298
Blank, Alan T............................ 301
Blasier, R Dale............................ 49
Bliden, Kevin...................... 144-145
Blonna, Davide...... 58, 71, 85, 201,
217, 219, 222, 224, 228-229, 233
Bloom, Kevin J.......................... 140
Bloom, Tamir..................... 219, 228
Blount, Thomas........................ 281
Blum, Yossef C......................... 258
Bluman, Eric M................. 196, 266
Blumenfeld, Thomas J....... 44, 128,
256
Blumenthal, Stephan................ 155
Blumstein, Gideon W................ 269
Index
Butler, Bennet............................. 92
Butler, Susan M-Wu................. 279
Bye, Angela N........................... 133
Bylski, Donita-Austrow.............. 156
Byrd, J.W. Thomas .. 107, 135, 147,
174, 186, 226, 229
Byrne, Daniel.............................. 59
Byun, David J........................... 168
Cabanela, Miguel E............ 60, 231
Cabezas, Andres F................... 279
Caccavallo, Pete....................... 185
Cadossi, Matteo............... 223, 228
Caetano, Edie........................... 203
Cafri, Guy.......... 70, 129, 138, 164,
188, 257
Cagan, Amanda............... 191, 286
Cage, Jason M......................... 287
Cahill, Catherine W................... 188
Cahill, Patrick J..... 44, 76, 158, 191
Cai, Jenny................................ 119
Cain, Christopher M.................. 281
Cain, E. Lyle............................... 54
Caird, Michelle S...................... 134
Caizzi, Gianni........................... 123
Cakmak, Selami............... 199, 211
Calabr, Teresa......... 104, 182-183
Calamelli, Carlotta............ 224, 235
Calderaro, Cosma........... 221, 225,
228-229, 287, 297
Caldwell, Lindsey...................... 114
Calfee, Ryan P........... 91, 149, 167
Callaghan, John J.......... 59, 82, 94,
104, 108, 133-134, 138, 201, 207,
247-248, 257, 272
Callahan, Charles D.................. 105
Callahan, Michael F.................. 103
Callanan, Mark C...................... 279
Callary, Stuart A............... 108, 139
Cal, Michel Jean..................... 219
Calvert, Graham............... 215, 282
Camacho, Pilar......................... 273
Cameron, Alexander............. 63-64
Cameron, John C................. 71, 96
Cameron, Kenneth L........... 99, 165
Camisa, William.78, 133, 214, 274,
276
Cammisa, Frank P.................... 281
Camp, Christopher L................ 225
Campbell, Abigail..................... 210
Campbell, John D..................... 144
Campbell, Kevin J.... 208, 265, 275,
293
Campbell, Kirk A....................... 248
Campbell, Patricia A................. 175
Campi, Fabrizio.................. 99, 292
Campi, Stefano........................... 99
Campochiaro, Gabriele............ 219
449
Index
450
Index
201
Deitch, Sandy............................. 59
Dejour, David.................... 116, 173
Dekutoski, Mark B.................... 186
Del Din, Rainero .............. 224, 229
Del Gaizo, Daniel J .................. 264
Del Rossi, Gianluca ................. 291
Deland, Jonathan T............ 80, 234
Delaney, Ruth A.......................... 86
Delanois, Ronald E................... 244
Delgado, Alberto......................... 50
Dell, Richard......................... 49, 52
Dell, ShelleyOrfano.................. 183
Della Rocca, Gregory J ........... 294
Della Valle, Alejandro Gonzalez ....
129, 242, 260, 263
Della Valle, Craig J ........................
43, 48, 82, 93, 105, 115, 138, 183,
195, 206, 230-231, 246, 248, 252,
260
Della Villa, Stefano .................. 142
Deluce, Simon R........................ 62
Demehri, Shadpour.......... 266, 292
DeMeo, Patrick J...................... 208
Demetracopoulos, Constantine.265
DeMill, Shyler L........................ 193
Demura, Satoru........ 169, 281, 284
Denard, Patrick J................ 85, 274
Denaro, Vincenzo.................. 98-99
Denehy, Kevin M....................... 233
Deng, Xiang-Hua.............. 143, 293
Dennis, Douglas A..... 68, 104, 255,
264
Dennison, David G............ 121-122
DeOrio, James K....... 194, 264-265
Deranlot, Julien........................... 85
Derman, Peter... 133, 151-152, 270
Dervan, Elizabeth E.................. 204
Dervin, Geoffrey F.......... 44, 88, 95
Desai, Pingal A......................... 182
Desai, Sagar....................... 70, 111
Deshmane, Prashant P............ 256
Deshmukh, Ajit J...................... 256
DeSmet, Koen A....... 175-176, 245,
251
Dettoni, Federico........ 97, 224, 229
Devereaux, Moira....................... 61
Devin, Clinton J.. 76, 115, 191, 281
Deviren, Vedat............... 78-79, 282
Devito, Dennis P......................... 89
Dewing, Christopher B............. 165
Deyer, Timothy W..................... 111
Dhand, Sabeen........................ 250
Dhooge, Yon FA........................ 266
Di Martino, Alessandro ...... 58, 292
Di Matteo, Berardo ............ 58, 292
Di Primio, Gina ........................ 302
Di Prun, Nicola Barbasetti ...... 201,
233
Di Sanzo, Vincenzo . 225, 228, 297
Di Sette, Priscilla ..... 221, 229, 259
451
Index
452
Index
453
454
Index
Hussain, Mohammed................. 63
Hussey, Kristen................... 98, 143
Hutchinson, Mark R.................... 58
Hutt, Jonathan R...................... 152
Hutzler, Lorraine... 87-88, 146, 213,
238, 248
Hwang, Bo-Hyun...................... 261
Hwang, Katherine..................... 139
Hyer, Christopher..................... 193
Hyman, Joshua E............... 88, 198
Hyzy, Sharon L......................... 286
Iannotti, Joseph P........ 60, 68, 147,
161, 177, 207, 260, 274, 278
Iannuzzi, James C.................... 202
Ibarra, Clemente....................... 143
Ibarra, Luis G............................ 143
Iborra, Alvaro............ 218, 222, 228
Ichiseki, Toru............................. 242
Igarashi, Kentaro....... 102, 301-302
Ike, Hiroyuki.............................. 253
Ikebuchi, Mitsuhiko................... 261
Ikeguchi, Ryosuke.................... 267
Ikuta, Kunihiro........................... 301
Ilgenfritz, Ryan M....................... 89
Illical, Emmanuel...................... 245
Ilyas, Asif M...................... 267, 305
Imam, Mohamed A................... 278
Imanishi, Takao......................... 170
Imatani, Junya............................ 58
Imbriglia, Joseph E...... 44, 88, 167,
198
Imbuldeniya, Arjuna M.............. 201
Imrie, Sussanna....................... 139
Inaba, Yutaka............................ 253
Inacio, Maria CS...... 129, 138, 162,
163, 178, 200, 204, 247, 257, 287
Incavo, Stephen J.... 119, 183, 218,
229, 250, 254
Indrekvam, Kari........................ 107
Inglis, Grahame S..................... 108
Ingoe, Helen............................. 298
Innocenti, Bernardo.... 96, 235, 264
Inoue, Daisuke.................. 252, 290
Inoue, Nozomu................. 214, 280
Inoue, Shinichi.................... 79, 281
Inui, Atsuyuki............................ 277
Iobst, Christopher A.................. 126
Iorio, Carlo................ 166, 190, 199
Iorio, Raffaele........... 221, 229, 259
Iorio, Richard........ 87-88, 118, 196,
198, 238, 273
Irgit, Kaan................................... 64
Iriberri, Iker............................... 278
Irrgang, James J....................... 239
Irwin, Todd A....................... 83, 134
Ishiguro, Naoki........... 102, 301-302
Ishii, Takayoshi................. 169, 284
Index
455
Index
456
Index
457
Index
458
Index
459
Index
460
195
Matsuda, Shuichi............... 266-268
Matsumine, Akihiko.................. 303
Matsumoto, Hiroko............. 88, 198
Matsumoto, Tadami.................. 242
Matsumoto, Tomoyuki.72, 204, 301
Matsuo, Kosuke........................ 302
Matsushita, Akinobu................. 192
Matsushita, Takehiko.......... 72, 204
Matsusue, Yoshitaka................. 110
Mattei, Lorenzo......................... 233
Matthies, Ashley............... 176, 248
Mattila, Ville.............................. 204
Matzon, Jonas L......................... 98
Mauck, Benjamin M.................... 99
Mauffrey, Cyril............... 47, 75, 294
Mauler, Flavien......................... 265
May, Keith................................. 204
Mayer, Annyce.......................... 255
Mayer, Eric A............................ 285
Mayerson, Joel......................... 138
Mayman, David J...... 211, 243, 260
Mayne, Ian.......................... 62, 273
Mayo, Meredith......................... 293
Mayor, Michael B...................... 211
Mazza, Daniele................. 221, 229
Mazza, Jason S........................ 305
Mazzotti, Antonio....... 224, 235-236
McAlister, Jeffrey E................... 193
McAllister, David R..................... 98
McAnany, Steven...................... 283
McAndrew, Christopher..... 65, 112,
145, 295
McAngus, Jillian K.................... 146
McAuley, James P...................... 57
McBirnie, Julie M...................... 156
McCabe, Lucy.......................... 167
McCalden, Richard W. 44, 57, 148,
253
McCann, Peter D........................ 54
McCarthy, Ian........................... 282
McCarthy, James J............. 47, 127
McCarthy, Joseph C......... 249, 288
McCarthy, Meagan M............... 155
McCarthy, Moira M............ 233, 240
McCarthy, Richard E.................. 90
McCarty, Eric C................ 149, 238
McCarty, Leroy P............... 156, 276
McCaslin, Michael.... 49, 52, 83, 94
McCauley, Julie C....................... 96
McClelland, Walter B................ 225
McClung, Anna................... 89, 270
McCormick, Frank..... 98, 143, 165,
221, 228, 238, 289-290
McCormick, Jeremy J... 54, 83, 265
McCormick, Kelly R.................... 80
McCulloch, Patrick C........ 206, 289
Index
461
Index
462
Index
463
Index
464
Index
465
Index
466
Index
467
Index
468
Index
469
Index
470
ATTENTION SUBMITTERS:
DISCLOSURE RULES
www.aaos.org/annual
EXPERIENCE
EXPERIENCE
UN I T E
PLATFORM SHOULDER SYSTEM
Every shoulder procedure provides unique challenges to the surgeon. That is why DePuy Synthes
At DePuy Synthes Companies, our solutions are defined by the people who inspire
Joint Reconstruction* created the GLOBAL UNITE Platform Shoulder Arthroplasty System,
a next generation platform system to provide the surgeon Principled Adaptability within the
providing the procedural support and services to help deliver more efficient outcomes.
Operating Room. When it comes to shoulder arthroplasty, were with you every step of the way.
When it comes to orthopaedic solutions, were with you every step of the way.
*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc. DePuy Synthes Joint Reconstruction, a division of DOI 2014
2014FinalProgram-8.5x10.875.indd 4
1/31/14 1:44 PM
2014FinalProgram-8.5x10.875.indd 2
1/31/14 2:47 PM
AAOS 2014
STABILITY IN MOTION. When it comes to knee replacement, were with you every step of the way.
AAOS Annual Meeting Booth 4049 March 1214, 2014
Annual Meeting
Introducing
Rotating
Platform
*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc. DePuy Synthes Joint Reconstruction, a division of DOI 2014
2014FinalProgram-8.5x10.875.indd 1
1/31/14 1:44 PM
FINAL PROGRAM